<SEC-DOCUMENT>0001903596-24-000045.txt : 20240131
<SEC-HEADER>0001903596-24-000045.hdr.sgml : 20240131
<ACCEPTANCE-DATETIME>20240131173052
ACCESSION NUMBER:		0001903596-24-000045
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		87
FILED AS OF DATE:		20240131
DATE AS OF CHANGE:		20240131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Expion360 Inc.
		CENTRAL INDEX KEY:			0001894954
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				812701049
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276663
		FILM NUMBER:		24584081

	BUSINESS ADDRESS:	
		STREET 1:		2025 SW DEERHOUND AVE
		CITY:			REDMOND
		STATE:			OR
		ZIP:			97756
		BUSINESS PHONE:		541 -797-6714

	MAIL ADDRESS:	
		STREET 1:		2025 SW DEERHOUND AVE
		CITY:			REDMOND
		STATE:			OR
		ZIP:			97756
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>xpon_s-1a.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:XPON="http://expion360.com/20230930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_XPON_expion360.com_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20230101_20230930 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DAmendmentDescription_This amendment is being filed to comply with regulations.  -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001894954 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:AmendmentFlag" id="ixv-21393">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:AmendmentDescription" id="ixv-21394">This amendment is being filed to comply with regulations.</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityCentralIndexKey" id="ixv-21395">0001894954</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl0083" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:LiabilityForSaleOfFutureRevenuesNet" contextRef="AsOf2022-12-31" id="xdx2ixbrl0089" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:NotesPayableCurrent1" contextRef="AsOf2022-12-31" id="xdx2ixbrl0092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0117" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0164" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0167" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0198" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0206" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:EffectOfInducedConversionOfDebt" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0211" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:EffectOfInducedConversionOfDebt" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0213" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForBuildingSignageValue" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0218" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0225" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesOne" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0239" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesTwo" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0253" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfDetachableWarrantsToLongTermDebt" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfDetachableWarrantsToLongTermDebt" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfWarrantsToUnderwriters" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0263" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfWarrantsToUnderwriters" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfWarrantsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfWarrantsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfOptionsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfOptionsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0275" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0278" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0279" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForIPOServicesAmount" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForIPOServicesAmount" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0300" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfStockOptions" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0304" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfStockOptions" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0306" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0310" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0312" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0314" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0315" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:AccruedInterestOnConvertibleNote" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InducedConversionOfConvertibleDebtExpense" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IncreaseInAllowanceForDoubtfulAccounts" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDeposits" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInCustomerDeposits" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IncreaseDecreaseInLiabilityForRefunds" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForProceedsFromProductiveAssets" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ProceedsFromSaleOfFutureRevenuesNetOfDiscount" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ConvertibleNotesAndAccruedInterestConvertedToCommonStock" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ReclassificationOfAccruedInterestToLongTermDebt" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ReclassificationOfModifiedConvertibleNoteToLongTermDebt" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfCommonStockInExchangeForPropertyAndequipment" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ReclassificationOfDepositToPropertyAndEquipment" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ConversionOfConvertibleNotesIntoCommonStock" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_ManufacturingEquipmentMember" id="xdx2ixbrl0629" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_QAEquipmentMember" id="xdx2ixbrl0633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_SeniorSecuredPromissoryNotesMember" id="xdx2ixbrl0686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableIndividualMember" id="xdx2ixbrl0700" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompanyMember" id="xdx2ixbrl0704" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl0716" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:LessNotePayableInDefaultPaid" contextRef="AsOf2022-12-31" id="xdx2ixbrl0720" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0760" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0761" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_custom_StockOptionsMember" id="xdx2ixbrl0844" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_custom_StockOptionsMember" id="xdx2ixbrl0846" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31_custom_StockOptionsMember" id="xdx2ixbrl0848" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" id="xdx2ixbrl0854" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" id="xdx2ixbrl0855" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" id="xdx2ixbrl0857" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" id="xdx2ixbrl0859" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" id="xdx2ixbrl0861" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" id="xdx2ixbrl0863" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:AggregateIntrinsicValueForfeited" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" id="xdx2ixbrl0865" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-12-31_custom_StockOptionsMember" id="xdx2ixbrl0873" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2022-12-31_custom_StockOptionsMember" id="xdx2ixbrl0881" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0923" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0924" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2022-12-31" id="xdx2ixbrl0964" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-12-31" id="xdx2ixbrl0973" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-12-31" id="xdx2ixbrl0974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-09-30" id="xdx2ixbrl1072" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl1073" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl1142" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl1147" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2022-07-012022-09-30" id="xdx2ixbrl1148" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl1150" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl1152" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:FranchiseTaxesRefund" contextRef="From2022-07-012022-09-30" id="xdx2ixbrl1168" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl1194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1195" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1208" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1215" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-04-012022-06-30" id="xdx2ixbrl1216" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1222" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1225" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1226" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:ProceedsReceivedFromExerciseOfWarrants" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1258" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl1270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1271" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UndistributedEarningsDiluted" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1284" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1289" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1290" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfWarrants" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfWarrants" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1306" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1308" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfRestrictedStockUnit" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:IssuanceOfRestrictedStockUnit" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1340" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl1353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:PaymentsOnLineofcreditAndShorttermRevolvingLoans" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:PaymentsOnLiabilityForSaleOfFutureRevenues" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl1416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1418" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:CashlessWarrantExercises" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl1449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="XPON:PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_RSUMember" id="xdx2ixbrl1596" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30_custom_ToolingAndMoldsMember" id="xdx2ixbrl1621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_custom_SeniorSecuredPromissoryNotesMember" id="xdx2ixbrl1676" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_SeniorSecuredPromissoryNotesMember" id="xdx2ixbrl1677" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_custom_NotePayableIndividualMember" id="xdx2ixbrl1684" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableIndividualMember" id="xdx2ixbrl1685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_custom_NotePayableFinanceCompanyMember" id="xdx2ixbrl1686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompanyMember" id="xdx2ixbrl1687" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_custom_NotePayableFinanceCompany1Member" id="xdx2ixbrl1688" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl1726" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl1731" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2022-07-012022-09-30" id="xdx2ixbrl1732" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2023-01-01to2023-09-30" id="xdx2ixbrl1733" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2022-01-012022-09-30" id="xdx2ixbrl1734" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="xdx2ixbrl1846" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="xdx2ixbrl1848" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="xpon-20230930.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_OfficeEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_OfficeEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ManufacturingEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ManufacturingEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_QAEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MaximumMember_custom_QAEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ToolingAndMoldsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_RSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:RSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:RSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OfficeFurnitureEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OfficeFurnitureEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ManufacturingEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ManufacturingEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_WarehouseEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_WarehouseEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_QAEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_QAEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ToolingAndMoldsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ToolingAndMoldsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SeniorSecuredPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeniorSecuredPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SeniorSecuredPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_NotesPayableToBanksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_NotesPayableToBanksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_NotesPayableToBanksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NotePayableCreditUnionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NotePayableCreditUnionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NotePayableCreditUnionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NotePayableSBAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NotePayableSBAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NotePayableSBAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NotePayableIndividualMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NotePayableIndividualMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NotePayableIndividualMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NotePayableFinanceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NotePayableFinanceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NotePayableFinanceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NotePayableFinanceCompany1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NotePayableFinanceCompany1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NotePayableFinanceCompany1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_GMFinancialMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_GMFinancialMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_GMFinancialMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePrice1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ExercisePrice1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePrice2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ExercisePrice2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePrice3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ExercisePrice3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ExercisePrice4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ExercisePrice4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_StockOptionsMember1100779328">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_UnrelatedToAnyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:UnrelatedToAnyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_OfficeFurnitureAndEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_srt_MaximumMember_custom_OfficeFurnitureAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_WarehouseEequipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEequipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_srt_MaximumMember_custom_WarehouseEequipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEequipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ToolingAndMoldsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_QAEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_srt_MaximumMember_custom_QAEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_OfficeFurnitureEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ManufacturingEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_WarehouseEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_QAEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ToolingAndMoldsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_SeniorSecuredPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_NotesPayableToBanksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_NotePayableCreditUnionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_NotePayableSBAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_NotePayableIndividualMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_NotePayableFinanceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_NotePayableFinanceCompany1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_GMFinancialMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ExercisePrice1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ExercisePricesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePricesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ExercisePrice2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ExercisePrice1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ExercisePrice3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ExercisePrice2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ExercisePrice4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ExercisePrice3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_ExercisePrice5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ExercisePrice4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_OptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:OptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_OptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:OptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_OptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:OptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_UnrelatedToAnyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:UnrelatedToAnyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894954</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As filed with the Securities and Exchange Commission
on January 31, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Registration No.&#160;333-276663</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>&#160;</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Amendment No. 1 to</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM&#160;S-1</b></span><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_905_edei--DocumentType_c20230101__20230930_zDBy4ywW6p6k" style="display: none"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:DocumentType" id="ixv-22936">S-1/A</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>UNDER</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>THE
SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="image_001.jpg" alt="Icon&#10;&#10;Description automatically generated" style="height: 84px; width: 80px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 24pt"><b><span id="xdx_906_edei--EntityRegistrantName_c20230101__20230930_zcnNM13FvVig"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityRegistrantName" id="ixv-22937">EXPION360
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20230101__20230930_zQRYrcgDTO88"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-22938">Nevada</ix:nonNumeric></span></b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3691</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20230101__20230930_zuUNdvzzRjv6"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="dei:EntityTaxIdentificationNumber" id="ixv-22939">81-2701049</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary Standard Industrial</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</span></td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation or Organization)</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification Code Number)</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2025 SW Deerhound Ave.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Redmond, OR 97756</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(541) 797-6714</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address,&#160;Including Zip Code, and Telephone Number,&#160;Including
Area Code, of Registrant&#8217;s Principal Executive Offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Corporation Service Company</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>112 North Curry Street</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Carson City, NV 89703</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(775) 684-5708</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name, address, including zip code, and telephone number,
including area code, of agent for service)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>Copies to:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Ryan C. Wilkins</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Amanda McFall</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Stradling Yocca Carlson &amp; Rauth LLP</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>660 Newport Center Drive, Suite 1600</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Newport Beach, CA 92660</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(949) 725-4000</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Approximate date of commencement of proposed sale
to the public: From time to time after this registration statement becomes effective.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If any of the securities being registered on this
Form&#160;are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933 check the following
box.&#160;&#9746;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If this Form&#160;is filed to register additional
securities for an offering pursuant to Rule&#160;462(b)&#160;under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If this Form&#160;is a post-effective amendment filed
pursuant to Rule&#160;462(c)&#160;under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&#160;&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If this Form&#160;is a post-effective amendment filed
pursuant to Rule&#160;462(d)&#160;under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&#160;&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is a
large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See
the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and
&#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 40%; padding-left: 0.25in; text-align: justify">Large accelerated filer</td>
<td style="width: 10%; text-align: justify">&#9744;</td>
<td style="width: 40%; text-align: justify">Accelerated filer</td>
<td style="width: 10%; text-align: justify">&#9744;</td></tr>
<tr style="vertical-align: top">
<td style="padding-left: 0.25in; text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="padding-left: 0.25in; text-align: justify"><span id="xdx_909_edei--EntityFilerCategory_c20230101__20230930_zD57MpKLiyO9"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-22940">Non-accelerated filer</ix:nonNumeric></span></td>
<td style="text-align: justify">&#9746;</td>
<td style="text-align: justify">Smaller reporting company</td>
<td style="text-align: justify"><span id="xdx_90C_edei--EntitySmallBusiness_c20230101__20230930_zmkgPFZXIIg4"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness" id="ixv-22941">&#9746;</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
<td style="padding-left: 0.25in; text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td colspan="2" style="text-align: justify">&#160;</td>
<td style="text-align: justify">Emerging growth company</td>
<td style="text-align: justify"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20230101__20230930_zTZstfWQ3At1"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany" id="ixv-22942">&#9746;</ix:nonNumeric></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided to Section&#160;7(a)(2)(B)&#160;of the Securities Act.&#160;<span id="xdx_902_edei--EntityExTransitionPeriod_c20230101__20230930_z62o3VaXIi6d"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod" id="ixv-22943">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>The Registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment, which
specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a)&#160;of the
Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission,
acting pursuant to said Section&#160;8(a), may determine. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"><b>SUBJECT TO COMPLETION, DATED JANUARY
31, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: red"><b>PRELIMINARY PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: red"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="image_001.jpg" alt="Icon&#10;&#10;Description automatically generated" style="height: 84px; width: 80px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXPION360 INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Up to 1,781,978 shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This prospectus relates to the resale, from time to
time, of up to 1,781,978 shares (the &#8220;Shares&#8221;) of common stock, <span style="color: #231F20">par value $0.001 per share (&#8220;Common
Stock&#8221;),</span> of Expion360 Inc. (the &#8220;Company,&#8221; &#8220;Expion360,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;)
by Tumim Stone Capital, LLC (&#8220;Tumim&#8221;), or its permitted transferees or other successors-in-interest (the &#8220;Offering&#8221;).
The Shares may be issued pursuant to a common stock purchase agreement, dated December 27, 2023, that we entered into with Tumim (the
&#8220;Equity Line Purchase Agreement&#8221;). See the sections of this prospectus titled &#8220;<i>The Equity Line Transaction</i>&#8221;
for a description of the Equity Line Purchase Agreement and &#8220;<i>Selling Stockholder</i>&#8221; for additional information regarding
Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim, or its permitted transferees or other successors-in-interest,
may offer and sell the Shares in a number of different ways and at varying prices, including through public or private transactions at
prevailing market prices, at prices related to prevailing market prices, or at privately negotiated prices. We provide additional information
about how Tumim may sell the Shares in the &#8220;<i>Plan of Distribution</i>&#8221; section on page 78 of this prospectus. Tumim
is an &#8220;underwriter&#8221; within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;). Tumim will pay or assume discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar expenses,
if any, incurred for the sale of the Shares. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred
in registering the Shares, including legal and accounting fees. No placement agent participated in this Offering. See the section of
this prospectus titled &#8220;<i>Plan of Distribution</i>&#8221; for additional information. References to &#8220;Tumim&#8221; in this
prospectus shall refer to any permitted transferees or other successors-in-interest to Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are not offering any shares of Common Stock for
sale under this prospectus and will not receive proceeds from the sale of the Shares by Tumim, if any. We are registering the offer and
resale of the Shares to satisfy contractual obligations owed by us to Tumim pursuant to the Equity Line Purchase Agreement and documents
ancillary thereto. Our registration of the Shares does not mean that Tumim will offer or sell any of the Shares. If the 1,781,978 Shares
offered by Tumim under this prospectus were issued and outstanding as of the date hereof, such Shares would represent, as of the date
hereof, approximately 25.5% of the total number of shares of our Common Stock outstanding as of January 12, 2024, and approximately 33.3%
of the total number of outstanding shares of our Common Stock held by&#160;non-affiliates as of January 12, 2024. Any Shares resold hereunder
will have been issued by us and acquired by Tumim prior to such resale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Common Stock is listed on The Nasdaq Capital Market
(&#8220;Nasdaq&#8221;) under the symbol &#8220;XPON.&#8221; On January 22, 2024, the last reported sale price of our Common Stock on Nasdaq
was $4.37 per share. We are an &#8220;emerging growth company&#8221; as that term is used in the Jumpstart Our Business Startups Act of
2012 (the &#8220;JOBS Act&#8221;) and, as such, have elected to comply with certain reduced public company reporting requirements for
this prospectus and future filings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Investing in our Common Stock is speculative
and involves a high degree of risk. See the section of this prospectus titled &#8220;<i>Risk Factors</i>&#8220; beginning on page
9 for a discussion of information that should be considered in connection with an investment in our Common Stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Neither the Securities and Exchange Commission
(the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>The date of this prospectus is&#8239;&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;,
2024.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: Red"><b>The information in this
prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities
and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy
these securities in any state where the offer or sale is not permitted.&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>TABLE OF CONTENTS<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup></sup></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b><span style="text-decoration: underline">Page</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 90%; text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">ABOUT THIS PROSPECTUS</a></span></td>
<td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">MARKET, INDUSTRY, AND OTHER DATA</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">PROSPECTUS SUMMARY</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">THE OFFERING</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">SECURITIES OFFERED</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">RISK FACTORS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">USE OF PROCEEDS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">DETERMINATION OF OFFERING PRICE</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">MARKET INFORMATION AND DIVIDEND POLICY</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">DILUTION</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">BUSINESS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">MANAGEMENT</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015">EXECUTIVE COMPENSATION</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">SELLING STOCKHOLDER</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">DESCRIPTION OF CAPITAL STOCK</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">PLAN OF DISTRIBUTION</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">THE EQUITY LINE TRANSACTION</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF OUR COMMON STOCK</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023">LEGAL MATTERS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in">87<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">EXPERTS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_026">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -0.25in; padding-top: 0in; padding-bottom: 0in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</a></span></td>
<td style="text-align: right; padding-top: 0in; padding-bottom: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_001"></span>ABOUT THIS PROSPECTUS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This prospectus is part of a Registration Statement
on Form&#160;S-1 (as amended from time to time, the &#8220;Registration Statement&#8221;), pursuant to which Tumim may offer and
sell the Shares in a number of different ways and at varying prices, including through public or private transactions at prevailing market
prices, at prices related to prevailing market prices, or at privately negotiated prices from time to time in one or more offerings as
described in this prospectus. We will not receive any of the proceeds from such sales of our Common Stock by Tumim. Tumim will pay or
assume discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar expenses, if any, incurred for the sale
of the Shares. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred in registering the Shares,
including legal and accounting fees. See the section of this prospectus titled &#8220;<i>Plan of Distribution</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may also file a prospectus supplement or post-effective
amendment to the Registration Statement of which this prospectus forms a part that may contain material information relating to this Offering.
The prospectus supplement or post-effective amendment may also add, update or change information contained in this prospectus. If there
is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment,
you should rely on the prospectus supplement or post-effective amendment, as applicable. Before purchasing any Shares, you should carefully
read this prospectus, any post-effective amendment, and any applicable prospectus supplement, together with the additional information
described in the &#8220;<i>Where You Can Find More Information</i>&#8221; section of this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Neither we nor Tumim has authorized anyone to provide
you with any information or to make any representations other than those contained in this prospectus, any post-effective amendment, or
any applicable prospectus supplement prepared by or on behalf of us or to which we have referred you. We and Tumim take no responsibility
for, and can provide no assurance as to the reliability of, any other information that others may give you. We and Tumim will not make
an offer to sell the Shares in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing
in this prospectus, any post-effective amendment and any applicable prospectus supplement to this prospectus is accurate only as of the
date on its respective cover. Our business, financial condition, results of operations and prospects may have changed since those dates.
This prospectus contains, and any post-effective amendment or any prospectus supplement may contain, market data and industry statistics
and forecasts that are based on independent industry publications and other publicly available information. Although we believe these
sources are reliable, we do not guarantee the accuracy or completeness of this information and we have not independently verified this
information. In addition, the market and industry data and forecasts that may be included in this prospectus, any post-effective amendment
or any prospectus supplement may involve estimates, assumptions and other risks and uncertainties and are subject to change based on various
factors, including those discussed in the &#8220;<i>Risk Factors</i>&#8221; section of this prospectus, any post-effective amendment and
the applicable prospectus supplement. Accordingly, investors should not place undue reliance on this information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_002"></span>MARKET, INDUSTRY, AND OTHER DATA</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Market data and certain industry data and forecasts
used throughout this prospectus were obtained from internal Company surveys, market research, consultant surveys, publicly available information,
reports of governmental agencies, and industry publications, articles, and surveys. Industry surveys, publications, consultant surveys,
and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable, but the accuracy
and completeness of such information is not guaranteed. We have not independently verified any of the data from third-party sources, nor
have we ascertained the underlying economic assumptions relied upon therein. Similarly, internal surveys, industry forecasts, and market
research, which we believe to be reliable based on our management&#8217;s knowledge of the industry, have not been independently verified.
Forecasts are particularly likely to be inaccurate, especially over long periods of time. Statements as to our market position are based
on the most currently available data. While we are not aware of any misstatements regarding the industry data presented in this prospectus,
our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the
headings &#8220;<i>Risk Factors</i>&#8221; and &#8220;<i>Cautionary Note Regarding Forward-Looking Statements</i>&#8221; in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The sources of certain statistical data, estimates,
and forecasts contained in this prospectus are provided below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clean Energy Group, <i>Report
Shows Strong Solar + Storage Market Growth&#8230;and Plenty of Room For Improvement</i>, August 2021.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumer Affairs, <i>How many
U.S. homes have solar panels?</i>, November 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expert Market Research, <i>Global
Recreational Vehicle Market Outlook</i>, January 2024.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global Market Insights, <i>U.S.
Electric Vehicle Market Size</i>, August 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The International Market Analysis
Research and Consulting Group (&#8220;IMARC&#8221;), <i>Lithium-ion Battery Market Report</i>, March 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Markets and Markets, <i>Global
Battery Energy Storage Systems Market</i>, February 2022.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and Markets, <i>Global
Electric Vehicle Market Size, Share &amp; Trends Analysis Report</i>, November 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>




<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_003"></span>PROSPECTUS SUMMARY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>This summary provides a brief overview of the key
aspects of our business and our securities. The reader should read the entire prospectus carefully, especially the risks of investing
in our securities discussed under the section of this prospectus titled </i>&#8220;<i>Risk Factors.</i>&#8221; <i>Some of the statements
contained in this prospectus, including statements under this section and </i>&#8220;<i>Risk Factors,</i>&#8221; <i>are forward-looking
statements and may involve a number of risks and uncertainties. Our actual results and future events may differ significantly based upon
a number of factors. The reader should not put undue reliance on the forward-looking statements in this document, which speak only as
of the date on the cover of this prospectus. See the section of this prospectus titled </i>&#8220;<i>Cautionary Note Regarding Forward-Looking
Statements.</i>&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Overview </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 focuses on the design, assembly, manufacturing,
and sales of lithium iron phosphate (&#8220;LiFePO4&#8221;) batteries and supporting accessories for recreational vehicles (&#8220;RVs&#8221;),
marine applications and recently announced our expansion into home energy storage products with plans to expand into industrial applications.
We design, assemble, and distribute high-powered, lithium battery solutions using ground-breaking concepts with a creative sales and marketing
approach. We believe that our product offerings include some of the most dense and minimal-footprint batteries in the RV and marine industries.
We are developing the e360 Home Energy Storage, a system that we expect to significantly change the industry in barrier price, flexibility,
and integration. We are deploying multiple intellectual property strategies with cutting-edge research and unique products to sustain
and scale the business. We currently have customers consisting of dealers, wholesalers, private label customers and original equipment
manufacturers who are driving revenue and brand awareness nationally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our corporate headquarters are based in Redmond, Oregon,
with assembly in the United States and suppliers based in Asia. We are currently in the process of building out manufacturing capacity
at our corporate headquarters. Our long-term target is to onshore the manufacturing of most of our components and assemblies, including
cell manufacturing, to the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our main target markets are currently the RV and marine
industries. We believe that we are well positioned to capitalize on the rapid market conversion from lead-acid to lithium batteries as
the primary method of power sourcing in these industries. Additional focus markets include home energy storage with our introduction of
two LiFePO4 battery storage solutions, where we aim to provide a cost-effective, low barrier of entry, flexible system for those looking
to power their homes via solar energy, wind, or grid back-up. Along with RV, marine and home energy storage markets, we aim to provide
additional capacities to the ever-expanding electric forklift and industrial material handling markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360&#8217;s e360 product line, which is manufactured
for the RV and marine industries, was launched in December 2020. The e360 product line, through its rapid sales growth, has shown to be
a preferred conversion solution for lead-acid batteries. In December 2023, we announced our entrance into the home energy storge market
with our introduction of two premium LiFePO4 battery storage solutions that enable residential and small business customers to create
their own stable micro-energy grid and lessen the impact of increasing power fluctuations and outages. We believe that our e360 Home Energy
Storage system has strong revenue potential with recurring income opportunities for us and our associated sales partners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our products provide numerous advantages for various
industries that are looking to migrate to lithium-based energy storage. They incorporate detailed-oriented design and engineering and
strong case materials and internal and structural layouts, and are backed by responsive customer service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Recent Developments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, John Yozamp retired as our Chief
Business Development Officer. In connection with Mr. Yozamp&#8217;s retirement, the Company and Mr. Yozamp entered into: (i) a consulting
agreement pursuant to which Mr. Yozamp has agreed to provide services as an independent sales representative for the Company for a period
of six months, subject to extension or earlier termination as provided for in the agreement, and (ii) a standard release agreement pursuant
to which Mr. Yozamp agreed to release certain claims against the Company.</p></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 6; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, we entered into a securities purchase
agreement (the &#8220;Note Purchase Agreement&#8221;) with 3i, LP (&#8220;3i&#8221;) pursuant to which we sold, and 3i purchased: (i)
a senior unsecured convertible note issued by the Company in the aggregate principal amount of $2,750,000, with an 10.0% original issue
discount and an interest rate of nine percent (9.0%) per annum (the &#8220;3i Note&#8221;), (ii) up to $247,500 in newly issued shares
of Common Stock (the &#8220;Interest Shares&#8221;), which may be payable, at the Company&#8217;s option and subject to the fulfillment
of certain conditions set forth in the 3i Note, to satisfy interest payments under the Note, and (c) 63,497 shares of Common Stock (the
&#8220;3i Commitment Shares&#8221;), which is equal to $300,000 of shares of Common Stock calculated as of the date of the Note Purchase
Agreement issued to 3i as consideration for its commitment to purchase the Note (collectively, the &#8220;3i Note Transaction&#8221;).
The 3i Note is convertible into a maximum of 727,387 shares of Common Stock. The conversion of the 3i Note is subject to the terms of
the Note Purchase Agreement, including the beneficial ownership limitations and share issuance caps specified therein. In connection with
the 3i Note Transaction, we filed a <span style="background-color: white">prospectus supplement with the SEC pursuant to Rule&#160;</span>424(b)<span style="background-color: white">&#160;under
the&#160;</span>Securities Act<span style="background-color: white">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, we entered into the Equity Line
Purchase Agreement with Tumim, pursuant to which we, in our sole discretion, may sell up to $20.0 million in aggregate of newly issued
common stock to Tumim, subject to certain beneficial ownership limitations and limitations on the maximum number of shares we may issue
and sell in accordance with Nasdaq listing requirements. In connection with the Equity Line Transaction (as defined below), we entered
into a registration rights agreement with Tumim, pursuant to which we will file a resale registration statement with respect to the shares
we may sell to Tumim under the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Risk Factor Summary </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Before you invest in our Common Stock, you should
carefully consider all of the information in this prospectus, including matters set forth under the section of this prospectus titled
&#8220;<i>Risk Factors.</i>&#8221; These risks include, but are not limited to, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a history of losses.
As our costs increase, we may not be able to generate sufficient revenue to achieve and sustain profitability.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our audited financial statements
include a statement that there is a substantial doubt about our ability to continue as a going concern and a continuation of negative
financial trends could result in our inability to continue as a going concern.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have substantial customer
concentration, with a limited number of customers accounting for a substantial portion of our sales in 2022 and 2021.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nearly all of our raw materials
enter the United States through a limited number of ports and we rely on third parties to store and ship some of our inventory; labor
unrest at these ports or other product deliver difficulties could interfere with our distribution plans and reduce our revenue.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increases in costs, disruption
of supply or shortage of any of our battery components, such as electronic and mechanical parts, or raw materials used in the production
of such parts could harm our business.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are currently, and will
likely continue to be, dependent on our two warehouse facilities. If our facilities become inoperable for any reason, our ability to
produce our products could be negatively impacted.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to raise capital
in the future may be limited, which could make us unable to fund our capital requirements and our stockholders may be diluted by future
securities offerings.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our stock price may fluctuate
significantly, and you may lose all or a part of your investment.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You may be diluted by the future
issuance of additional Common Stock in connection with our incentive plans, acquisitions or otherwise.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales of substantial amounts
of our securities in the public markets, or the perception that such sales might occur, could reduce the price of our securities and
may dilute your voting power and your ownership interest in us.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to maintain
a listing of our Common Stock on Nasdaq.</span></td></tr>
</table></div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our long-term lease and debt
obligations could adversely affect our ability to raise additional capital to fund operations and limit our ability to enter into certain
transactions.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our principal stockholder continues
to have substantial control over us.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is not possible to predict
the actual number of Shares we will sell under the Equity Line Purchase Agreement, or the actual gross proceeds resulting from such sales.
We may not have access to the full amount available under the Equity Line Purchase Agreement with Tumim.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may require additional financing
to sustain our operations and without it we will not be able to continue operations.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tumim may choose to sell the
Shares at prices below the current market price.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You may experience future dilution
as a result of issuance of the Shares, future equity offerings by us and other issuances of our Common Stock or other securities. In
addition, the issuance of the Shares and future equity offerings and other issuances of our Common Stock or other securities may adversely
affect our Common Stock price.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify"><b>Implications of Being an Emerging Growth
Company and a Smaller Reporting Company</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are an &#8220;emerging growth company,&#8221; as
defined in the JOBS Act. As such, we are eligible for exemptions from various reporting requirements applicable to other public companies
that are not emerging growth companies, including, but not limited to, presenting only two years of audited financial statements in addition
to any required unaudited interim financial statements with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations&#8221; disclosure in this prospectus, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), reduced disclosure obligations regarding
executive compensation and an exemption from the requirements to obtain a non-binding advisory vote on executive compensation or golden
parachute arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, an emerging growth company can take advantage
of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company
to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected
to avail ourselves of this provision of the JOBS Act. As a result, we will not be subject to new or revised accounting standards at the
same time as other public companies that are not emerging growth companies. Therefore, our consolidated financial statements may not be
comparable to those of companies that comply with new or revised accounting pronouncements as of their public company effective dates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We will remain an emerging growth company until the
earliest of: (i) the last day of the fiscal year following the fifth anniversary of the consummation of our initial public offering; (ii)
the last day of the fiscal year in which we have total annual gross revenue of at least $1.235 billion (as adjusted for inflation from
time to time pursuant to SEC rules); (iii) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer&#8221;
as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which would occur if
the market value of our Common Stock held by non-affiliates were at least $700.0 million as of the last business day of the second fiscal
quarter of such year; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior
three-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are also a &#8220;smaller reporting company&#8221;
as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company.
We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage
of these scaled disclosures for so long as our public float is less than $250.0 million measured on the last business day of our second
fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and our public float
is less than $700.0 million measured on the last business day of our second fiscal quarter. Even after we no longer qualify as an emerging
growth company, we may still qualify as a smaller reporting company, which would allow us to take advantage of many of the same exemptions
from disclosure requirements, such as reduced disclosure regarding executive compensation, among others.</p></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain risks related to our status as an emerging
growth company, see &#8220;<i>Risk Factors&#160;&#8212; Risks Related to Ownership of our Common Stock &#8212; We are an &#8220;emerging
growth company&#8221; and elect to comply with certain reduced reporting requirements applicable to emerging growth companies, which could
make our securities less attractive to investors.&#8221; </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify"><b>Channels For Disclosure of Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We announce material information to the public through
filings with the SEC, the investor relations page on our website (expion360.com), press releases, public conference calls, and public
webcasts. We encourage investors, the media and others to follow the channels listed above and to review the information disclosed through
such channels. Any updates to the list of disclosure channels through which we will announce information will be posted on the investor
relations page on our website. The inclusion of our website address in this prospectus is an inactive textual reference only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Corporate Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify">Expion360 was initially organized as a limited
liability company under the name &#8220;Yozamp Products Company, LLC&#8221; in the State of Oregon on June 16, 2016, and converted to
a Nevada corporation under its current name pursuant to articles of conversion dated as of November 16, 2021. Our principal executive
offices are located at 2025 SW Deerhound Ave, Redmond, Oregon 97756 and our phone number is (541) 797-6714. Our principal website is expion360.com.
The information contained on, or that can be accessed through, our website is not a part of this prospectus or the Registration Statement
of which it forms a part. The inclusion of our website address in this prospectus is an inactive textual reference only. Investors should
not rely on any such information in deciding whether to purchase our Common Stock.</p></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify">&#160;</p>

<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_004"></span>THE OFFERING</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On December 27, 2023, we
entered into the Equity Line Purchase Agreement with Tumim, pursuant to which Tumim committed to purchase up to $20.0&#160;million of
our Common Stock (the &#8220;Total Commitment&#8221;), at our direction from time to time over the term of the Equity Line Purchase Agreement,
subject to certain terms, conditions and limitations in the Equity Line Purchase Agreement. On December 27, 2023, we also entered into
a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;) with Tumim, pursuant to which we are filing the Registration
Statement of which this prospectus forms a part. Such Registration Statement is being filed to register for resale, under the Securities
Act, the Shares that may be issued to Tumim under the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The sale of our Common Stock
by us to Tumim under the Equity Line Purchase Agreement is subject to certain limitations and may occur, from time to time at our sole
discretion, over a 24-month&#160;period, commencing upon the date the Registration Statement of which this prospectus forms a part is
declared effective by the SEC (the &#8220;Effective Date&#8221;), provided that a final prospectus in connection therewith is filed, and
the other conditions set forth in the Equity Line Purchase Agreement are satisfied (collectively, the &#8220;Commencement&#8221;). From
and after the date on which the Commencement occurs (the &#8220;Commencement Date&#8221;), we have the right, but not the obligation,
from time to time at our sole discretion, to direct Tumim to purchase certain amounts of our Common Stock, subject to certain limitations
in the Equity Line Purchase Agreement, that we specify in purchase notices that we deliver to Tumim under the Equity Line Purchase Agreement
(each such purchase, a &#8220;Purchase&#8221;). The purchase price of the shares of our Common Stock that we may direct Tumim to purchase
in a Purchase will be equal to ninety-five percent (95.0%) of the lowest daily volume weighted average price (&#8220;VWAP&#8221;) of our
Common Stock on Nasdaq during the three consecutive trading&#160;day-period immediately following the trading day on which Tumim has received,
after 4:00 p.m. New York City time but prior to 6:30 p.m. New York City time on such trading day, the applicable purchase notice for such
Purchase (each such period, a &#8220;VWAP Purchase Valuation Period&#8221; and the trading day on which Tumim has received such applicable
purchase notice, the &#8220;VWAP Purchase Exercise Date&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">There is no upper limit on
the price per share that Tumim could be obligated to pay for our Common Stock under the Equity Line Purchase Agreement. The purchase price
per share of our Common Stock sold in a Purchase will be equitably adjusted for any reorganization, recapitalization,&#160;non-cash&#160;dividend,
stock split, reverse stock split or other similar transaction occurring during the applicable VWAP Purchase Valuation Period for such
Purchase.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Tumim has no right to require
us to sell any shares of our Common Stock to it, but Tumim is obligated to make purchases as directed by us, subject to the satisfaction
of conditions set forth in the Equity Line Purchase Agreement at Commencement and thereafter at each time that we direct Tumim to purchase
shares of our Common Stock under the Equity Line Purchase Agreement. Actual sales of shares of our Common Stock to Tumim will depend on
a variety of factors to be determined by us from time to time, including, among others, market conditions, the trading price of our Common
Stock and determinations by us as to the appropriate sources of funding for us and our operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Under the Nasdaq listing
rules, in no event may we issue or sell to Tumim under the Equity Line Purchase Agreement and the transactions contemplated thereby, shares
of our Common Stock in excess of 1,383,890 shares (the &#8220;Exchange Cap&#8221;), which is equal to 19.99% of the number of shares of
our Common Stock outstanding immediately prior to the execution of the Equity Line Purchase Agreement. We will need to obtain stockholder
approval to issue shares of our Common Stock in excess of the Exchange Cap, unless the average price of all applicable sales of our Common
Stock to Tumim under the Equity Line Purchase Agreement equals or exceeds $5.45 (which is the Nasdaq official closing price of the Common
Stock on the date of the Equity Line Purchase Agreement), in which case, under the Nasdaq listing rules, the Exchange Cap will not apply
to issuances and sales of our Common Stock under the Equity Line Purchase Agreement. In any event, the Equity Line Purchase Agreement
specifically provides that we may not issue or sell any shares of our Common Stock under the Equity Line Purchase Agreement if such issuance
or sale would breach any Nasdaq listing rule.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Equity Line Purchase
Agreement also prohibits us from directing Tumim to purchase any shares of our Common Stock if those shares, when aggregated with all
other shares of our Common Stock then beneficially owned by Tumim (as calculated pursuant to Section&#160;13(d) of the Securities Exchange
Act of 1934, as amended, and Rule&#160;13d-3 thereunder), would result in Tumim beneficially owning more than 9.99% of the outstanding
shares of Common Stock (the &#8220;Beneficial Ownership Limitation&#8221;).</p></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The net proceeds under the
Equity Line Purchase Agreement to us will depend on the frequency and prices at which we sell shares of our Common Stock to Tumim. We
expect that any proceeds received by us from such sales will be used for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">There are no restrictions
on future financings, rights of first refusal, participation rights, penalties or liquidated damages in the Equity Line Purchase Agreement
or Registration Rights Agreement, other than a prohibition on entering into certain types of &#8220;dilutive&#8221; equity transactions
during a pending purchase and prior to the full settlement thereof under the Equity Line Purchase Agreement, and a requirement for us
to pay certain liquidated damages to Tumim if we fail to meet certain obligations under the Registration Rights Agreement. Tumim has agreed
not to cause, or engage in any manner whatsoever, any direct or indirect short selling or hedging of our Common Stock during the term
of the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Equity Line Purchase
Agreement will automatically terminate upon the earliest of: (i)&#160;the first day of the calendar month immediately following the 24-month
anniversary of the Effective Date, (ii)&#160;the date on which Tumim shall have purchased the Total Commitment worth of Shares pursuant
to the Equity Line Purchase Agreement, or (iii)&#160;the occurrence of certain other events set forth in the Equity Line Purchase Agreement.
We have the right to terminate the Equity Line Purchase Agreement at any time after Commencement, at no cost or penalty, upon ten trading
days&#8217; prior written notice to Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Neither we nor Tumim may
assign or transfer any rights and obligations under the Equity Line Purchase Agreement, and no provision of the Equity Line Purchase Agreement
or the Registration Rights Agreement may be modified or waived by either the Company or Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Equity Line Purchase
Agreement and the Registration Rights Agreement contain customary representations, warranties, conditions and indemnification obligations
of the Company and Tumim. The representations, warranties and covenants contained in such agreements were made only for purposes of such
agreements and as of specific dates, were solely for the benefit of the Company and Tumim and may be subject to limitations agreed upon
by the Company and Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We do not know what the purchase
price for our Common Stock will be and therefore cannot be certain as to the number of shares we might issue to Tumim under the Equity
Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of January 12, 2024 there
were 6,986,409 shares of our Common Stock outstanding. If all of the Shares offered by Tumim for resale under this prospectus were issued
and outstanding as of the date hereof (without taking into account the Exchange Cap or the Beneficial Ownership Limitation), such Shares
would represent approximately 25.5% of the total number of shares of our Common Stock outstanding and approximately 33.3% of the total
number of outstanding shares held by&#160;non-affiliates,&#160;in each case as of January 12, 2024. If we elect to issue and sell more
than the Shares to Tumim, which we have the right, but not the obligation, to do, we must first register for resale under the Securities
Act any such additional shares, which could cause additional substantial dilution to our stockholders. The number of shares ultimately
offered for resale by Tumim is dependent upon the number of shares we may elect to sell to Tumim under the Equity Line Purchase Agreement
from and after the Commencement Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">There are substantial risks
to our stockholders as a result of the sale and issuance of our Common Stock to Tumim under the Equity Line Purchase Agreement. These
risks include substantial dilution, significant declines in our stock price and our inability to draw sufficient funds when needed. See
the section of this prospectus titled &#8220;<i>Risk Factors.</i>&#8221; Issuances of our Common Stock in this Offering will not affect
the rights or privileges of our existing stockholders, except that the economic and voting interests of each of our existing stockholders
will be diluted as a result of any such issuance. Although the number of shares of our Common Stock that our existing stockholders own
will not decrease, the shares owned by our existing stockholders will represent a smaller percentage of our total outstanding shares after
any such issuances to Tumim. See the section of this prospectus titled &#8220;<i>Dilution</i>.&#8221;</p></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_005"></span>SECURITIES OFFERED</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>The following summary contains basic information
about this Offering and our Common Stock and is not intended to be complete. It does not contain all of the information that may be important
to you. For a more complete understanding of our Common Stock, please refer to </i>&#8220;<i>Description of Capital Stock.</i>&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; width: 26%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock offered by Tumim</b></span></td>
<td style="vertical-align: bottom; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; width: 73%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
to 1,781,978 Shares we may sell to Tumim under the Equity Line Purchase Agreement from time to time after the date hereof.</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock outstanding prior to this Offering<sup>(1)</sup>&#160;</b></span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,986,409 shares of Common
Stock. &#160; &#160;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock to be outstanding after this Offering<sup>(1)</sup>&#160;</b></span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
to 8,768,387 shares of Common Stock, assuming the sale of an aggregate 1,781,978 Shares to Tumim under the Equity Line Purchase Agreement
from time to time after the date hereof. The actual number of shares issued will vary depending upon the actual sales prices under this
Offering.</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of proceeds</b></span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any proceeds from the resale of the Shares by Tumim included in this prospectus. We may receive up to $20.0 million
in aggregate gross proceeds under the Equity Line Purchase Agreement from sales of our Common Stock that we may elect to make to Tumim
pursuant to the Equity Line Purchase Agreement from time to time in our sole discretion, from and after the Commencement Date. We may
use the proceeds from sales of our Common Stock to Tumim for working capital and general corporate purposes. See the section of this
prospectus titled &#8220;<i>Use of Proceeds.</i>&#8221;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq
symbol</b></span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;XPON&#8221; &#160;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
<td style="padding: 0pt 0pt 0pt 10pt; vertical-align: top; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
factors</b></span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our Common Stock is speculative and involves a high degree of risk. See the section of this prospectus titled &#8220;<i>Risk
Factors</i>&#8221; beginning on page&#160;9 and other information appearing elsewhere in this prospectus for a discussion of factors
you should carefully consider before deciding whether to invest in our Common Stock. Additional risks and uncertainties not
presently known to us or that we currently deem to be immaterial may also impair our business and operations.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            number of shares of our Common Stock that will be outstanding immediately after this Offering
                                            is based on 6,986,409 shares outstanding as of January 12, 2024, and excludes the following:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,000 shares of Common Stock
issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at an exercise price of $2.90 per
share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">521,825 <span style="background-color: white">shares
</span>of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at an exercise
price of $3.32 per share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,<span style="background-color: white">005
</span>shares of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at
an exercise price of $9.10 per share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000 shares of Common Stock
issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at an exercise price of $5.00 per
share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000 <span style="background-color: white">shares
</span>of Common Stock issuable upon the exercise of options outstanding as of January 12, 2024, which were not issued under a specified
plan;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,111,585 shares of Common
Stock issuable upon the exercise of equity incentive awards outstanding under our 2021 Incentive Award Plan as of January 12, 2024;</span></td></tr>
</table></div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 99%"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">575,<span style="background-color: white">843
</span>shares of Common Stock available for future issuance under our 2021 Incentive Award Plan as of January 12, 2024;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any shares of Common Stock
available for future issuance under our 2021 Incentive Award Plan, which will continue to increase in future years pursuant to the plan&#8217;s
evergreen provision;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000 shares of Common
Stock available for future issuance under our 2021 Employee Stock Purchase Plan as of January 12, 2024;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of up to 779,669
shares of Common Stock, which consists of 727,387 shares issuable upon conversion of the 3i Note and up to 52,282 Interest Shares under
the Note Purchase Agreement; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any additional shares of Common
Stock we have issued or may issue from time to time after January 12, 2024.</span></td></tr>
</table></div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_006"></span>RISK FACTORS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><i>Investing
in our securities involves risks. Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed
below under </i>&#8220;<i>Cautionary Note Regarding Forward-Looking Statements,</i>&#8221; <i>you should carefully consider the specific
risks set forth herein. We have also identified a number of these factors under the heading </i>&#8220;<i>Risk Factors</i>&#8221; <i>in
our periodic reports we file with the SEC, including our quarterly reports on Form 10-Q for the quarters ended March 31, 2023, June 30,
2023, and September 30, 2023, and will do so in our future filings. If any of these risks actually occur, it may materially harm our business,
financial condition, liquidity, results of operations, and prospects. As a result, the market price of our securities could decline, and
you could lose all or part of your investment. Additionally, the risks and uncertainties described in this prospectus or any prospectus
supplement are not the only risks and uncertainties that we face. Additional risks and uncertainties not presently known to us or that
we currently believe to be immaterial may become material and adversely affect our business. If any of the following risks or other risks
not specified below materialize, our business, financial condition and results of operations could be materially and adversely affected.
In that case, the trading price of our shares of Common Stock could decline.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Risks Related to Our Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>We operate in an extremely competitive industry and are subject to
pricing pressures.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compete with a number of major international and
domestic manufacturers, assemblers and distributors, as well as a large number of smaller, regional competitors. In addition, our customers
have many choices for energy storage solutions in the markets that we serve including both traditional lead-acid products as well as lithium-ion
products. We anticipate continued competitive pricing pressure, including due to foreign producers who are able to employ labor at significantly
lower costs than producers in the U.S., expand their export capacity and increase their marketing presence in our major Americas markets.
Several of our competitors have strong technical, marketing, sales, manufacturing, distribution and other resources, as well as significant
name recognition, established positions in the market and long-standing relationships with OEMs and other customers. Our ability to maintain
and improve our operating margins has depended, and continues to depend, on our ability to control and reduce our costs. We cannot assure
you that we will be able to continue to control our operating, assembly and manufacturing expenses, to raise or maintain our prices or
increase our unit volume or unit mix, in order to maintain or improve our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We have a history of losses. As our costs increase,
we may not be able to generate sufficient revenue to achieve and sustain profitability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have experienced net losses in each period since
inception. We generated net losses of $7,536,540 and $4,720,858 for the years ended December 31, 2022 and 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Part of our business strategy is to focus on our long-term
growth. As a result, our profitability may be lower in the near-term than it would be if our strategy were to maximize short-term profitability.
Significant expenditures on sales and marketing efforts, expanding our platform, products, features, and functionality, and expanding
our research and development, each of which we intend to continue to invest in, may not ultimately grow our business or cause long-term
profitability. If we are ultimately unable to achieve profitability at the level anticipated by industry or financial analysts and our
stockholders, our stock price may decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our efforts to grow our business may be costlier than
we expect, or our revenue growth rate may be slower than we expect, and we may not be able to increase our revenue enough to offset the
increase in operating expenses resulting from these investments. If we are unable to continue to grow our revenue, the value of our business
and common stock may significantly decrease, which may in turn have a material adverse effect on our ability to raise capital to grow
our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
audited financial statements include a statement that there is a substantial doubt about our ability to continue as a going concern and
a continuation of negative financial trends could result in our inability to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audited financial statements as of and for the
years ended December 31, 2022 and 2021 were prepared on the assumption that we would continue as a going concern. For the years ended
December 31, 2022 and 2021, the Company has sustained recurring losses and negative cash flows from operations. These factors raise substantial
doubt about our ability to continue as a going concern over the next 12 months and our independent auditors have included a &#8220;going
concern&#8221; explanatory paragraph in their report on our financial statements as of and for the years ended December 31, 2022 and 2021.
If our operating results fail to improve and/or if we fail to raise additional debt or equity financing, then our financial condition
could render us unable to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Our business and future growth depends on the needs and success of
our customers. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our customers include dealers, wholesalers, private-label
customers and original equipment manufacturers (&#8220;OEMs&#8221;). The demand for our products ultimately depends on consumers in our
current end markets (primarily owners of RVs and marine vessels). These markets can be impacted by numerous factors, including, consumer
spending, travel restrictions, fuel costs and energy demands (including an increasing trend towards the use of green energy) and overall
economic conditions. Increases or decreases in these variables may significantly impact the demand for our products. If we fail to accurately
predict demand, we may be unable to meet our customers&#8217; needs, resulting in the loss of potential sales, or we may produce excess
products, resulting in increased inventory and overcapacity in our production facilities, increasing our unit production cost and decreasing
our operating margins.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We have substantial customer concentration,
with a limited number of customers accounting for a substantial portion of our sales in 2022 and 2021.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently derive a significant portion of our revenues
from a limited number of customers. During the year ended December 31, 2022, sales to our top three customers totaled $2,905,326, comprising
approximately 41% of our total sales, including sales to one customer, which totaled $1,346,344 or approximately 19% of our total sales.
Amounts due from these customers totaled $127,795, representing approximately 43% of our total accounts receivable at December 31, 2022.
During the year ended December 31, 2021, sales to one customer totaled $488,860 and comprised approximately 11% of our total sales. There
were no accounts receivable from this customer as of December 31, 2021; however, amounts due from three other customers totaling $658,317
represented approximately 85% of our total accounts receivable at December 31, 2021. There are inherent risks whenever a large percentage
of total revenues are concentrated with a limited number of customers. In addition, our sales are completed on a purchase order basis
and most are without firm, long-term revenue commitments or sales arrangements. It is not possible for us to predict the future level
of demand for our products and services that will be generated by our customers or the future demand for the products and services of
our other customers. If any of our customers experience declining or delayed sales due to market, economic or competitive conditions,
we could be pressured to reduce the prices we charge for our products which could have an adverse effect on our margins and financial
position and could negatively affect our revenues and results of operations and/or trading price of our Common Stock. Furthermore, there
is inherent risk associated with accounts receivable concentration as a deterioration in the financial condition of a limited number of
account debtors, or any other factor which affects their ability or willingness to pay could in turn have a material adverse effect on
our financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>We may not be able to successfully manage our growth.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have been continuously expanding our operations
since our founding in 2016. As we continue to grow, we must continue to improve our managerial, technical and operational knowledge and
allocation of resources, and to implement an effective management information system. To effectively manage our expanded operations, we
need to continue to recruit and train managerial, accounting, internal audit, engineering, assembly and manufacturing, technical, sales
and other staff to satisfy our development requirements and there are currently significant labor shortages in the market. In order to
fund our ongoing operations and our future growth, we need to have sufficient internal sources of liquidity or access to additional financing
from external sources. Furthermore, we will be required to manage relationships with a greater number of customers, suppliers, contractors,
service providers, lenders and other third parties. We will need to further strengthen our internal control and compliance functions to
ensure that we are able to comply with our legal and contractual obligations and to reduce our operational and compliance risks. We cannot
assure you that we will not experience issues such as capital constraints, construction delays, operational difficulties at new locations,
or difficulties in expanding our existing business and operations and in recruiting and training an increasing number of personnel to
manage and operate the expanded business. Our expansion plans may also adversely affect our existing operations and thereby have a material
adverse effect on our business, prospects, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our results of operations may be negatively
impacted by public health epidemics or outbreaks. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are exposed to risks associated with public health
crises and epidemics or pandemics. A widespread health crisis could adversely affect the global economy, resulting in an economic downturn
that could impact our operations and demand for our products and therefore have a material adverse effect on our business and results
of operations. For example, the COVID-19 global pandemic adversely impacted our operations, supply chains, and distribution systems as
well as those of our third-party suppliers and manufacturers, which are located in the United States, Asia and Europe. A future public
health epidemic or outbreak may make it more difficult for us and our third-party manufacturers to find sufficient components or raw materials
and component parts on a timely basis or at a cost-effective price. Any performance failure on the part of any of our significant suppliers
or third-party manufacturers could interrupt production of our products, which would have a material adverse effect on our business, financial
condition and results of operations. In addition, during the COVID-19 pandemic we experienced shortages and workforce slowdowns due to
stay-at-home mandates, illness among our workforce, delays in shipping finished products to customers, and delays in our receiving batteries
and certain components. The highly competitive labor market made it difficult to recruit and maintain a workforce properly sized and suited
for our operational and strategic needs, which further adversely impacted our business, and any future incidence of disease could similarly
impact our business. In addition, while the COVID-19 pandemic positively impacted our battery sales due to more consumers adopting the
RV lifestyle, there is no guarantee that any such increase would be sustained, which could cause our results of operations to fluctuate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>If we fail to expand our sales and distribution channels, our business
could suffer.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our success, and our ability to increase sales and
operate profitably, depends on our ability to identify target customers and convert these customers into meaningful orders, as well as
our continued development of existing customer relationships. If we are unable to expand our sales and distribution channels, we may not
be able to increase revenue or achieve market acceptance of our products. We have recently expanded our direct sales force and plan to
recruit additional sales personnel. New sales personnel will require training and take time to achieve full productivity, and there is
strong competition for qualified sales personnel in our business. In addition, we believe that our future success is dependent upon establishing
successful relationships with a variety of distribution partners. To date, we have entered into agreements with only a small number of
these distribution partners. We cannot be certain that we will be able to reach agreement with additional distribution partners on a timely
basis or at all, or that these distribution partners will devote adequate resources to selling our products. Furthermore, if our distribution
partners fail to adequately market or support our products, the reputation of our products in the market may suffer. In addition, we will
need to manage potential conflicts between our direct sales force and any third-party reselling efforts. There can be no assurances that
any of our efforts to expand our sales and distribution channels will be successful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Our ability to expand into international markets is uncertain.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our strategy is to expand our operations into international
markets. In addition to general risks associated with international expansion, such as foreign currency fluctuations and political and
economic instability, we face the following risks and uncertainties any of which could prevent us from selling our products in a particular
country or harm our business operations once we have established operations in that country:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the difficulties and costs
of localizing products for foreign markets;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the need to modify our products
to comply with local requirements in each country; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our lack of a direct sales
presence in other countries, our need to establish relationships with distribution partners to sell our products in these markets and
our reliance on the capabilities and performance of these distribution partners.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If we are unable to expand into international markets
in the manner expected, our business, financial condition, results of operations and prospects may be materially and adversely affected.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Nearly all of our raw materials enter the United
States through a limited number of ports and we rely on third parties to store and ship some of our inventory; labor unrest at these ports
or other product deliver difficulties could interfere with our distribution plans and reduce our revenue.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently rely exclusively on foreign manufacturers
to manufacture the lithium-ion batteries used as raw materials in our products, as well as certain other of our raw materials. We may
suffer delays in receiving raw materials due to work stoppages, strikes or lockouts or other bottlenecks at the ports through which our
raw materials are shipped. Likewise, we rely on trucking carriers to deliver products from the port of arrival to our distribution facilities
and from our distribution facilities to our customers. Additionally, in some cases, third parties sort, store and direct-ship products
to our customers. Labor unrest or other disruptions could result in product shortages and delays in distributing our products to retailers,
which could materially and adversely affect our business, financial condition, results of operations and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>The uncertainty in global economic conditions could negatively affect
the Company&#8217;s operating results.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our operating results are directly affected by the
general global economic conditions of the industries in which our major customer groups operate. Our business is also highly dependent
on the economic and market conditions in each of the geographic areas in which we operate. Our products are heavily dependent on the end
markets that we serve and our operating results will vary by location, depending on the economic environment in these markets. Sales of
our RV and marine power products, for example, depend significantly on demand for new electric products for RVs and marine applications,
which, in turn, depends on end-user demand for RVs and boats. The uncertainty in global economic conditions varies by geographic location
and can result in substantial volatility in global credit markets, particularly in the United States. These conditions, including levels
of consumer spending, economic recessions, slow economic growth, economic and pricing instability, inflation levels, increase of interest
rates, credit market volatility and adverse developments affecting financial institutions<b><i>,</i></b> could affect our business by
reducing prices that our customers may be able or willing to pay for our products or by reducing the demand for our products. In addition,
the Russia-Ukraine conflict has and may continue to further exacerbate disruptions in the global supply chain. As a result of sanctions
imposed in relation to the Russia-Ukraine conflict, gas prices in the United States have risen to historic levels. This rise in price
may cause a decrease in RV travel, which could ultimately negatively impact sales of our batteries for RVs. In 2022, we also experienced
increased shipping costs as a result of increased fuel costs and shutdowns at the ports through which our lithium-ion batteries and other
raw materials are shipped due to COVID-19 restrictions. Any of the above factors could, in turn, negatively impact our sales and earnings
generation and result in a material adverse effect on our business, cash flow, results of operations and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Government reviews, inquiries, investigations, and actions could
harm our business or reputation.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As we operate in various locations around the world,
our operations in certain countries are subject to significant governmental scrutiny and may be adversely impacted by the results of such
scrutiny. The regulatory environment with regard to our business is evolving, and officials often exercise broad discretion in deciding
how to interpret and apply applicable regulations. From time to time, we receive formal and informal inquiries from various government
regulatory authorities, as well as self-regulatory organizations, about our business and compliance with local laws, regulations or standards.
Any determination that our operations or activities, or the activities of our employees, are not in compliance with existing laws, regulations
or standards could result in the imposition of substantial fines, interruptions of business, loss of supplier, vendor, customer or other
third-party relationships, termination of necessary licenses and permits, or similar results, all of which could potentially harm our
business and/or reputation. Even if an inquiry does not result in these types of determinations, regulatory authorities could cause us
to incur substantial costs or require us to change our business practices in a manner materially adverse to our business, and it potentially
could create negative publicity which could harm our business and/or reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Our operating results could be adversely affected by changes in the
cost and availability of raw materials and we are dependent on third-party manufacturers and suppliers.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently rely on multiple third-party manufacturers
located in China who also produce our battery cells and we intend to continue to rely on these suppliers going forward. Lithium-ion batteries
are our most significant raw material and are used along with significant amounts of plastics, steel, copper and other materials in our
assembly and manufacturing processes. Our third-party manufacturers source the raw materials and battery components required for the production
of our batteries directly from third-party suppliers and thus we may have limited control over the agreed pricing for these raw materials
and battery components. We estimate that raw material costs account for over half of our cost of goods sold. The costs of these raw materials,
particularly lithium-ion batteries, are volatile and beyond our control. Additionally, availability of the raw materials used to manufacture
our products may be limited at times resulting in higher prices and/or the need to find alternative suppliers. Furthermore, the cost of
raw materials may also be influenced by transportation costs. Volatile raw material costs can significantly affect our operating results
and make period-to-period comparisons extremely difficult. We cannot assure you that we will be able to either hedge the costs or that
we or our third-party manufacturers will be able to secure the availability of our raw material requirements at a reasonable level or
that we will be able to pass on to our customers the increased costs of our raw materials without affecting demand, or that limited availability
of materials will not impact our production capabilities. Our inability to raise the price of our products in response to increases in
prices of raw materials or to maintain a proper supply of raw materials could have an adverse effect on our revenue, operating profit,
and net income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, during the years ended December 31, 2022
and 2021, approximately 85% and 90%, respectively, of inventory purchases were made from foreign suppliers in China and Hong Kong. Our
dependence on a limited number of key third-party manufacturers and suppliers exposes us to challenges and risks in ensuring that we maintain
adequate supplies required to produce our batteries. We do not have long-term purchase arrangements with our third-party manufacturers
and our purchases are completed on a purchase order basis. Thus, although we carefully manage our inventory and lead-times, we may experience
a delay or disruption in our supply chain and/or our current suppliers may not continue to provide us with lithium-ion batteries in our
required quantities or to our required specifications and quality levels or at attractive prices. Our close working relationships with
our China-based suppliers to-date, reflected in our ability to increase our purchase order volumes (qualifying us for related volume-based
discounts) and to order and receive delivery of components in advance of required demand, has helped us moderate or offset increased supply-related
costs associated with inflation, currency fluctuations and tariffs imposed on our battery imports by the U.S. government and avoid potential
shipment delays. If we are unable to enter into or maintain commercial arrangements with these suppliers on favorable terms, or if any
of these suppliers experience unanticipated delays, disruptions or shutdowns or other difficulties ramping up their supply of products
or materials to meet our requirements, our assembly operations and customer deliveries would be seriously impacted, potentially resulting
in liquidated damages and harm to our customer relationships. Although we believe we could locate alternative suppliers to fulfill our
needs, we may be unable to find a sufficient alternative supply in a reasonable time or on commercially reasonable terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, our dependence on these third-party suppliers
entails additional risks, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability, failure or unwillingness
of third-party suppliers to comply with regulatory requirements;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">breach of supply agreements
by the third-party suppliers;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">misappropriation or disclosure
of our proprietary information, including our trade secrets and know-how;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">relationships that third-party
suppliers may have with others, which may include our competitors, and failure of third-party suppliers to adequately fulfill contractual
duties, resulting in the need to enter into alternative arrangements, which may not be available, desirable or cost-effective; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">termination or nonrenewal of
agreements by third-party suppliers at times that are costly or inconvenient for us.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because our key manufacturers and suppliers are located
in China, we are exposed to the possibility of product supply disruption and increased costs in the event of changes in the policies,
laws, rules and regulations of the United States or Chinese governments, as well as political unrest or unstable economic conditions in
China. For example, trade tensions between the United States and China have been escalating in recent years. Most notably, several rounds
of U.S. tariffs have been placed on Chinese goods being exported to the United States. Each of these U.S. tariff impositions against Chinese
exports was followed by a round of retaliatory Chinese tariffs on U.S. exports to China. Our batteries and other components we purchase
from China have been, and may in the future be, subject to these tariffs, which could increase our manufacturing costs and could make
our products, if successfully developed and approved, less competitive than those of our competitors whose inputs are not subject to these
tariffs. We may otherwise experience supply disruptions or delays, and although we carefully manage our inventory and lead-times, our
suppliers may not continue to provide us with battery components in our required quantities, to our required specifications and quality
levels or at attractive prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, we may be unable to control price fluctuations
for these components or negotiate supply arrangements on favorable terms to us. We may also be exposed to fluctuations in the value of
the U.S. dollar relative to the Renminbi with any appreciation in the value of the Renminbi increasing our costs for lithium-ion batteries
and other raw materials sourced from China. Substantial increases in the prices for our lithium-ion batteries and other raw materials
would increase our operating costs and negatively impact our results of operations. In addition, foreign currency fluctuations relative
to the value of the U.S. dollar could affect the price of components and materials used in our batteries and sourced from countries other
than the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Increases in costs, disruption of supply or
shortage of any of our battery components, such as electronic and mechanical parts, or raw materials used in the production of such parts
could harm our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, we may experience increases in
the cost or a sustained interruption in the supply or shortage of battery components. For example, a global shortage and component supply
disruptions of electronic battery components are currently being reported, and the full impact to us is yet unknown. Other examples of
shortages and component supply disruptions could include the supply of electronic components and raw materials (such as resins and other
raw metal materials) that go into the production of our battery components. Any such cost increase or supply interruption could materially
and negatively impact our business, prospects, financial condition and operating results. The prices for our battery components fluctuate
depending on market conditions and global demand, and could adversely affect our business, prospects, financial condition and operating
results. For instance, we are exposed to multiple risks relating to price fluctuations for battery cells. These risks include, but are
not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">supply shortages caused by
the inability or unwillingness of suppliers and their competitors to build or operate component production facilities to supply the numbers
of battery components required to support the rapid growth of the electric RV and marine component vehicle industry and other industries
in which we operate as demand for such components increases;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption in the supply of
electronic circuits due to quality issues or insufficient raw materials;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a decrease in the number of
manufacturers of battery components; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an increase in the cost of
raw materials.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are dependent on the continued supply of battery
components for our products. Any disruption in the supply of battery components could temporarily disrupt production of our products by
our third-party manufacturers until a different supplier is fully qualified. The cost of our battery products depends in part upon the
prices and availability of raw materials such as lithium, nickel, cobalt, and/or other metals which are used to produce battery components.
Our third-party manufacturers source the raw materials and battery components required for the production of our batteries directly from
third-party suppliers and thus we may have limited control over the agreed pricing for these raw materials and battery components. The
prices for these materials fluctuate and their available supply may be unstable, depending on market conditions and global demand for
these materials, including as a result of increased global production of electric vehicles (&#8220;EVs&#8221;) and energy storage products
Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause us to experience significant increases in
freight charges. Any reduced availability of these raw materials or substantial increases in the prices for such materials may increase
the cost of our components and consequently, the cost of our products. There can be no assurance that we will be able to recoup increasing
costs of our components by increasing prices, which in turn could damage our brand, business, prospects, financial condition and operating
results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We are currently, and will likely continue to
be, dependent on our two warehouse facilities. If our facilities become inoperable for any reason, our ability to produce our products
could be negatively impacted.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of our battery assembly currently takes place
at our headquarters located in Redmond, Oregon. We currently operate one battery production line, which has been sufficient to meet customer
demand. If this production line were to be inoperable for any period of time, we would face delays in meeting orders, which could prevent
us from meeting demand or require us to incur unplanned costs, including capital expenditures. In addition, we have a second distribution
warehouse in Elkhart, Indiana to service and provide a stocking location for several large manufacturers in the area.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our facilities may be harmed or rendered inoperable
by natural or man-made disasters, including earthquakes, flooding, fire and power outages, utility and transportation infrastructure disruptions,
acts of war or terrorism, or by public health crises, such as the ongoing COVID-19 pandemic, which may render it difficult or impossible
for us to assemble our products for an extended period of time. The inability to produce our products or the backlog that could develop
if any of our facilities is inoperable for even a short period of time may result in increased costs, harm to our reputation, a loss of
customers or a material adverse effect on our business, financial condition or results of operations. Although we maintain property damage
and business interruption insurance, this insurance may not be sufficient to cover all of our potential losses and may not continue to
be available to us on acceptable terms, if at all.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our long-term target is to onshore the manufacturing
of most of our components and assemblies, including cell manufacturing, to the United States. As part of this agenda, we have leased another
facility in Redmond, Oregon and are in the process of constructing a new assembly line at this facility. Our plans for expansion may experience
delays, incur additional costs or cause disruption to our existing production lines. The costs to successfully achieve our expansion goals
may be greater than we expect, and we may fail to achieve our anticipated cost efficiencies, which could have a material adverse effect
on our business, financial condition and results of operations. Furthermore, while we are generally responsible for delivering products
to the customer, we do not maintain our own fleet of delivery vehicles and outsource this function to third parties. Any shortages in
trucking capacity, any increase in the cost thereof or any other disruption to the highway systems could limit our ability to deliver
our products in a timely manner or at all.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Lithium-ion battery cells have been observed to catch fire or release
smoke and flame, which may have a negative impact on our reputation and business. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our lithium-ion batteries use LiFePO4 as the cathode
material for lithium-ion cells. On rare occasions, lithium-ion cells can rapidly release the energy they contain by releasing smoke and
flames in a manner that can ignite nearby materials and other lithium-ion cells. This faulty result could subject us to lawsuits, product
recalls, or redesign efforts, all of which would be time consuming and expensive. Further, negative public perceptions regarding the suitability
or safety of lithium-ion cells or any future incident involving lithium-ion cells, such as a vehicle or other fire, even if such incident
does not involve our products, could seriously harm our business and reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To facilitate an uninterrupted supply of lithium-ion
batteries, we store a significant number of lithium-ion batteries at our facilities. Any mishandling, other safety issue or fire related
to the cells or batteries could disrupt our operations. In addition, any accident, whether occurring at our facilities or from the use
of our batteries, may result in significant production interruption, delays or claims for substantial damages caused by personal injuries
or property damage. Such damage or injury could lead to adverse publicity and potentially a product recall, which could have a material
adverse effect on our brand, business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We could face potential product liability claims
relating to our products, which could result in significant costs and liabilities, which would reduce our profitability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We face an inherent business risk of exposure to product
liability claims in the event that the use of any of our products results in personal injury or property damage. We are also exposed to
potential liability and product performance warranty risks that are inherent in the design, assemble, manufacture and sale of our products.
In the event that any of our products prove to be defective, we may be required to recall or redesign such products, which would result
in significant unexpected costs. Any insurance we maintain may not be available on terms acceptable to us or such coverage may not be
adequate for liabilities actually incurred. Further, any claim or product recall could result in adverse publicity against us, which could
adversely affect our sales or increase our costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Our operations expose us to litigation, tax, environmental and other
legal compliance risks.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to a variety of litigation, tax, environmental,
health and safety and other legal compliance risks. These risks include, among other things, possible liability relating to product liability
matters, personal injuries, intellectual property rights, contract-related claims, government contracts, taxes, health and safety liabilities,
environmental matters and compliance with competition laws and laws governing improper business practices. We could be charged with wrongdoing
as a result of such matters. If convicted or found liable, we could be subject to significant fines, penalties, repayments or other damages
(in certain cases, treble damages). In the area of taxes, changes in tax laws and regulations, as well as changes in related interpretations
and other tax guidance could materially impact our tax receivables and liabilities and our deferred tax assets and tax liabilities. We
plan to manufacture lithium-ion batteries in the future which involves processing, storing, disposing of and otherwise moving large amounts
of hazardous materials. As a result, we will be subject to extensive and changing environmental, health and safety laws, and regulations
governing, among other things: the generation, handling, storage, use, transportation and disposal of hazardous materials; remediation
of polluted ground or water; emissions or discharges of hazardous materials into the ground, air or water; and the health and safety of
our employees. Our ongoing compliance with environmental, health and safety laws, regulations and permits could require us to incur significant
expenses, limit our ability to modify or expand our facilities or continue production and require us to install additional pollution control
equipment and make other capital improvements. In addition, private parties, including employees, could bring personal injury or other
claims against us due to the presence of, or exposure to, hazardous substances used, stored or disposed of by us or contained in our products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain environmental laws assess liability on owners
or operators of real property for the cost of investigation, removal or remediation of hazardous substances at their current or former
properties or at properties at which they have disposed of hazardous substances. These laws may also assess costs to repair damage to
natural resources. We may be responsible for remediating damage to our properties caused by former owners by our existing operations or
by our future operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in environmental and climate laws or regulations
could lead to new or additional investment in production designs and could increase environmental compliance expenditures. For example,
the United States Environmental Protection Agency has promulgated regulations applicable to projects involving greenhouse gas emissions
above a certain threshold, and the United States and certain states within the United States have enacted, or are considering, limitations
on greenhouse gas emissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in climate change concerns, or in the regulation
of such concerns, including greenhouse gas emissions, could subject us to additional costs and restrictions, including increased energy
and raw materials costs. Additionally, we cannot assure you that we have been or at all times will be in compliance with environmental
laws and regulations or that we will not be required to expend significant funds to comply with, or discharge liabilities arising under,
environmental laws, regulations and permits, or that we will not be exposed to material environmental, health or safety litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to anti-corruption, anti-bribery, anti-money
laundering, financial and economic sanctions and similar laws and regulations in the jurisdictions in which we conduct or in the future
may conduct activities, including, the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;). The FCPA generally prohibits companies
and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. The FCPA
applies to companies, individual directors, officers, employees and agents. Under the FCPA, U.S. companies may be held liable for actions
taken by strategic or local partners or representatives. The FCPA also imposes accounting standards and requirements on publicly traded
U.S. corporations and their foreign affiliates, which are intended to prevent the diversion of corporate funds to the payment of bribes
and other improper payments. Our policies mandate compliance with these antibribery laws. Despite meaningful measures that we undertake
to facilitate lawful conduct, which include training and internal control policies, these measures may not always prevent reckless or
criminal acts by our employees or agents as we expand our operations from the United States domestically to abroad. As a result, we could
be subject to criminal and civil penalties, disgorgement, further changes or enhancements to our procedures, policies and controls, personnel
changes or other remedial actions. Violations of these laws, or allegations of such violations, could disrupt our operations, involve
significant management distraction and result in a material adverse effect on our competitive position, results of operations, cash flows
or financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our failure to introduce new products and product
enhancements and broad market acceptance of new technologies introduced by our competitors could adversely affect our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Many new energy storage technologies have been introduced
over the past several years. For certain important and growing markets, such as aerospace and defense, lithium-based battery technologies
have a large and growing market share. Our ability to achieve significant and sustained penetration of key developing markets, including
the RV and marine markets, will depend upon our success in developing or acquiring these and other technologies, either independently,
through joint ventures, or through acquisitions, which in each case may require significant capital. If we fail to develop or acquire,
assemble and manufacture and sell, products that satisfy our customers&#8217; demands, or we fail to respond effectively to new product
announcements by our competitors by quickly introducing competitive products, then market acceptance of our products could be reduced
and our business could be adversely affected. We cannot assure you that our portfolio of primarily lithium-ion products will remain competitive
with products based on new technologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We may not be able to adequately protect our
proprietary intellectual property and technology and we may need to defend ourselves against intellectual property infringement claims.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We rely on a combination of copyright, trademark,
patent and trade secret laws, non-disclosure agreements and other confidentiality procedures and contractual provisions to establish,
protect and maintain our proprietary intellectual property and technology and other confidential information. Certain of these technologies,
especially battery case construction, are important to our business and are not protected by patents. Despite our efforts to protect our
proprietary intellectual property and technology and other confidential information, unauthorized parties may attempt to copy or otherwise
obtain and use our intellectual property and proprietary technologies. If we are unable to protect our intellectual property and technology,
we may lose any technological advantage we currently enjoy and may be required to take an impairment charge with respect to the carrying
value of such intellectual property or goodwill established in connection with the acquisition thereof. In either case, our operating
results and net income may be adversely affected. In addition, entities holding intellectual property rights relating to our technology
may bring suits alleging infringement of such rights or otherwise asserting their rights and seeking licenses. Any such litigation or
claims, whether or not valid or successful, could result in substantial costs and diversion of resources and our management&#8217;s attention.
If we are determined to have infringed upon a third-party&#8217;s intellectual property rights, we may have to pay substantial damages,
obtain a license or cease making certain products, which in turn could have a material adverse effect on our business, operating results
and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Quality problems with our products could harm our reputation and
erode our competitive position.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The success of our business will depend upon the quality
of our products and our relationships with customers. In the event that our products fail to meet our customers&#8217; standards, our
reputation could be harmed, which would adversely affect our marketing and sales efforts. We cannot assure you that our customers will
not experience quality problems with our products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Any acquisitions that we complete may dilute
stockholder ownership interests in the Company, may have adverse effects on our financial condition and results of operations and may
cause unanticipated liabilities.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of our growth strategy, we may make future
investments in businesses, new technologies, services and other assets that complement our business. Future acquisitions may involve the
issuance of our equity securities as payment, in part or in full, for the businesses or assets acquired. Any future issuances of equity
securities would dilute stockholder ownership interests. In addition, future acquisitions might not increase, and may even decrease, our
earnings or earnings per share and the benefits derived by us from an acquisition might not outweigh or might not exceed the dilutive
effect of the acquisition. We also may incur additional debt or suffer adverse tax and accounting consequences in connection with any
future acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>If our electronic data is compromised, our business could be significantly
harmed.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We and our business partners maintain significant
amounts of data electronically in locations around the world. This data relates to all aspects of our business, including current and
future products and services under development, and also contains certain customer, supplier, partner and employee data. We maintain systems
and processes designed to protect this data, but notwithstanding such protective measures, there is a risk of intrusion, cyberattacks,
tampering, theft, misplaced or lost data, programming and/or human errors that could compromise the integrity and privacy of this data,
improper use of our systems, software solutions or networks, unauthorized access, use, disclosure, modification or destruction of information,
defective products, production downtimes and operational disruptions, which in turn could adversely affect our reputation, competitiveness,
and results of operations. In addition, we provide confidential and proprietary information to our third-party business partners in certain
cases where doing so is necessary to conduct our business. While we obtain assurances from those parties that they have systems and processes
in place to protect such data, and where applicable, that they will take steps to assure the protections of such data by third parties,
nonetheless those partners may also be subject to data intrusion or otherwise compromise the protection of such data. Any compromise of
the confidential data of our customers, suppliers, partners, employees or ourselves, or failure to prevent or mitigate the loss of or
damage to this data through breach of our information technology systems or other means could substantially disrupt our operations, harm
our customers, employees and other business partners, damage our reputation, violate applicable laws and regulations, subject us to potentially
significant costs and liabilities and result in a loss of business that could be material. We operate a number of critical computer systems
throughout our business that can fail for a variety of reasons. If such a failure were to occur, we may not be able to sufficiently recover
from the failure in time to avoid the loss of data or any adverse impact on certain of our operations that are dependent on such systems.
This could result in lost sales and the inefficient operation of our facilities for the duration of such a failure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our ability to raise capital in the future may
be limited, which could make us unable to fund our capital requirements and our stockholders may be diluted by future securities offerings.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our business and operations may consume resources
faster than we anticipate. In the future, we may need to raise additional funds through the issuance of new equity securities, debt or
a combination of both or by entering into credit facilities or securing other types of financing. Additional financing may not be available
on favorable terms or at all. If adequate funds are not available on acceptable terms, or at all, we may be unable to fund our capital
requirements. Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial
institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally,
or concerns or rumors about any events of these kinds or other similar risks, such as the closure of Silicon Valley Bank and the placement
into receivership of Signature Bank in March 2023, have in the past and may in the future lead to market-wide liquidity problems. Although
we do not have any cash or cash equivalent balances on deposit at Silicon Valley Bank as of the date of this prospectus, if other banks
and financial institutions enter receivership or become insolvent in the future in response to financial conditions affecting the banking
system and financial markets, our ability to raise additional financing or to access our existing cash, cash equivalents and investments
may be threatened.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If we incur new debt, the debt holders would have
rights senior to common stockholders to make claims on our assets, and the terms of any debt could restrict our operations, including
our ability to pay dividends on our Common Stock. If we issue additional equity securities, existing stockholders may experience dilution,
and the new equity securities could have rights senior to those of our Common Stock. Because our decision to issue securities in any future
offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature
of our future offerings. Thus, our stockholders bear the risk of our future securities offerings reducing the market price of our Common
Stock and diluting their interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We depend on our senior management team and
other key employees, and significant attrition within our management team or unsuccessful succession planning could adversely affect our
business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our success depends in part on our ability to attract,
retain and motivate senior management and other key employees. Achieving this objective may be difficult due to many factors, including
fluctuations in global economic and industry conditions, competitors&#8217; hiring practices, cost reduction activities, and the effectiveness
of our compensation programs. Competition for qualified personnel can be very intense. We must continue to recruit, retain and motivate
senior management and other key employees sufficient to maintain our current business and support our future projects. We are vulnerable
to attrition among our current senior management team and other key employees. A loss of any such personnel, or the inability to recruit
and retain qualified personnel in the future, could have an adverse effect on our business, financial condition and results of operations.
In addition, if we are unsuccessful in our succession planning efforts, the continuity of our business and results of operations could
be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Changes in tax laws or tax rulings could materially
affect our financial position, results of operations, and cash flows.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The income and non-income tax regimes we are subject
to or operate under are unsettled and may be subject to significant change. Changes in tax laws or tax rulings, or changes in interpretations
of existing laws, could materially affect our financial position, results of operations, and cash flows. For example, changes to U.S.
tax laws enacted in December 2017 had a significant impact on our tax obligations and effective tax rate beginning 2018. These enactments
and future possible guidance from the applicable taxing authorities may have a material impact on the Company&#8217;s operating results.
The Company closely monitors these proposals as they arise in the countries where it operates. Changes to the statutory tax rate may occur
at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted.
The Company regularly assesses the likely outcomes of its tax audits and disputes to determine the appropriateness of its tax reserves.
However, any tax authority could take a position on tax treatment that is contrary to the Company&#8217;s expectations, which could result
in tax liabilities in excess of reserves.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>A failure to keep pace with developments in
technology could impair our operations or competitive position.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our business continues to demand the use of sophisticated
systems and technology. These systems and technologies must be refined, updated and replaced with more advanced systems on a regular basis
in order for us to meet our customers&#8217; demands and expectations. If we are unable to do so on a timely basis or within reasonable
cost parameters, or if we are unable to appropriately and timely train our employees to operate any of these new systems, our business
could suffer. We also may not achieve the benefits that we anticipate from any new system or technology, such as fuel abatement technologies,
and a failure to do so could result in higher than anticipated costs or could impair our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Risks Related to Ownership of Our Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Our stock price may fluctuate significantly, and you may lose all
or a part of your investment.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The trading price of our securities may be volatile
and subject to wide price fluctuations in response to various factors, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">market conditions in the broader
stock market;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated fluctuations
in our quarterly financial condition and results of operations, or those of other companies in our industry;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated strategic,
technological, or regulatory threats, whether or not warranted by actual events;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether any securities analysts
cover our stock;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuance of new or changed
securities analysts&#8217; reports or recommendations, if any;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investor perceptions of our
Company, the lithium battery and accessory industry;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the volume of trading in our
stock;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in accounting standards,
policies, guidance, interpretations, or principles;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales, or anticipated sales,
of large blocks of our stock;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions or departures of
key management personnel, creative, or other talent;</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory or political developments,
including changes in laws or regulations that are applicable to our business;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation and governmental
investigations;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales or distributions of our
common stock by significant shareholders, the entity through which our controlling shareholder holds its investment, or other insiders;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">natural disasters and other
calamities; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">macroeconomic conditions.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the stock market has experienced extreme volatility that in some cases has been unrelated or disproportionate to the operating performance
of particular companies. These and other factors may c</span>ause the market price and demand for our securities to fluctuate substantially,
which may limit or prevent investors from readily selling their securities and it may otherwise negatively affect the liquidity of our
securities. In addition, in the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted
securities class action litigation against the Company that issued the stock. If any of our stockholders were to bring a lawsuit against
us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management
from our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We do not anticipate paying dividends on our
Common Stock in the foreseeable future, you may not receive any return on investment unless you sell your Common Stock for a price greater
than that which you paid for it.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We do not anticipate paying any dividends in the foreseeable
future on our Common Stock. We intend to retain all future earnings for the operation and expansion of our business and the repayment
of outstanding debt. Our credit documents contain, and any future indebtedness likely will contain, restrictive covenants that impose
significant operating and financial restrictions on us, including restrictions on our ability to pay dividends and make other restricted
payments. As a result, capital appreciation, if any, of our Common Stock may be your major source of gain for the foreseeable future.
While we may change this policy at some point in the future, we cannot assure you that we will make such a change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>If securities or industry analysts do not publish
research or reports about our business, if they adversely change their recommendations regarding our stock, or if our results of operations
do not meet their expectations, our stock price and trading volume could decline.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The trading market for our securities may be influenced
by the research and reports that securities or industry analysts publish about us or our business (or the absence of such research or
reports). If one or more of these analysts cease coverage of our Company or fail to publish reports on us regularly, we could lose visibility
in the financial markets, which in turn could cause our stock prices or trading volume to decline. Moreover, if one or more of the analysts
who cover us downgrade recommendations regarding our stock, or if our results of operations do not meet their expectations, our stock
prices could decline and such decline could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>You may be diluted by the future issuance of
additional Common Stock in connection with our incentive plans, acquisitions or otherwise.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will experience additional dilution upon the exercise
of options and warrants to purchase our Common Stock, including those options currently outstanding and possibly those granted in the
future, and the issuance of restricted stock or other equity awards under our stock incentive plans. As of January 12, 2024, we had 200,000,000
shares of Common Stock authorized of which 6,986,409 were issued. Our Articles of Incorporation authorizes us to issue shares of Common
Stock and options, rights, warrants and appreciation rights relating to Common Stock for the consideration and on the terms and conditions
established by our Board of Directors (&#8220;Board&#8221;) in its sole discretion, whether in connection with our incentive plans, acquisitions
or otherwise. We have reserved 1,000,000 shares of common stock for issuance upon the exercise of outstanding stock options under the
2021 Incentive Award Plan and 2,500,000 shares of Common Stock for issuance pursuant to our 2021 Employee Stock Purchase Plan. In addition,
as of March 27, 2023, there were 770,436 outstanding warrants to purchase 770,436 shares of our Common Stock. Any Common Stock that we
issue, including stock issued under our 2021 Incentive Award Plan or other equity incentive plans that we may adopt in the future, as
well as under outstanding options or warrants would dilute the percentage ownership held by our common stockholders. To the extent we
raise additional capital by issuing equity securities, our stockholders may also experience substantial additional dilution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Sales of substantial amounts of our securities
in the public markets, or the perception that such sales might occur, could reduce the price of our securities and may dilute your voting
power and your ownership interest in us.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If our existing stockholders sell substantial amounts
of our securities in the public market, the market price of our securities could decrease significantly. The perception in the public
market that our stockholders might sell securities could also depress our market price. As of January 12, 2024, we had 6,986,409 shares
of Common Stock outstanding. Pursuant to the terms of the Underwriter Warrants (as defined below), the holders of the Underwriter Warrants
have the right, subject to certain conditions, to require us to register the sale of the shares of our Common Stock underlying their Underwriter
Warrants under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the holders of the Underwriter Warrants exercise
their registration rights, the market price of shares of our securities may drop significantly. In addition, all of the shares of Common
Stock issuable upon exercise of outstanding stock options under the 2021 Incentive Award Plan and all of the shares of Common Stock issuable
pursuant to the 2021 Employee Stock Purchase Plan have been registered for public resale under the Securities Act. A decline in the price
of shares of our securities might impede our ability to raise capital through the issuance of additional shares of our Common Stock or
other equity securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We will continue to incur increased costs as
a result of operating as a public company, and our management will be required to devote substantial time to comply with public company
regulations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a public company, and particularly after we cease
to be an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, we will continue to incur significant legal, accounting and
other expenses. In addition, the Sarbanes-Oxley, as well as rules promulgated by the SEC and Nasdaq, require us to adopt corporate governance
practices applicable to U.S. public companies. Compliance with these rules and regulations will continue to increase our legal and financial
compliance costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sarbanes-Oxley, as well as rules and regulations subsequently
implemented by the SEC and Nasdaq, have imposed increased disclosure and enhanced corporate governance practices for public companies.
Our efforts to continue to comply with evolving laws, regulations and standards are likely to result in increased expenses and a diversion
of management&#8217;s time and attention from revenue-generating activities to compliance activities. We may not be successful in continuing
to implement these requirements and implementing them could adversely affect our business, results of operations and financial condition.
In addition, if we fail to implement the requirements with respect to our internal accounting and audit functions, our ability to report
our financial results on a timely and accurate basis could be impaired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Our management team has limited experience managing a public company.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most members of our management team have limited experience
managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws pertaining
to public companies. These obligations and constituents require significant attention from our senior management and can divert their
attention away from the day-to-day management of our business, which can harm our business, operating results and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We are an &#8220;emerging growth company&#8221;
and elect to comply with certain reduced reporting requirements applicable to emerging growth companies, which could make our securities
less attractive to investors.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As an &#8220;emerging growth company,&#8221; we take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404
of Sarbanes-Oxley, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute
payments not previously approved. We cannot predict if investors will find our securities less attractive because we chose to rely on
these exemptions. If some investors find our securities less attractive as a result, there may be a less active trading market for our
securities and the prices of our securities may be more volatile.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Section 107 of the JOBS Act also provides that an
&#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities
Act for complying with new or revised accounting standards. We choose to avail ourselves of this extended transition period and defer
adoption of certain changes in accounting standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As described in Section 101 of the JOBS Act, the &#8220;emerging
growth company&#8221; classification can be retained for up to five years following our initial public offering or until the earlier occurrence
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the last day of the fiscal
year: (a) following the fifth anniversary of the completion of this offering, (b) in which we have total annual gross revenue of at least
$1.235 billion, or (c) in which we deemed to be a large accelerated filer, which means the market value of our Common Stock that is held
by non-affiliates exceeded $700.0 million as of the prior June 30; or</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which we have issued
more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If some investors find our securities less attractive
as a result of any choices to reduce future disclosure, there may be a less active market for our securities and our stock price may be
more volatile.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Failure to maintain effective internal control
over financial reporting in accordance with Section 404 of Sarbanes-Oxley could have a material adverse effect on our business and stock
price.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are required to comply with certain SEC rules that
implement Sections 302 and 404 of Sarbanes-Oxley, which require management to certify financial and other information in our quarterly
and annual reports and beginning with the Annual Report on Form 10-K filed for the year ended December 31, 2023 (the &#8220;Annual Report&#8221;),
provide an annual management report on the effectiveness of our internal control over financial reporting. Though we are required to disclose
changes made in our internal control procedures on a quarterly basis, we take advantage of certain exceptions from reporting requirements
that are available to &#8220;emerging growth companies&#8221; under the JOBS Act. For example, each independent registered public accounting
firm that performs an audit for us has not been required to attest to and report on our annual assessment of our internal controls over
financial reporting pursuant to Section 404 and will not be required to do so until we are no longer an &#8220;emerging growth company&#8221;
as defined in the JOBS Act and a non-accelerated filer in accordance with Rule 12b-2 under the Exchange Act. While we expect to be ready
to comply with Section 404 of Sarbanes-Oxley by the applicable deadline, we cannot assure you that this will be the case. Furthermore,
we may identify material weaknesses that we may be unable to remediate in time to meet the applicable deadline imposed upon us for compliance
with the requirements of Section 404 of Sarbanes-Oxley. In addition, if we fail to achieve and maintain the adequacy of our internal controls,
as such standards are modified, supplemented or amended from time to time, we may be unable to conclude that we have effective internal
controls over financial reporting in accordance with Section 404 of Sarbanes-Oxley. If we are unable to implement the requirements of
Section 404 of Sarbanes-Oxley in a timely manner or with adequate compliance, our independent registered public accounting firm may issue
an adverse opinion due to ineffective internal controls over financial reporting and we may be subject to sanctions or investigation by
regulatory authorities, such as the SEC. As a result, there could be a negative reaction in the financial markets due to a loss of confidence
in the reliability of our financial statements. In addition, we may be required to incur costs in improving our internal control system
and the hiring of additional personnel. Any such action could have a material adverse effect on our business, prospects, results of operations,
and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our management continues to have broad discretion
as to the use of the net proceeds from our initial public offering.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While there have been no changes to our planned use
of proceeds from our initial public offering, as disclosed in the final prospectus for our initial public offering, our management continues
to have broad discretion in the application of the net proceeds. Accordingly, you will have to rely upon the judgment of our management
with respect to the use of these proceeds. Our management may spend a portion or all of the net proceeds from our initial public offering
in ways that holders of the shares may not desire or that may not yield a significant return or any return at all. Our management not
applying these funds effectively could harm our business. Pending their use, we may also invest the net proceeds from our initial public
offering in a manner that does not produce income or that loses value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>We may not be able to maintain a listing of our Common Stock on Nasdaq.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As our Common Stock is listed on Nasdaq, we must meet
certain financial and liquidity criteria to maintain such listing. If we violate Nasdaq listing requirements, our Common Stock may be
delisted. If we fail to meet any of Nasdaq&#8217;s listing standards, our Common Stock may be delisted. In addition, our Board may determine
that the cost of maintaining our listing on a national securities exchange outweighs the benefits of such listing. A delisting of our
Common Stock from Nasdaq may materially impair our stockholders&#8217; ability to buy and sell our Common Stock and could have an adverse
effect on the market price of, and the efficiency of the trading market for, our Common Stock. The delisting of our Common Stock could
significantly impair our ability to raise capital and the value of your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>If our shares become subject to the penny stock
rules, it would become more difficult to trade our shares.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The SEC has adopted rules that regulate broker-dealer
practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00,
other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems,
provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system.
If we do not retain a listing on Nasdaq or another national securities exchange and if the price of our Common Stock is less than $5.00,
our Common Stock could be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not
otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the
penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer
must make a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i) the purchaser&#8217;s
written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks;
and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the
trading activity in the secondary market for our common stock, and therefore stockholders may have difficulty selling their shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Risks Related to Our Capital Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our long-term lease and debt obligations could
adversely affect our ability to raise additional capital to fund operations and limit our ability to enter into certain transactions.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022, we had total liabilities
of $5,091,966, of which $3,220,019 was related to operating lease liabilities and $510,475 was related to debt obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If we cannot generate sufficient cash flow from operations
to service our lease and debt obligations, we may need to further refinance our debt, dispose of assets or issue equity to obtain necessary
funds. We do not know whether we will be able to do any of this on a timely basis or on terms satisfactory to us, or at all. Our substantial
lease and debt obligations could have important consequences, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to obtain additional
debt or equity financing for working capital, capital expenditures, debt service requirements, acquisitions, and general corporate or
other purposes may be limited;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a portion of our cash flows
from operations will be dedicated to payments on our lease and debt obligations and will not be available for other purposes, including
operations, capital expenditures and future business opportunities;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may be vulnerable in a downturn
in general economic conditions or in business or may be unable to carry on capital spending that is important to our growth;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictive covenants in our
debt documents may impose significant operating and financial restrictions on us, including our ability to pay dividends and make other
restricted payments or sell our collateral (other than inventory in the ordinary course of business);</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to introduce new products or new technologies
or exploit business opportunities may be restricted; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may be placed at a disadvantage compared with competitors
that have proportionately less lease and debt obligations.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Our principal stockholder continues to have substantial control over
us.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of January 12, 2024, John Yozamp, our Founder and
former Chief Business Development Officer, beneficially owns approximately 24.1% of our outstanding Common Stock, and, together with his
brother, James Yozamp, Jr., 7.9%. As a consequence, Mr. Yozamp and his affiliates, including his brother, are able to substantially influence
matters requiring stockholder approval, including the election of directors, a merger, consolidation or sale of all or substantially all
of our assets, and any other significant transaction. The interests of Mr. Yozamp and/or his affiliates may not always align with our
interests or the interests of our other stockholders. For instance, this concentration of ownership may have the effect of delaying or
preventing a change of control otherwise favored by our other stockholders and could depress our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our Articles of Incorporation provides that
the Nevada Eighth Judicial District Court of Clark County Nevada shall be the exclusive forum for certain litigation that may be initiated
by our stockholders, including claims under the Securities Act, which could limit our stockholders&#8217; ability to obtain a favorable
judicial forum for disputes with us or our directors, officers or employees. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Articles of Incorporation provides that, subject
to limited exceptions, the Nevada Eighth Judicial District Court of Clark County Nevada shall be, to the fullest extent permitted by law,
be the sole and exclusive forum for: (i) any derivative action or proceeding brought in the name or right of the Corporation or on its
behalf, (ii) any action asserting a claim for breach of a fiduciary duty owed by any of our directors, officers, employees or agents to
us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of Nevada Revised statutes Chapters 78 or
92A, our Articles of incorporation or our Bylaws, (iv) any action to interpret, apply, enforce or determine the validity of our Articles
of Incorporation or Bylaws, or (v) any action asserting a claim governed by the internal affairs doctrine.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although these choice of forum provisions would not
apply to suits brought to enforce any duty or liability created by the Exchange Act or rules and regulations thereunder, and suits brought
to enforce the Securities Act or rules and regulations thereunder are granted concurrent jurisdiction in federal and state courts pursuant
to preemptive federal law, these choice of forum provisions may otherwise limit a stockholder&#8217;s ability to bring a claim in a judicial
forum that it finds favorable for disputes with us or our directors, officers, employees or agents, which may discourage such lawsuits
against us and our directors, officers, employees and agents. Stockholders who do bring a claim in the Nevada Eighth Judicial District
Court of Clark County Nevada could face additional litigation costs in pursuing any such claim, particularly if they do not reside in
or near the State of Nevada. The Nevada Eighth Judicial District Court of Clark County Nevada may also reach different judgments or results
than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring
the action, and such judgments or results may be more favorable to us than to our stockholders. Alternatively, if a court were to find
the choice of forum provision contained in our Articles of Incorporation to be inapplicable or unenforceable in an action, we may incur
additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial
condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Risks Related to This Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>It is not possible
to predict the actual number of Shares we will sell under the Equity Line Purchase Agreement, or the actual gross proceeds resulting from
such sales. We may not have access to the full amount available under the Equity Line Purchase Agreement with Tumim.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On December 27, 2023, we
entered into the Equity Line Purchase Agreement with Tumim, pursuant to which Tumim committed to purchase up to $20.0&#160;million of
our Common Stock, subject to certain limitations and conditions set forth in the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The sale of our Common Stock
by us to Tumim under the Equity Line Purchase Agreement is subject to certain limitations and may occur, from time to time at our sole
discretion, over a 24-month&#160;period, commencing upon the Commencement Date. We generally have the right to control the timing and
amount of any sales of our Common Stock to Tumim under the Equity Line Purchase Agreement. Sales of our Common Stock to Tumim under the
Equity Line Purchase Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to
sell to Tumim all or a portion of the Shares that may be available pursuant to the Equity Line Purchase Agreement, or decide to terminate
the Equity Line Purchase Agreement and not sell to Tumim any Shares that may be available for us to sell to Tumim thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Because the purchase price
per share to be paid by Tumim for the Shares that we may elect to sell to Tumim under the Equity Line Purchase Agreement will fluctuate
based on the market prices of our Common Stock during the applicable VWAP Purchase Valuation Period for each Purchase, it is not possible
for us to predict, as of the date of this prospectus, the number of Shares that we will sell to Tumim under the Equity Line Purchase Agreement,
the purchase price per share that Tumim will pay for Shares purchased from us under the Equity Line Purchase Agreement, or the aggregate
gross proceeds that we will receive from such purchases by Tumim under the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">If we elect to sell to Tumim
all of the Shares in the Registration Statement of which this prospectus forms a part, the actual gross proceeds from the sale of all
such Shares may be substantially less than the Total Commitment originally available to us under the Equity Line Purchase Agreement, which
could materially adversely affect our liquidity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">If it becomes necessary for
us to issue and sell to Tumim under the Equity Line Purchase Agreement more than the 1,781,978 Shares being registered for resale under
the Registration Statement of which this prospectus forms a part in order to receive aggregate gross proceeds equal to the Total Commitment
under the Equity Line Purchase Agreement, we must file with the SEC one or more additional registration statements to register under the
Securities Act the resale by Tumim of any such additional shares of our Common Stock we wish to sell from time to time under the Equity
Line Purchase Agreement, which the SEC must declare effective. We will need to obtain stockholder approval to issue shares of our Common
Stock in excess of the Exchange Cap under the Equity Line Purchase Agreement in accordance with the Nasdaq listing rules, unless the average
per share purchase price paid by Tumim for all shares of our Common Stock sold under the Equity Line Purchase Agreement equals or exceeds
$5.45, in which case, under the Nasdaq listing rules, the Exchange Cap limitation will not apply to issuances and sales of our Common
Stock under the Equity Line Purchase Agreement. In addition, Tumim will not be required to purchase any shares of our Common Stock if
such sale would result in Tumim&#8217;s beneficial ownership exceeding 9.99% of the then outstanding shares of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Any issuance and sale by
us under the Equity Line Purchase Agreement of a substantial amount of Shares could cause additional substantial dilution to our stockholders.
The number of Shares ultimately offered for resale by Tumim is dependent upon the number of shares of our Common Stock we ultimately sell
to Tumim under the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our inability to access a
portion or the full amount available under the Equity Line Purchase Agreement, in the absence of any other financing sources, could have
a material adverse effect on our business. The extent to which we rely on Tumim as a source of funding will depend on a number of factors
including the prevailing market price of our Common Stock and the extent to which we are able to secure working capital from other sources.
If obtaining sufficient funding from Tumim were to prove unavailable or prohibitively dilutive, we will need to secure another source
of funding in order to satisfy our working capital needs. Even if we were to receive all $20.0&#160;million in gross proceeds under the
Equity Line Purchase Agreement, we may still need additional capital to fully implement our business, operating and development plans.
Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the
consequences could have a material adverse effect on our business, operating results, financial condition and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>Investors who buy shares
at different times will likely pay different prices.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Pursuant to the Equity Line
Purchase Agreement, we will have discretion, subject to market demand, to vary the timing, prices, and numbers of Shares sold to Tumim.
If and when we do elect to sell Shares to Tumim under the Equity Line Purchase Agreement, after Tumim has acquired such Shares, Tumim
may resell all or a portion of such Shares at any time or from time to time in its discretion and at different prices. As a result, investors
who purchase Shares from Tumim at different times will likely pay different prices for those Shares, and so may experience different levels
of dilution and in some cases substantial dilution and different outcomes in their investment results. Investors may experience a decline
in the value of the Shares they purchase from Tumim as a result of future sales made by us to Tumim at prices lower than the prices such
investors paid for their Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>We may require additional
financing to sustain our operations and without it we will not be able to continue operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Subject to the terms and
conditions of the Equity Line Purchase Agreement, as applicable, we may, at our sole discretion, direct Tumim to purchase up to $20.0&#160;million
of our Common Stock under the Equity Line Purchase Agreement from&#160;time to time&#160;over a 24-month&#160;period beginning on the
Commencement Date. The purchase price per share for the Shares that we may elect to sell to Tumim under the Equity Line Purchase Agreement
will fluctuate based on the market prices of our Common Stock during the applicable VWAP Purchase Valuation Period for each Purchase made
pursuant to the Equity Line Purchase Agreement. Accordingly, it is not currently possible to predict the number of Shares that will be
sold to Tumim, the actual purchase price per share to be paid by Tumim for such Shares, the actual gross proceeds to be raised in connection
with those sales, and whether or not we will need to register additional shares for resale by Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Assuming a purchase price
of $5.45 per share (which represents the Nasdaq official closing sale price of our Common Stock on the date the Equity Line Purchase Agreement
was executed), the purchase by Tumim of all the Shares under the Equity Line Purchase Agreement being registered for resale pursuant to
the Registration Statement of which this prospectus forms a part would result in aggregate gross proceeds to us of approximately $9.7
million, which is substantially less than the Total Commitment available to us under the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The extent to which we rely
on Tumim as a source of funding will depend on a number of factors, including the prevailing market price of our Common Stock and the
extent to which we are able to secure working capital from other sources. If obtaining sufficient funding from Tumim were to prove unavailable
or prohibitively dilutive, we may need to secure another source of funding in order to satisfy our working capital needs. Even if we were
to sell to Tumim all of the Shares available for sale to Tumim under the Equity Line Purchase Agreement, we will still need additional
capital to fully implement our business plan. Should the financing we require to sustain our working capital needs be unavailable or prohibitively
expensive when we require it, the consequences would have a material adverse effect on our business, operating results, financial condition
and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>Management will have
broad discretion as to the use of the proceeds from our sale of Shares to Tumim under the Equity Line Purchase Agreement, and such uses
may not improve our financial condition or market value.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We currently intend to use
the proceeds from any sales of Shares under the Equity Line Purchase Agreement for the working capital and general corporate purposes.
Our management will have broad discretion in the application of such proceeds, including for any of the purposes described in the section
titled &#8220;<i>Use of Proceeds</i>,&#8221; and we could spend the proceeds from the sale of Shares under the Equity Line Purchase Agreement,
if any, in ways our stockholders may not agree with or that do not yield a favorable return, or for corporate purposes that may not improve
our financial condition or advance our business objectives. You will not have the opportunity, as part of your investment decision, to
assess whether such proceeds are being used in a manner agreeable to you. You will be relying on the judgment of our management concerning
these uses and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately.
The failure of our management to apply these funds effectively could result in unfavorable returns and uncertainty about our prospects,
each of which could cause the price of our Common Stock to decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>Tumim may choose to
sell the Shares at prices below the current market price.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim is not restricted as to the prices at which
it may sell or otherwise dispose of the Shares covered by this prospectus. Sales or other dispositions of the Shares below the then-current
market prices could adversely affect the market price of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Neither we nor Tumim has authorized any other
party to provide you with information concerning us or this Offering.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You should carefully evaluate all of the information
in this prospectus. We may receive media coverage regarding the Company, including coverage that is not directly attributable to statements
made by our officers, that incorrectly reports on statements made by our officers or employees, or that is misleading as a result of omitting
information provided by us, our officers or employees. Neither we nor Tumim has authorized any other party to provide you with information
concerning us or this Offering, and recipients should not rely on this information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>You may experience future dilution as a result
of issuance of the Shares, future equity offerings by us and other issuances of our Common Stock or other securities. In addition, the
issuance of the Shares and future equity offerings and other issuances of our Common Stock or other securities may adversely affect our
Common Stock price.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Shares sold by Tumim will be freely tradable without
restriction or further registration under the Securities Act. As a result, a substantial number of shares of our Common Stock may be sold
in the public market following this Offering. If there are significantly more shares of our Common Stock offered for sale than buyers
are willing to purchase, then the market price of our Common Stock may decline to a market price at which buyers are willing to purchase
the offered Common Stock and sellers remain willing to sell our Common Stock. The issuance of the Shares or any future sales of a substantial
number of shares of our Common Stock in the public market, or the perception that such sales may occur, could also adversely affect the
price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common Stock or the availability
of those shares for sale will have on the market price of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, in order to raise additional capital,
we may in the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock
at prices that may not be the same as the price per share as prior issuances of Common Stock. We may not be able to sell shares of our
Common Stock or other securities in any other offering at a price per share that is equal to or greater than the price per share previously
paid by investors, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders.
The price per share at which we sell additional shares of our Common Stock or securities convertible into Common Stock in future transactions
may be higher or lower than the prices per share previously paid. You will incur dilution upon exercise of any outstanding stock options,
warrants or upon the issuance of shares of Common Stock under our stock incentive programs. In addition, the issuance of the Shares and
any future sales of a substantial number of shares of our Common Stock in the public market, or the perception that such sales may occur,
could adversely affect the price of our Common Stock. We cannot predict the effect, if any, that market sales of such shares of Common
Stock or the availability of such shares for sale will have on the market price of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>Future sales and issuances
of our Common Stock under the Equity Line Purchase Agreement or otherwise, or future sales of other securities, might result in significant
dilution and could cause the price of our Common Stock to decline.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">To raise capital, we may
sell our Common Stock, convertible securities or other equity securities in one or more transactions other than those contemplated by
the Equity Line Purchase Agreement, at prices and in a manner we determine from time to time. We may sell shares of our Common Stock or
other securities in any other offering at a price per share that is less than the price per share paid by Tumim, and Tumim or investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which
we sell additional shares of our Common Stock, or securities convertible or exchangeable into our Common Stock, in future transactions
may be higher or lower than the price per share paid by Tumim. Any sales of additional shares will dilute our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Sales of a substantial number
of shares of our Common Stock in the public market or the perception that these sales might occur could depress the market price of our
Common Stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict
the effect that sales may have on the prevailing market price of our Common Stock. In addition, the sale of substantial amounts of our
Common Stock could adversely impact its price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_007"></span>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This prospectus, together with any accompanying prospectus
supplement, may include &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act. All statements in this prospectus, together with any accompanying prospectus supplement, other than statements
of historical fact, are &#8220;forward-looking statements&#8221; for purposes of these provisions, including, without limitation, any
projections regarding the markets where we operate, any statements of the plans and objectives of our management for future operations,
any statements concerning proposed new products or services, any statements regarding expected capital expenditures, any statements regarding
future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All forward-looking statements
are made as of the date on which they were made and are based on information available to us as of such dates. We assume no obligation
to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as
&#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;should,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221;
&#8220;seeks,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;forecasts,&#8221; &#8220;continue,&#8221;
or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. Although we believe
that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such
expectations or any of the forward-looking statements will prove to be correct. Actual results will likely differ, and could differ materially,
from those projected or assumed in the forward-looking statements. Prospective investors are cautioned not to unduly rely on any such
forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Forward-looking statements are neither historical
facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding
the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions.
Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances
that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially
from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important
factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements
include, among others, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We operate in an extremely
competitive industry and are subject to pricing pressures.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a history of losses
and our audited financial statements include a statement that there is a substantial doubt about our ability to continue as a going concern.
As our costs increase, we may not be able to generate sufficient revenue to achieve and sustain profitability.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our business and future growth
depends on the needs and success of our customers, and we have substantial customer concentration.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to successfully
manage our growth.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may be negatively impacted
by public health epidemics or outbreaks, including the COVID-19 global pandemic, as well as uncertainty in global economic conditions.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may fail to expand our sales
and distribution channels and our ability to expend into international markets is uncertain.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nearly all of our raw materials
enter the United States through a limited number of ports, and we rely on third parties to store and ship some of our inventory; labor
unrest at these ports or other product delivery difficulties could interfere with our distribution plans and reduce our revenue.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government reviews, inquiries,
investigations, and actions could harm our business or reputation.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are dependent on third-party
manufacturers and suppliers, including suppliers located outside the United States, and our operating results could be adversely affected
by changes in the cost and availability of raw materials as well as increases in costs, disruption of supply, or shortage of any of our
battery components, such as electronic and mechanical parts, or raw materials used in the production of such parts.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely on two warehouse facilities
and if any of our facilities becomes inoperable for any reason or if our expansion plans fail, our ability to produce our products could
be negatively impacted.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lithium-ion battery cells have
been observed to catch fire or release smoke and flame, which may have a negative impact on our reputation and business.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We could face potential product
liability claims relating to our products, which could result in significant costs and liabilities, which would reduce our profitability.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations expose us to
litigation, tax, environmental, and other legal compliance risks.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our failure to introduce new
products and product enhancements and broad market acceptance of new technologies introduced by our competitors could adversely affect
our business.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to adequately
protect our proprietary intellectual property and technology and we may need to defend ourselves against intellectual property infringement
claims.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quality problems with our products
could harm our reputation and erode our competitive position.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to raise capital
in the future may be limited and our stockholders may be diluted by future securities offerings.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We depend on our senior management
team and other key employees, and significant attrition within our management team or unsuccessful succession planning could adversely
affect our business.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are an &#8220;emerging growth
company&#8221; and elect to comply with certain reduced reporting requirements applicable to emerging growth companies, which could make
our securities less attractive to investors.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All forward-looking statements attributable to us
or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Our actual results will likely
differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied
upon as predictions of future operating results, and we assume no obligation to update or disclose revisions to those estimates. If we
do update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates
or corrections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_008"></span>USE OF PROCEEDS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Shares offered by this prospectus are being registered
for the account of Tumim and we will not receive any proceeds from the resale of the Shares by Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may receive up to $20.0 million in aggregate
gross proceeds from sales of our Common Stock that we may elect to make to Tumim pursuant to the Equity Line Purchase Agreement from
time to time in our sole discretion, from and after the Commencement Date. We may use the proceeds from sales of our Common Stock to
Tumim for working capital and general corporate purposes. See &#8220;<i>Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations </i>&#8212; <i>Liquidity and Capital Resources</i>&#8221; and Note 5, 6, 7, 8, 9, and 15 to the
notes to our consolidated financial statements included elsewhere in this prospectus, and Notes 4, 5, 6, 7, 8, and 13to the notes to
our unaudited condensed consolidated financial statements included elsewhere in this prospectus for additional information regarding
our outstanding indebtedness, including the interest rates and maturity dates of such indebtedness. The proceeds of such
indebtedness were used for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our expected use of proceeds from sales of our Common
Stock that we may elect to make to Tumim pursuant to the Equity Line Purchase Agreement (if any) represents our intentions based on our
present plans and business conditions, which could change as our plans and business conditions evolve. The amounts and timing of our actual
expenditures will depend on numerous factors, including cash flows from operations, the extent and results of our research and development
efforts, the anticipated growth of our business, and other factors described under &#8220;<i>Risk Factors.</i>&#8221; We may find it necessary
or advisable to use such proceeds for other purposes, and, except as set forth above, we will have broad discretion in the application
of such proceeds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_009"></span>DETERMINATION OF OFFERING PRICE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We cannot currently determine the price or prices
at which the Shares may be sold by Tumim under this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_010"></span>MARKET INFORMATION AND DIVIDEND POLICY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Market Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our Common Stock began trading
on Nasdaq on April 1, 2022 under the symbol &#8220;XPON.&#8221; As of January 12, 2024, there were approximately 11 registered holders
of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Dividend Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have never declared or paid cash dividends on our
Common Stock. We do not anticipate declaring or paying any cash dividends on our Common Stock in the foreseeable future. See &#8220;<i>Description
of Capital Stock.</i>&#8221; We currently intend to retain all available funds and any future earnings to support our operations and finance
the growth and development of our business. Any future determination related to our dividend policy will be made at the discretion of
our Board and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual
restrictions, business prospects, and other factors our Board may deem relevant. &#8220;Further, the 3i Note and any future debt facilities
we may enter into may contain restrictions on our ability to pay dividends or make distributions, and any new credit facilities we may
enter into may contain similar restrictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_011"></span>DILUTION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The sale of our Common Stock to Tumim pursuant to
the Equity Line Purchase Agreement will have a dilutive impact on our stockholders. In addition, the lower our stock price is at the time
we exercise our right to sell Shares to Tumim, the more shares of our Common Stock we will have to issue to Tumim pursuant to the Equity
Line Purchase Agreement, as a result of which our existing stockholders would experience greater dilution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net tangible book value of our Common Stock as
of September 30, 2023 was approximately $6.8 million, or approximately $0.99 per share of Common Stock. Net tangible book value per share
of our Common Stock is determined by dividing the net of total tangible assets less total liabilities, by the aggregate number of shares
of Common Stock outstanding as of September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dilution per share represents the difference between
the assumed offering price per share of our Common Stock and the pro forma net tangible book value per share of our Common Stock included
in this Offering after giving effect to this Offering. Any sale of our Common Stock in this Offering at a price per share greater than
the net tangible book value per share will result in (after giving effect to estimated offering expenses payable by us) an increase in
our pro forma net tangible book value per share of Common Stock with respect to our existing stockholders and an immediate dilution in
net tangible book value per share of Common Stock to investors in shares of Common Stock in this Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">After giving effect to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the assumed sale of 1,781,978
Shares to Tumin pursuant to the Equity Line Purchase Agreement at an assumed sale price of $5.45 per Share (which is the Nasdaq official
closing price of the Common Stock on the date of the Equity Line Purchase Agreement); and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after deducting $80,000 in
estimated offering expenses payable by us,</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">our pro forma net tangible book value as of September
30, 2023 would have been approximately $16.5 million, or approximately $1.89 per share of Common Stock. This represents an immediate increase
in net tangible book value of $0.90 per share to our existing stockholders and immediate dilution of $1.08 per share to new investors
in this Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table illustrates this dilution on a
per share basis. The pro forma information is illustrative only and will adjust based on the actual number of Shares issued in this Offering
and other terms of this Offering determined at the time Shares are issued pursuant to this prospectus.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed offering price per share<sup>(1)</sup></span></td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">5.45</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt">&#160;Historical net tangible book value per share at September 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.99</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 20pt">Increase in net tangible book value per share attributable to this Offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.89</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Pro forma net tangible book value per share attributable to this Offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.90</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Dilution per share to new investors in this Offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.08</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assumed offering price
per share is the Nasdaq official closing price of the Common Stock on the date of the Equity Line Purchase Agreement.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our Common Stock that will be outstanding immediately after this Offering is based on 6,986,409 shares outstanding
as of January 12, 2024, and excludes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,000 shares of Common Stock
issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at an exercise price of $2.90 per
share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">521,825 <span style="background-color: white">shares
</span>of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at an exercise
price of $3.32 per share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,<span style="background-color: white">005
</span>shares of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at
an exercise price of $9.10 per share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000 shares of Common Stock
issuable upon the exercise of warrants to purchase Common Stock outstanding as of January 12, 2024, at an exercise price of $5.00 per
share;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000 <span style="background-color: white">shares
</span>of Common Stock issuable upon the exercise of options outstanding as of January 12, 2024, which were not issued under a specified
plan;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,111,585 shares of Common
Stock issuable upon the exercise of equity incentive awards outstanding under our 2021 Incentive Award Plan as of January 12, 2024;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">575,<span style="background-color: white">843
</span>shares of Common Stock available for future issuance under our 2021 Incentive Award Plan as of January 12, 2024;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any shares of Common Stock
available for future issuance under our 2021 Incentive Award Plan, which will continue to increase in future years pursuant to the plan&#8217;s
evergreen provision;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000 shares of Common
Stock available for future issuance under our 2021 Employee Stock Purchase Plan as of January 12, 2024;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of up to 779,669
shares of Common Stock, which consists of 727,387 shares issuable upon conversion of the 3i Note and up to 52,282 Interest Shares under
the Note Purchase Agreement; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any additional shares of Common
Stock we have issued or may issue from time to time after January 12, 2024.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To the extent that outstanding options or warrants
are exercised, or restricted stock awards are settled, you may experience further dilution. In addition, we may choose to raise additional
capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating
plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these
securities could result in further dilution to our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_012"></span>MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: #231F20"><i>The following discussion
of our financial condition and results of operations should be read in conjunction with our unaudited interim financial statements and
the related notes and other information for </i></span><i>the three and nine months ended September 30, 2023 and 2022 <span style="color: #231F20">and
our </span>audited financial statements and related notes for the fiscal years ended December 31, 2022 and 2021, included in our Annual
Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 30, 2023 (the </i>&#8220;<i>2022 Form 10-K</i>&#8221;<i>)<span style="color: #231F20">.
Historic results are not necessarily indicative of future results. Some of the information contained in this discussion and analysis or
set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business, includes forward-looking
statements based upon current plans, expectations and beliefs that involve risks and uncertainties. As a result of many factors, including
those factors set forth in the </span></i><span style="color: #231F20">&#8220;<i>Risk Factors</i>&#8221; <i>section of this prospectus,
our actual results could differ materially from the results described in or implied by these forward-looking statements. You should carefully
read the </i>&#8220;<i>Risk Factors</i>&#8221; <i>section to gain an understanding of the important factors that could cause actual results
to differ materially from our forward-looking statements. Please also see </i>&#8220;<i>Special Note Regarding Forward-Looking Statements.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>OVERVIEW</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 focuses on the design, assembly, manufacturing,
and sales of LiFePO4 batteries and supporting accessories for RVs, marine applications and recently announced our expansion into home
energy storage products with plans to expand into industrial applications. We design, assemble, and distribute high-powered, lithium battery
solutions using ground-breaking concepts with a creative sales and marketing approach. We believe that our product offerings include some
of the most dense and minimal-footprint batteries in the RV and marine industries. We are developing the e360 Home Energy Storage, a system
that we expect to significantly change the industry in barrier price, flexibility, and integration. We are deploying multiple intellectual
property strategies with cutting-edge research and unique products to sustain and scale the business. We currently have customers consisting
of dealers, wholesalers, private label customers and original equipment manufacturers who are driving revenue and brand awareness nationally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our main target markets are currently the RV and marine
industries. We believe that we are well-positioned to capitalize on the rapid market conversion from lead-acid to lithium batteries as
the primary method of power sourcing in these industries. Additional focus markets include home energy storage with our introduction of
two LiFePO4 battery storage solutions, where we aim to provide a cost-effective, low barrier of entry, flexible system for those looking
to power their homes via solar energy, wind, or grid back-up. Along with RV, marine and home energy storage markets, we aim to provide
additional capacities to the ever-expanding electric forklift and industrial material handling markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360&#8217;s e360 product line, which is manufactured
for the RV and marine industries, was launched in December 2020. The e360 product line, through its rapid sales growth, has shown to be
a preferred conversion solution for lead-acid batteries. In December 2023, we announced our entrance into the home energy storge market
with our introduction of two premium LiFePO4 battery storage solutions that enable residential and small business customers to create
their own stable micro-energy grid and lessen the impact of increasing power fluctuations and outages. We believe that our e360 Home Energy
Storage system has strong revenue potential with recurring income opportunities for us and our associated sales partners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our products provide numerous advantages for various
industries that are looking to migrate to lithium-based energy storage. They incorporate detailed-oriented design and engineering and
strong case materials and internal and structural layouts, and are backed by responsive customer service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>RECENT DEVELOPMENTS AND TRENDS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recent Developments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, John Yozamp retired as our Chief
Business Development Officer. In connection with Mr. Yozamp&#8217;s retirement, the Company and Mr. Yozamp entered into: (i) a consulting
agreement pursuant to which Mr. Yozamp has agreed to provide services as our independent sales representative for a period of six months,
subject to extension or earlier termination as provided for in the agreement, and (ii) a standard release agreement pursuant to which
Mr. Yozamp agreed to release certain claims against us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, we entered into a securities purchase
agreement (the &#8220;Note Purchase Agreement&#8221;) with 3i, LP (&#8220;3i&#8221;) pursuant to which we sold, and 3i purchased: (i)
a senior unsecured convertible note we issued in the aggregate principal amount of $2,750,000, with an 10.0% original issue discount and
an interest rate of 9.0% per annum (the &#8220;3i Note&#8221;), (ii) up to $247,500 in newly issued shares of Common Stock (the &#8220;Interest
Shares&#8221;), which may be payable, at our option and subject to the fulfillment of certain conditions set forth in the 3i Note, to
satisfy interest payments under the Note, and 63,497 shares of Common Stock, which is equal to $300,000 of shares of Common Stock calculated
as of the date of the Note Purchase Agreement issued to 3i as consideration for its commitment to purchase the Note (collectively, the
&#8220;3i Note Transaction&#8221;). The 3i Note is convertible into a maximum of 727,387 shares of Common Stock. The conversion of the
3i Note is subject to the terms of the Note Purchase Agreement, including the beneficial ownership limitations and share issuance caps
specified therein. In connection with the 3i Note Transaction, we filed a <span style="background-color: white">prospectus supplement
with the SEC pursuant to Rule&#160;</span>424(b)<span style="background-color: white">&#160;under the&#160;</span>Securities Act<span style="background-color: white">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Key Factors Affecting Our Operating Results</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our operating results and financial performance are
significantly dependent on the following factors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Consumer Demand</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although most of our current sales are generated through
dealers, wholesalers and original equipment manufacturers (&#8220;OEM&#8221;) focused on the RV and marine markets, ultimate demand for
our products is reliant on demand from consumers. Our sales are completed on a purchase order basis, and most are without firm, long-term
revenue commitments or sales arrangements, which we expect to continue going forward. Therefore, our future sales will be subject to risks
and uncertainties related to end user demand.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Demand from end users is affected by a number of factors
which may include fuel costs, overall macroeconomic conditions, and travel restrictions (resulting from COVID-19 or otherwise). During
the COVID-19 pandemic, the increased adoption of the RV lifestyle benefited battery suppliers. However, more recently we have seen a rise
in fuel costs, higher interest rates, and other changes in macroeconomic conditions which have created a decrease in end user spending
decisions which is affecting our markets. These conditions could have a negative effect on our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While RV and marine applications drive current revenues,
Expion360 announced in December 2023 its entry into the home energy storage market with its introduction of two LiFePO4 battery storage
solutions. Our e360 Home Energy Storage System aims to provide a cost-effective, low barrier of entry, flexible system for those looking
to power their homes via solar energy, wind, or grid back-up. We see the vision of stored energy as a portable, moving concept, where
stored energy can be transported from the home to other devices outside of it. The success of our strategy requires (1) continued growth
of these addressable markets in line with our expectations and (2) our ability to successfully enter these markets. We expect to incur
significant marketing costs understanding these new markets, and researching and targeting customers in these end markets, which may not
result in sales. If we fail to execute on this growth strategy in accordance with our expectations, our sales growth would be limited
to the growth of existing products and existing end markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Manufacturing and Supply Chain</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our batteries are manufactured by multiple third-party
manufacturers located in China, who also produce our battery cells. We then assemble and package the batteries in the United States for
sale to our customers. While we do not have long-term purchase arrangements with our third-party manufacturers and our purchases are completed
on a purchase order basis, we have had strong relationships with our third-party manufacturers spanning many years. Our close working
relationships with our China-based third-party manufacturers and cell suppliers, reflected in our ability to increase our purchase order
volumes (qualifying us for related volume-based discounts) and to order and receive delivery of cells in anticipation of required demand,
has helped us moderate increased supply-related costs associated with inflation, currency fluctuations, and U.S. government tariffs imposed
on our imports and to avoid potential shipment delays. We aim to maintain an appropriate level of inventory to satisfy our expected supply
requirements. We believe that we could locate alternative third-party manufacturers to fulfill our needs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our third-party manufacturers source the raw materials
and battery components required for the production of our batteries directly from third party suppliers that meet our approval and quality
standards, and as a result, we may have limited control over the agreed pricing for these raw materials and battery components. We estimate
that raw material costs account for over half of our cost of goods sold. The costs of these raw materials, particularly lithium-ion batteries,
are volatile and beyond our control. Additionally, availability of the raw materials used to manufacture our products may be limited at
times, resulting in higher prices and/or the need to find alternative suppliers. For example, a global shortage and component supply disruptions
of electronic battery components were reported during 2021 and 2022, but it is not currently affecting our supply chain. Our battery cell
manufacturers also have joint venture factories outside of China and have secured sourcing contracts from lithium suppliers in South America
and Australia. In addition, we secured a secondary source for lithium iron phosphate cells used in its batteries from a supplier in Denmark,
enabling us to source materials outside of China in the event it becomes necessary to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Product and Customer Mix</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023, we sell eight models of LiFEPO4
batteries, the AURA POWERCAP, and individual or bundled accessories for battery systems, two of which we have released over the last 12
months. Our products are sold to different customers (<i>i.e.</i>, dealers, wholesalers, OEMs, etc.) at differing prices and have varying
costs. The average selling price and costs of goods sold for a particular product, will vary with changes in the sales channel mix, volume
of products sold, and the prices of such products sold relative to other products. While we work with our suppliers to limit price and
supply cost increases, our products may see price increases resulting from a rise in supply costs due to currency fluctuations, inflation,
and tariffs. Accessory and OEM sales typically have lower average selling prices and resulting margins which could decrease our margins
and therefore negatively affect our growth or require us to increase the prices of our products. However, the benefits of increased sales
volumes typically offset these reductions. The relative margins of products sold also impact our results of operation. As we introduce
new products, we may see a change in product and sales channel mix which could result in period-to-period fluctuations in our overall
gross margin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Competition</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compete with both traditional lead-acid and lithium-ion
battery manufacturers that primarily either import their products or components or manufacture products under a private label. As we develop
new products and expand into new markets, we may experience competition with a broader range of companies. These companies may have more
resources than us and be able to allocate more resources to their current and future products. Our competitors may source products or
components at a lower cost than us which may require us to evaluate our own costs, lower our product prices, or increase our sales volume
to maintain our expected profitability levels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Research and Development</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We anticipate that additional investments in our infrastructure
and research and development spending will be required to scale our operations and increase productivity, to address the needs of our
customers, to further develop and enhance our service, and to expand into new geographic areas and market segments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">New technologies are rapidly emerging in the markets
where we conduct business and many new energy storage technologies have been introduced over the past several years. Our ability to achieve
significant and sustained penetration of key developing markets, including the RV and marine markets, will depend upon our success in
developing these and other technologies, either independently, through joint ventures, or through acquisitions, which in each case may
require significant capital and commitment of resources to research and development. As a result, we may need to raise additional funds
for these research and development efforts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>KEY LINE ITEMS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Revenue</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our revenue is generated from the sale of products
consisting primarily of batteries and accessories. We recognize revenue when control of goods or services is transferred to its customers
in an amount that reflects the consideration it is expected to be entitled to in exchange for those goods or services. All of our sales
are primarily within the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cost of Sales</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our primary cost of sales as a percentage of sales
is related to our direct product and landing costs. Direct labor costs consist of payroll costs (including taxes and benefits) of employees
directly engaged in assembly activities. Per full absorption cost accounting, overhead related to our cost of sales is added, consisting
primarily of warehouse rent and utilities. The costs can increase or decrease based on costs of product and assembly parts (purchased
at market pricing), customer supply requirements, and the amount of labor required to assemble a product, along with the allocation of
fixed overhead.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Selling, General and Administrative Expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling, general and administrative expenses consist
primarily of salaries, benefits, and sales and marketing costs. Other costs include facility and related costs, professional fees and
other legal expenses, consulting, and tax and accounting services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Interest and Other Income, net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest expense consists of interest costs on loans
with interest rates ranging from 3.75% to 10.0% and amortization of debt issuance costs. As of September 30, 2023, all debt issuance costs
have been fully amortized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Provision for Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to corporate federal and state income
taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets, including tax loss
and credit carryforwards, and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in
which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period that included the enactment date. Deferred income tax expense represents the change
during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when,
in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have adopted the provisions in ASC 740, Income
Taxes, related to accounting for uncertain tax positions. It requires that the Company recognize the impact of a tax position in the financial
statements if the position is more likely than not to be sustained upon examination and on the technical merits of the position. Management
has concluded that there were no material unrecognized tax benefits as of September 30, 2023 or December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our practice is to recognize interest and/or penalties
related to income tax matters in income tax expense. We had no accrual for interest or penalties on our balance sheet at September 30,
2023 or December 31, 2022 and recognize interest and/or penalties in the statement of operations for the years ended September 30, 2023
and 2022, since there are no material unrecognized tax benefits. Management believes no material change to the amount of unrecognized
tax benefits will occur within the next twelve months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Off-Balance Sheet Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have no material off-balance sheet arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS
ENDED SEPTEMBER 30, 2023 AND 2022 (UNAUDITED)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth certain operational
data as a percentage of sales:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
Months Ended</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
Months Ended</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
30,</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
30,</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.2</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.7</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross profit</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.1</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.8</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling, general, and administrative
expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121.2</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.2</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124.2</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(96.2</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(91.0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97.5</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(78.5</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expense - net</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.1</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(95.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(92.5</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(102.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(105.7</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(96.0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(92.5</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(102.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(105.7</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Sales, net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales, net for the three months ended September 30,
2023 increased by $507,000, or 36.7%, compared to the three months ended September 30, 2022. Sales were $1.4 million for the three months
ended September 30, 2022 and $1.9 million for the three months ended September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The increase for the three-month period was primarily
attributable to our expanded relationships with OEMs and integration partners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales, net for the nine months ended September 30,
2023 decreased by $619,000, or 10.8%, compared to the nine months ended September 30, 2022. Sales were $5.7 million for the nine months
ended September 30, 2022 and $5.1 million for the nine months ended September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The decrease for the nine-month period was primarily
attributable to a large initial stocking order for one of our resellers which was fulfilled in the first and second quarters of 2022.
Additionally, the second quarter of 2022 included back orders that were fulfilled with inventory purchased with initial public offering
proceeds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cost of Sales</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total cost of sales for the three months ended September
30, 2023 increased by $437,000, or 44.6%, compared to the three months ended September 30, 2022. Cost of sales were $980,000 for the three
months ended September 30, 2022 and $1.4 million for the three months ended September 30, 2023. Cost of sales as a percentage of sales
increased by 4.1% in that period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The percentage increase in cost of sales as a percentage
of sales for the three-month period was primarily due to changes in our product mix that resulted in reduced margins, the purchase of
tooling and molds to continue intellectual property development, and increased warehouse capacity needs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total cost of sales for the nine months ended September
30, 2023 decreased by $18,000, or 0.5%, compared to the nine months ended September 30, 2022. Cost of sales were $3.8 million for the
nine months ended September 30, 2022 and $3.8 million for the nine months ended September 30, 2023. Cost of sales as a percentage of sales
increased by 7.6% in that period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The percentage increase in cost of sales as a percentage
of sales for the nine-month period was primarily related to the lower sales volume resulting in lower absorption of our fixed facilities
costs and labor, along with changes in product mix related to sales, discount levels related to specific customer groups, purchases of
tooling and molds, and supplier and shipping costs, which we are currently monitoring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Gross Profit</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our gross profit for the three months ended September
30, 2023 increased by $70,000, or 17.3%, compared to the three months ended September 30, 2022. Gross profit was $403,000 for the three
months ended September 30, 2022 and $473,000 for the three months ended September 30, 2023. Gross profit as a percentage of sales decreased
by 4.1% for that period, from 29.1% for the three months ended September 30, 2022 to 25.0% for the three months ended September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The decrease in gross profit as a percentage of sales
for the three-month period was primarily attributable to changes in our product mix that resulted in reduced margins, the purchase of
tooling and molds to continue intellectual property development, and increased warehouse capacity needs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our gross profit for the nine months ended September
30, 2023 decreased by $601,000, or 30.5%, compared to the nine months ended September 30, 2022. Gross profit was $2.0 million for the
nine months ended September 30, 2022 and $1.4 million for the nine months ended September 30, 2023. Gross profit as a percentage of sales
decreased by 7.6% for that period, from 34.3% for the nine months ended September 30, 2022 to 26.8% for the nine months ended September
30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The decrease in gross profit as a percentage of sales
for the nine-month period was primarily attributable to the lower sales volume resulting in lower absorption of our fixed facilities costs
and labor, along with changes in product mix related to sales, discount levels related to specific customer groups, purchase of tooling
and molds, and supplier and shipping costs, which we are currently monitoring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Selling, General and Administrative Expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling, general and administrative expenses increased
by $629,000, or 37.8%, compared to the three months ended September 30, 2022. Selling, general and administrative expenses were $1.7 million
for the three months ended September 30, 2022 compared to $2.3 million for the three months ended September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling, general and administrative expenses decreased
by $116,000, or 1.8%, compared to the nine months ended September 30, 2023. Selling, general and administrative expenses were $6.5 million
for the nine months ended September 30, 2022 compared to $6.4 million for the nine months ended September 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The change in the three months ended September 30,
2023 is primarily due to increases in salary and benefits, legal and professional, and research and development. A significant portion
of our increased research and development expense was related to new product development, such as our new home energy storage solution
and our most energy dense 4.5 Ah battery cell which we introduced in the third quarter of 2023. The change in the nine months ended September
30, 2023 is primarily due to a decrease in non-cash stock-based compensation under salary and benefits, which was partially offset by
an increase in legal and professional services, research and development, and sales and marketing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Presented in the table below is the composition of
selling, general and administrative expenses:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                           Months Ended  </b></span></p>
                                           <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;September
                                           30,</b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine
                                           Months Ended &#160;</b></span></p>
                                           <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>September
                                           30,</b></span></p></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries and benefits</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">922,110</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">723,225</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,547,848</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,153,793</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal and professional</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">586,183</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,726</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,608,428</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">518,258</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales and marketing</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238,163</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,994</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">690,995</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">527,732</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145,111</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,355</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,369</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153,730</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rents, maintenance, utilities</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137,390</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,640</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,191</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,437</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software, fees, tech support</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,795</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,633</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,976</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127,694</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,298</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,564</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,438</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,718</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,033</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,112</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,480</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,005</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,513</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,676</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,055</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,077</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplies, office</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,719</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,796</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,431</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118,764</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,640</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,284</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,303</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,746</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,290,955</span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,662,005</span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,363,514</span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,479,954</span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Other (Income) / Expense</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our other (income)/expense for the three months ended
September 30, 2023 and 2022 was ($6,000) and $20,000, respectively. Other income for the three months ended September 30, 2023 was made
up of interest income related to investments and interest expense related to debt. Other expense for the three months ended September
30, 2022 was made up almost entirely of interest expense related to debt, partially offset by gains on sale of property and equipment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our other (income) / expense for the nine months ended
September 30, 2023 and 2022 was $276,000 and $1.6 million, respectively. Other (income) / expense for the nine months ended September
30, 2023 was made up almost entirely of interest income related to investments, interest expense related to debt, and settlement expense.
Other expense for the nine months ended September 30, 2022 was made up almost entirely of interest expense of debt obligations and the
amortization of debt discount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended September 30, 2023 and
2022, non-cash amortization of debt discount totaled $0 and $0, respectively. Interest expense attributable to debt obligations totaled
$27,000 and $34,000 during the three months ended September 30, 2023 and 2022, respectively. During the nine months ended September 30,
2023 and 2022, non-cash amortization of debt discount totaled $0 and $1.20 million, respectively. Interest expense attributable to debt
obligations totaled $92,000 and $375,000 during the nine months ended September 30, 2023 and 2022, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2022, with the use of proceeds from the initial
public offering, the Company paid off approximately $2.46 million in debt with interest rates ranging from 10 to 15%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Net Loss</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our net loss for the three months ended September
30, 2023 and 2022 was $1.8 million and $1.3 million, respectively. Our net loss for the nine months ended September 30, 2023 and 2022
was $5.3 million and $6.1 million, respectively. The increase in net loss for the three months ended September 30, 2023 was primarily
due to increases in legal and professional fees, salary and benefits, and research and development. The decrease in net loss for the nine
months ending September 30, 2023 was primarily the result of decreased interest expense, and salary and benefits, which were partially
offset by an increase in legal and professional fees. Within other expenses, for the nine months ended September 30, 2023, the Company
recognized $281,680 in non-cash stock-based settlement expenses, compared to $0 for the period ended September 30, 2022. See Item 1, &#8220;<i>Legal
Proceedings</i>,&#8221; of Part II Other Information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>RESULTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER
31, 2022 AND 2021</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth certain operational
data as a percentage of sales:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal Year Ended
12/31/2022</b></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal Year Ended
&#160; 12/31/2021</b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of Net sales</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of Net sales</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,162,837</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,517,499</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,874,392</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.1</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,871,770</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.6</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross profit</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,288,445</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,645,729</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.4</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling, general, and administrative
expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,241,859</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115.1</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,909,085</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64.4</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,953,414</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-83.1</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,263,356</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-28.0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expense - net</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,591,976</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-22.2</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,448,202</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,545,390</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-105.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,711,558</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-104.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,536,540</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-105.2</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,720,858</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-104.5</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Sales, net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales, net for the year ended December 31, 2022 increased
by $2.6 million, or 58.6%, compared to the year ended December 31, 2021. Sales were $4.5 million for the year ended December 31, 2021
and $7.2 million for the year ended December 31, 2022. The year over year increase was primarily attributable to increases in our overall
sales volumes as a result of our expanding product offerings, growing distribution network, and expanded OEM market penetration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cost of Sales</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total cost of sales for the year ended December 31,
2022 increased by $2.0 million, or 69.7%, compared to the year ended December 31, 2021. Cost of sales were $2.9 million for the year ended
December 31, 2021 and $4.9 million for the year ended December 31, 2022. Cost of sales as a percentage of sales increased by 4.5% in that
period. The increase in cost of sales was primarily related to increases in facilities costs and labor as we expanded our operations,
and in supplier and shipping costs, which the Company is currently monitoring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Gross Profit</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our gross profit for the year ended December 31, 2022
increased by $643,000, or 39.1%, compared to the year ended December 31, 2021. Gross profit was $1.6 million for the year ended December
31, 2021 and $2.3 million for the year ended December 31, 2022. Gross profit as a percentage of sales decreased by 4.5% for the year ended
December 31, 2022, from 31.9% to 36.4% for the year ended December 31, 2021. The decrease in gross profit for the year ended December
31, 2022 was primarily attributable to increases in facilities costs and labor as we expanded our operations, and in landed costs, which
the Company is currently monitoring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Selling, General and Administrative Expenses</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling, general and administrative expenses increased
by $5.3 million, or 183%, to $8.2 million for the year ended December 31, 2022 compared to $2.9 million for the year ended December 31,
2021, primarily due to increased costs to support our growth in sales and business development efforts along with various expenses that
were incurred due to planning and preparing for our initial public offering. The most substantial increases were in salaries and benefits,
of which $2,114,529 was a non-cash expense attributable to stock-based compensation, legal and professional services incurred in anticipation
of our initial public offering, sales and marketing, and rents and utilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Presented in the table below is the composition of
selling, general and administrative expenses:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
Year Ended December 31,</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries
and benefits</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,864,239</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,232,660</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal and
professional</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">887,741</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">754,510</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales and
marketing</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">677,679</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,431</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rents, maintenance,
utilities</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">616,141</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,600</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,382</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,544</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">217,626</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,354</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software,
fees, tech support</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,222</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,613</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,353</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,100</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplies,
office</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,187</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,448</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,202</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,563</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,087</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,262</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,241,859</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,909,085</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Other Expense</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our other expense for the year ended December 31,
2022 and 2021 was $1.6 million and $3.4 million, respectively. Other expense for the year ended December 31, 2022 was made up almost entirely
of interest expense. Other expense for the year ended December 31, 2021 was primarily attributable to extinguishment loss on debt settlement.
The extinguishment of debt was related to settlement on convertible notes issued in 2021. The noteholders agreed to settle the debt for
an aggregate 1,527,647 shares of common stock with a fair value of $5,545,359 ($3.63 per share). Since this transaction involved contemporaneous
issuance of shares of common stock by the Company to the converting noteholders, we evaluated the transaction for modification and extinguishment
accounting and determined that the debt was extinguished as a result of the issuance of shares that do not represent the exercise of a
conversion right contained in the original terms of the notes at issuance. The settlement of the debt resulted in a recognized loss of
$2,262,658 recorded as extinguishment loss on debt settlement on the accompanying statements of operations, calculated as the excess of
the fair value of the shares issued over the carrying amount of the debt. In addition, the fair value of warrants of $407,700 issued in
exchange for services related to obtain the notes and the unamortized portion of debt discount remaining at date of settlement of $120,729
were also recorded as extinguishment loss on debt settlement for an aggregate loss of $2,791,087 on the accompanying statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2022 and 2021,
non-cash amortization of debt discount totaled $1.2 million and $118,000, respectively. Interest expense attributable to debt obligations
totaled $409,000 and $436,000 during the year ended December 31, 2022 and 2021, respectively. In April 2022, with the use of proceeds
from the IPO, the Company paid off approximately $2.46 million in debt with interest rates ranging from 10% to 15%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Net Loss</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our net loss for the years ended December 31, 2022
and 2021 was $7.5 million and $4.7 million, respectively. The increase in net loss was primarily the result of increased selling, general,
and administrative expenses as we invested in human resources, facilities, and business development in preparation of our expanded growth
objectives along with an increase in legal and professional costs in connection with our initial public offering. Additionally, for the
year ended December 31, 2022, the Company recognized $2.1 million in non-cash expenses related to stock-based compensation, compared to
$188,000 for the year ended December 31, 2021. Further, for the year ended December 31, 2022, the Company recognized non-cash interest
expense of approximately $1.2 million. Therefore, of the $7.5 million net loss for the year ended December 31, 2022, a total of $3.3 million
was non-cash expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>LIQUIDITY AND CAPITAL RESOURCES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Overview</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our operations have been financed primarily through
net proceeds from the sale of securities and from borrowings. As of December 31, 2022 and 2021, our current assets exceeded current liabilities
by $10.8 million and $3.2 million, respectively, and we had cash and cash equivalents of $7.2 million and $773,000, respectively. On April
1, 2022, we closed our initial public offering which resulted in approximately $14.8 million of net proceeds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2023 and December 31, 2022, our
current assets exceeded current liabilities by $5.9 million and $10.8 million, respectively, and we had cash and cash equivalents of $2.9
million and $7.2 million, respectively. On April 1, 2022, we closed our initial public offering which resulted in approximately $14.8
million of net proceeds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We generally consider our short-term liquidity requirements
to consist of those items that are expected to be incurred within the next 12 months and believe those requirements to consist primarily
of funds necessary to pay operating expenses, interest and principal payments on our debt, and capital expenditures related to assembly
line expansion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022, we expect our short-term
liquidity requirements to include (a) approximately $379,000 of capital additions; (b) principal debt payments totaling approximately
$571,000; and (c) lease obligation payments of approximately $719,000, including imputed interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2023, we expect our short-term
liquidity requirements to include (a) approximately $270,000 of capital additions; (b) principal debt payments totaling approximately
$675,000; and (c) lease obligation payments of approximately $731,000, including imputed interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We generally consider our long-term liquidity requirements
to consist of those items that are expected to be incurred beyond the next 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our activities are subject to significant risks and
uncertainties, including failing to secure additional funding before the Company achieves sustainable revenues and profit from operations.
We expect to continue to incur additional losses for the foreseeable future, and we may need to raise additional debt or equity financing
to expand our presence in the marketplace, develop new products, achieve operating efficiencies, and accomplish its long-term business
plan over the next several years. There can be no assurance as to the availability or terms upon which such financing and capital might
be available. For the three and nine months ended September 30, 2023 and 2022, we sustained recurring losses and negative cash flows from
operations. These factors raise substantial doubt about our ability to continue as a going concern within 12 months after the date that
the financial statements for the period ended September 30, 2023 are issued. However, management is working to address its cash flow challenges,
including raising additional capital, managing inventory levels, identifying alternative supply chain resources, and managing operational
expenses. See also the risk factor entitled &#8220;<i>Our audited financial statements include a statement that there is a substantial
doubt about our ability to continue as a going concern and a continuation of negative financial trends could result in our inability to
continue as a going concern</i>&#8221; in Item 1A, &#8220;Risk Factors&#8221; of our 2022 Form 10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Financing Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 1, 2022, we closed our initial public offering
which resulted in approximately $14.8 million of net proceeds, of which approximately $2,464,000 was used to pay down principal and accrued
interest on high interest-bearing debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2023, our debt totaled $361,000,
comprised of $148,000 outstanding under a COVID-19 Economic Injury Disaster Loan, $207,000 outstanding under vehicle financing arrangements,
and an equipment loan for $7,000. In January 2023, we repaid a vehicle loan with an interest rate of 11.21% in the amount of $89,360 which
included principal, interest, and fees. In May 2023, we sold a vehicle including repayment of the related vehicle loan with an interest
rate of 5.89% in the amount of $31,568 which included principal and interest. In addition, as of September 30, 2023, we had outstanding
stockholder loans totaling $825,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stockholder Promissory Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unsecured promissory notes due to stockholders had
an outstanding principal balance of $825,000 as of September 30, 2023. The unsecured promissory notes require monthly interest-only payments
at 10% per annum and mature at various dates from January 2024 to December 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Vehicle Financing Arrangements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2023, the Company has five notes
payable to GM Financial for vehicles. In addition, the commercial line secured in April 2022 for $300,000 was renewed in April 2023 and
increased to $350,000. This commercial line may be used to finance vehicle purchases and expires in April 2024. The notes are payable
in aggregate monthly installments of $4,084, including interest at rates ranging from 5.89% to 7.29% per annum, mature at various dates
from October 2027 to May of 2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder
of the Company. A separate vehicle financing note has a current balance outstanding of $16,000, with monthly payments of $508 at an interest
rate of 5.45% and a maturity date of July 2026. See Note 7, <i>Long-Term Debt</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cash Flows</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following tables shows summaries of our cash flows
for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
Ended <br/>
December 31,</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
<td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
<td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,468,572</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,896,830</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash
used in investing activities</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(515,692</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(113,694</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash
provided by financing activities</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,412,270</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,493,087</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine
                                           Months Ended </b></span></p>
                                           <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;
                                           September 30,</b></span></p></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by / (used in) operating activities</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,207,717</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,699,620</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash
provided by / (used in) investing activities</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,578</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(382,779</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash
provided by / (used in) financing activities</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99,209</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,426,190</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cash flows used in operating activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our largest source of operating cash is cash collection
from sales of our products. Our primary use of cash in operating activities are for increases in inventory purchases, legal and professional
services, increased marketing, and research and development. In the last several years, we have generated negative cash flows from operating
activities and have supplemented working capital requirements through net proceeds from the sales of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generated negative cash flows from operating activities of $5.5 million for the year ended December 31, 2022, compared to negative cash
flows of $3.9 million for the corresponding period in 2021. Factors affecting operating cash flows during the periods included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December
31, 2022, our loss of $7.5 million was reduced by non-cash transactions including stock-based compensation of $2.1 million, amortization
of debt discount on convertible notes of $1.2 million, and depreciation of $165,000. For the year ended December 31, 2021, our loss of
$4.7 million was reduced by non-cash transactions including extinguishment loss on debt settlement of $2.8 million related to the settlement
of convertible notes issued in 2021, stock-based compensation of $188,000, amortization of debt discount on convertible notes of $118,000,
and debt conversion expense on induced conversion of $112,000.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash provided/(used) by accounts
receivable was $458,000 and ($566,000), for the year ended December 31, 2022 and 2021, respectively, representing a decrease in accounts
receivable for the year ended December 31, 2022 and an increase in accounts receivable for the year ended December 31, 2021, respectively.
Sales are generally collected within 30 to 45 days. These changes are mainly due to timing where a few large orders were placed and had
open balances as of December 31, 2021, but they were within payment terms.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other significant changes include
a decrease in customer deposits of $437,000 during the year ended December 31, 2022, representing a use of cash in 2022 that customers
deposited in 2021. Additionally, long-term deposits had no change during the year ended December 31, 2022 compared to an increase of
$56,000 for the corresponding period in 2021. The increase in deposits in 2021 was primarily due to the addition of lease properties
with corresponding security deposits paid in late 2021. No new deposits were made in 2022.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash used for inventory and
prepaid inventories increased by $1.5 million and $2.4 million for the years ended December 31, 2022 and 2021, respectively. These increases
are primarily due to significant purchases and prepayments of inventory to Chinese suppliers that were made in 2022 in order to have
sufficient inventory for projected sales in 2022 and 2023. Turnaround time for receiving inventory from foreign sources can take up to
120 days, with prepayments required. Sales for the year ended December 31, 2022 increased over sales for the year ended December 31,
2021 by $2.6 million.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generated negative cash flows from operating activities of $4.2 million for the nine months ended September 30, 2023, compared to negative
cash flows of $4.7 million for the corresponding period in 2022. Factors affecting operating cash flows during the periods included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September
30, 2023, our loss of $5.3 million was reduced by non-cash transactions including a stock-based settlement of $252,000, stock-based compensation
of $190,000, and depreciation of $154,000. For the nine months ended September 30, 2022, our loss of $6.1 million was adjusted and reduced
by non-cash transactions including stock-based compensation of $2.1 million, amortization of debt discount of $1.2 million, and depreciation
of $116,000.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable increased
by $156,000 and decreased by $475,000 for the nine months ended September 30, 2023 and 2022, respectively. Sales are generally collected
within 30 to 45 days. These changes are mainly due to timing where a few large orders were placed and had open balances at a given date.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable increased
by $207,000 and decreased by $87,000 for the nine months ended September 30, 2023 and 2022, respectively. These changes are mainly due
to timing of when payments are due. Payments are generally made within 30 days.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash used for inventory and
prepaid inventories decreased by $411,000 and increased by $2.2 million for the nine months ended September 30, 2023 and 2022, respectively.
The changes are primarily due to timing of significant purchases and prepayments of inventory to foreign suppliers. Turnaround time for
receiving inventory from foreign sources can take up to 120 days, with prepayments required.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other significant changes include:</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits increased
$46,000 during the nine months ended September 30, 2023 and decreased $275,000 during the nine months ended September 30, 2022. These
changes are mainly due to timing of customers paying deposits for customer orders and then placing orders against which the deposits
are applied.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other
current assets increased $46,000 and $134,000 for the nine months ended September 30, 2023 and 2022, respectively. These changes are
mainly due to the timing of the prepayments versus the expenses being incurred.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cash flows provided by / (used in) investing activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We used cash in investing activities of $516,000 for
the year ended December 31, 2022. Cash used for capital purchases of property and equipment related to expanding and improving our facilities
and infrastructure was $567,000 during the year ended December 31, 2022. This was offset by net proceeds of $52,000 received for the sale
of property and equipment during the year ended December 31, 2022. We anticipate that we will spend up to $379,000 in 2023 as we continue
to automate our new assembly line and enhance our quality control measures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net cash used in investing activities of $114,000
for the year ended December 31, 2021 consisted entirely of purchases of property and equipment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash was provided by investing activities in the amount
of $17,000 for the nine months ended September 30, 2023, and cash was used in investing activities in the amount of $383,000 for the nine
months ended September 30, 2022. We have had fewer purchases of property and equipment in the nine months ended September 30, 2023 than
we had in the same period in 2022. We have also received proceeds from selling property and equipment in the nine months ended September
30, 2023 that we did not have in the same period in 2022. We anticipate that we will spend up to $270,000 in the fourth quarter of 2023
as we continue to enhance our quality control measures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cash flows provided by / (used in) financing activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash provided by financing activities was $12.4 million
for the year ended December 31, 2022. For the year ended December 31, 2022, we paid down debt principal of $2.4 million, which was offset
by net cash proceeds of $14.8 million from the sale of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Net cash provided by financing activities of $4.5 million for the year
ended December 31, 2021, consisted of $4.2 million net proceeds from issuance of convertible notes and long-term debt, proceeds of $838,000
from the issuance of membership units/common stock, and proceeds of $125,000 on sale of future revenues. This was partially offset by
payments on debt and liability of future revenues of $636,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash used in financing activities was $99,000 for
the nine months ended September 30, 2023 and cash provided by financing activity was $12.4 million for the nine months ended September
30, 2022. For the nine months ended September 30, 2023, we paid down debt principal of $149,000, which was offset by net cash proceeds
of $50,000 from the exercise of warrants. For the nine months ended September 30, 2022, we had net proceeds from the issuance of Common
Stock of $14.8 million due to the initial public offering, paid down debt principal of $1.8 million, and paid lines of credit of $550,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Contractual and Other Obligations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our estimated future obligations consist of long-term
operating lease liabilities. As of September 30, 2023, the Company had $2.9 million in long-term operating lease liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>CRITICAL ACCOUNTING POLICIES AND ESTIMATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The above discussion and analysis of our financial
condition and results of operations is based upon our financial statements. The preparation of financial statements in conformity with
GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses,
and disclosures of contingent assets and liabilities. Our significant accounting policies are described in Note 2 of the accompanying
unaudited interim financial statements. Critical accounting policies are those that we consider to be the most important in portraying
our financial condition and results of operations and also require the greatest number of judgments by management. Judgments or uncertainties
regarding the application of these policies may result in materially different amounts being reported under different conditions or using
different assumptions. We consider the following policies to be the most critical in understanding the judgments that are involved in
preparing the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Inventory</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is stated at the lower of cost (first in,
first out) or net realizable value and consists of batteries and accessories, resale items, components, and related landing costs. As
of September 30, 2023 and December 31, 2022, the Company had inventory that consisted of finished assemblies totaling $3,306,972 and $3,243,485,
respectively, and raw materials (inventory components, parts, and packaging) totaling $851,511 and $1,286,651, respectively. The valuation
of inventory includes fixed production overhead costs based on normal capacity of the assembly warehouse.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company periodically reviews its inventory for
evidence of slow-moving or obsolete inventory and provides for an allowance when considered necessary. The Company determined that no
such reserve was necessary as of September 30, 2023 or December 31, 2022. The Company prepays for inventory purchases from foreign suppliers.
Prepaid inventory totaled $102,646 and $141,611 at September 30, 2023 and December 31, 2022, respectively, and included inventory in transit
where title had passed to the Company but had not yet been physically received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Property and Equipment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost less depreciation
calculated on the straight-line basis over the estimated useful lives of the related assets as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="border-top: black 1pt solid; padding-left: 10.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
and transportation equipment</span></td>
<td style="border-top: black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-top: black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
- 7 years</span></td>
<td style="border-top: black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-left: 10.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
furniture and equipment</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 - 7 years</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-left: 10.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
equipment</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 - 10 years</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-left: 10.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
equipment</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 - 10 years</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-left: 10.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA equipment</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 - 10 years</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="border-bottom: black 1pt solid; padding-left: 10.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
and molds</span></td>
<td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
- 10 years</span></td>
<td style="border-bottom: black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Leasehold improvements are amortized over the shorter
of the lease term or their estimated useful lives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Betterments, renewals, and extraordinary repairs that
extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed as incurred. The cost and related accumulated
depreciation and amortization applicable to assets retired are removed from the accounts, and the gain or loss on disposition is recognized
in the Statements of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company determines if an arrangement is a lease
at inception. Operating lease right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s right to use an underlying asset during
the lease term, and operating lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease.
Operating leases are included in ROU assets, current operating lease liabilities, and long-term operating lease liabilities on the Company&#8217;s
Balance Sheets. The Company does not have any finance leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lease ROU assets and lease liabilities are initially
recognized based on the present value of the future minimum lease payments over the lease term at commencement date calculated using the
Company&#8217;s incremental borrowing rate applicable to the lease asset, unless the implicit rate is readily determinable. ROU assets
also include any lease payments made at or before lease commencement and exclude any lease incentives received. The Company&#8217;s lease
terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases
with a term of 12 months or less are not recognized on the Company&#8217;s Balance Sheet. The Company&#8217;s leases do not contain any
residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for lease and non-lease components
as a single lease component for all its leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Revenue Recognition</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s revenue is generated from the
sale of products consisting primarily of batteries and accessories. The Company recognizes revenue when control of goods or services is
transferred to its customers in an amount that reflects the consideration it is expected to be entitled to in exchange for those goods
or services. To determine revenue recognition, the Company performs the following five steps: (i) identify the contract(s) with a customer;
(ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price
to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the performance obligation(s) are satisfied.
Revenue is recognized upon shipment or delivery to the customer, as that is when the customer obtains control of the promised goods and
the Company&#8217;s performance obligation is considered satisfied. As such, accounts receivable is recorded at the time of shipment or
will call, when the Company&#8217;s right to the consideration becomes unconditional and the Company determines there are no uncertainties
regarding payment terms or transfer of control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Shipping and Handling Costs</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shipping and handling fees billed to customers are
classified in the Statement of Operations in &#8220;Sales, net&#8221; and totaled $27,398 and $6,133 during the three months ended September
30, 2023 and 2022, respectively, and $52,296 and $17,514 during the nine months ended September 30, 2023 and 2022, respectively. Shipping
and handling costs for shipping product to customers totaled $58,141 and $54,840 during the three months ended September 30, 2023 and
2022, respectively, and $149,898 and $137,497 during the nine months ended September 30, 2023 and 2022, respectively, and are classified
in selling, general, and administrative expense in the accompanying Statements of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Research and Development</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are expensed as incurred.
Research and development costs charged to expense amounted to $145,111 and $41,355 for the three months ended September 30, 2023 and 2022,
respectively, and $316,369 and $153,730 for the nine months ended September 30, 2023 and 2022, respectively, and are included in selling,
general and administrative expenses in the accompanying Statements of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Income Taxes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective November 1, 2021, the Company converted
from an LLC to a C corporation and, as a result, became subject to corporate federal and state income taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of exiting
assets and liabilities and their respective tax basis. Deferred tax assets, including tax loss and credit carryforwards, and liabilities
are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period that included the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets
and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more
likely than not that some portion or all of the deferred tax assets will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 27, 2020, the United States enacted the Coronavirus
Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;). The Cares Act is an emergency economic stimulus package that includes
spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES
Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more significant provisions are removal of certain
limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing
the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. As of
September 30, 2023 and December 31, 2022, the Company has not recorded any income tax provision/(benefit) resulting from the CARES Act,
mainly due to the Company&#8217;s history of net operating losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 27, 2020, the United States enacted the
Consolidated Appropriations Act of 2021 (the &#8220;CAA&#8221;). The CAA includes provisions extending certain CARES Act provisions and
adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the impact of the CAA and its impact on its financial
statements in 2023 and beyond.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTICE REGARDING TRADEMARKS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This report includes trademarks, tradenames, and service
marks that are our property or the property of others. Solely for convenience, such trademarks and tradenames sometimes appear without
any &#8220;&#8482;&#8221; or &#8220;&#174;&#8221; symbol. However, failure to include such symbols is not intended to suggest, in any way,
that we will not assert our rights or the rights of any applicable licensor, to these trademarks and tradenames.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Evaluation of Disclosure Controls and Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management is responsible for establishing and
maintaining adequate disclosure controls and procedures for our Company. Consequently, our management, with the participation of our chief
executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule
13a-15 under the Exchange Act as of September 30, 2023. In designing and evaluating the disclosure controls and procedures, management
recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving
the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource
constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative
to their costs. Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls
and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are
required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within
the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including
our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Changes in Internal Control Over Financial Reporting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2022 and the nine
months ended September 30, 2023, there were no changes in our internal control over financial reporting that materially affected, or are
reasonably likely to materially affect, our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f) under the Securities Exchange Act of 1934).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_013"></span>BUSINESS</p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b>Our Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 focuses on the design, assembly, manufacturing,
and sales of LiFePO4 batteries and supporting accessories for RVs, marine applications and recently announced our expansion into home
energy storage products with plans to expand into industrial applications. We design, assemble, and distribute high-powered, lithium battery
solutions using ground-breaking concepts with a creative sales and marketing approach. We believe that our product offerings include some
of the most dense and minimal-footprint batteries in the RV and marine industries. We are developing the e360 Home Energy Storage, a system
that we expect to significantly change the industry in barrier price, flexibility, and integration. We are deploying multiple intellectual
property strategies with cutting-edge research and unique products to sustain and scale the business. We currently have customers consisting
of dealers, wholesalers, private label customers and original equipment manufacturers who are driving revenue and brand awareness nationally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our corporate headquarters are based in Redmond, Oregon,
with assembly in the United States and suppliers based in Asia and Europe. We are currently in the process of building out manufacturing
capacity at our corporate headquarters. Our long-term target is to onshore the manufacturing of most of our components and assemblies,
including cell manufacturing, to the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our main target markets are currently the RV and marine
industries. We believe that we are well positioned to capitalize on the rapid market conversion from lead-acid to lithium batteries as
the primary method of power sourcing in these industries. Additional focus markets include home energy storage with our introduction of
two LiFePO4 battery storage solutions, where we aim to provide a cost-effective, low barrier of entry, flexible system for those looking
to power their homes via solar energy, wind, or grid back-up. Along with RV, marine and home energy storage markets, we aim to provide
additional capacities to the ever-expanding electric forklift and industrial material handling markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360&#8217;s e360 product line, which is manufactured
for the RV and marine industries, was launched in December 2020. The e360 product line, through its rapid sales growth, has shown to be
a preferred conversion solution for lead-acid batteries. In December 2023, we announced our entrance into the home energy storge market
with our introduction of two premium LiFePO4 battery storage solutions that enable residential and small business customers to create
their own stable micro-energy grid and lessen the impact of increasing power fluctuations and outages. We believe that our e360 Home Energy
Storage system has strong revenue potential with recurring income opportunities for us and our associated sales partners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our products provide numerous advantages for various
industries that are looking to migrate to lithium-based energy storage. They incorporate detailed-oriented design and engineering and
strong case materials and internal and structural layouts, and are backed by responsive customer service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Our Market Opportunity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The trend of vehicle electrification is expected to
be a significant growth catalyst for lithium compounds over the next decade and beyond. According to ResearchAndMarkets.com, the global
EV market demand is expected to reach $1.66 trillion by 2030, expanding at a compound annual growth rate (&#8220;CAGR&#8221;) of 14.5%
over the forecast period. On a global level, the market is driven by initiatives taken by governments of various countries to promote
manufacturing of EVs. For example, the Electric Vehicles Initiative (&#8220;EVI&#8221;), a multi-government forum with 13 participating
countries, works to increase the adoption of EVs globally. Several campaigns and programs have been launched through the EVI forum, including
the EV30@30 in 2017 initiative, which aims to have at least 11 countries with EVs reflecting 30% of new vehicle sales by 2030. Further,
according to ResearchAndMarkets.com, the United States EV market size was valued at $49.1 billion in 2022 and is anticipated to expand
at a CAGR of over 15.5% between 2023 and 2032 due to the growing demand for efficient and eco-friendly vehicles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Furthermore, the North American RV market was estimated
at roughly $33.95 billion in 2021, and is projected to grow at a 5.0% CAGR from 2024 to 2032 according to Expert Market Research. There
are over 200 national chain RV dealers in the United States, further underscoring the robust market for these vehicles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At the intersection of both these trends lies the
rapidly expanding lithium battery market. According to IMARC, the market for lithium-ion batteries is projected to grow at 13.2% CAGR
to reach $93.3 billion by 2028.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The vast expansion of the lithium battery market can
be attributed to global trends promoting clean energy, as well as the compact and flexible nature of lithium battery packs which make
them easy to install in RVs and boats. Our technology, which we believe offers industry leading battery pack flexibility for the most
efficient energy storage, is poised to be able to offer power to these large vehicles such as RVs and recreational boats.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 is focused on expanding its position in
the deep cycle, off-grid and stationary energy storage markets. According to the Federal Consortium for Advanced Batteries, the United
States has five goals in mind to secure battery materials and the U.S. technology supply chain. They include (1) securing access to raw
materials; (2) support of the U.S. materials-processing base; (3) stimulation of U.S. electrode, cell, and pack manufacturing; (4) enabling
recycling and reuse of critical materials; and (5) support of scientific R&amp;D, STEM education and workforce development. Expion360
is well positioned to benefit from this national focus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Biden Administration has also laid out a bold
agenda to address the climate crisis and build a clean and equitable energy economy that achieves carbon-pollution-free electricity by
2035 and puts the United States on a path to achieve net-zero emissions, economy-wide. We believe this government support will continue
to drive rapid growth in the industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lithium-based batteries power our daily lives, from
consumer electronics to national defense. They enable electrification of the transportation sector and provide stationary grid storage,
critical to developing the clean-energy economy. The U.S. has a strong research community, a robust innovation infrastructure for technological
advancement of batteries, and an emerging lithium-based battery manufacturing industry, according to the US Department of Energy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">It is our desire to work closely with federal, state
and local governments, as well as private industry to help America be the leader in lithium battery technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b>Competitive</b></span><b>
Strengths </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe the following strengths differentiate Expion360
and create long-term, sustainable competitive advantages:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Superior Capacity to Lead Acid Competitors</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lead-acid batteries have always been the standard
in RV and marine transportation vehicles. Our lithium-ion batteries offer superior capacity to our lead-acid competitors. Our batteries
utilize lithium iron phosphate, and therefore, are expected to have a lifespan of approximately 12 years - three to four times that of
certain lead-acid batteries and with ten times the number of charging cycles. Furthermore, we believe that our typical battery provides
three times the power of the typical, lead-acid battery despite being half the weight (comparing, for example, a typical lead-acid battery
like Renogy Deep Cycle AGM, which is rated at 100Ah, to our own LFP 100Ah battery and assuming slow discharge at a .1C rate).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, in September 2023, Expion360 introduced
a new 4.5 Ah 26650 lithium-ion phosphate battery cell. This will allow us to increase energy density by over 32% compared to traditional
3.4 Ah 26650 cells. The 12 volt 450 Ah battery was introduced in September 2023 as our first e360 battery incorporating our 4.5 Ah cell
technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Battery Pack Flexibility</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our battery packs are also highly flexible, designed
to be moved and used in various applications seamlessly. We plan to onshore our semi-automated pack assembly in Redmond, Oregon. The initial
equipment has arrived and subject to market conditions, we are working on setup and development of additional equipment to automate the
line. This should allow us to use a more flexible approach to forming and creating new battery packs. By onshoring, we expect to be able
to react to market demands at a much quicker pace and increase profit levels over our competition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Long-Time RV and Marine Industry Experience
and Relationships and Strong Insider Ownership</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 is managed by a team with a strong track
record in the RV and clean energy spaces. John Yozamp, Founder of Expion360 and former Chief Business Development Officer and former Chief
Executive Officer, pioneered multiple new recreational concepts in the RV industry. As the founder and previous owner of Zamp Solar, he
has leveraged extensive relationships in the RV OEM industry. In addition, our co-founders own significant equity in the company, signaling
a strong commitment and personal investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Expansion into New Markets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In furtherance of our vision of stored energy, in
January 2023, we introduced two portable power generator products: the AURA POWERCAP&#8482; 600 and AURA POWERCAP&#8482; 800 (together,
the &#8220;Aura&#8221;). The AURA POWERCAP&#8482; 600 is designed to fit and convert any one of Expion360&#8217;s group 24 lithium batteries
into a 600W mobile power station while the AURA POWERCAP&#8482; 800 is designed to fit and convert any one of Expion360&#8217;s group
27 lithium batteries into an 800W mobile power station. The Aura&#8217;s proprietary patent pending design allows the AURA POWERCAP&#8482;
600 to join seamlessly to 60Ah, 80Ah, and 95Ah Expion360 batteries and the AURA POWERCAP&#8482; 800 to join to 100Ah and 120Ah Expion360
batteries. The AURA POWERCAP&#8482; 600 and AURA POWERCAP&#8482; 800 are an exclusive fit to Expion360 batteries and will not fit other
brands. The AURA POWERCAP&#8482; 600 and AURA POWERCAP&#8482; 800 contain beneficial features and functions for a compact portable power
unit, including the ability to recharge the battery from the input charge port using the included 7 Amp household charger and the ability
to recharge remotely with Expion360&#8217;s lightweight portable solar panel options, which are sold separately. We commenced deliveries
of the AURA POWERCAP&#8482; 600 in the second quarter of 2023, and are currently accepting pre-orders of the AURA POWERCAP&#8482; 800.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, in June 2023, we unveiled e360 SmartTalk,
an innovative mobile app that allows the seamless integration and management of e360 Bluetooth enabled LiFePO4 batteries. The technology
enables users to wirelessly monitor and manage e360 batteries, providing a view of individual battery conditions and performance as well
as a comprehensive view of an entire power bank consisting of multiple e360 batteries. The 48 Volt GC2 LiFePO4 battery was also introduced
in June 2023 as our first e360 SmartTalk Battery for powering electric golf carts and other light electric vehicles (LEVs).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, we entered the home energy storage
market with its introduction of two premium LiFePO4 battery storage solutions: a wall mounted all-in-one inverter and 10kW battery and
an expandable server rack style battery cabinet system. We believe our new home energy storage product line will benefit from a fast-growing
battery energy storage market, which is forecasted by Markets and Markets to grow at a 26.4% CAGR to reach $17.5 billion by 2028. Further,
according to Clean Energy Group, approximately 3.2 million homes in the United States have solar panels installed, but only about 6% of
residential solar systems have battery storage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Strong National Retail Customers and Distribution
Channels</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 has sales relationships with many major
RV retailers and with marine retailers and plans to use what we believe is a strong reputation in the lithium battery space to create
an even stronger distribution channel. John Yozamp has used his decades of experience in the energy and RV industries to cultivate relationships
with numerous retailers in the space. Expion360 has already established a sales relationship with several large retail customers, including
Camping World, a leading national RV retailer, as well as Meyer Distributing, Inc., a leading national marketer and distributor of automotive
and RV specialty products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Expion360 Products </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We focus on the design, assembly, and sales of LiFePO4
batteries and supporting accessories for RV and marine applications, as well as our recent expansion into home energy storage solutions.
Our batteries are designed and engineered in house using premium lithium iron phosphate cells with quality controls at every step We use
high-grade LiFePO4 encased in steel and meeting the UL 1642 standard (UL file no. MH64383). We believe that our materials and engineering
enhance the reliability, stability, and safety of our products. We reimagined the standard battery case and included built-in rubber feet,
radiused corners, 96.7% larger terminal connection pads, interior molded ribs for structural security, and the highest-grade ABS plastics
with additives for fire retardancy. To maximize the power and efficiency of our batteries, we welded our cells via thick copper/tin-machined
collector plates, welded all interior pack points, added a press break flange at each end to create a mechanical backbone for the battery
monitoring system (the &#8220;BMS&#8221;), used high-grade wiring and ring terminals throughout, and treated connections with industrial
epoxy for long-lasting protection. Our internal &#8220;smart&#8221; BMS design includes multiple safety and performance features, such
as: low temperature discharge, auto shutoff, short circuit protection, low- and high-voltage shutoffs, and overcurrent disconnect. Our
structurally sound BMS board features a bolted design, eliminating all unnecessary solder, resulting in one cohesive pack with a long
lifespan. We hold our lithium batteries to high safety standards, which has enabled us to achieve a UL 1973 compliance. We stand by our
batteries with an industry leading 12-year warranty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To enable us to provide a full range of components
to complement our battery offerings, we offer a suite of accessories and components for new installations or conversions which includes
but is not limited to chargers, monitors, inverters, and solar components from brands such as Victron Energy and RedArc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023, we offer the following products
for sale:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12v batteries:</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Group 24 batteries:</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 60Ah lithium battery</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 80Ah lithium battery</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 Extreme Density 95Ah lithium
battery</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Group 27 batteries:</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 100Ah lithium battery</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 Extreme Density 120Ah
lithium batterye360 custom form factor battery:</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 Extreme Density 360Ah
lithium battery</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 Extreme Density 450Ah
lithium battery 48v batteries:</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Group CG2 batteries:</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 1.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 36Ah lithium battery</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360 e360 Lithium Power
Bundle&#8482;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Battery monitors</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DC battery chargers</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial tie-downs - 7 models</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terminal blocks</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bus bars</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURA POWERCAP&#8482; 600</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e360 SmartTalk&#8482; mobile
app</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023, we have the following products
in our pipeline:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2023, we introduced
a new 4.5 Ah 26650 lithium-ion phosphate battery cell and 12 Volt 450 Ah e360 SmartTalk&#8482; lithium-ion battery. Expion360 began taking
pre-orders for the new 450 Ah e360 SmartTalk&#8482; battery starting in the fourth quarter of 2023, with initial shipments expected to
begin in the first quarter of 2024.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2023, we introduced
a pilot program to offer transformative solar and energy storage solutions in partnership with Renewable Energy Products Manufacturing
Corp., a pioneer in sustainable home and commercial solar technology and installations.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, we introduced
a wall mounted all-in-one inverter and 10kW battery and an expandable server rack style battery cabinet system. Expion360 will begin
taking orders for the new home energy storage solutions in first quarter of 2024 with anticipated deliveries beginning in second quarter
of 2024. See the section above titled &#8220;&#8212;<i>Competitive Strengths</i>&#8212;<i>Expansion into New Markets</i>&#8221; for additional
information about the new home energy storage solutions.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competitors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our competitors include lithium-ion battery manufacturers,
such as Relion (which was acquired by Brunswick Corporation in September 2021), Battle Born Batteries, Renogy, and Dakota Lithium. Lead-acid
battery manufactures also continue to have a presence in the marketplace. We have designed custom form factors in both the industry standard
Group 24 and Group 27 battery sizes allowing us to visually and structurally differentiate Expion360 within the market space. We believe
that our custom 360Ah battery also provides a unique capacity to footprint ratio compared to lead-acid and lithium battery competitors.
Our batteries utilize lithium iron phosphate, and therefore, are expected to have a lifespan of approximately 12 years - three to four
times that of certain lead-acid batteries and with ten times the number of charging cycles. Furthermore, we believe that our typical battery
provides three times the power of the typical, lead-acid battery despite being half the weight (comparing, for example, a typical lead-acid
battery like Renogy Deep Cycle AGM, which is rated at 100Ah, to our own LFP 100Ah battery and assuming slow discharge at a .1C rate).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Manufacturing and Supply Chain</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our batteries are manufactured by multiple third-party
manufacturers located in China, who also produce our battery cells. We then assemble and package the batteries in the United States for
sale to our customers. While we do not have long-term purchase agreements with our third-party manufacturers and our purchases are completed
on a purchase order basis, we have had strong relationships with our third-party manufacturers spanning many years. Our close working
relationships with our China-based third-party manufacturers and cell suppliers, reflected in our ability to increase our purchase order
volumes (qualifying us for related volume-based discounts) and to order and receive delivery of cells in anticipation of required demand,
has helped us moderate increased supply-related costs associated with inflation, currency fluctuations, and U.S. government tariffs imposed
on our imports and to avoid potential shipment delays. We aim to maintain an appropriate level of inventory to satisfy our expected supply
requirements. We believe that we could locate alternative third-party manufacturers to fulfill our needs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our third-party manufacturers source the raw materials
and battery components required for the production of our batteries directly from third-party suppliers that meet our approval and quality
standards and, as a result, we may have limited control over the agreed pricing for these raw materials and battery components. We estimate
that raw material costs account for over half of our cost of goods sold. The costs of these raw materials, particularly lithium-ion batteries,
are volatile and beyond our control. Additionally, availability of the raw materials used to manufacture our products may be limited at
times, resulting in higher prices and/or the need to find alternative suppliers. For example, a global shortage and component supply disruptions
of electronic battery components were reported during 2021 and 2022, but it is not currently affecting our supply chain. Our battery cell
manufacturers also have joint venture factories outside of China and have secured sourcing contracts from lithium suppliers in South America
and Australia. In addition, we secured a secondary source for lithium iron phosphate cells used in its batteries from a supplier in Denmark,
enabling us to source materials outside of China in the event it becomes necessary to do so. We aim to maintain an appropriate level of
inventory to satisfy our expected supply requirements. We believe that we could locate alternative third-party manufacturers to fulfill
our needs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lithium is a key raw material used to produce our
battery cells and as a result, the cost of our battery cells is dependent on the price and availability of lithium, which may be volatile
and unpredictable. From 2010 until 2015, the price of lithium stayed fairly flat. In 2016 the price started to rise, fueled by the fear
of material shortages. As a result of the higher prices, new mining operations that had been in development came online and companies
invested in more efficient extraction processes. The increases in production led to an oversupply of lithium in 2019 and a sharp drop
in prices. The lithium prices in 2020 ended below the 2016 prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to increased mining and newly located
reserves, there is also an industry push to provide more efficient ways to extract lithium from the mined ore. Another development of
the past few years is lithium cell recycling. This process will recapture the raw lithium from the cell for reuse in future cells. The
price of lithium remains subject to volatility and thus we aim to monitor any developments that might adversely affect our supply chain.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Customers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently have more than 300 customers across the
United States consisting of dealers, wholesalers, private-label customers and original equipment manufacturers who then sell our products
to end consumers. Our sales are completed on a purchase order basis and most are without firm, long-term revenue commitments or sales
arrangements. In addition, we also sell products directly to consumers. Expion360 has sales relationships with many major RV retailers,
including Camping World, a leading national RV retailer, as well as Meyer Distributing, Inc., a leading national marketer and distributor
of automotive and RV specialty products. In December 2022, we were selected as the exclusive supplier of lithium-ion batteries for an
overland trailer to be branded and sold by a top U.S. sports utility vehicle manufacturer. Due to the progress and success with our existing
sales and distribution activities and to avoid any channel conflicts, our previously announced value-added reseller program has been deferred,
pending additional review. We will continue to focus on our sales and distribution channels in order to develop existing customer relationships
and grow our customer base. We also offer a high level of technical support to our customers before and after product sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently derive a significant portion of our revenues
from a limited number of customers. During the year ended December 31, 2022, sales to our top three customers totaled $2,905,326, comprising
approximately 41% of our total sales, including sales to one customer, which totaled $1,346,344 or approximately 19% of our total sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Intellectual Property</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The success of our business and our technology leadership
is supported by our proprietary battery technology. We have filed 11 patent applications in the United States to provide protection for
our technology, including seven design patent applications and four utility patent applications. In addition, we rely upon a combination
of trademark and trade secret laws in the United States, as well as license agreements and other contractual protections, to establish,
maintain and enforce rights in our proprietary technologies. We also seek to protect our intellectual property rights through non-disclosure
and invention assignment agreements with our employees and consultants and through non-disclosure agreements with business partners and
other third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We periodically review our development efforts to
assess the existence and patentability of new intellectual property. We pursue the registration of our domain names and trademarks and
service marks in the United States and in an effort to protect our brand, as of December 31, 2023, we own 15 trademark registrations to
cover our house marks in the United States. We also own nine trademark registrations relating to our house marks in Canada.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Government Regulation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to inspections by federal, state, and
local regulators overseeing environmental health and safety, which could result in possible citations and/or fines. Lithium-ion battery
shipments are categorized as &#8220;dangerous goods&#8221; and are subject to rules governing their transportation. We have implemented
policies and procedures, trained our employees, and conducted internal audits to verify compliance with environmental health and safety
regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August of 2022, our Group 24 and Group 27 batteries
passed UL 1973 certification. In February 2023, our custom 360Ah battery also passed UL 1973 certification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Employees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023, we had 23 employees, all
full time. None of our employees are covered by collective bargaining agreements and we have never experienced an organized work stoppage,
strike, or labor dispute. We believe working conditions and compensation packages are competitive with those offered by competitors and
consider our relations with our employees to be good.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Environmental, Health, and Safety</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We and our third-party manufacturers and suppliers
are, and could become, subject to a wide range of international, federal, state, provincial, and local governmental regulations directed
at preventing or mitigating environmental harm, as well as to the storage, discharge, handling, generation, disposal and labeling of toxic
or other hazardous substances. Although we outsource our manufacturing, the manufacturing of our products by our third-party manufacturers
and suppliers require the use of hazardous materials that similarly subject these third parties, and therefore our business, to such environmental
laws and regulations. Our failure or the failure of these third parties to comply with these laws or regulations can result in regulatory,
civil, or criminal penalties, fines, and legal liabilities, suspension of production, alteration of manufacturing processes, including
for our products, reputational damage, and negative impact on our operations or sales of our products and services. Increased compliance
costs by our third-party manufacturing partners may also result in increased costs to our business. Our business and operations are also
subject to health and safety laws and regulations adopted by government agencies such as OSHA. Although we believe we are in material
compliance with applicable law concerning matters relating to health, safety, and the environment, the risk of liability relating to these
matters cannot be eliminated completely. To date, we have not incurred significant expenditures relating to environmental compliance nor
have we experienced any material issues relating to employee health and safety. See the section titled &#8220;<i>Risk Factors</i>&#8221;
for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Implications of Being an Emerging Growth Company
and a Smaller Reporting Company</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We qualify as an &#8220;emerging growth company&#8221;
as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As an emerging growth company, we have elected to take
advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions
include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the requirement that we provide
only two years of audited financial statements in addition to any required unaudited interim financial statements with correspondingly
reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced disclosure about our
executive compensation arrangements;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exemption from the requirement
that we hold a non-binding advisory vote on executive compensation or golden parachute arrangements; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exemption from the auditor
attestation requirement in the assessment of our internal control over financial reporting.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may take advantage of these exemptions for up to
five years or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company on the
date that is the earliest of (i) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more;
(ii) the last day of our fiscal year following the fifth anniversary of the date of the completion of our initial public offering; (iii)
the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; or (iv) the date on which
we are deemed to be a large accelerated filer under the rules of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are also a smaller reporting company as defined
in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may
take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these
scaled disclosures for so long as our voting and non-voting Common Stock held by non-affiliates is less than $250.0 million measured on
the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed
fiscal year and our voting and non-voting Common Stock held by non-affiliates is less than $700.0 million measured on the last business
day of our second fiscal quarter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Company Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 Inc. was initially organized as a limited
liability company under the name Yozamp Products Company, LLC in the State of Oregon on June 16, 2016, and converted to a Nevada corporation
under its current name pursuant to articles of conversion dated as of November 16, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our website is found at expion360.com and on the Investor
Relations section of our website, we post or will post, as applicable, the following filings as soon as reasonably practicable after they
are electronically filed with or furnished to the SEC: the Annual Report, our Proxy Statement on Schedule 14A, our Quarterly Reports on
Form 10-Q, our Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the information on our Investor Relations web
page is available to be viewed free of charge. Information contained on our website is not part of this prospectus or our other filings
with the SEC. We assume no obligation to update or revise any forward-looking statements in this prospectus whether as a result of new
information, future events or otherwise, unless we are required to do so by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The SEC also maintains a website found at http://www.sec.gov/
that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Properties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our corporate headquarters are in Redmond, Oregon.
This location houses our engineering, sales, accounting, and operations staff. It is also our primary product warehouse. Our headquarters
is approximately 14,976 square feet, leased at a base rent set to increase by 3% every 12 months after January 31 of each year. From January
31, 2022 to January 31, 2023, the rental cost of our headquarters was $18,510 per month. In the first quarter of 2022 we added a second
distribution warehouse in Elkhart, Indiana to service and provide a stocking location for several large manufacturers in the area. Elkhart
is a hub for RV manufacturing in the United States. Other East Coast customers are supported from this location to reduce shipping times
and costs to the customers. The square footage of this facility is approximately 7,000 square feet, leased at a cost of $4,853 per month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of our onshoring agenda, we have also entered
into an agreement to lease another facility in Redmond Oregon. This new facility is currently expected to be used for our first battery
pack assembly plant in the United States. The square footage of this facility is approximately 31,425 square feet leased at a cost of
$31,425 per month. Equipment for the assembly line was received in October 2022 due to a delay by our equipment supplier. We are working
on set-up and development of additional equipment to automate the line, subject to market conditions We believe that these facilities
are sufficient to meet our current and anticipated needs in the near term and that additional space can be obtained on commercially reasonable
terms as needed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Legal Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may become, from time to time, involved in routine
litigation or subject to disputes or claims related to our business activities. Other than as described below, we are not currently party
to any pending legal proceedings that we believe would, individually or in the aggregate, have a material adverse effect on our financial
condition, cash flows or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_014"></span>MANAGEMENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Executive Officers and Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth information regarding
our current executive officers and directors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1pt; width: 24%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Name</span></b></span></td>
<td style="border-bottom: Black 1pt solid; text-align: center; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 9%">&#160;</td>
<td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left; padding-bottom: 1pt; width: 61%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officer</b></span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
Shoun</span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Founder,
President, Chief Operating Officer and Director</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
Schaffner</span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer and Director</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg
Aydelott</span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Employee
Directors</b></span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
M. Shum<sup>(1)(2)(3)</sup></span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
Lefevre<sup>(1)(2)(3)</sup></span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tien
Nguyen<sup>(1)(2)(3)</sup></span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td style="text-align: justify">Member of the Audit Committee.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td style="text-align: justify">Member of the Compensation Committee.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td style="text-align: justify">Member of the Nominating and Corporate Governance Committee.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Executive Officer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.55pt; text-align: justify; text-indent: -0.55pt"><b><i>Paul Shoun
&#8211; Co-Founder, President, Chief Operating Officer, and Director</i></b>. Mr. Shoun has served as our Co-Founder, President and Chief
Operating Officer since January 26, 2023 and was previously our Chief Operating Officer since March 2020. Before joining the Company,
Mr. Shoun worked at Tensility International Corporation, a custom cable assemblies company, where he served as a Business Development
Manager, Project Manager and Manufacturing Manager from October 2014 to March 2020. Prior to October 2014, Mr. Shoun spent over 17 years
as the managing director of a corporate consulting firm. Mr. Shoun brings over 30 years of engineering and corporate management experience.
Mr. Shoun brings extensive expertise in project management, product development, engineering leadership, business accounting, ERP/CRM
system management, and product marketing. Mr. Shoun&#8217;s prior notable clients include Chrysler, Boeing, Nike IHM, Intel, and Daimler
Trucks North America. We believe Mr. Shoun is qualified to serve on our Board because of his extensive experience in engineering, product
development and product marketing and his role in building the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.55pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>Brian Schaffner
&#8211; Chief Executive Officer and Director</i></b>. Mr. Schaffner has served as our Chief Executive Officer since January 26, 2023 and
was previously our Chief Financial Officer beginning in February 2021. Mr. Schaffner also serves as a Professor of Business and Accounting
at Walla Walla University, a position he has held since July 2020. Prior to that, he served as Vice Principal of Finance for Monterey
Bay Academy from March 2019 to June 2020, and Vice Principal of Finance for Mount Ellis Academy from July 2015 through February 2018.
Mr. Schaffner also served as Development, Recruiting, Marketing and Alumni Relations Director of Mount Ellis Academy from March 2018 to
February 2019. Mr. Schaffner is a seasoned executive having served over the past three decades in a variety of capacities including CEO,
CFO, CIO, controller and VP Finance in senior-living, assisted-living skilled nursing facilities, retail stores and schools. In addition,
his educational instructional experience includes the secondary and university levels with courses including accounting, cost accounting,
management, personal finance, welding, auto mechanics and aviation ground school. Mr. Schaffner graduated from Walla Walla College with
a Bachelor of Science in Business Administration and Accounting in 1992, and from the University of Phoenix with a Master of Business
Administration in 1997. We believe Mr. Schaffner is qualified to serve as a member of our Board because of his executive leadership experience
and intimate knowledge of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>Greg Aydelott
&#8211; Chief Financial Officer. </i></b>Mr. Aydelott has served as our Chief Financial Officer since January 26, 2023 and was previously
our Chief Accounting Officer since May 10, 2022. Prior to his appointment as Chief Accounting Officer of the Company, Mr. Aydelott served
as our Controller from February 22, 2022 until May 10, 2022. Before joining the Company, Mr. Aydelott worked at Samaritan Health Services
in Corvallis, Oregon from June 2021 to March 2022, where he served as Sr. Financial Analyst. Samaritan Health Services is a regional hospital
system serving three counties and has no affiliation with the Company. Before joining Samaritan Health Services in June 2021, Mr. Aydelott
was Director of Business Operations of Mission Senior Living in Carson City, Nevada from January 2016 to June 2021. Mission Senior Living
is a growing senior housing company with communities in four states and has no affiliation with the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Non-Employee Directors<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup></sup></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>Steven M. Shum</i>
&#8211; <i>Independent Director. </i></b>Mr. Shum serves on our Board. Mr. Shum is the CEO and a director of INVO Bioscience, Inc. (Nasdaq:
INVO), a healthcare services company focused on fertility treatment, positions he has held since October 10, 2019 and October 11, 2017,
respectively. Previously, Mr. Shum was Interim Chief Executive Officer (from May 2019 to October 7, 2019) and Chief Financial Officer
of Eastside Distilling (Nasdaq: EAST) (from October 2015 to August 2019). Prior to joining Eastside, Mr. Shum served as an Officer and
Director of XZERES Corp, a publicly-traded global renewable energy company, from October 2008 until April 2015 in various officer roles,
including Chief Operating Officer from September 2014 until April 2015, Chief Financial Officer, Principal Accounting Officer and Secretary
from April 2010 until September 2014 (under former name, Cascade Wind Corp) and Chief Executive Officer and President from October 2008
to August 2010. Mr. Shum also serves as the managing principal of Core Fund Management, LP and the Fund Manager of Core Fund, LP. He was
a founder of Revere Data LLC (now part of Factset Research Systems, Inc.) and served as its Executive Vice President for four years, heading
up the product development efforts and contributing to operations, business development, and sales. He spent six years as an investment
research analyst and portfolio manager of D.N.B. Capital Management, Inc. His previous employers include Red Chip Review and Laughlin
Group of Companies. He earned a B.S. in Finance and a B.S. in General Management from Portland State University in 1992. We believe Mr.
Shum is qualified to serve on our Board because of his extensive experience serving in leadership roles at other public companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>George Lefevre
&#8211; Independent Director</i></b>.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup></sup></span> Mr.
Lefevre serves on our Board. Mr. Lefevre is a business consultant focused on business development and structural guidance for companies.
From 2009 through 2020, Mr. Lefevre was the founder of HAPA Capital, LLC. HAPA was a consulting firm specializing in biotechnology and
frontier technology. From 2014 through 2015, Mr. Lefevre was the CEO of a startup company that completed a change in management effective
June 26, 2014, and expanded into hemp and cannabidiol (&#8220;CBD&#8221;) industry. The expansion was focusing on the development, research,
and commercialization of products derived from hemp and cannabis plants. From 1991 to 1998, Mr. Lefevre directly invested in and managed
investment portfolios. Mr. Lefevre was also the President of GL Investment Group, a regional investment bank in Southern California where
he was directly responsible for providing in excess of $500 million in funding to biotechnology and high-tech companies. Mr. Lefevre graduated
from California State University, Long Beach with a Bachelor of Science in Business Administration, majoring in Finance. We believe Mr.
Lefevre is qualified to serve on our Board because of his extensive experience serving in leadership roles at other public companies and
extensive investment experience.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>Tien Q. Nguyen
&#8211; Independent Director</i></b>. Mr. Nguyen serves on our Board. He is a successful entrepreneur and executive with expertise in
engineering, technology, wireless systems, and energy storage. Mr. Nguyen has been managing personal and family investments from 2021
to present. Mr. Nguyen was a partner in Lumini Partner LLC to support and study international energy industrial projects using microgrid
systems to reduce utility dependency from 2019 to 2020. Mr. Nguyen was the founder of FitTech Software LLC, an artificial intelligence
software company in the health and fitness industry, and served as the Chairman from 2016 until 2019. From 2012 to 2016, Mr. Nguyen was
the Chief Executive Officer of Quantum Energy Storage Corporation, an energy storage company. Previously, Nr. Nguyen was the Chief Strategy
Officer of Onramp Wireless Inc. from 2010 to 2012 and the Chief Executive Officer of AppleTree Educational LLC from 2007 to 2010. Mr.
Nguyen was also the founder of CommASIC Inc., a leading wireless semiconductor broadband company, which was acquired by Freescale Semiconductor
in 2005. He served as a director of Freescale Semiconductor from 2005 until 2007. Prior to founding CommASIC Inc., Mr. Nguyen served as
the Chief Executive Officer of Linskys Consulting from 1997 until 2001. Mr. Nguyen began his career at General Dynamics and Qualcomm Inc.
where he was focused on ASIC engineering. Mr. Nguyen graduated from San Diego State University with a BSEE in 1983. We believe Mr. Nguyen
is qualified to serve as a member of our Board because of his extensive experience in the energy storage industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify; text-indent: -0.7pt"><b>Family Relationships</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify; text-indent: -0.7pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">There are no family
relationships among any of our executive officers or directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">A majority of our
directors satisfy the criteria for &#8220;independent directors,&#8221; under the Nasdaq rules. The Nominating and Corporate Governance
Committee is required to annually review each director&#8217;s independence and any material relationships such director has with the
Company. Following such review, only those directors who the Board affirmatively determines have no material relationship to the Company,
and otherwise satisfy the independence requirements of the Nasdaq rules, will be considered &#8220;independent directors.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Under the Nasdaq rules,
a majority of a listed company&#8217;s board must be comprised of independent directors. In addition, the Nasdaq rules require that, subject
to specified exceptions, each member of a listed company&#8217;s audit, compensation and nominations committees be independent and that
audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act and that compensation committee
members satisfy independence criteria set forth in Rule 10C-1 under the Exchange Act and related Nasdaq rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Under the Nasdaq rules,
a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the listed company&#8217;s board, that person
does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a
director. To be considered independent for purposes of Rule 10A-3 under the Exchange Act, a member of an audit committee of a listed company
may not, other than in his or her capacity as a member of the audit committee, the board, or any other board committee, accept, directly
or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries or otherwise be
an affiliated person of the listed company or any of its subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">In accordance with
Rule 10C-1 under the Exchange Act and the Nasdaq rules, in affirmatively determining the independence of any director who will serve on
a company&#8217;s compensation committee, the company&#8217;s board must consider all factors specifically relevant to determining whether
a director has a relationship to such company which is material to that director&#8217;s ability to be independent from management in
connection with the duties of a compensation committee member, including the source of compensation of such director (including any consulting,
advisory or other compensatory fee paid by such company to the director), and whether the director is affiliated with the company or any
of its subsidiaries or affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Our Board has affirmatively
determined that George Lefevre, Steven M. Shum and Tien Nguyen are independent directors under applicable Nasdaq and Exchange Act rules.
In addition, David Hendrickson, who was a member of the Board until his resignation on August 15, 2023, was an independent director under
applicable Nasdaq and Exchange Act rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">As a result, a majority
of our directors are independent, as required under applicable Nasdaq rules. As required under applicable Nasdaq rules, we anticipate
that our independent directors will meet in regularly scheduled executive sessions at which only independent directors are present.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Board Leadership</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Paul Shoun, our President
and Chief Operating Officer, also serves as Chairman of the Board. Currently, the Board does not have a Lead Independent Director. Although
the Board may assess the appropriate leadership structure from time to time in light of internal and external events or developments and
reserves the right to make changes in the future, it believes that the current structure, as described in this prospectus, is appropriate
at this time given the size and experience of the Board, as well as the background and experience of management. The Board does not believe
that having the President and Chief Operating Officer serve as Chairman of the Board materially impacts its process for risk oversight
because Board committees (comprised entirely of independent directors during the fiscal year ended December 31, 2022) play the central
role in risk oversight.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Director Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The independent members of the Board are each compensated
for their services as directors and committee chairs through cash compensation and equity grants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the compensation of our independent directors
during 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
    Earned or Paid in Cash ($)</b></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="color: Black"><b>Stock Awards</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="color: Black"><b>($)<sup>(1)</sup></b></span></p></td>
    <td style="padding-bottom: 1pt; vertical-align: top; text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option Awards ($)<sup>(2)(3)</sup></b></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other Compensation ($)</b></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    ($)</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; width: 18%; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Hendrickson</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,750</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,250<sup>(4)</sup></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George Lefevre</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven M. Shum</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,000</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tien
    Nguyen</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,962</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,962</span></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.65pt; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 95%; padding-right: 5.65pt; padding-left: 5.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    restricted stock units (&#8220;RSUs&#8221;) granted to the independent members of our board during our fiscal year ended December
    31, 2023. As of December 31, 2023, Messrs. Lefevre, Shum, and Nguyen each held 12,195 unvested RSUs, and Mr. Hendrickson&#8217;s
    12,195 RSUs had vested and settled in full.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.65pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-right: 5.65pt; padding-left: 5.65pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.65pt; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="padding-right: 5.65pt; padding-left: 5.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2023, Mr. Hendrickson held options to purchase 30,000 shares of our common stock, Mr. Lefevre held 30,000
    options to purchase shares of our common stock, and Mr. Shum held options to purchase 40,000 shares of our common stock. As of
    December 31, 2023, Mr. Nguyen did not hold any options to purchase shares of our common stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.65pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-right: 5.65pt; padding-left: 5.65pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.65pt; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="padding-right: 5.65pt; padding-left: 5.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    reflect the full grant-date fair value of stock awards and stock options granted during 2023 computed in accordance with ASC Topic
    718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to
    calculate the value of all option awards made to our directors in Note 12 to our audited financial statements for the fiscal year
    ended December 31, 2023 included herewith.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.65pt; padding-left: 5.65pt">&#160;</td>
    <td style="padding-right: 5.65pt; padding-left: 5.65pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.65pt; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="padding-right: 5.65pt; padding-left: 5.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Hendrickson resigned from the Board and each committee of the Board on August 15, 2023. Mr. Hendrickson was engaged as a consultant
    following his resignation from the Board and paid a consulting fee for his services as such.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b>Board Committees
and Charters</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">The Board has three
standing committees, an audit committee, a compensation committee, and a nominating and corporate governance committee. The Board maintains
charters for each of these standing committees, which were filed as appendices to our definitive proxy statement on Schedule 14A filed
with the SEC on September 6, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>Audit Committee</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We have a separately
designated standing audit committee (the &#8220;Audit Committee&#8221;) established in accordance with Section 3(a)(58)(A) of the Exchange
Act. Our Audit Committee consists of Steven M. Shum (chair), George Lefevre and Tien Nguyen, each of whom meet the requirements for independence
under the rules of Nasdaq and SEC rules and regulations and is financially literate. Mr. Shum is the chair of the Audit Committee and
has been determined by our Board to be an &#8220;audit committee financial expert&#8221; as such term is defined under SEC rules and regulations.
The Board has considered the independence and other characteristics of each existing member and each proposed member of our Audit Committee,
and the Board believes that each member meets the independence and other requirements of Nasdaq and the SEC. Our Audit Committee operates
under a written charter that satisfies the applicable standards of the SEC and Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee, among other things, is responsible for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing the integrity of
our financial statements and the other financial information we provide to our stockholders and other interested parties;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitoring the periodic reviews
of the adequacy of the auditing, accounting, and financial reporting processes and systems of internal control that are conducted by
our independent registered public accounting firm and management;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Being responsible for the selection,
retention, compensation, and termination of our independent registered public accounting firm;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing the independence
and performance of our independent registered public accounting firm;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facilitating communication
among our independent registered public accounting firm, management, and the Board;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing the audit committee
report required by SEC rules and regulations to be included in our annual proxy statement; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performing such other duties
and responsibilities as are enumerated in and consistent with the Audit Committee charter.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>Compensation
Committee</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We have a separately
designated standing compensation committee (the &#8220;Compensation Committee&#8221;), which is currently comprised of Tien Nguyen (chair),
George Lefevre and Steven M. Shum. The Board has considered the independence and other characteristics of each current and anticipated
member of our Compensation Committee. The Board believes that each member of our Compensation Committee meets the requirements for independence
under the current requirements of Nasdaq, is a nonemployee director as defined by Rule 16b-3 promulgated under the Exchange Act, and is
an outside director as defined pursuant to Section 162(m) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Our Compensation Committee
oversees the Company&#8217;s compensation structure and practices for both executive officers and director compensation, including incentive-based
compensation and equity-based plans. The Compensation Committee reviews and evaluates the performance of the Company&#8217;s directors
and executive officers and provides recommendations to the Board regarding the form and amount of compensation to be paid by the Company
to directors and executive officers. The Compensation Committee may use outside consultants it deems necessary or appropriate to carry
out its responsibilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Our Compensation Committee
operates under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards of Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Our Compensation Committee
is, among other things, responsible for:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assisting the Board in developing and reviewing compensation programs applicable to our executive officers and directors;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing our Company&#8217;s overall compensation philosophy, strategy, and objectives;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approving the total compensation opportunity, as well as each component of compensation, paid to our executive officers and directors;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administering our equity-based and cash-based compensation plans applicable to our directors, officers and employees;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing the report of the compensation committee required by SEC rules to be included in our annual proxy statement; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performing such other duties and responsibilities as are enumerated in and consistent with the compensation committee charter.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b></b></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><b><i>Nominating and
Corporate Governance Committee</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We have a separately
designated standing nominating and corporate governance committee (the &#8220;Nominating and Corporate Governance Committee&#8221;), which
is currently comprised of George Lefevre (chair), Steven M. Shum, and Tien Nguyen. Our Nominating and Corporate Governance Committee operates
under a written charter. Under our policy, the independent directors of our Board nominate our directors. We also consider any nominations
of director candidates validly made by our stockholders if submitted in a timely manner and will apply the same criteria to all persons
being considered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Our Nominating and
Corporate Governance Committee is, among other things, responsible for:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assisting the Board in identifying
candidates qualified to serve as directors, consistent with selection criteria approved by the Board and the Nominating and Corporate
Governance Committee;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommending to the Board the
appointment of director nominees that meet the selection criteria;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommending to the Board the
appointment of directors to serve on each committee of the Board;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing and recommending
to the Board such corporate governance policies and procedures as the Nominating and Corporate Governance Committee determines is appropriate
from time to time;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing the performance
of the Board, and of each committee of the Board; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performing such other duties
and responsibilities as are consistent with the Nominating and Corporate Governance Committee charter.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Code of Business Conduct and Ethics</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">On January 3, 2022,
our Board adopted a written Code of Business Conduct and Ethics that applies to our directors, officers, and employees, including our
principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.
Our Code of Business Conduct and Ethics is available on the investor relations page of our website at expion360.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We intend to disclose
future amendments to such code, or any waivers of its requirements, applicable to our principal executive officer, principal financial
officer, principal accounting officer or controller, or persons performing similar functions, or our directors, on our website identified
above. The inclusion of our website address in this prospectus does not include or incorporate by reference the information on our website
into this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Executive Compensation and Compensation Committee Interlocks</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">None of the members
of our compensation committee has ever been an executive officer or employee of ours. None of our executive officers currently serve,
or has served during the last completed fiscal year, on the compensation committee or Board of any other entity that has one or more executive
officers serving as a member of our Board or compensation committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_015"></span>EXECUTIVE COMPENSATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">As an emerging growth
company as defined in the JOBS Act, we are not required to include a Compensation Discussion and Analysis section and have elected to
comply with the scaled disclosure requirements applicable to emerging growth companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">This section discusses
the material components of the executive compensation program for our executive officers who are named in the &#8220;Summary Compensation
Table&#8221; below. In 2022 and 2023, our &#8220;named executive officers&#8221; and their positions were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner, who currently
serves as our Chief Executive Officer, and who served as our Chief Financial Officer through January 25, 2023;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Shoun, who serves as our
Co-Founder, President, and Chief Operating Officer; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Yozamp, our Co-Founder,
who served as Chief Business Development Officer through December 31, 2023 and served as our Chief Executive Officer through January
25, 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Summary Compensation Table</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">The following table
sets forth information concerning the compensation of our named executive officers for the years ended December 31, 2023 and December
31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Principal<br/>
&#160;Position </b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary ($)<sup>(1)</sup></b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus ($)<sup>(2)</sup></b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option Awards ($)<sup>(3)</sup></b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity Incentive Plan Compensation ($)<sup>(2)</sup></b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Nonqualified<br/>
    Deferred<br/>
    Compensation<br/>
    Earnings &#160;</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>($)</b></p></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other<br/>
Compensation ($)<sup>(4)</sup></b></span></td>
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total &#160; ($)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 36%; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner<sup>(5)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,400</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,040</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">203,447</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,000</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">497,847</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer; Former Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,741</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">401,004</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,805</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">515,550</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Shoun</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,400</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,040</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">203,447</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">497,847</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">534,672</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">815,672</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Yozamp</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,200</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">286,860</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">606,060</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Founder; Former Chief Business Development Officer; Former Chief Executive Officer</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376,845</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">742,845</span></td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts reflect base salary
earned by each named executive officer during the applicable year.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the named executive
officers voluntarily chose to forego any bonuses for 2022.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts reflect the full grant-date
fair value of stock options granted during 2022 and 2023 computed in accordance with ASC Topic 718, rather than the amounts paid to or
realized by the named individual. We provide information regarding the assumptions used to calculate the value of all option awards made
to executive officers in Note 12 to our audited financial statements included herein.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For 2022, includes: (i) $1,500
in consulting fees and $10,305 in home office expenses for Mr. Schaffner, (ii) $9,000 in home office expenses and $12,000 in automobile
expenses for Mr. Shoun, and (iii) $12,000 in home office expenses and $24,000 in automobile expenses for Mr. Yozamp. For 2023, includes:
(i) $1,000 in monthly automobile expenses for Mr. Schaffner and Mr. Shoun, (ii) $2,000 in monthly automobile expenses for Mr. Yozamp,
and (iii) $1,000 in monthly home office expenses for each of the named executive officers.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Schaffner served as a CFO
consultant from March 2021 until his appointment as Chief Financial Officer in February 2022.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Base Salaries; Consulting Fee </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify; text-indent: -0.7pt">The named executive
officers receive a base salary to compensate them for services rendered to us. The base salary payable to each named executive officer
is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role and responsibilities.
As of January 1, 2022, Mr. Schaffner was providing consulting services to the Company at the rate of $1,500 per month. He began receiving
an annual base salary of $120,000 beginning on February 21, 2022. As of January 1, 2022, the annual base salary for Mr. Shoun was $260,000
and the annual base salary for Mr. Yozamp was $330,000. The annual base salaries of Messrs. Schaffner, Shoun and Yozamp were changed to
$270,400, $270,400 and $283,200 respectively, effective January 26, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.4pt; text-align: justify; text-indent: -0.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Annual Bonuses </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">In 2022, target bonuses
were not established for the named executive officers, and they voluntarily declined participation in the discretionary year-end holiday
bonuses provided to other employees. Therefore, no annual bonuses were paid to the named executive officers in 2022. In 2023, Mr. Schaffner
and Mr. Shoun received cash and equity bonuses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Equity Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>2021 Incentive Award Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We have adopted the
2021 Incentive Award Plan (the &#8220;2021 Incentive Award Plan&#8221;). The purpose of the 2021 Incentive Award Plan is to enhance our
ability to attract, retain and motivate persons who make, or we believe can make, important contributions by providing these individuals
with equity ownership opportunities and/or equity-linked compensatory opportunities. We believe that equity awards are necessary to remain
competitive in the industry in which we operate in and are essential in recruiting and retaining the highly qualified service providers
who help thus meet our goals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">In 2022, Messrs. Yozamp,
Shoun and Schaffner were granted stock options under the 2021 Incentive Award Plan as set forth below. The stock options vested immediately
upon grant. The executive officers had not been granted stock options prior to 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: center; text-indent: -10pt">Named Executive Officer</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022 Stock Options Granted</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2023 Stock Options Granted</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 36%; text-align: left; text-indent: -10pt">Brian Schaffner</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 28%; text-align: left">150,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 28%; text-align: left">50,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Paul Shoun</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: left">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: left">50,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">John Yozamp</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: left">179,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: left">70,500</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Other Elements of Compensation </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Retirement Plans </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We maintain a 401(k)
retirement savings plan for our employees, including our named executive officers, who satisfy certain eligibility requirements. Substantially
all employees are eligible to participate. We have the option to make profit sharing contributions to our 401(k) plan at our discretion.
No profit-sharing contributions have yet been made. The Internal Revenue Code allows eligible employees to defer a portion of their compensation,
within prescribed limits, on a pre-tax basis through contributions to our 401(k) plan. We believe that providing a vehicle for tax-deferred
retirement savings through our 401(k) plan adds to the overall desirability of our executive compensation package and further incentivizes
our employees, including our named executive officers, in accordance with our compensation policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Employee Benefits and Perquisites</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Health/Welfare Plans</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">All of our full-time
employees, including our named executive officers, are eligible to participate in our health and welfare plans, which include medical
and vision benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Perquisites</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">In 2022 and 2023,
our named executive officers received reimbursements of automobile and home office expenses. Messrs. Shoun and Yozamp&#8217;s Initial
Employment Agreements (as defined below) each provide for full time security benefits, they did not receive any such benefits in 2022
or 2023. Each of our named executive officers are eligible to participate in our employee benefit plans, including our medical, dental,
and vision plans, on the same basis as all of our other employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Consulting Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Mr. Schaffner received
$1,500 for consulting work performed for the Company before being named Chief Financial Officer in February 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>No Tax Gross Ups</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We do not make gross-up
payments to cover our named executive officers&#8217; personal income taxes that may pertain to any of the compensation or perquisites
paid or provided by our company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Outstanding Equity Awards at Fiscal Year-End
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">The following table
summarizes the number of shares of Common Stock underlying outstanding equity incentive plan awards for each named executive officer as
of December 31, 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant
Date</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Securities Underlying Unexercised Options (#) Exercisable</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Securities Underlying Unexercised Options (#) Unexercisable</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
Exercise Price ($)</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
Expiration Date</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 1%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner<sup>(1)(2)</sup></span></td>
<td style="padding: 0pt 0pt 0pt 10pt; width: 1%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 12%; text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2022</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.36</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 15%; text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2032</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/23/2023</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.92</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/23/2033</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul </span>Shoun<sup>(1)(2)</sup></p></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2022</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.36</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2032</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/23/2023</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.92</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/23/2033</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Yozamp<sup>(1)(2)</sup></span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2022</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,500</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.70</span></td>
<td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2027</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/23/2023</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,500</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.92</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; padding-left: 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/23/2033</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% of each of the awards
were vested and exercisable immediately upon the grant date.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the stock options granted
to the named executive officers in 2023 are incentive stock options.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because Mr. Yozamp holds Common
Stock in the Company possessing more than 10% of the total combined voting power of all classes of stock in the Company, Section 422
of the Code requires that the exercise price of an incentive stock option granted to him will be at least 110% of the fair market value
of a share of Common Stock on the date of grant and will not remain exercisable for a period of longer than five years from the date
of grant.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation Arrangements</b><sup></sup></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>The Initial Employment Agreements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">On November 15, 2021,
we entered into employment agreements with our then Chief Executive Officer and Chairman of our Board, John Yozamp, and our Chief Operating
Officer, Paul Shoun; on February 21, 2022, we entered into an employment agreement with our then Chief Financial Officer, Brian Schaffner
(together, the &#8220;Initial Employment Agreements&#8221;) to reflect their compensation arrangements. The Initial Employment Agreements
entered into with Mr. Shoun and Mr. Yozamp each had a term of employment with a three-year duration, while the Initial Employment Agreement
entered into with Mr. Schaffner had an employment term with a one-year duration. Under the terms of the Initial Employment Agreements,
Mr. Schaffner was entitled to a base salary of $120,000, Mr. Shoun was entitled to a base salary of $260,000 and Mr. Yozamp was entitled
to a base salary of $330,000. Each executive officer was also eligible for an annual bonus, to be granted by the Company&#8217;s Board
or compensation committee based on performance objectives and targets established annually. Under the Initial Employment Agreements, Messrs.
Schaffner, Shoun and Yozamp were also entitled to participate in the Plan and in any profit sharing, qualified and nonqualified retirement
plans and any health, life, accident, disability insurance, vacation, paid time off, supplemental medical reimbursement insurance, or
benefit plans or programs as we may choose to make available at any point in time. Under the Initial Employment Agreements, the executive
officers were also entitled to annual fringe benefits and perquisites (including auto expense, security and reimbursement for the executive
officer&#8217;s home office) and reimbursement for reasonable and necessary out-of-pocket business, entertainment, and travel expenses
incurred in connection with the performance of their duties. In addition, the employment agreements contain provisions providing for severance
payments, including both base salary payment throughout the remainder of the executive&#8217;s term of employment, and a payment equal
to an additional 12 months of base salary, an amount equal to the executive annual bonus measured at target rate of performance, and continuation
of benefits under certain circumstances including termination by us without Cause or for Good Reason (each as defined in the Initial Employment
Agreements), upon execution of a general release of claims in our favor. The Initial Employment Agreements included restrictive covenants,
including a two-year non-competition provision, a two-year non-solicitation and non-disparagement provision and a confidentiality provision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>The Amended and Restated Schaffner Employment
Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">On January 26, 2023,
we promoted Brian Schaffner from his position as our Chief Financial Officer to our Chief Executive Officer. In connection with his new
role, we entered into an Amended and Restated Employment Agreement with Mr. Schaffner, effective January 26, 2023 (the &#8220;Schaffner
Employment Agreement&#8221;), setting forth the terms and conditions of Mr. Schaffner&#8217;s employment as Chief Executive Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">The Schaffner Employment
Agreement provides for a one-year term ending on April 1, 2023, the first anniversary of our initial public offering, which term renews
automatically unless terminated by the Company or Mr. Schaffner. Pursuant to the Schaffner Employment Agreement, the Company will pay
Mr. Schaffner a base salary of $270,400 per year, increased from $120,000. Like Mr. Schaffner&#8217;s existing employment agreement, the
Schaffner Agreement provides for an annual bonus award based on the achievement of performance objectives and targets established annually
by the Company&#8217;s Board or Compensation Committee,&#160;and standard employee benefits. Upon a termination of Mr. Schaffner&#8217;s
employment agreement by the Company without Cause or a resignation for Good Reason (each term as defined in the Schaffner Employment Agreement),
Mr. Schaffner will be paid (a) if terminated prior to April 1, 2023, an amount equal to the remaining unpaid amounts under the initial
employment term, (b) continued base salary for one year, (c) an amount equal to his annual target bonus for the year of termination, (d)
any earned but unpaid bonuses and (e) continued medical and dental benefits for up to one year. The Schaffner Agreement provides for the
same employee benefits as under Mr. Schaffner&#8217;s original employment agreement, except that he will also receive an automobile allowance
of $1,000 per month. The restrictive covenants in the Initial Employment Agreement to which Mr. Schaffner is a party will continue to
apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>The Amended and Restated Shoun Employment Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">On January 26, 2023,
we promoted Paul Shoun from his position as our Chief Operating Officer to our Co-Founder, President and Chief Operating Officer. In connection
with his new role, we entered into an Amended and Restated Employment Agreement with Mr. Shoun, effective January 26, 2023 (the &#8220;Shoun
Agreement&#8221;), setting forth the terms and conditions of Mr. Shoun&#8217;s employment as our Co-Founder, President and Chief Operating
Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">The Shoun Employment
Agreement provides for a three-year term ending on April 1, 2025, the third anniversary of our initial public offering, which term renews
automatically unless terminated by the Company or Mr. Shoun. Pursuant to the Shoun Employment Agreement, the Company will pay Mr. Shoun
a base salary of $270,400 per year, increased from $260,000. Like the Initial Employment Agreement to which Mr. Shoun is a party, the
Shoun Employment Agreement provides for an annual bonus award based on the achievement of performance objectives and targets established
annually by the Company&#8217;s Board or Compensation Committee,&#160;and standard employee benefits. Upon a termination of the Shoun
Employment Agreement by the Company without Cause or a resignation for Good Reason (each term as defined in the Shoun Employment Agreement),
Mr. Shoun will be paid (a) if terminated prior to April 1, 2025, an amount equal to the remaining unpaid amounts under the initial employment
term, (b) continued base salary for one year, (c) an amount equal to his annual target bonus for the year of termination, (d) any earned
but unpaid bonuses and (e) continued medical and dental benefits for up to one year. The Shoun Employment Agreement provides for the same
employee benefits as under the Initial Employment Agreement to which Mr. Shoun is a party, except that he will no longer be entitled to
security benefits. The restrictive covenants in the Initial Employment Agreement to which Mr. Shoun is a party will continue to apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>The Amended and Restated Yozamp Employment Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">On January 26, 2023,
we and Mr. Yozamp agreed that, effective January 25, 2023, he ceased to be our Chief Executive Officer and Chairman of the Company&#8217;s
Board and a member of our Board, and assumed the position of Co-Founder and Chief Business Development Officer. In connection with his
new role, we entered into an Amended and Restated Employment Agreement with Mr. Yozamp, effective January 26, 2023 (the &#8220;Yozamp
Employment Agreement&#8221;), setting forth the terms and conditions of Mr. Yozamp&#8217;s employment as our Co-Founder and Chief Business
Development Officer. The Yozamp Employment Agreement terminated on December 31, 2023, effective upon Mr. Yozamp&#8217;s retirement. The
restrictive covenants in the Initial Employment Agreement to which Mr. Yozamp is a party and the Yozamp Employment Agreement continue
to apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_016"></span>CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">We describe below
transactions and series of similar transactions, during our last three fiscal years or currently proposed, to which we were a party or
will be a party, in which:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amounts involved exceeded
or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any of our directors, executive
officers or beneficial holders of more than 5% of any class of our voting securities had or will have a direct or indirect material interest.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">Other than as described
below, there have not been, nor are there any currently proposed, transactions or series of similar transactions meeting these criteria
to which we have been or will be a party other than compensation arrangements, which are described under the sections titled &#8220;<i>Management&#8212;Director
Compensation</i>&#8221; and &#8220;<i>Executive Compensation.</i>&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.1pt; text-align: justify; text-indent: -0.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 1, 2018, the Company issued an unsecured
promissory note owed to H. Porter Burns, a holder of approximately 0.6% of our outstanding capital stock as of March 27, 2023, and business
partner at the time to John Yozamp, our Co-Founder and Chief Business Development Officer at the time (the &#8220;Porter Burns Note&#8221;),
in the principal amount of $500,000. The Porter Burns Note requires monthly interest-only payment at 10% per annum. The Porter Burns Note
had an original maturity date of August 1, 2023, but was extended to mature on August 1, 2024 by agreement dated June 30, 2023. As of
September 5, 2023, the Company had an outstanding principal balance of $500,000 under the Porter Burns Note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2019, the Company issued an unsecured
promissory note owed to James Yozamp, Jr., a holder of approximately 8.1% of our outstanding capital stock as of March 27, 2023, and brother
to John Yozamp, our Co-Founder and former Chief Business Development Officer (the &#8220;James Yozamp Note&#8221;) in the principal amount
of $200,000. The James Yozamp Note requires monthly interest only payments at 10% per annum. The James Yozamp Note matures on December
31, 2024. As of September 5, 2023, the Company had an outstanding principal balance of $200,000 under the James Yozamp Note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 1, 2019, the Company issued an unsecured
promissory note to John Yozamp, our Co-Founder and former Chief Business Development Officer (the &#8220;John Yozamp Note&#8221;) in the
amount of $250,000. The John Yozamp Note required monthly interest only payments at 10% per annum. The John Yozamp Note was converted
into a convertible debenture in May 2021 which was subsequently converted into 236,498 shares of our Common Stock on October 29, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Policies and Procedures for Related-Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have adopted a written related-party transaction
policy effective January 1, 2022 (the &#8220;Related-Party Transaction Policy&#8221;), setting forth the policies and procedures for the
review and approval or ratification of related-person transactions. This Related-Party Transaction Policy covers, with certain exceptions
set forth in Item 404 of Regulation S-K under the Securities Act, any transaction, arrangement or relationship, or any series of similar
transactions, arrangements or relationships in which we were or are to be a participant, where the amount involved exceeds $120,000 and
a related person had or will have a direct or indirect material interest, including, without limitation, purchases of goods or services
by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness
and employment by us of a related person. In reviewing and approving any such transactions, our Audit Committee is tasked to consider
all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that could
be obtained in an arm&#8217;s length transaction and the extent of the related person&#8217;s interest in the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_017"></span>SELLING STOCKHOLDER</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This prospectus relates to the possible resale from
time to time by Tumim of any or all of the Shares that may be issued by us to Tumim under the Equity Line Purchase Agreement. For additional
information regarding the issuance of Common Stock covered by this prospectus, see &#8220;<i>The Equity Line Transaction.</i>&#8221; We
are registering the Shares pursuant to the provisions of the Registration Rights Agreement in order to permit Tumim to offer the Shares
for resale from time to time. Except for the transactions contemplated by the Equity Line Purchase Agreement and the Registration Rights
Agreement, and the beneficial ownership of our securities, neither Tumim nor any persons who have control over Tumim have had any material
relationship with us within the past three years. We do not know how long Tumim will hold the Shares before selling them, and we are not
currently aware of any existing agreements, arrangements or understandings between Tumim and any other stockholder, broker, dealer, underwriter
or agent relating to the sale or distribution of the Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The table below presents information regarding Tumim
and the Shares that it may offer from time to time under this prospectus. This table is prepared based on information supplied to us by
Tumim, and reflects holdings as of January 12, 2024. The number of shares in the column &#8220;Maximum Number of Shares to be Offered
Pursuant to this Prospectus&#8221; represents all of the Shares that Tumim may offer under this prospectus. Tumim may sell some, all or
none of the Shares in this Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Beneficial ownership is determined in accordance with
Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of Common Stock with respect to which Tumim has voting
and investment power, as well as shares issuable upon the exercise or conversion of securities exercisable or convertible into shares
of Common Stock within 60 days of the measurement date held by Tumim. The percentage of shares of Common Stock beneficially owned by Tumim
prior to this Offering shown in the table below is based on an aggregate of 6,986,409 shares of our Common Stock outstanding as of January
12, 2024 and assumes the issuance and sale of the Shares that we may sell to Tumim under the Equity Line Purchase Agreement from time
to time after the date hereof (without taking into account the 19.99% Exchange Cap). Because the purchase price of the Shares issuable
under the Equity Line Purchase Agreement is determined during the applicable VWAP Purchase Valuation Period, with respect to a Purchase,
the number of shares that may actually be sold by the Company under the Equity Line Purchase Agreement may be fewer than the number of
Shares being offered by this prospectus. The fourth column assumes the sale of all of the Shares offered by Tumim pursuant to this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
Beneficially<br/> Owned Prior to<br/> Offering</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum<br/>
Number of<br/> Shares to be<br/> Offered Pursuant to this Prospectus</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
Number of Shares Beneficially Owned After<br/> Offering</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Selling Stockholders</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<sup>(1)</sup></b></span></td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage<sup>(2)</sup></b></span></td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<sup>(3)</sup></b></span></td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage<sup>(2)</sup></b></span></td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 35%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tumim
Stone Capital, LLC<sup>(4)</sup></span></td>
<td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,821,632&#160;</span></td>
<td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.8&#160;</span></td>
<td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,781,978</span></td>
<td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,654&#160;</span></td>
<td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
<td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">*<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">______________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">* Less than 1%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">This number reflects 39,654 of the 3i Commitment Shares beneficially owned
by Tumim and assumes the issuance and sale of the 1,781,978 Shares that we may sell to Tumim under the Equity Line Purchase Agreement
from time to time after the date hereof. The issuance of Shares is subject to certain agreed upon maximum amount limitations set forth
in the Equity Line Purchase Agreement. In addition, the Equity Line Purchase Agreement prohibits us from issuing and selling any Shares
to Tumim to the extent such Shares, when aggregated with all other shares of our Common Stock then beneficially owned by Tumim, would
cause Tumim&#8217;s beneficial ownership of our Common Stock to exceed the 9.99% Beneficial Ownership Limitation. The Equity Line Purchase
Agreement also prohibits us from issuing or selling Shares under the Equity Line Purchase Agreement in excess of the 19.99% Exchange
Cap, unless we obtain stockholder approval to do so, or unless sales of Shares are made at a price equal to or greater than $5.45 per
share (which is the Nasdaq official closing price of the Common Stock on the date of the Equity Line Purchase Agreement), such that the
Exchange Cap limitation would not apply under applicable Nasdaq rules. Subject to the foregoing, neither the Beneficial Ownership Limitation
nor the Exchange Cap (to the extent applicable under Nasdaq rules) may be amended or waived under the Equity Line Purchase Agreement.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt">&#160;<span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(2)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">Applicable percentage ownership is based on 6,986,409 shares of our Common
Stock outstanding as of January 12, 2024, plus the 1,781,978 Shares that we may sell to Tumim under the Equity Line Purchase Agreement.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(3)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">Assumes the sale of all Shares being offered pursuant to this prospectus.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(4)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The business address of Tumim is 2 Wooster Street, 2nd Floor, New York,
New York 10013. Tumim&#8217;s principal business is that of a private investor. 3i, LP is the sole member of Tumim. 3i Management, LLC
(&#8220;3i Management&#8221;) is the general partner of 3i, LP and the sole manager of Tumim. Maier Joshua Tarlow is the manager of 3i
Management and has sole voting control and investment discretion over securities beneficially owned directly by Tumim, and indirectly
by 3i Management and 3i, LP. Mr. Tarlow disclaims beneficial ownership of the securities owned directly by Tumim, and indirectly by 3i
Management and 3i, LP, except to the extent of his pecuniary interest therein.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_018"></span>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #ED0000">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based solely upon information made available to us,
the following table sets forth certain information with respect to the beneficial ownership of our Common Stock as of January 12, 2024
as to: (1) each person (or group of affiliated persons) who is known by us to own beneficially more than 5% of our Common Stock; (2) each
of our directors; (3) each of our executive officers; and (4) all directors and executive officers of the Company as a group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe that all persons named in the table have
sole voting and investment power with respect to all shares beneficially owned by them, except as noted. Unless otherwise indicated, the
address of each stockholder listed in the table is c/o Expion360, 2025 SW Deerhound Avenue, Redmond, OR 97756.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Beneficial ownership is determined in accordance with
SEC rules and includes voting or investment power with respect to securities. All shares of Common Stock subject to options or warrants
exercisable within 60 days of January 12, 2024, are deemed to be outstanding and beneficially owned by the persons holding those options
or warrants for the purpose of computing the number of shares beneficially owned and the percentage ownership of that person. They are
not, however, deemed to be outstanding and beneficially owned for the purpose of computing the percentage ownership of any other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subject to the paragraph above, percentage ownership
of outstanding shares is based on 6,986,409 shares of Common Stock outstanding as of January 12, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Beneficial
Owner</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Shares <br/> Beneficially Owned</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of Class</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; font-style: italic; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
Stockholder:</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
Yozamp, Jr.<sup>(1)</sup></span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">552,673</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Yozamp
(Co-Founder)<sup>(2)</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,685,552</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; font-style: italic; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;Directors
and Executive Officers:</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner
(Chief Executive Officer)<sup>(3)</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,332</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Shoun
(Chairman, Co-Founder, President, Chief Operating Officer and Director)<sup>(4)&#160;</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">345,803</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg Aydelott
(Chief Financial Officer)<sup>(5)</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,115</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tien Nguyen
(Independent Director)<sup>(6)</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George Lefevre
(Independent Director)<sup>(7)</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Shum
(Independent Director)<sup>(8)</sup></span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
and Executive Officers as a Group (six persons)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>635,250</b></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.1</b></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">______________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">* Less than 1%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">Based on a third-party report dated as of August 16, 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(2)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The number of shares of Common Stock shown as beneficially owned by Mr. John Yozamp consists of: (i) 1,500,177 shares of Common Stock owned directly by Mr. John Yozamp and (ii) 185,375 shares of Common Stock issuable upon the exercise of the vested options held by Mr. John Yozamp. As of December 31, 2023, Mr. Yozamp retired as our Chief Business Development Officer.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(3)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The number of shares of Common Stock beneficially owned by Mr. Schaffner consists of 158,332 shares of Common Stock issuable upon exercise of the vested options held by Mr. Schaffner.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(4)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The number of shares of Common Stock shown as beneficially owned by Mr. Shoun consists of: (i) 137,471 shares of Common Stock owned directly by Mr. Shoun and (ii) 208,332 shares of Common Stock issuable upon exercise of the vested options owned by Mr. Shoun.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(5)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The number of shares of Common Stock shown as beneficially owned by Mr. Aydelott consists of: (i) 2,783 shares of Common Stock owned directly by Mr. Aydelott and (ii) 58,332 shares of Common Stock issuable upon exercise of the vested options owned by Mr. Aydelott.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(6)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">Mr. Nguyen was appointed to our Board on August 24, 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(7)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The number of shares of Common Stock shown as beneficially owned by Mr. Lefevre consists of 30,000 shares of Common Stock issuable upon exercise of the vested options owned by Mr. Lefevre.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 17.4pt"><span style="font-size: 10pt">(8)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The number of shares of Common Stock shown as beneficially owned by Mr. Shum consists of 40,000 shares of Common Stock issuable upon exercise of the vested options owned by Mr. Shum.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.4pt; text-align: justify; text-indent: -17.4pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_019"></span>DESCRIPTION OF CAPITAL STOCK</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 has one class of securities registered under
Section 12 of the Securities Exchange Act: the Company&#8217;s Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following description of our capital stock is
a summary of the rights of our capital stock and summarizes certain provisions of our Articles of Incorporation and our Bylaws. This summary
does not purport to be complete and is qualified in its entirety by the provisions of our Articles of Incorporation and Bylaws, copies
of which have been filed as exhibits to the Registration Statement of which this prospectus forms a part, as well as to the applicable
provisions of Nevada law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our authorized capital stock consists of 200,000,000
shares of Common Stock and 20,000,000 shares of preferred stock, par value $0.001 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The holders of our Common Stock are entitled to one
vote for each share held on all matters submitted to a vote of the stockholders. The holders of our Common Stock do not have any cumulative
voting rights. Holders of our Common Stock are entitled to receive ratably any dividends declared by the Board out of funds legally available
for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. Our Common Stock has no preemptive rights,
conversion rights or other subscription rights or redemption or sinking fund provisions. We currently do not have any shares of, or securities
convertible into, preferred stock outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the event of our liquidation, dissolution or winding
up, holders of our Common Stock will be entitled to share ratably in all assets remaining after payment of all debts and other liabilities
and any liquidation preference of any outstanding preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>$2.90 Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 9, 2021, the Company issued warrants to
purchase 151,000 of shares of the Company&#8217;s Common Stock with an exercise price of $2.90 per share (the &#8220;$2.90 Warrants&#8221;).
The $2.90 Warrants are exercisable for a period of three years from date of grant. If holders of the $2.90 Warrants elect to exercise
them on a cashless basis, they would pay the exercise price by surrendering their $2.90 Warrants for that number of shares of Common Stock
equal to the quotient obtained by dividing (x) the difference between the &#8220;fair market value&#8221; (defined below) multiplied by
the number of shares underlying such holder&#8217;s $2.90 Warrants and the exercise price multiplied by the number of shares underlying
such holder&#8217;s $2.90 Warrants by (y) the fair market value. The &#8220;fair market value&#8221; shall mean the prior five-day average
closing price of the Common Stock on the date on which the holder elects to exercise their $2.90 Warrants. The $2.90 Warrants have certain
adjustment rights upon certain events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>$3.32 Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 22, 2021, the Company issued warrants
to purchase 559,431 shares of the Company&#8217;s Common Stock at an exercise price of $3.32 per share (the &#8220;$3.32 Warrants&#8221;).
The $3.32 Warrants are exercisable for a period of ten years from date of grant. If holders of the $3.32 Warrants elect to exercise them
on a cashless basis, they would pay the exercise price by surrendering their $3.32 Warrants for that number of shares of Common Stock
equal to the quotient obtained by dividing (x) the difference between the &#8220;fair market value&#8221; (defined below) multiplied by
the number of shares underlying such holder&#8217;s $3.32 Warrants and the exercise price multiplied by the number of shares underlying
such holder&#8217;s $3.32 Warrants by (y) the fair market value. The &#8220;fair market value&#8221; shall mean the volume weighted average
of the closing sales price of the Common Stock averaged over 20 consecutive trading days ending on the trading day prior to the date on
which &#8220;fair market value&#8221; is determined. The $3.32 Warrants have certain adjustment rights upon certain events. The Company
is required to cause a registration statement registering the resale of the shares of our Common Stock issuable upon exercise of the $3.32
Warrants to become effective in connection with its initial public offering. As of the date of this prospectus, the Company has an effective
registration statement which satisfies this requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Underwriter Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Concurrent with the closing of the initial public
offering, the Company issued warrants to purchase an aggregate of 128,700 shares of its Common Stock to Alexander Capital LP and Paulson
Investment Company LLC (as apportioned in accordance with agreements amongst them), or their designees, at an exercise price of $9.10
per share (the &#8220;Underwriter Warrants&#8221;). The Underwriter Warrants are initially exercisable on September 27, 2022 and expire
on March 31, 2027.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If there is not an effective registration statement
registering the resale of the shares of Common Stock issuable upon exercise of the Underwriter Warrants, holders of the Underwriter Warrants
may elect to exercise them on a cashless basis and pay the exercise price by surrendering their Underwriter Warrants for that number of
shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the
Underwriter Warrants, multiplied by the difference between (i) the daily volume weighted average price of the Common Stock on the trading
day immediately preceding the date of the exercise notice or on the date of the exercise notice (if delivered after regular trading hours)
and (ii) the exercise price of the Underwriter Warrants and by (y) the daily volume weighted average price of the Common Stock on the
trading day immediately preceding the date of the exercise notice or on the date of the exercise notice (if delivered after regular trading
hours). If the Company does not deliver Common Stock to a holder upon such holder&#8217;s exercise of their Underwriter Warrants in compliance
with the timing set out in the Underwriter Warrants, the Company will have to pay cash to such holder in accordance with the terms of
the Underwriter Warrants. The Underwriter Warrants include anti-dilution provisions (for stock dividends, splits and recapitalizations
and similar transactions), which results in the adjustment of the exercise price and entitles holders of the Underwriter Warrants to participate
in subsequent rights offerings or distributions to holders of the Company&#8217;s Common Stock, as applicable. The Underwriter Warrants
also have certain adjustment rights upon certain events. Further, the Underwriter Warrants provide for a one-time demand registration
right, exercisable until March 31, 2027 and unlimited piggyback rights, exercisable until September 27, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to our initial public offering, we issued options
to purchase 30,000 shares of Common Stock granted to one individual which had an exercise price of $3.32.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Anti-Takeover Effects of Provisions of Our Charter
Documents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provisions of Nevada law and our Bylaws may have
the effect of delaying, deferring or preventing another party from acquiring control of the company. These provisions may discourage and
prevent coercive takeover practices and inadequate takeover bids.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Nevada Law</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Nevada law contains a provision governing &#8220;acquisition
of controlling interest.&#8221; This law provides generally that any person or entity that acquires 20% or more of the outstanding voting
shares of a publicly-held Nevada corporation in the secondary public or private market may be denied voting rights with respect to the
acquired shares, unless a majority of the disinterested stockholders of the corporation elects to restore such voting rights in whole
or in part. The control share acquisition act provides that a person or entity acquires &#8220;control shares&#8221; whenever it acquires
shares that, but for the operation of the control share acquisition act, would bring its voting power within any of the following three
ranges: 20 to 33-1/3%; 33-1/3 to 50%; or more than 50%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Articles of Incorporation include a mandatory
forum provision that, to the fullest extent permitted by law, the Nevada Eighth Judicial District of Clark County Nevada shall be the
sole and exclusive forum for: (a) any derivative action or proceeding brought in the name or right of the Company or on its behalf, (b)
any action asserting a claim for breach of any fiduciary duty owed by any director, officer, employee or agent of the Company to the Company
or the Company&#8217;s stockholders, (c) any action arising or asserting a claim arising pursuant to any provision of NRS Chapters 78
or 92Aor any provision of the Articles of Incorporation or Bylaws, (d) any action to interpret, apply, enforce or determine the validity
of the Articles of Incorporation or Bylaws or (e) any action asserting a claim governed by the internal affairs doctrine. This exclusive
forum provision would not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act or
any other claim for which the federal courts have exclusive jurisdiction. To the extent that any such claims may be based upon federal
law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability
created by the Exchange Act or the rules and regulations thereunder. Furthermore, Section 22 of the Securities Act creates concurrent
jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or rules
and regulations thereunder and would preempt the choice of forum provisions in our Articles of Incorporation with respect to such matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A &#8220;control share acquisition&#8221; is generally
defined as the direct or indirect acquisition of either ownership or voting power associated with issued and outstanding control shares.
The stockholders or Board of Directors of a corporation may elect to exempt the stock of the corporation from the provisions of the control
share acquisition act through adoption of a provision to that effect in the articles of incorporation or bylaws of the corporation. Our
Articles of Incorporation and Bylaws do not exempt our Common Stock from the control share acquisition act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The control share acquisition act is applicable only
to shares of &#8220;Issuing Corporations&#8221; as defined by the Nevada law. An Issuing Corporation is a Nevada corporation which: (i)
has 200 or more stockholders, with at least 100 of such stockholders being both stockholders of record and residents of Nevada, and (ii)
does business in Nevada directly or through an affiliated corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At this time, we do not believe we have 100 stockholders
of record resident of Nevada and we do not conduct business in Nevada directly. Therefore, the provisions of the control share acquisition
act are believed not to apply to acquisitions of our shares and will not until such time as these requirements have been met. At such
time as they may apply, the provisions of the control share acquisition act may discourage companies or persons interested in acquiring
a significant interest in or control of us, regardless of whether such acquisition may be in the interest of our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Nevada &#8220;Combination with Interested Stockholders
Statute&#8221; may also have an effect of delaying or making it more difficult to effect a change in control of us. This statute prevents
an &#8220;interested stockholder&#8221; and a resident domestic Nevada corporation from entering into a &#8220;combination,&#8221; unless
certain conditions are met. The statute defines &#8220;combination&#8221; to include any merger or consolidation with an &#8220;interested
stockholder,&#8221; or any sale, lease, exchange, mortgage, pledge, transfer or other disposition, in one transaction or a series of transactions
with an &#8220;interested stockholder&#8221; having (i) an aggregate market value equal to 5% or more of the aggregate market value of
the assets of the corporation, (ii) an aggregate market value equal to 5% or more of the aggregate market value of all outstanding shares
of the corporation, or (iii) representing 10% or more of the earning power or net income of the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An &#8220;interested stockholder&#8221; means the
beneficial owner of 10% or more of the voting shares of a resident domestic corporation, or an affiliate or associate thereof. A corporation
affected by the statute may not engage in a &#8220;combination&#8221; within three years after the interested stockholder acquires its
shares unless the combination or purchase is approved by the Board of Directors before the interested stockholder acquired such shares.
If approval is not obtained, then after the expiration of the three-year period, the business combination may be consummated with the
approval of the Board of Directors or a majority of the voting power held by disinterested stockholders, or if the consideration to be
paid by the interested stockholder is at least equal to the highest of: (i) the highest price per share paid by the interested stockholder
within the three years immediately preceding the date of the announcement of the combination or in the transaction in which he became
an interested stockholder, whichever is higher, (ii) the market value per common share on the date of announcement of the combination
or the date the interested stockholder acquired the shares, whichever is higher, or (iii) if higher for the holders of preferred stock,
the highest liquidation value of the preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Articles of Incorporation and Bylaws</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Articles of Incorporation are silent as to cumulative
voting rights in the election of our directors. Nevada law requires the existence of cumulative voting rights to be provided for by a
corporation&#8217;s Articles of Incorporation. In the event that a few stockholders end up owning a significant portion of our issued
and outstanding Common Stock, the lack of cumulative voting would make it more difficult for other stockholders to replace our Board of
Directors or for a third party to obtain control of us by replacing our Board of Directors. Our Articles of Incorporation and Bylaws do
not contain any explicit provisions that would have an effect of delaying, deferring or preventing a change in control of us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Transfer Agent and Registrar</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The transfer agent and registrar for our common shares
is Pacific Stock Transfer Company. Pacific Stock Transfer Company&#8217;s address and phone number is: 6725 Via Austi Pkwy, Suite 300,
Las Vegas, Nevada 89119; telephone number (800) 785-7782.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Listing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Common Stock has been traded on Nasdaq under the
symbol &#8220;XPON&#8221; since April 1, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_020"></span>PLAN OF DISTRIBUTION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Shares offered by this prospectus are being offered
by Tumim. The Shares may be sold or distributed from time to time by Tumim, or its permitted transferees or other successors-in-interest,
directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing
at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed.
The sale of the ordinary Shares offered by this prospectus could be effected in one or more of the following methods:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokers&#8217; transactions;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transactions involving cross or block trades;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through brokers, dealers, or underwriters who may act solely as agents;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;at the market&#8221; into an existing market for the ordinary shares;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;&#160;an exchange distribution in accordance with the rules&#160;of the applicable exchange;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in transactions through broker-dealers that agree with Tumim to sell a specified number of such securities at a stipulated price per security;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in privately negotiated transactions;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any combination of the foregoing; or</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other method permitted pursuant to applicable law.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim may also sell securities under Rule 144 under
the Securities Act, if available, rather than under this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to comply with the securities laws of certain
states, if applicable, the Shares may be sold only through registered or licensed brokers or dealers. In addition, in certain states,
the Shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state&#8217;s
registration or qualification requirement is available and complied with.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim has informed us that it intends to use one or
more registered broker-dealers to effectuate all sales, if any, of our Common Stock that it has acquired and may in the future acquire
from us pursuant to the Equity Line Purchase Agreement. Such sales will be made at prices and at terms then prevailing or at prices related
to the then-current market price. Each such registered broker-dealer will be an underwriter within the meaning of Section&#160;2(a)(11)
of the Securities Act. Tumim has informed us that each such broker-dealer will receive commissions from Tumim that will not exceed customary
brokerage commissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Brokers, dealers, underwriters or agents participating
in the distribution of the Shares offered by this prospectus may receive compensation in the form of commissions, discounts, or concessions
from the purchasers, for whom the broker-dealers may act as agent, of the Shares sold by Tumim through this prospectus. The compensation
paid to any such particular broker-dealer by any such purchasers of Shares sold by Tumim may be less than or in excess of customary commissions
but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage
commission in compliance with FINRA Rule&#160;2121; and in the case of a principal transaction a markup or markdown in compliance with
FINRA Rule&#160;2121. Neither we nor Tumim can presently estimate the amount of compensation that any agent will receive from any purchasers
of Shares sold by Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We know of no existing arrangements between Tumim
or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the Shares offered by this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim is an &#8220;underwriter&#8221; and any broker-dealers
or agents that are involved in selling the Shares may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities
Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale
of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Tumim has informed
us that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the Shares
offered by this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We may from time to time file with the SEC one or
more supplements to this prospectus or amendments to the Registration Statement of which this prospectus forms a part to amend, supplement
or update information contained in this prospectus, including, if and when required under the Securities Act, to disclose certain information
relating to a particular sale of shares offered by this prospectus by Tumim, including the names of any brokers, dealers, underwriters
or agents participating in the distribution of such shares by Tumim, any compensation paid by Tumim to any such brokers, dealers, underwriters
or agents, and any other required information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We will pay the expenses incident to the registration
under the Securities Act of the offer and sale of the Shares covered by this prospectus by Tumim, and have agreed to reimburse Tumim for
the fees and disbursements of its counsel incurred in connection therewith. We also have agreed to indemnify Tumim and certain other persons
against certain liabilities in connection with this Offering of the Shares offered hereby, including liabilities arising under the Securities
Act or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Tumim has agreed to
indemnify us against liabilities under the Securities Act that may arise from certain written information furnished to us by Tumim specifically
for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling
persons, we have been advised that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities
Act and is therefore, unenforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We estimate that the total expenses for this Offering
will be approximately $80,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim has represented to us that at no time prior
to the date of the Equity Line Purchase Agreement has Tumim or its agents, representatives or affiliates engaged in or effected, in any
manner whatsoever, directly or indirectly, any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act)
of our Common Stock or any hedging transaction, which establishes a net short position with respect to our Common Stock. Tumim has agreed
that during the term of the Equity Line Purchase Agreement, neither Tumim, nor any of its agents, representatives or affiliates will enter
into or effect, directly or indirectly, any of the foregoing transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under applicable rules&#160;and regulations under
the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities
with respect to our Common Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.
In addition, Tumim will be subject to applicable provisions of the Exchange Act and the rules&#160;and regulations thereunder, including
Regulation M, which may limit the timing of purchases and sales of our Common Stock by Tumim or any other person. All of the foregoing
may affect the marketability of the securities offered by this prospectus. We will make copies of this prospectus available to Tumim and
are informing Tumim of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule&#160;172 under the Securities Act).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We intend to keep this prospectus effective until
the earlier of: (i)&#160;the date on which the Shares may be resold by Tumim without registration and without regard to any volume or
manner-of-sale limitations by reason of Rule&#160;144, without the requirement for us to be in compliance with the current public information
requirement under Rule&#160;144 under the Securities Act or any other rule&#160;of similar effect or (ii)&#160;all of the Shares have
been sold pursuant to this prospectus or Rule&#160;144 under the Securities Act or any other rule&#160;of similar effect. The resale Shares
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale Shares covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Offering will terminate on the date that all
Shares have been sold by Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Common Stock is currently listed on Nasdaq under
the symbol &#8220;XPON.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_021"></span>THE EQUITY LINE TRANSACTION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 27, 2023, we entered into the Equity Line
Purchase Agreement and the Registration Rights Agreement with Tumim, pursuant to which Tumim committed to purchase up to $20.0&#160;million
of our Common Stock, at our sole direction from time to time over the term of the Equity Line Purchase Agreement, subject to certain terms,
conditions and limitations in the Equity Line Purchase Agreement (the &#8220;Equity Line Transaction&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms and subject to the conditions of the
Equity Line Purchase Agreement, we have the right, but not the obligation, to sell to Tumim, and Tumim is obligated to purchase up to
$20.0&#160;million of our Common Stock. Such sales of Common Stock, if any, will be subject to certain limitations, and may occur from
time to time at our sole discretion, over the 24-month&#160;period commencing on the Commencement Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Tumim has no right to require
us to sell any shares of our Common Stock to it, but Tumim is obligated to make purchases as directed by us, subject to the satisfaction
of conditions set forth in the Equity Line Purchase Agreement at Commencement and thereafter at each time that we direct Tumim to purchase
shares of our Common Stock under the Equity Line Purchase Agreement. Actual sales of shares of our Common Stock to Tumim will depend on
a variety of factors to be determined by us from time to time, including, among others, market conditions, the trading price of our Common
Stock and determinations by us as to the appropriate sources of funding for us and our operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We do not know what the purchase price for our Common
Stock will be and therefore cannot be certain as to the number of Shares we might issue to Tumim under the Equity Line Purchase Agreement
after the Commencement Date. As of January 12, 2024, there were 6,986,409 shares of our Common Stock outstanding, of which 5,345,938 shares
were held by non-affiliates. Although the Equity Line Purchase Agreement provides that we may sell up to $20.0 million of our Common Stock
to Tumim, only 1,781,978 Shares are being registered under the&#160;Securities Act&#160;for resale by Tumim under this prospectus. Depending
on the market prices of our Common Stock at the time we elect to issue and sell shares to Tumim under the Equity Line Purchase Agreement,
we may need to register for resale under the&#160;Securities Act&#160;additional shares of our Common Stock in order to receive aggregate
gross proceeds equal to the Total Commitment available to us under the Equity Line Purchase Agreement.] If all of the Shares offered by
Tumim under this prospectus were issued and outstanding as of the date hereof (without taking into account the 19.99% Exchange Cap limitation),
such Shares would represent approximately 25.5% of the total number of shares of our Common Stock outstanding and approximately 33.3%
of the total number of outstanding shares held by&#160;non-affiliates,&#160;in each case as of the date hereof. If we elect to issue and
sell more than the 1,781,978 Shares under this prospectus to Tumim, which we have the right, but not the obligation, to do, we must first
register for resale under the&#160;Securities Act&#160;any such additional shares, which could cause additional substantial dilution to
our stockholders. The number of Shares ultimately offered for resale by Tumim is dependent upon the number of Shares we may elect to sell
to Tumim under the Equity Line Purchase Agreement from and after the Commencement Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under applicable rules of Nasdaq, in no event may
we issue or sell to Tumim under the Equity Line Purchase Agreement shares of our Common Stock in excess of the Exchange Cap, unless: (i)&#160;we
obtain stockholder approval&#160;to issue shares of Common Stock in excess of the Exchange Cap, or (ii)&#160;the average price of all
applicable sales of our Common Stock to Tumim under the Equity Line Purchase Agreement equals or exceeds $5.45 (which is the Nasdaq official
closing price of the Common Stock on the date of the Equity Line Purchase Agreement) plus an incremental amount, such that issuances and
sales of our Common Stock to Tumim under the Equity Line Purchase Agreement would be exempt from the Exchange Cap limitation under applicable
Nasdaq rules. In any event, the Equity Line Purchase Agreement specifically provides that we may not issue or sell any shares of our Common
Stock under the Equity Line Purchase Agreement if such issuance or sale would breach any applicable Nasdaq rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Equity Line Purchase Agreement also prohibits
us from directing Tumim to purchase any shares of our Common Stock if those shares, when aggregated with all other shares of our Common
Stock then beneficially owned by Tumim and its affiliates, would result in Tumim and its affiliates having beneficial ownership, at any
single point in time, of more than the Beneficial Ownership Limitation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net proceeds under the Equity Line Purchase Agreement
to us will depend on the frequency and prices at which we sell shares of our Common Stock to Tumim.&#160;We expect that any proceeds received
by us from such sales to Tumim will be used for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Purchase of Shares Under
the Equity Line Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Upon the Commencement, we have the right, but not
the obligation, from time to time at our sole discretion over the 24-month&#160;period from and after Commencement Date, to direct Tumim
to purchase amounts of our Common Stock under the Equity Line Purchase Agreement, that we specify in Purchase notices that we deliver
to Tumim under the Equity Line Purchase Agreement on any trading day. The maximum number of shares that may be purchased pursuant to a
Purchase is equal to a number of shares of Common Stock equal to the lowest of (the &#8220;VWAP Purchase Maximum Amount&#8221;):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% of the average daily trading
volume in the Common Stock on Nasdaq (or, in the event the Common Stock is then listed on an Eligible Market (as defined in the Equity
Line Purchase Agreement), 100% of the average daily trading volume in our Common Stock on such Eligible Market) for the five consecutive
trading-day period ending on (and including) the trading day immediately preceding the applicable VWAP Purchase Exercise Date for such
Purchase;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the product (rounded up or
down to the nearest whole number) obtained by multiplying: (i) the daily trading volume in our Common Stock on Nasdaq (or an Eligible
Market, as applicable) on the applicable VWAP Purchase Exercise Date for such Purchase by (ii) 0.40; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the quotient (rounded up or
down to the nearest whole number) obtained by dividing: (i) $2.0 million by (ii) the VWAP on Nasdaq (or an Eligible Market, as applicable)
on the trading day immediately preceding the applicable VWAP Purchase Exercise Date for such Purchase (in each case to be appropriately
adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction during
the applicable period).</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim is obligated to accept each Purchase notice
prepared and timely delivered on the VWAP Purchase Exercise Date by us in accordance with the terms of and subject to the satisfaction
of the conditions contained in the Equity Line Purchase Agreement; provided that, Tumim shall not be obligated to purchase any shares
of Common Stock set forth in a valid Purchase notice in excess of the VWAP Purchase Maximum Amount. We may deliver a Purchase notice on
a VWAP Purchase Exercise Date, provided that: (i)&#160;we may not deliver more than one Purchase notice to Tumim on any single trading
day, (ii)&#160;we may not deliver a Purchase notice to Tumim on any trading day during the period commencing on the VWAP Purchase Exercise
Date on which a prior Purchase notice has previously been delivered by us to Tumim under the Equity Line Purchase Agreement, and ending
on the applicable trading day immediately following the last trading day of the applicable Purchase Valuation Period (each such date,
a &#8220;Purchase Settlement Date&#8221;) or such later trading day on which Tumim shall have received all of the shares subject to such
prior Purchase notice in electronic form as &#8220;DWAC Shares&#8221; (as defined in the Equity Line Purchase Agreement), (iii)&#160;all
shares subject to all prior Purchase notices previously delivered by us to Tumim have in fact been received by Tumim as DWAC Shares prior
to our delivery of such Purchase notice to Tumim on such VWAP Purchase Exercise Date, and (iv) the Closing Sale Price (as defined in the
Equity Line Purchase Agreement) of our Common Stock on such VWAP Purchase Exercise Date is not less than the Threshold Price (as defined
in the Equity Line Purchase Agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The purchase price of the shares of Common Stock that
we may direct Tumim to purchase pursuant to a Purchase under the Equity Line Purchase Agreement will be equal to ninety-five (95%) of
the arithmetic average of the three VWAPs during the VWAP Purchase Valuation Period as set forth in the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The payment for, against simultaneous delivery of,
shares in respect of each Purchase under the Equity Line Purchase Agreement will be settled on the applicable Purchase Settlement Date
immediately following the applicable VWAP Purchase Valuation Period for such Purchase, as set forth in the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Conditions to Commencement
and Delivery of Purchase Notices</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our ability to deliver Purchase notices to Tumim under
the Equity Line Purchase Agreement is subject to the satisfaction, both at the time of Commencement and at the time of delivery by us
of any Purchase notice to Tumim, of certain conditions, all of which are entirely outside of Tumim&#8217;s control, including, among other
things, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the accuracy in all material respects of our representations and warranties
    included in the Equity Line Purchase Agreement;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">us having performed, satisfied and complied in all material respects
    with all covenants, agreements and conditions required by the Equity Line Purchase Agreement and the Registration Rights Agreement
    to be performed, satisfied or complied with by us;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the effectiveness of the Registration Statement that includes this
    prospectus;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the SEC shall not have issued any stop order suspending the effectiveness,
    prohibiting or suspending the use of the Registration Statement that includes this prospectus;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">there shall not have occurred any event and there shall not exist any
    condition or state of facts, which makes any statement of a material fact made in the Registration Statement that includes this prospectus
    untrue or which requires the making of any additions to or changes to the statements contained therein in order to state a material
    fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein not misleading;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">this prospectus, in final form, shall have been filed with the SEC
    under the Securities Act, and all reports, schedules, registrations, forms, statements, information and other documents required
    to have been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act, shall have been filed
    with the SEC;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">trading in our Common Stock shall not have been suspended by the SEC
    or Nasdaq, we shall not have received any final and non-appealable notice that the listing or quotation of the Common Stock on Nasdaq
    shall be terminated on a date certain (unless, prior to such date, the Common Stock is listed or quoted on The Nasdaq Global Market,
    Nasdaq, The Nasdaq Global Select Market, the New York Stock Exchange or the NYSE American (or any nationally recognized successor
    to any of the foregoing) (each, an &#8220;Eligible Market&#8221;)), and there shall be no suspension of, or restriction on, accepting
    additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we shall have complied with all applicable federal, state and local
    governmental laws, rules, regulations and ordinances in connection with the execution, delivery and performance of the Equity Line
    Purchase Agreement and the Registration Rights Agreement;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the absence of any statute, regulation, order, decree, writ, ruling
    or injunction by any court or governmental authority of competent jurisdiction which prohibits the consummation of or that would
    materially modify or delay any of the transactions contemplated by the Equity Line Purchase Agreement or the Registration Rights
    Agreement;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the absence of any action, suit or proceeding before any arbitrator
    or any court or governmental authority seeking to restrain, prevent or change the transactions contemplated by the Equity Line Purchase
    Agreement or the Registration Rights Agreement, or seeking material damages in connection with such transactions;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">all of the Shares that may be issued pursuant to the Equity Line Purchase
    Agreement shall have been approved for listing or quotation on Nasdaq (or if the Common Stock is not then listed on Nasdaq, on any
    Eligible Market);</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as defined in the Equity Line Purchase Agreement) shall have occurred and be continuing;</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">any voluntary or involuntary participation or threatened participation in insolvency or bankruptcy proceedings by or against us; and</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">the receipt by Tumim of the opinions, bring-down opinions and negative assurances from outside counsel to us in the forms mutually agreed to by us and Tumim prior to the date of the Equity Line Purchase Agreement.</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>No Short-Selling or Hedging
by Tumim</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tumim has covenanted not to cause or engage in any
manner whatsoever, any direct or indirect short selling or hedging of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Prohibition on Variable
Rate Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subject to specified exceptions included in the Equity
Line Purchase Agreement, we are limited in our ability to enter into specified &#8220;dilutive issuances&#8221; during the period of time
between the time we deliver a Purchase notice to Tumim under the Equity Line Purchase Agreement and the final Purchase Settlement Date
of such Purchase. Such transactions include, the issuance of Common Stock, or securities convertible into or exercisable for Common Stock,
at a price (or with a conversion or exercise price) that is less than the per share purchase price Tumim is required to pay for the shares
that are subject to such pending Purchase notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From and after the date of the Equity Line Purchase
Agreement until the termination of the Equity Line Purchase Agreement, we have also agreed not to enter into any &#8220;equity line of
credit&#8221; or other substantially similar continuous offering in which we may offer, issue or sell Common Stock or Common Stock equivalents
(or any combination of units thereof) at a future determined price; provided, however, that such prohibition shall not include any &#8220;at-the-market&#8221;
offering to the extent the gross proceeds to the Company from any such offering does not exceed an aggregate $10.0 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Termination of the Equity
Line Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unless earlier terminated as provided in the Equity
Line Purchase Agreement, the Equity Line Purchase Agreement will terminate automatically on the earliest to occur of:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the first day of the calendar
month immediately following the 24-month anniversary of the Effective Date;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which Tumim shall
have purchased shares of Common Stock under the Equity Line Purchase Agreement for an aggregate gross purchase price equal to its Total
Commitment under the Equity Line Purchase Agreement;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the Common
Stock shall have failed to be listed or quoted on Nasdaq or any other Eligible Market; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which we commence
a voluntary bankruptcy case or any third party commences a bankruptcy proceeding against us, a custodian is appointed for us in a bankruptcy
proceeding for all or substantially all of its property, or we make a general assignment for the benefit of its creditors.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have the right to terminate the Equity Line Purchase Agreement at any time after the Commencement Date, at no cost or penalty, upon ten
trading days&#8217; prior written notice to Tumim. We and Tumim may also terminate the Equity Line Purchase Agreement at any time by
mutual written consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tumim
also has the right to terminate the Equity Line Purchase Agreement upon ten trading days&#8217; prior written notice to us, but only
upon the occurrence of certain events, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the occurrence of a Material
Adverse Effect;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the occurrence of a Fundamental
Transaction (as defined in the Equity Line Purchase Agreement) involving us;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our failure to file with the
SEC the Registration Statement that includes this prospectus or any additional registration statement we file with the SEC pursuant to
the Registration Rights Agreement, within the time periods set forth in the Registration Rights Agreement or we are otherwise in breach
or default in any material respect under any of the other provisions of the Registration Rights Agreement, and, if such failure, breach
or default is capable of being cured, such failure, breach or default is not cured within ten trading days after notice of such failure,
breach or default is delivered to us;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the effectiveness of the Registration
Statement that includes this prospectus or any additional registration statement we file with the SEC pursuant to the Registration Rights
Agreement lapses for any reason (including the issuance of a stop order by the SEC), or this prospectus or the prospectus included in
any additional registration statement we file with the SEC pursuant to the Registration Rights Agreement otherwise becomes unavailable
to Tumim for the resale of all of the shares of Common Stock included therein, and such lapse or unavailability continues for a period
of 20 consecutive trading days or for more than an aggregate of 60 trading days in any 365-day period, other than due to acts of Tumim;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">trading in the Common Stock
on Nasdaq (or if the Common Stock is then listed on an Eligible Market, trading in the Common Stock on such Eligible Market) has been
suspended for a period of three consecutive trading days; or</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are in material breach or
default of the Equity Line Purchase Agreement, and, if such breach or default is capable of being cured, such breach or default is not
cured within ten trading days after notice of such breach or default is delivered to us.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unless notification thereof is required elsewhere
in the Equity Line Purchase Agreement, we are required to promptly (but in no event later than 24 hours) notify Tumim (and, if required
under applicable law, including, without limitation, Regulation FD promulgated by the SEC, or under the applicable rules and regulations
of the Trading Market, publicly disclose such information in accordance with Regulation FD and the applicable rules and regulations of
the Trading Market) upon becoming aware of any of the events set forth above giving rise to a termination right by Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No termination of the Equity Line Purchase Agreement
by us or by Tumim will become effective prior to the first trading day immediately following the applicable Purchase Settlement Date related
to any pending Purchase that has not been fully settled in accordance with the terms and conditions of the Equity Line Purchase Agreement,
and will not affect any of our respective rights and obligations under the Equity Line Purchase Agreement with respect to any pending
Purchase, and both we and Tumim have agreed to complete our respective obligations with respect to any such pending Purchase under the
Equity Line Purchase Agreement. Furthermore, no termination of the Equity Line Purchase Agreement will affect the Registration Rights
Agreement, which will survive any termination of the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Effect of Performance
of the Equity Line Purchase Agreement on our Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All Shares that may be issued or sold by us to Tumim
under the Equity Line Purchase Agreement that are being registered under the Securities Act for resale by Tumim in this Offering are expected
to be freely tradable. The Shares being registered for resale in this Offering may be issued and sold by us to Tumim from time to time
at our discretion over a period of up to 24-months commencing on the Commencement Date. The resale by Tumim of a significant amount of
Shares registered for resale in this Offering at any given time, or the perception that these sales may occur, could cause the market
price of our Common Stock to decline and to be highly volatile. Sales of our Common Stock, if any, to Tumim under the Equity Line Purchase
Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Tumim all,
some or none of the Shares that may be available for us to sell to Tumim pursuant to the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the terms of the Equity Line Purchase
Agreement, we have the right, but not the obligation, to direct Tumim to purchase up to $20.0&#160;million of our Common Stock, subject
to certain limitations. The number of Shares ultimately offered for resale under this prospectus is dependent upon the number of Shares
we direct Tumim to purchase under the Equity Line Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the amount of gross
proceeds we would receive from Tumim from our sale of Shares to Tumim under the Equity Line Purchase Agreement at varying purchase prices:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed<br/>
Average<br/>
Purchase&#160;Price<br/> Per&#160;Share</span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number&#160;of
Registered&#160;Shares to&#160;be&#160;Issued if&#160;Full&#160;Purchase<sup>(1)</sup></b></span></td>
<td style="font-style: italic"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i><b>Percentage&#160;of
Outstanding&#160;Shares After&#160;Giving&#160;Effect to the Issuance to Tumim<sup>(2)</sup></b></span></td>
<td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
Proceeds from the Sale&#160;of&#160;Shares&#160;to Tumim Under&#160;the Purchase Agreement</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.45</span></td>
<td style="vertical-align: top; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,781,978</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.8</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,711,780</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.60</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,781,978</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.8</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,979,077</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.75</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,781,978</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.8</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,246,374</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.90</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,781,978</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.8</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,513,670</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.05</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,781,978</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.8</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,780,967</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Equity Line Purchase Agreement provides that we may sell up to $20.0 million of our Common Stock to Tumim, we are only registering 1,781,978 Shares under this prospectus, which may or may not cover all the Shares we ultimately sell to Tumim under the Equity Line Purchase Agreement, depending on the purchase price per share. As a result, we have included in this column only those Shares that we are registering in this Offering. If we seek to issue shares of our Common Stock, including shares from other transactions that may be aggregated with the transactions contemplated by the Equity Line Purchase Agreement under applicable Nasdaq rules, in excess of 1,383,890 shares, or 19.99% of the total Common Stock outstanding immediately prior to the execution of the Equity Line Purchase Agreement, we may be required to seek stockholder approval in order to be in compliance with Nasdaq rules.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The denominator is based on 6,986,409 shares outstanding as of January 12, 2024. The numerator is based on the number of Shares issuable under the Equity Line Purchase Agreement at the corresponding assumed purchase price set forth in the first column, plus the 39,654 3i Commitment Shares beneficially owned by Tumim.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects Nasdaq official closing sale price of our Common Stock on the date the Equity Line Purchase Agreement was executed.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Registration Rights Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the Equity Line Transaction, we
entered into the Registration Rights Agreement. Under the Registration Rights Agreement, we agreed to file a resale Registration Statement
covering the resale of the Shares within 30 calendar days after the date of the Registration Rights Agreement, and to use commercially
reasonable efforts to cause such resale Registration Statement to be declared effective by the SEC as promptly as possible after the filing
thereof, but in any event no later than February 14, 2024 (the &#8220;Effectiveness Date&#8221;); provided, however, that in the event
we are notified by the SEC that the resale Registration Statement will not be reviewed or is no longer subject to further review, the
Effectiveness Date will be the fifth trading day following the date on which we are so notified if such date precedes the dates otherwise
required above. Under certain circumstances, if we fail to meet our obligations under the Registration Rights Agreement, Tumim may require
us to pay certain liquidated damages to Tumim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_022"></span>MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES<br/>
TO NON-U.S. HOLDERS OF OUR COMMON STOCK</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of the material U.S. federal
income tax considerations relating to the acquisition, ownership, and disposition of our Common Stock by&#160;non-U.S.&#160;holders (as
defined below). This summary deals only with Common Stock held as a capital asset (within the meaning of Section&#160;1221 of the Internal
Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) and does not discuss all of the U.S. federal income tax considerations applicable
to a&#160;non-U.S.&#160;holder that is subject to special treatment under U.S. federal income tax laws, including, but not limited to:
a dealer in securities or currencies; a broker-dealer; a financial institution; a qualified retirement plan, individual retirement plan,
or other&#160;tax-deferred&#160;account; a regulated investment company; a real estate investment trust; a&#160;tax-exempt&#160;organization;
an insurance company; a person holding Common Stock as part of a hedging, integrated, conversion, or straddle transaction or a person
deemed to sell Common Stock under the constructive sale provisions of the Code; a trader in securities that has elected the&#160;mark-to-market&#160;method
of tax accounting; an accrual method taxpayer subject to special tax accounting rules under Section&#160;451(b) of the Code; an entity
that is treated as a partnership for U.S. federal income tax purposes (or an investor therein); a person that received such Common Stock
in connection with services provided, including upon the exercise of an option; a corporation that accumulates earnings to avoid U.S.
federal income tax; a corporation organized outside the United States, any state thereof or the District of Columbia that is nonetheless
treated as a U.S. corporation for U.S. federal income tax purposes; a person that is not a&#160;non-U.S.&#160;holder; a &#8220;controlled
foreign corporation;&#8221; a &#8220;passive foreign investment company;&#8221; or a U.S. expatriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This summary is based upon provisions of the Code,
its legislative history, applicable U.S. Treasury regulations promulgated thereunder, published rulings, and judicial decisions, all as
in effect as of the date hereof. We have not sought, and will not seek, any ruling from the Internal Revenue Service (the &#8220;IRS&#8221;)
with respect to the tax consequences discussed herein, and there can be no assurance that the IRS will not take a position contrary to
the tax consequences discussed below or that any position taken by the IRS would not be sustained. Those authorities may be repealed,
revoked, or modified, perhaps retroactively, or may be subject to differing interpretations, which could result in U.S. federal income
tax consequences different from those discussed below. This summary does not address all aspects of U.S. federal income tax, does not
deal with all tax considerations that may be relevant to stockholders in light of their personal circumstances, and does not address the
Medicare tax imposed on certain investment income or any state, local, foreign, gift, estate, or alternative minimum tax considerations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of this discussion, a &#8220;U.S. holder&#8221;
is a beneficial holder of Common Stock that is for U.S. federal income tax purposes: an individual citizen or resident of the United States;
a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the
laws of the United States, any state thereof or the District of Columbia; an estate the income of which is subject to U.S. federal income
taxation regardless of its source; or a trust if it (1)&#160;is subject to the primary supervision of a court within the United States
and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (2)&#160;was in existence on August&#160;20,
1996 and has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of this discussion, a&#160;&#8221;non-U.S.&#160;holder&#8221;
is a beneficial owner of Common Stock that is neither a U.S. holder nor a partnership (or any other entity or arrangement that is treated
as a partnership) for U.S. federal income tax purposes regardless of its place of organization or formation. If a partnership (or an entity
or arrangement that is treated as a partnership for U.S. federal income tax purposes) holds Common Stock, the tax treatment of a partner
will generally depend upon the status of the partner and the activities of the partnership. A partner of a partnership holding Common
Stock is urged to consult its tax advisors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>PROSPECTIVE INVESTORS ARE URGED TO CONSULT THEIR
TAX ADVISORS CONCERNING THE U.S. FEDERAL INCOME, ESTATE, AND OTHER TAX CONSEQUENCES OF ACQUIRING, OWNING, AND DISPOSING OF OUR COMMON
STOCK IN LIGHT OF THEIR SPECIFIC SITUATIONS, AS WELL AS THE TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL, OR&#160;NON-U.S.&#160;TAX
LAWS AND ANY OTHER U.S. FEDERAL TAX LAWS (INCLUDING THE U.S. FEDERAL ESTATE AND GIFT TAX LAWS).</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Distributions on Our Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Distributions with respect to Common Stock, if any,
generally will constitute dividends for U.S. federal income tax purposes to the extent paid out of current or accumulated earnings and
profits, as determined for U.S. federal income tax purposes. Any portion of a distribution in excess of current or accumulated earnings
and profits will be treated as a return of capital and will first be applied to reduce the holder&#8217;s tax basis in its Common Stock,
but not below zero. Any remaining amount will then be treated as gain from the sale or exchange of the Common Stock and will be treated
as described under &#8220;<i>&#8212;Disposition of Our Common Stock</i>&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Distributions treated as dividends that are paid to
a&#160;non-U.S.&#160;holder, if any, with respect to shares of our Common Stock will be subject to U.S. federal withholding tax at a rate
of 30% (or such lower rate as may be specified in an applicable income tax treaty) of the gross amount of the dividends unless the dividends
are effectively connected with the&#160;non-U.S.&#160;holder&#8217;s conduct of a trade or business in the United States, subject to the
discussion below regarding foreign accounts. If a&#160;non-U.S.&#160;holder is engaged in a trade or business in the United States and
dividends with respect to the Common Stock are effectively connected with the conduct of that trade or business and, if required by an
applicable income tax treaty, are attributable to a U.S. permanent establishment, then although the&#160;non-U.S.&#160;holder will generally
be exempt from the 30% U.S. federal withholding tax, provided certain certification requirements are satisfied, the&#160;non-U.S.&#160;holder
will be subject to U.S. federal income tax on those dividends on a net income basis at regular U.S. federal income tax rates in the same
manner as if such holder were a resident of the United States. Any such effectively connected income received by a foreign corporation
may, under certain circumstances, be subject to an additional branch profits tax equal to 30% (or lower applicable income tax treaty rate)
of its effectively connected earnings and profits for the taxable year, as adjusted under the Code. To claim the exemption from withholding
with respect to any such effectively connected income, the&#160;non-U.S.&#160;holder must generally furnish to us or our paying agent
a properly executed IRS Form&#160;W-8ECI&#160;(or applicable successor form). In the case of a&#160;non-U.S.&#160;holder that is an entity,
Treasury Regulations and the relevant tax treaty provide rules to determine whether, for purposes of determining the applicability of
a tax treaty, dividends will be treated as paid to the entity or to those holding an interest in that entity. If a&#160;non-U.S.&#160;holder
holds stock through a financial institution or other agent acting on the holder&#8217;s behalf, the holder will be required to provide
appropriate documentation to such agent. Such holder&#8217;s agent will then be required to provide certification to us or our paying
agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A non-U.S. holder of shares of Common Stock who wishes
to claim the benefit of a reduced rate of withholding tax under an applicable treaty must furnish to us or our paying agent a valid IRS
Form&#160;W-8BEN&#160;or IRS Form&#160;W-8BEN-E&#160;(or applicable successor form) certifying such holder&#8217;s qualification for the
exemption or reduced rate. If a&#160;non-U.S.&#160;holder is eligible for a reduced rate of U.S. withholding tax pursuant to an income
tax treaty and does not timely file the required certification, it may obtain a refund or credit of any excess amounts withheld by timely
filing a U.S. tax return with the IRS.&#160;Non-U.S.&#160;holders are urged to consult their tax advisors regarding their entitlement
to benefits under a relevant income tax treaty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Disposition of Our Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subject to the discussion below regarding backup withholding,
a&#160;non-U.S.&#160;holder generally will not be subject to U.S. federal income tax on any gain from a sale, exchange or other disposition
of our stock unless: (a)&#160;that gain is effectively connected with the&#160;non-U.S.&#160;holder&#8217;s conduct of a trade or business
in the United States (and, if required by an applicable income tax treaty, is attributable to a U.S. permanent establishment maintained
by the&#160;non-U.S.&#160;holder); (b) the&#160;non-U.S.&#160;holder is a nonresident alien individual who is present in the United States
for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or (c)&#160;we are or have been a
&#8220;United States real property holding corporation&#8221; within the meaning of Code Section&#160;897(c)(2) for U.S. federal income
tax purposes at any time during the shorter of the five-year period preceding the date of disposition or the holder&#8217;s holding period
for our Common Stock, and certain other requirements are met. Although there can be no assurance, we believe that we are not, and we do
not anticipate becoming, a United States real property holding corporation for U.S. federal income tax purposes. Even if we are treated
as a United States real property holding corporation, gain realized by a&#160;non-U.S.&#160;holder on a disposition of our Common Stock
will not be subject to U.S. federal income tax so long as: (1)&#160;the&#160;non-U.S.&#160;holder owned, directly, indirectly and constructively,
no more than five percent of our Common Stock at all times within the shorter of (x)&#160;the five-year period preceding the disposition,
or (y)&#160;the holder&#8217;s holding period, and (2)&#160;our Common Stock is regularly traded on an established securities market.
Although Nasdaq qualifies as an established securities market, there can be no assurance that our Common Stock will continue to qualify
as regularly traded on an established securities market. If any gain on your disposition is taxable because we are a United States real
property holding corporation and your ownership of our Common Stock exceeds five percent, you will be taxed on such disposition generally
in the manner applicable to U.S. persons and in addition, a purchaser of your Common Stock may be required to withhold tax with respect
to that obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If a&#160;non-U.S.&#160;holder is described in clause
(a)&#160;of the preceding paragraph, the&#160;non-U.S.&#160;holder will generally be subject to tax on the net gain derived from the disposition
at the regular U.S. federal income tax rates in the same manner as if such&#160;non-U.S.&#160;holder were a U.S. person, unless an applicable
income tax treaty provides otherwise. In addition, a&#160;non-U.S.&#160;holder that is a corporation may be subject to the branch profits
tax at a rate equal to 30% (or lower applicable income tax treaty rate) of its effectively connected earnings and profits for the taxable
year, as adjusted under the Code. If the&#160;non-U.S.&#160;holder is an individual described in clause (b)&#160;of the preceding paragraph,
the&#160;non-U.S.&#160;holder will generally be subject to a flat 30% tax on the gain derived from the disposition, which may be offset
by U.S. source capital losses even though the&#160;non-U.S.&#160;holder is not considered a resident of the United States, provided that
the&#160;non-U.S.&#160;holder has timely filed U.S. federal income tax returns with respect to such losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Information Reporting and Backup Withholding Tax</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We report to our&#160;non-U.S.&#160;holders and the
IRS certain information with respect to any dividends we pay on our Common Stock, including the amount of dividends paid during each fiscal
year, the name and address of the recipient, and the amount, if any, of tax withheld. All distributions to holders of Common Stock are
subject to any applicable withholding. Information reporting requirements apply even if no withholding was required because the distributions
were effectively connected with the&#160;non-U.S.&#160;holder&#8217;s conduct of a U.S. trade or business or withholding was reduced by
an applicable income tax treaty. This information also may be made available under a specific treaty or agreement with the tax authorities
in the country in which the&#160;non-U.S.&#160;holder resides or is established. Under U.S. federal income tax law, interest, dividends,
and other reportable payments may, under certain circumstances, be subject to &#8220;backup withholding&#8221; at the then-applicable
rate (currently, 24%). Backup withholding, however, generally will not apply to distributions on our Common Stock to a&#160;non-U.S.&#160;holder,
provided the&#160;non-U.S.&#160;holder furnishes to us or our paying agent the required certification as to its&#160;non-U.S.&#160;status,
such as by providing a valid IRS Form&#160;W-8BEN,&#160;IRS Form&#160;W-8BEN-E&#160;or IRS Form&#160;W-8ECI,&#160;or certain other requirements
are met. Notwithstanding the foregoing, backup withholding may apply if either we or our paying agent has actual knowledge, or reason
to know, that the holder is a U.S. person that is not an exempt recipient. Backup withholding is not an additional tax but merely an advance
payment, which may be credited against the tax liability of persons subject to backup withholding or refunded to the extent it results
in an overpayment of tax and the appropriate information is timely supplied to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Foreign Accounts</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain withholding taxes may apply to certain types
of payments made to &#8220;foreign financial institutions&#8221; (as specially defined under these rules) and certain other&#160;non-U.S.&#160;entities
if certification, information reporting and other specified requirements are not met. A 30% withholding tax may apply to &#8220;withholdable
payments&#8221; if they are paid to a foreign financial institution or to a&#160;non-financial&#160;foreign entity, unless (a)&#160;the
foreign financial institution undertakes certain diligence and reporting obligations and other specified requirements are satisfied, or
(b)&#160;the&#160;non-financial&#160;foreign entity either certifies it does not have any substantial U.S. owners or furnishes identifying
information regarding each substantial U.S. owner and other specified requirements are satisfied. &#8220;Withholdable payment&#8221; generally
means any payment of interest, dividends, rents, and certain other types of generally passive income if such payment is from sources within
the United States. Treasury regulations proposed in December 2018 (and upon which taxpayers and withholding agents are entitled to rely)
eliminate possible withholding under these rules on the gross proceeds from any sale or other disposition of our Common Stock, previously
scheduled to apply beginning January&#160;1, 2022. If the payee is a foreign financial institution, it must enter into an agreement with
the U.S. Treasury requiring, among other things, that it undertake to identify accounts held by certain U.S. persons or U.S.-owned foreign
entities, annually report certain information about such accounts and withhold 30% on payments to account holders whose actions prevent
it from complying with these reporting and other requirements, or comply with comparable requirements under an applicable inter-governmental
agreement between the United States and the foreign financial institution&#8217;s home jurisdiction. If an investor does not provide the
information necessary to comply with these rules, it is possible that distributions to such investor that are attributable to withholdable
payments, such as dividends, will be subject to the 30% withholding tax. Holders should consult their own tax advisers regarding the implications
of these rules for their investment in our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_023"></span>LEGAL MATTERS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The validity of the Shares will be passed upon for
us by Stradling Yocca Carlson &amp; Rauth LLP, Newport Beach, California.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_024"></span>EXPERTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements of the Company
as of December 31, 2022 and 2021, and for each of the two years in the period ended December 31, 2022, included in this prospectus,
have been audited by M&amp;K CPAS, PLLC, an independent registered public accounting firm. Such financial statements are included
in reliance upon the report of such firm given their authority as experts in accounting and auditing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_025"></span>DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION
FOR SECURITIES ACT LIABILITIES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers or persons controlling us, we have been informed that in the opinion
of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_026"></span>WHERE YOU CAN FIND MORE INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have filed with the SEC a Registration Statement
on Form&#160;S-1 under the Securities Act with respect to the Shares being offered by this prospectus. This prospectus, which constitutes
part of the Registration Statement, does not include all of the information contained in the Registration Statement or the exhibits, schedules
and amendments to the Registration Statement. For further information with respect to us and our Common Stock, we refer you to the Registration
Statement, any documents incorporated by reference into the Registration Statement and to the exhibits and schedules to the Registration
Statement. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily
complete. If a contract or other document has been filed as an exhibit to the Registration Statement, please see the copy of the contract
or other document that has been filed. Each statement in this prospectus relating to a contract or other document filed as an exhibit
is qualified in all respects by the filed exhibit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We file annual, quarterly and current reports, proxy
statements and other information with the SEC. Our SEC filings are available to the public at the SEC&#8217;s website at www.sec.gov and
on our website at expion360.com. Information contained on or accessible through our website is not a part of this prospectus, and the
inclusion of our website address in this prospectus is an inactive textual reference only. You may inspect a copy of the Registration
Statement through the SEC&#8217;s website, as provided herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The SEC&#8217;s rules allow us to &#8220;incorporate
by reference&#8221; information into this prospectus provided we meet certain eligibility requirements, which means that if we become
eligible, including if we have filed an Annual Report on Form 10-K, we can disclose important information to you by referring you to another
document filed separately with the SEC. Any information incorporated by reference would be deemed to be part of this prospectus, and subsequent
information that we file with the SEC would automatically update and supersede that information. Any statement contained in this prospectus
or a previously filed document incorporated by reference would be deemed to be modified or superseded for purposes of this prospectus
to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces
that statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We refer you to the following documents which have
previously been filed with the SEC:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Annual Report, as filed
with the SEC on March 30, 2022;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Quarterly Reports on Form
10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Reports on Form&#160;8-K
filed with the SEC on&#160;February 1, 2023, August 16, 2023, August 24, 2023, October 16, 2023 and December 29, 2023; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Common
Stock contained in our registration statement on Form 8-A (File No. 001-41347), filed with the SEC on March 31, 2022, pursuant to Section
12 of the Exchange Act, as updated by Exhibit 4.4 to the Annual Report, filed with the SEC on March 30, 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If and when we are eligible to incorporate by reference,
all reports and other documents we subsequently file pursuant to Section&#160;13(a), 13(c), 14 or 15(d)&#160;of the Exchange Act prior
to the termination of this Offering shall be deemed to be incorporated by reference into this prospectus, and all such documents we may
file with the SEC after the date hereof and prior to the effectiveness of the Registration Statement, but excluding any information furnished
to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus
from the date of the filing of such reports and documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You may request a free copy of any of the documents
we refer to above, and any documents we incorporate by reference in this prospectus when we are eligible to do so, by writing or telephoning
us at the following address:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Expion360 Inc.<br/>
2025 SW Deerhound Ave</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Redmond, Oregon 97756</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(541) 797-6714</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Exhibits to the filings will not be sent, however,
unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_027"></span>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS<span style="font-weight: normal">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: rgb(204,238,255)">
    <td style="width: 86%; padding-right: 5.4pt; padding-left: 5.4pt"><b>Audited Consolidated Financial Statements</b></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_001">Report of Independent Registered Public Accounting Firm (PCAOB ID #2738)</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-1</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_002">Balance Sheets as of December 31, 2022 and 2021</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-3</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_003">Statements of Operations for the Years Ended December 31, 2022 and 2021</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-4</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_004">Statements of Stockholders&#8217; Equity (Deficit) for the Years Ended December 31, 2022 and 2021</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-5</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_005">Statements of Cash Flows for the Years Ended December 31, 2022 and 2021</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-6</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_006">Notes to Consolidated Financial Statements</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-8</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Unaudited Consolidated Financial Statements</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_007">Balance Sheets as of September 30, 2023 and 2022</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-30</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_008">Statements of Operations for the Three Months and Nine Months
    Ended September 30, 2023 and 2022</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-32</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <a href="#b_009">Statements of Stockholders&#8217; Equity (Deficit) for the Nine Months Ended September 30, 2023 and 2022</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-33</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_010">Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-34</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="#b_011">Notes to Consolidated Financial Statements</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">F-36</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="b_001"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">To the Board of Directors and<br/>
Stockholders of Expion360, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited the accompanying balance sheets of
Expion360, Inc. (the Company) as of December 31, 2022 and 2021, and the related statements of operations, stockholders&#8217; equity (deficit),
and cash flows for each of the years in the two-year period ended December 31, 2022, and the related notes (collectively referred to as
the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of
the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the two-year
period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 45.5pt 0 0; text-align: justify"><b>Going Concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 45.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company suffered a
net loss from operations and used cash in operations, which raises substantial doubt about its ability to continue as a going concern.
Management&#8217;s plans regarding those matters are also described in Note 2. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis for Opinion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audits in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal
control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal
control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Critical Audit Matter</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The critical audit matter communicated below is a
matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit
committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially
challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on
the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions
on the critical audit matter or on the accounts or disclosures to which it relates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Equity Transactions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in Note 13 to the financial statements,
the company issues options and warrants. The proper valuation of options and warrants requires significant management judgement in determining
the volatility and method used to calculate the option and warrant values.</p>

<!-- Field: Page; Sequence: 96; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To evaluate the appropriateness of the model and estimates
determined by management, we examined and evaluated the model, and the time period and stock prices used in determining the valuation
of the options and warrants issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">/s/ M&amp;K CPAS, PLLC</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have served as the Company&#8217;s auditor since
2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Houston, TX</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">March 30, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360
Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_002"></span>Balance
Sheets</b></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_111_zgVR1YR7JV64" summary="xdx: Statement - Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_498_20221231_zX79W7VSiWsj" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" id="xdx_492_20211231_z9gaaDnsxSNk" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2021</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsAbstract_iB_zm294H8jnOK2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrentAbstract_iB_zZXIJohPHmuk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_maACzydW_z3AWkkA6SpC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">&#160;&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22944">7,201,244</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22945">773,238</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsReceivableNetCurrent_iI_maACzydW_zMo7RWe1oaif" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22946">298,035</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22947">775,160</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryNet_iI_maACzydW_zs5XHWWM5i8b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;&#160;&#160;&#160;&#160;&#160;Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22948">4,530,136</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22949">2,051,880</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherInventoryInTransit_iI_maACzydW_zODz6bRZ2jX6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid/in-transit inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherInventoryInTransit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22950">141,611</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherInventoryInTransit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22951">1,081,225</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_maACzydW_zZhCpBqF4kLh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22952">171,791</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22953">71,703</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsCurrent_iTI_mtACzydW_maAzz1f_zBVNePFOF2f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22954">12,342,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22955">4,753,206</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzu7d_zdWh7S2gpKT6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22956">1,394,619</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22957">523,419</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzu7d_zEvIiGHHajWa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;Accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22958">250,861</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22959">96,190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzu7d_maAzz1f_zmNHidRFqnR8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22960">1,143,758</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22961">427,229</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsAbstract_iB_zJ3YdpVYlkP8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Other Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maOAzwWb_zpa7aTWvbvdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;&#160;Operating leases &#8211; right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22962">3,148,455</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22963">1,281,371</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DepositsAssetsNoncurrent_i01I_maOAzwWb_zjueiyb6rcAh" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;&#160;&#160;Deposits</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22964">63,901</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22965">63,901</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAssets_i01TI_mtOAzwWb_maAzz1f_zlVdr6EpGmc5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;Total other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22966">3,212,356</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22967">1,345,272</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Assets_iTI_mtCzySm_mtAzz1f_zh56gVioi4qh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22968">16,698,931</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22969">6,525,707</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zXaMsv6SluDi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Liabilities and stockholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrentAbstract_iB_zOqXbg5MYiKi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableCurrent_iI_maLCzWfp_zbOzTzIW6OAl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22970">230,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22971">63,180</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CustomerDepositsCurrent_iI_maLCzWfp_zf5IL5zs5552" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;Customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22972">58</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22973">436,648</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_maLCzWfp_zpV75zfn6ubb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;Accrued expenses and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22974">306,164</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22975">140,618</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LinesOfCreditCurrent_iI_maLCzWfp_zXA89seLdhC4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;Line of credit and short-term revolving loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0083">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22976">550,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maLCzWfp_z1ZGlNhbMISi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;Current portion of operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22977">465,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22978">218,788</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--LiabilityForSaleOfFutureRevenuesNet_iI_maLCzWfp_zwdxR6TJqzba" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;Liability for sale of future revenues, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0089">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:LiabilityForSaleOfFutureRevenuesNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22979">11,502</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--NotesPayableCurrent1_iI_maLCzWfp_zER4XdmFtxn5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;Note payable in default</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0092">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:NotesPayableCurrent1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22980">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LongTermDebtCurrent1_iI_maLCzWfp_zvqgg9LLryha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;&#160;Current portion of long-term debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:LongTermDebtCurrent1" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22981">571,426</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:LongTermDebtCurrent1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22982">51,135</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_iTI_mtLCzWfp_maLzY3Z_zIpjP3YdyWt1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22983">1,572,953</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22984">1,571,871</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_iI_maLzY3Z_zeQWYR6T21s7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Long-term debt, net of current portion and discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22985">439,049</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22986">779,486</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_maLzY3Z_znh4L05npJ0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;Operating lease liability, net of current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22987">2,754,964</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22988">1,092,861</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ShareholderPromissoryNotes_iI_maLzY3Z_z4KnMYwBiIDi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;Shareholder promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:ShareholderPromissoryNotes" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22989">325,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:ShareholderPromissoryNotes" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22990">825,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Liabilities_iTI_mtCzw0C_maCznCX_mtLzY3Z_maLASEzwWj_zXgufuez0tJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22991">5,091,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-22992">4,269,218</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_iB_zVkcSK7d7Zn" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;Stockholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PreferredStockValue_iI_maSEzdMI_zxqiMQ1bE9l1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred stock, par value $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zFKRXoRwrCP7"><span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zReszswFvL01"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares" id="ixv-22993"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares" id="ixv-22994">.001</ix:nonFraction></ix:nonFraction></span></span>; <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_z9rinpZKmUz5"><span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zMwA6sH6PYRj"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-22995"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-22996">20,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; zero shares issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0116">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CommonStockValue_iI_maCzqYh_maSEzdMI_z7dG3C3m17di" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock, par value $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231_zoEL2Fnb97Pg"><span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_z1Ow0SJZIgb3"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares" id="ixv-22997"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares" id="ixv-22998">.001</ix:nonFraction></ix:nonFraction></span></span>; <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20221231_zcilhEZx8dj7"><span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_z19HKl74plb1"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-22999"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23000">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20221231_zoLL7enWdWjc"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20221231_zcJtppYViXY"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23001"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23002">6,802,464</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20211231_zbbyWfqPXpRc"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_z5CFhL8NgaUi"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23003"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23004">4,300,000</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding as of December 31, 2022 and 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23005">6,802</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23006">4,300</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdditionalPaidInCapital_iI_maSEzdMI_zWRdX0WrYnfl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23007">25,239,654</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23008">8,355,140</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maSEzdMI_zDKnyVISk2Kg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;&#160;&#160;&#160;Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23009">13,639,491</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23010">6,102,951</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_iTI_mtSEzdMI_maLASEzwWj_z8tTcSA8XMOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;Total stockholders&#8217; equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23011">11,606,965</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23012">2,256,489</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtLASEzwWj_zBEEn87p0oqf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23013">16,698,931</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23014">6,525,707</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements</span></p>


<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360
Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_003"></span>Statements
of Operations</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_113_zUpMTBWgLgR" summary="xdx: Statement - Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49E_20220101__20221231_zLwWvl7nDqg6" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_490_20210101__20211231_zBil1KUJmfAb" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_maCzoi0_maGPzEYf_zCZVMcQOHfs6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Sales, net</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23015">7,162,837</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23016">4,517,499</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CostOfRevenue_msCzoi0_msGPzEYf_zhDVlusz2s6b" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23017">4,874,392</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23018">2,871,770</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GrossProfit_iT_mtCzoi0_maCzgXi_mtGPzEYf_zIgtml2t8jU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23019">2,288,445</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23020">1,645,729</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SellingGeneralAndAdministrativeExpense_msCzgXi_zCIruw1wHusl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Selling, general and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23021">8,241,859</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23022">2,909,085</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingIncomeLoss_iT_mtCzgXi_maCzx82_zI4dY8g5SsOk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23023">5,953,414</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23024">1,263,356</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other (Income) / Expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--InterestAndOtherIncome_iN_di_zSknY7x6dRz9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23025">239</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23026">169</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DebtConversionOriginalDebtAmount1_z9DryX4dNDx1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;Debt conversion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0164">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23027">112,133</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_zwTAbPvSePa8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;&#160;Extinguishment loss on debt settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0167">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23028">2,791,087</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InterestExpense_z9AiiWtH3OZk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23029">1,605,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23030">554,044</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GainLossOnSaleOfPropertyPlantEquipment_zvFSPvwlypX2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;&#160;Gain on sale of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23031">13,312</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23032">8,521</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--OtherOperatingIncome_iN_di_zUxEQYLJZVV8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;Other income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23033">389</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23034">372</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NonoperatingIncomeExpense_mtCzLPT_maCzx82_zV9XVDUZwGJ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total other (income) / expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23035">1,591,976</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23036">3,448,202</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzx82_maCzVQa_z1aLyLzZOo14" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23037">7,545,390</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23038">4,711,558</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_zFnSLuqKKvC2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Tax (income) / expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23039">8,850</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23040">9,300</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_iT_mtCzVQa_zQwMiGpSEOGe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23041">7,536,540</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23042">4,720,858</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NetLossPerShareBasicAndDiluted_zQRQrdzlrvae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share (basic and diluted)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23043">1.23</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23044">1.63</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zoZ1ACdtQYGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted-average number of common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23045">6,135,938</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23046">2,888,695</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements</span></p>


<!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360
Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_004"></span>Statements
of Stockholders&#8217; Equity (Deficit) for Twelve Months ended December 31, 2022 and 2021</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_114_zQwWmSKaejZ5" summary="xdx: Statement - Statements of Stockholders Equity (Deficit)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 5.4pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
                                                                                               <td style="font-weight: bold; text-align: center">&#160;</td>
                                                                                               <td style="font-weight: bold; text-align: center">&#160;</td>
                                                                                               <td style="font-weight: bold; text-align: center">&#160;</td>
                                                                                               <td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zc3OaRBadvAj" style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zLQ95ofKEoQ7" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z4QuMaVT9ika" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_4B9_zUP1J2YpYQx3" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional Paid-in Capital</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Deficit</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Stockholders&#8217; Equity (Deficit)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20210101__20211231_eus-gaap--StockholdersEquity_iS_zDjv96KC0Xif" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-weight: bold; padding-left: 5.4pt">Balance at December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbMIcwVoWDng" title="Beginning Balance" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23047">2,430,514</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23048">2,431</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0198">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23049">1,382,093</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23050">1,379,662</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zWSu36knKzM8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of shares upon conversion of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zI8ttabpXA8i" title="Issuance of shares upon conversion of convertible notes" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23051">59,515</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23052">59</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23053">173,098</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0206">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23054">173,157</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--EffectOfInducedConversionOfDebt_zGvZ8BvhbqR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Effect of induced conversion of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0211">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:EffectOfInducedConversionOfDebt" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23055">112,133</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0213">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:EffectOfInducedConversionOfDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23056">112,133</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IssuanceOfSharesInExchangeForBuildingSignageValue_zZassJbN0gHd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of shares in exchange for building signage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--IssuanceOfSharesInExchangeForBuildingSignage_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5rByZOaTRr6" title="Issuance of shares in exchange for building signage" style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForBuildingSignage" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23057">6,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForBuildingSignageValue" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23058">7</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForBuildingSignageValue" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23059">19,993</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0218">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForBuildingSignageValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23060">20,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z8u8GML2D908" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Issuance of shares for cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6MtTiNo35I6" title="Issuance of shares for cash Share" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23061">81,106</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23062">81</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23063">269,919</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0225">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23064">270,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueNewIssuesOne_ztKzQMrSABoa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt">Issuance of shares for cash class</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodValueNewIssuesOneShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjaZIBZSJoE6" title="Issuance of shares for cash Shares" style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesOneShares" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23065">75,662</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesOne" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23066">76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesOne" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23067">251,924</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0232">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesOne" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23068">252,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--IssuanceOfSharesUponSettlementOfConvertibleNotes_zShDzCYpSIhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of shares upon settlement of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--IssuanceOfSharesUponSettlementOfConvertibleNotesShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRjYxueDizMi" title="Issuance of shares upon settlement of convertible notes" style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesUponSettlementOfConvertibleNotesShares" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23069">1,527,647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23070">1,527</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23071">5,543,832</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0239">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23072">5,545,359</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_z2BH60yKmvhc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDFi2MqCabW9" title="Issuance of shares in exchange for service" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23073">30,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23074">30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23075">108,870</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0246">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23076">108,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueNewIssuesTwo_zzykIMvBvsEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Issuance of shares for cash amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueNewIssuesTwoShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQkytrnMbqje" title="Issuance of new shares  for cash" style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesTwoShares" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23077">88,889</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesTwo" contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23078">89</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesTwo" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23079">316,311</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0253">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:StockIssuedDuringPeriodValueNewIssuesTwo" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23080">316,400</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IssuanceOfDetachableWarrantsToLongTermDebt_z6bbJ0od5aw5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of detachable warrants to long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfDetachableWarrantsToLongTermDebt" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23081">809,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0260">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfDetachableWarrantsToLongTermDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23082">809,806</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--IssuanceOfWarrantsToUnderwriters_zpAAafTZNYag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of warrants to underwriters</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0263">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfWarrantsToUnderwriters" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23083">262,354</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfWarrantsToUnderwriters" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23084">262,354</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IssuanceOfWarrantsInExchangeForServicesOne_zh2KOER7Xmna" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of warrants in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0268">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfWarrantsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23085">407,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0270">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfWarrantsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23086">407,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IssuanceOfOptionsInExchangeForServicesOne_ze0qQXjmQm92" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of options in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfOptionsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23087">79,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0275">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfOptionsInExchangeForServicesOne" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23088">79,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zB00kcM8FCqb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0278">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0279">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23089">4,720,858</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23090">4,720,858</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_437_c20220101__20221231_eus-gaap--StockholdersEquity_iS_zeZCJesPgiM8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 5.4pt">Balance at December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIVTmAp5Rao9" title="Beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23091">4,300,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23092">4,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23093">8,355,140</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23094">6,102,951</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23095">2,256,489</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts_z3wCKeFT5Rjl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of shares, initial public offering, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbKhGy6Z8A6a" title="Issuance of shares, initial public offering, net of issuance costs" style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23096">2,466,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23097">2,466</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23098">14,770,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0292">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23099">14,772,487</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuanceOfSharesInExchangeForIPOServicesAmount_zCBBcBzw5u2b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of shares in exchange for IPO services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--IssuanceOfSharesInExchangeForIPOServices_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlB31rm6qAn2" title="Issuance of shares in exchange for IPO services" style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForIPOServices" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23100">35,714</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForIPOServicesAmount" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23101">36</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="XPON:IssuanceOfSharesInExchangeForIPOServicesAmount" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23102">36</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0299">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0300">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IssuanceOfStockOptions_zbUlPrrxXsng" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0304">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfStockOptions" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23103">2,114,529</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0306">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfStockOptions" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23104">2,114,529</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_zgRC81fSTF42" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Issuance of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0310">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0311">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0312">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_zWmpspIKcyib" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0314">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0315">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23105">7,536,540</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23106">7,536,540</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220101__20221231_eus-gaap--StockholdersEquity_iE_z53tuwVCt7Ab" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 5.4pt">Balance at December 31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXHFs9saTkG4" title="Beginning balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23107">6,802,464</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23108">6,802</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23109">25,239,654</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23110">13,639,491</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23111">11,606,965</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements</span></p>


<!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_005"></span>Expion360
Inc.<br/>
Statements of Cash Flows</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_112_zR9gvAORZ9cl" summary="xdx: Statement - Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20220101__20221231_zxd5ybOWhJ9f" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49B_20210101__20211231_z5d4NJkNRNz2" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zdlTaj5r1OXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01N_di_msCz47X_zvcYgBtmD4Nl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23112">7,536,540</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23113">4,720,858</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zA3SR24kAyci" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Depreciation_i01_maCz47X_maNCPBUzahJ_zRhSs5iwr6Hj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23114">164,767</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23115">61,084</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AccruedInterestOnConvertibleNote_i01_maCz47X_maNCPBUzahJ_zJeYX6TBGWrf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Accrued interest on convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0338">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:AccruedInterestOnConvertibleNote" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23116">103,701</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--AmortizationOfDebtDiscountSaleOfFutureRevenues_i01_maNCPBUzahJ_zvkqiHmzCyb5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Amortization of debt discount (sale of future revenues)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23117">295</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23118">95,284</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AmortizationOfDebtDiscountPremium_i01_maNCPBUzahJ_z0ucCqwyNIw6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Amortization of debt discount - notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23119">1,196,843</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23120">117,588</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--InducedConversionOfConvertibleDebtExpense_i01_maNCPBUzahJ_zPSvXUV51Rv7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Debt conversion expense on induced conversion of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InducedConversionOfConvertibleDebtExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23121">112,133</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_msNCPBUzahJ_ziF3jOfjyH41" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Extinguishment loss on debt settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23122">2,791,087</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GainLossOnDispositionOfAssets1_i01N_di_msNCPBUzahJ_zFHOn3Lw42Z4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Gain on sale of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23123">13,312</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23124">8,521</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--IncreaseInAllowanceForDoubtfulAccounts_i01_maNCPBUzahJ_zc6Pv86R72U" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Increase in allowance for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IncreaseInAllowanceForDoubtfulAccounts" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23125">18,804</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0357">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ShareBasedCompensation_i01_maNCPBUzahJ_zZQS90B3tdwk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23126">2,114,529</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23127">188,100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zbUUjGpnf801" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msNCPBUzahJ_zPae8ylSU8a5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">(Increase) / Decrease in accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23128">458,322</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23129">566,435</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msNCPBUzahJ_zPxynJ10x21k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">(Increase) in inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23130">2,478,256</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23131">1,683,602</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInPrepaidintransitInventory_i01N_di_msNCPBUzahJ_zlKCea5WCme4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">(Increase) / Decrease in prepaid/in-transit inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:IncreaseDecreaseInPrepaidintransitInventory" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23132">939,614</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="XPON:IncreaseDecreaseInPrepaidintransitInventory" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23133">728,033</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i01N_di_msNCPBUzahJ_zxtjhPbfuBRi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">(Increase) in prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23134">100,088</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23135">69,552</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDeposits_i01_maNCPBUzahJ_zNzDulEQabBf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">(Increase) in deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeposits" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23136">55,784</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maNCPBUzahJ_zJLNoqcBbUu8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Increase / (Decrease) in accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23137">3,792</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23138">11,177</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInCustomerDeposits_i01_maNCPBUzahJ_zRnlg2HrUJki" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">(Decrease) in customer deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInCustomerDeposits" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23139">436,590</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherAccruedLiabilities_i01_maNCPBUzahJ_zAQg9BC3RYG7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Increase in accrued expenses and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23140">165,546</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23141">494,553</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInLiabilityForRefunds_i01N_di_msNCPBUzahJ_zj7xTVvRp8Kk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">(Decrease) in liability for refunds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="XPON:IncreaseDecreaseInLiabilityForRefunds" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23142">58,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--IncreaseInRightofuseAssetsAndLeaseLiabilities_i01_maNCPBUzahJ_zu3P4toMcoZj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Increase in right-of-use assets and lease liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23143">41,286</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23144">19,248</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_maCzyeA_mtNCPBUzahJ_zpPaRqqtb4D1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23145">5,468,572</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23146">3,896,830</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zGb8hIZThMlk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_iN_di_msNCPBUzNfn_zOGCcTlbrHpb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Purchases of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23147">567,370</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23148">113,694</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsForProceedsFromProductiveAssets_msNCPBUzNfn_ztm7FtQRlkgg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;&#160;&#160;Net proceeds from sale of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsForProceedsFromProductiveAssets" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23149">51,678</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_maCzyeA_mtNCPBUzNfn_zhicoTyCUhIf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23150">515,692</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23151">113,694</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_z3wmNdiJc209" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RepaymentsOfLinesOfCredit_iN_di_msNCPBUzznR_zlkQ84gMTtM" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Payments on line of credit and short-term revolving loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23152">550,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23153">280,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromIssuanceOfDebt_maNCPBUzznR_zJjiNPqzC6cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Proceeds from issuance of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0416">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23154">1,385,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RepaymentsOfLongTermDebt_iN_di_msNCPBUzznR_zhqdA2NZz7O5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Principal payments on long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23155">1,798,420</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23156">26,687</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromSaleOfFutureRevenuesNetOfDiscount_maNCPBUzznR_z61hBk09yHS9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Proceeds from sale of future revenues, net of discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:ProceedsFromSaleOfFutureRevenuesNetOfDiscount" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23157">125,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--PaymentsOnLiabilityForSaleOfFutureRevenues_maNCPBUzznR_zJzET048DOzd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Payments on liability for sale of future revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="XPON:PaymentsOnLiabilityForSaleOfFutureRevenues" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23158">11,797</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="XPON:PaymentsOnLiabilityForSaleOfFutureRevenues" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23159">329,626</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--ProceedsFromConvertibleDebt_maNCPBUzznR_zgBHcZJuV792" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Proceeds from issuance of convertible notes, net of discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23160">2,781,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromIssuanceOfCommonStock_maNCPBUzznR_zcCpXwCsOql7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net proceeds from issuance of common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23161">14,772,487</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23162">838,400</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_maCzyeA_mtNCPBUzznR_zQRc82GqB05l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23163">12,412,270</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23164">4,493,087</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_mtCzyeA_z4YGxmeZCsxf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net change in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23165">6,428,006</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23166">482,563</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zlO2J5Fg0fTe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents, beginning</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23167">773,238</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23168">290,675</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zv3f37zqDEzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, ending</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23169">7,201,244</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23170">773,238</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>Expion360
Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
of Cash Flows - Continued</b></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Years Ended December 31,</td></tr>
  <tr id="xdx_40F_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zIGo5yMLODQc" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Supplemental disclosure of cash flow information:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaidNet_zrzQgaQB6WSd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Cash paid for interest</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23171">435,152</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23172">341,257</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxesPaidNet_zEItunIg6NT7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash paid for franchise taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23173">300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23174">1,829</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--NonCashOperatingActivities_zpYEJ1JLrXaj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-cash operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ConvertibleNotesAndAccruedInterestConvertedToCommonStock_z2CJdKluN03a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Convertible notes and accrued interest converted to common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:ConvertibleNotesAndAccruedInterestConvertedToCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23175">173,157</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ReclassificationOfAccruedInterestToLongTermDebt_zYOSsug3Hs6l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Reclassification of accrued interest to long-term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:ReclassificationOfAccruedInterestToLongTermDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23176">5,183</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ReclassificationOfModifiedConvertibleNoteToLongTermDebt_zfBoxW1Xhi4b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Reclassification of modified convertible note to long-term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0464">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:ReclassificationOfModifiedConvertibleNoteToLongTermDebt" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23177">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes_z5LahHuDoA7j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Reclassification of modified member promissory note to convertible notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23178">250,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IssuanceOfCommonStockInExchangeForPropertyAndequipment_zVyQgBlqHyW4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Issuance of common stock in exchange for property and equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:IssuanceOfCommonStockInExchangeForPropertyAndequipment" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23179">20,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability_zl7UkuQ6gDqj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Acquisition/modification of operating lease right-of-use asset and lease liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23180">2,348,509</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23181">1,268,089</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable_zdhcPgd8QAnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Purchases of property and equipment in exchange for long-term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23182">181,430</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23183">183,058</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt_zNkdPhODk5Hf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Purchases of property and equipment in exchange for short-term payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23184">170,863</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ReclassificationOfDepositToPropertyAndEquipment_zIosRXYT7w2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Reclassification of deposit to property and equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0482">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:ReclassificationOfDepositToPropertyAndEquipment" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23185">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ConversionOfConvertibleNotesIntoCommonStock_zTjAjCweaZV2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Conversion of 2021 convertible notes into common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0485">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:ConversionOfConvertibleNotesIntoCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23186">3,282,701</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita_z49cWCIJFi63" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Fair value of warrants issued in connection with long-term debt recorded as debt discount and additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23187">1,072,160</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation_zZGmUuNhXee8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Membership contributions reclassified to additional paid-in capital upon conversion to C corporation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="XPON:MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23188">827,290</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements</span></p>


<!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 12pt; font-weight: bold; text-transform: uppercase; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="b_006"></span>Notes
to the Financial Statements</span></span></p>

<p id="xdx_045_c20220101__20221231_zCVO7QzICbok" style="margin: 0 0 12pt; font-weight: bold; text-transform: uppercase; text-align: left">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:NatureOfOperations" id="ixv-10497"><p id="xdx_809_eus-gaap--NatureOfOperations_zDLg00LvNmfh" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>1.&#160;&#160;&#160;
<span id="xdx_827_zZvWsHtu3cjk">Organization and Nature of Operations</span></i></b></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360
Inc. (formerly Yozamp Products Company, LLC dba Expion360) (&#8220;the Company&#8221;) was incorporated in the state of Nevada in November
2021. Effective November 1, 2021, the Company converted to a C corporation. Prior to conversion, the Company was a limited liability
company (LLC) with an indefinite life organized in the State of Oregon in June 2016. The LLC elected to be treated as a Subchapter S
corporation effective January 1, 2017. Net profits and losses of the LLC and all distributions were allocated among the members in proportion
to the ownership units held. The Original LLC Agreement was amended and restated on January 1, 2021 to add additional members and a non-voting
class of member units. Upon conversion to a C corporation, all existing LLC members at the time of conversion were issued shares of common
stock and became shareholders of the Company. (See Note 11 &#8211; Conversion to a C Corporation).</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company designs, assembles, and distributes premium lithium batteries for RV, Marine, Golf, Industrial, Residential, and Off-The-Grid
needs. The Company uses lithium iron phosphate (LiFePO4) batteries. LiFePO4 batteries are considered a top choice for high energy density,
dependability, longevity, and safety, providing the ability to power anything, anywhere.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in March 2020, the COVID-19 pandemic and the measures imposed to contain this pandemic have disrupted and may continue to impact the
Company&#8217;s business. The magnitude of the impact of the COVID-19 pandemic on the Company&#8217;s productivity, results of operations,
and financial position, and its disruption to the Company&#8217;s business and battery development and timeline, will depend in part
on the length and severity of these restrictions and on the Company&#8217;s ability to conduct business in the ordinary course.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-10517"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zZCSyj0UPyae" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#160;&#160;&#160;
<span id="xdx_82F_z1u578H1k60g">Summary of Significant Accounting Policies</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-10523"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zosCWUTDZP34" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zcKmcVMiCX0f">Basis
of Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying audited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, all references to shares and shareholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="ixv-10538"><p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziidprNltiq8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zSrNnjseglo9">Reclassification
of Prior Year Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:LiquidityAndCapitalResourcesPolicyTextBlock" id="ixv-10549"><p id="xdx_840_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zAezeEXDtu25" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z4jgPTONCSic"><span id="xdx_860_z6aTGYt6Y5M5">Going
Concern, Liquidity and Capital Resources</span></span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.</span></p>

<ix:exclude><p id="xdx_233_zw0AmSWoHqy1" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
presented in the accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations.
These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the
date that the financial statements for the year ended December 31, 2022 are issued. However, management is working to address its cash
flow challenges, including raising additional capital, alternative supply chain resources, and in-house assembly lines.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the Company&#8217;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#8217;s sales for 2022 increased 59% over sales for 2021, as product demand continued to rise. On April 1, 2022, the
Company completed an initial public offering and listing of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of
costs, totaled $<span id="xdx_903_ecustom--ProccedsFromIpoNetsCost_c20220101__20221231_z7Q2DZxWDT4c" title="Procceds from IPO nets cost"><ix:nonFraction name="XPON:ProccedsFromIpoNetsCost" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23189">14,772,487</ix:nonFraction></span>, of which approximately $2,464,000 was used to pay down principal and accrued interest on high interest-bearing
debt. The remaining proceeds will be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in China.
In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S. and an assembly
facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management has secured a secondary
source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption issues with China arise.
Management believes that these factors will contribute to achieving operating efficiency and profitability. However, there can be no
assurance that the Company will be successful in achieving its objectives, including achieving operating efficiency and profitability.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#8217;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:UseOfEstimates" id="ixv-10583"><p id="xdx_843_eus-gaap--UseOfEstimates_z0ocRgWNWQZf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z3EVxd0y6wca">Use
of Estimates</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#8217;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#8217;s accounting estimates require the exercise of judgment.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-10598"><p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbaeIGyik0Mb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zNC12ITNVsB">Cash
and Cash Equivalents</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Accounts are secured by the Federal Deposit Insurance Corporation
(&#8220;FDIC&#8221;) up to $250,000 per institution. At times, balances may exceed federally insured limits. The Company has not experienced
any losses in such accounts and management believes that the Company is not exposed to any significant credit risk with respect to its
cash and cash equivalents. As of December 31, 2022, cash balances exceeded FDIC limits by $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zcGyEsa7W9l2" title="Cash balances exceeded FDIC"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23190">222,162</ix:nonFraction></span>.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-indent: 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had two accounts totaling $<span id="xdx_900_eus-gaap--DepositContractsAssets_iI_c20221231_zr5rvg17WSx8" title="Deposit"><ix:nonFraction name="us-gaap:DepositContractsAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23191">11,204</ix:nonFraction></span> with SVB. As of March 13, 2023 all funds were transferred to another
banking institution and no exposure currently exists.</span></p>

<ix:exclude><p id="xdx_23B_zKKEn3HfMmee" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 104 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ReceivablesPolicyTextBlock" id="ixv-10621"><p id="xdx_842_eus-gaap--ReceivablesPolicyTextBlock_zccEBi4gxRMb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zOIVAMD7VBVi">Accounts
Receivable</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any interest. The Company performs
ongoing credit evaluations of its customers and generally requires no collateral. An allowance for uncollectible accounts is recorded
to reduce accounts receivable to the estimated amount that will be collected. The allowance is based upon management&#8217;s review of
the accounts receivable aging and specific identification of potentially uncollectible balances. Recoveries of accounts previously written
off and adjustments to the allowance for uncollectible accounts are recorded as adjustments to bad debt expense. The allowance for doubtful
accounts totaled $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20221231_znRkir5rWLte" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23192">18,804</ix:nonFraction></span> as of December 31, 2022. There was no allowance for doubtful accounts as of December 31, 2021, as management
believed all outstanding amounts to be fully collectible.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:CustomerDepositsPolicyTextBlock" id="ixv-10633"><p id="xdx_84B_ecustom--CustomerDepositsPolicyTextBlock_zyS8bauBrXf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zEW3Jl2pLZOk">Customer
Deposits</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, the Company had customer deposits totaling $<span id="xdx_907_eus-gaap--CustomerDepositsCurrent_iI_c20221231_z8KvAEyLc4Wi" title="customer deposits"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23193">58</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--CustomerDepositsCurrent_iI_c20211231_zu7rv75fbhI1"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23194">436,648</ix:nonFraction></span>, respectively.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:InventoryPolicyTextBlock" id="ixv-10647"><p id="xdx_84E_eus-gaap--InventoryPolicyTextBlock_zf1aQfkRjwJc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zdHpw0ZUqF8d">Inventory</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and accessories, resale items,
components, and related landing costs. As of December 31, 2022 and December 31, 2021, the Company had inventory that consisted of finished
assemblies totaling $<span id="xdx_90F_eus-gaap--InventoryFinishedGoods_iBI_c20221231_z7JFutRuUqjk" title="Inventory, Finished Goods"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23195">2,722,765</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--InventoryFinishedGoods_iBI_c20211231_zzMpfUhaDOr"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23196">985,537</ix:nonFraction></span>, respectively, and raw materials (inventory components, parts, and packaging) totaling $<span id="xdx_90A_eus-gaap--InventoryRawMaterials_iI_c20221231_zDQEPRX2l6Ac" title="Raw materials"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23197">1,807,371</ix:nonFraction></span>
and $<span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20211231_z8ivsKbdTiph"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23198">1,066,343</ix:nonFraction></span>, respectively. The valuation of inventory includes fixed production overhead costs based on normal capacity of the assembly
warehouse. &#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of December 31, 2022 or December 31, 2021. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $<span id="xdx_90C_eus-gaap--OtherInventoryNetOfReserves_iI_c20221231_zmmUIXDfpCmi" title=" inventory"><ix:nonFraction name="us-gaap:OtherInventoryNetOfReserves" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23199">141,611</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--OtherInventoryNetOfReserves_iI_c20211231_zfgxFRsSTnof"><ix:nonFraction name="us-gaap:OtherInventoryNetOfReserves" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23200">1,081,225</ix:nonFraction></span> at December 31, 2022 and December 31,
2021, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" id="ixv-10668"><p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zBxViAQdVsP8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ztqVhnYxB5Je">Vendor
and Foreign Concentrations of Inventory Suppliers</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2022 and 2021, approximately 85% and 90%, respectively, of inventory purchases were made from foreign suppliers
in China and Hong Kong. Any adverse change in either the economic or political conditions abroad could negatively impact the Company&#8217;s
supply chain. The inability to obtain product to meet sales demand could adversely affect results of operations. However, the Company
has secured a secondary source for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company
to source materials outside of China in the event it becomes necessary to do so.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-10679"><p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zaxsA97CojTi" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zV00YnVTG9lb">Property
and Equipment</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:ScheduleOfEstimatedUsfulLivesTableTextBlock" id="ixv-10688"><p id="xdx_89D_ecustom--ScheduleOfEstimatedUsfulLivesTableTextBlock_zgjoYcW0kHt8" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zWohKwqbpHad" style="display: none">Schedule
of estimated useful lives&#160;</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_308_134_zeyesCta2Ejd" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; width: 73%; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z8JL4yFreas7"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23201">5</ix:nonNumeric></span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zEDbhRClpoEb" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23202">7</ix:nonNumeric></span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zxdcGLihMHHg"><ix:nonNumeric contextRef="AsOf2022-12-31_us-gaap_OfficeEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23203">3</ix:nonNumeric></span> - <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zHpM0h6TVSE6" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2021-12-31_us-gaap_OfficeEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23204">7</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4gROOUSc534"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23205">3</ix:nonNumeric></span> - <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zhWz2PaOHzpg" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2021-12-31_custom_ManufacturingEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23206">10</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zAiAlB8I49Hg"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23207">3</ix:nonNumeric></span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTHLP9GmS5gf" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2021-12-31_custom_ManufacturingEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23208">10</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHNVfYLdWUv9"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_QAEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23209">3</ix:nonNumeric></span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_znEhEelnV84k" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="AsOf2021-12-31_srt_MaximumMember_custom_QAEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23210">10</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zf1pseSy9Frd"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_ToolingAndMoldsMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23211">5</ix:nonNumeric></span>
    - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zidybgPumZf5"><ix:nonNumeric contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23212">10</ix:nonNumeric></span> years</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_zcUsV5UGCyba" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable
to assets retired are removed from the accounts, and the gain or loss on disposition is recognized in the Statements of Operations.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 105 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-10776"><p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_zpvUbeR694Od" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zk0QKaOFMT74">Leases</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#8220;ROU&#8221;) assets represent the
Company&#8217;s right to use an underlying asset during the lease term, and operating lease liabilities representthe Company&#8217;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease
liabilities, and long-term operating lease liabilities on the Company&#8217;s Balance Sheets. The Company does not have any finance
leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments over the lease
term at commencement date calculated using the Company&#8217;s incremental borrowing rate applicable to the lease asset, unless the implicit
rate is readily determinable. ROU assets also include any lease payments made at or before lease commencement and exclude any lease incentives
received. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the
Company will exercise that option. Leases with a term of 12 months or less are not recognized on the Company&#8217;s Balance Sheet. The
Company&#8217;s leases do not contain any residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line
basis over the lease term.&#160;</span></p>

<p style="margin: 0; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for lease and non-lease components as a single lease component for all its leases.</span></p>

<p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="ixv-10795"><p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zQLhdMjGG0e2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zfIapyfWjTE2">Impairment
of Long-Lived Assets</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the asset
to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted cash flows,
the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value. Fair value is determined
primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No long-lived asset impairment was
recognized during the years ended December 31, 2022 and 2021.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ExtendedProductWarrantyPolicy" id="ixv-10806"><p id="xdx_846_eus-gaap--ExtendedProductWarrantyPolicy_zduEi09mXQ5c" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zWZXkTaEJTF9">Product
Warranties</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sells the majority of its products to customers along with conditional repair or replacement warranties. The Company&#8217;s
branded DC mobile chargers are warrantied for two years from the date of sale. The company&#8217;s branded VPR 4EVER Classic and Platinum
batteries and re-branded e360 and e360 Extreme Density batteries are warrantied at gradually lesser levels over a twelve-year period
from date of sale. The Company determines its estimated liability for warranty claims based on the Company&#8217;s experience of the
amount of claims actually made. Management estimates no liability as of December 31, 2022 and December 31, 2021 because, historically,
there have been very few claims and costs for repairs or replacement parts have been nominal. It is possible that the Company&#8217;s
estimate of a liability for product liability claims will change in the near term.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:LiabilityForRefundsPolicyTextBlock" id="ixv-10817"><p id="xdx_845_ecustom--LiabilityForRefundsPolicyTextBlock_zrQ1zFEu2z69" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zwiLOZBMPZV8">Liability
for Refunds</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.
However, during 2020 the Company sold discontinued products and recorded a liability for refunds. As of December 31, 2020, the liability
totaled $58,000. During the year ended December 31, 2021, the Company issued credits totaling $58,000, respectively. As of December 31,
2021, all allowable discontinued products had been returned and the Company had no further refund liability. No refund liability was
recognized in the year ended December 31, 2022. Revenue is recorded net of this amount. Any returns of discontinued product are not added
back to inventory and therefore related costs are nominal and not recorded as an asset.</span></p>

<ix:exclude><p id="xdx_232_zifn5zyWqSkd" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 106 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-10834"><p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zW7E6Z2Oepa6" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zMrPJgFfm5Xc">Revenue
Recognition</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#8217;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#8217;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-10846"><p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zdcgPMDe3Chk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zbdgwFebNPs3">Concentration
of Major Customers</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, sales to three customers totaled $2.9 million, comprising approximately 41% of total sales. These customers
represented 43% of total accounts receivable as of December 31, 2022. During the year ended December 31, 2021, sales to one customer
totaled $486,000, comprising 11% of total sales. This customer did not have an accounts receivable balance as of December 31, 2021, but
three other customers had accounts receivable balances totaling $658,000 and representing a total of 85% of total accounts receivable
as of December 31, 2021.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ShippingAndHandlingCostPolicyTextBlock" id="ixv-10861"><p id="xdx_84F_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_z1IF9QSTe9Ja" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zgncV9FjaA1f">Shipping
and Handling Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling fees billed to customers are classified on the Statement of Operations as &#8220;Sales, net&#8221; and totaled $23,188 and
$25,688 during the years ended December 31, 2022 and 2021, respectively. Shipping and handling costs for shipping product to customers
totaled $169,335 and $102,653 during the years ended December 31, 2022 and 2021, respectively, and are classified in selling, general
and administrative expense in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="ixv-10872"><p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zl60rvUr3Xt7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zwb1FyLiAXC">Advertising
and Marketing Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20221231_zSuwZEm8gAgf" title="Advertising and marketing expense"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23213">239,814</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--MarketingAndAdvertisingExpense_c20210101__20211231_zmuk9fe4SgDg"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23214">67,394</ix:nonFraction></span> for the
years ended December 31, 2022 and 2021, respectively, and is included in selling, general and administrative expense in the accompanying
Statements of Operations. &#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-10886"><p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_z1UAWRgo5n11" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zz0IHaYK31Jj">Research
and Development</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_z1puF02fZCJb" title="Research and development costs"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23215">270,054</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_zfoG7iw5qB"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23216">58,044</ix:nonFraction></span> for
the years ended December 31, 2022 and 2021, respectively, and are included in selling, general and administrative expenses in the accompanying
Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-10899"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTaIjtjdXNag" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zcuS6ynhcTGh">Income
Taxes</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 1, 2017 to October 31, 2021, the Company was not subject to federal or state income taxes since it was a limited liability company
taxed as an S corporation. The Company&#8217;s taxable income or losses were allocated to its members in accordance with their respective
ownership percentages. Therefore, no provision or liability for federal income taxes was included in the accompanying financial statements
for the relevant periods in 2021. Certain states impose minimum franchise taxes on entities taxed as an S corporation. Accordingly, the
accompanying financial statements include provisions for state franchise tax fees.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-size: 10pt">Effective November 1, 2021, the Company converted
from an LLC to a C corporation and, as a result, became subject to corporate federal and state income taxes. Deferred tax assets and
liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts
of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including tax loss and credit carryforwards, and
liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences
are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that included the enactment date. Deferred income tax expense represents the change during the period in the deferred
tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.</span></p>
<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>


<ix:exclude><!-- Field: Page; Sequence: 107 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_z5ZSGld6svmg" style="margin: 0; text-align: justify"></p></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of December 31, 2022 and 2021, the Company has not recorded any income tax provision/(benefit)
resulting from the CARES Act, mainly due to the Company&#8217;s history of net operating losses.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2022 and beyond.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-10933"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zoC7OCnSrRU" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value of Financial Instruments</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, <i>Fair Value Measurement</i>. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1: </i>Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2: </i>Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3: </i>Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, shareholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the shareholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="ixv-10963"><p id="xdx_848_eus-gaap--SegmentReportingPolicyPolicyTextBlock_znUfrRrVLwhl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zTgQ346zzUFi">Segment
Reporting</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 108 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-10979"><p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zS1YFMYdVbj9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zB8JNZo8YXY4">Basic
and Diluted Net Loss Per Share</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shows the amounts used in computing net loss per share:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-10996"><p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z50CTcwuN1m1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_z44xU4SMZuO" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zrWQ6gqJKxi1" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20220101__20221231_z1r7BosSa6j9" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_490_20210101__20211231_zxvvFMeavWJj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_409_ecustom--NetLoss_zGDahUfcOWR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="XPON:NetLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23217">7,536,540</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="XPON:NetLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23218">4,720,858</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zzxXXZJfHJ82" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Weighted average common shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23219">6,135,938</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23220">2,888,695</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--NetLossPerShareBasicAndDiluted_z46cR1iXMXG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23221">1.23</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23222">1.63</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_z6t2bLfiorm5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the years ended December 31, 2022 and 2021, the Company has outstanding warrants and options convertible into 1,717,936 shares of
common stock, respectively. The following table sets forth the number of shares excluded from the computation of diluted loss per share,
as their inclusion would have been anti-dilutive.</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-11054"><p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zdDUbMmPGSle" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zA4OfQuOT4Y2" style="display: none">Schedule of anti-dilutive share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_zNr6DvcK9ZY4" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt">Stock options</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zToARjhdbPki" style="width: 12%; text-align: right"><ix:nonFraction name="XPON:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23223">829,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPDZLIp16ry7" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-12-31_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23224">30,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPoKd9ZSYdH6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23225">888,436</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zOZV8xjYB656" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23226">710,431</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zK3yOGTFlWT4" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23227">1,717,936</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zvdzQQEGM7hh" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23228">740,431</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_z9HzVV4rdFJl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="ixv-11102"><p id="xdx_842_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zVBPAuuC3y8j" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zo0xyQIDHiJk">Stock-Based
Compensation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-11120"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zXhYdKndQhDc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zen3BobqEmog">New
Accounting Pronouncements</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">In May 2021, the FASB issued ASU 2021-04,
&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation
(Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for
Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the Emerging Issues Task Force).&#8221;
ASU 2021-04 requires issuers to account for modifications or exchanges of freestanding equity-classified written call options that remain
equity classified after the modification or exchange based on the economic substance of the modification or exchange. Under the guidance,
an issuer determines the accounting for the modification or exchange based on whether the transaction was done to issue equity, to issue
or modify debt, or for other reasons. ASU 2021-04 is applied prospectively and is effective for fiscal years beginning after December
15, 2021, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of fiscal 2022, which
did not have a material impact on the Company&#8217;s financial statements or disclosures.</span></p>
<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>


<ix:exclude><!-- Field: Page; Sequence: 109 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_ztfDljHIxoo6" style="margin: 0; text-align: justify"></p></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity.
Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion
features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in
substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single
liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Similarly,
equity-classified convertible preferred stock instruments will be accounted for as single units of account in equity unless the conversion
feature needs to be bifurcated under Topic 815. The new guidance also made amendments to the earnings per share guidance in Topic 260,
Earnings Per Share, for convertible instruments, the most significant impact of which is requiring the use of the if-converted method
for diluted earnings per share calculation. Further, ASU 2020-06 made revisions to Subtopic 815-40, which provides guidance on how an
entity must determine whether a contract qualifies for a scope exception from derivative accounting. ASU 2020-06 is effective for fiscal
years beginning after December 15, 2021, with early adoption permitted. Adoption of the standard requires using either a modified retrospective
or a full retrospective approach. Effective January 1, 2021, the Company early adopted ASU 2020-06 using the modified retrospective approach.
Adoption of the new standard did not have a material impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01, Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint
Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.
The new guidance clarifies the interaction of accounting for the transition into and out of the equity method and the accounting for
measuring certain purchased options and forward contracts to acquire investments. ASU 2020-01 is effective for fiscal years beginning
after December 15, 2020, including interim periods within those fiscal years. Effective January 1, 2021, the Company adopted ASU 2020-01.
The adoption of this guidance did not have an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" id="ixv-11149"><p id="xdx_84E_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zn9Wxsicv9kd" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zH4wjNyLkeD6">Accounting
Guidance Issued but Not Yet Adopted</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#8221; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#8217;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, &#8220;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#8221; which amends the guidance in Topic 820, <i>Fair Value Measurement</i>, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 110 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#8221; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#8220;CECL&#8221;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have <i>not</i> yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company is currently evaluating the impact of this standard on our financial
statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#8221; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company is currently evaluating the impact of adopting this guidance.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-11183"><p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zohKyAPvYpPj" style="margin: 0 0 12pt; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#160;&#160;&#160;
<span><span id="xdx_820_z71Nkdd2P4Va">Property and Equipment, Net</span></span></span></p>
<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-11188"><p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zheh2nDuemJ8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zZSk3QJapL84" style="display: none">Schedule of property and equipment</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consist of the following:&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zyl9ODh44zjj" summary="xdx: Disclosure - Property and Equipment Net (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: justify">Vehicles and transportation equipment</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zclfbL84mvbe" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23229">593,097</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_pp0p0_zG3wpTA6rw54" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23230">298,752</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zdpddnciDVFg" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23231">314,819</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z65RUMXXIru8" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23232">59,316</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zjrmdOX5amL4" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_OfficeFurnitureEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23233">188,131</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_z0TZg163v1Ak" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_OfficeFurnitureEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23234">105,003</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Manufacturing equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zJ3b1EQ3sDfa" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23235">179,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_pp0p0_zZSd6s2xG7Df" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Warehouse equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zWYP5jd0nDpe" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_WarehouseEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23236">81,164</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_pp0p0_zLQ3c69Ut6Y8" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_WarehouseEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23237">44,356</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">QA equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zdM4YNqCyVgj" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_QAEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23238">22,142</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_z8ksLfKvcLB4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Tooling and Molds</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zVNzT45cvEV8" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_ToolingAndMoldsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23239">15,992</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zkNU2KiDiQEf" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_ToolingAndMoldsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23240">15,992</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zPsiNPMhdYJg" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23241">1,394,619</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zjGZJaS13Vzg" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23242">523,419</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSjZhBR4xesb" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23243">250,861</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20211231_zJKe8IIqHOge" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23244">96,190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zLxkDFZBppW4" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23245">1,143,758</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_z3ZdTatSVR7l" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23246">427,229</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zDy05SZOBbbc" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $<span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zBVtXSq4Iu8i" title="Depreciation expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23247">164,767</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zGYWn0tYEFTi"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23248">61,084</ix:nonFraction></span> for the years ended December 31, 2022 and 2021, respectively.</span></p>

<ix:exclude><p id="xdx_235_zBDZyj91OR48" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 111 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="ixv-11344"><p id="xdx_80F_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zUIwo8FtjeRk" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&#160;&#160;&#160;
<span id="xdx_825_zl0NjqQc1UAl">Accrued Expenses and Other Current Liabilities</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses and other current liabilities consist of the following:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="ixv-11352"><p id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zNqtcJxoSRDh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zk7zzpCVD1D9" style="display: none">Schedule of accrued expenses and other current liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_134_z9hlwjoLZxjj" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_491_20221231_zmbIREaO27xe" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_z8ny76WBoMjj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zhpqX93h8Hh1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Accrued salaries and payroll liabilities</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23249">169,337</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23250">12,449</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--RebateLiability_iI_zhjWjvLj3lhc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rebate liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:RebateLiability" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23251">26,015</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:RebateLiability" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23252">23,010</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredIncomeAndDepositSublease_iI_zXQGniVBXt" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred income and deposit (sublease)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:DeferredIncomeAndDepositSublease" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23253">14,168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:DeferredIncomeAndDepositSublease" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23254">13,690</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_zmtbonEZ5Olj" style="vertical-align: bottom; background-color: White">
    <td>Commissions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23255">9,720</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23256">29,120</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--FranchiseTax_iI_zemYreCq8QXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Franchise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:FranchiseTax" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23257">400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="XPON:FranchiseTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23258">9,300</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InterestPayableCurrent_iI_zJTY80T7h5y" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23259">222</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23260">26,301</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zu62oANbk07c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23261">86,302</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23262">26,748</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_zAaV9OLnW0Lb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Accrued expenses and other current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23263">306,164</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23264">140,618</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zhTvst50hEai" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock" id="ixv-11464"><p id="xdx_808_ecustom--LiabilitiesForSaleOfFutureRevenuesTextBlock_z4CSxbB7gMzk" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#160;&#160;&#160;
<span id="xdx_826_z8D6PMigDQwb">Liabilities for Sale of Future Revenues</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 10, 2020 and January 26, 2021, Reliant Funding, under two separate ACH Total Receipts Purchase Agreements (&#8220;Purchase Agreements&#8221;),
purchased a 50% interest in the Company&#8217;s future revenues for a total aggregate purchase price of $250,000. Pursuant to the terms
of the Purchase Agreements, the purchased percentage continued to be owned by Reliant Funding, until the Company paid the full purchased
amount of $349,750. Repayment of the purchased amount was achieved through 252 daily bank account withdrawals of $1,388 through December
15, 2021 and $694 thereafter through January 26, 2022. During the year ended December 31, 2022, the company repaid a total of $11,797,
including $295 of interest. During the year ended December 31, 2021, the company repaid a total of $329,626, including $95,284 of interest.
Interest was recognized at an effective annual interest rate of approximately 71%. As of December 31, 2021, the Company had a total remaining
liability related to the Purchase Agreements of $11,502 and total remaining payments of $11,797 (including interest). The Purchase Agreements
were secured by substantially all of the assets of the Company. As of December 31, 2022, the Company had no remaining liability related
to the Purchase Agreements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-11474"><p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zjeaCm706mAi" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&#160;&#160;&#160;
<span id="xdx_822_zDX4zbSYyd6b">Short-Term Revolving Loans</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 2020 to October 2020, the Company received funds totaling $900,000 under four unsecured Working Capital Loan Agreements (&#8220;WC
Loans&#8221;) from two different third-party lenders. As of December 31, 2021, a balance of $550,000 remained outstanding under the WC
Loan Agreements and in accordance with the modified terms, the Company was subject to monthly extended maturity interest of one percent
on the ending outstanding monthly balance which increased one percent for each month beyond the extended maturity date. The WC Loans
were repaid in full in April 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of each WC Loan are summarized below:</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150,000 limit - dated
    January 25, 2020; monthly interest-only payments at 10% annual interest, principal payment of $70,000 paid during the year ended
    December 31, 2020, balance of $80,000 due 12 months from date of issue and paid in full at maturity in 2021. </span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150,000 limit - dated
    January 28, 2020; monthly interest-only payments at 12% annual interest; principal due 12 months from date of issue. This note was
    modified effective January 1, 2021 to extend the maturity date to December 31, 2021 (see below) and was paid in full with a payment
    of $50,000 in July 2021 and $100,000 in September 2021.</span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$200,000 limit &#8211;
    dated March 22, 2020; monthly interest-only payments at 15% annual interest; principal due 12 months from date of issue. This note
    was modified effective January 1, 2021 to extend the maturity date to December 31, 2021. The Company paid $50,000 towards the principal
    balance in November 2021.&#160;&#160;The balance of $150,000 was paid in full in April 2022 (see below).</span></td></tr>
  </table>

<ix:exclude><!-- Field: Page; Sequence: 112 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$400,000 limit &#8211;
    dated August 31, 2020; monthly interest-only payments at 10% annual interest; pursuant to the WC Loan, the maturity was to be determined
    by mutual agreement and was to be at least 30 days after a maturity date is agreed upon. The note was modified effective January
    1, 2021 to establish a maturity date of December 31, 2021, and was paid in full in April 2022 (see below).</span></td></tr>
  </table>
<p style="margin: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2021, as noted above, three of the working capital loan agreements, all from the same investor, were modified. The modification
was to extend the maturity date on two of the notes from January 28, 2021 and March 22, 2021 to December 31, 2021, and to establish a
maturity date of December 31, 2021 for the WC Loan that left the maturity date open to negotiations in the original agreement.</span></p>

<p style="margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, a balance of $550,000 remained outstanding under the WC Loan Agreements and in accordance with the modified terms,
the Company was subject to monthly extended maturity interest of one percent on the ending outstanding monthly balance which increased
one percent for each month beyond the extended maturity date. The Company remained in compliance with all interest payments and paid
the WC Loans in full in April 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
fees incurred in connection with obtaining and modifying these agreements were nominal and, given the short-term maturity of one year,
were expensed as incurred. There was no accounting impact to the financial statements related to the modifications.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:LongTermDebtTextBlock" id="ixv-11546"><p id="xdx_806_eus-gaap--LongTermDebtTextBlock_z0EFiONoxBPf" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
&#160;&#160;&#160;&#160;<span id="xdx_82A_zIzAhgzAfnyg">Long-Term Debt</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
debt consisted of the following at December 31, 2022 and 2021:&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock" id="ixv-11554"><p id="xdx_893_eus-gaap--ScheduleOfDebtTableTextBlock_zWvGQ8QSbaRd" style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zRmASvuTs60l" style="display: none">Schedule of long-term debt</span>&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2022</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2021</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    secured promissory notes &#8211; various investors.&#160;&#160;Monthly payments of interest only at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_uPure_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zZKyK8XpZqp1"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23265">10</ix:nonFraction></span>% plus deferred interest of
    5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity. Matures the earlier of (a)
    May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of control. The notes are senior
    to all other debt and are secured by substantially all assets of the Company. The notes included detachable warrants to purchase
    <span id="xdx_90C_ecustom--WarrantsToPurchase_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zfMO8hsIn3fh"><ix:nonFraction name="XPON:WarrantsToPurchase" contextRef="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23266">482,268</ix:nonFraction></span> shares of common stock at an exercise price of $3.32 per share (see Note 12 &#8211; Stockholders&#8217; Equity). Debt issuance
    costs and discount totaling $1,287,160 at date of issuance were being amortized and recognized as additional interest expense over
    the term of the notes using the straight-line method because it was not substantially different from the effective interest rate
    method. We determined the expected life of the notes to be the contractual term. Interest expense related to these notes includes
    amortization of debt issuance costs and discount in the amount of $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zIQvOmcuQFHj"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23267">1,196,843</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zcEjj6PtTOS1"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-01-012021-12-31_custom_SeniorSecuredPromissoryNotesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23268">117,587</ix:nonFraction></span>, respectively, for the years ended December
    31, 2022 and 2021, respectively. The notes were paid in full in April 2022 </span></td>
    <td style="width: 2%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zYx3xMOCYyb6" style="width: 13%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0686">&#8212;</span></span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zGD2ZUqapJPb" style="width: 11%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_SeniorSecuredPromissoryNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23269">1,600,000</ix:nonFraction>&#160;</span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; bank. Payable in monthly installments of $332, including interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_ztDESItfaA9d"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_us-gaap_NotesPayableToBanksMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23270">5.8</ix:nonFraction></span>% per annum, due August 2025, secured by
    equipment and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zvU6a1BVSu95" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_us-gaap_NotesPayableToBanksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23271">9,825</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zz2Qg31uUbaa" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_us-gaap_NotesPayableToBanksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23272">13,135</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; credit union. Payable in monthly installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zLhsfu3eCvTa"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_us-gaap_NotesPayableToBanksMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23273">508</ix:nonFraction></span>, including interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zTjJzB5BxKq9"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_custom_NotePayableCreditUnionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23274">5.45</ix:nonFraction></span>% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_znmtb46bodLd" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableCreditUnionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23275">19,364</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zjbcIG5QZno3" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_NotePayableCreditUnionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23276">24,259</ix:nonFraction>&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; SBA. Economic Injury Disaster Loan payable in monthly installments of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z7S9irBvtpG3"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_custom_NotePayableSBAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23277">731</ix:nonFraction></span>, including interest at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zNsTbK2pbb4e"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_custom_NotePayableSBAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23278">3.75</ix:nonFraction></span>% per annum,
    due May 2050, and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zd8BoxCpitk2" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23279">150,114</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zj40g99Pl7C1" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_NotePayableSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23280">153,193</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<ix:exclude><!-- Field: Page; Sequence: 113 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; individual. Monthly payments of interest only at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3u5SAnmxLC7"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_custom_NotePayableIndividualMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23281">10</ix:nonFraction></span>% per annum, matured December 31, 2021 resulting in the entire
    principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31,
    2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each
    month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the
    note in full in April 2022 </span></td>
    <td style="width: 2%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zGyosTYw3wae" style="width: 13%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0700">&#8212;</span></span></td>
    <td style="width: 0%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3G2orNS6tW8" style="width: 11%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_NotePayableIndividualMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23282">100,000</ix:nonFraction>&#160;&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; finance company. Payable in monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zPgQIe5dOFDi"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompanyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23283">994</ix:nonFraction></span>, including interest at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zd3GuXrmp6zj"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompanyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23284">8.5</ix:nonFraction></span>% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a shareholder.&#160;&#160;The Note was paid in full September 2022.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_z1YywxSKXYOj" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0704">&#8212;</span></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zSpnkxWf2fOk" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_NotePayableFinanceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23285">45,832</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; finance company.&#160;&#160;Payable in monthly installments of $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_z59bSVoCe7Wb"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompany1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23286">2,204</ix:nonFraction></span>, including interest at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zLySIJ8C9Dah"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompany1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23287">11.21</ix:nonFraction></span>% per annum, due
    August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;&#160;The note was paid in full January 2023.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zbRfObC7xhgi" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompany1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23288">79,963</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zjFe69Eaiate" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_NotePayableFinanceCompany1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23289">96,155</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    payable &#8211; The Company has six and two notes payable to GM Financial for vehicles at September 30, 2022 and December 31, 2021.&#160;&#160;In
    April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;&#160;The agreement
    expires in April 2023 but prevailing GM Financial existing term notes will remain. The notes are payable in aggregate monthly installments
    of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zulP2wGynlJf"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-01-012022-12-31_custom_GMFinancialMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23290">4,676</ix:nonFraction></span>, including interest at rates ranging from 5.89% to <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zH91DES1X3Xf"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-01-012022-12-31_custom_GMFinancialMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23291">7.29</ix:nonFraction></span>% per annum, mature at various dates from October 2027 to May of
    2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zTgrFrT3rKEg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_GMFinancialMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23292">251,209</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_z34paL0EJGEi" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_GMFinancialMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23293">94,890</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20221231_zZ3tuazFx3xg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23294">510,475</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20211231_zF6oJOJqka66" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23295">2,127,464</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    unamortized debt issuance costs and discount</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20221231_z3dO63NDU293" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0716">&#8212;</span></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iNI_di_c20211231_zNEffcgIez0d" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23296">1,196,843</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    current portion</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zWSemRgK6Lb5" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:DebtCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23297">71,426</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><p style="margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td id="xdx_98F_eus-gaap--DebtCurrent_iNI_di_c20211231_zuWkMCLA18o5" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:DebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23298">51,135</ix:nonFraction></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    note payable in default (paid April 2022)</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_ecustom--LessNotePayableInDefaultPaid_iI_c20221231_zZTzkQCrpdYc" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0720">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_ecustom--LessNotePayableInDefaultPaid_iI_c20211231_zUSCMNE3I5j3" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:LessNotePayableInDefaultPaid" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23299">100,000</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    debt, net of unamortized debt discount and current portion</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_ztvWlEmU7OD7" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23300">439,049</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zQsCDtF94WS2" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23301">779,486</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zUl6EhVWAMY2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
maturities of long-term debt are as follows:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="ixv-11856"><p id="xdx_89A_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zWkH1ukykVXe" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zwZaZ5Ww3ut6" style="display: none">Schedule of long term debt payment</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_30C_134_zS5zgPNCBeJ7" summary="xdx: Disclosure - Long-Term Debt (Details 1)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49D_20221231_zVHKztI62H27">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years ending December 31,</b></span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zuUkStE0Btw" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 52%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: top; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23302">71,426</ix:nonFraction></span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_zreanSVKUTGa" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23303">77,226</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zELk68BZ2CVb" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23304">82,237</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zAqdCSwZ0Jdf" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturingInYearsTwoAndThree" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23305">73,963</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_z3nvIsw8ZUHf" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23306">55,305</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbaAMSVQt1Rh" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23307">150,318</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebt_iI_zxCGzJGaKiH9" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23308">510,475</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zmysnXVJXQtl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:ShareholderPromissoryNotesTextBlock" id="ixv-11936"><p id="xdx_80B_ecustom--ShareholderPromissoryNotesTextBlock_ztoxFcwbLfac" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&#160;&#160;&#160;&#160;&#160;<span id="xdx_822_zcs50HozZky2">Shareholder
Promissory Notes</span>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, the Company had an outstanding principal balance of $825,000 due to shareholders under unsecured
Promissory Notes Agreements (&#8220;Notes&#8221;). The Notes require monthly interest-only payments at 10% per annum. The Notes mature
at various dates from August 2023 to December 2024 as follows: August 2023 - $500,000; January 2024 - $125,000; and December 2024 - $200,000.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 114 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2021, the Company modified another shareholder Note in the amount of $250,000 to be a convertible note for the same amount. The
shareholder also invested additional proceeds of $24,000 for a total convertible note of $274,000. The convertible note included detachable
warrants to purchase 548,000 shares of the Company&#8217;s common stock. The convertible note bore interest at a rate of 10% per annum,
had an initial maturity of two years from date of issue, and was convertible at $0.50 per share. The modification resulted in a new effective
annual interest rate of 9.15%. There was no accounting impact to the financial statements related to these modifications. On October
29, 2021, concurrent with the anticipated conversion from an LLC to a C corporation, the convertible note and warrants were modified
under a Convertible Debenture Exercise and Waiver and Release Agreement and the shareholder agreed to convert the note and accrued interest
into 236,498 shares of common stock resulting in a conversion price of $1.21 per share (see Note 9 &#8211;Convertible Notes).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
paid to the shareholders under the Notes totaled $<span id="xdx_90F_eus-gaap--OtherMinorityInterests_iI_c20221231_zA0Z3p50Hrk1" title="Interest paid to the shareholders"><ix:nonFraction name="us-gaap:OtherMinorityInterests" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23309">82,508</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--OtherMinorityInterests_iI_c20211231_z0QupwYfidia"><ix:nonFraction name="us-gaap:OtherMinorityInterests" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23310">92,007</ix:nonFraction></span> during the years ended December 31, 2022 and 2021, respectively.
There was no accrued interest as of December 31, 2022 or 2021 related to these Notes.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:ConvertibleNotesTextBlock" id="ixv-11962"><p id="xdx_803_ecustom--ConvertibleNotesTextBlock_zhNglAH9OaR" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&#160;&#160;&#160;
<span id="xdx_82E_zajzCHSqgom6">Convertible Notes</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2020
Convertible Notes &#8211; Converted January 1, 2021</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2021, convertible debt holders were offered the opportunity for early conversion of their convertible notes into Class B LLC
member units. Three of the four convertible note holders converted notes with a principal balance of $170,000 and accrued interest of
$3,157 into 2,338 Class B member units (the equivalent of 59,515 shares of common stock) at per unit conversion prices ranging from $67
- $76 (per share prices ranging from $2.66 - $3.00). In accordance with FASB ASC 470-20, <i>Debt with Conversion and Other Options</i>,
the fair value of the additional units issued under the induced conversion over the value of the number of units issuable under the original
terms of the convertible note agreements is recognized as debt conversion expense. Accordingly, upon early conversion on January 1, 2021,
the Company recognized $112,133 of debt conversion expense with a corresponding entry to equity of $285,290 consisting of the $173,157
of principal and accrued interest converted and the excess fair value of $112,133.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fourth convertible note holder opted out of the early conversion and instead, the original note with a principal balance of $100,000
was modified into a term loan effective January 1, 2021 (see Note 7 &#8211; Long Term Debt). The modification included the elimination
of the conversion feature, an increase in the interest rate from the original 6% per annum to 10% per annum, to be paid monthly instead
of accrued, and an earlier maturity date of December 31, 2021. The modification resulted in a new effective annual interest rate of 9.58%,
and a revised one-year maturity on December 31, 2021 (see Note 6 &#8211;Short-Term Revolving Loans). There was no accounting impact to
the financial statements related to this modification. The note was paid in full in April 2022.</span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2021
Convertible Notes/Extinguishment Loss on Debt Settlement</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
May to September 2021, the Company received gross proceeds of $2,929,000 from the issuance of unsecured convertible notes (the &#8220;Notes&#8221;),
of which $44,000 was received from existing shareholders. Of the total proceeds, $1,820,000 was received during the three months ended
September 30, 2021. Additionally, in May 2021, a shareholder converted a promissory note to a convertible note identical in terms discussed
below (see Note 8 &#8211; Shareholder Promissory Notes).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">At the option of the Note holders and after
the completion of a merger with a Special Purpose Acquisition Company (&#8220;SPAC&#8221;) or an Initial Public Offering (&#8220;IPO&#8221;),
the holder could convert all or a part of the outstanding principal and accrued interest into shares of common stock of the merged or
public company. The Notes included detachable warrants (&#8220;Warrants&#8221;) to purchase 3,862,000 shares of the merged or public
company. The Notes bore interest at a rate of 10% per annum, had an initial maturity of two years from date of issue, and were convertible
at per-share prices ranging from $0.50 to $2.50. Effective January 1, 2021, the Company early adopted ASU 2020-06, and accordingly, no
beneficial conversion features were recognized. The Notes were accounted for in accordance with ASC 470-20, <i>Debt with Conversion and
Other Options</i> (&#8220;ASC 470-20&#8221;) and ASC 815-40, <i>Contracts in Entity&#8217;s Own Equity</i> (&#8220;ASC 815-40&#8221;)<i>.
</i>Under ASC 815-40, to qualify for equity classification (or nonbifurcation, if embedded) the instrument (or embedded feature) must
be both (1) indexed to the issuer&#8217;s stock and (2) meet the requirements of the equity classification guidance. Based upon the Company&#8217;s
analysis, it was determined the Notes do contain embedded features indexed to its own stock, but do not meet the requirements for bifurcation
and recognition as derivatives, and therefore do not need to be separately recognized. Accordingly, the proceeds received from the issuance
of the Notes were recorded as a single liability measured at amortized cost on the consolidated Balance Sheet. The Company incurred $148,000
of debt issuance costs relating to the issuance of the Notes, which were recorded as a reduction to the Notes on the Balance Sheet. The
debt issuance costs were being amortized and recognized as additional interest expense over the term of the Notes using the straight-line
method because it is not substantially different from the effective interest rate. Amortization of debt discount totaled $27,271 through
the effective date of the conversion from LLC to a C corporation. Since the Warrants were not exercisable until a merger with a SPAC
or an IPO, there was no impact on the financial statements at date of grant.</span></p>
<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"></p>


<ix:exclude><!-- Field: Page; Sequence: 115 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 29, 2021, in anticipation of conversion from LLC to a C corporation, the Notes and Warrants were modified under Convertible Debenture
Exercise and Waiver and Release Agreements with the individual creditors. The Note holders agreed to settle the debt for an aggregate
of 1,527,647 shares of common stock with a fair value of $5,545,359 ($3.63 per share). Since this transaction involved contemporaneous
issuance of shares of common stock by the Company to the Note holders, the Company evaluated the transaction for modification and extinguishment
accounting and determined that the debt was extinguished as a result of the issuance of shares that do not represent the exercise of
a conversion right contained in the original terms of the Notes at issuance.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
settlement of the debt resulted in a recognized loss of $2,262,658 recorded as extinguishment loss on debt settlement in November 2021,
calculated as the excess of the fair value of shares issued over the carrying amount of the debt. In addition, the fair value of warrants
of $407,700 issued in exchange for services related to the extinguished debt (see Note 12 &#8211; Stockholders&#8217; Equity) and the
unamortized portion of debt discount remaining at date of settlement of $120,729 were also recorded as extinguishment loss on debt settlement
for an aggregate loss of $2,791,087.</span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-12016"><p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zOdGAmeDWc21" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&#160;&#160;&#160;
<span id="xdx_826_zyFvc7kK10Kk">Commitments and Contingencies</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
Leases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases its warehouses and office space under long-term lease arrangements. None of its leases include characteristics specified
in ASC 842, <i>Leases</i>, that require classification as financing leases, and accordingly, these leases are accounted for as operating
leases. The Company does not recognize a right-of-use asset and lease liability for short term leases, which have terms of 12 months
or less. For longer-term lease arrangements that are recognized on the Company&#8217;s Balance Sheet, the right-of-use asset and lease
liability are initially measured at the commencement date based upon the present values of the lease payments due under the leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies
an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine
the present value of lease payments due under the arrangement. Under ASC 842, the incremental borrowing rate (IBR) for leases must be
(1) a rate of interest over a similar term, and (2) for an amount that is equal to the lease payments. The Company uses both the Federal
Reserve Economic Data (FRED) U.S. corporate debt effective yield and the U.S. Treasury rates adjusted for credit spread as the primary
data points for purposes of determining the IBR.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2022, the Company entered into two new long-term, non-cancelable operating lease agreements for office and warehouse
space resulting in the Company recognizing an additional lease liability totaling of $2,348,509, representing the present value of the
lease payments discounted using an effective interest rate of 8.07% and 8.86%, and corresponding right-of-use assets of $2,348,509. The
leases expire in December 2026 and December 2028. The second lease contains one three-year option to renew. The lease is guaranteed by
a co-founder.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">In the first quarter of 2021, the Company
entered into a long-term, non-cancelable operating lease agreement for office and warehouse space resulting in the Company recognizing
an additional lease liability totaling of $1,268,089, representing the present value of the lease payments discounted using an effective
interest rate of 7.47% and a corresponding right-of-use asset of $1,268,089. The lease expires in January 2028 and contains one three-year
option to renew. The lease is guaranteed by a co-founder.</span></p>
<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_230_z5J7qD6z8j2l" style="margin: 0; text-align: justify; text-indent: 0.5in"></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 116 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zcxtVo6Abpo3" style="margin: 0; text-align: justify"></p></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two other leases that expire in January 2023 and February 2025. The leases generally provide for annual increases based on
a fixed amount and generally require the Company to pay real estate taxes, insurance, and repairs. Both leases are guaranteed by a co-founder.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of total lease costs for the years ending December 31, 2022 and 2021:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:LeaseCostTableTextBlock" id="ixv-12064"><p id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zt70SzrJsHw1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zA4p04jJhsYk" style="display: none">Schedule of lease cost</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_133_zX3fB250hzhj" summary="xdx: Disclosure - Commitments and Contingencies (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20220101__20221231_zRDtWRW2QH0l" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49A_20210101__20211231_zl44k8wUpsEd" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseCost_zmQTo6RBzj6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Operating lease cost</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23311">760,743</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23312">304,082</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShortTermLeaseCost_z2KXGOEMdG5d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term lease costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23313">3,527</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23314">4,846</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--VariableLeaseCost_zdD6N9GLYygj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Variable lease costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0761">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z92E8zIzoqw4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Sublease income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23315">123,386</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23316">75,061</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--LeaseCost_zGEze4ciKth5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23317">640,884</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23318">233,867</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zK6c1kkwLKi2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term was 5.49 years and 5.64 years as of December 31, 2022 and 2021, respectively. The weighted average
discount rate was 8.48% and 8.02%, as of December 31, 2022 and 2021, respectively. Operating cash flows from the operating leases totaled
$440,139 and $177,688 for the years ended December 31, 2022 and 2021, respectively.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total lease liability as of December 31, 2022 and 2021 was $3,220,019 and $1,311,649, respectively.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of December 31, 2022, for
years ending December 31:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="ixv-12152"><p id="xdx_89F_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zjn8IGfiNrgd" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zSRXGfWYN6n6" style="display: none">Schedule of future minimum lease payment</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_30F_134_zGHc7CoNIRSk" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3" id="xdx_499_20221231_zKR809Gf9WHc" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
  <tr id="xdx_402_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_z1ctjPjZ7uo1" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23319">719,220</ix:nonFraction></span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zu24xqSWsK7i" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23320">727,709</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zn7WlNmhEmMh" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23321">718,157</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_ze7t6y0FIfsb" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23322">732,061</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_zcvwntGDFkX8" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23323">694,040</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeDlFAgqoT5b" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23324">471,736</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zw2OCi6FrEF3" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23325">4,062,923</ix:nonFraction> </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcZaGW3sYpI2" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23326">842,904</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zoRRLCDMRbGh" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23327">3,220,019</ix:nonFraction>
    </span></td>
    <td style="border-bottom: Black 1.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zjMnNoXpuL2k" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23328">465,055</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zVzbnmDfgRp3" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent lease liability</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23329">2,754,964</ix:nonFraction>
    </span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zKv4gfUZwLpk" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23330">3,220,019</ix:nonFraction>
    </span></td>
    <td style="border-bottom: Black 1.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zzuPucRkZaeh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subleases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company subleases office and warehouse space under three of its existing operating leases with similar terms as the Company&#8217;s lease
agreements. Because the Company is not relieved of its primary obligations under the original lease, the Company accounts for the subleases
as a lessor. Sublease rental income is recorded based on the contractual rental payments which are not substantially different from recognition
on a straight-line basis over the lease term and totaled $<span id="xdx_906_eus-gaap--OperatingLeasesRentExpenseNet_c20220101__20221231_ziE8GQVnIJR7" title="Sublease rental income"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23331">123,386</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--OperatingLeasesRentExpenseNet_c20210101__20211231_zdYG3v1hnLpg" title="Sub Rental Income"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23332">75,061</ix:nonFraction></span> during the years ended December 31, 2022 and 2021, respectively.
As of December 31, 2022 and 2021, deferred income and a sublease deposit totaled $<span id="xdx_903_ecustom--DeferredIncomeAndSubleaseDeposit_iI_c20221231_zrwtzhbpkyb4" title="Deferred income and sublease deposit"><ix:nonFraction name="XPON:DeferredIncomeAndSubleaseDeposit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23333">14,168</ix:nonFraction></span> and $<span id="xdx_904_ecustom--DeferredIncomeAndSubleaseDeposit_iI_c20211231_zAb689SXF2Nj"><ix:nonFraction name="XPON:DeferredIncomeAndSubleaseDeposit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23334">13,690</ix:nonFraction></span>, respectively, and is included in
accrued expenses and other current liabilities on the accompanying Balance Sheets.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 117 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the total future minimum sublease payments as of December 31, 2022:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" id="ixv-12307"><p id="xdx_894_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zogI97WN0Tzk" style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zqERv2OqsW1b" style="display: none">Schedule of future minimum sublease payments</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_305_134_zhF1WH9OjIuk" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49C_20221231_zDQyzMww9bPa" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 79%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years ending December 31,</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zf6T9vcYuKN4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23335">46,147</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_z1tyWIw2oB23" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23336">36,242</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_iI_zeyWDgF05una" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23337">6,070</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zPHSI71m273d" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactions" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23338">88,459</ix:nonFraction></span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zFVc6lYAtst2" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be involved from time to time in litigation or claims arising in the ordinary course of its business. While the ultimate
liability, if any, arising from these claims cannot be determined with certainty, the Company believes that the resolution of any such
matters will not likely have a material adverse effect on the Company&#8217;s financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 22, 2022, Expion360 Inc. (the &#8220;Company&#8221;) <span style="background-color: white">received notice of a complaint (the
&#8220;Complaint&#8221;) filed against it in Oregon state court by Ravi Sinha. The Complaint alleges,&#160;</span><i>inter alia</i><span style="background-color: white">,
that Mr. Sinha is entitled to 282,284 shares of the Company&#8217;s common stock, or in the alternative, $300,000 plus interest in connection
with services he previously rendered the Company as its chief executive officer. On March 21, 2023, the Company entered into a settlement
agreement with Mr. Sinha and the matter has been resolved.</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:ConversionOfStockTextBlock" id="ixv-12383"><p id="xdx_80E_ecustom--ConversionOfStockTextBlock_zdRfPj90rela" style="margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>11.&#160;&#160;&#160;<span id="xdx_825_zsnBXAk3PPHj">
Conversion to a C Corporation</span></i></b></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
November 1, 2021, the Company converted from an LLC to a C corporation under the State of Nevada statutes in anticipation of an upcoming
initial public offering, and changed its name to Expion360 Inc. The membership units of the existing LLC members and all existing convertible
note holders (see Note 9 - Convertible Notes) converted into an aggregate of 4,181,111 shares of common stock. Additionally, investors
purchased 88,889 shares of common stock for total proceeds of $316,400, and 30,000 shares of common stock were issued in exchange for
legal services. The 30,000 shares issued in exchange for legal services were valued at $108,900 at date of grant based on the per share
price of $3.63 paid for shares issued at the time of the conversion to a C corporation. The Company&#8217;s issued and outstanding shares
of common stock totaled 4,300,000 upon conversion to a C corporation.</span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-12395"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zNvn7GEnEaBa" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&#160;&#160;&#160;<span id="xdx_822_z3ypndUkQ1F">
Stockholders&#8217; Equity</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue an aggregate of 220,000,000 shares of capital stock, par value $0.001 per share, consisting of 200,000,000
shares of common stock and 20,000,000 shares of preferred stock. As of December 31, 2022 and December 31, 2021, 6,802,464 and 4,300,000
shares, respectively, of common stock were issued and outstanding. No shares of preferred stock have been issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of common stock is entitled to one vote for each share of common stock. The holders of common stock have no conversion, redemption
or preemptive rights and shall be entitled to receive dividends when, as, and if declared by the board of directors. Upon dissolution,
liquidation, or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, subject
to the rights, if any, of the holders of any class or series stock having a preference over the right to participate with common stock
with respect to the distribution of assets of the Company upon such dissolution, liquidation, or winding up of the Company, the holders
of common stock shall be entitled to receive the remaining assets of the Company available for distribution to its stockholders ratably
in proportion to the number of shares of common stock held.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
no shares of preferred stock have been issued, no rights and privileges of preferred stockholders have been defined.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
Public Offering</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company completed an initial public offering (&#8220;IPO&#8221;). A total of 2,466,750 shares of common stock were
sold at $7.00 per share in the IPO, for total gross proceeds of $17,267,250. The Company incurred IPO costs of $2,494,763 resulting in
net proceeds of $14,772,487. Additionally, during the year ended December 31, 2022,
the Company issued 35,714 shares of common stock at $7.00 per share to an outside third party in exchange for IPO services. The fair
value of the shares of $249,998 were recorded as an increase to common stock of $36 (35,714 shares at $.001 par value) and additional
paid in capital of $249,962 and a corresponding reduction to additional paid in capital of $249,998, resulting in a net decrease in additional
paid in capital of $36.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 118 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance
of Shares</i></span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to conversion from an LLC to a C corporation, the following membership units were issued and included in the membership units that were
converted into 4,181,111 shares of common stock upon the Company&#8217;s conversion to a C corporation (see Note 11 &#8211; Conversion
to a C corporation).</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2021, 8,000 membership units (equivalent to 192,234 shares) that were held in
                                            Trust were granted to three individuals.</span></td></tr></table>

<p style="margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2021, the Company issued 2,338 Class B member units (equivalent to 59,515 shares
                                            of common stock) upon the conversion of convertible notes and accrued interest totaling $173,157
                                            (see Note 9 - Convertible Notes).</span></td></tr></table>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2021, the Company issued 262 Class B membership units (equivalent to 6,667 shares
                                            of common stock) in exchange for building signage valued at $20,000.</span></td></tr></table>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            March 2021, the Company sold 3,185 Class B membership units (equivalent to 81,106 shares
                                            of common stock) to two new members for gross proceeds of $270,000.</span></td></tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            April 2021, the company sold 2,972 Class B membership units (equivalent to 75,662 shares
                                            of common stock) to one new member for gross proceeds of $252,000.</span></td></tr></table>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants/Options</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company issued warrants to IPO underwriters to purchase 148,005 shares of common stock at an exercise price of $9.10
per share. The warrants are exercisable 180 days after grant (September 27, 2022) and expire 5 years from date of grant (March 31, 2027).
The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions:
per share price of common stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest
rate of 2.55% and expected life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in
capital and a reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero
impact to additional paid-in capital.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2021, the Company issued 482,268 detachable warrants with secured promissory notes (see Note 7 &#8211; Long-Term Debt) for the
purchase of common stock. The relative fair value of the warrants of $809,806 at the time of issuance was recorded as additional paid-in
capital with a corresponding debt discount reducing the carrying value of the notes. Additionally, the Company issued 77,163 warrants
to purchase shares of common stock to underwriters in connection with obtaining the notes. The fair value of the warrants of $262,354
was recorded as additional paid-in capital and reduced the carrying value of the notes. The warrants are exercisable at $3.32 per share
for a period of 10 years from date of grant. The fair value of the warrants was determined at date of issuance using the Black-Scholes
option-pricing model and the following assumptions: per share price of common stock on date of grant of $3.63, expected dividend yield
of 0%, expected volatility of 110.8%, risk-free interest rate of 1.63% and expected life based on contractual life of 10 years.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in November 2021, the Company issued warrants to purchase 151,000 shares of common stock in in exchange for prior services related
to extinguished 2021 convertible notes and 30,000 options for the purchase of common stock in exchange for legal services. The
warrants are exercisable at $2.90 per share for a period of three years from the date of grant. The options are exercisable at $3.32
per share for a period of three years from the date of grant. The options issued were not issued under the Company&#8217;s stock
option plans. The fair value of the warrants of $407,700 was recorded as additional paid-in-capital and expensed to extinguishment
loss on debt settlement (see Note 9 &#8211; Convertible Notes). The fair value of the options of $79,200 was recorded as additional
paid-in capital with a
corresponding charge to legal expense. The fair value of the warrants and options was determined at date of issuance using the Black-Scholes
option-pricing model and the following assumptions: per share price of common stock on date of grant of $3.63, expected dividend yield
of 0%, expected volatility of 122.7%, risk-free interest rate of 0.71% and expected life based on contractual life of three years.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 119 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, a total of 858,436 and 710,431 warrants were issued and outstanding, respectively. As of
December 31, 2022 and December 31, 2021, a total of 30,000 options, which were not issued under a specified plan, were outstanding. As
of December 31, 2022, below is a summary of the various warrants/options issued and outstanding:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" id="ixv-12512"><p id="xdx_895_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zPf8dkwekrsb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zEzVKEpPWtxc" style="display: none">Schedule of various warrants/options issued and outstanding</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_306_134_zpjXu2OSB0dj" summary="xdx: Disclosure -  Stockholders Equity (Details)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 47%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of
    warrants/non-plan options</b></span></td>
    <td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    Price</b></span></td>
    <td style="width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    Average Remaining Life (Yrs)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zfwpDoIHXtF9" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_ExercisePrice1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23339">559,431</ix:nonFraction></span></td>
    <td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zyr2oR9dgU52" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31_custom_ExercisePrice1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23340">3.32</ix:nonFraction>
    </span></td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zg9KyrjASIWe"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_ExercisePrice1Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23341">8.90</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zExQ0hbqZOh5" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_ExercisePrice2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23342">151,000</ix:nonFraction></span></td>
    <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_z28elCJ7994l" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31_custom_ExercisePrice2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23343">2.90</ix:nonFraction>
    </span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zadaY99B6WYg"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_ExercisePrice2Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23344">1.86</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zbAYHtpkB53l" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_ExercisePrice3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23345">30,000</ix:nonFraction></span></td>
    <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zvIaZ1h8hcv7" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31_custom_ExercisePrice3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23346">3.32</ix:nonFraction>
    </span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zAL5rhjBdOp3"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_ExercisePrice3Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23347">1.86</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zGLs1JzSux5" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_ExercisePrice4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23348">148,005</ix:nonFraction></span></td>
    <td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zvBMWrSErvjj" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31_custom_ExercisePrice4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23349">9.10</ix:nonFraction>
    </span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zZEHNbQA7Aki"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_ExercisePrice4Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23350">4.25</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231_zY5DYu6afXz8" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23351">888,436</ix:nonFraction></span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_z4tAEbfvc9c5" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Option Plans</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had adopted two stock-based compensation plans, the 2021 Incentive Award Plan and the 2021 Employee
Stock Purchase Plan, both of which are described below and became effective upon the initial public offering. On May 2, 2022, the Company
granted 829,500 options under the 2021 Incentive Award Plan. No shares have been issued to date under the 2021 Employee Stock Purchase
Plan. The compensation cost that has been charged against operations was $2,114,529 for the year ended December 31, 2022.</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021
Incentive Award Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Company&#8217;s 2021 Incentive Award Plan is to enhance the Company&#8217;s ability to attract, retain and motivate persons
who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities.
Various stock-based awards may be granted under the plan to eligible employees, consultants, and non-employee directors. The number of
shares issued under the plan is subject to limits and is adjusted annually. No more than 1,000,000 shares may be issued pursuant to the
exercise of incentive stock options. The aggregate share limit will be subject to an annual increase on the first day of each calendar
year ending on and including January 1, 2031, by a number of shares equal to the lesser of (i) a number equal to 5% of the aggregate
number of shares of the Company's common stock outstanding on the final day of the immediately preceding calendar year and (ii) such
smaller number of shares as is determined by the Company's board or committee. As of December 31, 2022, the aggregate number of shares
that can be issued under the Plan is 859,500 of which 829,500 have been granted. The number of shares granted, the exercise price, and
the terms will be determined at date of grant, however, the exercise price shall not be less than 100% of the fair value on the grant
date (110% for options granted to greater than 10% shareholders) and the term shall not exceed ten years.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021
Employee Stock Purchase Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The purpose of the Company&#8217;s 2021 Employee
Stock Purchase Plan is to assist eligible employees of the Company in acquiring a stock ownership in the Company and to help such employees
provide for their future security and to encourage them to remain in the employment of the Company. The plan consists of a Section 423
Component and Non-Section 423 Component. The Section 423 Component is intended to qualify as an employee stock purchase plan and also
authorizes the grant of options. Options granted under the Non-Section 423 Component shall be granted pursuant to separate offerings
containing sub-plans. The Company may make one or more offerings under the plan. The duration and timing of each offering period may
be established or changed by the board, but in no event may an offering period exceed 27 months and in no event may the purchase period
for the option exceed the duration of the offering period under which it is established. On each exercise date for an offering period,
each participant shall automatically be deemed to have exercised the option to purchase the largest number of whole shares which can
be purchased under the offering. Option awards are generally granted with an exercise price equal to 85% of the lesser of the fair market
value of a share on (a) the applicable grant date and (b) the applicable exercise date, or such other price as designated by the administrator,
provided that in no event shall the option price be less that the per share par value price. The maximum number of shares granted under
the plan shall not exceed 2,500,000 shares.</span></p>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">&#160;</span></i></span></p>

<ix:exclude><p id="xdx_23A_zC1KAtdDEDlb" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"></p>


<ix:exclude><!-- Field: Page; Sequence: 120 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_z1UqhEQUf7Yl" style="margin: 0; text-align: justify"></p></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected
volatility was calculated based upon similar traded companies&#8217; historical share price movements as adequate historical experience
is not available to provide a reasonable estimate. Expected term is calculated based on the simplified method as adequate historical
experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience
is available to provide a reasonable estimate of the expected term. The risk-free interest rate is calculated based on the yield from
U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and have no foreseeable plans
to pay dividends.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has computed the fair value of all options granted during the year ended December 31, 2022 using the following assumptions:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-12622"><p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcJ8dxxZkHx8" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zeGzw2Rp6LDe" style="display: none">Schedule
of assumptions used</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_306_134_zk1RpYJzRAt9" summary="xdx: Disclosure -  Stockholders Equity (Details1)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility 	</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z24FkFYmlO1i"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23352">109.48</ix:nonFraction></span>% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zcF9lTf9RPy3"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-012022-12-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23353">113.32</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividends</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_zrSe1p1d5Dr5"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-012022-12-31" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23354">None</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (in years)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zqaEN7sJ00h2"><ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-23355">2.5</ix:nonNumeric></span> &#8211; <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zj8KGAYwQ0R9"><ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-23356">5.01</ix:nonNumeric></span> </span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    free rate	</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z54s1WVuj283"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23357">2.83</ix:nonFraction></span>% &#8211; <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z3TKXdHHvoUj"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-12-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23358">3.01</ix:nonFraction></span>%</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_z3yIi7NqvRla" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the Company&#8217;s stock option activity under the 2021 Incentive Plan:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-12679"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zpsFvxsyKuK2" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zFX4jIZq1BZ7" style="display: none">Schedule of stock option activity</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_301_134_zzfp0ZPVzO6j" summary="xdx: Disclosure -  Stockholders Equity (Details2)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 51%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of options</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average exercise price</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average remaining contractual term (in years)</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    intrinsic value (1)</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zJAYO72S2l31" title="Outstanding at beginning of period" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0844">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zQTcUdOPhvG3" title="Weighted average exercise price outstanding at beginning of period" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0846">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zxMld6jCZh9c" title="Aggregate intrinsic value Outstanding at beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0848">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zTrNZy6McZMb" title="Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23359">829,500</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zHQto8BXgup6" title="Weighted average exercise price granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23360">3.43</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zAlcAOVbD7eg" title="Aggregate intrinsic value granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_ztSN20Ia76i" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0855">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zBwJkFHMJ5sb" title="Weighted average exercise price exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0857">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zr8qW9ktYPhj" title="Aggregate intrinsic value exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0859">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zoh55x7y0jse" title="Exercised" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0861">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zRqC5AExY4T" title="Weighted average exercise price forfeited" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0863">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_ecustom--AggregateIntrinsicValueForfeited_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zFhE6mlaRA7g" title="Aggregate intrinsic value forfeited" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0865">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of period</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zju6BqTzL85b" title="Outstanding at end of period" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23361">829,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_z4Cl21GR35Za" title="Weighted average exercise price outstaning at end of period" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23362">3.43</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zX3UKdaPNM48" title="Weighted average remaining contractual term (in years)"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-23363">8.26</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zt1lLxMYkyLa" title="Aggregate intrinsic value end of period" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0873">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of period</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zZg3Cuz3ukza" title="Exercisable at end of period" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2022-12-31_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23364">829,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_iI_c20221231_z3lKBCxLGzgl" title="Weighted average Price exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23365">3.43</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zi952FVivqDj" title="Weighted average remaining contractual term (in years) exercisable"><ix:nonNumeric contextRef="From2022-01-012022-12-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-23366">8.26</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zsWZalj4hiS8" title="Aggregate intrinsic value exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0881">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AE_zzi8QPDGEpA7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
                                            aggregate intrinsic value of options outstanding and options exercisable as of December 31,
                                            2022 is $0, as all options are out of the money.</i></span></td></tr></table>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average grant-date fair value of the options granted during the nine months ended December 31, 2022 to employees and non-employees
was $<span id="xdx_90E_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20220101__20221231_zuIYfec0Wn6c" title="Options granted"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23367">1,847,193</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20210101__20211231_zvI3H0h5dnH9"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23368">267,336</ix:nonFraction></span>, respectively. All options were immediately vested and there was no unrecognized compensation expense as
of December 31, 2022.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Reserved for Future Issuance </i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of common stock shares reserved for future issuance as of December 31, 2022:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock" id="ixv-12964"><p id="xdx_89D_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_z90f1irLpWN6" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zgICDwR4qoh" style="display: none">Schedule
of common stock shares reserved for future issuance</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_133_z4kENF1cfmba" summary="xdx: Disclosure -  Stockholders Equity (Details 3)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 6pt; padding-left: 12pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20221231_znWZEU5eey41" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zly4ssWCud3l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: 6pt; padding-left: 12pt">Exercise of warrants 	</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2022-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23369">858,436</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zmxFQkzQUqvd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt">Exercise of options unrelated to any Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2022-12-31_custom_UnrelatedToAnyPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23370">30,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zyYgm42BRNQb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 6pt; padding-left: 12pt">Exercise of stock options &#8211; 2021 Incentive Award Plan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2022-12-31_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23371">829,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCBQtFy6EhV" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 6pt; padding-left: 12pt">Total shares of common stock reserved for future issuances	</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23372">1,717,936</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<ix:exclude><!-- Field: Page; Sequence: 121 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-13006"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zZKsCIc5Jol9" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&#160;&#160;&#160;
<span id="xdx_827_z9BdVN7137T7">Income Taxes</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
losses before income taxes for the year ended December 31, 2022 and for the two months ending December 31, 2021 were generated primarily
from U.S. operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no current or deferred provision for income taxes from continuing operations for the years ended December 31, 2022 and 2021.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant differences between the U.S. Federal statutory rate and our effective rate for financial reporting purposes are as follows:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-13022"><p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEtVZfzLHWcj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span id="xdx_8B3_zjcQ6x77CPU2" style="display: none">Schedule
of Effective Income Tax Rate Reconciliation</span></span></span></p>
<table cellpadding="0" cellspacing="0" id="xdx_308_134_zwbP73deKSi9" summary="xdx: Disclosure - Income Taxes (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_496_20220101__20221231_ztVgFHcgYj7h" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49C_20210101__20211231_zoKi8J2nW6gc" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_dp_uPure_zGJmKRRETVVl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Federal statutory tax rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure" id="ixv-23373">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">)%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure" id="ixv-23374">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_dp_uPure_zSsouv1ej8Pk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure" id="ixv-23375">5.3</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure" id="ixv-23376">1.7</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dt_uPure_zSDcgF6oc0bf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23377">26.4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure" id="ixv-23378">8.4</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationBeatPercent_dp_uPure_z8hQMHG06fq6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NQSO Comp &#8211; Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23379">0.0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23380">0.5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationFdiiPercent_dp_uPure_z6JxTFJotrz" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">EQ Comp &#8211; Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23381">0.0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23382">13.4</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_uPure_zFBT1vmZ4Ww3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">True-up Adjustment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure" id="ixv-23383">0.1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23384">0.4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zKiFl8AjglZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-012022-12-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23385">&#8212;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-012021-12-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23386">&#8212;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="ixv-13115"><p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zC4OARNncDdj" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_ziXukLYUoNWd" style="display: none">Schedule of Income
before Income Tax, Domestic and Foreign</span></span></p>



<p style="margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zb1NHB8OwHti" summary="xdx: Disclosure - Income Taxes (Details 1)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_496_20220101__20221231_zjevSpBUivch" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zHdMUqaY85k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of
    December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Current:</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_zo8Lkbra0hU8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Federal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0923">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zt5wGkkScfPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left">&#160;&#160;&#160;&#160;State Franchise Fees</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23387">8,850</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23388">9,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0; text-align: justify"></p>

</ix:nonNumeric></ix:nonNumeric><p id="xdx_8A0_zMccOFf4myda" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and
liabilities are as follows for the year ended December 31, 2022 and two months ended December 31, 2021.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income tax assets and liabilities consist of the following:</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="ixv-13183"><p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zrqqWNaZpNL8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zCkmsuoyAI94" style="display: none">Schedule of Components of Income Tax Expense</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_z4PMuvPF2Mrl" summary="xdx: Disclosure - Income Taxes (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_496_20221231_z89QQUgKEAVi" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_zNPhNqwwS8d1" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_zPDkTJWsp4Y8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLossCarryforwards_iI_z1KojXuaItub" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left">&#160;&#160;&#160;&#160;Net Operating Losses</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23389">1,719,889</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23390">151,797</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_zY5o7ofxAGS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23391">444,051</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23392">150,524</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_iI_zPOwsh21rPTg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23393">424,675</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23394">17,927</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zbpierLcBkek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23395">2,588,615</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23396">320,248</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iNI_di_zYAiOFhAOQ5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingLossCarryforwardsValuationAllowance" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23397">2,584,010</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingLossCarryforwardsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23398">297,815</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_z9RCY5agWj6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation_iI_z6gxUl9dblYg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;Depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="XPON:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23399">4,605</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="XPON:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23400">22,433</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zTwZORa2tz13" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, the Company incurred losses for the year ended December 31, 2022 and December 31, 2021 and for each period
since inception. Accordingly, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets.
At December 31, 2022, the Company had approximately $6.56 million of federal and state net operating losses.</span></p>

<ix:exclude><p id="xdx_23E_z50dz4MFJsod" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 122 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation between the amount of income tax benefit determined by applying the U.S statutory income tax rate to pre-tax loss is as
follows:</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="ixv-13313"><p id="xdx_892_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zPv7QMcA7cRk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zYENDrlL9PE9" style="display: none">Summary of Operating Loss Carryforward</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_134_zIUNOoP3rzEa" summary="xdx: Disclosure - Income Taxes (Details 3)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_497_20221231_zjBwkj1Wu1Yh" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_zZONGVJtCiA9" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iNI_di_zmJ0QSxopRXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Income tax provision at federal statutory rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23401">1,584,531</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23402">746,778</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iNI_di_zyhZ985TWJH" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23403">399,174</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23404">59,202</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_zVKR14O4RXk1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Stock-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0964">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23405">491,727</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsTaxCreditCarryforwardsOthers_iNI_di_zoHMOfr76WJa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="XPON:DeferredTaxAssetsTaxCreditCarryforwardsOthers" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23406">8,964</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:DeferredTaxAssetsTaxCreditCarryforwardsOthers" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23407">16,438</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsValuationAllowanceOne_iNI_di_zNsab0INGQ0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="XPON:DeferredTaxAssetsValuationAllowanceOne" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23408">1,992,669</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="XPON:DeferredTaxAssetsValuationAllowanceOne" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23409">297,815</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zDtRC7mosmRf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zzsIHje3BTw9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
positions are evaluated in a two-step process. The Company first determines whether it is more likely than not that a tax position will
be sustained upon examination. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine
the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is
greater than 50% likely of being realized upon ultimate settlement. The aggregate changes in the balance of gross unrecognized tax benefits,
which excludes penalties and interest, for the year ended December 31, 2022 is zero.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to taxation in the United States and Oregon. There are no ongoing examinations by taxing authorities at this time.
The Company&#8217;s various tax years 2017 through 2022 remain open for examination by various taxing jurisdictions.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2022, the Company
has not accrued any penalties or interest related to uncertain tax positions</span></p>

<p style="margin: 0 8pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
anticipation of an initial public offering, the Company converted from a limited liability company to a C corporation, a taxable entity,
effective November 1, 2021.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
October 31, 2021, the Company was treated as an S corporation for federal and state income tax purposes, such that the Company&#8217;s
taxable income is reported by members in their respective tax returns and the Company was only subject to state franchise taxes and fees.
For the year ended December 31, 2022 the Company reversed the 2021 accrual of $9,300 and accrued only $450 for state income taxes, as
we do not anticipate owing more than the minimum state income taxes for 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
converting to a C corporation, the Company has incurred losses and consequently recorded no provision for state or federal income taxes
for the year ended December 31, 2022. The Company maintains a full valuation allowance on all deferred tax assets, as it has concluded
that it is more likely than not that these assets will not be realized. As of December 31, 2022 and December 31, 2021, there were no
material unrecognized tax benefits included in the accompanying balance sheets that would, if recognized, affect the effective tax rate.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:DefinedBenefitPlanTextBlock" id="ixv-13427"><p id="xdx_804_eus-gaap--DefinedBenefitPlanTextBlock_zXvR4SR9bad7" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&#160;&#160;&#160;
<span id="xdx_821_zh0Q5EmUpQTi">401(k) Plan</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted a 401(k) Plan (&#8220;Plan&#8221;) for the benefit of its employees. Employees may contribute to the Plan within defined
limits as defined by the Internal Revenue Service. Substantially all employees are eligible to participate. The Company has the option
to make profit sharing contributions at its discretion. No profit-sharing contributions have been made.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-13437"><p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zNgtp9RUrU2h" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&#160;&#160;&#160;
<span id="xdx_828_zdFv0LBS2WZi">Related Party Transactions</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, related party transactions consisted of Shareholder Promissory Notes (see Note 8 &#8211;
Shareholder Promissory Notes).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, related party transactions consisted of Accounts Payables liability to board members for
2022 board compensation in the amount of $<span id="xdx_90A_ecustom--AccountsPayableRelatedPartiesCurrentOne_iI_c20221231_zjzEH1iVz8Eh" title="Accounts Payables liability"><ix:nonFraction name="XPON:AccountsPayableRelatedPartiesCurrentOne" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23410">100,000</ix:nonFraction></span> and $<span id="xdx_905_ecustom--AccountsPayableRelatedPartiesCurrentOne_iI_c20211231_zNYKjlqn9tz3"><ix:nonFraction name="XPON:AccountsPayableRelatedPartiesCurrentOne" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23411">0</ix:nonFraction></span>, respectively.</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 123 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-13458"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zx1L9HYbKae6" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&#160;&#160;&#160;
<span id="xdx_82C_ze2sfdm73dri">Subsequent Events</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date to which events occurring after December 31, 2022, the date of the most recent Balance Sheets, have been evaluated for possible
adjustment to the financial statements or disclosures is March 27, 2023, which is the date the financial statements were issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2023, the Company filed an 8-K related to a published press release announcing a new product, the AURA POWERCAP&#8482;.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 20, 2023 the company paid off a note payable in the amount of $89,360.11 which included principal, interest and fees.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2023, the Company made certain leadership changes. On January 30, 2023, the Company filed an 8-K related to a press release
announcing these changes. On February 1, 2023, the Company filed an 8-K with the details of the leadership changes.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the Company had 88,000 warrants exercised of which 73,000 were cashless resulting in 31,102 additional shares of common stock
issued. The remaining 15,000 exercised shares were exercised for a total of $49,975 which included $175.00 in fees.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2023, the Company entered into a settlement agreement with Ravi Sinha related to a complaint filed against the Company by Mr.
Sinha in Oregon state court and the matter has been resolved.</span></p>

</ix:nonNumeric><p id="xdx_812_zQstmBgDBjJh" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 124 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"></p><p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360 Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_007"></span>Balance Sheets</b></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_111_zesyxlCGOMij" summary="xdx: Statement - Balance Sheets (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_499_20230930_zwEodr0yPmMk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023 (unaudited)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_492_20221231_znJ2X6akgnCj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr id="xdx_409_eus-gaap--AssetsAbstract_iB_z2a9TveYTjkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Current
    Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_maCz9Ch_zEhm2AoEMwhc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Cash
    and cash equivalents</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23412">2,910,896</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23413">7,201,244</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccountsReceivableNetCurrent_iI_maCz9Ch_zQGFOPq4r4lj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Accounts
    receivable, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23414">473,284</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23415">298,035</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryNet_iI_maCz9Ch_zOVGXl1XSque" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23416">4,158,483</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23417">4,530,136</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OtherInventoryInTransit_iI_maCz9Ch_zbe6XczefLr2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid/in-transit
    inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherInventoryInTransit" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23418">102,646</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherInventoryInTransit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23419">141,611</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_maCz9Ch_zLZeEtawkOk8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid
    expenses and other current assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23420">217,550</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23421">171,791</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AssetsCurrent_iTI_mtCz9Ch_maCzM1v_z3DoXYuBpRgk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Total current
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23422">7,862,859</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23423">12,342,817</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_maCzGaN_zbL28vX1U2Si" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Property
    and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23424">1,348,326</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23425">1,394,619</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msCzGaN_zFKwn3pXuMdi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Accumulated
    depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23426">378,286</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23427">250,861</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtCzGaN_maCzM1v_zhaBLW569S76" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Property
    and equipment, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23428">970,040</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23429">1,143,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherAssetsAbstract_iB_zkKq5dC30AWe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Other Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_maCzdi3_zSzq65r4mW0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Operating
    leases &#8211; right-of-use asset</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23430">2,789,160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23431">3,148,455</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DepositsAssetsNoncurrent_iI_maCzdi3_zLHSadGiag9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Deposits</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23432">58,896</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23433">63,901</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAssets_iTI_mtCzdi3_maCzM1v_zSmiZGXuTdB7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Total
    other assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23434">2,848,056</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23435">3,212,356</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Assets_iTI_mtCzM1v_zx9RNm2hhnqa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23436">11,680,955</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23437">16,698,931</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zNYQxkRp4zw1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities and stockholders&#8217;
    equity</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrentAbstract_iB_z4WAJgNV3Dc8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Current
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableCurrent_iI_maCz1DP_zndYCGKTKLg9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;Accounts
    payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23438">437,236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23439">230,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CustomerDepositsCurrent_iI_maCz1DP_z8mf71PrjMta" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;Customer
    deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23440">46,248</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23441">58</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_maCz1DP_zXQVd6YvvQqh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;Accrued
    expenses and other current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23442">299,793</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23443">306,164</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maCz1DP_z9lW2Xh2cPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;Current
    portion of operating lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23444">506,743</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23445">465,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NotesPayableCurrent_iI_maCz1DP_zPVGdAymnXb6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;Current
    portion of stockholder promissory notes</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23446">625,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23447">500,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LongTermDebtCurrent_iI_maCz1DP_z4bx8PZprAUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;Current
    portion of long-term debt</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23448">50,058</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23449">71,426</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrent_iTI_mtCz1DP_maCzSnb_z1AjG8yoKCo6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Total current
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23450">1,965,078</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23451">1,572,953</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--ConvertibleDebtNoncurrent_iI_maCzSnb_zidFMflgkry1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Long-term
    debt, net of current portion and discount</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23452">311,431</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23453">439,049</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_maCzSnb_zH6xhdjhDdBi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Operating
    lease liability, net of current portion</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23454">2,376,474</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23455">2,754,964</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NotesPayable_iI_maCzSnb_zMGQvUbGan5e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Stockholder
    promissory notes, net of current portion</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23456">200,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23457">325,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Liabilities_iTI_mtCzSnb_maCztLj_z7KXIN0zoth" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23458">4,852,983</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23459">5,091,966</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(continued on next page)&#160;</span></p>

<p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: center"></p>

<p style="margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 125 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360 Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance Sheets
&#8211; Continued</b></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023 (unaudited)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB_zG8kM1ifpEf7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Stockholders&#8217;
    equity</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PreferredStockValue_iI_zryF9GGziXP3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    stock, par value $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230930_zBtwKn3RvRC"><span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zDdZYKzgkfd1"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30" decimals="INF" unitRef="USDPShares" id="ixv-23460"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares" id="ixv-23461">.001</ix:nonFraction></ix:nonFraction></span></span>; <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20230930_zVelBgFTtGm4"><span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zCVyNUfhzWJl"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23462"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23463">20,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; zero shares issued and outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1072">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1073">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CommonStockValue_iI_zMXdGjL1e2h9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, par value $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230930_zcKWbYhIAZG1"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231_zhtzS4cynIw1"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-30" decimals="INF" unitRef="USDPShares" id="ixv-23464"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares" id="ixv-23465">.001</ix:nonFraction></ix:nonFraction></span></span>; <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20230930_zcCuXpg9ZW45"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20221231_zzNlNc2Rpc4k"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23466"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23467">200,000,000</ix:nonFraction></ix:nonFraction></span></span>
    shares authorized; <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20230930_zTU4aaNO89Ta"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20230930_zuRF6tjKkbJ2"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23468"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23469">6,910,717</ix:nonFraction></ix:nonFraction></span></span>
    and <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20221231_zYFcmCl56MIj"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20221231_zVHt6bFqMZ35"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23470"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23471">6,802,464</ix:nonFraction></ix:nonFraction></span></span>
    issued and outstanding as of September 30, 2023     and December 31, 2022, respectively</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23472">6,911</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23473">6,802</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AdditionalPaidInCapital_iI_zaPes2N59yba" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Additional
    paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23474">25,730,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23475">25,239,654</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zZlkN4WIqrVf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;Accumulated
    deficit</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23476">18,909,772</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23477">13,639,491</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquity_iI_zYxaZxv1iZXj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Total
    stockholders&#8217; equity</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23478">6,827,972</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23479">11,606,965</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_iI_zDOS3MAlWnIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities and stockholders&#8217; equity</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23480">11,680,955</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23481">16,698,931</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral
part of these financial statements</span></p>

<p style="margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 126 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360 Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_008"></span>Statements of Operations
(Unaudited)</b></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Statements - Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_493_20230701__20230930_z9GZkapsfJOd" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_494_20220701__20220930_zWN7fi3ORMFg" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_493_20230101__20230930_zbeN9hjqxxO3" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220930_zZiG2ohNcFi4" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Three Months Ended September 30,</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Nine Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_402_eus-gaap--Revenues_maCzYd9_zmsWGpKkhWtj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales, net</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23482">1,890,115</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23483">1,383,011</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23484">5,122,415</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23485">5,741,075</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CostOfRevenue_msCzYd9_zR18YevoRsta" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23486">1,417,552</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23487">980,141</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23488">3,752,006</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23489">3,770,025</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--GrossProfit_iT_mtCzYd9_maCzDJf_zj1by9GyBCw9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23490">472,563</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23491">402,870</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23492">1,370,409</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23493">1,971,050</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--SellingGeneralAndAdministrativeExpense_msCzDJf_zaIkVi1pCylc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
    general and administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23494">2,290,955</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23495">1,662,005</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23496">6,363,514</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23497">6,479,954</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--OperatingIncomeLoss_iT_mtCzDJf_maCziWz_zL4oXXnlMCib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss from operations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23498">1,818,392</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23499">1,259,135</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23500">4,993,105</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23501">4,508,904</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zQsKJjrfC0if" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other (Income) / Expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--InterestAndOtherIncome_iN_di_maCzfVq_zKFZpbs2wsae" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Interest
    income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23502">33,048</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23503">64</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23504">100,945</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23505">158</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InterestExpense_msCzfVq_zk4qrDr15Tj5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Interest
    expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23506">27,491</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23507">34,016</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23508">92,067</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23509">1,571,848</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--GainLossOnSaleOfPropertyPlantEquipment_zKPC0Yw43vH8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Gain)
    / Loss on sale of property &amp; equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1142">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23510">13,312</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23511">3,426</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23512">13,312</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LitigationSettlementExpense_msCzfVq_z42CfPNH8ZE2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Settlement
    expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1147">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1148">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23513">281,680</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1150">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherOperatingIncomeExpenseNet_zbJfig2LZnag" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Other
    (income) / expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1152">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23514">471</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23515">394</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23516">389</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--NonoperatingIncomeExpense_mtCzfVq_zZcwckJA0qgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other (income) / expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23517">5,557</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23518">20,169</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23519">275,834</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23520">1,557,989</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCziWz_maCzS5G_z9BMLO05RMO2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23521">1,812,835</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23522">1,279,304</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23523">5,268,939</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23524">6,066,893</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FranchiseTaxesRefund_z9rVE1sqU9fk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Franchise
    taxes / (refund)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:FranchiseTaxesRefund" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23525">1,380</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1168">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:FranchiseTaxesRefund" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23526">1,342</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:FranchiseTaxesRefund" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23527">300</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_iT_mtCzS5G_zfBAtSb8MdP8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td><td style="text-align: justify; padding-bottom: 2.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23528">1,814,215</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="text-align: justify; padding-bottom: 2.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23529">1,279,304</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="text-align: justify; padding-bottom: 2.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23530">5,270,281</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="text-align: justify; padding-bottom: 2.5pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23531">6,067,193</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--NetLossPerShareBasicAndDiluted_zIXZPEmwM6H8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss per share (basic and diluted)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23532">0.26</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23533">0.19</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23534">0.77</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23535">1.03</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zEOtWdUWvfK5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average number of
    common shares outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23536">6,910,717</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23537">6,802,464</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23538">6,878,737</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23539">5,913,763</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral
part of these financial statements</span></p>

<p style="margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 127 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360 Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_009"></span>Statements of Stockholders&#8217;
Equity (Deficit) for Nine Months ended September 30, 2023 and 2022 (Unaudited)</b></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_114_z9HYAG5HFQOh" summary="xdx: Statement - Statements of Stockholders Equity (Deficit) (Unaudited)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z54mdiMYHQGf" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zVnRDnybuu4h" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zEKy4zNXwaJa" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" id="xdx_4BD_z7GNlYD3nYA7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock</span></td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Paid-in</span></td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated</span></td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Stock-holders&#8217; Equity</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td>
<td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</span></td>
<td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Deficit)</span></td></tr>
<tr id="xdx_43C_c20220101__20220331_eus-gaap--StockholdersEquity_iS_ziIT06W5VKP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; width: 35%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8REYsZKM61f" title="Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23540">4,300,000</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23541">4,300</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23542">8,355,140</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23543">6,102,951</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23544">2,256,489</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_zvT9DrCU3Kxl" style="vertical-align: bottom; background-color: White">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1194">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1195">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23545">696,853</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23546">696,853</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_431_c20220401__20220630_eus-gaap--StockholdersEquity_iS_zrPoloXXcG6j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at March 31, 2022</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0KnYWECOrOh" title="Beginning Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23547">4,300,000</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23548">4,300</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23549">8,355,140</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23550">6,799,804</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23551">1,559,636</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zIWRM4qZDpj7" style="vertical-align: bottom; background-color: White">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of shares, net of issuance costs</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMoHCSm301o2" title="Issuance of shares, net of issuance costs" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23552">2,466,750</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23553">2,466</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23554">14,770,021</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1208">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23555">14,772,487</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zTHPvBpVRHB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of shares in exchange for IPO services</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zS41uVSItp6" title="Issuance of shares in exchange for IPO services" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23556">35,714</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23557">36</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23558">36</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1215">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1216">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zGQYKWaGJMC5" style="vertical-align: bottom; background-color: White">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of stock options</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1220">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23559">2,114,529</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1222">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23560">2,114,529</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLoss_zwodP7qEKDB5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1225">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1226">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23561">4,091,036</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23562">4,091,036</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_43A_c20220701__20220930_eus-gaap--StockholdersEquity_iS_zKHz72iw3zog" style="vertical-align: bottom; background-color: White">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at June 30, 2022</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znc4kJHykBYi" title="Beginning Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23563">6,802,464</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23564">6,802</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23565">25,239,654</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23566">10,890,840</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23567">14,355,616</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--NetIncomeLoss_z1B2Zy9mXeD6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1238">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23568">1,279,304</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23569">1,279,304</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_43E_c20220701__20220930_eus-gaap--StockholdersEquity_iE_zEFnQy622zWi" style="vertical-align: bottom; background-color: White">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at September 30, 2022</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_98B_eus-gaap--SharesOutstanding_iE_c20220701__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb3uwetRoCFi" title="Ending balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23570">6,802,464</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23571">6,802</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23572">25,239,654</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23573">12,170,144</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23574">13,076,312</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43E_c20230101__20230331_eus-gaap--StockholdersEquity_iS_zHukc2HN6kRk" style="vertical-align: bottom; background-color: White">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2022</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqTpX1r3VEGd" title="Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23575">6,802,464</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23576">6,802</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23577">25,239,654</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23578">13,639,491</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23579">11,606,965</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--ProceedsReceivedFromExerciseOfWarrants_zoyhKgD3eX9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds received from exercise of warrants</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_988_ecustom--ProceedsReceivedFromExerciseOfWarrantsShares_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb3ONBeBv64a" title="Proceeds received from exercise of warrants" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:ProceedsReceivedFromExerciseOfWarrantsShares" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23580">46,102</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:ProceedsReceivedFromExerciseOfWarrants" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23581">47</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:ProceedsReceivedFromExerciseOfWarrants" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23582">49,740</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1258">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:ProceedsReceivedFromExerciseOfWarrants" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23583">49,787</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueOther_zCv5eQkCN6ob" style="vertical-align: bottom; background-color: White">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock issued as a result of litigation settlement</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_985_ecustom--StockIssuedAsResultOfLitigationSettlementShares_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z14lfWQvX04g" title="Stock issued as a result of litigation settlement" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:StockIssuedAsResultOfLitigationSettlementShares" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23584">52,000</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23585">52</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23586">251,628</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1265">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23587">251,680</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--NetIncomeLoss_zzwYtABifk35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1270">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1271">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23588">1,977,278</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23589">1,977,278</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_43F_c20230401__20230630_eus-gaap--StockholdersEquity_iS_zGyg8RvixzXh" style="vertical-align: bottom; background-color: White">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at March 31, 2023</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zodu2KNvHJSd" title="Beginning Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23590">6,900,566</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23591">6,901</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23592">25,541,022</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23593">15,616,769</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23594">9,931,154</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--UndistributedEarningsDiluted_zX0oprmTquQc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise of warrants</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_98B_ecustom--ExerciseOfWarrantsShares_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zx9VLf79I9Mk" title="Exercise of warrants" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:ExerciseOfWarrantsShares" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23595">10,151</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:UndistributedEarningsDiluted" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23596">10</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:UndistributedEarningsDiluted" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23597">20</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1284">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:UndistributedEarningsDiluted" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23598">10</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_40F_eus-gaap--NetIncomeLoss_zsWWRmXxeWz6" style="vertical-align: bottom; background-color: White">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1289">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1290">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23599">1,478,788</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23600">1,478,788</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_43F_c20230701__20230930_eus-gaap--StockholdersEquity_iS_zB6s5hwD0tvh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at June 30, 2023</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zi58uQyVfL1a" title="Beginning Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23601">6,910,717</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23602">6,911</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23603">25,541,002</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23604">17,095,557</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23605">8,452,356</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--IssuanceOfWarrants_zHO4J1D3wKmc" style="vertical-align: bottom; background-color: White">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of warrants</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1301">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:IssuanceOfWarrants" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23606">65,046</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1303">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:IssuanceOfWarrants" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23607">65,046</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zzWpIG8my8ye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of stock options</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1306">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23608">119,525</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1308">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23609">119,525</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--IssuanceOfRestrictedStockUnit_zALBjRPSZhxj" style="vertical-align: bottom; background-color: White">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of RSUs</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1311">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:IssuanceOfRestrictedStockUnit" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23610">5,260</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1313">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:IssuanceOfRestrictedStockUnit" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23611">5,260</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLoss_zk5UtYXEl2ji" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1316">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1317">&#8212;</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23612">1,814,215</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23613">1,814,215</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_438_c20230701__20230930_eus-gaap--StockholdersEquity_iE_zYX4bCOG7xK9" style="vertical-align: bottom; background-color: White">
<td style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at September 30, 2023</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEtsphP0LjVc" title="Ending balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23614">6,910,717</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23615">6,911</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23616">25,730,833</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23617">18,909,772</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23618">6,827,972</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral
part of these financial statements</span></p>

<p style="margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 128 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_010"></span>Expion360 Inc.<br/>
Statements of Cash Flows (Unaudited)</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_112_zzXc3LyL9oR7" summary="xdx: Statement - Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_491_20230101__20230930_zzrrPdhHIrAi" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_499_20220101__20220930_z7mol2tM53E5" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Nine Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zAw16IuWFfBa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>Cash flows&#160;from operating activities</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01N_di_msCzHqD_zUxj7DBvS9K" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23619">5,270,281</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23620">6,067,193</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zAstYFrVlGOk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments to reconcile net
    loss to net cash provided by (used in) operating activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--Depreciation_i01_maCzHqD_zSUPktiFWx7h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23621">153,714</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23622">115,670</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--AmortizationOfDebtDiscountSaleOfFutureRevenues_i01_maCzHqD_zQy6384YaPf7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of debt discount (sale of future revenues)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1340">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23623">295</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AmortizationOfDebtDiscountPremium_i01_maCzHqD_zoo7RkgAPk0d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of debt discount - notes</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1343">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23624">1,196,843</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--GainLossOnDispositionOfAssets1_i01_z4aEzccwyAJe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Gain)
    / Loss on sale of property and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23625">3,426</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23626">13,312</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInAllowanceForDoubtfulAccounts_i01N_di_msCzHqD_zo5KeOCS5MU5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    / (Decrease) in allowance for doubtful accounts</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:IncreaseDecreaseInAllowanceForDoubtfulAccounts" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23627">18,804</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:IncreaseDecreaseInAllowanceForDoubtfulAccounts" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23628">19,604</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--GainLossRelatedToLitigationSettlement_i01N_di_msCzHqD_zRMsYrBAeUGi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
    settlement</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23629">251,680</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1353">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AllocatedShareBasedCompensationExpense_i01_maCzHqD_zTACSeNyZ4wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23630">189,831</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23631">2,114,529</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zW9ObndCyxni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in operating assets
    and liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01_zzFYYcNAtFV1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Increase)
    / Decrease in accounts receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23632">156,445</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23633">475,091</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInInventories_i01_zp3DtMMEp6y9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Increase)
    / Decrease in inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23634">371,653</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23635">2,984,177</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01_zoEQqTe5rdO8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease
    in prepaid/in-transit inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23636">38,964</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23637">812,562</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i01N_di_msCzHqD_zJLzDa5fZ1R9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in prepaid expenses and other current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23638">45,759</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23639">134,191</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInDeposits_i01_z6uS4UKb9eZ9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Increase)
    / Decrease in deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeposits" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23640">5,005</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeposits" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23641">10,976</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_zFh98quPG5Ll" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    / (Decrease) in accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23642">206,986</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23643">87,369</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherDeposits_i01_maCzHqD_zvMAGtdVTcb5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    / (Decrease) in customer deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherDeposits" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23644">46,190</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherDeposits" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23645">274,857</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_i01_maCzHqD_zxbfBhoz8sO1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    / (Decrease) in accrued expenses and other current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23646">6,371</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23647">107,407</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--IncreaseInRightofuseAssetsAndLeaseLiabilities_i01_maCzHqD_zYmJBm14HCph" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in right-of-use assets and lease liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23648">22,494</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23649">30,454</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01_mtCzHqD_maCzuHK_zLGLu0Bd5tic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash used in operating
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23650">4,207,717</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23651">4,699,620</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z7kbNdbH3mFf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows from investing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_iN_di_msCzoln_zf1impsGAlFj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
    of property and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23652">20,170</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23653">434,458</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PaymentsForProceedsFromProductiveAssets_msCzoln_z75uWxiWk2P8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    proceeds from sale of property and equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PaymentsForProceedsFromProductiveAssets" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23654">36,748</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PaymentsForProceedsFromProductiveAssets" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23655">51,679</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivities_mtCzoln_maCzuHK_zzh83w5HIcka" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash provided by / (used
    in) investing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23656">16,578</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23657">382,779</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zjUUbJ4STZIf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows from financing
    activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--PaymentsOnLineofcreditAndShorttermRevolvingLoans_maCzH86_zPPAbwgW1W2k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
    on line-of-credit and short-term revolving loans</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1406">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:PaymentsOnLineofcreditAndShorttermRevolvingLoans" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23658">550,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_ecustom--PaymentsOnLiabilityForSaleOfFutureRevenues_maCzH86_zqm7KGcwhaze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
    on liability for sale of future revenues</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1409">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:PaymentsOnLiabilityForSaleOfFutureRevenues" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23659">11,797</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--RepaymentsOfLongTermDebt_iN_di_msCzH86_zWFIV5Jdi2Lg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    payments on long-term debt</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23660">148,986</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23661">1,784,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromWarrantExercises_maCzH86_z22gvsCi7zul" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net proceeds
    from exercise of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23662">49,777</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1416">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromIssuanceOfCommonStock_maCzH86_zLYGQxC882gd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    proceeds from issuance of common stock</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1418">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23663">14,772,487</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivities_mtCzH86_maCzuHK_zHJicoXH2Uv" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash provided by / (used
    in) financing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23664">99,209</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23665">12,426,190</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_mtCzuHK_zNydAQmtkAUj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net change in cash and cash
    equivalents</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23666">4,290,348</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23667">7,343,791</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zyNL9oJl7BSc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents, beginning</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23668">7,201,244</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23669">773,238</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zHISciOFoYza" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents, ending</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23670">2,910,896</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23671">8,117,029</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 129 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expion360 Inc.</b></span></p>

<p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of Cash
Flows (Unaudited) - Continued</b></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the Nine Months Ended September 30,</span></td></tr>
  <tr id="xdx_400_eus-gaap--SupplementalCashFlowElementsAbstract_iB_zzhzts1Ffkhb" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
    disclosure of cash flow information:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaid_zAAK8hrZCJkh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash paid for
    interest</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23672">92,136</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23673">401,037</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--CashPaidRefundedForFranchiseTaxes_zltMaE3RoFd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash paid / (refunded) for
    franchise taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:CashPaidRefundedForFranchiseTaxes" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23674">1,341</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:CashPaidRefundedForFranchiseTaxes" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23675">300</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherNoncashInvestingAndFinancingItemsAbstract_iB_zsNGi6X0AKdg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability_z3XLQIulKg2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition/modification
    of operating lease right-of-use asset and lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23676">13,993</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23677">2,348,509</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--CashlessWarrantExercises_zHr0QruwrfQa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless
    warrant exercises</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:CashlessWarrantExercises" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23678">41</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1449">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt_z85Uo8tQ9n2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
    of property and equipment in exchange for long-term debt</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1451">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23679">181,430</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable_zghb1b5IbnXj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased
    of property and equipment in exchange for short-term payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1454">&#8212;</span>&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23680">170,863</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral
part of these financial statements</span></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 130 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_011"></span>&#160;</b></span></p>

<p id="xdx_04E_c20230101__20230930_zj8hvGP4uyTk" style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:NatureOfOperations" id="ixv-17269"><p id="xdx_80F_eus-gaap--NatureOfOperations_znCNF2sT6TAa" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <span id="xdx_82E_zqxf4vA7YzK7">Organization
and Nature of Operations</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360
Inc. (formerly Yozamp Products Company, LLC dba Expion360) (&#8220;the Company&#8221;) was incorporated in the state of Nevada in November
2021. Effective November 1, 2021, the Company converted to a C corporation. Prior to conversion, the Company was a limited liability
company (LLC) with an indefinite life organized in the State of Oregon in June 2016. The LLC elected to be treated as a Subchapter S
corporation effective January 1, 2017. Net profits and losses of the LLC and all distributions were allocated among the members in proportion
to the ownership units held. The Original LLC Agreement was amended and restated on January 1, 2021 to add additional members and a non-voting
class of member units. Upon conversion to a C corporation, all existing LLC members at the time of conversion were issued shares of common
stock and became stockholders of the Company.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company designs, assembles, and distributes premium lithium batteries for RV, Marine, Golf, Industrial, Residential, and Off-The-Grid
needs. The Company uses lithium iron phosphate (LiFePO4) batteries. LiFePO4 batteries are considered a top choice for high energy density,
dependability, longevity, and safety, providing the ability to power anything, anywhere.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in March 2020, the COVID-19 pandemic and the measures imposed to contain this pandemic disrupted and may continue to impact the Company&#8217;s
business. While certain restrictions have eased recently, the magnitude of the impact of any new measures from a resurgence in the COVID-19
pandemic on the Company&#8217;s productivity, results of operations, and financial position, and its disruption to the Company&#8217;s
business and battery development and timeline will depend in part on the length and severity of these restrictions and on the Company&#8217;s
ability to conduct business in the ordinary course.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-17287"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zHPJaxbFW8ob" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <span id="xdx_82F_zy6UdrppacW6">Summary
of Significant Accounting Policies</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-17293"><p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgJ63UfhQ0tb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zznQ4gIlN0Nb">Basis of Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
results for the three- and nine-month periods ended September 30, 2023 and 2022 are not necessarily indicative of the results that may
be expected for the year ending December 31, 2023. The unaudited interim financial statements should be read in conjunction with our
Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 30, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, all references to shares and stockholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="ixv-17312"><p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziT5dCht3uFk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zOHKhw3PteE6">Reclassification
of Prior Year Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:LiquidityAndCapitalResourcesPolicyTextBlock" id="ixv-17323"><p id="xdx_847_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zpNgy4pYKooc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;<span id="xdx_863_z8gMJVTa1XI3">Going Concern,
Liquidity and Capital Resources</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 131 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As presented in the
accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations. These factors
raise substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the date that
the financial statements for the three and nine month periods ended September 30, 2023 are issued. However, management is working
to address its cash flow challenges, including raising additional capital, managing inventory levels, identifying alternative supply
chain resources, and managing operational expenses.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Historically, the
Company&#8217;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#8217;s sales for the three months ended September 30, 2023 increased 36.7% and sales for the nine months ended
September 30, 2023 decreased 10.8% compared to the same periods in 2022. For the nine months ended September 30, 2023, we received
net proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930_zTQpfpO0wX0e" title="Net proceeds from Warrants"><ix:nonFraction name="us-gaap:ProceedsFromRepurchaseOfEquity" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23681">49,777</ix:nonFraction></span> from warrant exercises. On April 1, 2022, the Company completed an initial public offering and listing
of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of costs, totaled $14,772,487, of which approximately
$2,464,000 was used to pay down principal and accrued interest on high interest-bearing debt. The remaining proceeds have thus
far and will continue to be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines&#160;to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in
China. In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S.
and an assembly facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management
has secured a secondary source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption
issues with China arise. Management believes that these factors will contribute to achieving operating efficiency and profitability.
However, there can be no assurance that the Company will be successful in achieving its objectives, including achieving operating
efficiency and profitability.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#8217;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:UseOfEstimates" id="ixv-17356"><p id="xdx_840_eus-gaap--UseOfEstimates_zANTPXXkTLag" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z1k09Z9f0CFj">Use of Estimates</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#8217;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#8217;s accounting estimates require the exercise of judgment.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-17371"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zM1t2IcH1W45" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zHFji1q7K1Hc">Cash and Cash
Equivalents</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Cash accounts are secured by the Federal Deposit Insurance Corporation
(&#8220;FDIC&#8221;) up to $250,000 per institution. At times, balances may exceed federally insured limits. Investment accounts are
placed in funds consisting of US Treasury-related ultra-short paper. The Company has not experienced any losses in such accounts and
management believes that the Company is not exposed to any significant credit risk with respect to its cash and cash equivalents. As
of September 30, 2023, cash balances exceeded FDIC limits by $<span id="xdx_900_eus-gaap--FDICIndemnificationAssetPeriodIncreaseDecrease_c20230101__20230930_zDrWcHx38j4c" title="FDIC Limits"><ix:nonFraction name="us-gaap:FDICIndemnificationAssetPeriodIncreaseDecrease" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23682">547,054</ix:nonFraction></span> and investment accounts totaling $<span id="xdx_902_ecustom--TreasuryRelatedPaper_c20230101__20230930_zdNTbYrQulzj" title="Treasury related paper"><ix:nonFraction name="XPON:TreasuryRelatedPaper" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23683">2,100,847</ix:nonFraction></span> are invested in US
Treasury-related ultra-short paper.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ReceivablesPolicyTextBlock" id="ixv-17391"><p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zg3CV4xsKrFl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zQx8Pw8Ksx8a">Accounts Receivable</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any
interest. The Company performs ongoing credit evaluations of its customers and generally requires no collateral. An allowance for
uncollectible accounts is recorded to reduce accounts receivable to the estimated amount that will be collected. The allowance
is based upon management&#8217;s review of the accounts receivable aging and specific identification of potentially uncollectible
balances. Recoveries of accounts previously written off and adjustments to the allowance for uncollectible accounts are recorded
as adjustments to bad debt expense. For the three months ended September 30, 2023 and 2022, the Company wrote off $<span id="xdx_902_ecustom--AdjustmentsToBadDebtExpense_c20230701__20230930_zhMWY4H08Hn1" title="Adjustments to bad debt expense"><ix:nonFraction name="XPON:AdjustmentsToBadDebtExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23684">388</ix:nonFraction></span> and $<span id="xdx_901_ecustom--AdjustmentsToBadDebtExpense_c20220701__20220930_zDdBmfX45atg" title="Adjustments to BadDebt Expense"><ix:nonFraction name="XPON:AdjustmentsToBadDebtExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23685">0</ix:nonFraction></span>,
respectively. For the nine months ended September 30, 2023 and 2022, the Company recovered a net of ($<span id="xdx_907_ecustom--AdjustmentsToBadDebtExpense_c20230101__20230930_zPJnfsusliMk" title="Adjustments to BadDebt Expense"><ix:nonFraction name="XPON:AdjustmentsToBadDebtExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23686">412</ix:nonFraction></span>) and wrote off $<span id="xdx_90E_ecustom--AdjustmentsToBadDebtExpense_c20220101__20220930_zBP1XuFjh8ql" title="Adjustments to BadDebt Expense"><ix:nonFraction name="XPON:AdjustmentsToBadDebtExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23687">19,604</ix:nonFraction></span>,
respectively. There was no allowance for doubtful accounts as of September 30, 2023 or December 31, 2022, as management believed
all outstanding amounts to be fully collectible.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:CustomerDepositsPolicyTextBlock" id="ixv-17406"><p id="xdx_841_ecustom--CustomerDepositsPolicyTextBlock_zNL2oEnKFQp7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z7xVitSlvKK5">Customer Deposits</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023 and December 31, 2022, the Company had customer deposits totaling $<span id="xdx_90F_eus-gaap--CustomerDepositsCurrent_iI_c20230930_zcJaJUhl5srd" title="Customer deposits"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23688">46,248</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--CustomerDepositsCurrent_iI_c20221231_zXlNpb7xgH27"><ix:nonFraction name="us-gaap:CustomerDepositsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23689">58</ix:nonFraction></span>, respectively.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:InventoryPolicyTextBlock" id="ixv-17419"><p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_z1GJZfvW8of1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zkDwjVdRHtk2">Inventory</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and
accessories, resale items, components, and related landing costs. As of September 30, 2023 and December 31, 2022, the Company had
inventory that consisted of finished assemblies&#160;totaling $<span id="xdx_904_eus-gaap--InventoryFinishedGoods_iI_c20230930_zVVqLoTHmu1" title="Finished Inventory"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23690">3,306,972</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--InventoryFinishedGoods_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zd3owKutQuS6"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23691">3,243,485</ix:nonFraction></span>, respectively, and raw materials (inventory
components, parts, and packaging) totaling $<span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20230930_zo57vJqNtxf4" title="Raw materials"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23692">851,511</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--InventoryRawMaterials_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zbJsGW95Todg"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23693">1,286,651</ix:nonFraction></span>, respectively. The valuation of inventory includes fixed production
overhead costs based on normal capacity of the assembly warehouse. &#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of September 30, 2023 or December 31, 2022. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $<span id="xdx_90F_eus-gaap--Supplies_iI_c20230930_zwDUndQS8Tof" title="Inventory purchases from foreign suppliers"><ix:nonFraction name="us-gaap:Supplies" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23694">102,646</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--Supplies_iI_c20221231_zFz97mIRGusc"><ix:nonFraction name="us-gaap:Supplies" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23695">141,611</ix:nonFraction></span> at September 30, 2023 and December 31,
2022, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" id="ixv-17440"><p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zSVrJSTrujuf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zuyyMUkC9sUk">Vendor and Foreign
Concentrations of Inventory Suppliers</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">During the three
months ended September 30, 2023 and 2022, respectively, approximately 61% and 91%, respectively, of inventory purchases were made
from foreign suppliers in China and Hong Kong. During the nine months ended September 30, 2023 and 2022, respectively, approximately
71% and 92%, respectively, of inventory purchases were made from foreign suppliers in China and Hong Kong. Any adverse change in
either the economic or political conditions abroad could negatively impact the Company&#8217;s supply chain. The inability to obtain
product to meet sales demand could adversely affect results of operations. However, the Company has secured a secondary source
for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company to source materials outside
of China in the event it becomes necessary to do so.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 133 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-17460"><p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zl6mWGf2skuf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zvBO0PDWsi3f">Property and Equipment</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:ScheduleOfEstimatedUsefulLivesTableTextBlock" id="ixv-17469"><p id="xdx_897_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zuXw7FtPdsIg" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zV5v1ps7r6D2" style="display: none">Schedule of estimated useful lives</span></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-top: black 1pt solid; padding: 0 0 0 10pt; width: 73%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZV5XzKnP4tg"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23696">5</ix:nonNumeric></span>
    - <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zpOXQnsnhsSd"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23697">7</ix:nonNumeric></span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zuIIeEWpXLRd"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_OfficeFurnitureAndEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23698">3</ix:nonNumeric></span> - <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember_zp71G5Uph898"><ix:nonNumeric contextRef="AsOf2023-09-30_srt_MaximumMember_custom_OfficeFurnitureAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23699">7</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zVhJtgsDPtx3"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23700">3</ix:nonNumeric></span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_z2aU44dnTkoh"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23701">10</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember__srt--RangeAxis__srt--MinimumMember_z7IJ1jOnBH4i"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_WarehouseEequipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23702">3</ix:nonNumeric></span> - <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember_zGVSRvGMW8yb"><ix:nonNumeric contextRef="AsOf2023-09-30_srt_MaximumMember_custom_WarehouseEequipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23703">10</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zcl7qmHKALgc"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_ToolingAndMoldsMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23704">3</ix:nonNumeric></span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zHwntN1vxfZ"><ix:nonNumeric contextRef="AsOf2023-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23705">10</ix:nonNumeric></span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4KW4plU2Hag"><ix:nonNumeric contextRef="AsOf2023-09-30_custom_QAEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23706">3</ix:nonNumeric></span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_ztN4onwQ4D17"><ix:nonNumeric contextRef="AsOf2023-09-30_srt_MaximumMember_custom_QAEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-23707">10</ix:nonNumeric></span> years&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_z62Oyv4K3jEj" style="margin: 0; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements
are amortized over the shorter of the lease term or their estimated useful lives.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable to assets retired are removed from the accounts,
and the gain or loss on disposition is recognized in the Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-17550"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zmsaz761uy13" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z2uhXnc33Ek8">Leases</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s
right to use an underlying asset during the lease term, and operating lease liabilities represent</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company&#8217;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease liabilities,
and long-term operating lease liabilities on the Company&#8217;s Balance Sheets. The Company does not have any finance leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments
over the lease term at commencement date calculated using the Company&#8217;s incremental borrowing rate applicable to the
lease asset, unless the implicit rate is readily determinable. ROU assets also include any lease payments made at or before
lease commencement and exclude any lease incentives received. The Company&#8217;s lease terms may include options to extend
or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12
months or less are not recognized on the Company&#8217;s Balance Sheet. The Company&#8217;s leases do not contain any
residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease
term.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for lease and non-lease components as a single lease component for all its leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="ixv-17571"><p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHZVlaRWukAi" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z3GfuMPhmwmd">Impairment of
Long-Lived Assets</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">Long-lived assets
consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the
asset to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted
cash flows, the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value.
Fair value is determined primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No
long-lived asset impairment was recognized during the three or nine months ended September 30, 2023 or 2022.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ExtendedProductWarrantyPolicy" id="ixv-17583"><p id="xdx_847_eus-gaap--ExtendedProductWarrantyPolicy_zyXGEm02mcJ7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_z8MAFVzfacCg">Product Warranties</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">The Company sells
the majority of its products to customers along with conditional repair or replacement warranties. The Company&#8217;s branded
DC mobile chargers are warrantied for two years from the date of sale and its branded VPR 4EVER Classic and Platinum batteries
are warrantied at gradually lesser levels over a twelve-year period from date of sale. The Company determines its estimated liability
for warranty claims based on the Company&#8217;s experience of the amount of claims actually made. Management estimates no liability
as of September 30, 2023 and December 31, 2022 because, historically, there have been very few claims and costs for repairs&#160;or
replacement parts have been nominal. It is possible that the Company&#8217;s estimate of liability for product liability claims
will change in the near term.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 134 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:LiabilityForRefundsPolicyTextBlock" id="ixv-17603"><p id="xdx_846_ecustom--LiabilityForRefundsPolicyTextBlock_zmaN7OQCgBK3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zJX7B0uqI7R9">Liability for
Refunds</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company does
not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-17615"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zaieuIHfl2p" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zRUXrxLYomUc">Revenue Recognition</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#8217;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#8217;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-17626"><p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zic28ONNMc66" style="margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zVF3VNW0l4w1">Concentration of Major Customers</span></i></span></p>

<p style="margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2023, sales to three customers totaled $700,071, comprising approximately 38% of total sales. These
customers represented 31% of total accounts receivable as of September 30, 2023. During the nine months ended September 30, 2023, sales
to two customers totaled $1,178,142, comprising approximately 23% of total sales. These customers represented 23% of total accounts receivable
as of September 30, 2023. Accounts receivable from three additional customers totaled $190,495, representing approximately 40% of accounts
receivable as of September 30, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During the
three months ended September 30, 2022, sales to two customers totaled $394,936, comprising approximately 28% of total sales. There
were no accounts receivable for these customers as of September 30, 2022. During the nine months ended September 30, 2022, sales
to two customers totaled $1,816,821, comprising approximately 32% of total sales. Accounts receivables for these customers totaled
$7,486, representing approximately 3% of total accounts receivable as of September 30, 2022. Accounts receivable from two additional
customers totaled $90,789, representing approximately 32% of total accounts receivables as of September 30, 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ShippingAndHandlingCostPolicyTextBlock" id="ixv-17645"><p id="xdx_848_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zTFf5ClWxhW8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zrgvvuszgBz">Shipping and Handling
Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">Shipping and handling
fees billed to customers are classified in&#160;the Statement of Operations in &#8220;Sales, net&#8221; and totaled $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230701__20230930_zYxhpTQflxFl" title="Shipping and handling fee"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23708">27,398</ix:nonFraction></span> and
$<span id="xdx_90B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220701__20220930_zCjQcgfDGpHi" title="Shipping and handling fee"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23709">6,133</ix:nonFraction></span> during the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_903_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230101__20230930_z0NAnTn3OiP4" title="Shipping and handling fee"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23710">52,296</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220101__20220930_zae99EQTdkpj" title="Shipping and handling fee"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23711">17,514</ix:nonFraction></span> during the nine months
ended September 30, 2023 and 2022, respectively. Shipping and handling costs for shipping product to customers totaled $<span id="xdx_906_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230701__20230930_zIZVrwz7Nox7" title="Shipping and handling costs for shipping product"><ix:nonFraction name="XPON:ShippingAndHandlingCostsForShippingProduct" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23712">58,141</ix:nonFraction></span>
and $<span id="xdx_901_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220701__20220930_zzteob8JfWW5" title="Shipping and Handling Costs for Shipping Product"><ix:nonFraction name="XPON:ShippingAndHandlingCostsForShippingProduct" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23713">54,840</ix:nonFraction></span> during the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_903_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230101__20230930_zvZPFMRMfkvg" title="Shipping and Handling Costs for Shipping Product"><ix:nonFraction name="XPON:ShippingAndHandlingCostsForShippingProduct" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23714">149,898</ix:nonFraction></span> and $<span id="xdx_902_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220101__20220930_z2w0cryYMxY2" title="Shipping and Handling Costs for Shipping Product"><ix:nonFraction name="XPON:ShippingAndHandlingCostsForShippingProduct" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23715">137,497</ix:nonFraction></span> during the nine
months ended September 30, 2023 and 2022, respectively, and are classified in selling, general, and administrative expense in the
accompanying Statements of Operations.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="ixv-17665"><p id="xdx_84C_eus-gaap--AdvertisingCostsPolicyTextBlock_zOgCRPqN9Duh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_z4X1Bsn8YSB6">Advertising and
Marketing Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20230701__20230930_zzpF76DA7O77" title="Advertising and marketing expense"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23716">238,163</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--MarketingAndAdvertisingExpense_c20220701__20220930_zoBYJRoRQ5Lf"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23717">215,994</ix:nonFraction></span> for the
three months ended September 30, 2023 and 2022, respectively and $<span id="xdx_90D_eus-gaap--MarketingAndAdvertisingExpense_c20230101__20230930_zfKEXxxy4Nce"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23718">690,995</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20220930_zbmh9L1WX0X1"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23719">527,732</ix:nonFraction></span> for the nine months ended September 30, 2023 and
2022, respectively, and is included in selling, general and administrative expense in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 135 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-17688"><p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu2zb5uSlDg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zIsTtfCV2Ls7">Research and Development</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20230701__20230930_z6QXmy9izALb" title="Research and development costs"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23720">145,111</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20220701__20220930_z8JZXu7QYOe9"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23721">41,355</ix:nonFraction></span> for
the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20230930_zLLzALUAO4wj"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23722">316,369</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20220930_zdrgDWnumJzi"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23723">153,730</ix:nonFraction></span> for the nine months ended September 30, 2023
and 2022, respectively, and are included in selling, general and administrative expenses in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-17703"><p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z5amL6LL3PC4" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zfT5BlKB4KE4">Income Taxes</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
November 1, 2021, the Company converted from an LLC to a C corporation and, as a result, became subject to corporate federal and state
income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including
tax loss and credit carryforwards, and liabilities are measured using the enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that included the enactment date. Deferred income tax expense represents
the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation
allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not
be realized.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of September 30, 2023 and December 31, 2022, the Company has not recorded any income tax
provision/(benefit) resulting from the CARES Act, mainly due to the Company&#8217;s history of net operating losses.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2023 and beyond.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-17722"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zV7PliosUCK6" style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_86F_z0q4RC6OBOsi">Fair Value of Financial Instruments</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, <i>Fair Value Measurement</i>. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1: </i>Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2: </i>Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3: </i>Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 136 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, stockholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the stockholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="ixv-17759"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z9J2A90KyAB1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zXdAiAjaTVfh">Segment Reporting</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-17770"><p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zcjAReRD1ima" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z1ojxA7cbqU7">Basic and Diluted
Net Loss Per Share</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shows the amounts used in computing net loss per share:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-17787"><p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zePybWaSuLEg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zQX2EFnNMBN3" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zvweiPURMUYg" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_493_20230701__20230930_zFiW3vb3LjVh" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220701__20220930_z75Hf7GwhZ0a" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20230101__20230930_zwhv0JvhSnll" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20220930_zeHqbQ6AOtlj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended September 30,</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_40E_ecustom--NetLossOne_ziztUNeD3Qo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossOne" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23724">1,814,215</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossOne" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23725">1,279,304</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossOne" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23726">5,270,281</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossOne" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-23727">6,067,193</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zwxiOedMoiLd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average common shares outstanding &#8211; basic and diluted</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23728">6,910,717</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23729">6,802,464</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23730">6,878,737</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:WeightedaverageNumberOfCommonSharesOutstanding" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23731">5,913,763</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--NetLossPerShareBasicAndDiluted_z1yj24NP6Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23732">0.26</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23733">0.19</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23734">0.77</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="XPON:NetLossPerShareBasicAndDiluted" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-23735">1.03</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zhji71lzjJIj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt">As
of September 30, 2023 and December 31, 2022, the Company has outstanding warrants, options, and restricted stock units (&#8220;RSUs&#8221;)
convertible into 1,926,610&#160;and 1,717,936 shares of common stock, respectively. The following table sets forth the number of
shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive.</p>



<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-17946"><p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zyoB77o7qJjh" style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zZmAWA3vVak8" style="display: none">Schedule
of anti-dilutive share</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_z0ucSeAjt4h3" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Warrants</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zUlM0wcirv51" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23736">802,830</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zT3f4cQ55Eul" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23737">888,436</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8RJRSgh28M1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23738">1,075,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQoUblAc9nu1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23739">829,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_z6xhWsB6cwAe" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_custom_RSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23740">48,780</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_ziAg5Zah8Nad" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1596">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930_zJ2ZxiTDCpT3" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23741">1,926,610</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zOAG9Jemb06g" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23742">1,717,936</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zzG6p9PN8rl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 137 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="ixv-18050"><p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zknouLL4YS84" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zyjXuR8kfUwb">Stock-Based Compensation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-18068"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK2ONxRis2ni" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zjomQiUVvQp2">New Accounting
Pronouncements</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#8221; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#8217;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the
Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#8221; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#8220;CECL&#8221;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have <i>not</i> yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company adopted this standard effective January 1, 2023, and the adoption of
this guidance did not have an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#8221; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the Company&#8217;s
financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have
an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 138 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" id="ixv-18099"><p id="xdx_84A_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zSnM0CB4zkV8" style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_860_zUd0W7Zv5zQf">Accounting Guidance Issued
but Not Yet Adopted</span></i>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the FASB issued ASU 2023-02, &#8220;Investments&#8212;Equity Method and Joint Ventures (Topic 323): Accounting for Investments
in Tax Credit Structures Using the Proportional Amortization Method.&#8221; This ASU was issued to allow reporting entities to consistently
account for equity investments made primarily for the purpose of receiving income tax credits and other income tax benefits. ASU 2023-02
is effective for the Company for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.
The Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, &#8220;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#8221; which amends the guidance in Topic 820, <i>Fair Value Measurement</i>, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-18115"><p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z4GFxnyrfzK7" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<span id="xdx_825_zWG33FeT4426">Property and Equipment, Net</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment
consist of the following:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-18123"><p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zdaIUz23Il85" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_z4Y1xZWpzqea" style="display: none">Schedule of property and equipment</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_134_zOfQ6BgUoqf8" summary="xdx: Disclosure - Property and Equipment, Net (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles and transportation
    equipment</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zmhsxJUgBDNb" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23743">551,906</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zyLFZEgqsNU9" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23744">593,097</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zXagIjEVvhof" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23745">314,819</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zAFW8MlYhu6g" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23746">314,819</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zUUYEEV7yPG" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30_custom_OfficeFurnitureEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23747">188,131</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zFnXkyfj7IGj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_OfficeFurnitureEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23748">188,131</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zdnBMdaZ2bJ" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30_custom_ManufacturingEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23749">179,274</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zBxYP1sx2i43" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23750">179,274</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSUenEwxox74" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30_custom_WarehouseEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23751">81,164</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSR022k9Qzwg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_WarehouseEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23752">81,164</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zaTF3uav4Tcf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30_custom_QAEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23753">33,032</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zWwlDJtq3DMd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_QAEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23754">22,142</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and Molds</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z8fU3Q1peZRk" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1621">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z9cWHbJvWOFd" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_ToolingAndMoldsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23755">15,992</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930_zp1L0wYDBBcb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23756">1,348,326</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zsAJvBmZMx6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23757">1,394,619</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230930_zqrB59mhZ0C" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23758">378,286</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSlyRdJTtSlj" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23759">250,861</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230930_z3Fu8HJbJTc4" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23760">970,040</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zfF1SGzFjrgd" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD" id="ixv-23761">1,143,758</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_za00vqdEvNXe" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Depreciation expense
was $<span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20230701__20230930_zLomK7IhHLHh" title="Depreciation expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23762">50,507</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--DepreciationAndAmortization_c20220701__20220930_zLvA60oLnhs2" title="Depreciation expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23763">48,364</ix:nonFraction></span> for the three months ended September 30, 2023 and 2022, respectively. Depreciation expense was $<span id="xdx_90F_eus-gaap--DepreciationAndAmortization_c20230101__20230930_zzppiBdgjAAh" title="Depreciation expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23764">153,714</ix:nonFraction></span>&#160;and
$<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20220101__20220930_zFPUOMgQcP6h" title="Depreciation expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23765">115,670</ix:nonFraction></span> for the nine months ended September 30, 2023 and 2022, respectively. There were disposals and sales of fixed assets during
the nine months ended September 30, 2023 and 2022 resulting in the net cash received of $<span id="xdx_90E_ecustom--DisposalsAndSalesOfFixedAssets_c20230101__20230930_zrFkVZLDD3Tl" title="Disposals and sales of fixed assets"><ix:nonFraction name="XPON:DisposalsAndSalesOfFixedAssets" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23766">36,748</ix:nonFraction></span> and $<span id="xdx_909_ecustom--DisposalsAndSalesOfFixedAssets_c20220101__20220930_z31xWulygkEj"><ix:nonFraction name="XPON:DisposalsAndSalesOfFixedAssets" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23767">51,679</ix:nonFraction></span>, respectively. &#160;</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="ixv-18374"><p id="xdx_80A_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zRHfi0uWeo6i" style="margin: 0; font-weight: bold; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<span id="xdx_828_zgkKIx4BkOde">Accrued Expenses and Other Current Liabilities</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses
and other current liabilities consist of the following:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="ixv-18382"><p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zk6LTjun6jrc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zdOXwVRN5Wrb" style="display: none">Schedule of accrued expenses and other current liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_134_zvzUAiCUBNYc" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49A_20230930_zQR2rqhREBhf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of September 30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_493_20221231_zgsXy1V5Yusa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2022</span></td></tr>
  <tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zq0jMIv8Urz1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued salaries
    and payroll liabilities</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23768">222,411</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23769">169,337</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--RebateLiability_iI_zUizvKchRVtd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rebate liability</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:RebateLiability" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23770">30,255</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:RebateLiability" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23771">26,015</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_z8sMPuBMufDe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23772">22,534</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23773">9,720</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--FranchiseTax_iI_zOfKItefXA8i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Franchise tax</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:FranchiseTax" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23774">4,999</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:FranchiseTax" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23775">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DeferredIncomeAndDepositSublease_iI_ziHGz8pZebJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income and deposit
    (sublease)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:DeferredIncomeAndDepositSublease" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23776">4,445</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="XPON:DeferredIncomeAndDepositSublease" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23777">14,168</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_zss7oswqOJGk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23778">153</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23779">222</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zkncTLZllNej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23780">14,996</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23781">86,302</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_z972uapb0iC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses and other current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23782">299,793</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23783">306,164</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zZHfzGEsQUH5" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 139 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock" id="ixv-18559"><p id="xdx_802_ecustom--LiabilitiesForSaleOfFutureRevenuesTextBlock_zSCqK8Q4K48j" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<span id="xdx_829_zy5ZbsItla3">Liabilities for Sale of Future Revenues</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">On December 8, 2020
and January 26, 2021, Reliant Funding, under two separate ACH Total Receipts Purchase Agreements (&#8220;Purchase Agreements&#8221;),
purchased a 50% interest in the Company&#8217;s future revenues for a total aggregate purchase price of $250,000. Pursuant to the
terms of the Purchase Agreements, the purchased percentage continued to be owned by Reliant Funding, until the Company paid the
full purchased amount of $349,750. Repayment of the purchased amount was achieved through 252 daily bank account withdrawals of
$1,388 through December 15, 2021 and $694 thereafter through January 26, 2022. There were no payments made in the three months&#160;ended
September 30, 2023 or the same period for 2022. Interest was recognized at an effective annual interest rate of approximately 71%.
The Purchase Agreements were secured by substantially all of the assets of the Company. As of September 30, 2023 and December 31,
2022, the Company had no remaining liability related to the Purchase Agreements.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-18570"><p id="xdx_805_eus-gaap--DebtDisclosureTextBlock_z7OPXUQd1dxb" style="margin: 0; font-weight: bold; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<span id="xdx_82E_zxPcZQgTOMGe">Short-Term Revolving Loans</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2020, the Company received funds under four unsecured Working Capital Loan Agreements (&#8220;WC Loans&#8221;). As of December 31, 2022,
the loans had been repaid and a balance of $0 was outstanding. Under the WC Loan Agreements and in accordance with the modified terms,
the Company was subject to monthly extended maturity interest of one percent on the ending outstanding monthly balance which increased
one percent for each month beyond the extended maturity date. The WC Loans were repaid in full in April 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">The terms of each WC Loan are summarized below:</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">$200,000
                                                                                                                                   limit
                                                                                                                                   &#8211;
                                                                                                                                   dated
                                                                                                                                   March
                                                                                                                                   22,
                                                                                                                                   2020;
                                                                                                                                   monthly
                                                                                                                                   interest-only
                                                                                                                                   payments
                                                                                                                                   at
                                                                                                                                   15%
                                                                                                                                   annual
                                                                                                                                   interest;
                                                                                                                                   principal
                                                                                                                                   due
                                                                                                                                   12
                                                                                                                                   months
                                                                                                                                   from
                                                                                                                                   date
                                                                                                                                   of
                                                                                                                                   issue.
                                                                                                                                   This
                                                                                                                                   note
                                                                                                                                   was
                                                                                                                                   modified
                                                                                                                                   effective
                                                                                                                                   January
                                                                                                                                   1,
                                                                                                                                   2021
                                                                                                                                   to
                                                                                                                                   extend
                                                                                                                                   the
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   to
                                                                                                                                   December
                                                                                                                                   31,
                                                                                                                                   2021.
                                                                                                                                   The
                                                                                                                                   Company
                                                                                                                                   paid
                                                                                                                                   $50,000
                                                                                                                                   towards
                                                                                                                                   the
                                                                                                                                   principal
                                                                                                                                   balance
                                                                                                                                   in
                                                                                                                                   November
                                                                                                                                   2021.
                                                                                                                                   The
                                                                                                                                   balance
                                                                                                                                   of
                                                                                                                                   $150,000
                                                                                                                                   was
                                                                                                                                   paid
                                                                                                                                   in
                                                                                                                                   full
                                                                                                                                   in
                                                                                                                                   April
                                                                                                                                   2022
                                                                                                                                   (see
                                                                                                                                   below).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">$400,000
                                                                                                                                   limit
                                                                                                                                   &#8211;
                                                                                                                                   dated
                                                                                                                                   August
                                                                                                                                   31,
                                                                                                                                   2020;
                                                                                                                                   monthly
                                                                                                                                   interest-only
                                                                                                                                   payments
                                                                                                                                   at
                                                                                                                                   10%
                                                                                                                                   annual
                                                                                                                                   interest;
                                                                                                                                   pursuant
                                                                                                                                   to
                                                                                                                                   the
                                                                                                                                   WC
                                                                                                                                   Loan,
                                                                                                                                   the
                                                                                                                                   maturity
                                                                                                                                   was
                                                                                                                                   to
                                                                                                                                   be
                                                                                                                                   determined
                                                                                                                                   by
                                                                                                                                   mutual
                                                                                                                                   agreement
                                                                                                                                   and
                                                                                                                                   was
                                                                                                                                   to
                                                                                                                                   be
                                                                                                                                   at
                                                                                                                                   least
                                                                                                                                   30
                                                                                                                                   days
                                                                                                                                   after
                                                                                                                                   a
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   is
                                                                                                                                   agreed
                                                                                                                                   upon.
                                                                                                                                   The
                                                                                                                                   note
                                                                                                                                   was
                                                                                                                                   modified
                                                                                                                                   effective
                                                                                                                                   January
                                                                                                                                   1,
                                                                                                                                   2021
                                                                                                                                   to
                                                                                                                                   establish
                                                                                                                                   a
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   of
                                                                                                                                   December
                                                                                                                                   31,
                                                                                                                                   2021,
                                                                                                                                   and
                                                                                                                                   was
                                                                                                                                   paid
                                                                                                                                   in
                                                                                                                                   full
                                                                                                                                   in
                                                                                                                                   April
                                                                                                                                   2022
                                                                                                                                   (see
                                                                                                                                   below).</span></td></tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
fees incurred in connection with obtaining and modifying these agreements were nominal and, given the short-term maturity of one year,
were expensed as incurred. There was no accounting impact to the financial statements related to the modifications.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2pt 0 0; font-weight: bold"></p>

<ix:exclude><!-- Field: Page; Sequence: 140 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:LongTermDebtTextBlock" id="ixv-18608"><p id="xdx_808_eus-gaap--LongTermDebtTextBlock_zS1WeD6dIZD6" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<span id="xdx_823_zOoRBNwTJqCc">Long-Term Debt</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Long-term debt consisted of the
following at September 30, 2023 and December 31, 2022:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock" id="ixv-18616"><p id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zKoF4A6jVerj" style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B8_zGCFf1z9NLmj" style="display: none">Schedule of long term debt payment</span>&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - Long-Term Debt (Details)" id="xdx_30A_134_zy8PBx78ip2i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2023</b></span></td>
<td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2022</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0">Senior secured promissory notes &#8211; various investors.&#160;&#160;Monthly payments of interest only at
10% plus deferred interest of 5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity.
Matures the earlier of (a) May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of
control. The notes are senior to all other debt and are secured by substantially all assets of the Company. The notes included
detachable warrants to purchase 482,268 shares of common stock at an exercise price of $3.32 per share (see Note 10 &#8211; Stockholders&#8217;
Equity in Item 1 &#8211; Financial Statements of Part I &#8211; Financial Information). Debt issuance costs and discount totaling
$1,287,160 at date of issuance were being amortized and recognized as additional interest expense over the term of the notes using
the straight-line method because it was not substantially different from the effective interest rate method. We determined the
expected life of the notes to be the contractual term. Interest expense related to these notes includes amortization of debt issuance
costs and discount in the amount of $0 and $1,196,843, respectively, for the three months and nine months ended September 30, 2022,
respectively. The notes were paid in full in April 2022.</p>


</td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zu2E1BAkZbv6" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1676">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zSYhmgsZ52z5" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1677">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 56%; font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; bank. Payable in monthly installments of $332, including interest at 5.8% per annum, due August 2025, secured by equipment and personally guaranteed by a co-founder.</span></td>
<td style="width: 8%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zWzRoJiUKBif" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_us-gaap_NotesPayableToBanksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23784">7,213</ix:nonFraction></span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 8%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zoU4N5Nx5wwb" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_us-gaap_NotesPayableToBanksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23785">9,825</ix:nonFraction></span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; credit union. Payable in monthly installments of $508, including interest at 5.45% per annum, due July 2026, secured by a vehicle and personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_z6Z8spHtDLjj" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_custom_NotePayableCreditUnionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23786">15,514</ix:nonFraction></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zfhsTgyta9mk" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableCreditUnionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23787">19,364</ix:nonFraction></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; SBA. Economic Injury Disaster Loan payable in monthly installments of $731, including interest at 3.75% per annum, due May 2050, and personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z3mXhXacRPZa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_custom_NotePayableSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23788">147,735</ix:nonFraction></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zmjRl5jKS2pa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23789">150,114</ix:nonFraction></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; individual. Monthly payments of interest only at 10% per annum, matured December 31, 2021 resulting in the entire principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31, 2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the note in full in April 2022.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zgZhqMNgTbPj" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1684">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zbVAN2AVINy4" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1685">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; finance company. Payable in monthly installments of $994, including interest at 8.5% per annum, due July 2026, secured by a vehicle and personally guaranteed by a stockholder.&#160;The Note was paid in full September 2022.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zCd81AxtILH8" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1686">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zMkCo5LyeyF3" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1687">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; finance company.&#160;Payable in monthly installments of $2,204, including interest at 11.21% per annum, due August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;The note was paid in full January 2023.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zoQEMg6apxVk" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1688">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zhaiJhr26jC" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompany1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23790">79,963</ix:nonFraction></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Notes payable &#8211; The Company has acquired six notes payable to GM Financial for vehicles.&#160;In April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;The agreement expired in April 2023 but was renewed for a commercial line up to $350,000 and prevailing GM Financial existing term notes will remain. The new agreement expires in April 2024.&#160;One note was paid off when the corresponding vehicle was sold in May 2023, so there are five notes remaining at September 30, 2023.&#160;The notes are currently payable in aggregate monthly installments of $4,084, including interest at rates ranging from 5.89% to 7.29% per annum, mature at various dates from October 2027 to May of 2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_989_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zYWmn3bXZ9Ri" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30_custom_GMFinancialMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23791">191,027</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zHD2sHkbLt8c" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31_custom_GMFinancialMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23792">251,209</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930_zOorhTjIBqxh" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23793">361,489</ix:nonFraction></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20221231_zrd187XCFUzi" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23794">510,475</ix:nonFraction></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less current portion</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98B_eus-gaap--DebtCurrent_iNI_di_c20230930_z9fb3gRYLdg9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DebtCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23795">50,058</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zeSIpKKGmET6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DebtCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23796">71,426</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Long-term debt, net of unamortized debt discount and current portion</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_980_eus-gaap--LongTermDebtNoncurrent_iI_c20230930_zPjwHvUcLtxi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23797">311,431</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_98E_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zgdRYecSgZ67" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23798">439,049</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>




</ix:nonNumeric><p id="xdx_8A8_zQ01OvCLcxPj" style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 141 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0 0 8pt"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future maturities of long-term debt are
as follows:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="ixv-18865"><p id="xdx_89F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zoBjrwmp3Mi4" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zmgYdrwEu1v2" style="display: none">Schedule of Maturities of Long-Term Debt</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_306_134_zjGUubLmMe11" summary="xdx: Disclosure - Long-Term Debt (Details 1)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_493_20230930_z88lrVy2dXJj">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Twelve months ending September 30,</b></span></td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zTotBDrcuNs" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="vertical-align: top; width: 6%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; width: 38%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23799">50,058</ix:nonFraction></span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_z6sqjfZ2mVbb" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23800">52,934</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zWG8oml8sPx1" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23801">50,982</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zm5GU6aGDNe5" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturingInYearsTwoAndThree" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23802">49,561</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_zUsPYrM1L2Ae" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23803">27,963</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbXNV0Ba8wa3" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23804">129,991</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermDebt_iI_zTfYwgAEQi2l" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23805">361,489</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AC_zcHIuxVQy0fb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:ShareholderPromissoryNotesTextBlock" id="ixv-18943"><p id="xdx_806_ecustom--ShareholderPromissoryNotesTextBlock_zbWD2LTaljQj" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<span id="xdx_824_zXHvZpM5ggfj">Stockholder Promissory Notes</span>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of both September 30, 2023 and December 31, 2022, the Company had an outstanding principal balance of $825,000 due to stockholders under
unsecured Promissory Notes Agreements (&#8220;Notes&#8221;). The Notes require monthly interest-only payments at 10% per annum. The Notes
mature at various dates from January 2024 to December 2024 as follows: January 2024 - $125,000; August 2024 - $500,000 (this note would
have matured at August 2023, but in June 2023, an agreement was signed extending the maturity date to August 2024); and December 2024
- $200,000.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
paid to the stockholders under the Notes totaled $20,627 and $20,627 during the three months ended September 30, 2023 and September 30,
2022, respectively. Interest paid to the stockholders under the Notes totaled $61,881 and $61,881 during the nine months ended September
30, 2023 and September 30, 2022, respectively. There was no accrued interest as of September 30, 2023 or December 31, 2022 related to
these Notes.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-18958"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z2yRbwEpMP07" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<span id="xdx_823_zLEra1kaGuNa">Commitments and Contingencies</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating Leases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases its warehouses and office space under long-term lease arrangements. None of its leases include characteristics specified
in ASC 842, <i>Leases</i>, that require classification as financing leases, and accordingly, these leases are accounted for as operating
leases. The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months
or less. For longer-term lease arrangements that are recognized on the Company&#8217;s Balance Sheet, the right-of-use asset and lease
liability are initially measured at the commencement date based upon the present values of the lease payments due under the leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies
an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine
the present value of lease payments due under the arrangement. Under ASC 842, the incremental borrowing rate (IBR) for leases must be
(1) a rate of interest over a similar term, and (2) for an amount that is equal to the lease payments. The Company uses both the Federal
Reserve Economic Data (FRED) U.S. corporate debt effective yield and the U.S. Treasury rates adjusted for credit spread as the primary
data points for purposes of determining the IBR.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">In the first quarter
of 2022, the Company entered into two new long-term, non-cancelable operating lease agreements for office and warehouse space resulting
in the Company recognizing an additional lease liability totaling of $2,348,509, representing the present value of the lease payments
discounted using an effective interest rate of 8.07% and 8.86%, and corresponding right-of-use assets of $2,348,509. The leases
expire in December 2026 &#160;and December 2028. The second lease contains one three-year option to renew. The lease is guaranteed
by a co-founder.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2021, the Company entered into a long-term, non-cancelable operating lease agreement for office and warehouse space
resulting in the Company recognizing an additional lease liability totaling of $1,268,089, representing the present value of the lease
payments discounted using an effective interest rate of 7.47% and a corresponding right-of-use asset of $1,268,089. The lease expires
in January 2028&#160;and contains one three-year option to renew. The lease is guaranteed by a co-founder.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company has two
other leases&#8212;one that expired in January 2023 and one that expires in February 2025. The leases generally provide for annual
increases based on a fixed amount and generally require the Company to pay real estate taxes, insurance, and repairs. Both leases
are guaranteed by a co-founder.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following
is a summary of total lease costs during the three months and nine months ended September 30, 2023 and 2022:</span>&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:LeaseCostTableTextBlock" id="ixv-18995"><p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zUAagphrgysl"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z7C6NbVV0b2l" style="display: none">Schedule of lease cost</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_zOChwuWPpONg" summary="xdx: Disclosure - Commitments and Contingencies (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_496_20230701__20230930_zpCtb6u0TWQd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49A_20220701__20220930_zjn2Ukg1guri" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_491_20230101__20230930_zcjxah3v4pwb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930_z1mY7KClAx0i" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended September 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseCost_zdHXFyt8Q7Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23806">187,315</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23807">198,795</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23808">562,660</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23809">561,949</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ShortTermLeaseCost_zgwvc8sv9ttj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    lease costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1726">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23810">450</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23811">150</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23812">3,077</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--VariableLeaseCost_z768GSysIESf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
    lease costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1732">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1733">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1734">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z0LQlFs692Q3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sublease
    income</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23813">10,440</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23814">25,022</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23815">39,476</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23816">98,364</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LeaseCost_z86NS0NEpHNk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23817">176,875</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23818">174,223</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23819">523,334</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23820">466,662</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AD_zW5wITcJk2x" style="margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 142 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0 0 8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term was 4.78 years and 5.49 years as of September 30, 2023 and December 31, 2022, respectively. The
weighted average discount rate was 8.48% and 8.48%, as of September 30, 2023 and December 31, 2022, respectively. Operating cash flows
from the operating leases totaled $116,591 and $115,442 for the three months ended September 30, 2023 and 2022, respectively, and $350,794
and $322,112 for the nine months ended September 30, 2023 and 2022, respectively.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total lease liability as of September 30, 2023 and December 31, 2022 was $2,883,217 and $3,220,019, respectively.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 8pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of September 30, 2023, for
years ending September 30:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="ixv-19245"><p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zcBi2eWnGRt2" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zwg0sSJc4HTj" style="display: none">Schedule of future minimum lease payment</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_302_134_z0HXTQAeHOf3" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_496_20230930_zqFoQwRjYQfd" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
  <tr id="xdx_406_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_znS99N1KgNG1" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 21%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23821">731,243</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_znalB1v5wi7f" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23822">725,589</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zJS3yuqzzhm9" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23823">727,150</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_zoHsE6MDZw31" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23824">703,541</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_z9jztcz5qWF" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23825">532,833</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeWcnKvm6tf2" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23826">112,569</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zeoRzoYcHEtc" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23827">3,532,925</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z6rqGlGgqvL5" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23828">649,708</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zSMg30yILxG4" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23829">2,883,217</ix:nonFraction>
    </span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zAeEkhFBNy9h" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23830">506,743</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zgPRi5p0tFGl" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent lease liability</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23831">2,376,474</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseLiability_iI_zZFLI6RvWVh4" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23832">2,883,217</ix:nonFraction>
    </span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zHLyThV1AnC6" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subleases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company subleases
office and warehouse space under one of its existing operating leases with similar terms as the Company&#8217;s lease agreements.
Because the Company is not relieved of its primary obligations under the original lease, the Company accounts for the subleases
as a lessor. Sublease rental income is recorded based on the contractual rental payments which are not substantially different
from recognition on a straight-line basis over the lease term and totaled $10,440 and $25,022 &#160;during the three months ended
September 30, 2023 and 2022, respectively, and $39,476 and $98,364 &#160;during the nine months ended September 30, 2023 and 2022,
respectively. As of September 30, 2023 and December 31, 2022, deferred income and a sublease deposit totaled $4,445 and $14,168,
respectively, and is included in accrued expenses and other current liabilities on the accompanying Balance Sheets.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following
are the total future minimum sublease payments as of September 30, 2023:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" id="ixv-19389"><p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zqFyPOJdbvG9" style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zJZs93bZvkCe" style="display: none">Schedule of
future minimum sublease payments</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_30A_134_ziZ4s47ADuQ2" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 77%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Twelve months ending September
    30,</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_49A_20230930_zU4ARZkGlgTi" style="width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zViBC96lzPGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23833">42,491</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_zUwuxibF07l" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23834">17,922</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zcBEZH0QOODb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease
    payments&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactions" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23835">60,413</ix:nonFraction></span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_zK0DL6lKgUn1" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be involved from time to time in litigation or claims arising in the ordinary course of its business. While the ultimate
liability, if any, arising from these claims cannot be determined with certainty, the Company believes that the resolution of any such
matters will not likely have a material adverse effect on the Company&#8217;s financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 143 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 22, 2022, Expion360 Inc. (the &#8220;Company&#8221;) <span style="background-color: white">received notice of a complaint (the
&#8220;Complaint&#8221;) filed against it in Oregon state court by Ravi Sinha. The Complaint alleges,&#160;</span><i>inter alia</i><span style="background-color: white">,
that Mr. Sinha is entitled to 282,284 shares of the Company&#8217;s common stock, or in the alternative, $300,000 plus interest in connection
with services he previously rendered the Company as its chief executive officer. On March 21, 2023, the Company entered into a settlement
agreement with Mr. Sinha and the matter has been resolved with cash and the issuance of common stock (see Note 10 &#8211; Stockholders&#8217;
Equity</span> in Item 1 &#8211; Financial Statements of Part I &#8211; Financial Information<span style="background-color: white">).</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-19458"><p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8mEXorYBGFe" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<span id="xdx_822_zV5OosiIvbO8">Stockholders&#8217; Equity</span><span style="font-weight: normal; color: windowtext">&#160;</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue an aggregate of 220,000,000 &#160;&#160;shares of capital stock, par value $0.001 per share, consisting
of 200,000,000 shares of common stock and 20,000,000 shares of preferred stock. On March 31, 2023, at the closing price of $4.84 per
share, the Company issued 52,000 shares of common stock as part of the settlement agreement with Mr. Sinha dated March 21, 2023. As of
September 30, 2023 and December 31, 2022, 6,910,717 and 6,802,464 shares, respectively, of common stock were issued and outstanding.
No shares of preferred stock have been issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of common stock is entitled to one vote for each share of common stock. The holders of common stock have no conversion, redemption
or preemptive rights and shall be entitled to receive dividends when, as, and if declared by the board of directors. Upon dissolution,
liquidation, or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, subject
to the rights, if any, of the holders of any class or series stock having a preference over the right to participate with common stock
with respect to the distribution of assets of the Company upon such dissolution, liquidation, or winding up of the Company, the holders
of common stock shall be entitled to receive the remaining assets of the Company available for distribution to its stockholders ratably
in proportion to the number of shares of common stock held.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
no shares of preferred stock have been issued, no rights and privileges of preferred stockholders have been defined.&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial Public
Offering</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company completed an initial public offering (&#8220;IPO&#8221;). A total of 2,466,750 shares of common stock were
sold at $7.00 per share in the IPO, for total gross proceeds of $17,267,250. The Company incurred IPO costs of $2,494,763 resulting in
net proceeds of $14,772,487. Additionally, during the year ended December 31, 2022, the Company issued 35,714 shares of common stock
at $7.00 per share to an outside third party in exchange for IPO services. The fair value of the shares of $249,998 were recorded as
an increase to common stock of $36 (35,714 shares at $.001 par value) and additional paid in capital of $249,962 and a corresponding
reduction to additional paid in capital of $249,998, resulting in a net decrease in additional paid in capital of $36.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants/Options</i>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">On August 10, 2023,
the Company issued 25,000 warrants to their investor relations firm in accordance with a letter of engagement signed July 22, 2022,
to purchase 25,000 shares of common stock at an exercise price of $5.00 per share. The warrants expire 2 years from date of grant
(August 9, 2025). The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model
and following assumptions: per share price of common stock on date of grant $5.20, expected dividend yield of 0%, expected volatility
of 88%, risk-free interest rate of 4.82% and expected life based on contractual life of 2 years. The fair value of $65,046&#160;
was recorded as an increase in additional paid-in capital and expensed to Legal and Professional Services.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company issued warrants to IPO underwriters to purchase 148,005 shares of common stock at an exercise price of $9.10
per share. The warrants are exercisable 180 days after grant (September 27, 2022) and expire 5 years from date of grant (March 31, 2027).
The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions:
per share price of common stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest
rate of 2.55% and expected life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in
capital and a reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero
impact to additional paid-in capital.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 144 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2023, 15,000 warrants exercisable at $3.32 per share were exercised on a cash basis which resulted
in the issuance of 15,000 shares of common stock. In addition, 22,606 warrants exercisable at $3.32 per share were exercised using the
cashless conversion option, which resulted in the issuance of 10,151 shares of common stock. This leaves 521,825 warrants remaining with
an exercise price of $3.32.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2023, 73,000 warrants exercisable at $2.90 per share were exercised using the cashless conversion
option which resulted in the issuance of 31,102 shares of common stock. This leaves 78,000 warrants remaining with an exercise price
of $2.90.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.35pt">As of September
30, 2023 and December 31, 2022, a total of 772,830 and 858,436 warrants were issued and outstanding, respectively. As of September
30, 2023 and December 31, 2022, a total of 30,000 options, which were not issued under a specified plan, were outstanding. As of
September 30, 2023, below is a summary of the various warrants/options issued and outstanding:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.35pt">&#160;</p>



<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" id="ixv-19518"><p id="xdx_89D_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zdD8GKq3aiYa" style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B7_zm75MT70gd62" style="display: none">Schedule of various warrants/options issued and outstanding</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_301_134_zABaZfFVn2lh" summary="xdx: Disclosure - Stockholders Equity (Details)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 47%; text-align: center"><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number
                                               of warrants/non-plan options</b></span></p>


</td>
    <td style="width: 23%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></span></td>
    <td style="width: 30%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Remaining
    Life (Yrs)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98D_ecustom--NumberOfWarrantsnonplanOptionsOne_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zKbapBLbOX7e" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="XPON:NumberOfWarrantsnonplanOptionsOne" contextRef="AsOf2023-09-30_custom_ExercisePrice1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23836">25,000</ix:nonFraction></span></td>
    <td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zZsB6XKMCa3b" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_ExercisePrice1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23837">5.00</ix:nonFraction></span></td>
    <td style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePricesMember_zKne3ypdaBk9"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_ExercisePricesMember" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23838">1.86</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_984_ecustom--NumberOfWarrantsnonplanOptionsTwo_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zo9CS0bUS2lb" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="XPON:NumberOfWarrantsnonplanOptionsTwo" contextRef="AsOf2023-09-30_custom_ExercisePrice2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23839">521,825</ix:nonFraction></span></td>
    <td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zCTh5SGjeYje" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_ExercisePrice2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23840">3.32</ix:nonFraction> </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zBp8z7jLCqMi"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_ExercisePrice1Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23841">8.15</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98C_ecustom--NumberOfWarrantsnonplanOptionsThree_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zTzqyoS76RNe" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="XPON:NumberOfWarrantsnonplanOptionsThree" contextRef="AsOf2023-09-30_custom_ExercisePrice3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23842">78,000</ix:nonFraction></span></td>
    <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zt1ripov30J3" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_ExercisePrice3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23843">2.90</ix:nonFraction> </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zclT3p4JMwBe"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_ExercisePrice2Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23844">1.11</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_985_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_z7B1Ksldnlf" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="XPON:NumberOfWarrantsnonplanOptionsFour" contextRef="AsOf2023-09-30_custom_ExercisePrice4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23845">30,000</ix:nonFraction></span></td>
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zah7kwM60dXh" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_ExercisePrice4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23846">3.32</ix:nonFraction> </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zW8SCQXV7SH7"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_ExercisePrice3Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23847">1.11</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_zcMZ6goDaZC6" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="XPON:NumberOfWarrantsnonplanOptionsFour" contextRef="AsOf2023-09-30_custom_ExercisePrice5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23848">148,005</ix:nonFraction></span></td>
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_z6UiFSsNAFFe" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_ExercisePrice5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23849">9.10</ix:nonFraction>
    </span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zgg7PK4bJNLd"><ix:nonNumeric contextRef="From2023-01-012023-09-30_custom_ExercisePrice4Member" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="ixv-23850">3.50</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zLl2b9MbIvle" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Option Plans</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As of September 30,
2023, the Company had adopted two stock-based compensation plans, the 2021 Incentive Award Plan and the 2021 Employee Stock Purchase
Plan, both of which are described below and became effective upon the initial public offering. On May 2, 2022, the Company granted
829,500 options and on August&#160; 23, 2023, the Company granted 245,500 options and 48,780 restricted stock units (&#8220;RSUs&#8221;)
under the 2021 Incentive Award Plan. No shares have been issued to date under the 2021 Employee Stock Purchase Plan. The compensation
cost that has been charged against operations was $2,114,529 for the year ended December 31, 2022 and $124,785 for the three months
ended September 30, 2023.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021 Incentive Award Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The purpose of the
Company&#8217;s 2021 Incentive Award Plan is to enhance the Company&#8217;s ability to attract, retain and motivate persons who
make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities.
Various stock-based awards may be granted under the plan to eligible employees, consultants, and non-employee directors. The number
of shares issued under the plan is subject to limits and is adjusted annually. No more than 1,000,000 shares may be issued pursuant
to the exercise of incentive stock options. The aggregate share limit will be subject to an annual increase on the first day of
each calendar year ending on and including January 1, 2031, by a number of shares equal to the lesser of (i) a number equal to
5% of the aggregate number of shares of the Company's common stock outstanding on the final day of the immediately preceding calendar
year and (ii) such smaller number of shares as is determined by the Company's board or committee. As of September 30, 2023, the
aggregate number of shares that can be issued under the Plan is 1,199,623, of which 1,075,000 options and 48,780 RSUs have been
granted. The number of shares granted, the exercise price, and the terms will be determined at date of grant; however, the exercise
price shall not be less than 100% of the fair value on the grant date (110% for options granted to greater than 10% stockholders)
and the term shall not exceed ten years.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 145 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021 Employee Stock Purchase Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Company&#8217;s 2021 Employee Stock Purchase Plan is to assist eligible employees of the Company in acquiring a stock
ownership in the Company and to help such employees provide for their future security and to encourage them to remain in the employment
of the Company. The plan consists of a Section 423 Component and Non-Section 423 Component. The Section 423 Component is intended to
qualify as an employee stock purchase plan and also authorizes the grant of options. Options granted under the Non-Section 423 Component
shall be granted pursuant to separate offerings containing sub-plans. The Company may make one or more offerings under the plan. The
duration and timing of each offering period may be established or changed by the board, but in no event may an offering period exceed
27 months and in no event may the purchase period for the option exceed the duration of the offering period under which it is established.
On each exercise date for an offering period, each participant shall automatically be deemed to have exercised the option to purchase
the largest number of whole shares which can be purchased under the offering. Option awards are generally granted with an exercise price
equal to 85% of the lesser of the fair market value of a share on (a) the applicable grant date and (b) the applicable exercise date,
or such other price as designated by the administrator, provided that in no event shall the option price be less that the per share par
value price. The maximum number of shares granted under the plan shall not exceed 2,500,000 shares.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected
volatility was calculated based upon similar traded companies&#8217; historical share price movements as adequate historical experience
is not available to provide a reasonable estimate. Expected term is calculated based on the simplified method as adequate historical
experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience
is available to provide a reasonable estimate of the expected term. The risk-free interest rate is calculated based on the yield from
U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and have no foreseeable plans
to pay dividends.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has computed the fair value of all options granted during the year ended December 31, 2022 using the following assumptions:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-19630"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ztNSL32BluSd" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zaGwniah05M8" style="display: none">Schedule of assumptions used</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_301_134_zP37qo3NCmWb" summary="xdx: Disclosure - Stockholders Equity (Details 1)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility 	</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z5Q8Iu4ucnH8" title="Expected Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23851">109.48</ix:nonFraction></span>% - <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zdJpsBdwwVzl" title="Expected Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-012022-12-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23852">113.32</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividends</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_z56B65SB3sea" title="Expected dividends"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-012022-12-31" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23853">None</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (in years)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zdbmgFKkfCJ6" title="Expected term (in years)"><ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-23854">2.5</ix:nonNumeric></span> &#8211; <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zBce8gkxjiif" title="Expected term (in years)"><ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-23855">5.01</ix:nonNumeric></span> </span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free
    rate	</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2wORi2sMc9" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23856">2.83</ix:nonFraction></span>% &#8211; <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z9fLngVTHOxa" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-12-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23857">3.01</ix:nonFraction></span>%</span></td></tr>
  </table>
<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has computed the fair value of the 245,500 options granted during the nine months ended September 30, 2023 using the following
assumptions:</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    volatility 	</span></td><td style="width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zcwAmmtAG005" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-01-012023-09-30_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23858">105</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    dividends</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20230101__20230930_zwaiTZw8rcu8" title="Expected dividends"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-01to2023-09-30" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23859">None</ix:nonFraction></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    term (in years)</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_znnUS4AW0cO3" title="Term"><ix:nonNumeric contextRef="From2023-01-012023-09-30_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-23860">6.0</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Risk
    free rate	</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230101__20230930_zje8AmlukpNa" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-01to2023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-23861">4.33</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>



<p style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

</ix:nonNumeric><p id="xdx_8A4_zGDKPfmcidVc" style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table
summarizes the Company&#8217;s stock option activity under the 2021 Incentive Plan:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-19736"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z34PqlRSQKW3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zPfQrUvEmeP2" style="display: none">Schedule of stock option activity</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_30A_134_zZo1xjomvR11" summary="xdx: Disclosure - Stockholders Equity (Details 2)" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 53%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of options</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average exercise price</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average remaining contractual term (in years)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    intrinsic value (1)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zV1RbkHg5RKc" title="Beginning balance" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-12-31_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23862">829,500</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zqQTWpASTkz3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23863">3.43</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_c20230101__20230930_zoIxiPNl1wAa" title="Weighted average remaining contractual term (in years)" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" id="ixv-23864">8.76</ix:nonNumeric></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_hus-gaap--AwardTypeAxis__us-gaap--OptionMember_zf1LTcykw98i" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,500</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zc7l5pLlrkOi" title="Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-09-30_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23865">4.92</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of period</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zmtib1YqEBZ6" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-09-30_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23866">1,075,000</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zEJqQXdp4z4j" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-09-30_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23867">3.77</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_c20230101__20230930_zyNJ9fklntAh" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" id="ixv-23868">9.02</ix:nonNumeric></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zZSCUdyZAHgd" title="Outstanding at end of period" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-09-30_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23869">567,595</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of period</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zL0TfMxpgLk7" title="Exercisable shares" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" contextRef="From2023-01-012023-09-30_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23870">829,500</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zuYL48xG3eph" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2023-09-30_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23871">3.43</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_c20230101__20230930_zDxeoYCBytaf" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" name="XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" id="ixv-23872">7.51</ix:nonNumeric></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_z0zO4r5djEx3" title="Exercisable at end of period" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-09-30_us-gaap_OptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-23873">567,595</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The aggregate intrinsic
    value of options outstanding and options exercisable at beginning of period is $0, as all options are out of the money.</i></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zm0IKKHLQUz9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"></p>

<ix:exclude><!-- Field: Page; Sequence: 146 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months ended
September 30, 2023 and 2022, the weighted-average grant-date fair value of the options granted to employees and non-employees was $998,924
and $1,847,193, respectively. Unrecognized compensation expense related to employees was $234,737 as of September 30, 2023. The options
granted in May 2022 were vested 100% at time of grant. The options granted in August 2023 began to vest in equal quarterly installments
beginning September 30, 2023 and ending June 30, 2026.</p>
<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table
summarizes the Company&#8217;s restricted stock unit (&#8220;RSU&#8221;) activity under the 2021 Incentive Plan:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="ixv-20010"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zSsS8b617s7b" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span id="xdx_8B2_zy8whRJJDSZe" style="display: none">Share-Based
Payment Arrangement, Restricted Stock Unit, Activity</span></span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_307_134_zUJ6sN1EO8pe" summary="xdx: Disclosure - Stockholders Equity (Details 3)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 68%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of restricted stock awards</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average grant-date fair value</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested at beginning of year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZ2PPCLrj7d" title="Numbers of Shares beginning balance" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1846">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6YprpuKHP6k" title="Begining balance" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1848">&#8212;</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKzVANoGVwK9" title="Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23874">48,780</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSyN7aXs5ARe" title="Weighted avergare granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23875">239,998</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested at end of year</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6xOLtHw31rg" title="Ending balance" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23876">48,780</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUhwOgnif0R5" title="Weigthed Average Ending balance" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-23877">239,998</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zZrbcU0QBAv3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $0.2 million of total unrecognized compensation cost related to non-vested RSUs that are expected to be recognized over a period
of up to 0.70 years.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock Reserved
for Future Issuance </i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of common stock shares reserved for future issuance as of September 30, 2023:</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock" id="ixv-20162"><p id="xdx_895_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_zXiJted72Hya" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_z2xjurY2BhMc" style="display: none">Schedule of common stock shares reserved for future issuance</span></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_305_134_zvYcYYRcQA6j" summary="xdx: Disclosure - Stockholders Equity (Details 4)" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 12pt; text-indent: 6pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49E_20230930_z1XzTdBLhml2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zD7IQnOKj873" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 71%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of warrants 	</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2023-09-30_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23878">772,830</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zO8rm0iRvH5d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of options unrelated to any Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2023-09-30_custom_UnrelatedToAnyPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23879">30,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zI24wLcLgZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of stock options &#8211; 2021 Incentive Award Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2023-09-30_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23880">1,075,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzFie7Js2KOa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of restricted stock units &#8211; 2021 Incentive Award Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23881">48,780</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCiODbzqpC4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    shares of common stock reserved for future issuances	</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-23882">1,926,610</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_z1gwMGplld3k" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-20230"><p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zvouYfSEF9I8" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<span id="xdx_82B_zqfAlZ9QMkz1">Income Taxes</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The Company
has incurred losses and consequently recorded no provision beyond the minimum or base tax rate for state or federal income taxes
for the three or nine months ended September 30, 2023. The Company maintains a full valuation allowance on all deferred tax assets,
as it has concluded that it is more likely than not that these assets will not be realized. As of September 30, 2023 and December
31, 2022, there were no material unrecognized tax benefits included in the accompanying balance sheets that would, if recognized,
affect the effective tax rate. For the three months ended September 30, 2023, the Company accrued $1,380 for 2023 state income
taxes, and for the three months ended September 30, 2022, the Company accrued and incurred state taxes of $0. For the nine months
ended September 30, 2023, the Company has net state tax expenses totaling $1,341 due to a small refund, and for the nine months
ended September 30, 2022, the Company incurred state taxes of $300.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:DefinedBenefitPlanTextBlock" id="ixv-20241"><p id="xdx_807_eus-gaap--DefinedBenefitPlanTextBlock_zlmh7pA5Dh5a" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<span id="xdx_824_zpMSTJRrlFgf">401(k) Plan</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted a 401(k) Plan (&#8220;Plan&#8221;) for the benefit of its employees. Employees may contribute to the Plan within defined
limits as defined by the Internal Revenue Service. Substantially all employees are eligible to participate. The Company has the option
to make profit sharing contributions at its discretion. No profit-sharing contributions have been made.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 147 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="XPON:RelatedPartyTransactionsTextBlock" id="ixv-20256"><p id="xdx_80E_ecustom--RelatedPartyTransactionsTextBlock_zzeHvqrLrxA1" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<span id="xdx_826_zJqmuZUbBwFh">Related Party Transactions</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023 and December 31, 2022, related party transactions consisted of Stockholder Promissory Notes (see Note 8 &#8211;
Stockholder Promissory Notes in Item 1 &#8211; Financial Statements of Part I &#8211; Financial Information).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-20266"><p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_z23DddUT4Y6i" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<span id="xdx_827_zcz1LV9zih3i">Subsequent Events</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date to which events occurring after September 30, 2023, the date of the most recent Balance Sheets, have been evaluated for possible
adjustment to the financial statements or disclosures is November 7, 2023, which is the date the financial statements were issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2023, the Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) during which the Company&#8217;s
stockholders approved an amendment to the Company&#8217;s 2021 Incentive Award Plan to increase by 250,000 the number of shares of Common
Stock authorized for issuance under the plan. The Company filed an 8-K related to the results of the Annual Meeting on October 16, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, the Company filed an 8-K related to a published press release introducing a pilot program to offer transformative solar
and energy storage solutions in partnership with REPM Corp.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 148 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img src="image_001.jpg" alt="Icon&#10;&#10;Description automatically generated" style="height: 84px; width: 80px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Expion360 Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Up to 1,781,978 Shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>The date of this prospectus is January 31,
2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<ix:exclude><!-- Field: Page; Sequence: 149; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PART&#160;II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>INFORMATION NOT REQUIRED IN PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the various expenses
to be incurred in connection with the sale and distribution of the Shares being registered hereby, all of which will be borne by us (except
any underwriting discounts and commissions and expenses incurred for brokerage, accounting, tax or legal services or any other expenses
incurred in disposing of the shares). All amounts shown are estimates except the SEC registration fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
Filing Fee</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,146.77</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
Fees and Expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Fees and Expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right">10,000</td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right">94,646.77</td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Nevada Revised Statutes (&#8220;NRS&#8221;) 78.138(7)
provides that, subject to limited statutory exceptions and unless the articles of incorporation or an amendment thereto (in each case
filed on or after October 1, 2003) provide for greater individual liability, a director or officer is not individually liable to a corporation
or its stockholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director or officer
unless it is proven that: (i) the act or failure to act constituted a breach of his or her fiduciary duties as a director or officer and
(ii) the breach of those duties involved intentional misconduct, fraud or a knowing violation of law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NRS 78.7502(1) provides that a corporation may indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of the
fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses,
including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection
with the action, suit or proceeding if the person (i) is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner
which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe the conduct was unlawful. NRS 78.7502(2) provides that a corporation may indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the
right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee
or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys&#8217;
fees actually and reasonably incurred by the person in connection with the defense or settlement of the action or suit if the person (a)
is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed
to the best interests of the corporation. To the extent that a director, officer, employee or agent of a corporation has been successful
on the merits or otherwise in defense of any such action, suit or proceeding, or in defense of any claim, issue or matter therein, the
corporation shall indemnify him or her against expenses, including attorneys&#8217; fees, actually and reasonably incurred by him or her
in connection with the defense. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a
plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to NRS 78.138
or did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the
corporation, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was
unlawful. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent
jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation,
unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines
upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such
expenses as the court deems proper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 150 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NRS 78.751(1) provides that any discretionary indemnification
pursuant to NRS 78.7502 (unless ordered by a court or advanced pursuant to NRS 78.751(2)), may be made by the corporation only as authorized
in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances.
The determination must be made (i) by the stockholders; (ii) by the board of directors by majority vote of a quorum consisting of directors
who were not parties to the action, suit or proceeding; (iii) if a majority vote of a quorum consisting of directors who were not parties
to the action, suit or proceeding so orders, by independent legal counsel in a written opinion; or (iv) if a quorum consisting of directors
who were not parties to the action, suit or proceeding cannot be obtained, by independent legal counsel in a written opinion. NRS 78.751(2)
provides that the corporation&#8217;s articles of incorporation or bylaws, or an agreement made by the corporation, may provide that the
expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding must be paid by the corporation
as they are incurred and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on
behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that the director
or officer is not entitled to be indemnified by the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the NRS, the indemnification pursuant to NRS
78.7502 and advancement of expenses authorized in or ordered by a court pursuant to NRS 78.751:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does not exclude any other
rights to which a person seeking indemnification or advancement of expenses may be entitled under the articles of incorporation or any
bylaw, agreement, vote of stockholders or disinterested directors or otherwise, for either an action in the person&#8217;s official capacity
or an action in another capacity while holding office, except that indemnification, unless ordered by a court pursuant to NRS 78.7502
or for the advancement of expenses made pursuant to NRS 78.751(2), may not be made to or on behalf of any director or officer if a final
adjudication establishes that the director&#8217;s or officer&#8217;s acts or omissions involved intentional misconduct, fraud or a knowing
violation of the law and was material to the cause of action; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continues for a person who
has ceased to be a director, officer, employee or agent and inures to the benefit of the heirs, executors and administrators of such
a person.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A right to indemnification or to advancement of expenses
arising under a provision of the articles of incorporation or any bylaw is not eliminated or impaired by an amendment to such provision
after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or
proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission
explicitly authorizes such elimination or impairment after such action or omission has occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Articles of Incorporation of the Company provide
that to the fullest extent permitted under the NRS (including, without limitation, to the fullest extent permitted under NRS 78.7502 and
78.751(3)) and other applicable law, we shall indemnify our directors and officers in their respective capacities as such and in any and
all other capacities in which any of them serves at our request. The Articles of Incorporation further provide that the liability of its
directors and officers shall be eliminated or limited to the fullest extent permitted by the NRS, and that if the NRS are amended to further
eliminate or limit or authorize corporate action to further eliminate or limit the liability of directors or officers, the liability of
our directors and officers shall be eliminated or limited to the fullest extent permitted by the NRS, as so amended from time to time;
and in addition to any other rights of indemnification permitted by the laws of the State of Nevada or as may be provided for by in our
Bylaws or by agreement, the expenses of directors and officers incurred in defending a civil or criminal action, suit or proceeding, involving
alleged acts or omissions of such director or officer in his or her capacity as a director or officer of the Company, must be paid, by
us or through insurance purchased and maintained by the Company or through other financial arrangements made by us, as they are incurred
and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director
or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that he or she is not entitled to be
indemnified by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 151 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, we have entered into indemnification arrangements
with each of its directors and executive officers that may be broader than the specific indemnification provisions contained in the NRS.
Such arrangements may require us, among other things, to advance expenses and otherwise indemnify its executive officers and directors
against certain liabilities that may arise by reason of their status or service as executive officers or directors, to the fullest extent
permitted by law. We intend to enter into indemnification arrangements with any new directors and executive officers in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We also have director and officer insurance&#160;providing
for indemnification for our directors and officers for certain liabilities, and such insurance provides for indemnification of our directors
and officers for liabilities under the&#160;Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following sets forth information regarding
all unregistered securities sold by the Registrant since January 1, 2019. Each of the issuances was exclusively to &#8220;accredited
investors&#8221; as defined in&#160;Regulation D&#160;under the&#160;Securities Act&#160;and in reliance on the exemptions available
pursuant to&#160;Regulation D&#160;under, and Section 4(a)(2) of, the&#160;Securities Act). </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August and October 2020,
we received proceeds totaling $270,000 from the issuance of four Convertible Notes (&#8220;2020 Notes&#8221;). The 2020 Notes accrue
monthly interest at 6% per annum and include two options for conversion: (1) automatic conversion of the principal balance and accrued
interest into new financing securities issued in a new financing round of at least $1.0 million, not including the 2020 Notes &#8212;
the conversion price will be equal to 85% of the price per unit at which the investor in the new financing purchased their equity securities;
(2) optional conversion in founder securities if (a) the Company gives the investor notice of its intent to prepay its 2020 Note, or
(b) the Company has not consummated a new financing prior to maturity. The conversion price is equal to $17.0 million divided by the
number of founder securities outstanding at the date of the 2020 Notes (100,000 units), or $170.00 per unit. The 2020 Notes mature three
years from date of issue. The outstanding balance at December 31, 2020, was $273,157, including accrued interest of $3,157, which was
recognized as interest expense during 2020.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In late 2020, all convertible
debt holders were offered the opportunity for early conversion of their convertible notes into Class B member units effective January
1, 2021. Three of the four convertible note holders converted notes with a principal balance of $170,000 and accrued interest of $3,157
into 2,338 Class B member units at per unit conversion prices ranging from $67.00 - $76.00. In accordance with FASB&#160;ASC 470-20,&#160;<i>Debt
with Conversion and Other Options</i>, the fair value of the additional units issued under the induced conversion over the value of the
number of units issuable under the original terms of the convertible note agreements is recognized as debt conversion expense. Accordingly,
upon early conversion on January 1, 2021, the Company recognized $112,133 of debt conversion expense with a corresponding entry to members&#8217;
deficit of $285,290 consisting of the $173,157 of principal and interest converted and the excess fair value of $112,133. The fourth
convertible note holder opted out of the early conversion and instead, the original note was modified into a term loan effective January
1, 2021. The modification included the elimination of the conversion feature, an increase in the interest rate from the original 6% per
annum to 10% per annum, to be paid monthly instead of accrued, and an earlier maturity date of December 31, 2021. The modification resulted
in a new effective annual interest rate of 9.58%, and a revised one-year maturity on December 31, 2021. The modification resulted in
less than a 10% difference in the present values of cash flows of the original note compared to the modified note. Accordingly, there
was no accounting changes related to these modifications.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2021, we issued
2,338 Class B member units upon the conversion of convertible notes and accrued interest totaling $173,157.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 152 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2021, we issued
262 Class B membership units in exchange for building signage valued at $20,000.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March and April 2021, we
sold 6,157 of Class B membership units to three new members for gross proceeds of $522,000.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 15, 2021, we modified
a Promissory Note Agreement in the amount of $250,000 to be a convertible note for the same amount with detachable warrants to purchase
548,000 shares of Common Stock. The modification resulted in a new effective annual interest rate of 9.15%. The modification resulted
in less than a 10% difference in the present values of cash flows of the original note compared to the modified note. Accordingly, there
was no accounting changes related to these modifications. The convertible note was issued under the same terms and conditions as the
convertible notes issued to third-party investors and therefore, in substance, was not a capital transaction. Effective November 1, 2021,
all terms under the convertible note, including the warrants, were rescinded and the member agreed to convert the note at a conversion
price of $1.21 per share.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 29, 2021, in anticipation of conversion from LLC to a C corporation, the Notes and
                                            Warrants were modified under Convertible Debenture Exercise and Waiver and Release Agreements
                                            with the individual creditors. The Note holders agreed to settle the debt for an aggregate
                                            1,527,647 shares of common stock with a fair value of $5,545,359 ($3.63 per share). Since
                                            this transaction involved contemporaneous issuance of shares of common stock by the Company
                                            to the Note holders, we evaluated the transaction for modification and extinguishment accounting
                                            and determined that the debt was extinguished as a result of the issuance of shares that
                                            do not represent the exercise of a conversion right contained in the original terms of the
                                            Notes at issuance.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2021, we issued
30,000 shares of Common Stock in exchange for legal services.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2021, we issued
482,268 detachable warrants with secured promissory notes for the purchase of Common Stock. The relative fair value of the warrants of
$809,806 at the time of issuance was recorded as additional paid-in capital with a corresponding debt discount reducing the carrying
value of the notes. Additionally, we issued 77,163 warrants to purchase shares of Common Stock to underwriters in connection with obtaining
the notes. The fair value of the warrants of $262,354 was recorded as additional paid-in capital and reduced the carrying value of the
notes. The warrants are exercisable at $3.32 per share for a period of ten years from date of grant. The fair value of the warrants was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $3.63, expected dividend yield of 0%, expected volatility of 110.8%, risk-free interest rate of 1.63% and expected
life based on contractual life of 10 years.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also in November 2021, we issued
warrants to purchase 151,000 shares of Common Stock in exchange for prior services related to extinguished 2021 convertible notes and
30,000 options for the purchase of common stock in exchange for legal services. The warrants are exercisable at $2.90 per share for a
period of three years from the date of grant. The options are exercisable at $3.32 per share for a period of three years from the date
of grant. The options issued were not issued under the Company&#8217;s stock option plans. The fair value of the warrants of $407,700
was recorded as additional paid-in-capital and expensed to extinguishment loss on debt settlement. The fair value of the options of $79,200
was recorded as additional paid-in capital with a corresponding charge to legal expense. The fair value of the warrants and options was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $3.63, expected dividend yield of 0%, expected volatility of 122.7%, risk-free interest rate of 0.71% and expected
life based on contractual life of three years.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 22, 2021, we completed
a private placement (the &#8220;Secured Note Financing&#8221;). In connection therewith, we issued an aggregate of $1,600,000 of 15%
senior secured notes (the &#8220;Senior Secured Notes&#8221;) and warrants to purchase an aggregate of 559,431 shares of common stock
at an exercise price of $3.32 per share (the &#8220;Warrants Senior Secured Notes&#8221;). After deducting offering related expenses,
including legal fees of $15,000 and certain diligence and advisory fees of $200,000 paid to an entity owned by the spouse of an employee
of the underwriter, the net proceeds to us were approximately $1,385,000. Out of the total warrants, warrants to purchase 28,935 shares
of our common stock were issued to the same entity owned by the spouse of an employee of the underwriter that received the advisory fee.
The maturity date of the Senior Secured Notes is the earlier of (i) May 15, 2023, (ii) the closing a Qualified Subsequent Equity Financing
and (iii) the closing of a Change of Control. The Senior Secured Notes bear interest at a rate of 15% per annum of which (i) 10% accrues
from the Closing Date and is paid to holder within 10 days after the first day of each month and (ii) 5% accrues and compound annually
and payable in arrears on the Maturity Date. The Senior Secured Notes are general secured obligations as set forth in a security agreement
between us and the noteholders. The Warrants are exercisable for a period of 10-years from the date of issuance and may be exercised
via cashless exercise/net exercise provisions contained in the Warrants.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 153 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December
31, 2021, we received gross proceeds of $2,929,000 from the issuance of unsecured convertible notes, of which $44,000 was received from
existing members/shareholders. Additionally, a member/shareholder converted a promissory note to a convertible note identical in terms
discussed below.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 1, 2022, we issued
warrants to IPO underwriters to purchase 148,005 shares of Common Stock at an exercise price of $9.10 per share. The warrants are exercisable
180 days after grant (September 27, 2022) and expire five years from date of grant (March 31, 2027). The fair value of the warrants was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest rate of 2.55% and expected
life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in capital and a
reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero impact to additional
paid-in capital.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, holders of 73,000
warrants we previously issued on November 9, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;) with an exercise price of $2.90 exercised their warrants on a cashless basis,
which resulted in the issuance of an additional 31,102 shares of Common Stock. During the same period, holders of 15,000 warrants previously
issued by the Company on November 22, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities
Act with an exercise price of $3.32 exercised their warrants by paying the exercise price, which resulted in the issuance of an additional
15,000 shares of common stock and the receipt by the Company of $49,800.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2023, at the closing
price of $4.84 per share, the Company issued 52,000 shares of Common Stock in reliance on the exemption from registration pursuant to
Section 4(a)(2) of the Securities Act as part of the settlement agreement with Ravi Sinha dated March 21, 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2023, holders of 22,606
warrants previously issued by the Company on November 22, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2)
of the Securities Act with an exercise price of $3.32 exercised their warrants on a cashless basis, which resulted in the issuance of
an additional 10,151 shares of Common Stock.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 10, 2023, we issued
25,000 warrants to our investor relations firm in accordance with a letter of engagement signed July 22, 2022, as partial compensation
for services provided by the investor relations firm. The warrants were issued in reliance on the exemption from registration pursuant
to Section 4(a)(2) of the Securities Act. The warrants are fully vested and exercisable with an expiration date two years from date of
issue (August 9, 2025) and are exercisable at a price of $5.00 per share.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<ix:exclude><!-- Field: Page; Sequence: 154 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 16. EXHIBIT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">See the Exhibit Index immediately
preceding the signature page hereto for a list of exhibits filed as part of this Registration Statement on Form&#160;S-1,&#160;which Exhibit
Index is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
Statement Schedules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">All other schedules have
been omitted because the information required to be set forth therein is not applicable or is shown in the consolidated financial statements
or related notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 17. UNDERTAKINGS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The undersigned registrant
hereby undertakes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
include any prospectus required by Section&#160;10(a)(3)&#160;of the Securities Act;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration
Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b)&#160;if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Filing Fee&#8221;
table in the effective Registration Statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any
material change to such information in the Registration Statement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>provided, however, </i>that paragraphs (a)(1)(i),
(a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act
that are incorporated by reference in the Registration Statement, or is contained in a form of prospectus filed pursuant to Rule 424(b)
that is part of the Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining any liability under the Securities Act, each such post- effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of this Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining liability under the Securities Act to any purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus filed pursuant to Rule&#160;424(b)(3)&#160;shall be deemed to be part of the Registration Statement as of the date the filed
prospectus was deemed part of and included in the Registration Statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5)&#160;or (b)(7)&#160;as part of a registration statement in reliance
on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing
the information required by Section&#160;10(a)&#160;of the Securities Act shall be deemed to be part of and included in the registration
statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of
sale of securities in this Offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and
any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the Registration Statement relating
to the securities in the Registration Statement to which that prospectus relates, and this Offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof. <i>Provided, however</i>, that no statement made in a registration statement or
prospectus that is part of the Registration Statement or made in a document incorporated or deemed incorporated by reference into the
Registration Statement or prospectus that is part of the Registration Statement will, as to a purchaser with a time of contract of sale
prior to such effective date, supersede or modify any statement that was made in the Registration Statement or prospectus that was part
of the Registration Statement or made in any such document immediately prior to such effective date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></p>

<ix:exclude><!-- Field: Page; Sequence: 155 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the
securities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The undersigned registrant undertakes that in a primary
offering of securities of the undersigned registrant pursuant to this Registration Statement, regardless of the underwriting method used
to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications,
the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the
undersigned registrant;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant&#8217;s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated by reference in
the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim
for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<ix:exclude><!-- Field: Page; Sequence: 156 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white"><b>	EXHIBIT INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-top: 2pt"><b>Exhibit<br/>
Number</b></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-top: 2pt"><b>Description</b></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"><b>Form</b></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"><b>Exhibit</b></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="border-top: Black 1pt none; border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"><b>Filing Date</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">3.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex3_1.htm">Articles of Incorporation of the Company, effective as of November 4, 2021</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">3.2</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex3_2.htm">Bylaws of the Company currently in effect</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3.2</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_1.htm">Form of the Company&#8217;s common stock certificate</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.2</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_4.htm">Form of Representative&#8217;s Warrant</a> <span style="color: blue"><span style="text-decoration: underline">Agreement</span></span></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4.4</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.3</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_5.htm">Form of Senior Secured Promissory Note issued to bridge loan investors</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4.5</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.4</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/ex10_15.htm">Form of Warrant with an Exercise Price of $2.90</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.12</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/30/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.5</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/ex10_16.htm">Form of Warrant with an Exercise Price of $3.32&#160;</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.13</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/30/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">5.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_5-1.htm"><span style="background-color: white">Opinion of Stradling Yocca Carlson &amp; Rauth LLP</span>&#160;</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_1.htm">Form of common stock warrant issued to Selling Stockholders</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.2&#8224; </td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_2.htm">Expion360 Inc. 2021 Incentive Award Plan</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.2</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.3&#8224; </td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_3.htm">Expion360 Inc. 2021 Employee Stock Purchase Plan</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.3</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.4</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_7.htm">Form of Security Agreement issued to bridge loan investors</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.7</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.5</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_8.htm">Commercial Lease of premises at 2045 SW Deerhound Avenue Redmond, OR</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.8</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.6</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_11.htm">Commercial Lease of premises at 1266 SW Lake Blvd., Redmond, OR</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.11</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.7</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000149/sfsxpon8k040522ex1_1.htm">Underwriting Agreement dated March 31, 2022, between the Company and Alexander Capital, LP as Representative of the Underwriters</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">1.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4/05/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.8&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_1.htm">Amended and Restated Employment Agreement, between John Yozamp and Expion360 Inc., dated January 26, 2023</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.9&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_2.htm"><span style="color: #0000EE">Amended and Restated Employment Agreement, between Brian Schaffner and Expion360 Inc., dated January 26, 2023</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.10&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_3.htm"><span style="color: #0000EE">Amended and Restated Employment Agreement, between Paul Shoun and Expion360 Inc., dated January 26, 2023</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.11&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_4.htm"><span style="color: #0000EE">Amended and Restated Employment Agreement, between Greg Aydelott and Expion360 Inc., dated January 26, 2023</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.14*</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000983/ex10_2.htm"><span style="background-color: white">Common Stock Purchase Agreement, dated December 27, 2023, between Expion360 Inc. and Tumim Stone Capital, LLC</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.2</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">12/29/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.15*</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000983/ex10_3.htm">Registration Rights Agreement, dated December 27, 2023, between Expion360 Inc. and Tumim Stone Capital, LLC</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.3</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">12/29/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">21.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex21_1.htm"><span style="color: #0000EE">Subsidiaries of the Company</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">21.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">23.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_23-1.htm">Consent of M&amp;K CPAS PLLC&#160;</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">23.2</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_5-1.htm">Consent of Stradling Yocca Carlson &amp; Rauth LLP (included in Exhibit 5.1)</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">24.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="#p_001">Power of Attorney (reference is made to the signature page hereto)</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.INS</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Instance Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.SCH</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Schema Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.CAL</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.DEF</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Definition Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.LAB</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Label Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.PRE</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">104</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101)</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">107</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_107.htm">Filing Fee Table</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
<td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates a management
contract or compensatory plan or arrangement.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
<td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
schedules and exhibits to this agreement have been omitted pursuant to Item&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">601(a)(5)<span style="background-color: white">&#160;of&#160;</span>Regulation
S-K<span style="background-color: white">. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.<b>&#160;</b></span></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 157 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Act
of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the Redmond, Oregon, on this 31st day of January, 2024.</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 48%">&#160;</td>
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPION360 INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: /s/ Brian Schaffner</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Act
of 1933, this Amendment No. 1 to Registration Statement on Form&#160;S-1 has been signed by the following persons in the
capacities and on the dates indicated.</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 55%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brian Schaffner</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Principal Executive Officer</i>)</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Greg Aydelott</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg Aydelott</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal Financial and Accounting Officer)</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George Lefevre</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven M. Shum</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Shoun</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tien Q. Nguyen</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;*By: /s/ Brian Schaffner, attorney-in-fact</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">II-11</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



</ix:nonNumeric></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex_5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; padding: 0pt; width: 50%; font: 10pt/10.5pt Times New Roman, Times, Serif; text-indent: 0pt; vertical-align: bottom"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 38px; width: 105px">&nbsp;</TD>
<TD STYLE="font: 10pt/10.5pt Times New Roman, Times, Serif; text-align: right; padding: 0pt; width: 50%; text-indent: 0pt">Stradling Yocca Carlson &amp; Rauth LLP<BR> 660 Newport Center Drive, Suite 1600<BR> Newport Beach, CA 92660-6422<BR> 949 725 4000<BR> stradlinglaw.com</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">January 31, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Expion360 Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2025 SW Deerhound Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Redmond, OR 97756</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Re:</I></FONT></TD>
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Securities Registered under Registration Statement on
Form S-1</I></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You have requested our opinion
with respect to certain matters in connection with the Registration Statement on Form S-1 (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;)
filed by Expion360 Inc., a Nevada corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), with the Securities and Exchange Commission (the
&ldquo;<B><I>Commission</I></B>&rdquo;) on the date hereof for the purpose of registering under the Securities Act of 1933, as amended
(the &ldquo;<B><I>Securities Act</I></B>&rdquo;), the resale, from time to time, of up to 1,781,978 shares (the &ldquo;<B><I>Shares</I></B>&rdquo;)
of the Company&rsquo;s common stock, par value $0.001 per share, pursuant to the terms of that certain Common Stock Purchase Agreement,
dated December 27, 2023, by and between the Company and Tumim Stone Capital, LLC, a Delaware limited liability company (the &ldquo;<B><I>Equity
Line Purchase Agreement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the preparation
of this opinion, we have examined such documents and considered such questions of law as we have deemed necessary or appropriate. We have
assumed the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as
copies thereof and the genuineness of all signatures. As to questions of fact material to our opinion, we have relied upon the certificates
of certain officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Based
upon the foregoing and in reliance thereon, and subject to the qualifications, limitations, exceptions and assumptions set forth herein,
we are of the opinion that the Shares have been duly authorized by the Company and, when issued and delivered by the Company in the manner
described in Equity Line Purchase Agreement, will be validly issued, fully paid and&nbsp;non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">We render
this opinion only with respect to Chapter 78 of the Nevada Revised Statutes, and we express no opinion herein concerning the application
or effect of the laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We hereby consent to the use of
this opinion as Exhibit 5.1 to the Registration Statement filed with the Commission as of the date hereof, and further consent to the
use of our name under the caption entitled &ldquo;<I>Legal Matters</I>&rdquo; in the Registration Statement. In giving such consent, we
do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the
rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This opinion is intended solely
for use in connection with the resale of the Shares pursuant to the Registration Statement, and may only be relied upon by you and by
persons entitled by law to rely upon it pursuant to the applicable provisions of the federal securities laws. This opinion is rendered
as of the date hereof and based solely on our understanding of facts in existence as of such date after the examination described in this
opinion. We assume no obligation to advise you of any fact, circumstance, event or change in the law or the facts that may hereafter be
brought to our attention whether or not such occurrence would affect or modify the opinions expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Stradling Yocca Carlson &amp;
  Rauth LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Stradling Yocca Carlson &amp; Rauth LLP</I></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; background-color: white">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex_23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">We
hereby consent to the use in this Registration Statement on Form S-1 of our report dated March 30, 2023, of Expion360 Inc. relating
to the audit of the financial statements for the periods ending December 31, 2022 and 2021 and the reference to our firm under the caption
&ldquo;Experts&rdquo; in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><U>/s/ M&amp;K CPAS, PLLC </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">www.mkacpas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Houston, Texas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">January 31, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ex_107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Calculation of Filing Fee Tables</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPION360 INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Table 1: Newly Registered and Carry Forward Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; border-top: black 1pt solid; border-right: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 30%; border-top: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee</B></FONT></TD>
    <TD STYLE="width: 11%; border-top: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT></TD>
    <TD STYLE="width: 11%; border-top: black 1pt solid; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 11%; border-top: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>or Carry</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registered<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount of</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price Per</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class Title</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unit<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee Rate</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee<SUP>(2)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; padding-left: 26pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities to Be Registered</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-left: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees to</FONT></TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Common Stock,</FONT></TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Be Paid</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value $0.001 per share</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,781,978</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.36</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$7,769,424</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 4.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0001476</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;$1,146.77</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Offering Amounts</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$7,769,424</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;$1,146.77</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Fees Previously Paid</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;$1,146.77</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Fee Offsets</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;$1,146.77</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net Fee Due</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;$0</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to Rule 416(a) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this Registration Statement shall also
cover any additional shares of common stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;), of the registrant that become issuable
by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with Rule 457(c), based on the average of the high ($4.52) and low ($4.20) prices of the Common Stock on The Nasdaq Stock Market
on January 22, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 40.5pt 0 45pt; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0 0.15in; text-indent: -0.15in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0 0.15in; text-indent: -0.15in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !4 % # 2(  A$! Q$!_\0
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M/<NP!6,8Z9/8 =?K4N,9;H329\^75S/>W+W-S(TDTA!=SU/&/Y"BV_X^X?\
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MKX<U^<Z?;V5WI]U(K&)S/YBD@9P:Y^!2E[$C##+*%(]PV#3C.[MU!.Y-JO\
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:8TGPO9&TTNV$8;F21CN>0^K-W_E110(__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  F &D# 2(  A$! Q$!_\0
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M\3ZGXO\ "NL7&HQQ32I(\*11+L##8#M_'.,U3N_!&NZQJL*SR6^GV7DCS9H
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&@HZKJ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>xpon-20230930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96sps7xRiXgOn8uFZn9MSaiOKbOdx5Z7CelBtmV7bYmary8pE0K6iiGqWejW8V8I -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:XPON="http://expion360.com/20230930" elementFormDefault="qualified" targetNamespace="http://expion360.com/20230930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://expion360.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficit" id="StatementsOfStockholdersEquityDeficit">
          <link:definition>00000005 - Statement - Statements of Stockholders Equity (Deficit)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/BalanceSheetsStatement" id="BalanceSheetsStatement">
          <link:definition>00000007 - Statement - Balance Sheets (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/BalanceSheetsParentheticalStatement" id="BalanceSheetsParentheticalStatement">
          <link:definition>00000008 - Statement - Balance Sheets (Unaudited) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement" id="StatementsOfStockholdersEquityDeficitStatement">
          <link:definition>00000009 - Statement - Statements of Stockholders Equity (Deficit) (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StatementsOfCashFlowsStatement" id="StatementsOfCashFlowsStatement">
          <link:definition>00000010 - Statement - Statements of Cash Flows (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/OrganizationAndNatureOfOperations" id="OrganizationAndNatureOfOperations">
          <link:definition>00000011 - Disclosure - Organization and Nature of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000012 - Disclosure - Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
          <link:definition>00000013 - Disclosure - Property and Equipment, Net</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities" id="AccruedExpensesAndOtherCurrentLiabilities">
          <link:definition>00000014 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues" id="LiabilitiesForSaleOfFutureRevenues">
          <link:definition>00000015 - Disclosure - Liabilities for Sale of Future Revenues</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/Short-termRevolvingLoans" id="Short-termRevolvingLoans">
          <link:definition>00000016 - Disclosure - Short-Term Revolving Loans</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/Long-termDebt" id="Long-termDebt">
          <link:definition>00000017 - Disclosure - Long-Term Debt</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/ShareholderPromissoryNotes" id="ShareholderPromissoryNotes">
          <link:definition>00000018 - Disclosure - Shareholder Promissory Notes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/ConvertibleNotes" id="ConvertibleNotes">
          <link:definition>00000019 - Disclosure - Convertible Notes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000020 - Disclosure - Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/ConversionToCCorporation" id="ConversionToCCorporation">
          <link:definition>00000021 - Disclosure - Conversion to a C Corporation</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquity" id="StockholdersEquity">
          <link:definition>00000022 - Disclosure - Stockholders&#8217; Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000023 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/KPlan" id="KPlan">
          <link:definition>00000024 - Disclosure - 401(k) Plan</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000025 - Disclosure - Related Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000026 - Disclosure - Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholderPromissoryNotes" id="StockholderPromissoryNotes">
          <link:definition>00000027 - Disclosure - Stockholder Promissory Notes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000028 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000029 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
          <link:definition>00000030 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" id="AccruedExpensesAndOtherCurrentLiabilitiesTables">
          <link:definition>00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/Long-termDebtTables" id="Long-termDebtTables">
          <link:definition>00000032 - Disclosure - Long-Term Debt (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
          <link:definition>00000033 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
          <link:definition>00000034 - Disclosure - Stockholders&#8217; Equity (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000035 - Disclosure - Income Taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
          <link:definition>00000036 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1" id="SummaryOfSignificantAccountingPoliciesDetails1">
          <link:definition>00000037 - Disclosure - Summary of Significant Accounting Policies (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2" id="SummaryOfSignificantAccountingPoliciesDetails2">
          <link:definition>00000038 - Disclosure - Summary of Significant Accounting Policies (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
          <link:definition>00000040 - Disclosure - Property and Equipment Net (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative" id="PropertyAndEquipmentNetDetailsNarrative">
          <link:definition>00000041 - Disclosure - Property and Equipment, Net (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" id="AccruedExpensesAndOtherCurrentLiabilitiesDetails">
          <link:definition>00000042 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/ScheduleOfLong-termDebtDetails" id="ScheduleOfLong-termDebtDetails">
          <link:definition>00000043 - Disclosure - Schedule of long-term debt (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/Long-termDebtDetails1" id="Long-termDebtDetails1">
          <link:definition>00000044 - Disclosure - Long-Term Debt (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative" id="ShareholderPromissoryNotesDetailsNarrative">
          <link:definition>00000045 - Disclosure - Shareholder Promissory Notes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
          <link:definition>00000046 - Disclosure - Commitments and Contingencies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails1" id="CommitmentsAndContingenciesDetails1">
          <link:definition>00000047 - Disclosure - Commitments and Contingencies (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails2" id="CommitmentsAndContingenciesDetails2">
          <link:definition>00000048 - Disclosure - Commitments and Contingencies (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000049 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
          <link:definition>00000050 - Disclosure -  Stockholders Equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails1" id="StockholdersEquityDetails1">
          <link:definition>00000051 - Disclosure -  Stockholders Equity (Details1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails2" id="StockholdersEquityDetails2">
          <link:definition>00000052 - Disclosure -  Stockholders Equity (Details2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails3" id="StockholdersEquityDetails3">
          <link:definition>00000053 - Disclosure -  Stockholders Equity (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
          <link:definition>00000054 - Disclosure - Stockholders&#8217; Equity (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
          <link:definition>00000055 - Disclosure - Income Taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
          <link:definition>00000056 - Disclosure - Income Taxes (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/IncomeTaxesDetails2" id="IncomeTaxesDetails2">
          <link:definition>00000057 - Disclosure - Income Taxes (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/IncomeTaxesDetails3" id="IncomeTaxesDetails3">
          <link:definition>00000058 - Disclosure - Income Taxes (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000059 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails" id="ScheduleOfEstimatedUsefulLivesDetails">
          <link:definition>00000060 - Disclosure - Schedule of estimated useful lives (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure" id="PropertyAndEquipmentNetDetailsDisclosure">
          <link:definition>00000061 - Disclosure - Property and Equipment, Net (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/Long-termDebtDetails" id="Long-termDebtDetails">
          <link:definition>00000062 - Disclosure - Long-Term Debt (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetailsDisclosure" id="StockholdersEquityDetailsDisclosure">
          <link:definition>00000063 - Disclosure - Stockholders Equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails1Disclosure" id="StockholdersEquityDetails1Disclosure">
          <link:definition>00000064 - Disclosure - Stockholders Equity (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails2Disclosure" id="StockholdersEquityDetails2Disclosure">
          <link:definition>00000065 - Disclosure - Stockholders Equity (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails3Disclosure" id="StockholdersEquityDetails3Disclosure">
          <link:definition>00000066 - Disclosure - Stockholders Equity (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://expion360.com/role/StockholdersEquityDetails4" id="StockholdersEquityDetails4">
          <link:definition>00000067 - Disclosure - Stockholders Equity (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="xpon-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="xpon-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="xpon-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="xpon-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="XPON_VehiclesAndTransportationEquipmentMember" name="VehiclesAndTransportationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ManufacturingEquipmentMember" name="ManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_QAEquipmentMember" name="QAEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ToolingAndMoldsMember" name="ToolingAndMoldsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_StockOptionsMember" name="StockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_RSUMember" name="RSUMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_OfficeFurnitureEquipmentMember" name="OfficeFurnitureEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_WarehouseEquipmentMember" name="WarehouseEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_SeniorSecuredPromissoryNotesMember" name="SeniorSecuredPromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NotePayableCreditUnionMember" name="NotePayableCreditUnionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NotePayableSBAMember" name="NotePayableSBAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NotePayableIndividualMember" name="NotePayableIndividualMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NotePayableFinanceCompanyMember" name="NotePayableFinanceCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NotePayableFinanceCompany1Member" name="NotePayableFinanceCompany1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_GMFinancialMember" name="GMFinancialMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ExercisePrice1Member" name="ExercisePrice1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ExercisePrice2Member" name="ExercisePrice2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ExercisePrice3Member" name="ExercisePrice3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ExercisePrice4Member" name="ExercisePrice4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_UnrelatedToAnyPlanMember" name="UnrelatedToAnyPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_OfficeFurnitureAndEquipmentMember" name="OfficeFurnitureAndEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_WarehouseEequipmentMember" name="WarehouseEequipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ExercisePricesMember" name="ExercisePricesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ExercisePrice5Member" name="ExercisePrice5Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_LiabilityForSaleOfFutureRevenuesNet" name="LiabilityForSaleOfFutureRevenuesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NotesPayableCurrent1" name="NotesPayableCurrent1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_LongTermDebtCurrent1" name="LongTermDebtCurrent1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ShareholderPromissoryNotes" name="ShareholderPromissoryNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NetLossPerShareBasicAndDiluted" name="NetLossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_WeightedaverageNumberOfCommonSharesOutstanding" name="WeightedaverageNumberOfCommonSharesOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_EffectOfInducedConversionOfDebt" name="EffectOfInducedConversionOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesInExchangeForBuildingSignageValue" name="IssuanceOfSharesInExchangeForBuildingSignageValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesInExchangeForBuildingSignage" name="IssuanceOfSharesInExchangeForBuildingSignage" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_StockIssuedDuringPeriodValueNewIssuesOne" name="StockIssuedDuringPeriodValueNewIssuesOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_StockIssuedDuringPeriodValueNewIssuesOneShares" name="StockIssuedDuringPeriodValueNewIssuesOneShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes" name="IssuanceOfSharesUponSettlementOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares" name="IssuanceOfSharesUponSettlementOfConvertibleNotesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_StockIssuedDuringPeriodValueNewIssuesTwo" name="StockIssuedDuringPeriodValueNewIssuesTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares" name="StockIssuedDuringPeriodValueNewIssuesTwoShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfDetachableWarrantsToLongTermDebt" name="IssuanceOfDetachableWarrantsToLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfWarrantsToUnderwriters" name="IssuanceOfWarrantsToUnderwriters" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfWarrantsInExchangeForServicesOne" name="IssuanceOfWarrantsInExchangeForServicesOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfOptionsInExchangeForServicesOne" name="IssuanceOfOptionsInExchangeForServicesOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" name="IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" name="IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesInExchangeForIPOServicesAmount" name="IssuanceOfSharesInExchangeForIPOServicesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfSharesInExchangeForIPOServices" name="IssuanceOfSharesInExchangeForIPOServices" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfStockOptions" name="IssuanceOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AccruedInterestOnConvertibleNote" name="AccruedInterestOnConvertibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" name="AmortizationOfDebtDiscountSaleOfFutureRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IncreaseInAllowanceForDoubtfulAccounts" name="IncreaseInAllowanceForDoubtfulAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IncreaseDecreaseInPrepaidintransitInventory" name="IncreaseDecreaseInPrepaidintransitInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IncreaseDecreaseInLiabilityForRefunds" name="IncreaseDecreaseInLiabilityForRefunds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" name="IncreaseInRightofuseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount" name="ProceedsFromSaleOfFutureRevenuesNetOfDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" name="PaymentsOnLiabilityForSaleOfFutureRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NonCashOperatingActivities" name="NonCashOperatingActivities" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock" name="ConvertibleNotesAndAccruedInterestConvertedToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ReclassificationOfAccruedInterestToLongTermDebt" name="ReclassificationOfAccruedInterestToLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt" name="ReclassificationOfModifiedConvertibleNoteToLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" name="ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment" name="IssuanceOfCommonStockInExchangeForPropertyAndequipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" name="AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" name="PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" name="PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ReclassificationOfDepositToPropertyAndEquipment" name="ReclassificationOfDepositToPropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ConversionOfConvertibleNotesIntoCommonStock" name="ConversionOfConvertibleNotesIntoCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" name="FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" name="MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_FranchiseTaxesRefund" name="FranchiseTaxesRefund" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ProceedsReceivedFromExerciseOfWarrants" name="ProceedsReceivedFromExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ProceedsReceivedFromExerciseOfWarrantsShares" name="ProceedsReceivedFromExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_StockIssuedAsResultOfLitigationSettlementShares" name="StockIssuedAsResultOfLitigationSettlementShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ExerciseOfWarrantsShares" name="ExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfWarrants" name="IssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IssuanceOfRestrictedStockUnit" name="IssuanceOfRestrictedStockUnit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts" name="IncreaseDecreaseInAllowanceForDoubtfulAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans" name="PaymentsOnLineofcreditAndShorttermRevolvingLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_CashPaidRefundedForFranchiseTaxes" name="CashPaidRefundedForFranchiseTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_CashlessWarrantExercises" name="CashlessWarrantExercises" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" name="PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" name="DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock" name="LiabilitiesForSaleOfFutureRevenuesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DisclosureShareholderPromissoryNotesAbstract" name="DisclosureShareholderPromissoryNotesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ShareholderPromissoryNotesTextBlock" name="ShareholderPromissoryNotesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DisclosureConvertibleNotesAbstract" name="DisclosureConvertibleNotesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ConvertibleNotesTextBlock" name="ConvertibleNotesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DisclosureConversionToCCorporationAbstract" name="DisclosureConversionToCCorporationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ConversionOfStockTextBlock" name="ConversionOfStockTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_RelatedPartyTransactionsTextBlock" name="RelatedPartyTransactionsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DisclosureStockholderPromissoryNotesAbstract" name="DisclosureStockholderPromissoryNotesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_LiquidityAndCapitalResourcesPolicyTextBlock" name="LiquidityAndCapitalResourcesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_CustomerDepositsPolicyTextBlock" name="CustomerDepositsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" name="VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_LiabilityForRefundsPolicyTextBlock" name="LiabilityForRefundsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" name="AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock" name="ScheduleOfEstimatedUsfulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock" name="ScheduleOfEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" name="ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForIssuanceTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NetLoss" name="NetLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NetLossOne" name="NetLossOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ProccedsFromIpoNetsCost" name="ProccedsFromIpoNetsCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_TreasuryRelatedPaper" name="TreasuryRelatedPaper" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AdjustmentsToBadDebtExpense" name="AdjustmentsToBadDebtExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ShippingAndHandlingCostsForShippingProduct" name="ShippingAndHandlingCostsForShippingProduct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DisposalsAndSalesOfFixedAssets" name="DisposalsAndSalesOfFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_RebateLiability" name="RebateLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DeferredIncomeAndDepositSublease" name="DeferredIncomeAndDepositSublease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_FranchiseTax" name="FranchiseTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_WarrantsToPurchase" name="WarrantsToPurchase" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_LessNotePayableInDefaultPaid" name="LessNotePayableInDefaultPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DeferredIncomeAndSubleaseDeposit" name="DeferredIncomeAndSubleaseDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AggregateIntrinsicValueForfeited" name="AggregateIntrinsicValueForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" name="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers" name="DeferredTaxAssetsTaxCreditCarryforwardsOthers" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_DeferredTaxAssetsValuationAllowanceOne" name="DeferredTaxAssetsValuationAllowanceOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_AccountsPayableRelatedPartiesCurrentOne" name="AccountsPayableRelatedPartiesCurrentOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NumberOfWarrantsnonplanOptionsOne" name="NumberOfWarrantsnonplanOptionsOne" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NumberOfWarrantsnonplanOptionsTwo" name="NumberOfWarrantsnonplanOptionsTwo" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NumberOfWarrantsnonplanOptionsThree" name="NumberOfWarrantsnonplanOptionsThree" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_NumberOfWarrantsnonplanOptionsFour" name="NumberOfWarrantsnonplanOptionsFour" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>xpon-20230930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://expion360.com/role/Cover" xlink:href="xpon-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheets" xlink:href="xpon-20230930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsParenthetical" xlink:href="xpon-20230930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfOperations" xlink:href="xpon-20230930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="xpon-20230930.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfCashFlows" xlink:href="xpon-20230930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsStatement" xlink:href="xpon-20230930.xsd#BalanceSheetsStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsParentheticalStatement" xlink:href="xpon-20230930.xsd#BalanceSheetsParentheticalStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement" xlink:href="xpon-20230930.xsd#StatementsOfStockholdersEquityDeficitStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfCashFlowsStatement" xlink:href="xpon-20230930.xsd#StatementsOfCashFlowsStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/OrganizationAndNatureOfOperations" xlink:href="xpon-20230930.xsd#OrganizationAndNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNet" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues" xlink:href="xpon-20230930.xsd#LiabilitiesForSaleOfFutureRevenues" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Short-termRevolvingLoans" xlink:href="xpon-20230930.xsd#Short-termRevolvingLoans" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebt" xlink:href="xpon-20230930.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ShareholderPromissoryNotes" xlink:href="xpon-20230930.xsd#ShareholderPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ConvertibleNotes" xlink:href="xpon-20230930.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingencies" xlink:href="xpon-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ConversionToCCorporation" xlink:href="xpon-20230930.xsd#ConversionToCCorporation" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquity" xlink:href="xpon-20230930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxes" xlink:href="xpon-20230930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/KPlan" xlink:href="xpon-20230930.xsd#KPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/RelatedPartyTransactions" xlink:href="xpon-20230930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SubsequentEvents" xlink:href="xpon-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholderPromissoryNotes" xlink:href="xpon-20230930.xsd#StockholderPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetTables" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtTables" xlink:href="xpon-20230930.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesTables" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityTables" xlink:href="xpon-20230930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesTables" xlink:href="xpon-20230930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetails" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ScheduleOfLong-termDebtDetails" xlink:href="xpon-20230930.xsd#ScheduleOfLong-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtDetails1" xlink:href="xpon-20230930.xsd#Long-termDebtDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative" xlink:href="xpon-20230930.xsd#ShareholderPromissoryNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails1" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails2" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails1" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails2" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails3" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetailsNarrative" xlink:href="xpon-20230930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails1" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails2" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails3" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="xpon-20230930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="xpon-20230930.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtDetails" xlink:href="xpon-20230930.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetailsDisclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails1Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails1Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails2Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails2Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails3Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails3Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails4" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails4" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryInTransit" xlink:label="loc_us-gaapOtherInventoryInTransit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherInventoryInTransit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="loc_us-gaapCustomerDepositsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCustomerDepositsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiabilityForSaleOfFutureRevenuesNet" xlink:label="loc_XPONLiabilityForSaleOfFutureRevenuesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_XPONLiabilityForSaleOfFutureRevenuesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotesPayableCurrent1" xlink:label="loc_XPONNotesPayableCurrent1" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_XPONNotesPayableCurrent1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LongTermDebtCurrent1" xlink:label="loc_XPONLongTermDebtCurrent1" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_XPONLongTermDebtCurrent1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Statements of Stockholders Equity (Deficit)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AccruedInterestOnConvertibleNote" xlink:label="loc_XPONAccruedInterestOnConvertibleNote" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONAccruedInterestOnConvertibleNote" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:label="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:label="loc_us-gaapInducedConversionOfConvertibleDebtExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInducedConversionOfConvertibleDebtExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInAllowanceForDoubtfulAccounts" xlink:label="loc_XPONIncreaseInAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONIncreaseInAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInPrepaidintransitInventory" xlink:label="loc_XPONIncreaseDecreaseInPrepaidintransitInventory" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONIncreaseDecreaseInPrepaidintransitInventory" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInDeposits" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInCustomerDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInCustomerDeposits" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInLiabilityForRefunds" xlink:label="loc_XPONIncreaseDecreaseInLiabilityForRefunds" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONIncreaseDecreaseInLiabilityForRefunds" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:label="loc_us-gaapPaymentsForProceedsFromProductiveAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount" xlink:label="loc_XPONProceedsFromSaleOfFutureRevenuesNetOfDiscount" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_XPONProceedsFromSaleOfFutureRevenuesNetOfDiscount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" xlink:label="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsStatement" xlink:title="00000007 - Statement - Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryInTransit" xlink:label="loc_us-gaapOtherInventoryInTransit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherInventoryInTransit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="loc_us-gaapCustomerDepositsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCustomerDepositsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapLitigationSettlementExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsParentheticalStatement" xlink:title="00000008 - Statement - Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement" xlink:title="00000009 - Statement - Statements of Stockholders Equity (Deficit) (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfCashFlowsStatement" xlink:title="00000010 - Statement - Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:label="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts" xlink:label="loc_XPONIncreaseDecreaseInAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONIncreaseDecreaseInAllowanceForDoubtfulAccounts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInOtherDeposits" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:label="loc_us-gaapPaymentsForProceedsFromProductiveAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans" xlink:label="loc_XPONPaymentsOnLineofcreditAndShorttermRevolvingLoans" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_XPONPaymentsOnLineofcreditAndShorttermRevolvingLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" xlink:label="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/OrganizationAndNatureOfOperations" xlink:title="00000011 - Disclosure - Organization and Nature of Operations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000012 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNet" xlink:title="00000013 - Disclosure - Property and Equipment, Net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:title="00000014 - Disclosure - Accrued Expenses and Other Current Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues" xlink:title="00000015 - Disclosure - Liabilities for Sale of Future Revenues" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/Short-termRevolvingLoans" xlink:title="00000016 - Disclosure - Short-Term Revolving Loans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebt" xlink:title="00000017 - Disclosure - Long-Term Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/ShareholderPromissoryNotes" xlink:title="00000018 - Disclosure - Shareholder Promissory Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/ConvertibleNotes" xlink:title="00000019 - Disclosure - Convertible Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingencies" xlink:title="00000020 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/ConversionToCCorporation" xlink:title="00000021 - Disclosure - Conversion to a C Corporation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquity" xlink:title="00000022 - Disclosure - Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/KPlan" xlink:title="00000024 - Disclosure - 401(k) Plan" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/RelatedPartyTransactions" xlink:title="00000025 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SubsequentEvents" xlink:title="00000026 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholderPromissoryNotes" xlink:title="00000027 - Disclosure - Stockholder Promissory Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetTables" xlink:title="00000030 - Disclosure - Property and Equipment, Net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtTables" xlink:title="00000032 - Disclosure - Long-Term Debt (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesTables" xlink:title="00000033 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityTables" xlink:title="00000034 - Disclosure - Stockholders&#8217; Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesTables" xlink:title="00000035 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2" xlink:title="00000038 - Disclosure - Summary of Significant Accounting Policies (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000040 - Disclosure - Property and Equipment Net (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000041 - Disclosure - Property and Equipment, Net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="00000042 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/ScheduleOfLong-termDebtDetails" xlink:title="00000043 - Disclosure - Schedule of long-term debt (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtDetails1" xlink:title="00000044 - Disclosure - Long-Term Debt (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative" xlink:title="00000045 - Disclosure - Shareholder Promissory Notes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000046 - Disclosure - Commitments and Contingencies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails1" xlink:title="00000047 - Disclosure - Commitments and Contingencies (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails2" xlink:title="00000048 - Disclosure - Commitments and Contingencies (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000049 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails" xlink:title="00000050 - Disclosure -  Stockholders Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails1" xlink:title="00000051 - Disclosure -  Stockholders Equity (Details1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails2" xlink:title="00000052 - Disclosure -  Stockholders Equity (Details2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails3" xlink:title="00000053 - Disclosure -  Stockholders Equity (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000054 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails" xlink:title="00000055 - Disclosure - Income Taxes (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails1" xlink:title="00000056 - Disclosure - Income Taxes (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails2" xlink:title="00000057 - Disclosure - Income Taxes (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails3" xlink:title="00000058 - Disclosure - Income Taxes (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000059 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000060 - Disclosure - Schedule of estimated useful lives (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure" xlink:title="00000061 - Disclosure - Property and Equipment, Net (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtDetails" xlink:title="00000062 - Disclosure - Long-Term Debt (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetailsDisclosure" xlink:title="00000063 - Disclosure - Stockholders Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails1Disclosure" xlink:title="00000064 - Disclosure - Stockholders Equity (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails2Disclosure" xlink:title="00000065 - Disclosure - Stockholders Equity (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails3Disclosure" xlink:title="00000066 - Disclosure - Stockholders Equity (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails4" xlink:title="00000067 - Disclosure - Stockholders Equity (Details 4)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>xpon-20230930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://expion360.com/role/Cover" xlink:href="xpon-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheets" xlink:href="xpon-20230930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsParenthetical" xlink:href="xpon-20230930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfOperations" xlink:href="xpon-20230930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="xpon-20230930.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfCashFlows" xlink:href="xpon-20230930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsStatement" xlink:href="xpon-20230930.xsd#BalanceSheetsStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsParentheticalStatement" xlink:href="xpon-20230930.xsd#BalanceSheetsParentheticalStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement" xlink:href="xpon-20230930.xsd#StatementsOfStockholdersEquityDeficitStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfCashFlowsStatement" xlink:href="xpon-20230930.xsd#StatementsOfCashFlowsStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/OrganizationAndNatureOfOperations" xlink:href="xpon-20230930.xsd#OrganizationAndNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNet" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues" xlink:href="xpon-20230930.xsd#LiabilitiesForSaleOfFutureRevenues" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Short-termRevolvingLoans" xlink:href="xpon-20230930.xsd#Short-termRevolvingLoans" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebt" xlink:href="xpon-20230930.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ShareholderPromissoryNotes" xlink:href="xpon-20230930.xsd#ShareholderPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ConvertibleNotes" xlink:href="xpon-20230930.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingencies" xlink:href="xpon-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ConversionToCCorporation" xlink:href="xpon-20230930.xsd#ConversionToCCorporation" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquity" xlink:href="xpon-20230930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxes" xlink:href="xpon-20230930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/KPlan" xlink:href="xpon-20230930.xsd#KPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/RelatedPartyTransactions" xlink:href="xpon-20230930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SubsequentEvents" xlink:href="xpon-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholderPromissoryNotes" xlink:href="xpon-20230930.xsd#StockholderPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetTables" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtTables" xlink:href="xpon-20230930.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesTables" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityTables" xlink:href="xpon-20230930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesTables" xlink:href="xpon-20230930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetails" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ScheduleOfLong-termDebtDetails" xlink:href="xpon-20230930.xsd#ScheduleOfLong-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtDetails1" xlink:href="xpon-20230930.xsd#Long-termDebtDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative" xlink:href="xpon-20230930.xsd#ShareholderPromissoryNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails1" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails2" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails1" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails2" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails3" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetailsNarrative" xlink:href="xpon-20230930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails1" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails2" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails3" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="xpon-20230930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="xpon-20230930.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtDetails" xlink:href="xpon-20230930.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetailsDisclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails1Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails1Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails2Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails2Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails3Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails3Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails4" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails4" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Statements of Stockholders Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_EffectOfInducedConversionOfDebt" xlink:label="loc_XPONEffectOfInducedConversionOfDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONEffectOfInducedConversionOfDebt_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForBuildingSignageValue" xlink:label="loc_XPONIssuanceOfSharesInExchangeForBuildingSignageValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForBuildingSignageValue_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForBuildingSignage" xlink:label="loc_XPONIssuanceOfSharesInExchangeForBuildingSignage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForBuildingSignage_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesOne" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesOne_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesOne_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesOneShares" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesOneShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesOneShares_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes" xlink:label="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotes_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotes_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares" xlink:label="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotesShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotesShares_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwo_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwoShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwoShares_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfDetachableWarrantsToLongTermDebt" xlink:label="loc_XPONIssuanceOfDetachableWarrantsToLongTermDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfDetachableWarrantsToLongTermDebt_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrantsToUnderwriters" xlink:label="loc_XPONIssuanceOfWarrantsToUnderwriters_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfWarrantsToUnderwriters_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrantsInExchangeForServicesOne" xlink:label="loc_XPONIssuanceOfWarrantsInExchangeForServicesOne_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfWarrantsInExchangeForServicesOne_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfOptionsInExchangeForServicesOne" xlink:label="loc_XPONIssuanceOfOptionsInExchangeForServicesOne_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfOptionsInExchangeForServicesOne_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" xlink:label="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" xlink:label="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForIPOServicesAmount" xlink:label="loc_XPONIssuanceOfSharesInExchangeForIPOServicesAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForIPOServicesAmount_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForIPOServices" xlink:label="loc_XPONIssuanceOfSharesInExchangeForIPOServices_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForIPOServices_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfStockOptions" xlink:label="loc_XPONIssuanceOfStockOptions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfStockOptions_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_50" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsStatement" xlink:title="00000007 - Statement - Balance Sheets (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsParentheticalStatement" xlink:title="00000008 - Statement - Balance Sheets (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement" xlink:title="00000009 - Statement - Statements of Stockholders Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsReceivedFromExerciseOfWarrants" xlink:label="loc_XPONProceedsReceivedFromExerciseOfWarrants_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONProceedsReceivedFromExerciseOfWarrants_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsReceivedFromExerciseOfWarrantsShares" xlink:label="loc_XPONProceedsReceivedFromExerciseOfWarrantsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONProceedsReceivedFromExerciseOfWarrantsShares_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedAsResultOfLitigationSettlementShares" xlink:label="loc_XPONStockIssuedAsResultOfLitigationSettlementShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedAsResultOfLitigationSettlementShares_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsDiluted" xlink:label="loc_us-gaapUndistributedEarningsDiluted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUndistributedEarningsDiluted_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExerciseOfWarrantsShares" xlink:label="loc_XPONExerciseOfWarrantsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONExerciseOfWarrantsShares_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrants" xlink:label="loc_XPONIssuanceOfWarrants_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfWarrants_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfRestrictedStockUnit" xlink:label="loc_XPONIssuanceOfRestrictedStockUnit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfRestrictedStockUnit_50" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfCashFlowsStatement" xlink:title="00000010 - Statement - Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/OrganizationAndNatureOfOperations" xlink:title="00000011 - Disclosure - Organization and Nature of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000012 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNet" xlink:title="00000013 - Disclosure - Property and Equipment, Net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:title="00000014 - Disclosure - Accrued Expenses and Other Current Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues" xlink:title="00000015 - Disclosure - Liabilities for Sale of Future Revenues" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/Short-termRevolvingLoans" xlink:title="00000016 - Disclosure - Short-Term Revolving Loans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebt" xlink:title="00000017 - Disclosure - Long-Term Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/ShareholderPromissoryNotes" xlink:title="00000018 - Disclosure - Shareholder Promissory Notes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/ConvertibleNotes" xlink:title="00000019 - Disclosure - Convertible Notes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingencies" xlink:title="00000020 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/ConversionToCCorporation" xlink:title="00000021 - Disclosure - Conversion to a C Corporation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquity" xlink:title="00000022 - Disclosure - Stockholders&#8217; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/KPlan" xlink:title="00000024 - Disclosure - 401(k) Plan" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/RelatedPartyTransactions" xlink:title="00000025 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SubsequentEvents" xlink:title="00000026 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholderPromissoryNotes" xlink:title="00000027 - Disclosure - Stockholder Promissory Notes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetTables" xlink:title="00000030 - Disclosure - Property and Equipment, Net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtTables" xlink:title="00000032 - Disclosure - Long-Term Debt (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesTables" xlink:title="00000033 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityTables" xlink:title="00000034 - Disclosure - Stockholders&#8217; Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesTables" xlink:title="00000035 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2" xlink:title="00000038 - Disclosure - Summary of Significant Accounting Policies (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_XPONStockOptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_RSUMember" xlink:label="loc_XPONRSUMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_XPONRSUMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" xlink:label="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" xlink:label="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_120" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProccedsFromIpoNetsCost" xlink:label="loc_XPONProccedsFromIpoNetsCost_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONProccedsFromIpoNetsCost_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositContractsAssets" xlink:label="loc_us-gaapDepositContractsAssets_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositContractsAssets_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="loc_us-gaapCustomerDepositsCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCustomerDepositsCurrent_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryFinishedGoods_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryRawMaterials_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryNetOfReserves" xlink:label="loc_us-gaapOtherInventoryNetOfReserves_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherInventoryNetOfReserves_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepurchaseOfEquity" xlink:label="loc_us-gaapProceedsFromRepurchaseOfEquity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfEquity_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease" xlink:label="loc_us-gaapFDICIndemnificationAssetPeriodIncreaseDecrease_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFDICIndemnificationAssetPeriodIncreaseDecrease_110" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_TreasuryRelatedPaper" xlink:label="loc_XPONTreasuryRelatedPaper_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONTreasuryRelatedPaper_110" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AdjustmentsToBadDebtExpense" xlink:label="loc_XPONAdjustmentsToBadDebtExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONAdjustmentsToBadDebtExpense_110" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies" xlink:label="loc_us-gaapSupplies_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplies_110" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_110" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShippingAndHandlingCostsForShippingProduct" xlink:label="loc_XPONShippingAndHandlingCostsForShippingProduct_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONShippingAndHandlingCostsForShippingProduct_110" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000040 - Disclosure - Property and Equipment Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureEquipmentMember" xlink:label="loc_XPONOfficeFurnitureEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONOfficeFurnitureEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEquipmentMember" xlink:label="loc_XPONWarehouseEquipmentMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONWarehouseEquipmentMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_170" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000041 - Disclosure - Property and Equipment, Net (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="00000042 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/ScheduleOfLong-termDebtDetails" xlink:title="00000043 - Disclosure - Schedule of long-term debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SeniorSecuredPromissoryNotesMember" xlink:label="loc_XPONSeniorSecuredPromissoryNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONSeniorSecuredPromissoryNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="loc_us-gaapNotesPayableToBanksMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapNotesPayableToBanksMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableCreditUnionMember" xlink:label="loc_XPONNotePayableCreditUnionMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableCreditUnionMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableSBAMember" xlink:label="loc_XPONNotePayableSBAMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableSBAMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableIndividualMember" xlink:label="loc_XPONNotePayableIndividualMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableIndividualMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompanyMember" xlink:label="loc_XPONNotePayableFinanceCompanyMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompanyMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompany1Member" xlink:label="loc_XPONNotePayableFinanceCompany1Member_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompany1Member_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_GMFinancialMember" xlink:label="loc_XPONGMFinancialMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONGMFinancialMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarrantsToPurchase" xlink:label="loc_XPONWarrantsToPurchase_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_XPONWarrantsToPurchase_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaapDebtCurrent_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtCurrent_280" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LessNotePayableInDefaultPaid" xlink:label="loc_XPONLessNotePayableInDefaultPaid_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_XPONLessNotePayableInDefaultPaid_280" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_280" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtDetails1" xlink:title="00000044 - Disclosure - Long-Term Debt (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative" xlink:title="00000045 - Disclosure - Shareholder Promissory Notes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000046 - Disclosure - Commitments and Contingencies (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails1" xlink:title="00000047 - Disclosure - Commitments and Contingencies (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails2" xlink:title="00000048 - Disclosure - Commitments and Contingencies (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000049 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails" xlink:title="00000050 - Disclosure -  Stockholders Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice1Member" xlink:label="loc_XPONExercisePrice1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice2Member" xlink:label="loc_XPONExercisePrice2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice3Member" xlink:label="loc_XPONExercisePrice3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice4Member" xlink:label="loc_XPONExercisePrice4Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice4Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_100" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails1" xlink:title="00000051 - Disclosure -  Stockholders Equity (Details1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails2" xlink:title="00000052 - Disclosure -  Stockholders Equity (Details2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONStockOptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AggregateIntrinsicValueForfeited" xlink:label="loc_XPONAggregateIntrinsicValueForfeited_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONAggregateIntrinsicValueForfeited_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:label="loc_XPONShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails3" xlink:title="00000053 - Disclosure -  Stockholders Equity (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_UnrelatedToAnyPlanMember" xlink:label="loc_XPONUnrelatedToAnyPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONUnrelatedToAnyPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONStockOptionsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000054 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails" xlink:title="00000055 - Disclosure - Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails1" xlink:title="00000056 - Disclosure - Income Taxes (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails2" xlink:title="00000057 - Disclosure - Income Taxes (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails3" xlink:title="00000058 - Disclosure - Income Taxes (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000059 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000060 - Disclosure - Schedule of estimated useful lives (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureAndEquipmentMember" xlink:label="loc_XPONOfficeFurnitureAndEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONOfficeFurnitureAndEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEequipmentMember" xlink:label="loc_XPONWarehouseEequipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONWarehouseEequipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure" xlink:title="00000061 - Disclosure - Property and Equipment, Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureEquipmentMember" xlink:label="loc_XPONOfficeFurnitureEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONOfficeFurnitureEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEquipmentMember" xlink:label="loc_XPONWarehouseEquipmentMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONWarehouseEquipmentMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_170" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtDetails" xlink:title="00000062 - Disclosure - Long-Term Debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SeniorSecuredPromissoryNotesMember" xlink:label="loc_XPONSeniorSecuredPromissoryNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONSeniorSecuredPromissoryNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="loc_us-gaapNotesPayableToBanksMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapNotesPayableToBanksMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableCreditUnionMember" xlink:label="loc_XPONNotePayableCreditUnionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableCreditUnionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableSBAMember" xlink:label="loc_XPONNotePayableSBAMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableSBAMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableIndividualMember" xlink:label="loc_XPONNotePayableIndividualMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableIndividualMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompanyMember" xlink:label="loc_XPONNotePayableFinanceCompanyMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompanyMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompany1Member" xlink:label="loc_XPONNotePayableFinanceCompany1Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompany1Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_GMFinancialMember" xlink:label="loc_XPONGMFinancialMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONGMFinancialMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaapDebtCurrent_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtCurrent_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_190" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetailsDisclosure" xlink:title="00000063 - Disclosure - Stockholders Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice1Member" xlink:label="loc_XPONExercisePrice1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePricesMember" xlink:label="loc_XPONExercisePricesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePricesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice2Member" xlink:label="loc_XPONExercisePrice2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice3Member" xlink:label="loc_XPONExercisePrice3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice4Member" xlink:label="loc_XPONExercisePrice4Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice4Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice5Member" xlink:label="loc_XPONExercisePrice5Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice5Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsOne" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsOne_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsOne_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsTwo" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsTwo_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsTwo_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsThree" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsThree_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsThree_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsFour" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsFour_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsFour_110" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails1Disclosure" xlink:title="00000064 - Disclosure - Stockholders Equity (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails2Disclosure" xlink:title="00000065 - Disclosure - Stockholders Equity (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionMember" xlink:label="loc_us-gaapOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" xlink:label="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" xlink:label="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:label="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_50" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails3Disclosure" xlink:title="00000066 - Disclosure - Stockholders Equity (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails4" xlink:title="00000067 - Disclosure - Stockholders Equity (Details 4)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_UnrelatedToAnyPlanMember" xlink:label="loc_XPONUnrelatedToAnyPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONUnrelatedToAnyPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONStockOptionsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_60" xlink:type="arc" order="0" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>xpon-20230930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="XPON_VehiclesAndTransportationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_VehiclesAndTransportationEquipmentMember" xlink:to="XPON_VehiclesAndTransportationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_VehiclesAndTransportationEquipmentMember_lbl" xml:lang="en-US">Vehicles And Transportation Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="XPON_ManufacturingEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ManufacturingEquipmentMember" xlink:to="XPON_ManufacturingEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ManufacturingEquipmentMember_lbl" xml:lang="en-US">Manufacturing Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="XPON_QAEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_QAEquipmentMember" xlink:to="XPON_QAEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_QAEquipmentMember_lbl" xml:lang="en-US">Q A Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="XPON_ToolingAndMoldsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ToolingAndMoldsMember" xlink:to="XPON_ToolingAndMoldsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ToolingAndMoldsMember_lbl" xml:lang="en-US">Tooling And Molds [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="XPON_StockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_StockOptionsMember" xlink:to="XPON_StockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_StockOptionsMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_RSUMember" xlink:label="XPON_RSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_RSUMember" xlink:to="XPON_RSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_RSUMember_lbl" xml:lang="en-US">R S U [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureEquipmentMember" xlink:label="XPON_OfficeFurnitureEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_OfficeFurnitureEquipmentMember" xlink:to="XPON_OfficeFurnitureEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_OfficeFurnitureEquipmentMember_lbl" xml:lang="en-US">Office Furniture Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEquipmentMember" xlink:label="XPON_WarehouseEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_WarehouseEquipmentMember" xlink:to="XPON_WarehouseEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_WarehouseEquipmentMember_lbl" xml:lang="en-US">Warehouse Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SeniorSecuredPromissoryNotesMember" xlink:label="XPON_SeniorSecuredPromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_SeniorSecuredPromissoryNotesMember" xlink:to="XPON_SeniorSecuredPromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_SeniorSecuredPromissoryNotesMember_lbl" xml:lang="en-US">Senior Secured Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="us-gaap_NotesPayableToBanksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableToBanksMember" xlink:to="us-gaap_NotesPayableToBanksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableToBanksMember_lbl" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableCreditUnionMember" xlink:label="XPON_NotePayableCreditUnionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NotePayableCreditUnionMember" xlink:to="XPON_NotePayableCreditUnionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NotePayableCreditUnionMember_lbl" xml:lang="en-US">Note Payable Credit Union [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableSBAMember" xlink:label="XPON_NotePayableSBAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NotePayableSBAMember" xlink:to="XPON_NotePayableSBAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NotePayableSBAMember_lbl" xml:lang="en-US">Note Payable S B A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableIndividualMember" xlink:label="XPON_NotePayableIndividualMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NotePayableIndividualMember" xlink:to="XPON_NotePayableIndividualMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NotePayableIndividualMember_lbl" xml:lang="en-US">Note Payable Individual [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompanyMember" xlink:label="XPON_NotePayableFinanceCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NotePayableFinanceCompanyMember" xlink:to="XPON_NotePayableFinanceCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NotePayableFinanceCompanyMember_lbl" xml:lang="en-US">Note Payable Finance Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompany1Member" xlink:label="XPON_NotePayableFinanceCompany1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NotePayableFinanceCompany1Member" xlink:to="XPON_NotePayableFinanceCompany1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NotePayableFinanceCompany1Member_lbl" xml:lang="en-US">Note Payable Finance Company 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_GMFinancialMember" xlink:label="XPON_GMFinancialMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_GMFinancialMember" xlink:to="XPON_GMFinancialMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_GMFinancialMember_lbl" xml:lang="en-US">G M Financial [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice1Member" xlink:label="XPON_ExercisePrice1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExercisePrice1Member" xlink:to="XPON_ExercisePrice1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ExercisePrice1Member_lbl" xml:lang="en-US">Exercise Price 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice2Member" xlink:label="XPON_ExercisePrice2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExercisePrice2Member" xlink:to="XPON_ExercisePrice2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ExercisePrice2Member_lbl" xml:lang="en-US">Exercise Price 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice3Member" xlink:label="XPON_ExercisePrice3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExercisePrice3Member" xlink:to="XPON_ExercisePrice3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ExercisePrice3Member_lbl" xml:lang="en-US">Exercise Price 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice4Member" xlink:label="XPON_ExercisePrice4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExercisePrice4Member" xlink:to="XPON_ExercisePrice4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ExercisePrice4Member_lbl" xml:lang="en-US">Exercise Price 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_UnrelatedToAnyPlanMember" xlink:label="XPON_UnrelatedToAnyPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_UnrelatedToAnyPlanMember" xlink:to="XPON_UnrelatedToAnyPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_UnrelatedToAnyPlanMember_lbl" xml:lang="en-US">Unrelated To Any Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureAndEquipmentMember" xlink:label="XPON_OfficeFurnitureAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_OfficeFurnitureAndEquipmentMember" xlink:to="XPON_OfficeFurnitureAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_OfficeFurnitureAndEquipmentMember_lbl" xml:lang="en-US">Office Furniture And Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEequipmentMember" xlink:label="XPON_WarehouseEequipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_WarehouseEequipmentMember" xlink:to="XPON_WarehouseEequipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_WarehouseEequipmentMember_lbl" xml:lang="en-US">Warehouse Eequipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePricesMember" xlink:label="XPON_ExercisePricesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExercisePricesMember" xlink:to="XPON_ExercisePricesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ExercisePricesMember_lbl" xml:lang="en-US">Exercise Prices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice5Member" xlink:label="XPON_ExercisePrice5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExercisePrice5Member" xlink:to="XPON_ExercisePrice5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ExercisePrice5Member_lbl" xml:lang="en-US">Exercise Price 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionMember" xlink:label="us-gaap_OptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionMember" xlink:to="us-gaap_OptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionMember_lbl" xml:lang="en-US">Options Held [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">&#160;&#160;&#160;Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryInTransit" xlink:label="us-gaap_OtherInventoryInTransit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryInTransit" xlink:to="us-gaap_OtherInventoryInTransit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventoryInTransit_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid/in-transit inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">&#160;&#160;&#160;Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">&#160;&#160;&#160;Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">&#160;&#160;&#160;Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">&#160;&#160;&#160;Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Operating leases &#8211; right-of-use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">&#160;&#160;&#160;Total other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">&#160;&#160;&#160;Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="us-gaap_CustomerDepositsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerDepositsCurrent" xlink:to="us-gaap_CustomerDepositsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerDepositsCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Accrued expenses and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Line of credit and short-term revolving loans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiabilityForSaleOfFutureRevenuesNet" xlink:label="XPON_LiabilityForSaleOfFutureRevenuesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_LiabilityForSaleOfFutureRevenuesNet" xlink:to="XPON_LiabilityForSaleOfFutureRevenuesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_LiabilityForSaleOfFutureRevenuesNet_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Liability for sale of future revenues, net</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotesPayableCurrent1" xlink:label="XPON_NotesPayableCurrent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NotesPayableCurrent1" xlink:to="XPON_NotesPayableCurrent1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NotesPayableCurrent1_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Note payable in default</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LongTermDebtCurrent1" xlink:label="XPON_LongTermDebtCurrent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_LongTermDebtCurrent1" xlink:to="XPON_LongTermDebtCurrent1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_LongTermDebtCurrent1_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;Long-term debt, net of current portion and discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;Operating lease liability, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareholderPromissoryNotes" xlink:label="XPON_ShareholderPromissoryNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ShareholderPromissoryNotes" xlink:to="XPON_ShareholderPromissoryNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ShareholderPromissoryNotes_lbl" xml:lang="en-US">&#160;&#160;&#160;Shareholder promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">&#160;&#160;&#160;Stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, par value $.001; 20,000,000 shares authorized; zero shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $.001; 200,000,000 shares authorized; 6,802,464 and 4,300,000 issued and outstanding as of December 31, 2022 and 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">&#160;&#160;&#160;Total stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Sales, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">&#160;&#160;&#160;Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US">&#160;&#160;&#160;Debt conversion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">&#160;&#160;&#160;Extinguishment loss on debt settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">&#160;&#160;&#160;Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">&#160;&#160;Gain on sale of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncome" xlink:label="us-gaap_OtherOperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherOperatingIncome_lbl" xml:lang="en-US">&#160;&#160;&#160;Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other (income) / expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Tax (income) / expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLossPerShareBasicAndDiluted" xlink:label="XPON_NetLossPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NetLossPerShareBasicAndDiluted" xlink:to="XPON_NetLossPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NetLossPerShareBasicAndDiluted_lbl" xml:lang="en-US">Net loss per share (basic and diluted)</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WeightedaverageNumberOfCommonSharesOutstanding" xlink:label="XPON_WeightedaverageNumberOfCommonSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_WeightedaverageNumberOfCommonSharesOutstanding" xlink:to="XPON_WeightedaverageNumberOfCommonSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_WeightedaverageNumberOfCommonSharesOutstanding_lbl" xml:lang="en-US">Weighted-average number of common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xml:lang="en-US">Issuance of shares upon conversion of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of shares upon conversion of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_EffectOfInducedConversionOfDebt" xlink:label="XPON_EffectOfInducedConversionOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_EffectOfInducedConversionOfDebt" xlink:to="XPON_EffectOfInducedConversionOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_EffectOfInducedConversionOfDebt_lbl" xml:lang="en-US">Effect of induced conversion of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForBuildingSignageValue" xlink:label="XPON_IssuanceOfSharesInExchangeForBuildingSignageValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesInExchangeForBuildingSignageValue" xlink:to="XPON_IssuanceOfSharesInExchangeForBuildingSignageValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesInExchangeForBuildingSignageValue_lbl" xml:lang="en-US">Issuance of shares in exchange for building signage</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForBuildingSignage" xlink:label="XPON_IssuanceOfSharesInExchangeForBuildingSignage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesInExchangeForBuildingSignage" xlink:to="XPON_IssuanceOfSharesInExchangeForBuildingSignage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_IssuanceOfSharesInExchangeForBuildingSignage_lbl" xml:lang="en-US">Issuance of shares in exchange for building signage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of shares for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of shares for cash Share</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesOne" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_StockIssuedDuringPeriodValueNewIssuesOne" xlink:to="XPON_StockIssuedDuringPeriodValueNewIssuesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesOne_lbl" xml:lang="en-US">Issuance of shares for cash class</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesOneShares" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesOneShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_StockIssuedDuringPeriodValueNewIssuesOneShares" xlink:to="XPON_StockIssuedDuringPeriodValueNewIssuesOneShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesOneShares_lbl" xml:lang="en-US">Issuance of shares for cash Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes" xlink:label="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes" xlink:to="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes_lbl" xml:lang="en-US">Issuance of shares upon settlement of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares" xlink:label="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares" xlink:to="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares_lbl" xml:lang="en-US">Issuance of shares upon settlement of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of shares in exchange for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of shares in exchange for service</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:to="XPON_StockIssuedDuringPeriodValueNewIssuesTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesTwo_lbl" xml:lang="en-US">Issuance of shares for cash amount</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares" xlink:to="XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares_lbl" xml:lang="en-US">Issuance of new shares for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfDetachableWarrantsToLongTermDebt" xlink:label="XPON_IssuanceOfDetachableWarrantsToLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfDetachableWarrantsToLongTermDebt" xlink:to="XPON_IssuanceOfDetachableWarrantsToLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfDetachableWarrantsToLongTermDebt_lbl" xml:lang="en-US">Issuance of detachable warrants to long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrantsToUnderwriters" xlink:label="XPON_IssuanceOfWarrantsToUnderwriters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfWarrantsToUnderwriters" xlink:to="XPON_IssuanceOfWarrantsToUnderwriters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfWarrantsToUnderwriters_lbl" xml:lang="en-US">Issuance of warrants to underwriters</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrantsInExchangeForServicesOne" xlink:label="XPON_IssuanceOfWarrantsInExchangeForServicesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfWarrantsInExchangeForServicesOne" xlink:to="XPON_IssuanceOfWarrantsInExchangeForServicesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfWarrantsInExchangeForServicesOne_lbl" xml:lang="en-US">Issuance of warrants in exchange for services</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfOptionsInExchangeForServicesOne" xlink:label="XPON_IssuanceOfOptionsInExchangeForServicesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfOptionsInExchangeForServicesOne" xlink:to="XPON_IssuanceOfOptionsInExchangeForServicesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfOptionsInExchangeForServicesOne_lbl" xml:lang="en-US">Issuance of options in exchange for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" xlink:label="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" xlink:to="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts_lbl" xml:lang="en-US">Issuance of shares, initial public offering, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" xlink:label="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" xlink:to="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares_lbl" xml:lang="en-US">Issuance of shares, initial public offering, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForIPOServicesAmount" xlink:label="XPON_IssuanceOfSharesInExchangeForIPOServicesAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesInExchangeForIPOServicesAmount" xlink:to="XPON_IssuanceOfSharesInExchangeForIPOServicesAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesInExchangeForIPOServicesAmount_lbl" xml:lang="en-US">Issuance of shares in exchange for IPO services</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForIPOServices" xlink:label="XPON_IssuanceOfSharesInExchangeForIPOServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesInExchangeForIPOServices" xlink:to="XPON_IssuanceOfSharesInExchangeForIPOServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_IssuanceOfSharesInExchangeForIPOServices_lbl" xml:lang="en-US">Issuance of shares in exchange for IPO services</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfStockOptions" xlink:label="XPON_IssuanceOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfStockOptions" xlink:to="XPON_IssuanceOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfStockOptions_lbl" xml:lang="en-US">Issuance of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xml:lang="en-US">Issuance of stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AccruedInterestOnConvertibleNote" xlink:label="XPON_AccruedInterestOnConvertibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AccruedInterestOnConvertibleNote" xlink:to="XPON_AccruedInterestOnConvertibleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AccruedInterestOnConvertibleNote_lbl" xml:lang="en-US">Accrued interest on convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:label="XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:to="XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues_lbl" xml:lang="en-US">Amortization of debt discount (sale of future revenues)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount - notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:label="us-gaap_InducedConversionOfConvertibleDebtExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:to="us-gaap_InducedConversionOfConvertibleDebtExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InducedConversionOfConvertibleDebtExpense_lbl" xml:lang="en-US">Debt conversion expense on induced conversion of convertible notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Extinguishment loss on debt settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Gain on sale of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInAllowanceForDoubtfulAccounts" xlink:label="XPON_IncreaseInAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseInAllowanceForDoubtfulAccounts" xlink:to="XPON_IncreaseInAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IncreaseInAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Increase in allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">(Increase) / Decrease in accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">(Increase) in inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInPrepaidintransitInventory" xlink:label="XPON_IncreaseDecreaseInPrepaidintransitInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseDecreaseInPrepaidintransitInventory" xlink:to="XPON_IncreaseDecreaseInPrepaidintransitInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="XPON_IncreaseDecreaseInPrepaidintransitInventory_lbl" xml:lang="en-US">(Increase) / Decrease in prepaid/in-transit inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">(Increase) in prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeposits" xlink:label="us-gaap_IncreaseDecreaseInDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeposits" xlink:to="us-gaap_IncreaseDecreaseInDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeposits_lbl" xml:lang="en-US">(Increase) in deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Increase / (Decrease) in accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInCustomerDeposits" xlink:label="us-gaap_IncreaseDecreaseInCustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerDeposits" xlink:to="us-gaap_IncreaseDecreaseInCustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCustomerDeposits_lbl" xml:lang="en-US">(Decrease) in customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xml:lang="en-US">Increase in accrued expenses and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInLiabilityForRefunds" xlink:label="XPON_IncreaseDecreaseInLiabilityForRefunds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseDecreaseInLiabilityForRefunds" xlink:to="XPON_IncreaseDecreaseInLiabilityForRefunds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="XPON_IncreaseDecreaseInLiabilityForRefunds_lbl" xml:lang="en-US">(Decrease) in liability for refunds</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:label="XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:to="XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Increase in right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:label="us-gaap_PaymentsForProceedsFromProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:to="us-gaap_PaymentsForProceedsFromProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromProductiveAssets_lbl" xml:lang="en-US">&#160;&#160;&#160;Net proceeds from sale of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Payments on line of credit and short-term revolving loans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Principal payments on long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount" xlink:label="XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount" xlink:to="XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount_lbl" xml:lang="en-US">Proceeds from sale of future revenues, net of discount</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" xlink:label="XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" xlink:to="XPON_PaymentsOnLiabilityForSaleOfFutureRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_PaymentsOnLiabilityForSaleOfFutureRevenues_lbl" xml:lang="en-US">Payments on liability for sale of future revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from issuance of convertible notes, net of discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents, beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for franchise taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NonCashOperatingActivities" xlink:label="XPON_NonCashOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NonCashOperatingActivities" xlink:to="XPON_NonCashOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NonCashOperatingActivities_lbl" xml:lang="en-US">Non-cash operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock" xlink:label="XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock" xlink:to="XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock_lbl" xml:lang="en-US">Convertible notes and accrued interest converted to common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfAccruedInterestToLongTermDebt" xlink:label="XPON_ReclassificationOfAccruedInterestToLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ReclassificationOfAccruedInterestToLongTermDebt" xlink:to="XPON_ReclassificationOfAccruedInterestToLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ReclassificationOfAccruedInterestToLongTermDebt_lbl" xml:lang="en-US">Reclassification of accrued interest to long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt" xlink:label="XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt" xlink:to="XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt_lbl" xml:lang="en-US">Reclassification of modified convertible note to long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" xlink:label="XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" xlink:to="XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes_lbl" xml:lang="en-US">Reclassification of modified member promissory note to convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment" xlink:label="XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment" xlink:to="XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment_lbl" xml:lang="en-US">Issuance of common stock in exchange for property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" xlink:label="XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" xlink:to="XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability_lbl" xml:lang="en-US">Acquisition/modification of operating lease right-of-use asset and lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" xlink:label="XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" xlink:to="XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable_lbl" xml:lang="en-US">Purchases of property and equipment in exchange for long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" xlink:label="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" xlink:to="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt_lbl" xml:lang="en-US">Purchases of property and equipment in exchange for short-term payable</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfDepositToPropertyAndEquipment" xlink:label="XPON_ReclassificationOfDepositToPropertyAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ReclassificationOfDepositToPropertyAndEquipment" xlink:to="XPON_ReclassificationOfDepositToPropertyAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ReclassificationOfDepositToPropertyAndEquipment_lbl" xml:lang="en-US">Reclassification of deposit to property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConversionOfConvertibleNotesIntoCommonStock" xlink:label="XPON_ConversionOfConvertibleNotesIntoCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ConversionOfConvertibleNotesIntoCommonStock" xlink:to="XPON_ConversionOfConvertibleNotesIntoCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ConversionOfConvertibleNotesIntoCommonStock_lbl" xml:lang="en-US">Conversion of 2021 convertible notes into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" xlink:label="XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" xlink:to="XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita_lbl" xml:lang="en-US">Fair value of warrants issued in connection with long-term debt recorded as debt discount and additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" xlink:label="XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" xlink:to="XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation_lbl" xml:lang="en-US">Membership contributions reclassified to additional paid-in capital upon conversion to C corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Current portion of stockholder promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xml:lang="en-US">&#160;&#160;&#160;Long-term debt, net of current portion and discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">&#160;&#160;&#160;Stockholder promissory notes, net of current portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common stock, par value $.001; 200,000,000 shares authorized; 6,910,717 and 6,802,464 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">&#160;&#160;&#160;Total stockholders&#8217; equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other (Income) / Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xml:lang="en-US">(Gain) / Loss on sale of property &amp; equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xml:lang="en-US">&#160;&#160;&#160;Settlement expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">&#160;&#160;&#160;Other (income) / expense</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_FranchiseTaxesRefund" xlink:label="XPON_FranchiseTaxesRefund" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_FranchiseTaxesRefund" xlink:to="XPON_FranchiseTaxesRefund_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_FranchiseTaxesRefund_lbl" xml:lang="en-US">Franchise taxes / (refund)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Issuance of shares, net of issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Issuance of shares, net of issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Issuance of shares in exchange for IPO services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Issuance of shares in exchange for IPO services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsReceivedFromExerciseOfWarrants" xlink:label="XPON_ProceedsReceivedFromExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ProceedsReceivedFromExerciseOfWarrants" xlink:to="XPON_ProceedsReceivedFromExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ProceedsReceivedFromExerciseOfWarrants_lbl" xml:lang="en-US">Proceeds received from exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsReceivedFromExerciseOfWarrantsShares" xlink:label="XPON_ProceedsReceivedFromExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ProceedsReceivedFromExerciseOfWarrantsShares" xlink:to="XPON_ProceedsReceivedFromExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_ProceedsReceivedFromExerciseOfWarrantsShares_lbl" xml:lang="en-US">Proceeds received from exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Stock issued as a result of litigation settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedAsResultOfLitigationSettlementShares" xlink:label="XPON_StockIssuedAsResultOfLitigationSettlementShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_StockIssuedAsResultOfLitigationSettlementShares" xlink:to="XPON_StockIssuedAsResultOfLitigationSettlementShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_StockIssuedAsResultOfLitigationSettlementShares_lbl" xml:lang="en-US">Stock issued as a result of litigation settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsDiluted" xlink:label="us-gaap_UndistributedEarningsDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsDiluted" xlink:to="us-gaap_UndistributedEarningsDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsDiluted_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExerciseOfWarrantsShares" xlink:label="XPON_ExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExerciseOfWarrantsShares" xlink:to="XPON_ExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_ExerciseOfWarrantsShares_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrants" xlink:label="XPON_IssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfWarrants" xlink:to="XPON_IssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfWarrants_lbl" xml:lang="en-US">Issuance of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfRestrictedStockUnit" xlink:label="XPON_IssuanceOfRestrictedStockUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfRestrictedStockUnit" xlink:to="XPON_IssuanceOfRestrictedStockUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfRestrictedStockUnit_lbl" xml:lang="en-US">Issuance of RSUs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2_lbl" xml:lang="en-US">Cash flows&#160;from operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xml:lang="en-US">(Gain) / Loss on sale of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts" xlink:label="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts" xlink:to="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Increase / (Decrease) in allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement_lbl" xml:lang="en-US">Stock-based settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">(Increase) / Decrease in accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">(Increase) / Decrease in inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Decrease in prepaid/in-transit inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase in prepaid expenses and other current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeposits" xlink:to="us-gaap_IncreaseDecreaseInDeposits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeposits_2_lbl" xml:lang="en-US">(Increase) / Decrease in deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeposits" xlink:label="us-gaap_IncreaseDecreaseInOtherDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherDeposits" xlink:to="us-gaap_IncreaseDecreaseInOtherDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherDeposits_lbl" xml:lang="en-US">Increase / (Decrease) in customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xml:lang="en-US">Increase / (Decrease) in accrued expenses and other current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:to="us-gaap_PaymentsForProceedsFromProductiveAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsForProceedsFromProductiveAssets_2_lbl" xml:lang="en-US">Net proceeds from sale of property and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net cash provided by / (used in) investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans" xlink:label="XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans" xlink:to="XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans_lbl" xml:lang="en-US">Payments on line-of-credit and short-term revolving loans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Net proceeds from exercise of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net cash provided by / (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_CashPaidRefundedForFranchiseTaxes" xlink:label="XPON_CashPaidRefundedForFranchiseTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_CashPaidRefundedForFranchiseTaxes" xlink:to="XPON_CashPaidRefundedForFranchiseTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_CashPaidRefundedForFranchiseTaxes_lbl" xml:lang="en-US">Cash paid / (refunded) for franchise taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_CashlessWarrantExercises" xlink:label="XPON_CashlessWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_CashlessWarrantExercises" xlink:to="XPON_CashlessWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_CashlessWarrantExercises_lbl" xml:lang="en-US">Cashless warrant exercises</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" xlink:to="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt_2_lbl" xml:lang="en-US">Purchases of property and equipment in exchange for long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" xlink:label="XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" xlink:to="XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable_lbl" xml:lang="en-US">Purchased of property and equipment in exchange for short-term payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Organization and Nature of Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" xlink:label="XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" xlink:to="XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract_lbl" xml:lang="en-US">Liabilities For Sale Of Future Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock" xlink:label="XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock" xlink:to="XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock_lbl" xml:lang="en-US">Liabilities for Sale of Future Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Short-Term Revolving Loans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureShareholderPromissoryNotesAbstract" xlink:label="XPON_DisclosureShareholderPromissoryNotesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DisclosureShareholderPromissoryNotesAbstract" xlink:to="XPON_DisclosureShareholderPromissoryNotesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DisclosureShareholderPromissoryNotesAbstract_lbl" xml:lang="en-US">Shareholder Promissory Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareholderPromissoryNotesTextBlock" xlink:label="XPON_ShareholderPromissoryNotesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ShareholderPromissoryNotesTextBlock" xlink:to="XPON_ShareholderPromissoryNotesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_ShareholderPromissoryNotesTextBlock_lbl" xml:lang="en-US">Shareholder Promissory Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureConvertibleNotesAbstract" xlink:label="XPON_DisclosureConvertibleNotesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DisclosureConvertibleNotesAbstract" xlink:to="XPON_DisclosureConvertibleNotesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DisclosureConvertibleNotesAbstract_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConvertibleNotesTextBlock" xlink:label="XPON_ConvertibleNotesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ConvertibleNotesTextBlock" xlink:to="XPON_ConvertibleNotesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_ConvertibleNotesTextBlock_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureConversionToCCorporationAbstract" xlink:label="XPON_DisclosureConversionToCCorporationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DisclosureConversionToCCorporationAbstract" xlink:to="XPON_DisclosureConversionToCCorporationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DisclosureConversionToCCorporationAbstract_lbl" xml:lang="en-US">Conversion To C Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConversionOfStockTextBlock" xlink:label="XPON_ConversionOfStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ConversionOfStockTextBlock" xlink:to="XPON_ConversionOfStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ConversionOfStockTextBlock_lbl" xml:lang="en-US">Conversion to a C Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanTextBlock" xlink:label="us-gaap_DefinedBenefitPlanTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanTextBlock" xlink:to="us-gaap_DefinedBenefitPlanTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanTextBlock_lbl" xml:lang="en-US">401(k) Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_RelatedPartyTransactionsTextBlock" xlink:label="XPON_RelatedPartyTransactionsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_RelatedPartyTransactionsTextBlock" xlink:to="XPON_RelatedPartyTransactionsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_RelatedPartyTransactionsTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:label="XPON_DisclosureStockholderPromissoryNotesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:to="XPON_DisclosureStockholderPromissoryNotesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DisclosureStockholderPromissoryNotesAbstract_lbl" xml:lang="en-US">Stockholder Promissory Notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ShareholderPromissoryNotesTextBlock" xlink:to="XPON_ShareholderPromissoryNotesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="XPON_ShareholderPromissoryNotesTextBlock_2_lbl" xml:lang="en-US">Stockholder Promissory Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassification of Prior Year Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:label="XPON_LiquidityAndCapitalResourcesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:to="XPON_LiquidityAndCapitalResourcesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_LiquidityAndCapitalResourcesPolicyTextBlock_lbl" xml:lang="en-US">Going Concern, Liquidity and Capital Resources</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_CustomerDepositsPolicyTextBlock" xlink:label="XPON_CustomerDepositsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_CustomerDepositsPolicyTextBlock" xlink:to="XPON_CustomerDepositsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_CustomerDepositsPolicyTextBlock_lbl" xml:lang="en-US">Customer Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" xlink:label="XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" xlink:to="XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_lbl" xml:lang="en-US">Vendor and Foreign Concentrations of Inventory Suppliers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtendedProductWarrantyPolicy" xlink:label="us-gaap_ExtendedProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtendedProductWarrantyPolicy" xlink:to="us-gaap_ExtendedProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtendedProductWarrantyPolicy_lbl" xml:lang="en-US">Product Warranties</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiabilityForRefundsPolicyTextBlock" xlink:label="XPON_LiabilityForRefundsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_LiabilityForRefundsPolicyTextBlock" xlink:to="XPON_LiabilityForRefundsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_LiabilityForRefundsPolicyTextBlock_lbl" xml:lang="en-US">Liability for Refunds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Major Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShippingAndHandlingCostPolicyTextBlock" xlink:label="us-gaap_ShippingAndHandlingCostPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingCostPolicyTextBlock" xlink:to="us-gaap_ShippingAndHandlingCostPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingCostPolicyTextBlock_lbl" xml:lang="en-US">Shipping and Handling Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising and Marketing Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" xlink:label="XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" xlink:to="XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_lbl" xml:lang="en-US">Accounting Guidance Issued but Not Yet Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock" xlink:label="XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock" xlink:to="XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of anti-dilutive share</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:label="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:to="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accrued expenses and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of long term debt payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Maturities of Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum lease payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum sublease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" xlink:label="XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" xlink:to="XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of various warrants/options issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions used</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:label="XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:to="XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xml:lang="en-US">Schedule of common stock shares reserved for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xml:lang="en-US">Summary of Operating Loss Carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLoss" xlink:label="XPON_NetLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NetLoss" xlink:to="XPON_NetLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_NetLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_WeightedaverageNumberOfCommonSharesOutstanding" xlink:to="XPON_WeightedaverageNumberOfCommonSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_WeightedaverageNumberOfCommonSharesOutstanding_2_lbl" xml:lang="en-US">Weighted average common shares outstanding &#8211; basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NetLossPerShareBasicAndDiluted" xlink:to="XPON_NetLossPerShareBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_NetLossPerShareBasicAndDiluted_2_lbl" xml:lang="en-US">Basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLossOne" xlink:label="XPON_NetLossOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NetLossOne" xlink:to="XPON_NetLossOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_NetLossOne_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" xlink:label="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" xlink:to="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_lbl" xml:lang="en-US">[custom:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" xlink:label="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" xlink:to="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_lbl" xml:lang="en-US">[custom:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProccedsFromIpoNetsCost" xlink:label="XPON_ProccedsFromIpoNetsCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ProccedsFromIpoNetsCost" xlink:to="XPON_ProccedsFromIpoNetsCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ProccedsFromIpoNetsCost_lbl" xml:lang="en-US">Procceds from IPO nets cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash balances exceeded FDIC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositContractsAssets" xlink:label="us-gaap_DepositContractsAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositContractsAssets" xlink:to="us-gaap_DepositContractsAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositContractsAssets_lbl" xml:lang="en-US">Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerDepositsCurrent" xlink:to="us-gaap_CustomerDepositsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CustomerDepositsCurrent_2_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Inventory, Finished Goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryNetOfReserves" xlink:label="us-gaap_OtherInventoryNetOfReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryNetOfReserves" xlink:to="us-gaap_OtherInventoryNetOfReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventoryNetOfReserves_lbl" xml:lang="en-US">inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Advertising and marketing expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepurchaseOfEquity" xlink:label="us-gaap_ProceedsFromRepurchaseOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="us-gaap_ProceedsFromRepurchaseOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepurchaseOfEquity_lbl" xml:lang="en-US">Net proceeds from Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease" xlink:label="us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease" xlink:to="us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease_lbl" xml:lang="en-US">FDIC Limits</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_TreasuryRelatedPaper" xlink:label="XPON_TreasuryRelatedPaper" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_TreasuryRelatedPaper" xlink:to="XPON_TreasuryRelatedPaper_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_TreasuryRelatedPaper_lbl" xml:lang="en-US">Treasury related paper</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AdjustmentsToBadDebtExpense" xlink:label="XPON_AdjustmentsToBadDebtExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AdjustmentsToBadDebtExpense" xlink:to="XPON_AdjustmentsToBadDebtExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AdjustmentsToBadDebtExpense_lbl" xml:lang="en-US">Adjustments to BadDebt Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryFinishedGoods_2_lbl" xml:lang="en-US">Finished Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies" xlink:label="us-gaap_Supplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Supplies" xlink:to="us-gaap_Supplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Supplies_lbl" xml:lang="en-US">Inventory purchases from foreign suppliers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Shipping and handling fee</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShippingAndHandlingCostsForShippingProduct" xlink:label="XPON_ShippingAndHandlingCostsForShippingProduct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ShippingAndHandlingCostsForShippingProduct" xlink:to="XPON_ShippingAndHandlingCostsForShippingProduct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ShippingAndHandlingCostsForShippingProduct_lbl" xml:lang="en-US">Shipping and Handling Costs for Shipping Product</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisposalsAndSalesOfFixedAssets" xlink:label="XPON_DisposalsAndSalesOfFixedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DisposalsAndSalesOfFixedAssets" xlink:to="XPON_DisposalsAndSalesOfFixedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DisposalsAndSalesOfFixedAssets_lbl" xml:lang="en-US">Disposals and sales of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued salaries and payroll liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_RebateLiability" xlink:label="XPON_RebateLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_RebateLiability" xlink:to="XPON_RebateLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_RebateLiability_lbl" xml:lang="en-US">Rebate liability</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredIncomeAndDepositSublease" xlink:label="XPON_DeferredIncomeAndDepositSublease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DeferredIncomeAndDepositSublease" xlink:to="XPON_DeferredIncomeAndDepositSublease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DeferredIncomeAndDepositSublease_lbl" xml:lang="en-US">Deferred income and deposit (sublease)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrent_lbl" xml:lang="en-US">Commissions</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_FranchiseTax" xlink:label="XPON_FranchiseTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_FranchiseTax" xlink:to="XPON_FranchiseTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_FranchiseTax_lbl" xml:lang="en-US">Franchise tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_2_lbl" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarrantsToPurchase" xlink:label="XPON_WarrantsToPurchase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_WarrantsToPurchase" xlink:to="XPON_WarrantsToPurchase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_WarrantsToPurchase_lbl" xml:lang="en-US">[custom:WarrantsToPurchase]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_2_lbl" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtCurrent" xlink:to="us-gaap_DebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtCurrent_lbl" xml:lang="en-US">Debt, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LessNotePayableInDefaultPaid" xlink:label="XPON_LessNotePayableInDefaultPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_LessNotePayableInDefaultPaid" xlink:to="XPON_LessNotePayableInDefaultPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_LessNotePayableInDefaultPaid_lbl" xml:lang="en-US">Less note payable in default (paid April 2022)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_2_lbl" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:label="us-gaap_LongTermDebtMaturingInYearsTwoAndThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:to="us-gaap_LongTermDebtMaturingInYearsTwoAndThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturingInYearsTwoAndThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherMinorityInterests" xlink:label="us-gaap_OtherMinorityInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherMinorityInterests" xlink:to="us-gaap_OtherMinorityInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherMinorityInterests_lbl" xml:lang="en-US">Interest paid to the shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short-term lease costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US">Variable lease costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US">Sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Total future minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Current lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Noncurrent lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions_lbl" xml:lang="en-US">Total future minimum lease payments&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Sub Rental Income</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredIncomeAndSubleaseDeposit" xlink:label="XPON_DeferredIncomeAndSubleaseDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DeferredIncomeAndSubleaseDeposit" xlink:to="XPON_DeferredIncomeAndSubleaseDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DeferredIncomeAndSubleaseDeposit_lbl" xml:lang="en-US">Deferred income and sublease deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price outstanding at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value Outstanding at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AggregateIntrinsicValueForfeited" xlink:label="XPON_AggregateIntrinsicValueForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AggregateIntrinsicValueForfeited" xlink:to="XPON_AggregateIntrinsicValueForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AggregateIntrinsicValueForfeited_lbl" xml:lang="en-US">Aggregate intrinsic value forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding at end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price outstaning at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual term (in years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate intrinsic value end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:label="XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:to="XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Weighted average Price exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted average remaining contractual term (in years) exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Total shares of common stock reserved for future issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_lbl" xml:lang="en-US">Federal statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_lbl" xml:lang="en-US">State taxes, net of federal tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent_lbl" xml:lang="en-US">NQSO Comp &#8211; Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent_lbl" xml:lang="en-US">EQ Comp &#8211; Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">True-up Adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;State Franchise Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;Net Operating Losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="us-gaap_OperatingLossCarryforwardsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" xlink:label="XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" xlink:to="XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation_lbl" xml:lang="en-US">&#160;&#160;&#160;&#160;Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">Income tax provision at federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US">State taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers" xlink:label="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers" xlink:to="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredTaxAssetsValuationAllowanceOne" xlink:label="XPON_DeferredTaxAssetsValuationAllowanceOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DeferredTaxAssetsValuationAllowanceOne" xlink:to="XPON_DeferredTaxAssetsValuationAllowanceOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="XPON_DeferredTaxAssetsValuationAllowanceOne_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AccountsPayableRelatedPartiesCurrentOne" xlink:label="XPON_AccountsPayableRelatedPartiesCurrentOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_AccountsPayableRelatedPartiesCurrentOne" xlink:to="XPON_AccountsPayableRelatedPartiesCurrentOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_AccountsPayableRelatedPartiesCurrentOne_lbl" xml:lang="en-US">Accounts Payables liability</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsOne" xlink:label="XPON_NumberOfWarrantsnonplanOptionsOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NumberOfWarrantsnonplanOptionsOne" xlink:to="XPON_NumberOfWarrantsnonplanOptionsOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NumberOfWarrantsnonplanOptionsOne_lbl" xml:lang="en-US">[custom:NumberOfWarrantsnonplanOptionsOne-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsTwo" xlink:label="XPON_NumberOfWarrantsnonplanOptionsTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NumberOfWarrantsnonplanOptionsTwo" xlink:to="XPON_NumberOfWarrantsnonplanOptionsTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NumberOfWarrantsnonplanOptionsTwo_lbl" xml:lang="en-US">[custom:NumberOfWarrantsnonplanOptionsTwo-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsThree" xlink:label="XPON_NumberOfWarrantsnonplanOptionsThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NumberOfWarrantsnonplanOptionsThree" xlink:to="XPON_NumberOfWarrantsnonplanOptionsThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NumberOfWarrantsnonplanOptionsThree_lbl" xml:lang="en-US">[custom:NumberOfWarrantsnonplanOptionsThree-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsFour" xlink:label="XPON_NumberOfWarrantsnonplanOptionsFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NumberOfWarrantsnonplanOptionsFour" xlink:to="XPON_NumberOfWarrantsnonplanOptionsFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NumberOfWarrantsnonplanOptionsFour_lbl" xml:lang="en-US">[custom:NumberOfWarrantsnonplanOptionsFour-0]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xml:lang="en-US">Expected dividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" xlink:label="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" xlink:to="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_lbl" xml:lang="en-US">Weighted average remaining contractual term (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" xlink:label="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" xlink:to="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Outstanding at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_lbl" xml:lang="en-US">Exercisable shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:label="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:to="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Exercisable at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Numbers of Shares beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted avergare granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_2_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_2_lbl" xml:lang="en-US">Interest and Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncome_2_lbl" xml:lang="en-US">Other Operating Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesInExchangeForBuildingSignage" xlink:to="XPON_IssuanceOfSharesInExchangeForBuildingSignage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesInExchangeForBuildingSignage_2_lbl" xml:lang="en-US">IssuanceOfSharesInExchangeForBuildingSignage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares" xlink:to="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares_2_lbl" xml:lang="en-US">Issuance of shares upon settlement of convertible notes [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" xlink:to="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares_2_lbl" xml:lang="en-US">Issuance of shares, initial public offering, net of issuance costs [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IssuanceOfSharesInExchangeForIPOServices" xlink:to="XPON_IssuanceOfSharesInExchangeForIPOServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IssuanceOfSharesInExchangeForIPOServices_2_lbl" xml:lang="en-US">Issuance of shares in exchange for IPO services [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Ownership Plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseDecreaseInPrepaidintransitInventory" xlink:to="XPON_IncreaseDecreaseInPrepaidintransitInventory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IncreaseDecreaseInPrepaidintransitInventory_2_lbl" xml:lang="en-US">IncreaseDecreaseInPrepaidintransitInventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_3_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseDecreaseInLiabilityForRefunds" xlink:to="XPON_IncreaseDecreaseInLiabilityForRefunds_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IncreaseDecreaseInLiabilityForRefunds_2_lbl" xml:lang="en-US">IncreaseDecreaseInLiabilityForRefunds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xml:lang="en-US">Repayments of Lines of Credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_2_lbl" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ProceedsReceivedFromExerciseOfWarrantsShares" xlink:to="XPON_ProceedsReceivedFromExerciseOfWarrantsShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ProceedsReceivedFromExerciseOfWarrantsShares_2_lbl" xml:lang="en-US">ProceedsReceivedFromExerciseOfWarrantsShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_StockIssuedAsResultOfLitigationSettlementShares" xlink:to="XPON_StockIssuedAsResultOfLitigationSettlementShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_StockIssuedAsResultOfLitigationSettlementShares_2_lbl" xml:lang="en-US">StockIssuedAsResultOfLitigationSettlementShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ExerciseOfWarrantsShares" xlink:to="XPON_ExerciseOfWarrantsShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ExerciseOfWarrantsShares_2_lbl" xml:lang="en-US">ExerciseOfWarrantsShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts" xlink:to="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts_2_lbl" xml:lang="en-US">IncreaseDecreaseInAllowanceForDoubtfulAccounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="us-gaap_GainLossRelatedToLitigationSettlement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossRelatedToLitigationSettlement_2_lbl" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_2_lbl" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ShareholderPromissoryNotesTextBlock" xlink:to="XPON_ShareholderPromissoryNotesTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ShareholderPromissoryNotesTextBlock_3_lbl" xml:lang="en-US">ShareholderPromissoryNotesTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ConvertibleNotesTextBlock" xlink:to="XPON_ConvertibleNotesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ConvertibleNotesTextBlock_2_lbl" xml:lang="en-US">ConvertibleNotesTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_RelatedPartyTransactionsTextBlock" xlink:to="XPON_RelatedPartyTransactionsTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_RelatedPartyTransactionsTextBlock_2_lbl" xml:lang="en-US">RelatedPartyTransactionsTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:to="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfEstimatedUsefulLivesTableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NetLoss" xlink:to="XPON_NetLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NetLoss_2_lbl" xml:lang="en-US">NetLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_NetLossOne" xlink:to="XPON_NetLossOne_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_NetLossOne_2_lbl" xml:lang="en-US">NetLossOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtCurrent" xlink:to="us-gaap_DebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtCurrent_2_lbl" xml:lang="en-US">Debt, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubleaseIncome_2_lbl" xml:lang="en-US">Sublease Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_2_lbl" xml:lang="en-US">Purchase Obligation, to be Paid, Remainder of Fiscal Year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_2_lbl" xml:lang="en-US">Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next 12 Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_2_lbl" xml:lang="en-US">Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_2_lbl" xml:lang="en-US">Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="us-gaap_OperatingLossCarryforwardsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsValuationAllowance_2_lbl" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_2_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_2_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers" xlink:to="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers_2_lbl" xml:lang="en-US">DeferredTaxAssetsTaxCreditCarryforwardsOthers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_DeferredTaxAssetsValuationAllowanceOne" xlink:to="XPON_DeferredTaxAssetsValuationAllowanceOne_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_DeferredTaxAssetsValuationAllowanceOne_2_lbl" xml:lang="en-US">DeferredTaxAssetsValuationAllowanceOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" xlink:to="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_3_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>xpon-20230930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://expion360.com/role/Cover" xlink:href="xpon-20230930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheets" xlink:href="xpon-20230930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsParenthetical" xlink:href="xpon-20230930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfOperations" xlink:href="xpon-20230930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="xpon-20230930.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfCashFlows" xlink:href="xpon-20230930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsStatement" xlink:href="xpon-20230930.xsd#BalanceSheetsStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/BalanceSheetsParentheticalStatement" xlink:href="xpon-20230930.xsd#BalanceSheetsParentheticalStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement" xlink:href="xpon-20230930.xsd#StatementsOfStockholdersEquityDeficitStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StatementsOfCashFlowsStatement" xlink:href="xpon-20230930.xsd#StatementsOfCashFlowsStatement" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/OrganizationAndNatureOfOperations" xlink:href="xpon-20230930.xsd#OrganizationAndNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNet" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues" xlink:href="xpon-20230930.xsd#LiabilitiesForSaleOfFutureRevenues" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Short-termRevolvingLoans" xlink:href="xpon-20230930.xsd#Short-termRevolvingLoans" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebt" xlink:href="xpon-20230930.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ShareholderPromissoryNotes" xlink:href="xpon-20230930.xsd#ShareholderPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ConvertibleNotes" xlink:href="xpon-20230930.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingencies" xlink:href="xpon-20230930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ConversionToCCorporation" xlink:href="xpon-20230930.xsd#ConversionToCCorporation" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquity" xlink:href="xpon-20230930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxes" xlink:href="xpon-20230930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/KPlan" xlink:href="xpon-20230930.xsd#KPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/RelatedPartyTransactions" xlink:href="xpon-20230930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SubsequentEvents" xlink:href="xpon-20230930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholderPromissoryNotes" xlink:href="xpon-20230930.xsd#StockholderPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetTables" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtTables" xlink:href="xpon-20230930.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesTables" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityTables" xlink:href="xpon-20230930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesTables" xlink:href="xpon-20230930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="xpon-20230930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetails" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="xpon-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ScheduleOfLong-termDebtDetails" xlink:href="xpon-20230930.xsd#ScheduleOfLong-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtDetails1" xlink:href="xpon-20230930.xsd#Long-termDebtDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative" xlink:href="xpon-20230930.xsd#ShareholderPromissoryNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails1" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetails2" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="xpon-20230930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails1" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails2" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails3" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetailsNarrative" xlink:href="xpon-20230930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails1" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails2" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/IncomeTaxesDetails3" xlink:href="xpon-20230930.xsd#IncomeTaxesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="xpon-20230930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="xpon-20230930.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure" xlink:href="xpon-20230930.xsd#PropertyAndEquipmentNetDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/Long-termDebtDetails" xlink:href="xpon-20230930.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetailsDisclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails1Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails1Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails2Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails2Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails3Disclosure" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails3Disclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://expion360.com/role/StockholdersEquityDetails4" xlink:href="xpon-20230930.xsd#StockholdersEquityDetails4" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryInTransit" xlink:label="loc_us-gaapOtherInventoryInTransit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherInventoryInTransit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="loc_us-gaapCustomerDepositsCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCustomerDepositsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiabilityForSaleOfFutureRevenuesNet" xlink:label="loc_XPONLiabilityForSaleOfFutureRevenuesNet" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_XPONLiabilityForSaleOfFutureRevenuesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotesPayableCurrent1" xlink:label="loc_XPONNotesPayableCurrent1" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_XPONNotesPayableCurrent1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LongTermDebtCurrent1" xlink:label="loc_XPONLongTermDebtCurrent1" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_XPONLongTermDebtCurrent1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareholderPromissoryNotes" xlink:label="loc_XPONShareholderPromissoryNotes" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_XPONShareholderPromissoryNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherOperatingIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLossPerShareBasicAndDiluted" xlink:label="loc_XPONNetLossPerShareBasicAndDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_XPONNetLossPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WeightedaverageNumberOfCommonSharesOutstanding" xlink:label="loc_XPONWeightedaverageNumberOfCommonSharesOutstanding" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_XPONWeightedaverageNumberOfCommonSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Statements of Stockholders Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_EffectOfInducedConversionOfDebt" xlink:label="loc_XPONEffectOfInducedConversionOfDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONEffectOfInducedConversionOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForBuildingSignageValue" xlink:label="loc_XPONIssuanceOfSharesInExchangeForBuildingSignageValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForBuildingSignageValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForBuildingSignage" xlink:label="loc_XPONIssuanceOfSharesInExchangeForBuildingSignage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForBuildingSignage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesOne" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesOne" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesOneShares" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesOneShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesOneShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes" xlink:label="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotes" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares" xlink:label="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotesShares" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesUponSettlementOfConvertibleNotesShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesTwo" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwo" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares" xlink:label="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwoShares" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedDuringPeriodValueNewIssuesTwoShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfDetachableWarrantsToLongTermDebt" xlink:label="loc_XPONIssuanceOfDetachableWarrantsToLongTermDebt" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfDetachableWarrantsToLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrantsToUnderwriters" xlink:label="loc_XPONIssuanceOfWarrantsToUnderwriters" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfWarrantsToUnderwriters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrantsInExchangeForServicesOne" xlink:label="loc_XPONIssuanceOfWarrantsInExchangeForServicesOne" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfWarrantsInExchangeForServicesOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfOptionsInExchangeForServicesOne" xlink:label="loc_XPONIssuanceOfOptionsInExchangeForServicesOne" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfOptionsInExchangeForServicesOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" xlink:label="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" xlink:label="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForIPOServicesAmount" xlink:label="loc_XPONIssuanceOfSharesInExchangeForIPOServicesAmount" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForIPOServicesAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfSharesInExchangeForIPOServices" xlink:label="loc_XPONIssuanceOfSharesInExchangeForIPOServices" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfSharesInExchangeForIPOServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfStockOptions" xlink:label="loc_XPONIssuanceOfStockOptions" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AccruedInterestOnConvertibleNote" xlink:label="loc_XPONAccruedInterestOnConvertibleNote" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONAccruedInterestOnConvertibleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:label="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:label="loc_us-gaapInducedConversionOfConvertibleDebtExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInducedConversionOfConvertibleDebtExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInAllowanceForDoubtfulAccounts" xlink:label="loc_XPONIncreaseInAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONIncreaseInAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInPrepaidintransitInventory" xlink:label="loc_XPONIncreaseDecreaseInPrepaidintransitInventory" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONIncreaseDecreaseInPrepaidintransitInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInDeposits" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInCustomerDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInCustomerDeposits" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInLiabilityForRefunds" xlink:label="loc_XPONIncreaseDecreaseInLiabilityForRefunds" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONIncreaseDecreaseInLiabilityForRefunds" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:label="loc_us-gaapPaymentsForProceedsFromProductiveAssets" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount" xlink:label="loc_XPONProceedsFromSaleOfFutureRevenuesNetOfDiscount" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONProceedsFromSaleOfFutureRevenuesNetOfDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" xlink:label="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NonCashOperatingActivities" xlink:label="loc_XPONNonCashOperatingActivities" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONNonCashOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock" xlink:label="loc_XPONConvertibleNotesAndAccruedInterestConvertedToCommonStock" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONConvertibleNotesAndAccruedInterestConvertedToCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfAccruedInterestToLongTermDebt" xlink:label="loc_XPONReclassificationOfAccruedInterestToLongTermDebt" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONReclassificationOfAccruedInterestToLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt" xlink:label="loc_XPONReclassificationOfModifiedConvertibleNoteToLongTermDebt" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONReclassificationOfModifiedConvertibleNoteToLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" xlink:label="loc_XPONReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment" xlink:label="loc_XPONIssuanceOfCommonStockInExchangeForPropertyAndequipment" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONIssuanceOfCommonStockInExchangeForPropertyAndequipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" xlink:label="loc_XPONAcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONAcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" xlink:label="loc_XPONPurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONPurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" xlink:label="loc_XPONPurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONPurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ReclassificationOfDepositToPropertyAndEquipment" xlink:label="loc_XPONReclassificationOfDepositToPropertyAndEquipment" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONReclassificationOfDepositToPropertyAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConversionOfConvertibleNotesIntoCommonStock" xlink:label="loc_XPONConversionOfConvertibleNotesIntoCommonStock" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONConversionOfConvertibleNotesIntoCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" xlink:label="loc_XPONFairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONFairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" xlink:label="loc_XPONMembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONMembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsStatement" xlink:title="00000007 - Statement - Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryInTransit" xlink:label="loc_us-gaapOtherInventoryInTransit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherInventoryInTransit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="loc_us-gaapCustomerDepositsCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCustomerDepositsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLitigationSettlementExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_FranchiseTaxesRefund" xlink:label="loc_XPONFranchiseTaxesRefund" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_XPONFranchiseTaxesRefund" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLossPerShareBasicAndDiluted" xlink:label="loc_XPONNetLossPerShareBasicAndDiluted" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_XPONNetLossPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WeightedaverageNumberOfCommonSharesOutstanding" xlink:label="loc_XPONWeightedaverageNumberOfCommonSharesOutstanding" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_XPONWeightedaverageNumberOfCommonSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/BalanceSheetsParentheticalStatement" xlink:title="00000008 - Statement - Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement" xlink:title="00000009 - Statement - Statements of Stockholders Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsReceivedFromExerciseOfWarrants" xlink:label="loc_XPONProceedsReceivedFromExerciseOfWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONProceedsReceivedFromExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProceedsReceivedFromExerciseOfWarrantsShares" xlink:label="loc_XPONProceedsReceivedFromExerciseOfWarrantsShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONProceedsReceivedFromExerciseOfWarrantsShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockIssuedAsResultOfLitigationSettlementShares" xlink:label="loc_XPONStockIssuedAsResultOfLitigationSettlementShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONStockIssuedAsResultOfLitigationSettlementShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsDiluted" xlink:label="loc_us-gaapUndistributedEarningsDiluted" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUndistributedEarningsDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExerciseOfWarrantsShares" xlink:label="loc_XPONExerciseOfWarrantsShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONExerciseOfWarrantsShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfWarrants" xlink:label="loc_XPONIssuanceOfWarrants" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IssuanceOfRestrictedStockUnit" xlink:label="loc_XPONIssuanceOfRestrictedStockUnit" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONIssuanceOfRestrictedStockUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StatementsOfCashFlowsStatement" xlink:title="00000010 - Statement - Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:label="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONAmortizationOfDebtDiscountSaleOfFutureRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts" xlink:label="loc_XPONIncreaseDecreaseInAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONIncreaseDecreaseInAllowanceForDoubtfulAccounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaapGainLossRelatedToLitigationSettlement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossRelatedToLitigationSettlement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInDeposits" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeposits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInOtherDeposits" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_XPONIncreaseInRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:label="loc_us-gaapPaymentsForProceedsFromProductiveAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromProductiveAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans" xlink:label="loc_XPONPaymentsOnLineofcreditAndShorttermRevolvingLoans" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONPaymentsOnLineofcreditAndShorttermRevolvingLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PaymentsOnLiabilityForSaleOfFutureRevenues" xlink:label="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONPaymentsOnLiabilityForSaleOfFutureRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_CashPaidRefundedForFranchiseTaxes" xlink:label="loc_XPONCashPaidRefundedForFranchiseTaxes" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONCashPaidRefundedForFranchiseTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapOtherNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapOtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" xlink:label="loc_XPONAcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONAcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_CashlessWarrantExercises" xlink:label="loc_XPONCashlessWarrantExercises" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONCashlessWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" xlink:label="loc_XPONPurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONPurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" xlink:label="loc_XPONPurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_XPONPurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/OrganizationAndNatureOfOperations" xlink:title="00000011 - Disclosure - Organization and Nature of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000012 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNet" xlink:title="00000013 - Disclosure - Property and Equipment, Net">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:title="00000014 - Disclosure - Accrued Expenses and Other Current Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues" xlink:title="00000015 - Disclosure - Liabilities for Sale of Future Revenues">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" xlink:label="loc_XPONDisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock" xlink:label="loc_XPONLiabilitiesForSaleOfFutureRevenuesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureLiabilitiesForSaleOfFutureRevenuesAbstract" xlink:to="loc_XPONLiabilitiesForSaleOfFutureRevenuesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/Short-termRevolvingLoans" xlink:title="00000016 - Disclosure - Short-Term Revolving Loans">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebt" xlink:title="00000017 - Disclosure - Long-Term Debt">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/ShareholderPromissoryNotes" xlink:title="00000018 - Disclosure - Shareholder Promissory Notes">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureShareholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureShareholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareholderPromissoryNotesTextBlock" xlink:label="loc_XPONShareholderPromissoryNotesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureShareholderPromissoryNotesAbstract" xlink:to="loc_XPONShareholderPromissoryNotesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/ConvertibleNotes" xlink:title="00000019 - Disclosure - Convertible Notes">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureConvertibleNotesAbstract" xlink:label="loc_XPONDisclosureConvertibleNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConvertibleNotesTextBlock" xlink:label="loc_XPONConvertibleNotesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureConvertibleNotesAbstract" xlink:to="loc_XPONConvertibleNotesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingencies" xlink:title="00000020 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/ConversionToCCorporation" xlink:title="00000021 - Disclosure - Conversion to a C Corporation">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureConversionToCCorporationAbstract" xlink:label="loc_XPONDisclosureConversionToCCorporationAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ConversionOfStockTextBlock" xlink:label="loc_XPONConversionOfStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureConversionToCCorporationAbstract" xlink:to="loc_XPONConversionOfStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquity" xlink:title="00000022 - Disclosure - Stockholders&#8217; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/KPlan" xlink:title="00000024 - Disclosure - 401(k) Plan">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanTextBlock" xlink:label="loc_us-gaapDefinedBenefitPlanTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/RelatedPartyTransactions" xlink:title="00000025 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_RelatedPartyTransactionsTextBlock" xlink:label="loc_XPONRelatedPartyTransactionsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_XPONRelatedPartyTransactionsTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SubsequentEvents" xlink:title="00000026 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholderPromissoryNotes" xlink:title="00000027 - Disclosure - Stockholder Promissory Notes">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureStockholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareholderPromissoryNotesTextBlock" xlink:label="loc_XPONShareholderPromissoryNotesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureStockholderPromissoryNotesAbstract" xlink:to="loc_XPONShareholderPromissoryNotesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiquidityAndCapitalResourcesPolicyTextBlock" xlink:label="loc_XPONLiquidityAndCapitalResourcesPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONLiquidityAndCapitalResourcesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_CustomerDepositsPolicyTextBlock" xlink:label="loc_XPONCustomerDepositsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONCustomerDepositsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" xlink:label="loc_XPONVendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONVendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtendedProductWarrantyPolicy" xlink:label="loc_us-gaapExtendedProductWarrantyPolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapExtendedProductWarrantyPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LiabilityForRefundsPolicyTextBlock" xlink:label="loc_XPONLiabilityForRefundsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONLiabilityForRefundsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShippingAndHandlingCostPolicyTextBlock" xlink:label="loc_us-gaapShippingAndHandlingCostPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShippingAndHandlingCostPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" xlink:label="loc_XPONAccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONAccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock" xlink:label="loc_XPONScheduleOfEstimatedUsfulLivesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONScheduleOfEstimatedUsfulLivesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:label="loc_XPONScheduleOfEstimatedUsefulLivesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetTables" xlink:title="00000030 - Disclosure - Property and Equipment, Net (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtTables" xlink:title="00000032 - Disclosure - Long-Term Debt (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesTables" xlink:title="00000033 - Disclosure - Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityTables" xlink:title="00000034 - Disclosure - Stockholders&#8217; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" xlink:label="loc_XPONScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_XPONScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:label="loc_XPONScheduleOfCommonStockReservedForIssuanceTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_XPONScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesTables" xlink:title="00000035 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLoss" xlink:label="loc_XPONNetLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONNetLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WeightedaverageNumberOfCommonSharesOutstanding" xlink:label="loc_XPONWeightedaverageNumberOfCommonSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONWeightedaverageNumberOfCommonSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLossPerShareBasicAndDiluted" xlink:label="loc_XPONNetLossPerShareBasicAndDiluted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONNetLossPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NetLossOne" xlink:label="loc_XPONNetLossOne" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_XPONNetLossOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2" xlink:title="00000038 - Disclosure - Summary of Significant Accounting Policies (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_XPONStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_RSUMember" xlink:label="loc_XPONRSUMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_XPONRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" xlink:label="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" xlink:label="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_XPONAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ProccedsFromIpoNetsCost" xlink:label="loc_XPONProccedsFromIpoNetsCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONProccedsFromIpoNetsCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositContractsAssets" xlink:label="loc_us-gaapDepositContractsAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositContractsAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="loc_us-gaapCustomerDepositsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCustomerDepositsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryNetOfReserves" xlink:label="loc_us-gaapOtherInventoryNetOfReserves" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherInventoryNetOfReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepurchaseOfEquity" xlink:label="loc_us-gaapProceedsFromRepurchaseOfEquity" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromRepurchaseOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease" xlink:label="loc_us-gaapFDICIndemnificationAssetPeriodIncreaseDecrease" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFDICIndemnificationAssetPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_TreasuryRelatedPaper" xlink:label="loc_XPONTreasuryRelatedPaper" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONTreasuryRelatedPaper" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AdjustmentsToBadDebtExpense" xlink:label="loc_XPONAdjustmentsToBadDebtExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONAdjustmentsToBadDebtExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryFinishedGoods_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies" xlink:label="loc_us-gaapSupplies" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShippingAndHandlingCostsForShippingProduct" xlink:label="loc_XPONShippingAndHandlingCostsForShippingProduct" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_XPONShippingAndHandlingCostsForShippingProduct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000040 - Disclosure - Property and Equipment Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureEquipmentMember" xlink:label="loc_XPONOfficeFurnitureEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONOfficeFurnitureEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEquipmentMember" xlink:label="loc_XPONWarehouseEquipmentMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONWarehouseEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000041 - Disclosure - Property and Equipment, Net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisposalsAndSalesOfFixedAssets" xlink:label="loc_XPONDisposalsAndSalesOfFixedAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_XPONDisposalsAndSalesOfFixedAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="00000042 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_RebateLiability" xlink:label="loc_XPONRebateLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_XPONRebateLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredIncomeAndDepositSublease" xlink:label="loc_XPONDeferredIncomeAndDepositSublease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_XPONDeferredIncomeAndDepositSublease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_FranchiseTax" xlink:label="loc_XPONFranchiseTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_XPONFranchiseTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/ScheduleOfLong-termDebtDetails" xlink:title="00000043 - Disclosure - Schedule of long-term debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SeniorSecuredPromissoryNotesMember" xlink:label="loc_XPONSeniorSecuredPromissoryNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONSeniorSecuredPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="loc_us-gaapNotesPayableToBanksMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapNotesPayableToBanksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableCreditUnionMember" xlink:label="loc_XPONNotePayableCreditUnionMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableCreditUnionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableSBAMember" xlink:label="loc_XPONNotePayableSBAMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableSBAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableIndividualMember" xlink:label="loc_XPONNotePayableIndividualMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableIndividualMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompanyMember" xlink:label="loc_XPONNotePayableFinanceCompanyMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompany1Member" xlink:label="loc_XPONNotePayableFinanceCompany1Member" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompany1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_GMFinancialMember" xlink:label="loc_XPONGMFinancialMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONGMFinancialMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarrantsToPurchase" xlink:label="loc_XPONWarrantsToPurchase" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_XPONWarrantsToPurchase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaapDebtCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_LessNotePayableInDefaultPaid" xlink:label="loc_XPONLessNotePayableInDefaultPaid" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_XPONLessNotePayableInDefaultPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtDetails1" xlink:title="00000044 - Disclosure - Long-Term Debt (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturingInYearsTwoAndThree" xlink:label="loc_us-gaapLongTermDebtMaturingInYearsTwoAndThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturingInYearsTwoAndThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative" xlink:title="00000045 - Disclosure - Shareholder Promissory Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureShareholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureShareholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherMinorityInterests" xlink:label="loc_us-gaapOtherMinorityInterests" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureShareholderPromissoryNotesAbstract" xlink:to="loc_us-gaapOtherMinorityInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000046 - Disclosure - Commitments and Contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaapShortTermLeaseCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapShortTermLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaapVariableLeaseCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapVariableLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails1" xlink:title="00000047 - Disclosure - Commitments and Contingencies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapPurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetails2" xlink:title="00000048 - Disclosure - Commitments and Contingencies (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:label="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:label="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:label="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions" xlink:label="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapFutureMinimumSubleaseRentalsSaleLeasebackTransactions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000049 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredIncomeAndSubleaseDeposit" xlink:label="loc_XPONDeferredIncomeAndSubleaseDeposit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_XPONDeferredIncomeAndSubleaseDeposit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails" xlink:title="00000050 - Disclosure -  Stockholders Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice1Member" xlink:label="loc_XPONExercisePrice1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice2Member" xlink:label="loc_XPONExercisePrice2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice3Member" xlink:label="loc_XPONExercisePrice3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice4Member" xlink:label="loc_XPONExercisePrice4Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails1" xlink:title="00000051 - Disclosure -  Stockholders Equity (Details1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails2" xlink:title="00000052 - Disclosure -  Stockholders Equity (Details2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AggregateIntrinsicValueForfeited" xlink:label="loc_XPONAggregateIntrinsicValueForfeited" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONAggregateIntrinsicValueForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:label="loc_XPONShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails3" xlink:title="00000053 - Disclosure -  Stockholders Equity (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_UnrelatedToAnyPlanMember" xlink:label="loc_XPONUnrelatedToAnyPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONUnrelatedToAnyPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000054 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails" xlink:title="00000055 - Disclosure - Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationBeatPercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationBeatPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationFdiiPercent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationFdiiPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails1" xlink:title="00000056 - Disclosure - Income Taxes (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails2" xlink:title="00000057 - Disclosure - Income Taxes (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsGrossAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaapOperatingLossCarryforwardsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" xlink:label="loc_XPONDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_XPONDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/IncomeTaxesDetails3" xlink:title="00000058 - Disclosure - Income Taxes (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers" xlink:label="loc_XPONDeferredTaxAssetsTaxCreditCarryforwardsOthers" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_XPONDeferredTaxAssetsTaxCreditCarryforwardsOthers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DeferredTaxAssetsValuationAllowanceOne" xlink:label="loc_XPONDeferredTaxAssetsValuationAllowanceOne" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_XPONDeferredTaxAssetsValuationAllowanceOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000059 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_AccountsPayableRelatedPartiesCurrentOne" xlink:label="loc_XPONAccountsPayableRelatedPartiesCurrentOne" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_XPONAccountsPayableRelatedPartiesCurrentOne" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000060 - Disclosure - Schedule of estimated useful lives (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureAndEquipmentMember" xlink:label="loc_XPONOfficeFurnitureAndEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONOfficeFurnitureAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEequipmentMember" xlink:label="loc_XPONWarehouseEequipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONWarehouseEequipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure" xlink:title="00000061 - Disclosure - Property and Equipment, Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_VehiclesAndTransportationEquipmentMember" xlink:label="loc_XPONVehiclesAndTransportationEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONVehiclesAndTransportationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_OfficeFurnitureEquipmentMember" xlink:label="loc_XPONOfficeFurnitureEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONOfficeFurnitureEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ManufacturingEquipmentMember" xlink:label="loc_XPONManufacturingEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONManufacturingEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_WarehouseEquipmentMember" xlink:label="loc_XPONWarehouseEquipmentMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONWarehouseEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_QAEquipmentMember" xlink:label="loc_XPONQAEquipmentMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONQAEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ToolingAndMoldsMember" xlink:label="loc_XPONToolingAndMoldsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_XPONToolingAndMoldsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/Long-termDebtDetails" xlink:title="00000062 - Disclosure - Long-Term Debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SeniorSecuredPromissoryNotesMember" xlink:label="loc_XPONSeniorSecuredPromissoryNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONSeniorSecuredPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="loc_us-gaapNotesPayableToBanksMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapNotesPayableToBanksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableCreditUnionMember" xlink:label="loc_XPONNotePayableCreditUnionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableCreditUnionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableSBAMember" xlink:label="loc_XPONNotePayableSBAMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableSBAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableIndividualMember" xlink:label="loc_XPONNotePayableIndividualMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableIndividualMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompanyMember" xlink:label="loc_XPONNotePayableFinanceCompanyMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NotePayableFinanceCompany1Member" xlink:label="loc_XPONNotePayableFinanceCompany1Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONNotePayableFinanceCompany1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_GMFinancialMember" xlink:label="loc_XPONGMFinancialMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_XPONGMFinancialMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaapDebtCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetailsDisclosure" xlink:title="00000063 - Disclosure - Stockholders Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureStockholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureStockholderPromissoryNotesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice1Member" xlink:label="loc_XPONExercisePrice1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePricesMember" xlink:label="loc_XPONExercisePricesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePricesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice2Member" xlink:label="loc_XPONExercisePrice2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice3Member" xlink:label="loc_XPONExercisePrice3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice4Member" xlink:label="loc_XPONExercisePrice4Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_ExercisePrice5Member" xlink:label="loc_XPONExercisePrice5Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_XPONExercisePrice5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsOne" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsOne" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsTwo" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsThree" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_NumberOfWarrantsnonplanOptionsFour" xlink:label="loc_XPONNumberOfWarrantsnonplanOptionsFour" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_XPONNumberOfWarrantsnonplanOptionsFour" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails1Disclosure" xlink:title="00000064 - Disclosure - Stockholders Equity (Details 1)">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureStockholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureStockholderPromissoryNotesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails2Disclosure" xlink:title="00000065 - Disclosure - Stockholders Equity (Details 2)">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureStockholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureStockholderPromissoryNotesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OptionMember" xlink:label="loc_us-gaapOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" xlink:label="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" xlink:label="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:label="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_XPONSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails3Disclosure" xlink:title="00000066 - Disclosure - Stockholders Equity (Details 3)">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureStockholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureStockholderPromissoryNotesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://expion360.com/role/StockholdersEquityDetails4" xlink:title="00000067 - Disclosure - Stockholders Equity (Details 4)">
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_DisclosureStockholderPromissoryNotesAbstract" xlink:label="loc_XPONDisclosureStockholderPromissoryNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_XPONDisclosureStockholderPromissoryNotesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_UnrelatedToAnyPlanMember" xlink:label="loc_XPONUnrelatedToAnyPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONUnrelatedToAnyPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="xpon-20230930.xsd#XPON_StockOptionsMember" xlink:label="loc_XPONStockOptionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_XPONStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292341120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">This amendment is being filed to comply with regulations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXPION360
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001894954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-2701049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291841840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>&#160;&#160;&#160;Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">&#160;&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</a></td>
<td class="nump">$ 7,201,244<span></span>
</td>
<td class="nump">$ 773,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">&#160;&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</a></td>
<td class="nump">298,035<span></span>
</td>
<td class="nump">775,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">&#160;&#160;&#160;&#160;&#160;&#160;Inventory</a></td>
<td class="nump">4,530,136<span></span>
</td>
<td class="nump">2,051,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryInTransit', window );">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid/in-transit inventory</a></td>
<td class="nump">141,611<span></span>
</td>
<td class="nump">1,081,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</a></td>
<td class="nump">171,791<span></span>
</td>
<td class="nump">71,703<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">&#160;&#160;&#160;Total current assets</a></td>
<td class="nump">12,342,817<span></span>
</td>
<td class="nump">4,753,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">&#160;&#160;&#160;Property and equipment</a></td>
<td class="nump">1,394,619<span></span>
</td>
<td class="nump">523,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">&#160;&#160;&#160;Accumulated depreciation</a></td>
<td class="num">(250,861)<span></span>
</td>
<td class="num">(96,190)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">&#160;&#160;&#160;Property and equipment, net</a></td>
<td class="nump">1,143,758<span></span>
</td>
<td class="nump">427,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>&#160;&#160;&#160;Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">&#160;&#160;&#160;&#160;&#160;&#160;Operating leases &#8211; right-of-use asset</a></td>
<td class="nump">3,148,455<span></span>
</td>
<td class="nump">1,281,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">&#160;&#160;&#160;&#160;&#160;&#160;Deposits</a></td>
<td class="nump">63,901<span></span>
</td>
<td class="nump">63,901<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">&#160;&#160;&#160;Total other assets</a></td>
<td class="nump">3,212,356<span></span>
</td>
<td class="nump">1,345,272<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,698,931<span></span>
</td>
<td class="nump">6,525,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>&#160;&#160;&#160;Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">&#160;&#160;&#160;&#160;&#160;Accounts payable</a></td>
<td class="nump">230,250<span></span>
</td>
<td class="nump">63,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CustomerDepositsCurrent', window );">&#160;&#160;&#160;&#160;&#160;Customer deposits</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">436,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">&#160;&#160;&#160;&#160;&#160;Accrued expenses and other current liabilities</a></td>
<td class="nump">306,164<span></span>
</td>
<td class="nump">140,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">&#160;&#160;&#160;&#160;&#160;Line of credit and short-term revolving loans</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">&#160;&#160;&#160;&#160;&#160;Current portion of operating lease liability</a></td>
<td class="nump">465,055<span></span>
</td>
<td class="nump">218,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_LiabilityForSaleOfFutureRevenuesNet', window );">&#160;&#160;&#160;&#160;&#160;Liability for sale of future revenues, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NotesPayableCurrent1', window );">&#160;&#160;&#160;&#160;&#160;Note payable in default</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_LongTermDebtCurrent1', window );">&#160;&#160;&#160;&#160;&#160;Current portion of long-term debt</a></td>
<td class="nump">571,426<span></span>
</td>
<td class="nump">51,135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">&#160;&#160;&#160;Total current liabilities</a></td>
<td class="nump">1,572,953<span></span>
</td>
<td class="nump">1,571,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">&#160;&#160;&#160;Long-term debt, net of current portion and discount</a></td>
<td class="nump">439,049<span></span>
</td>
<td class="nump">779,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">&#160;&#160;&#160;Operating lease liability, net of current portion</a></td>
<td class="nump">2,754,964<span></span>
</td>
<td class="nump">1,092,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ShareholderPromissoryNotes', window );">&#160;&#160;&#160;Shareholder promissory notes</a></td>
<td class="nump">325,000<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,091,966<span></span>
</td>
<td class="nump">4,269,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>&#160;&#160;&#160;Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $.001; 20,000,000 shares authorized; zero shares issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.001; 200,000,000 shares authorized; 6,802,464 and 4,300,000 issued and outstanding as of December 31, 2022 and 2021, respectively</a></td>
<td class="nump">6,802<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</a></td>
<td class="nump">25,239,654<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">&#160;&#160;&#160;&#160;&#160;&#160;Accumulated deficit</a></td>
<td class="num">(13,639,491)<span></span>
</td>
<td class="num">(6,102,951)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">&#160;&#160;&#160;Total stockholders&#8217; equity</a></td>
<td class="nump">11,606,965<span></span>
</td>
<td class="nump">2,256,489<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 16,698,931<span></span>
</td>
<td class="nump">$ 6,525,707<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_LiabilityForSaleOfFutureRevenuesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_LiabilityForSaleOfFutureRevenuesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_LongTermDebtCurrent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_LongTermDebtCurrent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NotesPayableCurrent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NotesPayableCurrent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ShareholderPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ShareholderPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerDepositsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current portion of money or property received from customers which is either to be returned upon satisfactory contract completion or applied to customer receivables in accordance with the terms of the contract or the understandings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerDepositsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryInTransit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryInTransit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292267168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="nump">6,802,464<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="nump">6,802,464<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291594208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales, net</a></td>
<td class="nump">$ 7,162,837<span></span>
</td>
<td class="nump">$ 4,517,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">4,874,392<span></span>
</td>
<td class="nump">2,871,770<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,288,445<span></span>
</td>
<td class="nump">1,645,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">8,241,859<span></span>
</td>
<td class="nump">2,909,085<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(5,953,414)<span></span>
</td>
<td class="num">(1,263,356)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">&#160;&#160;&#160;Interest income</a></td>
<td class="num">(239)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">&#160;&#160;&#160;Debt conversion expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">112,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">&#160;&#160;&#160;Extinguishment loss on debt settlement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,791,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">&#160;&#160;&#160;Interest expense</a></td>
<td class="nump">1,605,916<span></span>
</td>
<td class="nump">554,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">&#160;&#160;Gain on sale of property and equipment</a></td>
<td class="num">(13,312)<span></span>
</td>
<td class="num">(8,521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">&#160;&#160;&#160;Other income</a></td>
<td class="num">(389)<span></span>
</td>
<td class="num">(372)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (income) / expense</a></td>
<td class="nump">1,591,976<span></span>
</td>
<td class="nump">3,448,202<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes</a></td>
<td class="num">(7,545,390)<span></span>
</td>
<td class="num">(4,711,558)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax (income) / expense</a></td>
<td class="num">(8,850)<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,536,540)<span></span>
</td>
<td class="num">$ (4,720,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NetLossPerShareBasicAndDiluted', window );">Net loss per share (basic and diluted)</a></td>
<td class="num">$ (1.23)<span></span>
</td>
<td class="num">$ (1.63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_WeightedaverageNumberOfCommonSharesOutstanding', window );">Weighted-average number of common shares outstanding</a></td>
<td class="nump">6,135,938<span></span>
</td>
<td class="nump">2,888,695<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NetLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NetLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_WeightedaverageNumberOfCommonSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_WeightedaverageNumberOfCommonSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962287794288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Stockholders Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 2,431<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,382,093)<span></span>
</td>
<td class="num">$ (1,379,662)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">2,430,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Issuance of shares upon conversion of convertible notes</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">173,098<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">173,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of shares upon conversion of convertible notes</a></td>
<td class="nump">59,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_EffectOfInducedConversionOfDebt', window );">Effect of induced conversion of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">112,133<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">112,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesInExchangeForBuildingSignageValue', window );">Issuance of shares in exchange for building signage</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">19,993<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesInExchangeForBuildingSignage', window );">Issuance of shares in exchange for building signage</a></td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares for cash</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">269,919<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">270,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares for cash Share</a></td>
<td class="nump">81,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_StockIssuedDuringPeriodValueNewIssuesOne', window );">Issuance of shares for cash class</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">251,924<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">252,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_StockIssuedDuringPeriodValueNewIssuesOneShares', window );">Issuance of shares for cash Shares</a></td>
<td class="nump">75,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes', window );">Issuance of shares upon settlement of convertible notes</a></td>
<td class="nump">$ 1,527<span></span>
</td>
<td class="nump">5,543,832<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,545,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares', window );">Issuance of shares upon settlement of convertible notes</a></td>
<td class="nump">1,527,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of shares in exchange for services</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">108,870<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">108,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares in exchange for service</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_StockIssuedDuringPeriodValueNewIssuesTwo', window );">Issuance of shares for cash amount</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">316,311<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">316,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares', window );">Issuance of new shares for cash</a></td>
<td class="nump">88,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfDetachableWarrantsToLongTermDebt', window );">Issuance of detachable warrants to long-term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">809,806<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">809,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfWarrantsToUnderwriters', window );">Issuance of warrants to underwriters</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">262,354<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">262,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfWarrantsInExchangeForServicesOne', window );">Issuance of warrants in exchange for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">407,700<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">407,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfOptionsInExchangeForServicesOne', window );">Issuance of options in exchange for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">79,200<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">79,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,720,858)<span></span>
</td>
<td class="num">(4,720,858)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,102,951)<span></span>
</td>
<td class="nump">2,256,489<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(696,853)<span></span>
</td>
<td class="num">(696,853)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,799,804)<span></span>
</td>
<td class="nump">1,559,636<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,102,951)<span></span>
</td>
<td class="nump">2,256,489<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,067,193)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(12,170,144)<span></span>
</td>
<td class="nump">13,076,312<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,102,951)<span></span>
</td>
<td class="nump">2,256,489<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,536,540)<span></span>
</td>
<td class="num">(7,536,540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts', window );">Issuance of shares, initial public offering, net of issuance costs</a></td>
<td class="nump">$ 2,466<span></span>
</td>
<td class="nump">14,770,021<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,772,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares', window );">Issuance of shares, initial public offering, net of issuance costs</a></td>
<td class="nump">2,466,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesInExchangeForIPOServicesAmount', window );">Issuance of shares in exchange for IPO services</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfSharesInExchangeForIPOServices', window );">Issuance of shares in exchange for IPO services</a></td>
<td class="nump">35,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfStockOptions', window );">Issuance of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,114,529<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,114,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan', window );">Issuance of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(13,639,491)<span></span>
</td>
<td class="nump">11,606,965<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,799,804)<span></span>
</td>
<td class="nump">1,559,636<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares for cash</a></td>
<td class="nump">$ 2,466<span></span>
</td>
<td class="nump">14,770,021<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,772,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares for cash Share</a></td>
<td class="nump">2,466,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of shares in exchange for services</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares in exchange for service</a></td>
<td class="nump">35,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,091,036)<span></span>
</td>
<td class="num">(4,091,036)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(10,890,840)<span></span>
</td>
<td class="nump">14,355,616<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,279,304)<span></span>
</td>
<td class="num">(1,279,304)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(12,170,144)<span></span>
</td>
<td class="nump">13,076,312<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(13,639,491)<span></span>
</td>
<td class="nump">11,606,965<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,977,278)<span></span>
</td>
<td class="num">(1,977,278)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Mar. 31, 2023</a></td>
<td class="nump">$ 6,901<span></span>
</td>
<td class="nump">25,541,022<span></span>
</td>
<td class="num">(15,616,769)<span></span>
</td>
<td class="nump">9,931,154<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">6,900,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(13,639,491)<span></span>
</td>
<td class="nump">11,606,965<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,270,281)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2023</a></td>
<td class="nump">$ 6,911<span></span>
</td>
<td class="nump">25,730,833<span></span>
</td>
<td class="num">(18,909,772)<span></span>
</td>
<td class="nump">6,827,972<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2023</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2023</a></td>
<td class="nump">$ 6,901<span></span>
</td>
<td class="nump">25,541,022<span></span>
</td>
<td class="num">(15,616,769)<span></span>
</td>
<td class="nump">9,931,154<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">6,900,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,478,788)<span></span>
</td>
<td class="num">(1,478,788)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2023</a></td>
<td class="nump">$ 6,911<span></span>
</td>
<td class="nump">25,541,002<span></span>
</td>
<td class="num">(17,095,557)<span></span>
</td>
<td class="nump">8,452,356<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Jun. 30, 2023</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,814,215)<span></span>
</td>
<td class="num">(1,814,215)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2023</a></td>
<td class="nump">$ 6,911<span></span>
</td>
<td class="nump">$ 25,730,833<span></span>
</td>
<td class="num">$ (18,909,772)<span></span>
</td>
<td class="nump">$ 6,827,972<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2023</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_EffectOfInducedConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_EffectOfInducedConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfDetachableWarrantsToLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfDetachableWarrantsToLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfOptionsInExchangeForServicesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfOptionsInExchangeForServicesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesInExchangeForBuildingSignage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesInExchangeForBuildingSignage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesInExchangeForBuildingSignageValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesInExchangeForBuildingSignageValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesInExchangeForIPOServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesInExchangeForIPOServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesInExchangeForIPOServicesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesInExchangeForIPOServicesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfWarrantsInExchangeForServicesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfWarrantsInExchangeForServicesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfWarrantsToUnderwriters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfWarrantsToUnderwriters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_StockIssuedDuringPeriodValueNewIssuesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_StockIssuedDuringPeriodValueNewIssuesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_StockIssuedDuringPeriodValueNewIssuesOneShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_StockIssuedDuringPeriodValueNewIssuesOneShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_StockIssuedDuringPeriodValueNewIssuesTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_StockIssuedDuringPeriodValueNewIssuesTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480637/718-40-25-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291869392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (7,536,540)<span></span>
</td>
<td class="num">$ (4,720,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">164,767<span></span>
</td>
<td class="nump">61,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AccruedInterestOnConvertibleNote', window );">Accrued interest on convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">103,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues', window );">Amortization of debt discount (sale of future revenues)</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">95,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount - notes</a></td>
<td class="nump">1,196,843<span></span>
</td>
<td class="nump">117,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InducedConversionOfConvertibleDebtExpense', window );">Debt conversion expense on induced conversion of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">112,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Extinguishment loss on debt settlement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,791,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on sale of property and equipment</a></td>
<td class="num">(13,312)<span></span>
</td>
<td class="num">(8,521)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IncreaseInAllowanceForDoubtfulAccounts', window );">Increase in allowance for doubtful accounts</a></td>
<td class="nump">18,804<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">2,114,529<span></span>
</td>
<td class="nump">188,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) / Decrease in accounts receivable</a></td>
<td class="nump">458,322<span></span>
</td>
<td class="num">(566,435)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">(Increase) in inventory</a></td>
<td class="num">(2,478,256)<span></span>
</td>
<td class="num">(1,683,602)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IncreaseDecreaseInPrepaidintransitInventory', window );">(Increase) / Decrease in prepaid/in-transit inventory</a></td>
<td class="nump">939,614<span></span>
</td>
<td class="num">(728,033)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">(Increase) in prepaid expenses and other current assets</a></td>
<td class="num">(100,088)<span></span>
</td>
<td class="num">(69,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeposits', window );">(Increase) in deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(55,784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase / (Decrease) in accounts payable</a></td>
<td class="num">(3,792)<span></span>
</td>
<td class="nump">11,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerDeposits', window );">(Decrease) in customer deposits</a></td>
<td class="num">(436,590)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Increase in accrued expenses and other current liabilities</a></td>
<td class="nump">165,546<span></span>
</td>
<td class="nump">494,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IncreaseDecreaseInLiabilityForRefunds', window );">(Decrease) in liability for refunds</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities', window );">Increase in right-of-use assets and lease liabilities</a></td>
<td class="nump">41,286<span></span>
</td>
<td class="nump">19,248<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(5,468,572)<span></span>
</td>
<td class="num">(3,896,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(567,370)<span></span>
</td>
<td class="num">(113,694)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromProductiveAssets', window );">&#160;&#160;&#160;Net proceeds from sale of property and equipment</a></td>
<td class="nump">51,678<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(515,692)<span></span>
</td>
<td class="num">(113,694)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on line of credit and short-term revolving loans</a></td>
<td class="num">(550,000)<span></span>
</td>
<td class="num">(280,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,385,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="num">(1,798,420)<span></span>
</td>
<td class="num">(26,687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount', window );">Proceeds from sale of future revenues, net of discount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_PaymentsOnLiabilityForSaleOfFutureRevenues', window );">Payments on liability for sale of future revenues</a></td>
<td class="num">(11,797)<span></span>
</td>
<td class="num">(329,626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of discount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,781,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">14,772,487<span></span>
</td>
<td class="nump">838,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">12,412,270<span></span>
</td>
<td class="nump">4,493,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">6,428,006<span></span>
</td>
<td class="nump">482,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning</a></td>
<td class="nump">773,238<span></span>
</td>
<td class="nump">290,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, ending</a></td>
<td class="nump">7,201,244<span></span>
</td>
<td class="nump">773,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">435,152<span></span>
</td>
<td class="nump">341,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for franchise taxes</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">1,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NonCashOperatingActivities', window );"><strong>Non-cash operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock', window );">Convertible notes and accrued interest converted to common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">173,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ReclassificationOfAccruedInterestToLongTermDebt', window );">Reclassification of accrued interest to long-term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt', window );">Reclassification of modified convertible note to long-term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes', window );">Reclassification of modified member promissory note to convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment', window );">Issuance of common stock in exchange for property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability', window );">Acquisition/modification of operating lease right-of-use asset and lease liability</a></td>
<td class="nump">2,348,509<span></span>
</td>
<td class="nump">1,268,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable', window );">Purchases of property and equipment in exchange for long-term debt</a></td>
<td class="nump">181,430<span></span>
</td>
<td class="nump">183,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt', window );">Purchases of property and equipment in exchange for short-term payable</a></td>
<td class="nump">170,863<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ReclassificationOfDepositToPropertyAndEquipment', window );">Reclassification of deposit to property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ConversionOfConvertibleNotesIntoCommonStock', window );">Conversion of 2021 convertible notes into common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,282,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita', window );">Fair value of warrants issued in connection with long-term debt recorded as debt discount and additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,072,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation', window );">Membership contributions reclassified to additional paid-in capital upon conversion to C corporation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 827,290<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AccruedInterestOnConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AccruedInterestOnConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ConversionOfConvertibleNotesIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ConversionOfConvertibleNotesIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IncreaseDecreaseInLiabilityForRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IncreaseDecreaseInLiabilityForRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IncreaseDecreaseInPrepaidintransitInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IncreaseDecreaseInPrepaidintransitInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IncreaseInAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IncreaseInAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NonCashOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NonCashOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_PaymentsOnLiabilityForSaleOfFutureRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_PaymentsOnLiabilityForSaleOfFutureRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ReclassificationOfAccruedInterestToLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ReclassificationOfAccruedInterestToLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ReclassificationOfDepositToPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ReclassificationOfDepositToPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount of customer money held in customer accounts, including security deposits, collateral for a current or future transactions, initial payment of the cost of acquisition or for the right to enter into a contract or agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481160/942-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InducedConversionOfConvertibleDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 40<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481194/470-20-40-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InducedConversionOfConvertibleDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285724704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheets (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">&#160;&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</a></td>
<td class="nump">$ 2,910,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,910,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,201,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">&#160;&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</a></td>
<td class="nump">473,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">473,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">&#160;&#160;&#160;&#160;&#160;&#160;Inventory</a></td>
<td class="nump">4,158,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,158,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,530,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryInTransit', window );">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid/in-transit inventory</a></td>
<td class="nump">102,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">&#160;&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</a></td>
<td class="nump">217,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,791<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">&#160;&#160;&#160;Total current assets</a></td>
<td class="nump">7,862,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,862,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,342,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">&#160;&#160;&#160;Property and equipment</a></td>
<td class="nump">1,348,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,348,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,394,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">&#160;&#160;&#160;Accumulated depreciation</a></td>
<td class="num">(378,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(378,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250,861)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">&#160;&#160;&#160;Property and equipment, net</a></td>
<td class="nump">970,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">970,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,143,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>&#160;&#160;&#160;Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">&#160;&#160;&#160;&#160;&#160;&#160;Operating leases &#8211; right-of-use asset</a></td>
<td class="nump">2,789,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,789,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,148,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">&#160;&#160;&#160;&#160;&#160;&#160;Deposits</a></td>
<td class="nump">58,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,901<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">&#160;&#160;&#160;Total other assets</a></td>
<td class="nump">2,848,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,848,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,212,356<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,680,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,680,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,698,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>&#160;&#160;&#160;Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">&#160;&#160;&#160;&#160;&#160;Accounts payable</a></td>
<td class="nump">437,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CustomerDepositsCurrent', window );">&#160;&#160;&#160;&#160;&#160;Customer deposits</a></td>
<td class="nump">46,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">&#160;&#160;&#160;&#160;&#160;Accrued expenses and other current liabilities</a></td>
<td class="nump">299,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">306,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">&#160;&#160;&#160;&#160;&#160;Current portion of operating lease liability</a></td>
<td class="nump">506,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">506,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">&#160;&#160;&#160;&#160;&#160;Current portion of stockholder promissory notes</a></td>
<td class="nump">625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">&#160;&#160;&#160;&#160;&#160;Current portion of long-term debt</a></td>
<td class="nump">50,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,426<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">&#160;&#160;&#160;Total current liabilities</a></td>
<td class="nump">1,965,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,965,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,572,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">&#160;&#160;&#160;Long-term debt, net of current portion and discount</a></td>
<td class="nump">311,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">&#160;&#160;&#160;Operating lease liability, net of current portion</a></td>
<td class="nump">2,376,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,376,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,754,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">&#160;&#160;&#160;Stockholder promissory notes, net of current portion</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,852,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,852,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,091,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>&#160;&#160;&#160;Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $.001; 20,000,000 shares authorized; zero shares issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.001; 200,000,000 shares authorized; 6,910,717 and 6,802,464 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">6,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</a></td>
<td class="nump">25,730,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,730,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">&#160;&#160;&#160;&#160;&#160;&#160;Accumulated deficit</a></td>
<td class="num">(18,909,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,909,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,639,491)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">&#160;&#160;&#160;Total stockholders&#8217; equity</a></td>
<td class="nump">6,827,972<span></span>
</td>
<td class="nump">$ 13,076,312<span></span>
</td>
<td class="nump">6,827,972<span></span>
</td>
<td class="nump">$ 13,076,312<span></span>
</td>
<td class="nump">11,606,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">11,680,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,680,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,698,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales, net</a></td>
<td class="nump">1,890,115<span></span>
</td>
<td class="nump">1,383,011<span></span>
</td>
<td class="nump">5,122,415<span></span>
</td>
<td class="nump">5,741,075<span></span>
</td>
<td class="nump">7,162,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">1,417,552<span></span>
</td>
<td class="nump">980,141<span></span>
</td>
<td class="nump">3,752,006<span></span>
</td>
<td class="nump">3,770,025<span></span>
</td>
<td class="nump">4,874,392<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">472,563<span></span>
</td>
<td class="nump">402,870<span></span>
</td>
<td class="nump">1,370,409<span></span>
</td>
<td class="nump">1,971,050<span></span>
</td>
<td class="nump">2,288,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">2,290,955<span></span>
</td>
<td class="nump">1,662,005<span></span>
</td>
<td class="nump">6,363,514<span></span>
</td>
<td class="nump">6,479,954<span></span>
</td>
<td class="nump">8,241,859<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,818,392)<span></span>
</td>
<td class="num">(1,259,135)<span></span>
</td>
<td class="num">(4,993,105)<span></span>
</td>
<td class="num">(4,508,904)<span></span>
</td>
<td class="num">(5,953,414)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (Income) / Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">&#160;&#160;&#160;Interest income</a></td>
<td class="num">(33,048)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(100,945)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">&#160;&#160;&#160;Interest expense</a></td>
<td class="nump">27,491<span></span>
</td>
<td class="nump">34,016<span></span>
</td>
<td class="nump">92,067<span></span>
</td>
<td class="nump">1,571,848<span></span>
</td>
<td class="nump">1,605,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">(Gain) / Loss on sale of property &amp; equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(13,312)<span></span>
</td>
<td class="nump">3,426<span></span>
</td>
<td class="num">(13,312)<span></span>
</td>
<td class="num">(13,312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">&#160;&#160;&#160;Settlement expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">281,680<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">&#160;&#160;&#160;Other (income) / expense</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(471)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
<td class="num">(389)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (income) / expense</a></td>
<td class="num">(5,557)<span></span>
</td>
<td class="nump">20,169<span></span>
</td>
<td class="nump">275,834<span></span>
</td>
<td class="nump">1,557,989<span></span>
</td>
<td class="nump">1,591,976<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes</a></td>
<td class="num">(1,812,835)<span></span>
</td>
<td class="num">(1,279,304)<span></span>
</td>
<td class="num">(5,268,939)<span></span>
</td>
<td class="num">(6,066,893)<span></span>
</td>
<td class="num">(7,545,390)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_FranchiseTaxesRefund', window );">Franchise taxes / (refund)</a></td>
<td class="nump">1,380<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,342<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,814,215)<span></span>
</td>
<td class="num">$ (1,279,304)<span></span>
</td>
<td class="num">$ (5,270,281)<span></span>
</td>
<td class="num">$ (6,067,193)<span></span>
</td>
<td class="num">$ (7,536,540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NetLossPerShareBasicAndDiluted', window );">Net loss per share (basic and diluted)</a></td>
<td class="num">$ (0.26)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.77)<span></span>
</td>
<td class="num">$ (1.03)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_WeightedaverageNumberOfCommonSharesOutstanding', window );">Weighted-average number of common shares outstanding</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="nump">6,802,464<span></span>
</td>
<td class="nump">6,878,737<span></span>
</td>
<td class="nump">5,913,763<span></span>
</td>
<td class="nump">6,135,938<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_FranchiseTaxesRefund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_FranchiseTaxesRefund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NetLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NetLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_WeightedaverageNumberOfCommonSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_WeightedaverageNumberOfCommonSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerDepositsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current portion of money or property received from customers which is either to be returned upon satisfactory contract completion or applied to customer receivables in accordance with the terms of the contract or the understandings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerDepositsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryInTransit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryInTransit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294975712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="nump">6,802,464<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="nump">6,802,464<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293010400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Stockholders Equity (Deficit) (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 2,431<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,382,093)<span></span>
</td>
<td class="num">$ (1,379,662)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">2,430,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,720,858)<span></span>
</td>
<td class="num">(4,720,858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares, net of issuance costs</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">269,919<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">270,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, net of issuance costs</a></td>
<td class="nump">81,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of shares in exchange for IPO services</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">108,870<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">108,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares in exchange for IPO services</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,102,951)<span></span>
</td>
<td class="nump">2,256,489<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(696,853)<span></span>
</td>
<td class="num">(696,853)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,799,804)<span></span>
</td>
<td class="nump">1,559,636<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,102,951)<span></span>
</td>
<td class="nump">2,256,489<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,067,193)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(12,170,144)<span></span>
</td>
<td class="nump">13,076,312<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,102,951)<span></span>
</td>
<td class="nump">2,256,489<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,536,540)<span></span>
</td>
<td class="num">(7,536,540)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(13,639,491)<span></span>
</td>
<td class="nump">11,606,965<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">8,355,140<span></span>
</td>
<td class="num">(6,799,804)<span></span>
</td>
<td class="nump">1,559,636<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,091,036)<span></span>
</td>
<td class="num">(4,091,036)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares, net of issuance costs</a></td>
<td class="nump">$ 2,466<span></span>
</td>
<td class="nump">14,770,021<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,772,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, net of issuance costs</a></td>
<td class="nump">2,466,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of shares in exchange for IPO services</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares in exchange for IPO services</a></td>
<td class="nump">35,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,114,529<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,114,529<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(10,890,840)<span></span>
</td>
<td class="nump">14,355,616<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,279,304)<span></span>
</td>
<td class="num">(1,279,304)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(12,170,144)<span></span>
</td>
<td class="nump">13,076,312<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(13,639,491)<span></span>
</td>
<td class="nump">11,606,965<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,977,278)<span></span>
</td>
<td class="num">(1,977,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ProceedsReceivedFromExerciseOfWarrants', window );">Proceeds received from exercise of warrants</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">49,740<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">49,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ProceedsReceivedFromExerciseOfWarrantsShares', window );">Proceeds received from exercise of warrants</a></td>
<td class="nump">46,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Stock issued as a result of litigation settlement</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">251,628<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">251,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_StockIssuedAsResultOfLitigationSettlementShares', window );">Stock issued as a result of litigation settlement</a></td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Mar. 31, 2023</a></td>
<td class="nump">$ 6,901<span></span>
</td>
<td class="nump">25,541,022<span></span>
</td>
<td class="num">(15,616,769)<span></span>
</td>
<td class="nump">9,931,154<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">6,900,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2022</a></td>
<td class="nump">$ 6,802<span></span>
</td>
<td class="nump">25,239,654<span></span>
</td>
<td class="num">(13,639,491)<span></span>
</td>
<td class="nump">11,606,965<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">6,802,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,270,281)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2023</a></td>
<td class="nump">$ 6,911<span></span>
</td>
<td class="nump">25,730,833<span></span>
</td>
<td class="num">(18,909,772)<span></span>
</td>
<td class="nump">6,827,972<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2023</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2023</a></td>
<td class="nump">$ 6,901<span></span>
</td>
<td class="nump">25,541,022<span></span>
</td>
<td class="num">(15,616,769)<span></span>
</td>
<td class="nump">9,931,154<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">6,900,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,478,788)<span></span>
</td>
<td class="num">(1,478,788)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsDiluted', window );">Exercise of warrants</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ExerciseOfWarrantsShares', window );">Exercise of warrants</a></td>
<td class="nump">10,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2023</a></td>
<td class="nump">$ 6,911<span></span>
</td>
<td class="nump">25,541,002<span></span>
</td>
<td class="num">(17,095,557)<span></span>
</td>
<td class="nump">8,452,356<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Jun. 30, 2023</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,814,215)<span></span>
</td>
<td class="num">(1,814,215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">119,525<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">119,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfWarrants', window );">Issuance of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">65,046<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">65,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IssuanceOfRestrictedStockUnit', window );">Issuance of RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,260<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,260<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2023</a></td>
<td class="nump">$ 6,911<span></span>
</td>
<td class="nump">$ 25,730,833<span></span>
</td>
<td class="num">$ (18,909,772)<span></span>
</td>
<td class="nump">$ 6,827,972<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance at Sep. 30, 2023</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfRestrictedStockUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfRestrictedStockUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ProceedsReceivedFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ProceedsReceivedFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ProceedsReceivedFromExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ProceedsReceivedFromExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_StockIssuedAsResultOfLitigationSettlementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_StockIssuedAsResultOfLitigationSettlementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed. Includes the adjustments resulting from the assumption that dilutive securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962399645456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows&#160;from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (5,270,281)<span></span>
</td>
<td class="num">$ (6,067,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">153,714<span></span>
</td>
<td class="nump">115,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues', window );">Amortization of debt discount (sale of future revenues)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount - notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,196,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">(Gain) / Loss on sale of property and equipment</a></td>
<td class="nump">3,426<span></span>
</td>
<td class="num">(13,312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts', window );">Increase / (Decrease) in allowance for doubtful accounts</a></td>
<td class="num">(18,804)<span></span>
</td>
<td class="nump">19,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Stock-based settlement</a></td>
<td class="nump">251,680<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">189,831<span></span>
</td>
<td class="nump">2,114,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) / Decrease in accounts receivable</a></td>
<td class="num">(156,445)<span></span>
</td>
<td class="nump">475,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">(Increase) / Decrease in inventory</a></td>
<td class="nump">371,653<span></span>
</td>
<td class="num">(2,984,177)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Decrease in prepaid/in-transit inventory</a></td>
<td class="nump">38,964<span></span>
</td>
<td class="nump">812,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Increase in prepaid expenses and other current assets</a></td>
<td class="num">(45,759)<span></span>
</td>
<td class="num">(134,191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeposits', window );">(Increase) / Decrease in deposits</a></td>
<td class="nump">5,005<span></span>
</td>
<td class="num">(10,976)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase / (Decrease) in accounts payable</a></td>
<td class="nump">206,986<span></span>
</td>
<td class="num">(87,369)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeposits', window );">Increase / (Decrease) in customer deposits</a></td>
<td class="nump">46,190<span></span>
</td>
<td class="num">(274,857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Increase / (Decrease) in accrued expenses and other current liabilities</a></td>
<td class="num">(6,371)<span></span>
</td>
<td class="nump">107,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities', window );">Increase in right-of-use assets and lease liabilities</a></td>
<td class="nump">22,494<span></span>
</td>
<td class="nump">30,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(4,207,717)<span></span>
</td>
<td class="num">(4,699,620)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(20,170)<span></span>
</td>
<td class="num">(434,458)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromProductiveAssets', window );">Net proceeds from sale of property and equipment</a></td>
<td class="nump">36,748<span></span>
</td>
<td class="nump">51,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by / (used in) investing activities</a></td>
<td class="nump">16,578<span></span>
</td>
<td class="num">(382,779)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans', window );">Payments on line-of-credit and short-term revolving loans</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(550,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_PaymentsOnLiabilityForSaleOfFutureRevenues', window );">Payments on liability for sale of future revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(11,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="num">(148,986)<span></span>
</td>
<td class="num">(1,784,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Net proceeds from exercise of warrants</a></td>
<td class="nump">49,777<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,772,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by / (used in) financing activities</a></td>
<td class="num">(99,209)<span></span>
</td>
<td class="nump">12,426,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="num">(4,290,348)<span></span>
</td>
<td class="nump">7,343,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning</a></td>
<td class="nump">7,201,244<span></span>
</td>
<td class="nump">773,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, ending</a></td>
<td class="nump">2,910,896<span></span>
</td>
<td class="nump">8,117,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
<td class="nump">92,136<span></span>
</td>
<td class="nump">401,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_CashPaidRefundedForFranchiseTaxes', window );">Cash paid / (refunded) for franchise taxes</a></td>
<td class="nump">1,341<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability', window );">Acquisition/modification of operating lease right-of-use asset and lease liability</a></td>
<td class="num">(13,993)<span></span>
</td>
<td class="nump">2,348,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_CashlessWarrantExercises', window );">Cashless warrant exercises</a></td>
<td class="nump">41<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt', window );">Purchases of property and equipment in exchange for long-term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">181,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable', window );">Purchased of property and equipment in exchange for short-term payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 170,863<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_CashPaidRefundedForFranchiseTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_CashPaidRefundedForFranchiseTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_CashlessWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_CashlessWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_PaymentsOnLiabilityForSaleOfFutureRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_PaymentsOnLiabilityForSaleOfFutureRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481160/942-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deposit liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962295043312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Nature of Operations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Nature of Operations</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--NatureOfOperations_znCNF2sT6TAa" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <span id="xdx_82E_zqxf4vA7YzK7">Organization
and Nature of Operations</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360
Inc. (formerly Yozamp Products Company, LLC dba Expion360) (&#8220;the Company&#8221;) was incorporated in the state of Nevada in November
2021. Effective November 1, 2021, the Company converted to a C corporation. Prior to conversion, the Company was a limited liability
company (LLC) with an indefinite life organized in the State of Oregon in June 2016. The LLC elected to be treated as a Subchapter S
corporation effective January 1, 2017. Net profits and losses of the LLC and all distributions were allocated among the members in proportion
to the ownership units held. The Original LLC Agreement was amended and restated on January 1, 2021 to add additional members and a non-voting
class of member units. Upon conversion to a C corporation, all existing LLC members at the time of conversion were issued shares of common
stock and became stockholders of the Company.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company designs, assembles, and distributes premium lithium batteries for RV, Marine, Golf, Industrial, Residential, and Off-The-Grid
needs. The Company uses lithium iron phosphate (LiFePO4) batteries. LiFePO4 batteries are considered a top choice for high energy density,
dependability, longevity, and safety, providing the ability to power anything, anywhere.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in March 2020, the COVID-19 pandemic and the measures imposed to contain this pandemic disrupted and may continue to impact the Company&#8217;s
business. While certain restrictions have eased recently, the magnitude of the impact of any new measures from a resurgence in the COVID-19
pandemic on the Company&#8217;s productivity, results of operations, and financial position, and its disruption to the Company&#8217;s
business and battery development and timeline will depend in part on the length and severity of these restrictions and on the Company&#8217;s
ability to conduct business in the ordinary course.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--NatureOfOperations_zDLg00LvNmfh" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>1.&#160;&#160;&#160;
<span id="xdx_827_zZvWsHtu3cjk">Organization and Nature of Operations</span></i></b></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360
Inc. (formerly Yozamp Products Company, LLC dba Expion360) (&#8220;the Company&#8221;) was incorporated in the state of Nevada in November
2021. Effective November 1, 2021, the Company converted to a C corporation. Prior to conversion, the Company was a limited liability
company (LLC) with an indefinite life organized in the State of Oregon in June 2016. The LLC elected to be treated as a Subchapter S
corporation effective January 1, 2017. Net profits and losses of the LLC and all distributions were allocated among the members in proportion
to the ownership units held. The Original LLC Agreement was amended and restated on January 1, 2021 to add additional members and a non-voting
class of member units. Upon conversion to a C corporation, all existing LLC members at the time of conversion were issued shares of common
stock and became shareholders of the Company. (See Note 11 &#8211; Conversion to a C Corporation).</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company designs, assembles, and distributes premium lithium batteries for RV, Marine, Golf, Industrial, Residential, and Off-The-Grid
needs. The Company uses lithium iron phosphate (LiFePO4) batteries. LiFePO4 batteries are considered a top choice for high energy density,
dependability, longevity, and safety, providing the ability to power anything, anywhere.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
in March 2020, the COVID-19 pandemic and the measures imposed to contain this pandemic have disrupted and may continue to impact the
Company&#8217;s business. The magnitude of the impact of the COVID-19 pandemic on the Company&#8217;s productivity, results of operations,
and financial position, and its disruption to the Company&#8217;s business and battery development and timeline, will depend in part
on the length and severity of these restrictions and on the Company&#8217;s ability to conduct business in the ordinary course.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962287786304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zHPJaxbFW8ob" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <span id="xdx_82F_zy6UdrppacW6">Summary
of Significant Accounting Policies</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgJ63UfhQ0tb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zznQ4gIlN0Nb">Basis of Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
results for the three- and nine-month periods ended September 30, 2023 and 2022 are not necessarily indicative of the results that may
be expected for the year ending December 31, 2023. The unaudited interim financial statements should be read in conjunction with our
Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 30, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, all references to shares and stockholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziT5dCht3uFk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zOHKhw3PteE6">Reclassification
of Prior Year Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zpNgy4pYKooc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;<span id="xdx_863_z8gMJVTa1XI3">Going Concern,
Liquidity and Capital Resources</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As presented in the
accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations. These factors
raise substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the date that
the financial statements for the three and nine month periods ended September 30, 2023 are issued. However, management is working
to address its cash flow challenges, including raising additional capital, managing inventory levels, identifying alternative supply
chain resources, and managing operational expenses.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Historically, the
Company&#8217;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#8217;s sales for the three months ended September 30, 2023 increased 36.7% and sales for the nine months ended
September 30, 2023 decreased 10.8% compared to the same periods in 2022. For the nine months ended September 30, 2023, we received
net proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930_zTQpfpO0wX0e" title="Net proceeds from Warrants">49,777</span> from warrant exercises. On April 1, 2022, the Company completed an initial public offering and listing
of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of costs, totaled $14,772,487, of which approximately
$2,464,000 was used to pay down principal and accrued interest on high interest-bearing debt. The remaining proceeds have thus
far and will continue to be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines&#160;to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in
China. In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S.
and an assembly facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management
has secured a secondary source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption
issues with China arise. Management believes that these factors will contribute to achieving operating efficiency and profitability.
However, there can be no assurance that the Company will be successful in achieving its objectives, including achieving operating
efficiency and profitability.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#8217;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--UseOfEstimates_zANTPXXkTLag" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z1k09Z9f0CFj">Use of Estimates</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#8217;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#8217;s accounting estimates require the exercise of judgment.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zM1t2IcH1W45" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zHFji1q7K1Hc">Cash and Cash
Equivalents</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Cash accounts are secured by the Federal Deposit Insurance Corporation
(&#8220;FDIC&#8221;) up to $250,000 per institution. At times, balances may exceed federally insured limits. Investment accounts are
placed in funds consisting of US Treasury-related ultra-short paper. The Company has not experienced any losses in such accounts and
management believes that the Company is not exposed to any significant credit risk with respect to its cash and cash equivalents. As
of September 30, 2023, cash balances exceeded FDIC limits by $<span id="xdx_900_eus-gaap--FDICIndemnificationAssetPeriodIncreaseDecrease_c20230101__20230930_zDrWcHx38j4c" title="FDIC Limits">547,054</span> and investment accounts totaling $<span id="xdx_902_ecustom--TreasuryRelatedPaper_c20230101__20230930_zdNTbYrQulzj" title="Treasury related paper">2,100,847</span> are invested in US
Treasury-related ultra-short paper.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt">&#160;</p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zg3CV4xsKrFl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zQx8Pw8Ksx8a">Accounts Receivable</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any
interest. The Company performs ongoing credit evaluations of its customers and generally requires no collateral. An allowance for
uncollectible accounts is recorded to reduce accounts receivable to the estimated amount that will be collected. The allowance
is based upon management&#8217;s review of the accounts receivable aging and specific identification of potentially uncollectible
balances. Recoveries of accounts previously written off and adjustments to the allowance for uncollectible accounts are recorded
as adjustments to bad debt expense. For the three months ended September 30, 2023 and 2022, the Company wrote off $<span id="xdx_902_ecustom--AdjustmentsToBadDebtExpense_c20230701__20230930_zhMWY4H08Hn1" title="Adjustments to bad debt expense">388</span> and $<span id="xdx_901_ecustom--AdjustmentsToBadDebtExpense_c20220701__20220930_zDdBmfX45atg" title="Adjustments to BadDebt Expense">0</span>,
respectively. For the nine months ended September 30, 2023 and 2022, the Company recovered a net of ($<span id="xdx_907_ecustom--AdjustmentsToBadDebtExpense_c20230101__20230930_zPJnfsusliMk" title="Adjustments to BadDebt Expense">412</span>) and wrote off $<span id="xdx_90E_ecustom--AdjustmentsToBadDebtExpense_c20220101__20220930_zBP1XuFjh8ql" title="Adjustments to BadDebt Expense">19,604</span>,
respectively. There was no allowance for doubtful accounts as of September 30, 2023 or December 31, 2022, as management believed
all outstanding amounts to be fully collectible.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_ecustom--CustomerDepositsPolicyTextBlock_zNL2oEnKFQp7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z7xVitSlvKK5">Customer Deposits</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023 and December 31, 2022, the Company had customer deposits totaling $<span id="xdx_90F_eus-gaap--CustomerDepositsCurrent_iI_c20230930_zcJaJUhl5srd" title="Customer deposits">46,248</span> and $<span id="xdx_900_eus-gaap--CustomerDepositsCurrent_iI_c20221231_zXlNpb7xgH27">58</span>, respectively.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_z1GJZfvW8of1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zkDwjVdRHtk2">Inventory</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and
accessories, resale items, components, and related landing costs. As of September 30, 2023 and December 31, 2022, the Company had
inventory that consisted of finished assemblies&#160;totaling $<span id="xdx_904_eus-gaap--InventoryFinishedGoods_iI_c20230930_zVVqLoTHmu1" title="Finished Inventory">3,306,972</span> and $<span id="xdx_90E_eus-gaap--InventoryFinishedGoods_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zd3owKutQuS6">3,243,485</span>, respectively, and raw materials (inventory
components, parts, and packaging) totaling $<span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20230930_zo57vJqNtxf4" title="Raw materials">851,511</span> and $<span id="xdx_906_eus-gaap--InventoryRawMaterials_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zbJsGW95Todg">1,286,651</span>, respectively. The valuation of inventory includes fixed production
overhead costs based on normal capacity of the assembly warehouse. &#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of September 30, 2023 or December 31, 2022. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $<span id="xdx_90F_eus-gaap--Supplies_iI_c20230930_zwDUndQS8Tof" title="Inventory purchases from foreign suppliers">102,646</span> and $<span id="xdx_905_eus-gaap--Supplies_iI_c20221231_zFz97mIRGusc">141,611</span> at September 30, 2023 and December 31,
2022, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zSVrJSTrujuf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zuyyMUkC9sUk">Vendor and Foreign
Concentrations of Inventory Suppliers</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">During the three
months ended September 30, 2023 and 2022, respectively, approximately 61% and 91%, respectively, of inventory purchases were made
from foreign suppliers in China and Hong Kong. During the nine months ended September 30, 2023 and 2022, respectively, approximately
71% and 92%, respectively, of inventory purchases were made from foreign suppliers in China and Hong Kong. Any adverse change in
either the economic or political conditions abroad could negatively impact the Company&#8217;s supply chain. The inability to obtain
product to meet sales demand could adversely affect results of operations. However, the Company has secured a secondary source
for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company to source materials outside
of China in the event it becomes necessary to do so.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zl6mWGf2skuf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zvBO0PDWsi3f">Property and Equipment</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:</span></p>

<p id="xdx_897_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zuXw7FtPdsIg" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zV5v1ps7r6D2" style="display: none">Schedule of estimated useful lives</span></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-top: black 1pt solid; padding: 0 0 0 10pt; width: 73%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZV5XzKnP4tg">5</span>
    - <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zpOXQnsnhsSd">7</span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zuIIeEWpXLRd">3</span> - <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember_zp71G5Uph898">7</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zVhJtgsDPtx3">3</span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_z2aU44dnTkoh">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember__srt--RangeAxis__srt--MinimumMember_z7IJ1jOnBH4i">3</span> - <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember_zGVSRvGMW8yb">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zcl7qmHKALgc">3</span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zHwntN1vxfZ">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4KW4plU2Hag">3</span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_ztN4onwQ4D17">10</span> years&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8AD_z62Oyv4K3jEj" style="margin: 0; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements
are amortized over the shorter of the lease term or their estimated useful lives.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable to assets retired are removed from the accounts,
and the gain or loss on disposition is recognized in the Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zmsaz761uy13" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z2uhXnc33Ek8">Leases</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s
right to use an underlying asset during the lease term, and operating lease liabilities represent</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company&#8217;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease liabilities,
and long-term operating lease liabilities on the Company&#8217;s Balance Sheets. The Company does not have any finance leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments
over the lease term at commencement date calculated using the Company&#8217;s incremental borrowing rate applicable to the
lease asset, unless the implicit rate is readily determinable. ROU assets also include any lease payments made at or before
lease commencement and exclude any lease incentives received. The Company&#8217;s lease terms may include options to extend
or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12
months or less are not recognized on the Company&#8217;s Balance Sheet. The Company&#8217;s leases do not contain any
residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease
term.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for lease and non-lease components as a single lease component for all its leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHZVlaRWukAi" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z3GfuMPhmwmd">Impairment of
Long-Lived Assets</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">Long-lived assets
consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the
asset to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted
cash flows, the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value.
Fair value is determined primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No
long-lived asset impairment was recognized during the three or nine months ended September 30, 2023 or 2022.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--ExtendedProductWarrantyPolicy_zyXGEm02mcJ7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_z8MAFVzfacCg">Product Warranties</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">The Company sells
the majority of its products to customers along with conditional repair or replacement warranties. The Company&#8217;s branded
DC mobile chargers are warrantied for two years from the date of sale and its branded VPR 4EVER Classic and Platinum batteries
are warrantied at gradually lesser levels over a twelve-year period from date of sale. The Company determines its estimated liability
for warranty claims based on the Company&#8217;s experience of the amount of claims actually made. Management estimates no liability
as of September 30, 2023 and December 31, 2022 because, historically, there have been very few claims and costs for repairs&#160;or
replacement parts have been nominal. It is possible that the Company&#8217;s estimate of liability for product liability claims
will change in the near term.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--LiabilityForRefundsPolicyTextBlock_zmaN7OQCgBK3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zJX7B0uqI7R9">Liability for
Refunds</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company does
not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zaieuIHfl2p" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zRUXrxLYomUc">Revenue Recognition</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#8217;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#8217;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zic28ONNMc66" style="margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zVF3VNW0l4w1">Concentration of Major Customers</span></i></span></p>

<p style="margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2023, sales to three customers totaled $700,071, comprising approximately 38% of total sales. These
customers represented 31% of total accounts receivable as of September 30, 2023. During the nine months ended September 30, 2023, sales
to two customers totaled $1,178,142, comprising approximately 23% of total sales. These customers represented 23% of total accounts receivable
as of September 30, 2023. Accounts receivable from three additional customers totaled $190,495, representing approximately 40% of accounts
receivable as of September 30, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During the
three months ended September 30, 2022, sales to two customers totaled $394,936, comprising approximately 28% of total sales. There
were no accounts receivable for these customers as of September 30, 2022. During the nine months ended September 30, 2022, sales
to two customers totaled $1,816,821, comprising approximately 32% of total sales. Accounts receivables for these customers totaled
$7,486, representing approximately 3% of total accounts receivable as of September 30, 2022. Accounts receivable from two additional
customers totaled $90,789, representing approximately 32% of total accounts receivables as of September 30, 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zTFf5ClWxhW8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zrgvvuszgBz">Shipping and Handling
Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">Shipping and handling
fees billed to customers are classified in&#160;the Statement of Operations in &#8220;Sales, net&#8221; and totaled $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230701__20230930_zYxhpTQflxFl" title="Shipping and handling fee">27,398</span> and
$<span id="xdx_90B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220701__20220930_zCjQcgfDGpHi" title="Shipping and handling fee">6,133</span> during the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_903_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230101__20230930_z0NAnTn3OiP4" title="Shipping and handling fee">52,296</span> and $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220101__20220930_zae99EQTdkpj" title="Shipping and handling fee">17,514</span> during the nine months
ended September 30, 2023 and 2022, respectively. Shipping and handling costs for shipping product to customers totaled $<span id="xdx_906_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230701__20230930_zIZVrwz7Nox7" title="Shipping and handling costs for shipping product">58,141</span>
and $<span id="xdx_901_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220701__20220930_zzteob8JfWW5" title="Shipping and Handling Costs for Shipping Product">54,840</span> during the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_903_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230101__20230930_zvZPFMRMfkvg" title="Shipping and Handling Costs for Shipping Product">149,898</span> and $<span id="xdx_902_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220101__20220930_z2w0cryYMxY2" title="Shipping and Handling Costs for Shipping Product">137,497</span> during the nine
months ended September 30, 2023 and 2022, respectively, and are classified in selling, general, and administrative expense in the
accompanying Statements of Operations.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--AdvertisingCostsPolicyTextBlock_zOgCRPqN9Duh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_z4X1Bsn8YSB6">Advertising and
Marketing Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20230701__20230930_zzpF76DA7O77" title="Advertising and marketing expense">238,163</span> and $<span id="xdx_909_eus-gaap--MarketingAndAdvertisingExpense_c20220701__20220930_zoBYJRoRQ5Lf">215,994</span> for the
three months ended September 30, 2023 and 2022, respectively and $<span id="xdx_90D_eus-gaap--MarketingAndAdvertisingExpense_c20230101__20230930_zfKEXxxy4Nce">690,995</span> and $<span id="xdx_902_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20220930_zbmh9L1WX0X1">527,732</span> for the nine months ended September 30, 2023 and
2022, respectively, and is included in selling, general and administrative expense in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu2zb5uSlDg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zIsTtfCV2Ls7">Research and Development</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20230701__20230930_z6QXmy9izALb" title="Research and development costs">145,111</span> and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20220701__20220930_z8JZXu7QYOe9">41,355</span> for
the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20230930_zLLzALUAO4wj">316,369</span> and $<span id="xdx_90F_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20220930_zdrgDWnumJzi">153,730</span> for the nine months ended September 30, 2023
and 2022, respectively, and are included in selling, general and administrative expenses in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z5amL6LL3PC4" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zfT5BlKB4KE4">Income Taxes</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
November 1, 2021, the Company converted from an LLC to a C corporation and, as a result, became subject to corporate federal and state
income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including
tax loss and credit carryforwards, and liabilities are measured using the enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that included the enactment date. Deferred income tax expense represents
the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation
allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not
be realized.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of September 30, 2023 and December 31, 2022, the Company has not recorded any income tax
provision/(benefit) resulting from the CARES Act, mainly due to the Company&#8217;s history of net operating losses.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2023 and beyond.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zV7PliosUCK6" style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_86F_z0q4RC6OBOsi">Fair Value of Financial Instruments</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, <i>Fair Value Measurement</i>. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1: </i>Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2: </i>Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3: </i>Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, stockholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the stockholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z9J2A90KyAB1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zXdAiAjaTVfh">Segment Reporting</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zcjAReRD1ima" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z1ojxA7cbqU7">Basic and Diluted
Net Loss Per Share</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shows the amounts used in computing net loss per share:</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zePybWaSuLEg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zQX2EFnNMBN3" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zvweiPURMUYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_493_20230701__20230930_zFiW3vb3LjVh" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220701__20220930_z75Hf7GwhZ0a" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20230101__20230930_zwhv0JvhSnll" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20220930_zeHqbQ6AOtlj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended September 30,</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_40E_ecustom--NetLossOne_ziztUNeD3Qo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,814,215</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,279,304</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,270,281</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,067,193</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zwxiOedMoiLd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average common shares outstanding &#8211; basic and diluted</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,910,717</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,802,464</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,878,737</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,913,763</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--NetLossPerShareBasicAndDiluted_z1yj24NP6Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.26</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.19</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.77</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.03</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p id="xdx_8A3_zhji71lzjJIj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt">As
of September 30, 2023 and December 31, 2022, the Company has outstanding warrants, options, and restricted stock units (&#8220;RSUs&#8221;)
convertible into 1,926,610&#160;and 1,717,936 shares of common stock, respectively. The following table sets forth the number of
shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive.</p>



<p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zyoB77o7qJjh" style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zZmAWA3vVak8" style="display: none">Schedule
of anti-dilutive share</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_z0ucSeAjt4h3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Warrants</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zUlM0wcirv51" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">802,830</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zT3f4cQ55Eul" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">888,436</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8RJRSgh28M1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,075,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQoUblAc9nu1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_z6xhWsB6cwAe" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_ziAg5Zah8Nad" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1596">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930_zJ2ZxiTDCpT3" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,926,610</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zOAG9Jemb06g" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,717,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zzG6p9PN8rl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zknouLL4YS84" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zyjXuR8kfUwb">Stock-Based Compensation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK2ONxRis2ni" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zjomQiUVvQp2">New Accounting
Pronouncements</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#8221; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#8217;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the
Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#8221; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#8220;CECL&#8221;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have <i>not</i> yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company adopted this standard effective January 1, 2023, and the adoption of
this guidance did not have an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#8221; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the Company&#8217;s
financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have
an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"></p>



<p style="margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84A_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zSnM0CB4zkV8" style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_860_zUd0W7Zv5zQf">Accounting Guidance Issued
but Not Yet Adopted</span></i>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the FASB issued ASU 2023-02, &#8220;Investments&#8212;Equity Method and Joint Ventures (Topic 323): Accounting for Investments
in Tax Credit Structures Using the Proportional Amortization Method.&#8221; This ASU was issued to allow reporting entities to consistently
account for equity investments made primarily for the purpose of receiving income tax credits and other income tax benefits. ASU 2023-02
is effective for the Company for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.
The Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, &#8220;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#8221; which amends the guidance in Topic 820, <i>Fair Value Measurement</i>, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zZCSyj0UPyae" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#160;&#160;&#160;
<span id="xdx_82F_z1u578H1k60g">Summary of Significant Accounting Policies</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zosCWUTDZP34" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zcKmcVMiCX0f">Basis
of Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying audited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, all references to shares and shareholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziidprNltiq8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zSrNnjseglo9">Reclassification
of Prior Year Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zAezeEXDtu25" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z4jgPTONCSic"><span id="xdx_860_z6aTGYt6Y5M5">Going
Concern, Liquidity and Capital Resources</span></span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.</span></p>






<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
presented in the accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations.
These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the
date that the financial statements for the year ended December 31, 2022 are issued. However, management is working to address its cash
flow challenges, including raising additional capital, alternative supply chain resources, and in-house assembly lines.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the Company&#8217;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#8217;s sales for 2022 increased 59% over sales for 2021, as product demand continued to rise. On April 1, 2022, the
Company completed an initial public offering and listing of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of
costs, totaled $<span id="xdx_903_ecustom--ProccedsFromIpoNetsCost_c20220101__20221231_z7Q2DZxWDT4c" title="Procceds from IPO nets cost">14,772,487</span>, of which approximately $2,464,000 was used to pay down principal and accrued interest on high interest-bearing
debt. The remaining proceeds will be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in China.
In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S. and an assembly
facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management has secured a secondary
source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption issues with China arise.
Management believes that these factors will contribute to achieving operating efficiency and profitability. However, there can be no
assurance that the Company will be successful in achieving its objectives, including achieving operating efficiency and profitability.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#8217;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_843_eus-gaap--UseOfEstimates_z0ocRgWNWQZf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z3EVxd0y6wca">Use
of Estimates</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#8217;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#8217;s accounting estimates require the exercise of judgment.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbaeIGyik0Mb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zNC12ITNVsB">Cash
and Cash Equivalents</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Accounts are secured by the Federal Deposit Insurance Corporation
(&#8220;FDIC&#8221;) up to $250,000 per institution. At times, balances may exceed federally insured limits. The Company has not experienced
any losses in such accounts and management believes that the Company is not exposed to any significant credit risk with respect to its
cash and cash equivalents. As of December 31, 2022, cash balances exceeded FDIC limits by $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zcGyEsa7W9l2" title="Cash balances exceeded FDIC">222,162</span>.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-indent: 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had two accounts totaling $<span id="xdx_900_eus-gaap--DepositContractsAssets_iI_c20221231_zr5rvg17WSx8" title="Deposit">11,204</span> with SVB. As of March 13, 2023 all funds were transferred to another
banking institution and no exposure currently exists.</span></p>






<p id="xdx_842_eus-gaap--ReceivablesPolicyTextBlock_zccEBi4gxRMb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zOIVAMD7VBVi">Accounts
Receivable</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any interest. The Company performs
ongoing credit evaluations of its customers and generally requires no collateral. An allowance for uncollectible accounts is recorded
to reduce accounts receivable to the estimated amount that will be collected. The allowance is based upon management&#8217;s review of
the accounts receivable aging and specific identification of potentially uncollectible balances. Recoveries of accounts previously written
off and adjustments to the allowance for uncollectible accounts are recorded as adjustments to bad debt expense. The allowance for doubtful
accounts totaled $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20221231_znRkir5rWLte" title="Allowance for doubtful accounts">18,804</span> as of December 31, 2022. There was no allowance for doubtful accounts as of December 31, 2021, as management
believed all outstanding amounts to be fully collectible.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_ecustom--CustomerDepositsPolicyTextBlock_zyS8bauBrXf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zEW3Jl2pLZOk">Customer
Deposits</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, the Company had customer deposits totaling $<span id="xdx_907_eus-gaap--CustomerDepositsCurrent_iI_c20221231_z8KvAEyLc4Wi" title="customer deposits">58</span> and $<span id="xdx_902_eus-gaap--CustomerDepositsCurrent_iI_c20211231_zu7rv75fbhI1">436,648</span>, respectively.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_84E_eus-gaap--InventoryPolicyTextBlock_zf1aQfkRjwJc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zdHpw0ZUqF8d">Inventory</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and accessories, resale items,
components, and related landing costs. As of December 31, 2022 and December 31, 2021, the Company had inventory that consisted of finished
assemblies totaling $<span id="xdx_90F_eus-gaap--InventoryFinishedGoods_iBI_c20221231_z7JFutRuUqjk" title="Inventory, Finished Goods">2,722,765</span> and $<span id="xdx_90B_eus-gaap--InventoryFinishedGoods_iBI_c20211231_zzMpfUhaDOr">985,537</span>, respectively, and raw materials (inventory components, parts, and packaging) totaling $<span id="xdx_90A_eus-gaap--InventoryRawMaterials_iI_c20221231_zDQEPRX2l6Ac" title="Raw materials">1,807,371</span>
and $<span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20211231_z8ivsKbdTiph">1,066,343</span>, respectively. The valuation of inventory includes fixed production overhead costs based on normal capacity of the assembly
warehouse. &#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of December 31, 2022 or December 31, 2021. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $<span id="xdx_90C_eus-gaap--OtherInventoryNetOfReserves_iI_c20221231_zmmUIXDfpCmi" title=" inventory">141,611</span> and $<span id="xdx_906_eus-gaap--OtherInventoryNetOfReserves_iI_c20211231_zfgxFRsSTnof">1,081,225</span> at December 31, 2022 and December 31,
2021, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zBxViAQdVsP8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ztqVhnYxB5Je">Vendor
and Foreign Concentrations of Inventory Suppliers</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2022 and 2021, approximately 85% and 90%, respectively, of inventory purchases were made from foreign suppliers
in China and Hong Kong. Any adverse change in either the economic or political conditions abroad could negatively impact the Company&#8217;s
supply chain. The inability to obtain product to meet sales demand could adversely affect results of operations. However, the Company
has secured a secondary source for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company
to source materials outside of China in the event it becomes necessary to do so.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zaxsA97CojTi" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zV00YnVTG9lb">Property
and Equipment</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:</span></p>

<p id="xdx_89D_ecustom--ScheduleOfEstimatedUsfulLivesTableTextBlock_zgjoYcW0kHt8" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zWohKwqbpHad" style="display: none">Schedule
of estimated useful lives&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zeyesCta2Ejd" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; width: 73%; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z8JL4yFreas7">5</span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zEDbhRClpoEb" title="Property, Plant and Equipment, Useful Life">7</span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zxdcGLihMHHg">3</span> - <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zHpM0h6TVSE6" title="Property, Plant and Equipment, Useful Life">7</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4gROOUSc534">3</span> - <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zhWz2PaOHzpg" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zAiAlB8I49Hg">3</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTHLP9GmS5gf" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHNVfYLdWUv9">3</span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_znEhEelnV84k" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zf1pseSy9Frd">5</span>
    - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zidybgPumZf5">10</span> years</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A6_zcUsV5UGCyba" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable
to assets retired are removed from the accounts, and the gain or loss on disposition is recognized in the Statements of Operations.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_zpvUbeR694Od" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zk0QKaOFMT74">Leases</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#8220;ROU&#8221;) assets represent the
Company&#8217;s right to use an underlying asset during the lease term, and operating lease liabilities representthe Company&#8217;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease
liabilities, and long-term operating lease liabilities on the Company&#8217;s Balance Sheets. The Company does not have any finance
leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments over the lease
term at commencement date calculated using the Company&#8217;s incremental borrowing rate applicable to the lease asset, unless the implicit
rate is readily determinable. ROU assets also include any lease payments made at or before lease commencement and exclude any lease incentives
received. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the
Company will exercise that option. Leases with a term of 12 months or less are not recognized on the Company&#8217;s Balance Sheet. The
Company&#8217;s leases do not contain any residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line
basis over the lease term.&#160;</span></p>

<p style="margin: 0; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for lease and non-lease components as a single lease component for all its leases.</span></p>

<p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zQLhdMjGG0e2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zfIapyfWjTE2">Impairment
of Long-Lived Assets</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the asset
to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted cash flows,
the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value. Fair value is determined
primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No long-lived asset impairment was
recognized during the years ended December 31, 2022 and 2021.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--ExtendedProductWarrantyPolicy_zduEi09mXQ5c" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zWZXkTaEJTF9">Product
Warranties</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sells the majority of its products to customers along with conditional repair or replacement warranties. The Company&#8217;s
branded DC mobile chargers are warrantied for two years from the date of sale. The company&#8217;s branded VPR 4EVER Classic and Platinum
batteries and re-branded e360 and e360 Extreme Density batteries are warrantied at gradually lesser levels over a twelve-year period
from date of sale. The Company determines its estimated liability for warranty claims based on the Company&#8217;s experience of the
amount of claims actually made. Management estimates no liability as of December 31, 2022 and December 31, 2021 because, historically,
there have been very few claims and costs for repairs or replacement parts have been nominal. It is possible that the Company&#8217;s
estimate of a liability for product liability claims will change in the near term.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_ecustom--LiabilityForRefundsPolicyTextBlock_zrQ1zFEu2z69" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zwiLOZBMPZV8">Liability
for Refunds</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.
However, during 2020 the Company sold discontinued products and recorded a liability for refunds. As of December 31, 2020, the liability
totaled $58,000. During the year ended December 31, 2021, the Company issued credits totaling $58,000, respectively. As of December 31,
2021, all allowable discontinued products had been returned and the Company had no further refund liability. No refund liability was
recognized in the year ended December 31, 2022. Revenue is recorded net of this amount. Any returns of discontinued product are not added
back to inventory and therefore related costs are nominal and not recorded as an asset.</span></p>






<p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zW7E6Z2Oepa6" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zMrPJgFfm5Xc">Revenue
Recognition</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#8217;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#8217;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zdcgPMDe3Chk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zbdgwFebNPs3">Concentration
of Major Customers</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, sales to three customers totaled $2.9 million, comprising approximately 41% of total sales. These customers
represented 43% of total accounts receivable as of December 31, 2022. During the year ended December 31, 2021, sales to one customer
totaled $486,000, comprising 11% of total sales. This customer did not have an accounts receivable balance as of December 31, 2021, but
three other customers had accounts receivable balances totaling $658,000 and representing a total of 85% of total accounts receivable
as of December 31, 2021.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_z1IF9QSTe9Ja" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zgncV9FjaA1f">Shipping
and Handling Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling fees billed to customers are classified on the Statement of Operations as &#8220;Sales, net&#8221; and totaled $23,188 and
$25,688 during the years ended December 31, 2022 and 2021, respectively. Shipping and handling costs for shipping product to customers
totaled $169,335 and $102,653 during the years ended December 31, 2022 and 2021, respectively, and are classified in selling, general
and administrative expense in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zl60rvUr3Xt7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zwb1FyLiAXC">Advertising
and Marketing Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20221231_zSuwZEm8gAgf" title="Advertising and marketing expense">239,814</span> and $<span id="xdx_90F_eus-gaap--MarketingAndAdvertisingExpense_c20210101__20211231_zmuk9fe4SgDg">67,394</span> for the
years ended December 31, 2022 and 2021, respectively, and is included in selling, general and administrative expense in the accompanying
Statements of Operations. &#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_z1UAWRgo5n11" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zz0IHaYK31Jj">Research
and Development</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_z1puF02fZCJb" title="Research and development costs">270,054</span> and $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_zfoG7iw5qB">58,044</span> for
the years ended December 31, 2022 and 2021, respectively, and are included in selling, general and administrative expenses in the accompanying
Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTaIjtjdXNag" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zcuS6ynhcTGh">Income
Taxes</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 1, 2017 to October 31, 2021, the Company was not subject to federal or state income taxes since it was a limited liability company
taxed as an S corporation. The Company&#8217;s taxable income or losses were allocated to its members in accordance with their respective
ownership percentages. Therefore, no provision or liability for federal income taxes was included in the accompanying financial statements
for the relevant periods in 2021. Certain states impose minimum franchise taxes on entities taxed as an S corporation. Accordingly, the
accompanying financial statements include provisions for state franchise tax fees.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-size: 10pt">Effective November 1, 2021, the Company converted
from an LLC to a C corporation and, as a result, became subject to corporate federal and state income taxes. Deferred tax assets and
liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts
of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including tax loss and credit carryforwards, and
liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences
are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that included the enactment date. Deferred income tax expense represents the change during the period in the deferred
tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.</span></p>
<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>






<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of December 31, 2022 and 2021, the Company has not recorded any income tax provision/(benefit)
resulting from the CARES Act, mainly due to the Company&#8217;s history of net operating losses.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2022 and beyond.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zoC7OCnSrRU" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value of Financial Instruments</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, <i>Fair Value Measurement</i>. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1: </i>Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2: </i>Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3: </i>Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, shareholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the shareholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--SegmentReportingPolicyPolicyTextBlock_znUfrRrVLwhl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zTgQ346zzUFi">Segment
Reporting</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zS1YFMYdVbj9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zB8JNZo8YXY4">Basic
and Diluted Net Loss Per Share</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shows the amounts used in computing net loss per share:</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z50CTcwuN1m1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_z44xU4SMZuO" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zrWQ6gqJKxi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20220101__20221231_z1r7BosSa6j9" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_490_20210101__20211231_zxvvFMeavWJj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_409_ecustom--NetLoss_zGDahUfcOWR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(7,536,540</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(4,720,858</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zzxXXZJfHJ82" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Weighted average common shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,135,938</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,888,695</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--NetLossPerShareBasicAndDiluted_z46cR1iXMXG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.23</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.63</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AD_z6t2bLfiorm5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the years ended December 31, 2022 and 2021, the Company has outstanding warrants and options convertible into 1,717,936 shares of
common stock, respectively. The following table sets forth the number of shares excluded from the computation of diluted loss per share,
as their inclusion would have been anti-dilutive.</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zdDUbMmPGSle" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zA4OfQuOT4Y2" style="display: none">Schedule of anti-dilutive share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_zNr6DvcK9ZY4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt">Stock options</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zToARjhdbPki" style="width: 12%; text-align: right">829,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPDZLIp16ry7" style="width: 12%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPoKd9ZSYdH6" style="border-bottom: Black 1pt solid; text-align: right">888,436</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zOZV8xjYB656" style="border-bottom: Black 1pt solid; text-align: right">710,431</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zK3yOGTFlWT4" style="border-bottom: Black 2.5pt double; text-align: right">1,717,936</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zvdzQQEGM7hh" style="border-bottom: Black 2.5pt double; text-align: right">740,431</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_z9HzVV4rdFJl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_842_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zVBPAuuC3y8j" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zo0xyQIDHiJk">Stock-Based
Compensation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zXhYdKndQhDc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zen3BobqEmog">New
Accounting Pronouncements</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">In May 2021, the FASB issued ASU 2021-04,
&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation
(Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for
Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the Emerging Issues Task Force).&#8221;
ASU 2021-04 requires issuers to account for modifications or exchanges of freestanding equity-classified written call options that remain
equity classified after the modification or exchange based on the economic substance of the modification or exchange. Under the guidance,
an issuer determines the accounting for the modification or exchange based on whether the transaction was done to issue equity, to issue
or modify debt, or for other reasons. ASU 2021-04 is applied prospectively and is effective for fiscal years beginning after December
15, 2021, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of fiscal 2022, which
did not have a material impact on the Company&#8217;s financial statements or disclosures.</span></p>
<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>






<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity.
Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion
features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in
substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single
liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Similarly,
equity-classified convertible preferred stock instruments will be accounted for as single units of account in equity unless the conversion
feature needs to be bifurcated under Topic 815. The new guidance also made amendments to the earnings per share guidance in Topic 260,
Earnings Per Share, for convertible instruments, the most significant impact of which is requiring the use of the if-converted method
for diluted earnings per share calculation. Further, ASU 2020-06 made revisions to Subtopic 815-40, which provides guidance on how an
entity must determine whether a contract qualifies for a scope exception from derivative accounting. ASU 2020-06 is effective for fiscal
years beginning after December 15, 2021, with early adoption permitted. Adoption of the standard requires using either a modified retrospective
or a full retrospective approach. Effective January 1, 2021, the Company early adopted ASU 2020-06 using the modified retrospective approach.
Adoption of the new standard did not have a material impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01, Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint
Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.
The new guidance clarifies the interaction of accounting for the transition into and out of the equity method and the accounting for
measuring certain purchased options and forward contracts to acquire investments. ASU 2020-01 is effective for fiscal years beginning
after December 15, 2020, including interim periods within those fiscal years. Effective January 1, 2021, the Company adopted ASU 2020-01.
The adoption of this guidance did not have an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zn9Wxsicv9kd" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zH4wjNyLkeD6">Accounting
Guidance Issued but Not Yet Adopted</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#8221; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#8217;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, &#8220;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#8221; which amends the guidance in Topic 820, <i>Fair Value Measurement</i>, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#8221; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#8220;CECL&#8221;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have <i>not</i> yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company is currently evaluating the impact of this standard on our financial
statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#8221; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company is currently evaluating the impact of adopting this guidance.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962297647488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z4GFxnyrfzK7" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<span id="xdx_825_zWG33FeT4426">Property and Equipment, Net</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment
consist of the following:</span></p>

<p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zdaIUz23Il85" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_z4Y1xZWpzqea" style="display: none">Schedule of property and equipment</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_134_zOfQ6BgUoqf8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, Net (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles and transportation
    equipment</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zmhsxJUgBDNb" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">551,906</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zyLFZEgqsNU9" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">593,097</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zXagIjEVvhof" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,819</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zAFW8MlYhu6g" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,819</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zUUYEEV7yPG" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,131</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zFnXkyfj7IGj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,131</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zdnBMdaZ2bJ" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,274</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zBxYP1sx2i43" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,274</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSUenEwxox74" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,164</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSR022k9Qzwg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,164</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zaTF3uav4Tcf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,032</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zWwlDJtq3DMd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,142</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and Molds</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z8fU3Q1peZRk" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1621">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z9cWHbJvWOFd" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,992</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930_zp1L0wYDBBcb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,348,326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zsAJvBmZMx6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,394,619</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230930_zqrB59mhZ0C" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(378,286</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSlyRdJTtSlj" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(250,861</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230930_z3Fu8HJbJTc4" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">970,040</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zfF1SGzFjrgd" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A7_za00vqdEvNXe" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Depreciation expense
was $<span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20230701__20230930_zLomK7IhHLHh" title="Depreciation expense">50,507</span> and $<span id="xdx_904_eus-gaap--DepreciationAndAmortization_c20220701__20220930_zLvA60oLnhs2" title="Depreciation expense">48,364</span> for the three months ended September 30, 2023 and 2022, respectively. Depreciation expense was $<span id="xdx_90F_eus-gaap--DepreciationAndAmortization_c20230101__20230930_zzppiBdgjAAh" title="Depreciation expense">153,714</span>&#160;and
$<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20220101__20220930_zFPUOMgQcP6h" title="Depreciation expense">115,670</span> for the nine months ended September 30, 2023 and 2022, respectively. There were disposals and sales of fixed assets during
the nine months ended September 30, 2023 and 2022 resulting in the net cash received of $<span id="xdx_90E_ecustom--DisposalsAndSalesOfFixedAssets_c20230101__20230930_zrFkVZLDD3Tl" title="Disposals and sales of fixed assets">36,748</span> and $<span id="xdx_909_ecustom--DisposalsAndSalesOfFixedAssets_c20220101__20220930_z31xWulygkEj">51,679</span>, respectively. &#160;</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zohKyAPvYpPj" style="margin: 0 0 12pt; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#160;&#160;&#160;
<span><span id="xdx_820_z71Nkdd2P4Va">Property and Equipment, Net</span></span></span></p>
<p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zheh2nDuemJ8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zZSk3QJapL84" style="display: none">Schedule of property and equipment</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consist of the following:&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zyl9ODh44zjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment Net (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: justify">Vehicles and transportation equipment</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zclfbL84mvbe" style="width: 12%; text-align: right">593,097</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_pp0p0_zG3wpTA6rw54" style="width: 12%; text-align: right">298,752</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zdpddnciDVFg" style="text-align: right">314,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z65RUMXXIru8" style="text-align: right">59,316</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zjrmdOX5amL4" style="text-align: right">188,131</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_z0TZg163v1Ak" style="text-align: right">105,003</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Manufacturing equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zJ3b1EQ3sDfa" style="text-align: right">179,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_pp0p0_zZSd6s2xG7Df" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Warehouse equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zWYP5jd0nDpe" style="text-align: right">81,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_pp0p0_zLQ3c69Ut6Y8" style="text-align: right">44,356</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">QA equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zdM4YNqCyVgj" style="text-align: right">22,142</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_z8ksLfKvcLB4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Tooling and Molds</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zVNzT45cvEV8" style="border-bottom: Black 1pt solid; text-align: right">15,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zkNU2KiDiQEf" style="border-bottom: Black 1pt solid; text-align: right">15,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zPsiNPMhdYJg" style="text-align: right">1,394,619</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zjGZJaS13Vzg" style="text-align: right">523,419</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSjZhBR4xesb" style="border-bottom: Black 1pt solid; text-align: right">(250,861</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20211231_zJKe8IIqHOge" style="border-bottom: Black 1pt solid; text-align: right">(96,190</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zLxkDFZBppW4" style="border-bottom: Black 2.5pt double; text-align: right">1,143,758</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_z3ZdTatSVR7l" style="border-bottom: Black 2.5pt double; text-align: right">427,229</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zDy05SZOBbbc" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $<span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zBVtXSq4Iu8i" title="Depreciation expense">164,767</span> and $<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zGYWn0tYEFTi">61,084</span> for the years ended December 31, 2022 and 2021, respectively.</span></p>






<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292300880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zRHfi0uWeo6i" style="margin: 0; font-weight: bold; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<span id="xdx_828_zgkKIx4BkOde">Accrued Expenses and Other Current Liabilities</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses
and other current liabilities consist of the following:</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zk6LTjun6jrc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zdOXwVRN5Wrb" style="display: none">Schedule of accrued expenses and other current liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_134_zvzUAiCUBNYc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49A_20230930_zQR2rqhREBhf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of September 30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_493_20221231_zgsXy1V5Yusa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2022</span></td></tr>
  <tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zq0jMIv8Urz1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued salaries
    and payroll liabilities</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,411</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,337</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--RebateLiability_iI_zUizvKchRVtd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rebate liability</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,255</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,015</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_z8sMPuBMufDe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,534</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,720</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--FranchiseTax_iI_zOfKItefXA8i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Franchise tax</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,999</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DeferredIncomeAndDepositSublease_iI_ziHGz8pZebJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income and deposit
    (sublease)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,445</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,168</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_zss7oswqOJGk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zkncTLZllNej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,996</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,302</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_z972uapb0iC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses and other current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,793</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">306,164</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zZHfzGEsQUH5" style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80F_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zUIwo8FtjeRk" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&#160;&#160;&#160;
<span id="xdx_825_zl0NjqQc1UAl">Accrued Expenses and Other Current Liabilities</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses and other current liabilities consist of the following:</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zNqtcJxoSRDh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zk7zzpCVD1D9" style="display: none">Schedule of accrued expenses and other current liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_134_z9hlwjoLZxjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_491_20221231_zmbIREaO27xe" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_z8ny76WBoMjj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zhpqX93h8Hh1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Accrued salaries and payroll liabilities</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">169,337</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,449</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--RebateLiability_iI_zhjWjvLj3lhc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rebate liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,010</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredIncomeAndDepositSublease_iI_zXQGniVBXt" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred income and deposit (sublease)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,168</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,690</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_zmtbonEZ5Olj" style="vertical-align: bottom; background-color: White">
    <td>Commissions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,720</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,120</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--FranchiseTax_iI_zemYreCq8QXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Franchise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,300</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InterestPayableCurrent_iI_zJTY80T7h5y" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,301</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zu62oANbk07c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">86,302</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,748</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_zAaV9OLnW0Lb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Accrued expenses and other current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">306,164</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">140,618</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zhTvst50hEai" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296570816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities for Sale of Future Revenues<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract', window );"><strong>Liabilities For Sale Of Future Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock', window );">Liabilities for Sale of Future Revenues</a></td>
<td class="text"><p id="xdx_802_ecustom--LiabilitiesForSaleOfFutureRevenuesTextBlock_zSCqK8Q4K48j" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<span id="xdx_829_zy5ZbsItla3">Liabilities for Sale of Future Revenues</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">On December 8, 2020
and January 26, 2021, Reliant Funding, under two separate ACH Total Receipts Purchase Agreements (&#8220;Purchase Agreements&#8221;),
purchased a 50% interest in the Company&#8217;s future revenues for a total aggregate purchase price of $250,000. Pursuant to the
terms of the Purchase Agreements, the purchased percentage continued to be owned by Reliant Funding, until the Company paid the
full purchased amount of $349,750. Repayment of the purchased amount was achieved through 252 daily bank account withdrawals of
$1,388 through December 15, 2021 and $694 thereafter through January 26, 2022. There were no payments made in the three months&#160;ended
September 30, 2023 or the same period for 2022. Interest was recognized at an effective annual interest rate of approximately 71%.
The Purchase Agreements were secured by substantially all of the assets of the Company. As of September 30, 2023 and December 31,
2022, the Company had no remaining liability related to the Purchase Agreements.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_ecustom--LiabilitiesForSaleOfFutureRevenuesTextBlock_z4CSxbB7gMzk" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#160;&#160;&#160;
<span id="xdx_826_z8D6PMigDQwb">Liabilities for Sale of Future Revenues</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 10, 2020 and January 26, 2021, Reliant Funding, under two separate ACH Total Receipts Purchase Agreements (&#8220;Purchase Agreements&#8221;),
purchased a 50% interest in the Company&#8217;s future revenues for a total aggregate purchase price of $250,000. Pursuant to the terms
of the Purchase Agreements, the purchased percentage continued to be owned by Reliant Funding, until the Company paid the full purchased
amount of $349,750. Repayment of the purchased amount was achieved through 252 daily bank account withdrawals of $1,388 through December
15, 2021 and $694 thereafter through January 26, 2022. During the year ended December 31, 2022, the company repaid a total of $11,797,
including $295 of interest. During the year ended December 31, 2021, the company repaid a total of $329,626, including $95,284 of interest.
Interest was recognized at an effective annual interest rate of approximately 71%. As of December 31, 2021, the Company had a total remaining
liability related to the Purchase Agreements of $11,502 and total remaining payments of $11,797 (including interest). The Purchase Agreements
were secured by substantially all of the assets of the Company. As of December 31, 2022, the Company had no remaining liability related
to the Purchase Agreements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296515744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Revolving Loans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Short-Term Revolving Loans</a></td>
<td class="text"><p id="xdx_805_eus-gaap--DebtDisclosureTextBlock_z7OPXUQd1dxb" style="margin: 0; font-weight: bold; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<span id="xdx_82E_zxPcZQgTOMGe">Short-Term Revolving Loans</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2020, the Company received funds under four unsecured Working Capital Loan Agreements (&#8220;WC Loans&#8221;). As of December 31, 2022,
the loans had been repaid and a balance of $0 was outstanding. Under the WC Loan Agreements and in accordance with the modified terms,
the Company was subject to monthly extended maturity interest of one percent on the ending outstanding monthly balance which increased
one percent for each month beyond the extended maturity date. The WC Loans were repaid in full in April 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">The terms of each WC Loan are summarized below:</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">$200,000
                                                                                                                                   limit
                                                                                                                                   &#8211;
                                                                                                                                   dated
                                                                                                                                   March
                                                                                                                                   22,
                                                                                                                                   2020;
                                                                                                                                   monthly
                                                                                                                                   interest-only
                                                                                                                                   payments
                                                                                                                                   at
                                                                                                                                   15%
                                                                                                                                   annual
                                                                                                                                   interest;
                                                                                                                                   principal
                                                                                                                                   due
                                                                                                                                   12
                                                                                                                                   months
                                                                                                                                   from
                                                                                                                                   date
                                                                                                                                   of
                                                                                                                                   issue.
                                                                                                                                   This
                                                                                                                                   note
                                                                                                                                   was
                                                                                                                                   modified
                                                                                                                                   effective
                                                                                                                                   January
                                                                                                                                   1,
                                                                                                                                   2021
                                                                                                                                   to
                                                                                                                                   extend
                                                                                                                                   the
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   to
                                                                                                                                   December
                                                                                                                                   31,
                                                                                                                                   2021.
                                                                                                                                   The
                                                                                                                                   Company
                                                                                                                                   paid
                                                                                                                                   $50,000
                                                                                                                                   towards
                                                                                                                                   the
                                                                                                                                   principal
                                                                                                                                   balance
                                                                                                                                   in
                                                                                                                                   November
                                                                                                                                   2021.
                                                                                                                                   The
                                                                                                                                   balance
                                                                                                                                   of
                                                                                                                                   $150,000
                                                                                                                                   was
                                                                                                                                   paid
                                                                                                                                   in
                                                                                                                                   full
                                                                                                                                   in
                                                                                                                                   April
                                                                                                                                   2022
                                                                                                                                   (see
                                                                                                                                   below).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">$400,000
                                                                                                                                   limit
                                                                                                                                   &#8211;
                                                                                                                                   dated
                                                                                                                                   August
                                                                                                                                   31,
                                                                                                                                   2020;
                                                                                                                                   monthly
                                                                                                                                   interest-only
                                                                                                                                   payments
                                                                                                                                   at
                                                                                                                                   10%
                                                                                                                                   annual
                                                                                                                                   interest;
                                                                                                                                   pursuant
                                                                                                                                   to
                                                                                                                                   the
                                                                                                                                   WC
                                                                                                                                   Loan,
                                                                                                                                   the
                                                                                                                                   maturity
                                                                                                                                   was
                                                                                                                                   to
                                                                                                                                   be
                                                                                                                                   determined
                                                                                                                                   by
                                                                                                                                   mutual
                                                                                                                                   agreement
                                                                                                                                   and
                                                                                                                                   was
                                                                                                                                   to
                                                                                                                                   be
                                                                                                                                   at
                                                                                                                                   least
                                                                                                                                   30
                                                                                                                                   days
                                                                                                                                   after
                                                                                                                                   a
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   is
                                                                                                                                   agreed
                                                                                                                                   upon.
                                                                                                                                   The
                                                                                                                                   note
                                                                                                                                   was
                                                                                                                                   modified
                                                                                                                                   effective
                                                                                                                                   January
                                                                                                                                   1,
                                                                                                                                   2021
                                                                                                                                   to
                                                                                                                                   establish
                                                                                                                                   a
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   of
                                                                                                                                   December
                                                                                                                                   31,
                                                                                                                                   2021,
                                                                                                                                   and
                                                                                                                                   was
                                                                                                                                   paid
                                                                                                                                   in
                                                                                                                                   full
                                                                                                                                   in
                                                                                                                                   April
                                                                                                                                   2022
                                                                                                                                   (see
                                                                                                                                   below).</span></td></tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
fees incurred in connection with obtaining and modifying these agreements were nominal and, given the short-term maturity of one year,
were expensed as incurred. There was no accounting impact to the financial statements related to the modifications.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2pt 0 0; font-weight: bold"></p>



<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zjeaCm706mAi" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&#160;&#160;&#160;
<span id="xdx_822_zDX4zbSYyd6b">Short-Term Revolving Loans</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 2020 to October 2020, the Company received funds totaling $900,000 under four unsecured Working Capital Loan Agreements (&#8220;WC
Loans&#8221;) from two different third-party lenders. As of December 31, 2021, a balance of $550,000 remained outstanding under the WC
Loan Agreements and in accordance with the modified terms, the Company was subject to monthly extended maturity interest of one percent
on the ending outstanding monthly balance which increased one percent for each month beyond the extended maturity date. The WC Loans
were repaid in full in April 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of each WC Loan are summarized below:</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150,000 limit - dated
    January 25, 2020; monthly interest-only payments at 10% annual interest, principal payment of $70,000 paid during the year ended
    December 31, 2020, balance of $80,000 due 12 months from date of issue and paid in full at maturity in 2021. </span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150,000 limit - dated
    January 28, 2020; monthly interest-only payments at 12% annual interest; principal due 12 months from date of issue. This note was
    modified effective January 1, 2021 to extend the maturity date to December 31, 2021 (see below) and was paid in full with a payment
    of $50,000 in July 2021 and $100,000 in September 2021.</span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$200,000 limit &#8211;
    dated March 22, 2020; monthly interest-only payments at 15% annual interest; principal due 12 months from date of issue. This note
    was modified effective January 1, 2021 to extend the maturity date to December 31, 2021. The Company paid $50,000 towards the principal
    balance in November 2021.&#160;&#160;The balance of $150,000 was paid in full in April 2022 (see below).</span></td></tr>
  </table>



<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$400,000 limit &#8211;
    dated August 31, 2020; monthly interest-only payments at 10% annual interest; pursuant to the WC Loan, the maturity was to be determined
    by mutual agreement and was to be at least 30 days after a maturity date is agreed upon. The note was modified effective January
    1, 2021 to establish a maturity date of December 31, 2021, and was paid in full in April 2022 (see below).</span></td></tr>
  </table>
<p style="margin: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2021, as noted above, three of the working capital loan agreements, all from the same investor, were modified. The modification
was to extend the maturity date on two of the notes from January 28, 2021 and March 22, 2021 to December 31, 2021, and to establish a
maturity date of December 31, 2021 for the WC Loan that left the maturity date open to negotiations in the original agreement.</span></p>

<p style="margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, a balance of $550,000 remained outstanding under the WC Loan Agreements and in accordance with the modified terms,
the Company was subject to monthly extended maturity interest of one percent on the ending outstanding monthly balance which increased
one percent for each month beyond the extended maturity date. The Company remained in compliance with all interest payments and paid
the WC Loans in full in April 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
fees incurred in connection with obtaining and modifying these agreements were nominal and, given the short-term maturity of one year,
were expensed as incurred. There was no accounting impact to the financial statements related to the modifications.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294960336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text"><p id="xdx_808_eus-gaap--LongTermDebtTextBlock_zS1WeD6dIZD6" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<span id="xdx_823_zOoRBNwTJqCc">Long-Term Debt</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Long-term debt consisted of the
following at September 30, 2023 and December 31, 2022:</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zKoF4A6jVerj" style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B8_zGCFf1z9NLmj" style="display: none">Schedule of long term debt payment</span>&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zy8PBx78ip2i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-Term Debt (Details)">
<tr style="vertical-align: bottom">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2023</b></span></td>
<td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2022</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0">Senior secured promissory notes &#8211; various investors.&#160;&#160;Monthly payments of interest only at
10% plus deferred interest of 5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity.
Matures the earlier of (a) May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of
control. The notes are senior to all other debt and are secured by substantially all assets of the Company. The notes included
detachable warrants to purchase 482,268 shares of common stock at an exercise price of $3.32 per share (see Note 10 &#8211; Stockholders&#8217;
Equity in Item 1 &#8211; Financial Statements of Part I &#8211; Financial Information). Debt issuance costs and discount totaling
$1,287,160 at date of issuance were being amortized and recognized as additional interest expense over the term of the notes using
the straight-line method because it was not substantially different from the effective interest rate method. We determined the
expected life of the notes to be the contractual term. Interest expense related to these notes includes amortization of debt issuance
costs and discount in the amount of $0 and $1,196,843, respectively, for the three months and nine months ended September 30, 2022,
respectively. The notes were paid in full in April 2022.</p>


</td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zu2E1BAkZbv6" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1676">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zSYhmgsZ52z5" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1677">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 56%; font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; bank. Payable in monthly installments of $332, including interest at 5.8% per annum, due August 2025, secured by equipment and personally guaranteed by a co-founder.</span></td>
<td style="width: 8%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zWzRoJiUKBif" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,213</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 8%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zoU4N5Nx5wwb" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,825</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; credit union. Payable in monthly installments of $508, including interest at 5.45% per annum, due July 2026, secured by a vehicle and personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_z6Z8spHtDLjj" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">15,514</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zfhsTgyta9mk" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">19,364</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; SBA. Economic Injury Disaster Loan payable in monthly installments of $731, including interest at 3.75% per annum, due May 2050, and personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z3mXhXacRPZa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">147,735</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zmjRl5jKS2pa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">150,114</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; individual. Monthly payments of interest only at 10% per annum, matured December 31, 2021 resulting in the entire principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31, 2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the note in full in April 2022.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zgZhqMNgTbPj" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1684">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zbVAN2AVINy4" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1685">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; finance company. Payable in monthly installments of $994, including interest at 8.5% per annum, due July 2026, secured by a vehicle and personally guaranteed by a stockholder.&#160;The Note was paid in full September 2022.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zCd81AxtILH8" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1686">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zMkCo5LyeyF3" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1687">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; finance company.&#160;Payable in monthly installments of $2,204, including interest at 11.21% per annum, due August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;The note was paid in full January 2023.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zoQEMg6apxVk" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1688">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zhaiJhr26jC" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">79,963</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Notes payable &#8211; The Company has acquired six notes payable to GM Financial for vehicles.&#160;In April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;The agreement expired in April 2023 but was renewed for a commercial line up to $350,000 and prevailing GM Financial existing term notes will remain. The new agreement expires in April 2024.&#160;One note was paid off when the corresponding vehicle was sold in May 2023, so there are five notes remaining at September 30, 2023.&#160;The notes are currently payable in aggregate monthly installments of $4,084, including interest at rates ranging from 5.89% to 7.29% per annum, mature at various dates from October 2027 to May of 2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_989_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zYWmn3bXZ9Ri" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">191,027</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zHD2sHkbLt8c" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">251,209</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930_zOorhTjIBqxh" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">361,489</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20221231_zrd187XCFUzi" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">510,475</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less current portion</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98B_eus-gaap--DebtCurrent_iNI_di_c20230930_z9fb3gRYLdg9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(50,058</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zeSIpKKGmET6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(71,426</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Long-term debt, net of unamortized debt discount and current portion</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_980_eus-gaap--LongTermDebtNoncurrent_iI_c20230930_zPjwHvUcLtxi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">311,431</span></td>
<td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_98E_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zgdRYecSgZ67" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">439,049</span></td>
<td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>




<p id="xdx_8A8_zQ01OvCLcxPj" style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="margin: 0 0 8pt"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future maturities of long-term debt are
as follows:</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zoBjrwmp3Mi4" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zmgYdrwEu1v2" style="display: none">Schedule of Maturities of Long-Term Debt</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zjGUubLmMe11" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_493_20230930_z88lrVy2dXJj">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Twelve months ending September 30,</b></span></td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zTotBDrcuNs" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="vertical-align: top; width: 6%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; width: 38%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,058</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_z6sqjfZ2mVbb" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,934</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zWG8oml8sPx1" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,982</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zm5GU6aGDNe5" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,561</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_zUsPYrM1L2Ae" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,963</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbXNV0Ba8wa3" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129,991</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermDebt_iI_zTfYwgAEQi2l" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">361,489</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8AC_zcHIuxVQy0fb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--LongTermDebtTextBlock_z0EFiONoxBPf" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
&#160;&#160;&#160;&#160;<span id="xdx_82A_zIzAhgzAfnyg">Long-Term Debt</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
debt consisted of the following at December 31, 2022 and 2021:&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfDebtTableTextBlock_zWvGQ8QSbaRd" style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zRmASvuTs60l" style="display: none">Schedule of long-term debt</span>&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2022</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2021</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    secured promissory notes &#8211; various investors.&#160;&#160;Monthly payments of interest only at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_uPure_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zZKyK8XpZqp1">10</span>% plus deferred interest of
    5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity. Matures the earlier of (a)
    May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of control. The notes are senior
    to all other debt and are secured by substantially all assets of the Company. The notes included detachable warrants to purchase
    <span id="xdx_90C_ecustom--WarrantsToPurchase_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zfMO8hsIn3fh">482,268</span> shares of common stock at an exercise price of $3.32 per share (see Note 12 &#8211; Stockholders&#8217; Equity). Debt issuance
    costs and discount totaling $1,287,160 at date of issuance were being amortized and recognized as additional interest expense over
    the term of the notes using the straight-line method because it was not substantially different from the effective interest rate
    method. We determined the expected life of the notes to be the contractual term. Interest expense related to these notes includes
    amortization of debt issuance costs and discount in the amount of $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zIQvOmcuQFHj">1,196,843</span> and $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zcEjj6PtTOS1">117,587</span>, respectively, for the years ended December
    31, 2022 and 2021, respectively. The notes were paid in full in April 2022 </span></td>
    <td style="width: 2%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zYx3xMOCYyb6" style="width: 13%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0686">&#8212;</span></span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zGD2ZUqapJPb" style="width: 11%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,600,000&#160;</span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; bank. Payable in monthly installments of $332, including interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_ztDESItfaA9d">5.8</span>% per annum, due August 2025, secured by
    equipment and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zvU6a1BVSu95" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,825</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zz2Qg31uUbaa" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,135</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; credit union. Payable in monthly installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zLhsfu3eCvTa">508</span>, including interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zTjJzB5BxKq9">5.45</span>% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_znmtb46bodLd" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,364</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zjbcIG5QZno3" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,259&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; SBA. Economic Injury Disaster Loan payable in monthly installments of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z7S9irBvtpG3">731</span>, including interest at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zNsTbK2pbb4e">3.75</span>% per annum,
    due May 2050, and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zd8BoxCpitk2" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,114</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zj40g99Pl7C1" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153,193</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; individual. Monthly payments of interest only at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3u5SAnmxLC7">10</span>% per annum, matured December 31, 2021 resulting in the entire
    principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31,
    2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each
    month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the
    note in full in April 2022 </span></td>
    <td style="width: 2%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zGyosTYw3wae" style="width: 13%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0700">&#8212;</span></span></td>
    <td style="width: 0%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3G2orNS6tW8" style="width: 11%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000&#160;&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; finance company. Payable in monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zPgQIe5dOFDi">994</span>, including interest at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zd3GuXrmp6zj">8.5</span>% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a shareholder.&#160;&#160;The Note was paid in full September 2022.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_z1YywxSKXYOj" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0704">&#8212;</span></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zSpnkxWf2fOk" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,832</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; finance company.&#160;&#160;Payable in monthly installments of $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_z59bSVoCe7Wb">2,204</span>, including interest at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zLySIJ8C9Dah">11.21</span>% per annum, due
    August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;&#160;The note was paid in full January 2023.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zbRfObC7xhgi" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79,963</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zjFe69Eaiate" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,155</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    payable &#8211; The Company has six and two notes payable to GM Financial for vehicles at September 30, 2022 and December 31, 2021.&#160;&#160;In
    April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;&#160;The agreement
    expires in April 2023 but prevailing GM Financial existing term notes will remain. The notes are payable in aggregate monthly installments
    of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zulP2wGynlJf">4,676</span>, including interest at rates ranging from 5.89% to <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zH91DES1X3Xf">7.29</span>% per annum, mature at various dates from October 2027 to May of
    2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zTgrFrT3rKEg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,209</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_z34paL0EJGEi" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,890</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20221231_zZ3tuazFx3xg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">510,475</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20211231_zF6oJOJqka66" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,127,464</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    unamortized debt issuance costs and discount</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20221231_z3dO63NDU293" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0716">&#8212;</span></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iNI_di_c20211231_zNEffcgIez0d" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,196,843</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    current portion</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zWSemRgK6Lb5" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(71,426</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><p style="margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td id="xdx_98F_eus-gaap--DebtCurrent_iNI_di_c20211231_zuWkMCLA18o5" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51,135</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    note payable in default (paid April 2022)</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_ecustom--LessNotePayableInDefaultPaid_iI_c20221231_zZTzkQCrpdYc" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0720">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_ecustom--LessNotePayableInDefaultPaid_iI_c20211231_zUSCMNE3I5j3" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    debt, net of unamortized debt discount and current portion</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_ztvWlEmU7OD7" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">439,049</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zQsCDtF94WS2" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,486</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zUl6EhVWAMY2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
maturities of long-term debt are as follows:</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zWkH1ukykVXe" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zwZaZ5Ww3ut6" style="display: none">Schedule of long term debt payment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_134_zS5zgPNCBeJ7" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49D_20221231_zVHKztI62H27">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years ending December 31,</b></span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zuUkStE0Btw" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 52%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: top; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,426</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_zreanSVKUTGa" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,226</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zELk68BZ2CVb" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,237</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zAqdCSwZ0Jdf" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,963</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_z3nvIsw8ZUHf" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,305</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbaAMSVQt1Rh" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,318</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebt_iI_zxCGzJGaKiH9" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">510,475</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_zmysnXVJXQtl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296648400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder Promissory Notes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DisclosureShareholderPromissoryNotesAbstract', window );"><strong>Shareholder Promissory Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ShareholderPromissoryNotesTextBlock', window );">Shareholder Promissory Notes</a></td>
<td class="text"><p id="xdx_806_ecustom--ShareholderPromissoryNotesTextBlock_zbWD2LTaljQj" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<span id="xdx_824_zXHvZpM5ggfj">Stockholder Promissory Notes</span>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of both September 30, 2023 and December 31, 2022, the Company had an outstanding principal balance of $825,000 due to stockholders under
unsecured Promissory Notes Agreements (&#8220;Notes&#8221;). The Notes require monthly interest-only payments at 10% per annum. The Notes
mature at various dates from January 2024 to December 2024 as follows: January 2024 - $125,000; August 2024 - $500,000 (this note would
have matured at August 2023, but in June 2023, an agreement was signed extending the maturity date to August 2024); and December 2024
- $200,000.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
paid to the stockholders under the Notes totaled $20,627 and $20,627 during the three months ended September 30, 2023 and September 30,
2022, respectively. Interest paid to the stockholders under the Notes totaled $61,881 and $61,881 during the nine months ended September
30, 2023 and September 30, 2022, respectively. There was no accrued interest as of September 30, 2023 or December 31, 2022 related to
these Notes.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80B_ecustom--ShareholderPromissoryNotesTextBlock_ztoxFcwbLfac" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&#160;&#160;&#160;&#160;&#160;<span id="xdx_822_zcs50HozZky2">Shareholder
Promissory Notes</span>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, the Company had an outstanding principal balance of $825,000 due to shareholders under unsecured
Promissory Notes Agreements (&#8220;Notes&#8221;). The Notes require monthly interest-only payments at 10% per annum. The Notes mature
at various dates from August 2023 to December 2024 as follows: August 2023 - $500,000; January 2024 - $125,000; and December 2024 - $200,000.</span></p>




<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2021, the Company modified another shareholder Note in the amount of $250,000 to be a convertible note for the same amount. The
shareholder also invested additional proceeds of $24,000 for a total convertible note of $274,000. The convertible note included detachable
warrants to purchase 548,000 shares of the Company&#8217;s common stock. The convertible note bore interest at a rate of 10% per annum,
had an initial maturity of two years from date of issue, and was convertible at $0.50 per share. The modification resulted in a new effective
annual interest rate of 9.15%. There was no accounting impact to the financial statements related to these modifications. On October
29, 2021, concurrent with the anticipated conversion from an LLC to a C corporation, the convertible note and warrants were modified
under a Convertible Debenture Exercise and Waiver and Release Agreement and the shareholder agreed to convert the note and accrued interest
into 236,498 shares of common stock resulting in a conversion price of $1.21 per share (see Note 9 &#8211;Convertible Notes).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
paid to the shareholders under the Notes totaled $<span id="xdx_90F_eus-gaap--OtherMinorityInterests_iI_c20221231_zA0Z3p50Hrk1" title="Interest paid to the shareholders">82,508</span> and $<span id="xdx_907_eus-gaap--OtherMinorityInterests_iI_c20211231_z0QupwYfidia">92,007</span> during the years ended December 31, 2022 and 2021, respectively.
There was no accrued interest as of December 31, 2022 or 2021 related to these Notes.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DisclosureShareholderPromissoryNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DisclosureShareholderPromissoryNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ShareholderPromissoryNotesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ShareholderPromissoryNotesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962295117680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DisclosureConvertibleNotesAbstract', window );"><strong>Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ConvertibleNotesTextBlock', window );">Convertible Notes</a></td>
<td class="text"><p id="xdx_803_ecustom--ConvertibleNotesTextBlock_zhNglAH9OaR" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&#160;&#160;&#160;
<span id="xdx_82E_zajzCHSqgom6">Convertible Notes</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2020
Convertible Notes &#8211; Converted January 1, 2021</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2021, convertible debt holders were offered the opportunity for early conversion of their convertible notes into Class B LLC
member units. Three of the four convertible note holders converted notes with a principal balance of $170,000 and accrued interest of
$3,157 into 2,338 Class B member units (the equivalent of 59,515 shares of common stock) at per unit conversion prices ranging from $67
- $76 (per share prices ranging from $2.66 - $3.00). In accordance with FASB ASC 470-20, <i>Debt with Conversion and Other Options</i>,
the fair value of the additional units issued under the induced conversion over the value of the number of units issuable under the original
terms of the convertible note agreements is recognized as debt conversion expense. Accordingly, upon early conversion on January 1, 2021,
the Company recognized $112,133 of debt conversion expense with a corresponding entry to equity of $285,290 consisting of the $173,157
of principal and accrued interest converted and the excess fair value of $112,133.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fourth convertible note holder opted out of the early conversion and instead, the original note with a principal balance of $100,000
was modified into a term loan effective January 1, 2021 (see Note 7 &#8211; Long Term Debt). The modification included the elimination
of the conversion feature, an increase in the interest rate from the original 6% per annum to 10% per annum, to be paid monthly instead
of accrued, and an earlier maturity date of December 31, 2021. The modification resulted in a new effective annual interest rate of 9.58%,
and a revised one-year maturity on December 31, 2021 (see Note 6 &#8211;Short-Term Revolving Loans). There was no accounting impact to
the financial statements related to this modification. The note was paid in full in April 2022.</span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2021
Convertible Notes/Extinguishment Loss on Debt Settlement</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
May to September 2021, the Company received gross proceeds of $2,929,000 from the issuance of unsecured convertible notes (the &#8220;Notes&#8221;),
of which $44,000 was received from existing shareholders. Of the total proceeds, $1,820,000 was received during the three months ended
September 30, 2021. Additionally, in May 2021, a shareholder converted a promissory note to a convertible note identical in terms discussed
below (see Note 8 &#8211; Shareholder Promissory Notes).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">At the option of the Note holders and after
the completion of a merger with a Special Purpose Acquisition Company (&#8220;SPAC&#8221;) or an Initial Public Offering (&#8220;IPO&#8221;),
the holder could convert all or a part of the outstanding principal and accrued interest into shares of common stock of the merged or
public company. The Notes included detachable warrants (&#8220;Warrants&#8221;) to purchase 3,862,000 shares of the merged or public
company. The Notes bore interest at a rate of 10% per annum, had an initial maturity of two years from date of issue, and were convertible
at per-share prices ranging from $0.50 to $2.50. Effective January 1, 2021, the Company early adopted ASU 2020-06, and accordingly, no
beneficial conversion features were recognized. The Notes were accounted for in accordance with ASC 470-20, <i>Debt with Conversion and
Other Options</i> (&#8220;ASC 470-20&#8221;) and ASC 815-40, <i>Contracts in Entity&#8217;s Own Equity</i> (&#8220;ASC 815-40&#8221;)<i>.
</i>Under ASC 815-40, to qualify for equity classification (or nonbifurcation, if embedded) the instrument (or embedded feature) must
be both (1) indexed to the issuer&#8217;s stock and (2) meet the requirements of the equity classification guidance. Based upon the Company&#8217;s
analysis, it was determined the Notes do contain embedded features indexed to its own stock, but do not meet the requirements for bifurcation
and recognition as derivatives, and therefore do not need to be separately recognized. Accordingly, the proceeds received from the issuance
of the Notes were recorded as a single liability measured at amortized cost on the consolidated Balance Sheet. The Company incurred $148,000
of debt issuance costs relating to the issuance of the Notes, which were recorded as a reduction to the Notes on the Balance Sheet. The
debt issuance costs were being amortized and recognized as additional interest expense over the term of the Notes using the straight-line
method because it is not substantially different from the effective interest rate. Amortization of debt discount totaled $27,271 through
the effective date of the conversion from LLC to a C corporation. Since the Warrants were not exercisable until a merger with a SPAC
or an IPO, there was no impact on the financial statements at date of grant.</span></p>
<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"></p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 29, 2021, in anticipation of conversion from LLC to a C corporation, the Notes and Warrants were modified under Convertible Debenture
Exercise and Waiver and Release Agreements with the individual creditors. The Note holders agreed to settle the debt for an aggregate
of 1,527,647 shares of common stock with a fair value of $5,545,359 ($3.63 per share). Since this transaction involved contemporaneous
issuance of shares of common stock by the Company to the Note holders, the Company evaluated the transaction for modification and extinguishment
accounting and determined that the debt was extinguished as a result of the issuance of shares that do not represent the exercise of
a conversion right contained in the original terms of the Notes at issuance.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
settlement of the debt resulted in a recognized loss of $2,262,658 recorded as extinguishment loss on debt settlement in November 2021,
calculated as the excess of the fair value of shares issued over the carrying amount of the debt. In addition, the fair value of warrants
of $407,700 issued in exchange for services related to the extinguished debt (see Note 12 &#8211; Stockholders&#8217; Equity) and the
unamortized portion of debt discount remaining at date of settlement of $120,729 were also recorded as extinguishment loss on debt settlement
for an aggregate loss of $2,791,087.</span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ConvertibleNotesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ConvertibleNotesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DisclosureConvertibleNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DisclosureConvertibleNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962297435504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z2yRbwEpMP07" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<span id="xdx_823_zLEra1kaGuNa">Commitments and Contingencies</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating Leases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases its warehouses and office space under long-term lease arrangements. None of its leases include characteristics specified
in ASC 842, <i>Leases</i>, that require classification as financing leases, and accordingly, these leases are accounted for as operating
leases. The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months
or less. For longer-term lease arrangements that are recognized on the Company&#8217;s Balance Sheet, the right-of-use asset and lease
liability are initially measured at the commencement date based upon the present values of the lease payments due under the leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies
an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine
the present value of lease payments due under the arrangement. Under ASC 842, the incremental borrowing rate (IBR) for leases must be
(1) a rate of interest over a similar term, and (2) for an amount that is equal to the lease payments. The Company uses both the Federal
Reserve Economic Data (FRED) U.S. corporate debt effective yield and the U.S. Treasury rates adjusted for credit spread as the primary
data points for purposes of determining the IBR.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">In the first quarter
of 2022, the Company entered into two new long-term, non-cancelable operating lease agreements for office and warehouse space resulting
in the Company recognizing an additional lease liability totaling of $2,348,509, representing the present value of the lease payments
discounted using an effective interest rate of 8.07% and 8.86%, and corresponding right-of-use assets of $2,348,509. The leases
expire in December 2026 &#160;and December 2028. The second lease contains one three-year option to renew. The lease is guaranteed
by a co-founder.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2021, the Company entered into a long-term, non-cancelable operating lease agreement for office and warehouse space
resulting in the Company recognizing an additional lease liability totaling of $1,268,089, representing the present value of the lease
payments discounted using an effective interest rate of 7.47% and a corresponding right-of-use asset of $1,268,089. The lease expires
in January 2028&#160;and contains one three-year option to renew. The lease is guaranteed by a co-founder.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company has two
other leases&#8212;one that expired in January 2023 and one that expires in February 2025. The leases generally provide for annual
increases based on a fixed amount and generally require the Company to pay real estate taxes, insurance, and repairs. Both leases
are guaranteed by a co-founder.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following
is a summary of total lease costs during the three months and nine months ended September 30, 2023 and 2022:</span>&#160;</p>

<p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zUAagphrgysl"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z7C6NbVV0b2l" style="display: none">Schedule of lease cost</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_zOChwuWPpONg" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_496_20230701__20230930_zpCtb6u0TWQd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49A_20220701__20220930_zjn2Ukg1guri" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_491_20230101__20230930_zcjxah3v4pwb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930_z1mY7KClAx0i" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended September 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseCost_zdHXFyt8Q7Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187,315</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">562,660</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,949</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ShortTermLeaseCost_zgwvc8sv9ttj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    lease costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1726">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">450</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,077</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--VariableLeaseCost_z768GSysIESf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
    lease costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1732">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1733">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1734">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z0LQlFs692Q3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sublease
    income</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,440</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39,476</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,364</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LeaseCost_z86NS0NEpHNk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">176,875</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,223</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">523,334</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,662</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



<p id="xdx_8AD_zW5wITcJk2x" style="margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin: 0 0 8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term was 4.78 years and 5.49 years as of September 30, 2023 and December 31, 2022, respectively. The
weighted average discount rate was 8.48% and 8.48%, as of September 30, 2023 and December 31, 2022, respectively. Operating cash flows
from the operating leases totaled $116,591 and $115,442 for the three months ended September 30, 2023 and 2022, respectively, and $350,794
and $322,112 for the nine months ended September 30, 2023 and 2022, respectively.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total lease liability as of September 30, 2023 and December 31, 2022 was $2,883,217 and $3,220,019, respectively.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 8pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of September 30, 2023, for
years ending September 30:</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zcBi2eWnGRt2" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zwg0sSJc4HTj" style="display: none">Schedule of future minimum lease payment</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_134_z0HXTQAeHOf3" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_496_20230930_zqFoQwRjYQfd" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
  <tr id="xdx_406_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_znS99N1KgNG1" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 21%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">731,243</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_znalB1v5wi7f" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">725,589</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zJS3yuqzzhm9" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">727,150</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_zoHsE6MDZw31" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">703,541</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_z9jztcz5qWF" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">532,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeWcnKvm6tf2" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,569</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zeoRzoYcHEtc" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,532,925</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z6rqGlGgqvL5" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(649,708</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zSMg30yILxG4" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,883,217
    </span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zAeEkhFBNy9h" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">506,743</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zgPRi5p0tFGl" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent lease liability</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,376,474</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseLiability_iI_zZFLI6RvWVh4" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,883,217
    </span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A2_zHLyThV1AnC6" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subleases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company subleases
office and warehouse space under one of its existing operating leases with similar terms as the Company&#8217;s lease agreements.
Because the Company is not relieved of its primary obligations under the original lease, the Company accounts for the subleases
as a lessor. Sublease rental income is recorded based on the contractual rental payments which are not substantially different
from recognition on a straight-line basis over the lease term and totaled $10,440 and $25,022 &#160;during the three months ended
September 30, 2023 and 2022, respectively, and $39,476 and $98,364 &#160;during the nine months ended September 30, 2023 and 2022,
respectively. As of September 30, 2023 and December 31, 2022, deferred income and a sublease deposit totaled $4,445 and $14,168,
respectively, and is included in accrued expenses and other current liabilities on the accompanying Balance Sheets.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following
are the total future minimum sublease payments as of September 30, 2023:</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zqFyPOJdbvG9" style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zJZs93bZvkCe" style="display: none">Schedule of
future minimum sublease payments</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_ziZ4s47ADuQ2" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="width: 77%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Twelve months ending September
    30,</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_49A_20230930_zU4ARZkGlgTi" style="width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zViBC96lzPGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,491</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_zUwuxibF07l" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,922</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zcBEZH0QOODb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease
    payments&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,413</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8AD_zK0DL6lKgUn1" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be involved from time to time in litigation or claims arising in the ordinary course of its business. While the ultimate
liability, if any, arising from these claims cannot be determined with certainty, the Company believes that the resolution of any such
matters will not likely have a material adverse effect on the Company&#8217;s financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt">&#160;</p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 22, 2022, Expion360 Inc. (the &#8220;Company&#8221;) <span style="background-color: white">received notice of a complaint (the
&#8220;Complaint&#8221;) filed against it in Oregon state court by Ravi Sinha. The Complaint alleges,&#160;</span><i>inter alia</i><span style="background-color: white">,
that Mr. Sinha is entitled to 282,284 shares of the Company&#8217;s common stock, or in the alternative, $300,000 plus interest in connection
with services he previously rendered the Company as its chief executive officer. On March 21, 2023, the Company entered into a settlement
agreement with Mr. Sinha and the matter has been resolved with cash and the issuance of common stock (see Note 10 &#8211; Stockholders&#8217;
Equity</span> in Item 1 &#8211; Financial Statements of Part I &#8211; Financial Information<span style="background-color: white">).</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zOdGAmeDWc21" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&#160;&#160;&#160;
<span id="xdx_826_zyFvc7kK10Kk">Commitments and Contingencies</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
Leases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases its warehouses and office space under long-term lease arrangements. None of its leases include characteristics specified
in ASC 842, <i>Leases</i>, that require classification as financing leases, and accordingly, these leases are accounted for as operating
leases. The Company does not recognize a right-of-use asset and lease liability for short term leases, which have terms of 12 months
or less. For longer-term lease arrangements that are recognized on the Company&#8217;s Balance Sheet, the right-of-use asset and lease
liability are initially measured at the commencement date based upon the present values of the lease payments due under the leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies
an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine
the present value of lease payments due under the arrangement. Under ASC 842, the incremental borrowing rate (IBR) for leases must be
(1) a rate of interest over a similar term, and (2) for an amount that is equal to the lease payments. The Company uses both the Federal
Reserve Economic Data (FRED) U.S. corporate debt effective yield and the U.S. Treasury rates adjusted for credit spread as the primary
data points for purposes of determining the IBR.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2022, the Company entered into two new long-term, non-cancelable operating lease agreements for office and warehouse
space resulting in the Company recognizing an additional lease liability totaling of $2,348,509, representing the present value of the
lease payments discounted using an effective interest rate of 8.07% and 8.86%, and corresponding right-of-use assets of $2,348,509. The
leases expire in December 2026 and December 2028. The second lease contains one three-year option to renew. The lease is guaranteed by
a co-founder.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">In the first quarter of 2021, the Company
entered into a long-term, non-cancelable operating lease agreement for office and warehouse space resulting in the Company recognizing
an additional lease liability totaling of $1,268,089, representing the present value of the lease payments discounted using an effective
interest rate of 7.47% and a corresponding right-of-use asset of $1,268,089. The lease expires in January 2028 and contains one three-year
option to renew. The lease is guaranteed by a co-founder.</span></p>
<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>








<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two other leases that expire in January 2023 and February 2025. The leases generally provide for annual increases based on
a fixed amount and generally require the Company to pay real estate taxes, insurance, and repairs. Both leases are guaranteed by a co-founder.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of total lease costs for the years ending December 31, 2022 and 2021:</span></p>

<p id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zt70SzrJsHw1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zA4p04jJhsYk" style="display: none">Schedule of lease cost</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_133_zX3fB250hzhj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20220101__20221231_zRDtWRW2QH0l" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49A_20210101__20211231_zl44k8wUpsEd" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseCost_zmQTo6RBzj6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Operating lease cost</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">760,743</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">304,082</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShortTermLeaseCost_z2KXGOEMdG5d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term lease costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,527</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,846</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--VariableLeaseCost_zdD6N9GLYygj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Variable lease costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0761">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z92E8zIzoqw4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Sublease income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(123,386</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(75,061</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--LeaseCost_zGEze4ciKth5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">640,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">233,867</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zK6c1kkwLKi2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average remaining lease term was 5.49 years and 5.64 years as of December 31, 2022 and 2021, respectively. The weighted average
discount rate was 8.48% and 8.02%, as of December 31, 2022 and 2021, respectively. Operating cash flows from the operating leases totaled
$440,139 and $177,688 for the years ended December 31, 2022 and 2021, respectively.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total lease liability as of December 31, 2022 and 2021 was $3,220,019 and $1,311,649, respectively.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of December 31, 2022, for
years ending December 31:</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zjn8IGfiNrgd" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zSRXGfWYN6n6" style="display: none">Schedule of future minimum lease payment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_134_zGHc7CoNIRSk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3" id="xdx_499_20221231_zKR809Gf9WHc" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
  <tr id="xdx_402_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_z1ctjPjZ7uo1" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">719,220</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zu24xqSWsK7i" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">727,709</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zn7WlNmhEmMh" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">718,157</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_ze7t6y0FIfsb" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">732,061</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_zcvwntGDFkX8" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">694,040</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeDlFAgqoT5b" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,736</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zw2OCi6FrEF3" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,062,923 </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcZaGW3sYpI2" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(842,904</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zoRRLCDMRbGh" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220,019
    </span></td>
    <td style="border-bottom: Black 1.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zjMnNoXpuL2k" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,055</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zVzbnmDfgRp3" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent lease liability</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,754,964
    </span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zKv4gfUZwLpk" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220,019
    </span></td>
    <td style="border-bottom: Black 1.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A5_zzuPucRkZaeh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subleases</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company subleases office and warehouse space under three of its existing operating leases with similar terms as the Company&#8217;s lease
agreements. Because the Company is not relieved of its primary obligations under the original lease, the Company accounts for the subleases
as a lessor. Sublease rental income is recorded based on the contractual rental payments which are not substantially different from recognition
on a straight-line basis over the lease term and totaled $<span id="xdx_906_eus-gaap--OperatingLeasesRentExpenseNet_c20220101__20221231_ziE8GQVnIJR7" title="Sublease rental income">123,386</span> and $<span id="xdx_909_eus-gaap--OperatingLeasesRentExpenseNet_c20210101__20211231_zdYG3v1hnLpg" title="Sub Rental Income">75,061</span> during the years ended December 31, 2022 and 2021, respectively.
As of December 31, 2022 and 2021, deferred income and a sublease deposit totaled $<span id="xdx_903_ecustom--DeferredIncomeAndSubleaseDeposit_iI_c20221231_zrwtzhbpkyb4" title="Deferred income and sublease deposit">14,168</span> and $<span id="xdx_904_ecustom--DeferredIncomeAndSubleaseDeposit_iI_c20211231_zAb689SXF2Nj">13,690</span>, respectively, and is included in
accrued expenses and other current liabilities on the accompanying Balance Sheets.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the total future minimum sublease payments as of December 31, 2022:</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zogI97WN0Tzk" style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zqERv2OqsW1b" style="display: none">Schedule of future minimum sublease payments</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_134_zhF1WH9OjIuk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49C_20221231_zDQyzMww9bPa" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 79%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years ending December 31,</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zf6T9vcYuKN4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,147</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_z1tyWIw2oB23" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,242</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_iI_zeyWDgF05una" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,070</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zPHSI71m273d" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,459</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A8_zFVc6lYAtst2" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be involved from time to time in litigation or claims arising in the ordinary course of its business. While the ultimate
liability, if any, arising from these claims cannot be determined with certainty, the Company believes that the resolution of any such
matters will not likely have a material adverse effect on the Company&#8217;s financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 22, 2022, Expion360 Inc. (the &#8220;Company&#8221;) <span style="background-color: white">received notice of a complaint (the
&#8220;Complaint&#8221;) filed against it in Oregon state court by Ravi Sinha. The Complaint alleges,&#160;</span><i>inter alia</i><span style="background-color: white">,
that Mr. Sinha is entitled to 282,284 shares of the Company&#8217;s common stock, or in the alternative, $300,000 plus interest in connection
with services he previously rendered the Company as its chief executive officer. On March 21, 2023, the Company entered into a settlement
agreement with Mr. Sinha and the matter has been resolved.</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296612880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Conversion to a C Corporation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DisclosureConversionToCCorporationAbstract', window );"><strong>Conversion To C Corporation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ConversionOfStockTextBlock', window );">Conversion to a C Corporation</a></td>
<td class="text"><p id="xdx_80E_ecustom--ConversionOfStockTextBlock_zdRfPj90rela" style="margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>11.&#160;&#160;&#160;<span id="xdx_825_zsnBXAk3PPHj">
Conversion to a C Corporation</span></i></b></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
November 1, 2021, the Company converted from an LLC to a C corporation under the State of Nevada statutes in anticipation of an upcoming
initial public offering, and changed its name to Expion360 Inc. The membership units of the existing LLC members and all existing convertible
note holders (see Note 9 - Convertible Notes) converted into an aggregate of 4,181,111 shares of common stock. Additionally, investors
purchased 88,889 shares of common stock for total proceeds of $316,400, and 30,000 shares of common stock were issued in exchange for
legal services. The 30,000 shares issued in exchange for legal services were valued at $108,900 at date of grant based on the per share
price of $3.63 paid for shares issued at the time of the conversion to a C corporation. The Company&#8217;s issued and outstanding shares
of common stock totaled 4,300,000 upon conversion to a C corporation.</span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ConversionOfStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ConversionOfStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DisclosureConversionToCCorporationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DisclosureConversionToCCorporationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296582288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text"><p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8mEXorYBGFe" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<span id="xdx_822_zV5OosiIvbO8">Stockholders&#8217; Equity</span><span style="font-weight: normal; color: windowtext">&#160;</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue an aggregate of 220,000,000 &#160;&#160;shares of capital stock, par value $0.001 per share, consisting
of 200,000,000 shares of common stock and 20,000,000 shares of preferred stock. On March 31, 2023, at the closing price of $4.84 per
share, the Company issued 52,000 shares of common stock as part of the settlement agreement with Mr. Sinha dated March 21, 2023. As of
September 30, 2023 and December 31, 2022, 6,910,717 and 6,802,464 shares, respectively, of common stock were issued and outstanding.
No shares of preferred stock have been issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of common stock is entitled to one vote for each share of common stock. The holders of common stock have no conversion, redemption
or preemptive rights and shall be entitled to receive dividends when, as, and if declared by the board of directors. Upon dissolution,
liquidation, or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, subject
to the rights, if any, of the holders of any class or series stock having a preference over the right to participate with common stock
with respect to the distribution of assets of the Company upon such dissolution, liquidation, or winding up of the Company, the holders
of common stock shall be entitled to receive the remaining assets of the Company available for distribution to its stockholders ratably
in proportion to the number of shares of common stock held.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
no shares of preferred stock have been issued, no rights and privileges of preferred stockholders have been defined.&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial Public
Offering</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company completed an initial public offering (&#8220;IPO&#8221;). A total of 2,466,750 shares of common stock were
sold at $7.00 per share in the IPO, for total gross proceeds of $17,267,250. The Company incurred IPO costs of $2,494,763 resulting in
net proceeds of $14,772,487. Additionally, during the year ended December 31, 2022, the Company issued 35,714 shares of common stock
at $7.00 per share to an outside third party in exchange for IPO services. The fair value of the shares of $249,998 were recorded as
an increase to common stock of $36 (35,714 shares at $.001 par value) and additional paid in capital of $249,962 and a corresponding
reduction to additional paid in capital of $249,998, resulting in a net decrease in additional paid in capital of $36.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants/Options</i>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">On August 10, 2023,
the Company issued 25,000 warrants to their investor relations firm in accordance with a letter of engagement signed July 22, 2022,
to purchase 25,000 shares of common stock at an exercise price of $5.00 per share. The warrants expire 2 years from date of grant
(August 9, 2025). The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model
and following assumptions: per share price of common stock on date of grant $5.20, expected dividend yield of 0%, expected volatility
of 88%, risk-free interest rate of 4.82% and expected life based on contractual life of 2 years. The fair value of $65,046&#160;
was recorded as an increase in additional paid-in capital and expensed to Legal and Professional Services.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company issued warrants to IPO underwriters to purchase 148,005 shares of common stock at an exercise price of $9.10
per share. The warrants are exercisable 180 days after grant (September 27, 2022) and expire 5 years from date of grant (March 31, 2027).
The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions:
per share price of common stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest
rate of 2.55% and expected life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in
capital and a reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero
impact to additional paid-in capital.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0">&#160;</p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2023, 15,000 warrants exercisable at $3.32 per share were exercised on a cash basis which resulted
in the issuance of 15,000 shares of common stock. In addition, 22,606 warrants exercisable at $3.32 per share were exercised using the
cashless conversion option, which resulted in the issuance of 10,151 shares of common stock. This leaves 521,825 warrants remaining with
an exercise price of $3.32.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2023, 73,000 warrants exercisable at $2.90 per share were exercised using the cashless conversion
option which resulted in the issuance of 31,102 shares of common stock. This leaves 78,000 warrants remaining with an exercise price
of $2.90.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.35pt">As of September
30, 2023 and December 31, 2022, a total of 772,830 and 858,436 warrants were issued and outstanding, respectively. As of September
30, 2023 and December 31, 2022, a total of 30,000 options, which were not issued under a specified plan, were outstanding. As of
September 30, 2023, below is a summary of the various warrants/options issued and outstanding:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.35pt">&#160;</p>



<p id="xdx_89D_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zdD8GKq3aiYa" style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B7_zm75MT70gd62" style="display: none">Schedule of various warrants/options issued and outstanding</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_134_zABaZfFVn2lh" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details)">
  <tr style="vertical-align: bottom">
    <td style="width: 47%; text-align: center"><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number
                                               of warrants/non-plan options</b></span></p>


</td>
    <td style="width: 23%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></span></td>
    <td style="width: 30%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Remaining
    Life (Yrs)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98D_ecustom--NumberOfWarrantsnonplanOptionsOne_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zKbapBLbOX7e" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">25,000</span></td>
    <td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zZsB6XKMCa3b" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">$5.00</span></td>
    <td style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePricesMember_zKne3ypdaBk9">1.86</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_984_ecustom--NumberOfWarrantsnonplanOptionsTwo_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zo9CS0bUS2lb" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">521,825</span></td>
    <td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zCTh5SGjeYje" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$3.32 </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zBp8z7jLCqMi">8.15</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98C_ecustom--NumberOfWarrantsnonplanOptionsThree_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zTzqyoS76RNe" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">78,000</span></td>
    <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zt1ripov30J3" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$2.90 </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zclT3p4JMwBe">1.11</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_985_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_z7B1Ksldnlf" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">30,000</span></td>
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zah7kwM60dXh" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$3.32 </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zW8SCQXV7SH7">1.11</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_zcMZ6goDaZC6" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">148,005</span></td>
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_z6UiFSsNAFFe" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$9.10
    </span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zgg7PK4bJNLd">3.50</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p id="xdx_8A4_zLl2b9MbIvle" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Option Plans</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As of September 30,
2023, the Company had adopted two stock-based compensation plans, the 2021 Incentive Award Plan and the 2021 Employee Stock Purchase
Plan, both of which are described below and became effective upon the initial public offering. On May 2, 2022, the Company granted
829,500 options and on August&#160; 23, 2023, the Company granted 245,500 options and 48,780 restricted stock units (&#8220;RSUs&#8221;)
under the 2021 Incentive Award Plan. No shares have been issued to date under the 2021 Employee Stock Purchase Plan. The compensation
cost that has been charged against operations was $2,114,529 for the year ended December 31, 2022 and $124,785 for the three months
ended September 30, 2023.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021 Incentive Award Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The purpose of the
Company&#8217;s 2021 Incentive Award Plan is to enhance the Company&#8217;s ability to attract, retain and motivate persons who
make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities.
Various stock-based awards may be granted under the plan to eligible employees, consultants, and non-employee directors. The number
of shares issued under the plan is subject to limits and is adjusted annually. No more than 1,000,000 shares may be issued pursuant
to the exercise of incentive stock options. The aggregate share limit will be subject to an annual increase on the first day of
each calendar year ending on and including January 1, 2031, by a number of shares equal to the lesser of (i) a number equal to
5% of the aggregate number of shares of the Company's common stock outstanding on the final day of the immediately preceding calendar
year and (ii) such smaller number of shares as is determined by the Company's board or committee. As of September 30, 2023, the
aggregate number of shares that can be issued under the Plan is 1,199,623, of which 1,075,000 options and 48,780 RSUs have been
granted. The number of shares granted, the exercise price, and the terms will be determined at date of grant; however, the exercise
price shall not be less than 100% of the fair value on the grant date (110% for options granted to greater than 10% stockholders)
and the term shall not exceed ten years.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0"></p>



<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021 Employee Stock Purchase Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Company&#8217;s 2021 Employee Stock Purchase Plan is to assist eligible employees of the Company in acquiring a stock
ownership in the Company and to help such employees provide for their future security and to encourage them to remain in the employment
of the Company. The plan consists of a Section 423 Component and Non-Section 423 Component. The Section 423 Component is intended to
qualify as an employee stock purchase plan and also authorizes the grant of options. Options granted under the Non-Section 423 Component
shall be granted pursuant to separate offerings containing sub-plans. The Company may make one or more offerings under the plan. The
duration and timing of each offering period may be established or changed by the board, but in no event may an offering period exceed
27 months and in no event may the purchase period for the option exceed the duration of the offering period under which it is established.
On each exercise date for an offering period, each participant shall automatically be deemed to have exercised the option to purchase
the largest number of whole shares which can be purchased under the offering. Option awards are generally granted with an exercise price
equal to 85% of the lesser of the fair market value of a share on (a) the applicable grant date and (b) the applicable exercise date,
or such other price as designated by the administrator, provided that in no event shall the option price be less that the per share par
value price. The maximum number of shares granted under the plan shall not exceed 2,500,000 shares.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected
volatility was calculated based upon similar traded companies&#8217; historical share price movements as adequate historical experience
is not available to provide a reasonable estimate. Expected term is calculated based on the simplified method as adequate historical
experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience
is available to provide a reasonable estimate of the expected term. The risk-free interest rate is calculated based on the yield from
U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and have no foreseeable plans
to pay dividends.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has computed the fair value of all options granted during the year ended December 31, 2022 using the following assumptions:</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ztNSL32BluSd" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zaGwniah05M8" style="display: none">Schedule of assumptions used</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_134_zP37qo3NCmWb" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 1)">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility 	</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z5Q8Iu4ucnH8" title="Expected Volatility">109.48</span>% - <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zdJpsBdwwVzl" title="Expected Volatility">113.32</span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividends</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_z56B65SB3sea" title="Expected dividends">None</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (in years)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zdbmgFKkfCJ6" title="Expected term (in years)">2.5</span> &#8211; <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zBce8gkxjiif" title="Expected term (in years)">5.01</span> </span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free
    rate	</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2wORi2sMc9" title="Risk free rate">2.83</span>% &#8211; <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z9fLngVTHOxa" title="Risk free rate">3.01</span>%</span></td></tr>
  </table>
<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has computed the fair value of the 245,500 options granted during the nine months ended September 30, 2023 using the following
assumptions:</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    volatility 	</span></td><td style="width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zcwAmmtAG005" title="Expected volatility">105</span></span></td><td style="width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    dividends</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20230101__20230930_zwaiTZw8rcu8" title="Expected dividends">None</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    term (in years)</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_znnUS4AW0cO3" title="Term">6.0</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Risk
    free rate	</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230101__20230930_zje8AmlukpNa" title="Risk free rate">4.33</span></span><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>



<p style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p id="xdx_8A4_zGDKPfmcidVc" style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table
summarizes the Company&#8217;s stock option activity under the 2021 Incentive Plan:</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z34PqlRSQKW3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zPfQrUvEmeP2" style="display: none">Schedule of stock option activity</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zZo1xjomvR11" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="width: 53%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of options</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average exercise price</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average remaining contractual term (in years)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    intrinsic value (1)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zV1RbkHg5RKc" style="text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zqQTWpASTkz3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_c20230101__20230930_zoIxiPNl1wAa" style="text-align: right" title="Weighted average remaining contractual term (in years)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.76</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_hus-gaap--AwardTypeAxis__us-gaap--OptionMember_zf1LTcykw98i" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,500</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zc7l5pLlrkOi" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.92</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of period</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zmtib1YqEBZ6" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,075,000</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zEJqQXdp4z4j" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.77</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_c20230101__20230930_zyNJ9fklntAh" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.02</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zZSCUdyZAHgd" style="border-bottom: black 1pt solid; text-align: right" title="Outstanding at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">567,595</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of period</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zL0TfMxpgLk7" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zuYL48xG3eph" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_c20230101__20230930_zDxeoYCBytaf" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.51</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_z0zO4r5djEx3" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">567,595</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The aggregate intrinsic
    value of options outstanding and options exercisable at beginning of period is $0, as all options are out of the money.</i></span></td></tr>
  </table>
<p id="xdx_8A4_zm0IKKHLQUz9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"></p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months ended
September 30, 2023 and 2022, the weighted-average grant-date fair value of the options granted to employees and non-employees was $998,924
and $1,847,193, respectively. Unrecognized compensation expense related to employees was $234,737 as of September 30, 2023. The options
granted in May 2022 were vested 100% at time of grant. The options granted in August 2023 began to vest in equal quarterly installments
beginning September 30, 2023 and ending June 30, 2026.</p>
<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table
summarizes the Company&#8217;s restricted stock unit (&#8220;RSU&#8221;) activity under the 2021 Incentive Plan:</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zSsS8b617s7b" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span id="xdx_8B2_zy8whRJJDSZe" style="display: none">Share-Based
Payment Arrangement, Restricted Stock Unit, Activity</span></span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zUJ6sN1EO8pe" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 3)">
  <tr style="vertical-align: bottom">
    <td style="width: 68%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of restricted stock awards</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average grant-date fair value</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested at beginning of year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZ2PPCLrj7d" style="text-align: right" title="Numbers of Shares beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1846">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6YprpuKHP6k" style="text-align: right" title="Begining balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1848">&#8212;</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKzVANoGVwK9" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSyN7aXs5ARe" style="text-align: right" title="Weighted avergare granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">239,998</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested at end of year</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6xOLtHw31rg" style="border-bottom: black 1pt solid; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUhwOgnif0R5" style="border-bottom: black 1pt solid; text-align: right" title="Weigthed Average Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">239,998</span></td></tr>
  </table>
<p id="xdx_8A0_zZrbcU0QBAv3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $0.2 million of total unrecognized compensation cost related to non-vested RSUs that are expected to be recognized over a period
of up to 0.70 years.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock Reserved
for Future Issuance </i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of common stock shares reserved for future issuance as of September 30, 2023:</span></p>

<p id="xdx_895_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_zXiJted72Hya" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_z2xjurY2BhMc" style="display: none">Schedule of common stock shares reserved for future issuance</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_134_zvYcYYRcQA6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 4)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 12pt; text-indent: 6pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49E_20230930_z1XzTdBLhml2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zD7IQnOKj873" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 71%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of warrants 	</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">772,830</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zO8rm0iRvH5d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of options unrelated to any Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zI24wLcLgZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of stock options &#8211; 2021 Incentive Award Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,075,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzFie7Js2KOa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of restricted stock units &#8211; 2021 Incentive Award Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCiODbzqpC4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    shares of common stock reserved for future issuances	</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,926,610</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_z1gwMGplld3k" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zNvn7GEnEaBa" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&#160;&#160;&#160;<span id="xdx_822_z3ypndUkQ1F">
Stockholders&#8217; Equity</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue an aggregate of 220,000,000 shares of capital stock, par value $0.001 per share, consisting of 200,000,000
shares of common stock and 20,000,000 shares of preferred stock. As of December 31, 2022 and December 31, 2021, 6,802,464 and 4,300,000
shares, respectively, of common stock were issued and outstanding. No shares of preferred stock have been issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of common stock is entitled to one vote for each share of common stock. The holders of common stock have no conversion, redemption
or preemptive rights and shall be entitled to receive dividends when, as, and if declared by the board of directors. Upon dissolution,
liquidation, or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, subject
to the rights, if any, of the holders of any class or series stock having a preference over the right to participate with common stock
with respect to the distribution of assets of the Company upon such dissolution, liquidation, or winding up of the Company, the holders
of common stock shall be entitled to receive the remaining assets of the Company available for distribution to its stockholders ratably
in proportion to the number of shares of common stock held.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
no shares of preferred stock have been issued, no rights and privileges of preferred stockholders have been defined.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
Public Offering</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company completed an initial public offering (&#8220;IPO&#8221;). A total of 2,466,750 shares of common stock were
sold at $7.00 per share in the IPO, for total gross proceeds of $17,267,250. The Company incurred IPO costs of $2,494,763 resulting in
net proceeds of $14,772,487. Additionally, during the year ended December 31, 2022,
the Company issued 35,714 shares of common stock at $7.00 per share to an outside third party in exchange for IPO services. The fair
value of the shares of $249,998 were recorded as an increase to common stock of $36 (35,714 shares at $.001 par value) and additional
paid in capital of $249,962 and a corresponding reduction to additional paid in capital of $249,998, resulting in a net decrease in additional
paid in capital of $36.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance
of Shares</i></span></p>

<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to conversion from an LLC to a C corporation, the following membership units were issued and included in the membership units that were
converted into 4,181,111 shares of common stock upon the Company&#8217;s conversion to a C corporation (see Note 11 &#8211; Conversion
to a C corporation).</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2021, 8,000 membership units (equivalent to 192,234 shares) that were held in
                                            Trust were granted to three individuals.</span></td></tr></table>

<p style="margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2021, the Company issued 2,338 Class B member units (equivalent to 59,515 shares
                                            of common stock) upon the conversion of convertible notes and accrued interest totaling $173,157
                                            (see Note 9 - Convertible Notes).</span></td></tr></table>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 1, 2021, the Company issued 262 Class B membership units (equivalent to 6,667 shares
                                            of common stock) in exchange for building signage valued at $20,000.</span></td></tr></table>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            March 2021, the Company sold 3,185 Class B membership units (equivalent to 81,106 shares
                                            of common stock) to two new members for gross proceeds of $270,000.</span></td></tr></table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            April 2021, the company sold 2,972 Class B membership units (equivalent to 75,662 shares
                                            of common stock) to one new member for gross proceeds of $252,000.</span></td></tr></table>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants/Options</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company issued warrants to IPO underwriters to purchase 148,005 shares of common stock at an exercise price of $9.10
per share. The warrants are exercisable 180 days after grant (September 27, 2022) and expire 5 years from date of grant (March 31, 2027).
The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions:
per share price of common stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest
rate of 2.55% and expected life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in
capital and a reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero
impact to additional paid-in capital.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2021, the Company issued 482,268 detachable warrants with secured promissory notes (see Note 7 &#8211; Long-Term Debt) for the
purchase of common stock. The relative fair value of the warrants of $809,806 at the time of issuance was recorded as additional paid-in
capital with a corresponding debt discount reducing the carrying value of the notes. Additionally, the Company issued 77,163 warrants
to purchase shares of common stock to underwriters in connection with obtaining the notes. The fair value of the warrants of $262,354
was recorded as additional paid-in capital and reduced the carrying value of the notes. The warrants are exercisable at $3.32 per share
for a period of 10 years from date of grant. The fair value of the warrants was determined at date of issuance using the Black-Scholes
option-pricing model and the following assumptions: per share price of common stock on date of grant of $3.63, expected dividend yield
of 0%, expected volatility of 110.8%, risk-free interest rate of 1.63% and expected life based on contractual life of 10 years.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
in November 2021, the Company issued warrants to purchase 151,000 shares of common stock in in exchange for prior services related
to extinguished 2021 convertible notes and 30,000 options for the purchase of common stock in exchange for legal services. The
warrants are exercisable at $2.90 per share for a period of three years from the date of grant. The options are exercisable at $3.32
per share for a period of three years from the date of grant. The options issued were not issued under the Company&#8217;s stock
option plans. The fair value of the warrants of $407,700 was recorded as additional paid-in-capital and expensed to extinguishment
loss on debt settlement (see Note 9 &#8211; Convertible Notes). The fair value of the options of $79,200 was recorded as additional
paid-in capital with a
corresponding charge to legal expense. The fair value of the warrants and options was determined at date of issuance using the Black-Scholes
option-pricing model and the following assumptions: per share price of common stock on date of grant of $3.63, expected dividend yield
of 0%, expected volatility of 122.7%, risk-free interest rate of 0.71% and expected life based on contractual life of three years.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, a total of 858,436 and 710,431 warrants were issued and outstanding, respectively. As of
December 31, 2022 and December 31, 2021, a total of 30,000 options, which were not issued under a specified plan, were outstanding. As
of December 31, 2022, below is a summary of the various warrants/options issued and outstanding:</span></p>

<p id="xdx_895_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zPf8dkwekrsb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zEzVKEpPWtxc" style="display: none">Schedule of various warrants/options issued and outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zpjXu2OSB0dj" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details)">
  <tr style="vertical-align: bottom">
    <td style="width: 47%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of
    warrants/non-plan options</b></span></td>
    <td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    Price</b></span></td>
    <td style="width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    Average Remaining Life (Yrs)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zfwpDoIHXtF9" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,431</span></td>
    <td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zyr2oR9dgU52" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$3.32
    </span></td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zg9KyrjASIWe">8.90</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zExQ0hbqZOh5" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,000</span></td>
    <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_z28elCJ7994l" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$2.90
    </span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zadaY99B6WYg">1.86</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zbAYHtpkB53l" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td>
    <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zvIaZ1h8hcv7" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$3.32
    </span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zAL5rhjBdOp3">1.86</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zGLs1JzSux5" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,005</span></td>
    <td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zvBMWrSErvjj" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$9.10
    </span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zZEHNbQA7Aki">4.25</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231_zY5DYu6afXz8" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">888,436</span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A6_z4tAEbfvc9c5" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Option Plans</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had adopted two stock-based compensation plans, the 2021 Incentive Award Plan and the 2021 Employee
Stock Purchase Plan, both of which are described below and became effective upon the initial public offering. On May 2, 2022, the Company
granted 829,500 options under the 2021 Incentive Award Plan. No shares have been issued to date under the 2021 Employee Stock Purchase
Plan. The compensation cost that has been charged against operations was $2,114,529 for the year ended December 31, 2022.</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021
Incentive Award Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Company&#8217;s 2021 Incentive Award Plan is to enhance the Company&#8217;s ability to attract, retain and motivate persons
who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities.
Various stock-based awards may be granted under the plan to eligible employees, consultants, and non-employee directors. The number of
shares issued under the plan is subject to limits and is adjusted annually. No more than 1,000,000 shares may be issued pursuant to the
exercise of incentive stock options. The aggregate share limit will be subject to an annual increase on the first day of each calendar
year ending on and including January 1, 2031, by a number of shares equal to the lesser of (i) a number equal to 5% of the aggregate
number of shares of the Company's common stock outstanding on the final day of the immediately preceding calendar year and (ii) such
smaller number of shares as is determined by the Company's board or committee. As of December 31, 2022, the aggregate number of shares
that can be issued under the Plan is 859,500 of which 829,500 have been granted. The number of shares granted, the exercise price, and
the terms will be determined at date of grant, however, the exercise price shall not be less than 100% of the fair value on the grant
date (110% for options granted to greater than 10% shareholders) and the term shall not exceed ten years.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2021
Employee Stock Purchase Plan</span></i></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The purpose of the Company&#8217;s 2021 Employee
Stock Purchase Plan is to assist eligible employees of the Company in acquiring a stock ownership in the Company and to help such employees
provide for their future security and to encourage them to remain in the employment of the Company. The plan consists of a Section 423
Component and Non-Section 423 Component. The Section 423 Component is intended to qualify as an employee stock purchase plan and also
authorizes the grant of options. Options granted under the Non-Section 423 Component shall be granted pursuant to separate offerings
containing sub-plans. The Company may make one or more offerings under the plan. The duration and timing of each offering period may
be established or changed by the board, but in no event may an offering period exceed 27 months and in no event may the purchase period
for the option exceed the duration of the offering period under which it is established. On each exercise date for an offering period,
each participant shall automatically be deemed to have exercised the option to purchase the largest number of whole shares which can
be purchased under the offering. Option awards are generally granted with an exercise price equal to 85% of the lesser of the fair market
value of a share on (a) the applicable grant date and (b) the applicable exercise date, or such other price as designated by the administrator,
provided that in no event shall the option price be less that the per share par value price. The maximum number of shares granted under
the plan shall not exceed 2,500,000 shares.</span></p>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">&#160;</span></i></span></p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"></p>






<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected
volatility was calculated based upon similar traded companies&#8217; historical share price movements as adequate historical experience
is not available to provide a reasonable estimate. Expected term is calculated based on the simplified method as adequate historical
experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience
is available to provide a reasonable estimate of the expected term. The risk-free interest rate is calculated based on the yield from
U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and have no foreseeable plans
to pay dividends.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has computed the fair value of all options granted during the year ended December 31, 2022 using the following assumptions:</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcJ8dxxZkHx8" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zeGzw2Rp6LDe" style="display: none">Schedule
of assumptions used</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zk1RpYJzRAt9" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details1)">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility 	</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z24FkFYmlO1i">109.48</span>% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zcF9lTf9RPy3">113.32</span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividends</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_zrSe1p1d5Dr5">None</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (in years)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zqaEN7sJ00h2">2.5</span> &#8211; <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zj8KGAYwQ0R9">5.01</span> </span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    free rate	</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z54s1WVuj283">2.83</span>% &#8211; <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z3TKXdHHvoUj">3.01</span>%</span></td></tr>
  </table>
<p id="xdx_8AD_z3yIi7NqvRla" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the Company&#8217;s stock option activity under the 2021 Incentive Plan:</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zpsFvxsyKuK2" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zFX4jIZq1BZ7" style="display: none">Schedule of stock option activity</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_134_zzfp0ZPVzO6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details2)">
  <tr style="vertical-align: bottom">
    <td style="width: 51%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of options</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average exercise price</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average remaining contractual term (in years)</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    intrinsic value (1)</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zJAYO72S2l31" style="text-align: right" title="Outstanding at beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0844">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zQTcUdOPhvG3" style="text-align: right" title="Weighted average exercise price outstanding at beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0846">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zxMld6jCZh9c" style="text-align: right" title="Aggregate intrinsic value Outstanding at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0848">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zTrNZy6McZMb" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zHQto8BXgup6" style="text-align: right" title="Weighted average exercise price granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zAlcAOVbD7eg" style="text-align: right" title="Aggregate intrinsic value granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_ztSN20Ia76i" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0855">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zBwJkFHMJ5sb" style="text-align: right" title="Weighted average exercise price exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0857">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zr8qW9ktYPhj" style="text-align: right" title="Aggregate intrinsic value exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0859">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zoh55x7y0jse" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0861">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zRqC5AExY4T" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0863">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_ecustom--AggregateIntrinsicValueForfeited_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zFhE6mlaRA7g" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0865">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of period</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zju6BqTzL85b" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_z4Cl21GR35Za" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstaning at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zX3UKdaPNM48" title="Weighted average remaining contractual term (in years)">8.26</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zt1lLxMYkyLa" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0873">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of period</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zZg3Cuz3ukza" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_iI_c20221231_z3lKBCxLGzgl" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average Price exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zi952FVivqDj" title="Weighted average remaining contractual term (in years) exercisable">8.26</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zsWZalj4hiS8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0881">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8AE_zzi8QPDGEpA7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
                                            aggregate intrinsic value of options outstanding and options exercisable as of December 31,
                                            2022 is $0, as all options are out of the money.</i></span></td></tr></table>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average grant-date fair value of the options granted during the nine months ended December 31, 2022 to employees and non-employees
was $<span id="xdx_90E_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20220101__20221231_zuIYfec0Wn6c" title="Options granted">1,847,193</span> and $<span id="xdx_909_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20210101__20211231_zvI3H0h5dnH9">267,336</span>, respectively. All options were immediately vested and there was no unrecognized compensation expense as
of December 31, 2022.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock Reserved for Future Issuance </i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of common stock shares reserved for future issuance as of December 31, 2022:</span></p>

<p id="xdx_89D_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_z90f1irLpWN6" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zgICDwR4qoh" style="display: none">Schedule
of common stock shares reserved for future issuance</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_133_z4kENF1cfmba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  Stockholders Equity (Details 3)">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 6pt; padding-left: 12pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20221231_znWZEU5eey41" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zly4ssWCud3l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: 6pt; padding-left: 12pt">Exercise of warrants 	</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">858,436</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zmxFQkzQUqvd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt">Exercise of options unrelated to any Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zyYgm42BRNQb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 6pt; padding-left: 12pt">Exercise of stock options &#8211; 2021 Incentive Award Plan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">829,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCBQtFy6EhV" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 6pt; padding-left: 12pt">Total shares of common stock reserved for future issuances	</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,717,936</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296753264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zvouYfSEF9I8" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<span id="xdx_82B_zqfAlZ9QMkz1">Income Taxes</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The Company
has incurred losses and consequently recorded no provision beyond the minimum or base tax rate for state or federal income taxes
for the three or nine months ended September 30, 2023. The Company maintains a full valuation allowance on all deferred tax assets,
as it has concluded that it is more likely than not that these assets will not be realized. As of September 30, 2023 and December
31, 2022, there were no material unrecognized tax benefits included in the accompanying balance sheets that would, if recognized,
affect the effective tax rate. For the three months ended September 30, 2023, the Company accrued $1,380 for 2023 state income
taxes, and for the three months ended September 30, 2022, the Company accrued and incurred state taxes of $0. For the nine months
ended September 30, 2023, the Company has net state tax expenses totaling $1,341 due to a small refund, and for the nine months
ended September 30, 2022, the Company incurred state taxes of $300.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zZKsCIc5Jol9" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&#160;&#160;&#160;
<span id="xdx_827_z9BdVN7137T7">Income Taxes</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
losses before income taxes for the year ended December 31, 2022 and for the two months ending December 31, 2021 were generated primarily
from U.S. operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no current or deferred provision for income taxes from continuing operations for the years ended December 31, 2022 and 2021.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant differences between the U.S. Federal statutory rate and our effective rate for financial reporting purposes are as follows:</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEtVZfzLHWcj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span id="xdx_8B3_zjcQ6x77CPU2" style="display: none">Schedule
of Effective Income Tax Rate Reconciliation</span></span></span></p>
<table cellpadding="0" cellspacing="0" id="xdx_308_134_zwbP73deKSi9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_496_20220101__20221231_ztVgFHcgYj7h" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49C_20210101__20211231_zoKi8J2nW6gc" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_dp_uPure_zGJmKRRETVVl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Federal statutory tax rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_dp_uPure_zSsouv1ej8Pk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.7</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dt_uPure_zSDcgF6oc0bf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.4</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationBeatPercent_dp_uPure_z8hQMHG06fq6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NQSO Comp &#8211; Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.5</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationFdiiPercent_dp_uPure_z6JxTFJotrz" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">EQ Comp &#8211; Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.4</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_uPure_zFBT1vmZ4Ww3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">True-up Adjustment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zKiFl8AjglZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="margin: 0; text-align: justify">&#160;</p>

<p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zC4OARNncDdj" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_ziXukLYUoNWd" style="display: none">Schedule of Income
before Income Tax, Domestic and Foreign</span></span></p>



<p style="margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zb1NHB8OwHti" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_496_20220101__20221231_zjevSpBUivch" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zHdMUqaY85k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of
    December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Current:</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_zo8Lkbra0hU8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Federal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0923">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zt5wGkkScfPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left">&#160;&#160;&#160;&#160;State Franchise Fees</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(8,850</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">9,300</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0; text-align: justify"></p>

<p id="xdx_8A0_zMccOFf4myda" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and
liabilities are as follows for the year ended December 31, 2022 and two months ended December 31, 2021.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income tax assets and liabilities consist of the following:</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zrqqWNaZpNL8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zCkmsuoyAI94" style="display: none">Schedule of Components of Income Tax Expense</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_z4PMuvPF2Mrl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 2)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_496_20221231_z89QQUgKEAVi" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_zNPhNqwwS8d1" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_zPDkTJWsp4Y8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLossCarryforwards_iI_z1KojXuaItub" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left">&#160;&#160;&#160;&#160;Net Operating Losses</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,719,889</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">151,797</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_zY5o7ofxAGS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">444,051</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,524</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_iI_zPOwsh21rPTg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">424,675</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17,927</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zbpierLcBkek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,588,615</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">320,248</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iNI_di_zYAiOFhAOQ5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,584,010</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(297,815</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_z9RCY5agWj6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation_iI_z6gxUl9dblYg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;Depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,605</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(22,433</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zTwZORa2tz13" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, the Company incurred losses for the year ended December 31, 2022 and December 31, 2021 and for each period
since inception. Accordingly, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets.
At December 31, 2022, the Company had approximately $6.56 million of federal and state net operating losses.</span></p>






<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation between the amount of income tax benefit determined by applying the U.S statutory income tax rate to pre-tax loss is as
follows:</span></p>

<p id="xdx_892_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zPv7QMcA7cRk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zYENDrlL9PE9" style="display: none">Summary of Operating Loss Carryforward</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_134_zIUNOoP3rzEa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 3)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_497_20221231_zjBwkj1Wu1Yh" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_zZONGVJtCiA9" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iNI_di_zmJ0QSxopRXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Income tax provision at federal statutory rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,584,531</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(746,778</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iNI_di_zyhZ985TWJH" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(399,174</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59,202</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_zVKR14O4RXk1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Stock-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0964">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">491,727</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsTaxCreditCarryforwardsOthers_iNI_di_zoHMOfr76WJa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,964</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,438</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsValuationAllowanceOne_iNI_di_zNsab0INGQ0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,992,669</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(297,815</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zDtRC7mosmRf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_zzsIHje3BTw9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
positions are evaluated in a two-step process. The Company first determines whether it is more likely than not that a tax position will
be sustained upon examination. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine
the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is
greater than 50% likely of being realized upon ultimate settlement. The aggregate changes in the balance of gross unrecognized tax benefits,
which excludes penalties and interest, for the year ended December 31, 2022 is zero.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to taxation in the United States and Oregon. There are no ongoing examinations by taxing authorities at this time.
The Company&#8217;s various tax years 2017 through 2022 remain open for examination by various taxing jurisdictions.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2022, the Company
has not accrued any penalties or interest related to uncertain tax positions</span></p>

<p style="margin: 0 8pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
anticipation of an initial public offering, the Company converted from a limited liability company to a C corporation, a taxable entity,
effective November 1, 2021.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
October 31, 2021, the Company was treated as an S corporation for federal and state income tax purposes, such that the Company&#8217;s
taxable income is reported by members in their respective tax returns and the Company was only subject to state franchise taxes and fees.
For the year ended December 31, 2022 the Company reversed the 2021 accrual of $9,300 and accrued only $450 for state income taxes, as
we do not anticipate owing more than the minimum state income taxes for 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
converting to a C corporation, the Company has incurred losses and consequently recorded no provision for state or federal income taxes
for the year ended December 31, 2022. The Company maintains a full valuation allowance on all deferred tax assets, as it has concluded
that it is more likely than not that these assets will not be realized. As of December 31, 2022 and December 31, 2021, there were no
material unrecognized tax benefits included in the accompanying balance sheets that would, if recognized, affect the effective tax rate.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296629824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Plan<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTextBlock', window );">401(k) Plan</a></td>
<td class="text"><p id="xdx_807_eus-gaap--DefinedBenefitPlanTextBlock_zlmh7pA5Dh5a" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<span id="xdx_824_zpMSTJRrlFgf">401(k) Plan</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted a 401(k) Plan (&#8220;Plan&#8221;) for the benefit of its employees. Employees may contribute to the Plan within defined
limits as defined by the Internal Revenue Service. Substantially all employees are eligible to participate. The Company has the option
to make profit sharing contributions at its discretion. No profit-sharing contributions have been made.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--DefinedBenefitPlanTextBlock_zXvR4SR9bad7" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&#160;&#160;&#160;
<span id="xdx_821_zh0Q5EmUpQTi">401(k) Plan</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted a 401(k) Plan (&#8220;Plan&#8221;) for the benefit of its employees. Employees may contribute to the Plan within defined
limits as defined by the Internal Revenue Service. Substantially all employees are eligible to participate. The Company has the option
to make profit sharing contributions at its discretion. No profit-sharing contributions have been made.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 715<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482236/912-715-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962297550160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zNgtp9RUrU2h" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&#160;&#160;&#160;
<span id="xdx_828_zdFv0LBS2WZi">Related Party Transactions</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, related party transactions consisted of Shareholder Promissory Notes (see Note 8 &#8211;
Shareholder Promissory Notes).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, related party transactions consisted of Accounts Payables liability to board members for
2022 board compensation in the amount of $<span id="xdx_90A_ecustom--AccountsPayableRelatedPartiesCurrentOne_iI_c20221231_zjzEH1iVz8Eh" title="Accounts Payables liability">100,000</span> and $<span id="xdx_905_ecustom--AccountsPayableRelatedPartiesCurrentOne_iI_c20211231_zNYKjlqn9tz3">0</span>, respectively.</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_RelatedPartyTransactionsTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_80E_ecustom--RelatedPartyTransactionsTextBlock_zzeHvqrLrxA1" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<span id="xdx_826_zJqmuZUbBwFh">Related Party Transactions</span></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023 and December 31, 2022, related party transactions consisted of Stockholder Promissory Notes (see Note 8 &#8211;
Stockholder Promissory Notes in Item 1 &#8211; Financial Statements of Part I &#8211; Financial Information).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_RelatedPartyTransactionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_RelatedPartyTransactionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294411104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_z23DddUT4Y6i" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<span id="xdx_827_zcz1LV9zih3i">Subsequent Events</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date to which events occurring after September 30, 2023, the date of the most recent Balance Sheets, have been evaluated for possible
adjustment to the financial statements or disclosures is November 7, 2023, which is the date the financial statements were issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2023, the Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) during which the Company&#8217;s
stockholders approved an amendment to the Company&#8217;s 2021 Incentive Award Plan to increase by 250,000 the number of shares of Common
Stock authorized for issuance under the plan. The Company filed an 8-K related to the results of the Annual Meeting on October 16, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, the Company filed an 8-K related to a published press release introducing a pilot program to offer transformative solar
and energy storage solutions in partnership with REPM Corp.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><img alt="Icon

Description automatically generated" src="image_001.jpg" style="height: 84px; width: 80px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Expion360 Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Up to 1,781,978 Shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>The date of this prospectus is January 31,
2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PART&#160;II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>INFORMATION NOT REQUIRED IN PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the various expenses
to be incurred in connection with the sale and distribution of the Shares being registered hereby, all of which will be borne by us (except
any underwriting discounts and commissions and expenses incurred for brokerage, accounting, tax or legal services or any other expenses
incurred in disposing of the shares). All amounts shown are estimates except the SEC registration fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
Filing Fee</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,146.77</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
Fees and Expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Fees and Expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right">10,000</td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right">94,646.77</td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Nevada Revised Statutes (&#8220;NRS&#8221;) 78.138(7)
provides that, subject to limited statutory exceptions and unless the articles of incorporation or an amendment thereto (in each case
filed on or after October 1, 2003) provide for greater individual liability, a director or officer is not individually liable to a corporation
or its stockholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director or officer
unless it is proven that: (i) the act or failure to act constituted a breach of his or her fiduciary duties as a director or officer and
(ii) the breach of those duties involved intentional misconduct, fraud or a knowing violation of law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NRS 78.7502(1) provides that a corporation may indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of the
fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses,
including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection
with the action, suit or proceeding if the person (i) is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner
which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe the conduct was unlawful. NRS 78.7502(2) provides that a corporation may indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the
right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee
or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys&#8217;
fees actually and reasonably incurred by the person in connection with the defense or settlement of the action or suit if the person (a)
is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed
to the best interests of the corporation. To the extent that a director, officer, employee or agent of a corporation has been successful
on the merits or otherwise in defense of any such action, suit or proceeding, or in defense of any claim, issue or matter therein, the
corporation shall indemnify him or her against expenses, including attorneys&#8217; fees, actually and reasonably incurred by him or her
in connection with the defense. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a
plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to NRS 78.138
or did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the
corporation, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was
unlawful. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent
jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation,
unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines
upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such
expenses as the court deems proper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NRS 78.751(1) provides that any discretionary indemnification
pursuant to NRS 78.7502 (unless ordered by a court or advanced pursuant to NRS 78.751(2)), may be made by the corporation only as authorized
in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances.
The determination must be made (i) by the stockholders; (ii) by the board of directors by majority vote of a quorum consisting of directors
who were not parties to the action, suit or proceeding; (iii) if a majority vote of a quorum consisting of directors who were not parties
to the action, suit or proceeding so orders, by independent legal counsel in a written opinion; or (iv) if a quorum consisting of directors
who were not parties to the action, suit or proceeding cannot be obtained, by independent legal counsel in a written opinion. NRS 78.751(2)
provides that the corporation&#8217;s articles of incorporation or bylaws, or an agreement made by the corporation, may provide that the
expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding must be paid by the corporation
as they are incurred and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on
behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that the director
or officer is not entitled to be indemnified by the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the NRS, the indemnification pursuant to NRS
78.7502 and advancement of expenses authorized in or ordered by a court pursuant to NRS 78.751:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does not exclude any other
rights to which a person seeking indemnification or advancement of expenses may be entitled under the articles of incorporation or any
bylaw, agreement, vote of stockholders or disinterested directors or otherwise, for either an action in the person&#8217;s official capacity
or an action in another capacity while holding office, except that indemnification, unless ordered by a court pursuant to NRS 78.7502
or for the advancement of expenses made pursuant to NRS 78.751(2), may not be made to or on behalf of any director or officer if a final
adjudication establishes that the director&#8217;s or officer&#8217;s acts or omissions involved intentional misconduct, fraud or a knowing
violation of the law and was material to the cause of action; and</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continues for a person who
has ceased to be a director, officer, employee or agent and inures to the benefit of the heirs, executors and administrators of such
a person.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A right to indemnification or to advancement of expenses
arising under a provision of the articles of incorporation or any bylaw is not eliminated or impaired by an amendment to such provision
after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or
proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission
explicitly authorizes such elimination or impairment after such action or omission has occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Articles of Incorporation of the Company provide
that to the fullest extent permitted under the NRS (including, without limitation, to the fullest extent permitted under NRS 78.7502 and
78.751(3)) and other applicable law, we shall indemnify our directors and officers in their respective capacities as such and in any and
all other capacities in which any of them serves at our request. The Articles of Incorporation further provide that the liability of its
directors and officers shall be eliminated or limited to the fullest extent permitted by the NRS, and that if the NRS are amended to further
eliminate or limit or authorize corporate action to further eliminate or limit the liability of directors or officers, the liability of
our directors and officers shall be eliminated or limited to the fullest extent permitted by the NRS, as so amended from time to time;
and in addition to any other rights of indemnification permitted by the laws of the State of Nevada or as may be provided for by in our
Bylaws or by agreement, the expenses of directors and officers incurred in defending a civil or criminal action, suit or proceeding, involving
alleged acts or omissions of such director or officer in his or her capacity as a director or officer of the Company, must be paid, by
us or through insurance purchased and maintained by the Company or through other financial arrangements made by us, as they are incurred
and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director
or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that he or she is not entitled to be
indemnified by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, we have entered into indemnification arrangements
with each of its directors and executive officers that may be broader than the specific indemnification provisions contained in the NRS.
Such arrangements may require us, among other things, to advance expenses and otherwise indemnify its executive officers and directors
against certain liabilities that may arise by reason of their status or service as executive officers or directors, to the fullest extent
permitted by law. We intend to enter into indemnification arrangements with any new directors and executive officers in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We also have director and officer insurance&#160;providing
for indemnification for our directors and officers for certain liabilities, and such insurance provides for indemnification of our directors
and officers for liabilities under the&#160;Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following sets forth information regarding
all unregistered securities sold by the Registrant since January 1, 2019. Each of the issuances was exclusively to &#8220;accredited
investors&#8221; as defined in&#160;Regulation D&#160;under the&#160;Securities Act&#160;and in reliance on the exemptions available
pursuant to&#160;Regulation D&#160;under, and Section 4(a)(2) of, the&#160;Securities Act). </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August and October 2020,
we received proceeds totaling $270,000 from the issuance of four Convertible Notes (&#8220;2020 Notes&#8221;). The 2020 Notes accrue
monthly interest at 6% per annum and include two options for conversion: (1) automatic conversion of the principal balance and accrued
interest into new financing securities issued in a new financing round of at least $1.0 million, not including the 2020 Notes &#8212;
the conversion price will be equal to 85% of the price per unit at which the investor in the new financing purchased their equity securities;
(2) optional conversion in founder securities if (a) the Company gives the investor notice of its intent to prepay its 2020 Note, or
(b) the Company has not consummated a new financing prior to maturity. The conversion price is equal to $17.0 million divided by the
number of founder securities outstanding at the date of the 2020 Notes (100,000 units), or $170.00 per unit. The 2020 Notes mature three
years from date of issue. The outstanding balance at December 31, 2020, was $273,157, including accrued interest of $3,157, which was
recognized as interest expense during 2020.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In late 2020, all convertible
debt holders were offered the opportunity for early conversion of their convertible notes into Class B member units effective January
1, 2021. Three of the four convertible note holders converted notes with a principal balance of $170,000 and accrued interest of $3,157
into 2,338 Class B member units at per unit conversion prices ranging from $67.00 - $76.00. In accordance with FASB&#160;ASC 470-20,&#160;<i>Debt
with Conversion and Other Options</i>, the fair value of the additional units issued under the induced conversion over the value of the
number of units issuable under the original terms of the convertible note agreements is recognized as debt conversion expense. Accordingly,
upon early conversion on January 1, 2021, the Company recognized $112,133 of debt conversion expense with a corresponding entry to members&#8217;
deficit of $285,290 consisting of the $173,157 of principal and interest converted and the excess fair value of $112,133. The fourth
convertible note holder opted out of the early conversion and instead, the original note was modified into a term loan effective January
1, 2021. The modification included the elimination of the conversion feature, an increase in the interest rate from the original 6% per
annum to 10% per annum, to be paid monthly instead of accrued, and an earlier maturity date of December 31, 2021. The modification resulted
in a new effective annual interest rate of 9.58%, and a revised one-year maturity on December 31, 2021. The modification resulted in
less than a 10% difference in the present values of cash flows of the original note compared to the modified note. Accordingly, there
was no accounting changes related to these modifications.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2021, we issued
2,338 Class B member units upon the conversion of convertible notes and accrued interest totaling $173,157.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2021, we issued
262 Class B membership units in exchange for building signage valued at $20,000.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March and April 2021, we
sold 6,157 of Class B membership units to three new members for gross proceeds of $522,000.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 15, 2021, we modified
a Promissory Note Agreement in the amount of $250,000 to be a convertible note for the same amount with detachable warrants to purchase
548,000 shares of Common Stock. The modification resulted in a new effective annual interest rate of 9.15%. The modification resulted
in less than a 10% difference in the present values of cash flows of the original note compared to the modified note. Accordingly, there
was no accounting changes related to these modifications. The convertible note was issued under the same terms and conditions as the
convertible notes issued to third-party investors and therefore, in substance, was not a capital transaction. Effective November 1, 2021,
all terms under the convertible note, including the warrants, were rescinded and the member agreed to convert the note at a conversion
price of $1.21 per share.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 29, 2021, in anticipation of conversion from LLC to a C corporation, the Notes and
                                            Warrants were modified under Convertible Debenture Exercise and Waiver and Release Agreements
                                            with the individual creditors. The Note holders agreed to settle the debt for an aggregate
                                            1,527,647 shares of common stock with a fair value of $5,545,359 ($3.63 per share). Since
                                            this transaction involved contemporaneous issuance of shares of common stock by the Company
                                            to the Note holders, we evaluated the transaction for modification and extinguishment accounting
                                            and determined that the debt was extinguished as a result of the issuance of shares that
                                            do not represent the exercise of a conversion right contained in the original terms of the
                                            Notes at issuance.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2021, we issued
30,000 shares of Common Stock in exchange for legal services.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2021, we issued
482,268 detachable warrants with secured promissory notes for the purchase of Common Stock. The relative fair value of the warrants of
$809,806 at the time of issuance was recorded as additional paid-in capital with a corresponding debt discount reducing the carrying
value of the notes. Additionally, we issued 77,163 warrants to purchase shares of Common Stock to underwriters in connection with obtaining
the notes. The fair value of the warrants of $262,354 was recorded as additional paid-in capital and reduced the carrying value of the
notes. The warrants are exercisable at $3.32 per share for a period of ten years from date of grant. The fair value of the warrants was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $3.63, expected dividend yield of 0%, expected volatility of 110.8%, risk-free interest rate of 1.63% and expected
life based on contractual life of 10 years.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also in November 2021, we issued
warrants to purchase 151,000 shares of Common Stock in exchange for prior services related to extinguished 2021 convertible notes and
30,000 options for the purchase of common stock in exchange for legal services. The warrants are exercisable at $2.90 per share for a
period of three years from the date of grant. The options are exercisable at $3.32 per share for a period of three years from the date
of grant. The options issued were not issued under the Company&#8217;s stock option plans. The fair value of the warrants of $407,700
was recorded as additional paid-in-capital and expensed to extinguishment loss on debt settlement. The fair value of the options of $79,200
was recorded as additional paid-in capital with a corresponding charge to legal expense. The fair value of the warrants and options was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $3.63, expected dividend yield of 0%, expected volatility of 122.7%, risk-free interest rate of 0.71% and expected
life based on contractual life of three years.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 22, 2021, we completed
a private placement (the &#8220;Secured Note Financing&#8221;). In connection therewith, we issued an aggregate of $1,600,000 of 15%
senior secured notes (the &#8220;Senior Secured Notes&#8221;) and warrants to purchase an aggregate of 559,431 shares of common stock
at an exercise price of $3.32 per share (the &#8220;Warrants Senior Secured Notes&#8221;). After deducting offering related expenses,
including legal fees of $15,000 and certain diligence and advisory fees of $200,000 paid to an entity owned by the spouse of an employee
of the underwriter, the net proceeds to us were approximately $1,385,000. Out of the total warrants, warrants to purchase 28,935 shares
of our common stock were issued to the same entity owned by the spouse of an employee of the underwriter that received the advisory fee.
The maturity date of the Senior Secured Notes is the earlier of (i) May 15, 2023, (ii) the closing a Qualified Subsequent Equity Financing
and (iii) the closing of a Change of Control. The Senior Secured Notes bear interest at a rate of 15% per annum of which (i) 10% accrues
from the Closing Date and is paid to holder within 10 days after the first day of each month and (ii) 5% accrues and compound annually
and payable in arrears on the Maturity Date. The Senior Secured Notes are general secured obligations as set forth in a security agreement
between us and the noteholders. The Warrants are exercisable for a period of 10-years from the date of issuance and may be exercised
via cashless exercise/net exercise provisions contained in the Warrants.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December
31, 2021, we received gross proceeds of $2,929,000 from the issuance of unsecured convertible notes, of which $44,000 was received from
existing members/shareholders. Additionally, a member/shareholder converted a promissory note to a convertible note identical in terms
discussed below.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 1, 2022, we issued
warrants to IPO underwriters to purchase 148,005 shares of Common Stock at an exercise price of $9.10 per share. The warrants are exercisable
180 days after grant (September 27, 2022) and expire five years from date of grant (March 31, 2027). The fair value of the warrants was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest rate of 2.55% and expected
life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in capital and a
reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero impact to additional
paid-in capital.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, holders of 73,000
warrants we previously issued on November 9, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;) with an exercise price of $2.90 exercised their warrants on a cashless basis,
which resulted in the issuance of an additional 31,102 shares of Common Stock. During the same period, holders of 15,000 warrants previously
issued by the Company on November 22, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities
Act with an exercise price of $3.32 exercised their warrants by paying the exercise price, which resulted in the issuance of an additional
15,000 shares of common stock and the receipt by the Company of $49,800.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2023, at the closing
price of $4.84 per share, the Company issued 52,000 shares of Common Stock in reliance on the exemption from registration pursuant to
Section 4(a)(2) of the Securities Act as part of the settlement agreement with Ravi Sinha dated March 21, 2023.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2023, holders of 22,606
warrants previously issued by the Company on November 22, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2)
of the Securities Act with an exercise price of $3.32 exercised their warrants on a cashless basis, which resulted in the issuance of
an additional 10,151 shares of Common Stock.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 10, 2023, we issued
25,000 warrants to our investor relations firm in accordance with a letter of engagement signed July 22, 2022, as partial compensation
for services provided by the investor relations firm. The warrants were issued in reliance on the exemption from registration pursuant
to Section 4(a)(2) of the Securities Act. The warrants are fully vested and exercisable with an expiration date two years from date of
issue (August 9, 2025) and are exercisable at a price of $5.00 per share.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 16. EXHIBIT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">See the Exhibit Index immediately
preceding the signature page hereto for a list of exhibits filed as part of this Registration Statement on Form&#160;S-1,&#160;which Exhibit
Index is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
Statement Schedules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">All other schedules have
been omitted because the information required to be set forth therein is not applicable or is shown in the consolidated financial statements
or related notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ITEM 17. UNDERTAKINGS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The undersigned registrant
hereby undertakes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
include any prospectus required by Section&#160;10(a)(3)&#160;of the Securities Act;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration
Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b)&#160;if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Filing Fee&#8221;
table in the effective Registration Statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any
material change to such information in the Registration Statement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>provided, however, </i>that paragraphs (a)(1)(i),
(a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act
that are incorporated by reference in the Registration Statement, or is contained in a form of prospectus filed pursuant to Rule 424(b)
that is part of the Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining any liability under the Securities Act, each such post- effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of this Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining liability under the Securities Act to any purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus filed pursuant to Rule&#160;424(b)(3)&#160;shall be deemed to be part of the Registration Statement as of the date the filed
prospectus was deemed part of and included in the Registration Statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5)&#160;or (b)(7)&#160;as part of a registration statement in reliance
on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing
the information required by Section&#160;10(a)&#160;of the Securities Act shall be deemed to be part of and included in the registration
statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of
sale of securities in this Offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and
any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the Registration Statement relating
to the securities in the Registration Statement to which that prospectus relates, and this Offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof. <i>Provided, however</i>, that no statement made in a registration statement or
prospectus that is part of the Registration Statement or made in a document incorporated or deemed incorporated by reference into the
Registration Statement or prospectus that is part of the Registration Statement will, as to a purchaser with a time of contract of sale
prior to such effective date, supersede or modify any statement that was made in the Registration Statement or prospectus that was part
of the Registration Statement or made in any such document immediately prior to such effective date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the
securities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The undersigned registrant undertakes that in a primary
offering of securities of the undersigned registrant pursuant to this Registration Statement, regardless of the underwriting method used
to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications,
the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the
undersigned registrant;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant&#8217;s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated by reference in
the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim
for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white"><b>	EXHIBIT INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-top: 2pt"><b>Exhibit<br/>
Number</b></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-top: 2pt"><b>Description</b></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"><b>Form</b></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"><b>Exhibit</b></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="border-top: Black 1pt none; border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"><b>Filing Date</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">3.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex3_1.htm">Articles of Incorporation of the Company, effective as of November 4, 2021</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">3.2</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex3_2.htm">Bylaws of the Company currently in effect</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3.2</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_1.htm">Form of the Company&#8217;s common stock certificate</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.2</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_4.htm">Form of Representative&#8217;s Warrant</a> <span style="color: blue"><span style="text-decoration: underline">Agreement</span></span></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4.4</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.3</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_5.htm">Form of Senior Secured Promissory Note issued to bridge loan investors</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4.5</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.4</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/ex10_15.htm">Form of Warrant with an Exercise Price of $2.90</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.12</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/30/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">4.5</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/ex10_16.htm">Form of Warrant with an Exercise Price of $3.32&#160;</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.13</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/30/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">5.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_5-1.htm"><span style="background-color: white">Opinion of Stradling Yocca Carlson &amp; Rauth LLP</span>&#160;</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_1.htm">Form of common stock warrant issued to Selling Stockholders</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.2&#8224; </td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_2.htm">Expion360 Inc. 2021 Incentive Award Plan</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.2</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.3&#8224; </td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_3.htm">Expion360 Inc. 2021 Employee Stock Purchase Plan</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.3</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.4</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_7.htm">Form of Security Agreement issued to bridge loan investors</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.7</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.5</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_8.htm">Commercial Lease of premises at 2045 SW Deerhound Avenue Redmond, OR</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.8</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.6</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_11.htm">Commercial Lease of premises at 1266 SW Lake Blvd., Redmond, OR</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.11</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.7</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000149/sfsxpon8k040522ex1_1.htm">Underwriting Agreement dated March 31, 2022, between the Company and Alexander Capital, LP as Representative of the Underwriters</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">1.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">4/05/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.8&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_1.htm">Amended and Restated Employment Agreement, between John Yozamp and Expion360 Inc., dated January 26, 2023</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.9&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_2.htm"><span style="color: #0000EE">Amended and Restated Employment Agreement, between Brian Schaffner and Expion360 Inc., dated January 26, 2023</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.10&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_3.htm"><span style="color: #0000EE">Amended and Restated Employment Agreement, between Paul Shoun and Expion360 Inc., dated January 26, 2023</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.11&#8224;</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_4.htm"><span style="color: #0000EE">Amended and Restated Employment Agreement, between Greg Aydelott and Expion360 Inc., dated January 26, 2023</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">2/01/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.14*</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000983/ex10_2.htm"><span style="background-color: white">Common Stock Purchase Agreement, dated December 27, 2023, between Expion360 Inc. and Tumim Stone Capital, LLC</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.2</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">12/29/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">10.15*</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000983/ex10_3.htm">Registration Rights Agreement, dated December 27, 2023, between Expion360 Inc. and Tumim Stone Capital, LLC</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">8-K</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">10.3</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">12/29/2023</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">21.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex21_1.htm"><span style="color: #0000EE">Subsidiaries of the Company</span></a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">S-1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">21.1</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">3/31/2022</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">23.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_23-1.htm">Consent of M&amp;K CPAS PLLC&#160;</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">23.2</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_5-1.htm">Consent of Stradling Yocca Carlson &amp; Rauth LLP (included in Exhibit 5.1)</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">24.1</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="#p_001">Power of Attorney (reference is made to the signature page hereto)</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.INS</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Instance Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.SCH</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Schema Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.CAL</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.DEF</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Definition Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.LAB</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Label Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">101.PRE</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">104</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt">Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101)</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">-</td></tr>
  <tr>
    <td style="vertical-align: top; padding-top: 2pt">107</td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt"><a href="ex_107.htm">Filing Fee Table</a></td>
    <td style="vertical-align: top; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; text-align: center">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
<td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates a management
contract or compensatory plan or arrangement.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
<td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
schedules and exhibits to this agreement have been omitted pursuant to Item&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">601(a)(5)<span style="background-color: white">&#160;of&#160;</span>Regulation
S-K<span style="background-color: white">. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.<b>&#160;</b></span></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Act
of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the Redmond, Oregon, on this 31st day of January, 2024.</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 48%">&#160;</td>
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPION360 INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: /s/ Brian Schaffner</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Act
of 1933, this Amendment No. 1 to Registration Statement on Form&#160;S-1 has been signed by the following persons in the
capacities and on the dates indicated.</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 55%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brian Schaffner</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Schaffner</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Principal Executive Officer</i>)</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Greg Aydelott</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg Aydelott</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal Financial and Accounting Officer)</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George Lefevre</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven M. Shum</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Shoun</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    *</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 31, 2024</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tien Q. Nguyen</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;*By: /s/ Brian Schaffner, attorney-in-fact</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">II-11</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



<span></span>
</td>
<td class="text"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zx1L9HYbKae6" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&#160;&#160;&#160;
<span id="xdx_82C_ze2sfdm73dri">Subsequent Events</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date to which events occurring after December 31, 2022, the date of the most recent Balance Sheets, have been evaluated for possible
adjustment to the financial statements or disclosures is March 27, 2023, which is the date the financial statements were issued.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2023, the Company filed an 8-K related to a published press release announcing a new product, the AURA POWERCAP&#8482;.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 20, 2023 the company paid off a note payable in the amount of $89,360.11 which included principal, interest and fees.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2023, the Company made certain leadership changes. On January 30, 2023, the Company filed an 8-K related to a press release
announcing these changes. On February 1, 2023, the Company filed an 8-K with the details of the leadership changes.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the Company had 88,000 warrants exercised of which 73,000 were cashless resulting in 31,102 additional shares of common stock
issued. The remaining 15,000 exercised shares were exercised for a total of $49,975 which included $175.00 in fees.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2023, the Company entered into a settlement agreement with Ravi Sinha related to a complaint filed against the Company by Mr.
Sinha in Oregon state court and the matter has been resolved.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296582416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Promissory Notes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DisclosureStockholderPromissoryNotesAbstract', window );"><strong>Stockholder Promissory Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ShareholderPromissoryNotesTextBlock', window );">Stockholder Promissory Notes</a></td>
<td class="text"><p id="xdx_806_ecustom--ShareholderPromissoryNotesTextBlock_zbWD2LTaljQj" style="margin: 2pt 0 0; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<span id="xdx_824_zXHvZpM5ggfj">Stockholder Promissory Notes</span>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of both September 30, 2023 and December 31, 2022, the Company had an outstanding principal balance of $825,000 due to stockholders under
unsecured Promissory Notes Agreements (&#8220;Notes&#8221;). The Notes require monthly interest-only payments at 10% per annum. The Notes
mature at various dates from January 2024 to December 2024 as follows: January 2024 - $125,000; August 2024 - $500,000 (this note would
have matured at August 2023, but in June 2023, an agreement was signed extending the maturity date to August 2024); and December 2024
- $200,000.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
paid to the stockholders under the Notes totaled $20,627 and $20,627 during the three months ended September 30, 2023 and September 30,
2022, respectively. Interest paid to the stockholders under the Notes totaled $61,881 and $61,881 during the nine months ended September
30, 2023 and September 30, 2022, respectively. There was no accrued interest as of September 30, 2023 or December 31, 2022 related to
these Notes.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80B_ecustom--ShareholderPromissoryNotesTextBlock_ztoxFcwbLfac" style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&#160;&#160;&#160;&#160;&#160;<span id="xdx_822_zcs50HozZky2">Shareholder
Promissory Notes</span>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, the Company had an outstanding principal balance of $825,000 due to shareholders under unsecured
Promissory Notes Agreements (&#8220;Notes&#8221;). The Notes require monthly interest-only payments at 10% per annum. The Notes mature
at various dates from August 2023 to December 2024 as follows: August 2023 - $500,000; January 2024 - $125,000; and December 2024 - $200,000.</span></p>




<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2021, the Company modified another shareholder Note in the amount of $250,000 to be a convertible note for the same amount. The
shareholder also invested additional proceeds of $24,000 for a total convertible note of $274,000. The convertible note included detachable
warrants to purchase 548,000 shares of the Company&#8217;s common stock. The convertible note bore interest at a rate of 10% per annum,
had an initial maturity of two years from date of issue, and was convertible at $0.50 per share. The modification resulted in a new effective
annual interest rate of 9.15%. There was no accounting impact to the financial statements related to these modifications. On October
29, 2021, concurrent with the anticipated conversion from an LLC to a C corporation, the convertible note and warrants were modified
under a Convertible Debenture Exercise and Waiver and Release Agreement and the shareholder agreed to convert the note and accrued interest
into 236,498 shares of common stock resulting in a conversion price of $1.21 per share (see Note 9 &#8211;Convertible Notes).</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
paid to the shareholders under the Notes totaled $<span id="xdx_90F_eus-gaap--OtherMinorityInterests_iI_c20221231_zA0Z3p50Hrk1" title="Interest paid to the shareholders">82,508</span> and $<span id="xdx_907_eus-gaap--OtherMinorityInterests_iI_c20211231_z0QupwYfidia">92,007</span> during the years ended December 31, 2022 and 2021, respectively.
There was no accrued interest as of December 31, 2022 or 2021 related to these Notes.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DisclosureStockholderPromissoryNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DisclosureStockholderPromissoryNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ShareholderPromissoryNotesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ShareholderPromissoryNotesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962288882928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgJ63UfhQ0tb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zznQ4gIlN0Nb">Basis of Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
results for the three- and nine-month periods ended September 30, 2023 and 2022 are not necessarily indicative of the results that may
be expected for the year ending December 31, 2023. The unaudited interim financial statements should be read in conjunction with our
Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 30, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, all references to shares and stockholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zosCWUTDZP34" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zcKmcVMiCX0f">Basis
of Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying audited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, all references to shares and shareholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification of Prior Year Presentation</a></td>
<td class="text"><p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziT5dCht3uFk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zOHKhw3PteE6">Reclassification
of Prior Year Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziidprNltiq8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zSrNnjseglo9">Reclassification
of Prior Year Presentation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_LiquidityAndCapitalResourcesPolicyTextBlock', window );">Going Concern, Liquidity and Capital Resources</a></td>
<td class="text"><p id="xdx_847_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zpNgy4pYKooc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;<span id="xdx_863_z8gMJVTa1XI3">Going Concern,
Liquidity and Capital Resources</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">As presented in the
accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations. These factors
raise substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the date that
the financial statements for the three and nine month periods ended September 30, 2023 are issued. However, management is working
to address its cash flow challenges, including raising additional capital, managing inventory levels, identifying alternative supply
chain resources, and managing operational expenses.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Historically, the
Company&#8217;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#8217;s sales for the three months ended September 30, 2023 increased 36.7% and sales for the nine months ended
September 30, 2023 decreased 10.8% compared to the same periods in 2022. For the nine months ended September 30, 2023, we received
net proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930_zTQpfpO0wX0e" title="Net proceeds from Warrants">49,777</span> from warrant exercises. On April 1, 2022, the Company completed an initial public offering and listing
of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of costs, totaled $14,772,487, of which approximately
$2,464,000 was used to pay down principal and accrued interest on high interest-bearing debt. The remaining proceeds have thus
far and will continue to be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines&#160;to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in
China. In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S.
and an assembly facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management
has secured a secondary source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption
issues with China arise. Management believes that these factors will contribute to achieving operating efficiency and profitability.
However, there can be no assurance that the Company will be successful in achieving its objectives, including achieving operating
efficiency and profitability.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#8217;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zAezeEXDtu25" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z4jgPTONCSic"><span id="xdx_860_z6aTGYt6Y5M5">Going
Concern, Liquidity and Capital Resources</span></span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.</span></p>






<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
presented in the accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations.
These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the
date that the financial statements for the year ended December 31, 2022 are issued. However, management is working to address its cash
flow challenges, including raising additional capital, alternative supply chain resources, and in-house assembly lines.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the Company&#8217;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#8217;s sales for 2022 increased 59% over sales for 2021, as product demand continued to rise. On April 1, 2022, the
Company completed an initial public offering and listing of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of
costs, totaled $<span id="xdx_903_ecustom--ProccedsFromIpoNetsCost_c20220101__20221231_z7Q2DZxWDT4c" title="Procceds from IPO nets cost">14,772,487</span>, of which approximately $2,464,000 was used to pay down principal and accrued interest on high interest-bearing
debt. The remaining proceeds will be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in China.
In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S. and an assembly
facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management has secured a secondary
source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption issues with China arise.
Management believes that these factors will contribute to achieving operating efficiency and profitability. However, there can be no
assurance that the Company will be successful in achieving its objectives, including achieving operating efficiency and profitability.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#8217;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_840_eus-gaap--UseOfEstimates_zANTPXXkTLag" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z1k09Z9f0CFj">Use of Estimates</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#8217;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#8217;s accounting estimates require the exercise of judgment.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--UseOfEstimates_z0ocRgWNWQZf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z3EVxd0y6wca">Use
of Estimates</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#8217;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#8217;s accounting estimates require the exercise of judgment.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zM1t2IcH1W45" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zHFji1q7K1Hc">Cash and Cash
Equivalents</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Cash accounts are secured by the Federal Deposit Insurance Corporation
(&#8220;FDIC&#8221;) up to $250,000 per institution. At times, balances may exceed federally insured limits. Investment accounts are
placed in funds consisting of US Treasury-related ultra-short paper. The Company has not experienced any losses in such accounts and
management believes that the Company is not exposed to any significant credit risk with respect to its cash and cash equivalents. As
of September 30, 2023, cash balances exceeded FDIC limits by $<span id="xdx_900_eus-gaap--FDICIndemnificationAssetPeriodIncreaseDecrease_c20230101__20230930_zDrWcHx38j4c" title="FDIC Limits">547,054</span> and investment accounts totaling $<span id="xdx_902_ecustom--TreasuryRelatedPaper_c20230101__20230930_zdNTbYrQulzj" title="Treasury related paper">2,100,847</span> are invested in US
Treasury-related ultra-short paper.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt">&#160;</p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbaeIGyik0Mb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zNC12ITNVsB">Cash
and Cash Equivalents</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Accounts are secured by the Federal Deposit Insurance Corporation
(&#8220;FDIC&#8221;) up to $250,000 per institution. At times, balances may exceed federally insured limits. The Company has not experienced
any losses in such accounts and management believes that the Company is not exposed to any significant credit risk with respect to its
cash and cash equivalents. As of December 31, 2022, cash balances exceeded FDIC limits by $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zcGyEsa7W9l2" title="Cash balances exceeded FDIC">222,162</span>.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-indent: 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had two accounts totaling $<span id="xdx_900_eus-gaap--DepositContractsAssets_iI_c20221231_zr5rvg17WSx8" title="Deposit">11,204</span> with SVB. As of March 13, 2023 all funds were transferred to another
banking institution and no exposure currently exists.</span></p>






<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zg3CV4xsKrFl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zQx8Pw8Ksx8a">Accounts Receivable</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any
interest. The Company performs ongoing credit evaluations of its customers and generally requires no collateral. An allowance for
uncollectible accounts is recorded to reduce accounts receivable to the estimated amount that will be collected. The allowance
is based upon management&#8217;s review of the accounts receivable aging and specific identification of potentially uncollectible
balances. Recoveries of accounts previously written off and adjustments to the allowance for uncollectible accounts are recorded
as adjustments to bad debt expense. For the three months ended September 30, 2023 and 2022, the Company wrote off $<span id="xdx_902_ecustom--AdjustmentsToBadDebtExpense_c20230701__20230930_zhMWY4H08Hn1" title="Adjustments to bad debt expense">388</span> and $<span id="xdx_901_ecustom--AdjustmentsToBadDebtExpense_c20220701__20220930_zDdBmfX45atg" title="Adjustments to BadDebt Expense">0</span>,
respectively. For the nine months ended September 30, 2023 and 2022, the Company recovered a net of ($<span id="xdx_907_ecustom--AdjustmentsToBadDebtExpense_c20230101__20230930_zPJnfsusliMk" title="Adjustments to BadDebt Expense">412</span>) and wrote off $<span id="xdx_90E_ecustom--AdjustmentsToBadDebtExpense_c20220101__20220930_zBP1XuFjh8ql" title="Adjustments to BadDebt Expense">19,604</span>,
respectively. There was no allowance for doubtful accounts as of September 30, 2023 or December 31, 2022, as management believed
all outstanding amounts to be fully collectible.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--ReceivablesPolicyTextBlock_zccEBi4gxRMb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zOIVAMD7VBVi">Accounts
Receivable</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any interest. The Company performs
ongoing credit evaluations of its customers and generally requires no collateral. An allowance for uncollectible accounts is recorded
to reduce accounts receivable to the estimated amount that will be collected. The allowance is based upon management&#8217;s review of
the accounts receivable aging and specific identification of potentially uncollectible balances. Recoveries of accounts previously written
off and adjustments to the allowance for uncollectible accounts are recorded as adjustments to bad debt expense. The allowance for doubtful
accounts totaled $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20221231_znRkir5rWLte" title="Allowance for doubtful accounts">18,804</span> as of December 31, 2022. There was no allowance for doubtful accounts as of December 31, 2021, as management
believed all outstanding amounts to be fully collectible.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_CustomerDepositsPolicyTextBlock', window );">Customer Deposits</a></td>
<td class="text"><p id="xdx_841_ecustom--CustomerDepositsPolicyTextBlock_zNL2oEnKFQp7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z7xVitSlvKK5">Customer Deposits</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2023 and December 31, 2022, the Company had customer deposits totaling $<span id="xdx_90F_eus-gaap--CustomerDepositsCurrent_iI_c20230930_zcJaJUhl5srd" title="Customer deposits">46,248</span> and $<span id="xdx_900_eus-gaap--CustomerDepositsCurrent_iI_c20221231_zXlNpb7xgH27">58</span>, respectively.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_ecustom--CustomerDepositsPolicyTextBlock_zyS8bauBrXf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zEW3Jl2pLZOk">Customer
Deposits</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and December 31, 2021, the Company had customer deposits totaling $<span id="xdx_907_eus-gaap--CustomerDepositsCurrent_iI_c20221231_z8KvAEyLc4Wi" title="customer deposits">58</span> and $<span id="xdx_902_eus-gaap--CustomerDepositsCurrent_iI_c20211231_zu7rv75fbhI1">436,648</span>, respectively.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_z1GJZfvW8of1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zkDwjVdRHtk2">Inventory</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and
accessories, resale items, components, and related landing costs. As of September 30, 2023 and December 31, 2022, the Company had
inventory that consisted of finished assemblies&#160;totaling $<span id="xdx_904_eus-gaap--InventoryFinishedGoods_iI_c20230930_zVVqLoTHmu1" title="Finished Inventory">3,306,972</span> and $<span id="xdx_90E_eus-gaap--InventoryFinishedGoods_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zd3owKutQuS6">3,243,485</span>, respectively, and raw materials (inventory
components, parts, and packaging) totaling $<span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20230930_zo57vJqNtxf4" title="Raw materials">851,511</span> and $<span id="xdx_906_eus-gaap--InventoryRawMaterials_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zbJsGW95Todg">1,286,651</span>, respectively. The valuation of inventory includes fixed production
overhead costs based on normal capacity of the assembly warehouse. &#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of September 30, 2023 or December 31, 2022. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $<span id="xdx_90F_eus-gaap--Supplies_iI_c20230930_zwDUndQS8Tof" title="Inventory purchases from foreign suppliers">102,646</span> and $<span id="xdx_905_eus-gaap--Supplies_iI_c20221231_zFz97mIRGusc">141,611</span> at September 30, 2023 and December 31,
2022, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--InventoryPolicyTextBlock_zf1aQfkRjwJc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zdHpw0ZUqF8d">Inventory</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and accessories, resale items,
components, and related landing costs. As of December 31, 2022 and December 31, 2021, the Company had inventory that consisted of finished
assemblies totaling $<span id="xdx_90F_eus-gaap--InventoryFinishedGoods_iBI_c20221231_z7JFutRuUqjk" title="Inventory, Finished Goods">2,722,765</span> and $<span id="xdx_90B_eus-gaap--InventoryFinishedGoods_iBI_c20211231_zzMpfUhaDOr">985,537</span>, respectively, and raw materials (inventory components, parts, and packaging) totaling $<span id="xdx_90A_eus-gaap--InventoryRawMaterials_iI_c20221231_zDQEPRX2l6Ac" title="Raw materials">1,807,371</span>
and $<span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20211231_z8ivsKbdTiph">1,066,343</span>, respectively. The valuation of inventory includes fixed production overhead costs based on normal capacity of the assembly
warehouse. &#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of December 31, 2022 or December 31, 2021. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $<span id="xdx_90C_eus-gaap--OtherInventoryNetOfReserves_iI_c20221231_zmmUIXDfpCmi" title=" inventory">141,611</span> and $<span id="xdx_906_eus-gaap--OtherInventoryNetOfReserves_iI_c20211231_zfgxFRsSTnof">1,081,225</span> at December 31, 2022 and December 31,
2021, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock', window );">Vendor and Foreign Concentrations of Inventory Suppliers</a></td>
<td class="text"><p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zSVrJSTrujuf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zuyyMUkC9sUk">Vendor and Foreign
Concentrations of Inventory Suppliers</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">During the three
months ended September 30, 2023 and 2022, respectively, approximately 61% and 91%, respectively, of inventory purchases were made
from foreign suppliers in China and Hong Kong. During the nine months ended September 30, 2023 and 2022, respectively, approximately
71% and 92%, respectively, of inventory purchases were made from foreign suppliers in China and Hong Kong. Any adverse change in
either the economic or political conditions abroad could negatively impact the Company&#8217;s supply chain. The inability to obtain
product to meet sales demand could adversely affect results of operations. However, the Company has secured a secondary source
for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company to source materials outside
of China in the event it becomes necessary to do so.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zBxViAQdVsP8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ztqVhnYxB5Je">Vendor
and Foreign Concentrations of Inventory Suppliers</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2022 and 2021, approximately 85% and 90%, respectively, of inventory purchases were made from foreign suppliers
in China and Hong Kong. Any adverse change in either the economic or political conditions abroad could negatively impact the Company&#8217;s
supply chain. The inability to obtain product to meet sales demand could adversely affect results of operations. However, the Company
has secured a secondary source for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company
to source materials outside of China in the event it becomes necessary to do so.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zl6mWGf2skuf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zvBO0PDWsi3f">Property and Equipment</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:</span></p>

<p id="xdx_897_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zuXw7FtPdsIg" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zV5v1ps7r6D2" style="display: none">Schedule of estimated useful lives</span></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-top: black 1pt solid; padding: 0 0 0 10pt; width: 73%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZV5XzKnP4tg">5</span>
    - <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zpOXQnsnhsSd">7</span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zuIIeEWpXLRd">3</span> - <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember_zp71G5Uph898">7</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zVhJtgsDPtx3">3</span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_z2aU44dnTkoh">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember__srt--RangeAxis__srt--MinimumMember_z7IJ1jOnBH4i">3</span> - <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember_zGVSRvGMW8yb">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zcl7qmHKALgc">3</span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zHwntN1vxfZ">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4KW4plU2Hag">3</span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_ztN4onwQ4D17">10</span> years&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8AD_z62Oyv4K3jEj" style="margin: 0; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements
are amortized over the shorter of the lease term or their estimated useful lives.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable to assets retired are removed from the accounts,
and the gain or loss on disposition is recognized in the Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zaxsA97CojTi" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zV00YnVTG9lb">Property
and Equipment</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:</span></p>

<p id="xdx_89D_ecustom--ScheduleOfEstimatedUsfulLivesTableTextBlock_zgjoYcW0kHt8" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zWohKwqbpHad" style="display: none">Schedule
of estimated useful lives&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zeyesCta2Ejd" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; width: 73%; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z8JL4yFreas7">5</span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zEDbhRClpoEb" title="Property, Plant and Equipment, Useful Life">7</span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zxdcGLihMHHg">3</span> - <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zHpM0h6TVSE6" title="Property, Plant and Equipment, Useful Life">7</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4gROOUSc534">3</span> - <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zhWz2PaOHzpg" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zAiAlB8I49Hg">3</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTHLP9GmS5gf" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHNVfYLdWUv9">3</span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_znEhEelnV84k" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zf1pseSy9Frd">5</span>
    - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zidybgPumZf5">10</span> years</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A6_zcUsV5UGCyba" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable
to assets retired are removed from the accounts, and the gain or loss on disposition is recognized in the Statements of Operations.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zmsaz761uy13" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z2uhXnc33Ek8">Leases</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s
right to use an underlying asset during the lease term, and operating lease liabilities represent</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company&#8217;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease liabilities,
and long-term operating lease liabilities on the Company&#8217;s Balance Sheets. The Company does not have any finance leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments
over the lease term at commencement date calculated using the Company&#8217;s incremental borrowing rate applicable to the
lease asset, unless the implicit rate is readily determinable. ROU assets also include any lease payments made at or before
lease commencement and exclude any lease incentives received. The Company&#8217;s lease terms may include options to extend
or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12
months or less are not recognized on the Company&#8217;s Balance Sheet. The Company&#8217;s leases do not contain any
residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease
term.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for lease and non-lease components as a single lease component for all its leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_zpvUbeR694Od" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zk0QKaOFMT74">Leases</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#8220;ROU&#8221;) assets represent the
Company&#8217;s right to use an underlying asset during the lease term, and operating lease liabilities representthe Company&#8217;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease
liabilities, and long-term operating lease liabilities on the Company&#8217;s Balance Sheets. The Company does not have any finance
leases.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments over the lease
term at commencement date calculated using the Company&#8217;s incremental borrowing rate applicable to the lease asset, unless the implicit
rate is readily determinable. ROU assets also include any lease payments made at or before lease commencement and exclude any lease incentives
received. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the
Company will exercise that option. Leases with a term of 12 months or less are not recognized on the Company&#8217;s Balance Sheet. The
Company&#8217;s leases do not contain any residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line
basis over the lease term.&#160;</span></p>

<p style="margin: 0; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for lease and non-lease components as a single lease component for all its leases.</span></p>

<p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHZVlaRWukAi" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z3GfuMPhmwmd">Impairment of
Long-Lived Assets</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">Long-lived assets
consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the
asset to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted
cash flows, the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value.
Fair value is determined primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No
long-lived asset impairment was recognized during the three or nine months ended September 30, 2023 or 2022.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zQLhdMjGG0e2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zfIapyfWjTE2">Impairment
of Long-Lived Assets</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the asset
to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted cash flows,
the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value. Fair value is determined
primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No long-lived asset impairment was
recognized during the years ended December 31, 2022 and 2021.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyPolicy', window );">Product Warranties</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ExtendedProductWarrantyPolicy_zyXGEm02mcJ7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_z8MAFVzfacCg">Product Warranties</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">The Company sells
the majority of its products to customers along with conditional repair or replacement warranties. The Company&#8217;s branded
DC mobile chargers are warrantied for two years from the date of sale and its branded VPR 4EVER Classic and Platinum batteries
are warrantied at gradually lesser levels over a twelve-year period from date of sale. The Company determines its estimated liability
for warranty claims based on the Company&#8217;s experience of the amount of claims actually made. Management estimates no liability
as of September 30, 2023 and December 31, 2022 because, historically, there have been very few claims and costs for repairs&#160;or
replacement parts have been nominal. It is possible that the Company&#8217;s estimate of liability for product liability claims
will change in the near term.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--ExtendedProductWarrantyPolicy_zduEi09mXQ5c" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zWZXkTaEJTF9">Product
Warranties</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sells the majority of its products to customers along with conditional repair or replacement warranties. The Company&#8217;s
branded DC mobile chargers are warrantied for two years from the date of sale. The company&#8217;s branded VPR 4EVER Classic and Platinum
batteries and re-branded e360 and e360 Extreme Density batteries are warrantied at gradually lesser levels over a twelve-year period
from date of sale. The Company determines its estimated liability for warranty claims based on the Company&#8217;s experience of the
amount of claims actually made. Management estimates no liability as of December 31, 2022 and December 31, 2021 because, historically,
there have been very few claims and costs for repairs or replacement parts have been nominal. It is possible that the Company&#8217;s
estimate of a liability for product liability claims will change in the near term.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_LiabilityForRefundsPolicyTextBlock', window );">Liability for Refunds</a></td>
<td class="text"><p id="xdx_846_ecustom--LiabilityForRefundsPolicyTextBlock_zmaN7OQCgBK3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zJX7B0uqI7R9">Liability for
Refunds</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The Company does
not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.</p>



<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_ecustom--LiabilityForRefundsPolicyTextBlock_zrQ1zFEu2z69" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zwiLOZBMPZV8">Liability
for Refunds</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.
However, during 2020 the Company sold discontinued products and recorded a liability for refunds. As of December 31, 2020, the liability
totaled $58,000. During the year ended December 31, 2021, the Company issued credits totaling $58,000, respectively. As of December 31,
2021, all allowable discontinued products had been returned and the Company had no further refund liability. No refund liability was
recognized in the year ended December 31, 2022. Revenue is recorded net of this amount. Any returns of discontinued product are not added
back to inventory and therefore related costs are nominal and not recorded as an asset.</span></p>






<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zaieuIHfl2p" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zRUXrxLYomUc">Revenue Recognition</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#8217;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#8217;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zW7E6Z2Oepa6" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zMrPJgFfm5Xc">Revenue
Recognition</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#8217;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#8217;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Major Customers</a></td>
<td class="text"><p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zic28ONNMc66" style="margin: 0; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zVF3VNW0l4w1">Concentration of Major Customers</span></i></span></p>

<p style="margin: 0; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2023, sales to three customers totaled $700,071, comprising approximately 38% of total sales. These
customers represented 31% of total accounts receivable as of September 30, 2023. During the nine months ended September 30, 2023, sales
to two customers totaled $1,178,142, comprising approximately 23% of total sales. These customers represented 23% of total accounts receivable
as of September 30, 2023. Accounts receivable from three additional customers totaled $190,495, representing approximately 40% of accounts
receivable as of September 30, 2023.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During the
three months ended September 30, 2022, sales to two customers totaled $394,936, comprising approximately 28% of total sales. There
were no accounts receivable for these customers as of September 30, 2022. During the nine months ended September 30, 2022, sales
to two customers totaled $1,816,821, comprising approximately 32% of total sales. Accounts receivables for these customers totaled
$7,486, representing approximately 3% of total accounts receivable as of September 30, 2022. Accounts receivable from two additional
customers totaled $90,789, representing approximately 32% of total accounts receivables as of September 30, 2022.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zdcgPMDe3Chk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zbdgwFebNPs3">Concentration
of Major Customers</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, sales to three customers totaled $2.9 million, comprising approximately 41% of total sales. These customers
represented 43% of total accounts receivable as of December 31, 2022. During the year ended December 31, 2021, sales to one customer
totaled $486,000, comprising 11% of total sales. This customer did not have an accounts receivable balance as of December 31, 2021, but
three other customers had accounts receivable balances totaling $658,000 and representing a total of 85% of total accounts receivable
as of December 31, 2021.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zTFf5ClWxhW8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zrgvvuszgBz">Shipping and Handling
Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt">Shipping and handling
fees billed to customers are classified in&#160;the Statement of Operations in &#8220;Sales, net&#8221; and totaled $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230701__20230930_zYxhpTQflxFl" title="Shipping and handling fee">27,398</span> and
$<span id="xdx_90B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220701__20220930_zCjQcgfDGpHi" title="Shipping and handling fee">6,133</span> during the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_903_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230101__20230930_z0NAnTn3OiP4" title="Shipping and handling fee">52,296</span> and $<span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220101__20220930_zae99EQTdkpj" title="Shipping and handling fee">17,514</span> during the nine months
ended September 30, 2023 and 2022, respectively. Shipping and handling costs for shipping product to customers totaled $<span id="xdx_906_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230701__20230930_zIZVrwz7Nox7" title="Shipping and handling costs for shipping product">58,141</span>
and $<span id="xdx_901_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220701__20220930_zzteob8JfWW5" title="Shipping and Handling Costs for Shipping Product">54,840</span> during the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_903_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230101__20230930_zvZPFMRMfkvg" title="Shipping and Handling Costs for Shipping Product">149,898</span> and $<span id="xdx_902_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220101__20220930_z2w0cryYMxY2" title="Shipping and Handling Costs for Shipping Product">137,497</span> during the nine
months ended September 30, 2023 and 2022, respectively, and are classified in selling, general, and administrative expense in the
accompanying Statements of Operations.</p>



<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_z1IF9QSTe9Ja" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zgncV9FjaA1f">Shipping
and Handling Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling fees billed to customers are classified on the Statement of Operations as &#8220;Sales, net&#8221; and totaled $23,188 and
$25,688 during the years ended December 31, 2022 and 2021, respectively. Shipping and handling costs for shipping product to customers
totaled $169,335 and $102,653 during the years ended December 31, 2022 and 2021, respectively, and are classified in selling, general
and administrative expense in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising and Marketing Costs</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--AdvertisingCostsPolicyTextBlock_zOgCRPqN9Duh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_z4X1Bsn8YSB6">Advertising and
Marketing Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20230701__20230930_zzpF76DA7O77" title="Advertising and marketing expense">238,163</span> and $<span id="xdx_909_eus-gaap--MarketingAndAdvertisingExpense_c20220701__20220930_zoBYJRoRQ5Lf">215,994</span> for the
three months ended September 30, 2023 and 2022, respectively and $<span id="xdx_90D_eus-gaap--MarketingAndAdvertisingExpense_c20230101__20230930_zfKEXxxy4Nce">690,995</span> and $<span id="xdx_902_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20220930_zbmh9L1WX0X1">527,732</span> for the nine months ended September 30, 2023 and
2022, respectively, and is included in selling, general and administrative expense in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zl60rvUr3Xt7" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zwb1FyLiAXC">Advertising
and Marketing Costs</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20221231_zSuwZEm8gAgf" title="Advertising and marketing expense">239,814</span> and $<span id="xdx_90F_eus-gaap--MarketingAndAdvertisingExpense_c20210101__20211231_zmuk9fe4SgDg">67,394</span> for the
years ended December 31, 2022 and 2021, respectively, and is included in selling, general and administrative expense in the accompanying
Statements of Operations. &#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu2zb5uSlDg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zIsTtfCV2Ls7">Research and Development</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20230701__20230930_z6QXmy9izALb" title="Research and development costs">145,111</span> and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20220701__20220930_z8JZXu7QYOe9">41,355</span> for
the three months ended September 30, 2023 and 2022, respectively, and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20230930_zLLzALUAO4wj">316,369</span> and $<span id="xdx_90F_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20220930_zdrgDWnumJzi">153,730</span> for the nine months ended September 30, 2023
and 2022, respectively, and are included in selling, general and administrative expenses in the accompanying Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_z1UAWRgo5n11" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zz0IHaYK31Jj">Research
and Development</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $<span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_z1puF02fZCJb" title="Research and development costs">270,054</span> and $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_zfoG7iw5qB">58,044</span> for
the years ended December 31, 2022 and 2021, respectively, and are included in selling, general and administrative expenses in the accompanying
Statements of Operations.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z5amL6LL3PC4" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zfT5BlKB4KE4">Income Taxes</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
November 1, 2021, the Company converted from an LLC to a C corporation and, as a result, became subject to corporate federal and state
income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including
tax loss and credit carryforwards, and liabilities are measured using the enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that included the enactment date. Deferred income tax expense represents
the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation
allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not
be realized.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of September 30, 2023 and December 31, 2022, the Company has not recorded any income tax
provision/(benefit) resulting from the CARES Act, mainly due to the Company&#8217;s history of net operating losses.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2023 and beyond.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTaIjtjdXNag" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zcuS6ynhcTGh">Income
Taxes</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January 1, 2017 to October 31, 2021, the Company was not subject to federal or state income taxes since it was a limited liability company
taxed as an S corporation. The Company&#8217;s taxable income or losses were allocated to its members in accordance with their respective
ownership percentages. Therefore, no provision or liability for federal income taxes was included in the accompanying financial statements
for the relevant periods in 2021. Certain states impose minimum franchise taxes on entities taxed as an S corporation. Accordingly, the
accompanying financial statements include provisions for state franchise tax fees.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-size: 10pt">Effective November 1, 2021, the Company converted
from an LLC to a C corporation and, as a result, became subject to corporate federal and state income taxes. Deferred tax assets and
liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts
of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including tax loss and credit carryforwards, and
liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences
are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that included the enactment date. Deferred income tax expense represents the change during the period in the deferred
tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.</span></p>
<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>






<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of December 31, 2022 and 2021, the Company has not recorded any income tax provision/(benefit)
resulting from the CARES Act, mainly due to the Company&#8217;s history of net operating losses.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2022 and beyond.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zV7PliosUCK6" style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_86F_z0q4RC6OBOsi">Fair Value of Financial Instruments</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, <i>Fair Value Measurement</i>. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1: </i>Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2: </i>Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3: </i>Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, stockholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the stockholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zoC7OCnSrRU" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value of Financial Instruments</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, <i>Fair Value Measurement</i>. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
1: </i>Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
2: </i>Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0 0 0 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level
3: </i>Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, shareholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the shareholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z9J2A90KyAB1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zXdAiAjaTVfh">Segment Reporting</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--SegmentReportingPolicyPolicyTextBlock_znUfrRrVLwhl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zTgQ346zzUFi">Segment
Reporting</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</span></p>




<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zcjAReRD1ima" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z1ojxA7cbqU7">Basic and Diluted
Net Loss Per Share</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shows the amounts used in computing net loss per share:</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zePybWaSuLEg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zQX2EFnNMBN3" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zvweiPURMUYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_493_20230701__20230930_zFiW3vb3LjVh" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220701__20220930_z75Hf7GwhZ0a" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20230101__20230930_zwhv0JvhSnll" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20220930_zeHqbQ6AOtlj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended September 30,</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_40E_ecustom--NetLossOne_ziztUNeD3Qo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,814,215</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,279,304</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,270,281</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,067,193</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zwxiOedMoiLd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average common shares outstanding &#8211; basic and diluted</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,910,717</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,802,464</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,878,737</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,913,763</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--NetLossPerShareBasicAndDiluted_z1yj24NP6Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.26</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.19</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.77</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.03</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p id="xdx_8A3_zhji71lzjJIj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt">As
of September 30, 2023 and December 31, 2022, the Company has outstanding warrants, options, and restricted stock units (&#8220;RSUs&#8221;)
convertible into 1,926,610&#160;and 1,717,936 shares of common stock, respectively. The following table sets forth the number of
shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive.</p>



<p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zyoB77o7qJjh" style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zZmAWA3vVak8" style="display: none">Schedule
of anti-dilutive share</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_z0ucSeAjt4h3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Warrants</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zUlM0wcirv51" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">802,830</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zT3f4cQ55Eul" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">888,436</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8RJRSgh28M1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,075,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQoUblAc9nu1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_z6xhWsB6cwAe" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_ziAg5Zah8Nad" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1596">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930_zJ2ZxiTDCpT3" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,926,610</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zOAG9Jemb06g" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,717,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zzG6p9PN8rl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zS1YFMYdVbj9" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zB8JNZo8YXY4">Basic
and Diluted Net Loss Per Share</span></i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following shows the amounts used in computing net loss per share:</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z50CTcwuN1m1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_z44xU4SMZuO" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zrWQ6gqJKxi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20220101__20221231_z1r7BosSa6j9" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_490_20210101__20211231_zxvvFMeavWJj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_409_ecustom--NetLoss_zGDahUfcOWR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(7,536,540</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(4,720,858</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zzxXXZJfHJ82" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Weighted average common shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,135,938</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,888,695</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--NetLossPerShareBasicAndDiluted_z46cR1iXMXG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.23</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.63</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AD_z6t2bLfiorm5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the years ended December 31, 2022 and 2021, the Company has outstanding warrants and options convertible into 1,717,936 shares of
common stock, respectively. The following table sets forth the number of shares excluded from the computation of diluted loss per share,
as their inclusion would have been anti-dilutive.</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zdDUbMmPGSle" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zA4OfQuOT4Y2" style="display: none">Schedule of anti-dilutive share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_zNr6DvcK9ZY4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt">Stock options</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zToARjhdbPki" style="width: 12%; text-align: right">829,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPDZLIp16ry7" style="width: 12%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPoKd9ZSYdH6" style="border-bottom: Black 1pt solid; text-align: right">888,436</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zOZV8xjYB656" style="border-bottom: Black 1pt solid; text-align: right">710,431</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zK3yOGTFlWT4" style="border-bottom: Black 2.5pt double; text-align: right">1,717,936</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zvdzQQEGM7hh" style="border-bottom: Black 2.5pt double; text-align: right">740,431</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_z9HzVV4rdFJl" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zknouLL4YS84" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zyjXuR8kfUwb">Stock-Based Compensation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zVBPAuuC3y8j" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zo0xyQIDHiJk">Stock-Based
Compensation</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK2ONxRis2ni" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zjomQiUVvQp2">New Accounting
Pronouncements</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#8221; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#8217;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the
Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#8221; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#8220;CECL&#8221;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have <i>not</i> yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company adopted this standard effective January 1, 2023, and the adoption of
this guidance did not have an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#8221; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the Company&#8217;s
financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have
an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"></p>



<p style="margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zXhYdKndQhDc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zen3BobqEmog">New
Accounting Pronouncements</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">In May 2021, the FASB issued ASU 2021-04,
&#8220;Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation
(Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for
Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the Emerging Issues Task Force).&#8221;
ASU 2021-04 requires issuers to account for modifications or exchanges of freestanding equity-classified written call options that remain
equity classified after the modification or exchange based on the economic substance of the modification or exchange. Under the guidance,
an issuer determines the accounting for the modification or exchange based on whether the transaction was done to issue equity, to issue
or modify debt, or for other reasons. ASU 2021-04 is applied prospectively and is effective for fiscal years beginning after December
15, 2021, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of fiscal 2022, which
did not have a material impact on the Company&#8217;s financial statements or disclosures.</span></p>
<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"></p>






<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity.
Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion
features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in
substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single
liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Similarly,
equity-classified convertible preferred stock instruments will be accounted for as single units of account in equity unless the conversion
feature needs to be bifurcated under Topic 815. The new guidance also made amendments to the earnings per share guidance in Topic 260,
Earnings Per Share, for convertible instruments, the most significant impact of which is requiring the use of the if-converted method
for diluted earnings per share calculation. Further, ASU 2020-06 made revisions to Subtopic 815-40, which provides guidance on how an
entity must determine whether a contract qualifies for a scope exception from derivative accounting. ASU 2020-06 is effective for fiscal
years beginning after December 15, 2021, with early adoption permitted. Adoption of the standard requires using either a modified retrospective
or a full retrospective approach. Effective January 1, 2021, the Company early adopted ASU 2020-06 using the modified retrospective approach.
Adoption of the new standard did not have a material impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01, Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint
Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.
The new guidance clarifies the interaction of accounting for the transition into and out of the equity method and the accounting for
measuring certain purchased options and forward contracts to acquire investments. ASU 2020-01 is effective for fiscal years beginning
after December 15, 2020, including interim periods within those fiscal years. Effective January 1, 2021, the Company adopted ASU 2020-01.
The adoption of this guidance did not have an impact on the Company&#8217;s financial statements or disclosures.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock', window );">Accounting Guidance Issued but Not Yet Adopted</a></td>
<td class="text"><p id="xdx_84A_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zSnM0CB4zkV8" style="margin: 0; text-align: justify; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_860_zUd0W7Zv5zQf">Accounting Guidance Issued
but Not Yet Adopted</span></i>&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2023, the FASB issued ASU 2023-02, &#8220;Investments&#8212;Equity Method and Joint Ventures (Topic 323): Accounting for Investments
in Tax Credit Structures Using the Proportional Amortization Method.&#8221; This ASU was issued to allow reporting entities to consistently
account for equity investments made primarily for the purpose of receiving income tax credits and other income tax benefits. ASU 2023-02
is effective for the Company for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.
The Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, &#8220;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#8221; which amends the guidance in Topic 820, <i>Fair Value Measurement</i>, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zn9Wxsicv9kd" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zH4wjNyLkeD6">Accounting
Guidance Issued but Not Yet Adopted</span></i></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, the FASB issued ASU 2022-04, &#8220;Liabilities&#8212;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#8221; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#8217;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU 2022-03, &#8220;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#8221; which amends the guidance in Topic 820, <i>Fair Value Measurement</i>, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#8221; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#8220;CECL&#8221;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have <i>not</i> yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company is currently evaluating the impact of this standard on our financial
statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#8221; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company is currently evaluating the impact of this standard on our financial statements.</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company is currently evaluating the impact of adopting this guidance.</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_CustomerDepositsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_CustomerDepositsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_LiabilityForRefundsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_LiabilityForRefundsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_LiquidityAndCapitalResourcesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_LiquidityAndCapitalResourcesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShippingAndHandlingCostPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293352432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock', window );">Schedule of estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfEstimatedUsfulLivesTableTextBlock_zgjoYcW0kHt8" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zWohKwqbpHad" style="display: none">Schedule
of estimated useful lives&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zeyesCta2Ejd" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; width: 73%; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z8JL4yFreas7">5</span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zEDbhRClpoEb" title="Property, Plant and Equipment, Useful Life">7</span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zxdcGLihMHHg">3</span> - <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zHpM0h6TVSE6" title="Property, Plant and Equipment, Useful Life">7</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4gROOUSc534">3</span> - <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zhWz2PaOHzpg" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zAiAlB8I49Hg">3</span> - <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTHLP9GmS5gf" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHNVfYLdWUv9">3</span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_znEhEelnV84k" title="Property, Plant and Equipment, Useful Life">10</span> years</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zf1pseSy9Frd">5</span>
    - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zidybgPumZf5">10</span> years</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of net loss per share</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zePybWaSuLEg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zQX2EFnNMBN3" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zvweiPURMUYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_493_20230701__20230930_zFiW3vb3LjVh" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220701__20220930_z75Hf7GwhZ0a" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_492_20230101__20230930_zwhv0JvhSnll" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20220930_zeHqbQ6AOtlj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended September 30,</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_40E_ecustom--NetLossOne_ziztUNeD3Qo6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,814,215</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,279,304</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,270,281</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,067,193</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zwxiOedMoiLd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average common shares outstanding &#8211; basic and diluted</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,910,717</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,802,464</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,878,737</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,913,763</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--NetLossPerShareBasicAndDiluted_z1yj24NP6Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.26</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.19</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.77</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.03</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z50CTcwuN1m1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_z44xU4SMZuO" style="display: none">Schedule of net loss per share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zrWQ6gqJKxi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49C_20220101__20221231_z1r7BosSa6j9" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_490_20210101__20211231_zxvvFMeavWJj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_409_ecustom--NetLoss_zGDahUfcOWR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(7,536,540</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(4,720,858</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zzxXXZJfHJ82" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Weighted average common shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,135,938</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,888,695</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--NetLossPerShareBasicAndDiluted_z46cR1iXMXG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.23</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.63</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of anti-dilutive share</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zyoB77o7qJjh" style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zZmAWA3vVak8" style="display: none">Schedule
of anti-dilutive share</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_z0ucSeAjt4h3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of:</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Warrants</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zUlM0wcirv51" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">802,830</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zT3f4cQ55Eul" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">888,436</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8RJRSgh28M1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,075,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQoUblAc9nu1" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_z6xhWsB6cwAe" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_ziAg5Zah8Nad" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1596">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930_zJ2ZxiTDCpT3" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,926,610</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zOAG9Jemb06g" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,717,936</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zdDUbMmPGSle" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zA4OfQuOT4Y2" style="display: none">Schedule of anti-dilutive share</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_zNr6DvcK9ZY4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt">Stock options</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zToARjhdbPki" style="width: 12%; text-align: right">829,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPDZLIp16ry7" style="width: 12%; text-align: right">30,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPoKd9ZSYdH6" style="border-bottom: Black 1pt solid; text-align: right">888,436</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zOZV8xjYB656" style="border-bottom: Black 1pt solid; text-align: right">710,431</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zK3yOGTFlWT4" style="border-bottom: Black 2.5pt double; text-align: right">1,717,936</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zvdzQQEGM7hh" style="border-bottom: Black 2.5pt double; text-align: right">740,431</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock', window );">Schedule of estimated useful lives</a></td>
<td class="text"><p id="xdx_897_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zuXw7FtPdsIg" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zV5v1ps7r6D2" style="display: none">Schedule of estimated useful lives</span></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-top: black 1pt solid; padding: 0 0 0 10pt; width: 73%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles
    and transportation equipment</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; width: 25%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZV5XzKnP4tg">5</span>
    - <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zpOXQnsnhsSd">7</span> years</span></td>
    <td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    furniture and equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zuIIeEWpXLRd">3</span> - <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember_zp71G5Uph898">7</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zVhJtgsDPtx3">3</span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_z2aU44dnTkoh">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember__srt--RangeAxis__srt--MinimumMember_z7IJ1jOnBH4i">3</span> - <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember_zGVSRvGMW8yb">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA
    equipment</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zcl7qmHKALgc">3</span> - <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zHwntN1vxfZ">10</span> years</span></td>
    <td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding: 0 0 0 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and molds&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4KW4plU2Hag">3</span>
    - <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_ztN4onwQ4D17">10</span> years&#160;&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291995552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zdaIUz23Il85" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_z4Y1xZWpzqea" style="display: none">Schedule of property and equipment</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_134_zOfQ6BgUoqf8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, Net (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles and transportation
    equipment</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zmhsxJUgBDNb" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">551,906</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zyLFZEgqsNU9" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">593,097</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zXagIjEVvhof" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,819</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zAFW8MlYhu6g" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">314,819</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zUUYEEV7yPG" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,131</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zFnXkyfj7IGj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,131</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zdnBMdaZ2bJ" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,274</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zBxYP1sx2i43" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,274</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSUenEwxox74" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,164</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSR022k9Qzwg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,164</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QA equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zaTF3uav4Tcf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,032</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zWwlDJtq3DMd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,142</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tooling
    and Molds</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z8fU3Q1peZRk" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1621">&#8212;</span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z9cWHbJvWOFd" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,992</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930_zp1L0wYDBBcb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,348,326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zsAJvBmZMx6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,394,619</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230930_zqrB59mhZ0C" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(378,286</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSlyRdJTtSlj" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(250,861</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230930_z3Fu8HJbJTc4" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">970,040</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zfF1SGzFjrgd" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,143,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zheh2nDuemJ8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zZSk3QJapL84" style="display: none">Schedule of property and equipment</span></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consist of the following:&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_134_zyl9ODh44zjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment Net (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: justify">Vehicles and transportation equipment</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zclfbL84mvbe" style="width: 12%; text-align: right">593,097</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_pp0p0_zG3wpTA6rw54" style="width: 12%; text-align: right">298,752</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zdpddnciDVFg" style="text-align: right">314,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z65RUMXXIru8" style="text-align: right">59,316</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zjrmdOX5amL4" style="text-align: right">188,131</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_z0TZg163v1Ak" style="text-align: right">105,003</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Manufacturing equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zJ3b1EQ3sDfa" style="text-align: right">179,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_pp0p0_zZSd6s2xG7Df" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Warehouse equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zWYP5jd0nDpe" style="text-align: right">81,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_pp0p0_zLQ3c69Ut6Y8" style="text-align: right">44,356</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">QA equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zdM4YNqCyVgj" style="text-align: right">22,142</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_z8ksLfKvcLB4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt">Tooling and Molds</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zVNzT45cvEV8" style="border-bottom: Black 1pt solid; text-align: right">15,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zkNU2KiDiQEf" style="border-bottom: Black 1pt solid; text-align: right">15,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zPsiNPMhdYJg" style="text-align: right">1,394,619</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zjGZJaS13Vzg" style="text-align: right">523,419</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSjZhBR4xesb" style="border-bottom: Black 1pt solid; text-align: right">(250,861</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20211231_zJKe8IIqHOge" style="border-bottom: Black 1pt solid; text-align: right">(96,190</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zLxkDFZBppW4" style="border-bottom: Black 2.5pt double; text-align: right">1,143,758</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_z3ZdTatSVR7l" style="border-bottom: Black 2.5pt double; text-align: right">427,229</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962297489152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses and other current liabilities</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zk6LTjun6jrc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zdOXwVRN5Wrb" style="display: none">Schedule of accrued expenses and other current liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_134_zvzUAiCUBNYc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49A_20230930_zQR2rqhREBhf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of September 30, 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_493_20221231_zgsXy1V5Yusa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2022</span></td></tr>
  <tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zq0jMIv8Urz1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued salaries
    and payroll liabilities</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,411</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,337</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--RebateLiability_iI_zUizvKchRVtd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rebate liability</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,255</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,015</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_z8sMPuBMufDe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissions</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,534</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,720</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--FranchiseTax_iI_zOfKItefXA8i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Franchise tax</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,999</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DeferredIncomeAndDepositSublease_iI_ziHGz8pZebJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income and deposit
    (sublease)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,445</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,168</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_zss7oswqOJGk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zkncTLZllNej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,996</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,302</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_z972uapb0iC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    expenses and other current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,793</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">306,164</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zNqtcJxoSRDh" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zk7zzpCVD1D9" style="display: none">Schedule of accrued expenses and other current liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_134_z9hlwjoLZxjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_491_20221231_zmbIREaO27xe" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_z8ny76WBoMjj" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zhpqX93h8Hh1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Accrued salaries and payroll liabilities</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">169,337</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,449</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--RebateLiability_iI_zhjWjvLj3lhc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rebate liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,010</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredIncomeAndDepositSublease_iI_zXQGniVBXt" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred income and deposit (sublease)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,168</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,690</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_zmtbonEZ5Olj" style="vertical-align: bottom; background-color: White">
    <td>Commissions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,720</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,120</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--FranchiseTax_iI_zemYreCq8QXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Franchise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,300</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InterestPayableCurrent_iI_zJTY80T7h5y" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,301</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zu62oANbk07c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">86,302</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,748</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_zAaV9OLnW0Lb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Accrued expenses and other current liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">306,164</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">140,618</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285708624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of long term debt payment</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zKoF4A6jVerj" style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B8_zGCFf1z9NLmj" style="display: none">Schedule of long term debt payment</span>&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zy8PBx78ip2i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-Term Debt (Details)">
<tr style="vertical-align: bottom">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2023</b></span></td>
<td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2022</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0">Senior secured promissory notes &#8211; various investors.&#160;&#160;Monthly payments of interest only at
10% plus deferred interest of 5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity.
Matures the earlier of (a) May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of
control. The notes are senior to all other debt and are secured by substantially all assets of the Company. The notes included
detachable warrants to purchase 482,268 shares of common stock at an exercise price of $3.32 per share (see Note 10 &#8211; Stockholders&#8217;
Equity in Item 1 &#8211; Financial Statements of Part I &#8211; Financial Information). Debt issuance costs and discount totaling
$1,287,160 at date of issuance were being amortized and recognized as additional interest expense over the term of the notes using
the straight-line method because it was not substantially different from the effective interest rate method. We determined the
expected life of the notes to be the contractual term. Interest expense related to these notes includes amortization of debt issuance
costs and discount in the amount of $0 and $1,196,843, respectively, for the three months and nine months ended September 30, 2022,
respectively. The notes were paid in full in April 2022.</p>


</td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zu2E1BAkZbv6" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1676">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zSYhmgsZ52z5" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1677">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 56%; font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; bank. Payable in monthly installments of $332, including interest at 5.8% per annum, due August 2025, secured by equipment and personally guaranteed by a co-founder.</span></td>
<td style="width: 8%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zWzRoJiUKBif" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,213</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 8%; font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zoU4N5Nx5wwb" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,825</span></td>
<td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; credit union. Payable in monthly installments of $508, including interest at 5.45% per annum, due July 2026, secured by a vehicle and personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_z6Z8spHtDLjj" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">15,514</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zfhsTgyta9mk" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">19,364</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; SBA. Economic Injury Disaster Loan payable in monthly installments of $731, including interest at 3.75% per annum, due May 2050, and personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z3mXhXacRPZa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">147,735</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zmjRl5jKS2pa" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">150,114</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; individual. Monthly payments of interest only at 10% per annum, matured December 31, 2021 resulting in the entire principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31, 2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the note in full in April 2022.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zgZhqMNgTbPj" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1684">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zbVAN2AVINy4" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1685">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; finance company. Payable in monthly installments of $994, including interest at 8.5% per annum, due July 2026, secured by a vehicle and personally guaranteed by a stockholder.&#160;The Note was paid in full September 2022.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zCd81AxtILH8" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1686">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zMkCo5LyeyF3" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1687">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Note payable &#8211; finance company.&#160;Payable in monthly installments of $2,204, including interest at 11.21% per annum, due August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;The note was paid in full January 2023.</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zoQEMg6apxVk" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1688">&#8212;</span></span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zhaiJhr26jC" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">79,963</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Notes payable &#8211; The Company has acquired six notes payable to GM Financial for vehicles.&#160;In April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;The agreement expired in April 2023 but was renewed for a commercial line up to $350,000 and prevailing GM Financial existing term notes will remain. The new agreement expires in April 2024.&#160;One note was paid off when the corresponding vehicle was sold in May 2023, so there are five notes remaining at September 30, 2023.&#160;The notes are currently payable in aggregate monthly installments of $4,084, including interest at rates ranging from 5.89% to 7.29% per annum, mature at various dates from October 2027 to May of 2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_989_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zYWmn3bXZ9Ri" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">191,027</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zHD2sHkbLt8c" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">251,209</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930_zOorhTjIBqxh" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">361,489</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_983_eus-gaap--LongTermDebt_iI_c20221231_zrd187XCFUzi" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">510,475</span></td>
<td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less current portion</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_98B_eus-gaap--DebtCurrent_iNI_di_c20230930_z9fb3gRYLdg9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(50,058</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zeSIpKKGmET6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(71,426</span></td>
<td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Long-term debt, net of unamortized debt discount and current portion</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_980_eus-gaap--LongTermDebtNoncurrent_iI_c20230930_zPjwHvUcLtxi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">311,431</span></td>
<td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
<td id="xdx_98E_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zgdRYecSgZ67" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">439,049</span></td>
<td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>




<span></span>
</td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfDebtTableTextBlock_zWvGQ8QSbaRd" style="margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zRmASvuTs60l" style="display: none">Schedule of long-term debt</span>&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2022</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2021</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    secured promissory notes &#8211; various investors.&#160;&#160;Monthly payments of interest only at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_uPure_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zZKyK8XpZqp1">10</span>% plus deferred interest of
    5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity. Matures the earlier of (a)
    May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of control. The notes are senior
    to all other debt and are secured by substantially all assets of the Company. The notes included detachable warrants to purchase
    <span id="xdx_90C_ecustom--WarrantsToPurchase_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zfMO8hsIn3fh">482,268</span> shares of common stock at an exercise price of $3.32 per share (see Note 12 &#8211; Stockholders&#8217; Equity). Debt issuance
    costs and discount totaling $1,287,160 at date of issuance were being amortized and recognized as additional interest expense over
    the term of the notes using the straight-line method because it was not substantially different from the effective interest rate
    method. We determined the expected life of the notes to be the contractual term. Interest expense related to these notes includes
    amortization of debt issuance costs and discount in the amount of $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zIQvOmcuQFHj">1,196,843</span> and $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zcEjj6PtTOS1">117,587</span>, respectively, for the years ended December
    31, 2022 and 2021, respectively. The notes were paid in full in April 2022 </span></td>
    <td style="width: 2%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zYx3xMOCYyb6" style="width: 13%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0686">&#8212;</span></span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zGD2ZUqapJPb" style="width: 11%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,600,000&#160;</span></td>
    <td style="width: 1%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; bank. Payable in monthly installments of $332, including interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_ztDESItfaA9d">5.8</span>% per annum, due August 2025, secured by
    equipment and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zvU6a1BVSu95" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,825</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zz2Qg31uUbaa" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,135</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; credit union. Payable in monthly installments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zLhsfu3eCvTa">508</span>, including interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zTjJzB5BxKq9">5.45</span>% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_znmtb46bodLd" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,364</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zjbcIG5QZno3" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,259&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; SBA. Economic Injury Disaster Loan payable in monthly installments of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z7S9irBvtpG3">731</span>, including interest at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zNsTbK2pbb4e">3.75</span>% per annum,
    due May 2050, and personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zd8BoxCpitk2" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,114</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zj40g99Pl7C1" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153,193</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; individual. Monthly payments of interest only at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3u5SAnmxLC7">10</span>% per annum, matured December 31, 2021 resulting in the entire
    principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31,
    2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each
    month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the
    note in full in April 2022 </span></td>
    <td style="width: 2%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zGyosTYw3wae" style="width: 13%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0700">&#8212;</span></span></td>
    <td style="width: 0%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3G2orNS6tW8" style="width: 11%; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000&#160;&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; finance company. Payable in monthly installments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zPgQIe5dOFDi">994</span>, including interest at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zd3GuXrmp6zj">8.5</span>% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a shareholder.&#160;&#160;The Note was paid in full September 2022.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_z1YywxSKXYOj" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0704">&#8212;</span></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zSpnkxWf2fOk" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,832</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
    payable &#8211; finance company.&#160;&#160;Payable in monthly installments of $<span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_z59bSVoCe7Wb">2,204</span>, including interest at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zLySIJ8C9Dah">11.21</span>% per annum, due
    August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;&#160;The note was paid in full January 2023.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zbRfObC7xhgi" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79,963</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zjFe69Eaiate" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,155</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    payable &#8211; The Company has six and two notes payable to GM Financial for vehicles at September 30, 2022 and December 31, 2021.&#160;&#160;In
    April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;&#160;The agreement
    expires in April 2023 but prevailing GM Financial existing term notes will remain. The notes are payable in aggregate monthly installments
    of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zulP2wGynlJf">4,676</span>, including interest at rates ranging from 5.89% to <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zH91DES1X3Xf">7.29</span>% per annum, mature at various dates from October 2027 to May of
    2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zTgrFrT3rKEg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,209</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_z34paL0EJGEi" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,890</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20221231_zZ3tuazFx3xg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">510,475</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20211231_zF6oJOJqka66" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,127,464</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    unamortized debt issuance costs and discount</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20221231_z3dO63NDU293" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0716">&#8212;</span></span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iNI_di_c20211231_zNEffcgIez0d" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,196,843</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    current portion</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zWSemRgK6Lb5" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(71,426</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><p style="margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td id="xdx_98F_eus-gaap--DebtCurrent_iNI_di_c20211231_zuWkMCLA18o5" style="padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51,135</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    note payable in default (paid April 2022)</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_ecustom--LessNotePayableInDefaultPaid_iI_c20221231_zZTzkQCrpdYc" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0720">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_ecustom--LessNotePayableInDefaultPaid_iI_c20211231_zUSCMNE3I5j3" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 5.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    debt, net of unamortized debt discount and current portion</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_ztvWlEmU7OD7" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">439,049</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zQsCDtF94WS2" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">779,486</span></td>
    <td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-Term Debt</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zoBjrwmp3Mi4" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zmgYdrwEu1v2" style="display: none">Schedule of Maturities of Long-Term Debt</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zjGUubLmMe11" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" id="xdx_493_20230930_z88lrVy2dXJj">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Twelve months ending September 30,</b></span></td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zTotBDrcuNs" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="vertical-align: top; width: 6%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; width: 38%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,058</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_z6sqjfZ2mVbb" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,934</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zWG8oml8sPx1" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,982</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zm5GU6aGDNe5" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,561</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_zUsPYrM1L2Ae" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,963</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbXNV0Ba8wa3" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129,991</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermDebt_iI_zTfYwgAEQi2l" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">361,489</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zWkH1ukykVXe" style="margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zwZaZ5Ww3ut6" style="display: none">Schedule of long term debt payment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_134_zS5zgPNCBeJ7" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49D_20221231_zVHKztI62H27">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years ending December 31,</b></span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zuUkStE0Btw" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 52%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: top; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,426</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_zreanSVKUTGa" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,226</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zELk68BZ2CVb" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,237</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zAqdCSwZ0Jdf" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,963</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_z3nvIsw8ZUHf" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,305</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbaAMSVQt1Rh" style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,318</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebt_iI_zxCGzJGaKiH9" style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">510,475</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292738752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of lease cost</a></td>
<td class="text"><p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zUAagphrgysl"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z7C6NbVV0b2l" style="display: none">Schedule of lease cost</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_134_zOChwuWPpONg" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_496_20230701__20230930_zpCtb6u0TWQd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49A_20220701__20220930_zjn2Ukg1guri" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_491_20230101__20230930_zcjxah3v4pwb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930_z1mY7KClAx0i" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months Ended September 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
    Months Ended September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseCost_zdHXFyt8Q7Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease cost</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187,315</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">562,660</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,949</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ShortTermLeaseCost_zgwvc8sv9ttj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    lease costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1726">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">450</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,077</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--VariableLeaseCost_z768GSysIESf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variable
    lease costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1732">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1733">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1734">&#8212;</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z0LQlFs692Q3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sublease
    income</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,440</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39,476</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,364</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LeaseCost_z86NS0NEpHNk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">176,875</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,223</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">523,334</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,662</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>



<span></span>
</td>
<td class="text"><p id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zt70SzrJsHw1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zA4p04jJhsYk" style="display: none">Schedule of lease cost</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_133_zX3fB250hzhj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_490_20220101__20221231_zRDtWRW2QH0l" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49A_20210101__20211231_zl44k8wUpsEd" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseCost_zmQTo6RBzj6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Operating lease cost</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">760,743</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">304,082</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShortTermLeaseCost_z2KXGOEMdG5d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term lease costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,527</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,846</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--VariableLeaseCost_zdD6N9GLYygj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Variable lease costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0761">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z92E8zIzoqw4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Sublease income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(123,386</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(75,061</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--LeaseCost_zGEze4ciKth5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">640,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">233,867</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum lease payment</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zcBi2eWnGRt2" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zwg0sSJc4HTj" style="display: none">Schedule of future minimum lease payment</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_134_z0HXTQAeHOf3" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_496_20230930_zqFoQwRjYQfd" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
  <tr id="xdx_406_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_znS99N1KgNG1" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 21%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">731,243</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_znalB1v5wi7f" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">725,589</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zJS3yuqzzhm9" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">727,150</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_zoHsE6MDZw31" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">703,541</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_z9jztcz5qWF" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">532,833</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeWcnKvm6tf2" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,569</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zeoRzoYcHEtc" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,532,925</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z6rqGlGgqvL5" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(649,708</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zSMg30yILxG4" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,883,217
    </span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zAeEkhFBNy9h" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">506,743</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zgPRi5p0tFGl" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent lease liability</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,376,474</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseLiability_iI_zZFLI6RvWVh4" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,883,217
    </span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zjn8IGfiNrgd" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zSRXGfWYN6n6" style="display: none">Schedule of future minimum lease payment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_134_zGHc7CoNIRSk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3" id="xdx_499_20221231_zKR809Gf9WHc" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
  <tr id="xdx_402_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_z1ctjPjZ7uo1" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">719,220</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zu24xqSWsK7i" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">727,709</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zn7WlNmhEmMh" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">718,157</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_ze7t6y0FIfsb" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">732,061</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_zcvwntGDFkX8" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">694,040</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeDlFAgqoT5b" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,736</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zw2OCi6FrEF3" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,062,923 </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcZaGW3sYpI2" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(842,904</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zoRRLCDMRbGh" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220,019
    </span></td>
    <td style="border-bottom: Black 1.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zjMnNoXpuL2k" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,055</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zVzbnmDfgRp3" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncurrent lease liability</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,754,964
    </span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zKv4gfUZwLpk" style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220,019
    </span></td>
    <td style="border-bottom: Black 1.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock', window );">Schedule of future minimum sublease payments</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zqFyPOJdbvG9" style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zJZs93bZvkCe" style="display: none">Schedule of
future minimum sublease payments</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_ziZ4s47ADuQ2" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="width: 77%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Twelve months ending September
    30,</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_49A_20230930_zU4ARZkGlgTi" style="width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zViBC96lzPGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,491</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_zUwuxibF07l" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,922</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zcBEZH0QOODb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease
    payments&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,413</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zogI97WN0Tzk" style="margin: 0 0 8pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zqERv2OqsW1b" style="display: none">Schedule of future minimum sublease payments</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_134_zhF1WH9OjIuk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49C_20221231_zDQyzMww9bPa" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 79%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years ending December 31,</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zf6T9vcYuKN4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,147</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_z1tyWIw2oB23" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,242</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_iI_zeyWDgF05una" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,070</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zPHSI71m273d" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments&#160;</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,459</span></td>
    <td style="border-bottom: Black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481161/840-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294606576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock', window );">Schedule of various warrants/options issued and outstanding</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zdD8GKq3aiYa" style="margin: 0; text-align: justify; text-indent: 27.35pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B7_zm75MT70gd62" style="display: none">Schedule of various warrants/options issued and outstanding</span></span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_134_zABaZfFVn2lh" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details)">
  <tr style="vertical-align: bottom">
    <td style="width: 47%; text-align: center"><p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number
                                               of warrants/non-plan options</b></span></p>


</td>
    <td style="width: 23%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></span></td>
    <td style="width: 30%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Remaining
    Life (Yrs)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98D_ecustom--NumberOfWarrantsnonplanOptionsOne_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zKbapBLbOX7e" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">25,000</span></td>
    <td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zZsB6XKMCa3b" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">$5.00</span></td>
    <td style="border-top: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePricesMember_zKne3ypdaBk9">1.86</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_984_ecustom--NumberOfWarrantsnonplanOptionsTwo_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zo9CS0bUS2lb" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">521,825</span></td>
    <td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zCTh5SGjeYje" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$3.32 </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zBp8z7jLCqMi">8.15</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98C_ecustom--NumberOfWarrantsnonplanOptionsThree_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zTzqyoS76RNe" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">78,000</span></td>
    <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zt1ripov30J3" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$2.90 </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zclT3p4JMwBe">1.11</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_985_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_z7B1Ksldnlf" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">30,000</span></td>
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zah7kwM60dXh" style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$3.32 </span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zW8SCQXV7SH7">1.11</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_zcMZ6goDaZC6" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">148,005</span></td>
    <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_z6UiFSsNAFFe" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;$9.10
    </span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zgg7PK4bJNLd">3.50</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<span></span>
</td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zPf8dkwekrsb" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zEzVKEpPWtxc" style="display: none">Schedule of various warrants/options issued and outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zpjXu2OSB0dj" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details)">
  <tr style="vertical-align: bottom">
    <td style="width: 47%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of
    warrants/non-plan options</b></span></td>
    <td style="width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    Price</b></span></td>
    <td style="width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    Average Remaining Life (Yrs)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zfwpDoIHXtF9" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,431</span></td>
    <td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zyr2oR9dgU52" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$3.32
    </span></td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zg9KyrjASIWe">8.90</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zExQ0hbqZOh5" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,000</span></td>
    <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_z28elCJ7994l" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$2.90
    </span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zadaY99B6WYg">1.86</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zbAYHtpkB53l" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td>
    <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zvIaZ1h8hcv7" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$3.32
    </span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zAL5rhjBdOp3">1.86</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zGLs1JzSux5" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,005</span></td>
    <td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zvBMWrSErvjj" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$9.10
    </span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zZEHNbQA7Aki">4.25</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231_zY5DYu6afXz8" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">888,436</span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ztNSL32BluSd" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zaGwniah05M8" style="display: none">Schedule of assumptions used</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_134_zP37qo3NCmWb" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 1)">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility 	</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z5Q8Iu4ucnH8" title="Expected Volatility">109.48</span>% - <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zdJpsBdwwVzl" title="Expected Volatility">113.32</span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividends</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_z56B65SB3sea" title="Expected dividends">None</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (in years)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zdbmgFKkfCJ6" title="Expected term (in years)">2.5</span> &#8211; <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zBce8gkxjiif" title="Expected term (in years)">5.01</span> </span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free
    rate	</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2wORi2sMc9" title="Risk free rate">2.83</span>% &#8211; <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z9fLngVTHOxa" title="Risk free rate">3.01</span>%</span></td></tr>
  </table>
<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has computed the fair value of the 245,500 options granted during the nine months ended September 30, 2023 using the following
assumptions:</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    volatility 	</span></td><td style="width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zcwAmmtAG005" title="Expected volatility">105</span></span></td><td style="width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    dividends</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20230101__20230930_zwaiTZw8rcu8" title="Expected dividends">None</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Expected
    term (in years)</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_znnUS4AW0cO3" title="Term">6.0</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt"><span style="font: 10pt Times New Roman, Times, Serif">Risk
    free rate	</span></td><td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td colspan="2" style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230101__20230930_zje8AmlukpNa" title="Risk free rate">4.33</span></span><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>



<p style="margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcJ8dxxZkHx8" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zeGzw2Rp6LDe" style="display: none">Schedule
of assumptions used</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_134_zk1RpYJzRAt9" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details1)">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility 	</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z24FkFYmlO1i">109.48</span>% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zcF9lTf9RPy3">113.32</span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividends</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_zrSe1p1d5Dr5">None</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (in years)</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zqaEN7sJ00h2">2.5</span> &#8211; <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zj8KGAYwQ0R9">5.01</span> </span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    free rate	</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z54s1WVuj283">2.83</span>% &#8211; <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z3TKXdHHvoUj">3.01</span>%</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z34PqlRSQKW3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zPfQrUvEmeP2" style="display: none">Schedule of stock option activity</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zZo1xjomvR11" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="width: 53%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of options</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average exercise price</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average remaining contractual term (in years)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    intrinsic value (1)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zV1RbkHg5RKc" style="text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zqQTWpASTkz3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_c20230101__20230930_zoIxiPNl1wAa" style="text-align: right" title="Weighted average remaining contractual term (in years)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.76</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_hus-gaap--AwardTypeAxis__us-gaap--OptionMember_zf1LTcykw98i" style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,500</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zc7l5pLlrkOi" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.92</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of period</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zmtib1YqEBZ6" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,075,000</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zEJqQXdp4z4j" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.77</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_c20230101__20230930_zyNJ9fklntAh" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.02</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zZSCUdyZAHgd" style="border-bottom: black 1pt solid; text-align: right" title="Outstanding at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">567,595</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of period</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zL0TfMxpgLk7" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zuYL48xG3eph" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_c20230101__20230930_zDxeoYCBytaf" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.51</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_z0zO4r5djEx3" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">567,595</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The aggregate intrinsic
    value of options outstanding and options exercisable at beginning of period is $0, as all options are out of the money.</i></span></td></tr>
  </table>
<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zpsFvxsyKuK2" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zFX4jIZq1BZ7" style="display: none">Schedule of stock option activity</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_134_zzfp0ZPVzO6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details2)">
  <tr style="vertical-align: bottom">
    <td style="width: 51%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of options</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average exercise price</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average remaining contractual term (in years)</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    intrinsic value (1)</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zJAYO72S2l31" style="text-align: right" title="Outstanding at beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0844">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zQTcUdOPhvG3" style="text-align: right" title="Weighted average exercise price outstanding at beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0846">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zxMld6jCZh9c" style="text-align: right" title="Aggregate intrinsic value Outstanding at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0848">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zTrNZy6McZMb" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zHQto8BXgup6" style="text-align: right" title="Weighted average exercise price granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zAlcAOVbD7eg" style="text-align: right" title="Aggregate intrinsic value granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_ztSN20Ia76i" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0855">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zBwJkFHMJ5sb" style="text-align: right" title="Weighted average exercise price exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0857">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zr8qW9ktYPhj" style="text-align: right" title="Aggregate intrinsic value exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0859">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zoh55x7y0jse" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0861">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zRqC5AExY4T" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0863">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_ecustom--AggregateIntrinsicValueForfeited_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zFhE6mlaRA7g" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0865">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of period</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zju6BqTzL85b" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_z4Cl21GR35Za" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstaning at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zX3UKdaPNM48" title="Weighted average remaining contractual term (in years)">8.26</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zt1lLxMYkyLa" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0873">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of period</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zZg3Cuz3ukza" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable at end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">829,500</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_iI_c20221231_z3lKBCxLGzgl" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average Price exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.43</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zi952FVivqDj" title="Weighted average remaining contractual term (in years) exercisable">8.26</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zsWZalj4hiS8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0881">&#8212;</span></span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock', window );">Schedule of common stock shares reserved for future issuance</a></td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_zXiJted72Hya" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_z2xjurY2BhMc" style="display: none">Schedule of common stock shares reserved for future issuance</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_134_zvYcYYRcQA6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 4)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 12pt; text-indent: 6pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49E_20230930_z1XzTdBLhml2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zD7IQnOKj873" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 71%; padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of warrants 	</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">772,830</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zO8rm0iRvH5d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of options unrelated to any Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zI24wLcLgZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of stock options &#8211; 2021 Incentive Award Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,075,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzFie7Js2KOa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of restricted stock units &#8211; 2021 Incentive Award Plan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCiODbzqpC4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 12pt; text-indent: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    shares of common stock reserved for future issuances	</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,926,610</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_z90f1irLpWN6" style="margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zgICDwR4qoh" style="display: none">Schedule
of common stock shares reserved for future issuance</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_133_z4kENF1cfmba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  Stockholders Equity (Details 3)">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 6pt; padding-left: 12pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20221231_znWZEU5eey41" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zly4ssWCud3l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: 6pt; padding-left: 12pt">Exercise of warrants 	</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">858,436</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zmxFQkzQUqvd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 6pt; padding-left: 12pt">Exercise of options unrelated to any Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zyYgm42BRNQb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 6pt; padding-left: 12pt">Exercise of stock options &#8211; 2021 Incentive Award Plan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">829,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCBQtFy6EhV" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 6pt; padding-left: 12pt">Total shares of common stock reserved for future issuances	</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,717,936</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="margin: 0; font-style: italic; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Share-Based Payment Arrangement, Restricted Stock Unit, Activity</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zSsS8b617s7b" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span id="xdx_8B2_zy8whRJJDSZe" style="display: none">Share-Based
Payment Arrangement, Restricted Stock Unit, Activity</span></span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_134_zUJ6sN1EO8pe" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 3)">
  <tr style="vertical-align: bottom">
    <td style="width: 68%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in thousands
    except number of options and per options data)</i></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of restricted stock awards</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average grant-date fair value</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested at beginning of year</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZ2PPCLrj7d" style="text-align: right" title="Numbers of Shares beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1846">&#8212;</span></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6YprpuKHP6k" style="text-align: right" title="Begining balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1848">&#8212;</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKzVANoGVwK9" style="text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSyN7aXs5ARe" style="text-align: right" title="Weighted avergare granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">239,998</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested at end of year</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6xOLtHw31rg" style="border-bottom: black 1pt solid; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,780</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUhwOgnif0R5" style="border-bottom: black 1pt solid; text-align: right" title="Weigthed Average Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">239,998</span></td></tr>
  </table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293489456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEtVZfzLHWcj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span id="xdx_8B3_zjcQ6x77CPU2" style="display: none">Schedule
of Effective Income Tax Rate Reconciliation</span></span></span></p>
<table cellpadding="0" cellspacing="0" id="xdx_308_134_zwbP73deKSi9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_496_20220101__20221231_ztVgFHcgYj7h" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49C_20210101__20211231_zoKi8J2nW6gc" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_dp_uPure_zGJmKRRETVVl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Federal statutory tax rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_dp_uPure_zSsouv1ej8Pk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.7</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dt_uPure_zSDcgF6oc0bf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.4</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationBeatPercent_dp_uPure_z8hQMHG06fq6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NQSO Comp &#8211; Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.5</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationFdiiPercent_dp_uPure_z6JxTFJotrz" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">EQ Comp &#8211; Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.4</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_uPure_zFBT1vmZ4Ww3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">True-up Adjustment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zKiFl8AjglZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="margin: 0; text-align: justify">&#160;</p>

<p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zC4OARNncDdj" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_ziXukLYUoNWd" style="display: none">Schedule of Income
before Income Tax, Domestic and Foreign</span></span></p>



<p style="margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zb1NHB8OwHti" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_496_20220101__20221231_zjevSpBUivch" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zHdMUqaY85k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of
    December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Current:</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_zo8Lkbra0hU8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Federal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0923">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zt5wGkkScfPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left">&#160;&#160;&#160;&#160;State Franchise Fees</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(8,850</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">9,300</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0; text-align: justify"></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zC4OARNncDdj" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_ziXukLYUoNWd" style="display: none">Schedule of Income
before Income Tax, Domestic and Foreign</span></span></p>



<p style="margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_zb1NHB8OwHti" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td id="xdx_496_20220101__20221231_zjevSpBUivch" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zHdMUqaY85k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of
    December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Current:</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_zo8Lkbra0hU8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Federal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0923">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zt5wGkkScfPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left">&#160;&#160;&#160;&#160;State Franchise Fees</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(8,850</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">9,300</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0; text-align: justify"></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zrqqWNaZpNL8" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zCkmsuoyAI94" style="display: none">Schedule of Components of Income Tax Expense</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_134_z4PMuvPF2Mrl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 2)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_496_20221231_z89QQUgKEAVi" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_49F_20211231_zNPhNqwwS8d1" style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_zPDkTJWsp4Y8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLossCarryforwards_iI_z1KojXuaItub" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left">&#160;&#160;&#160;&#160;Net Operating Losses</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,719,889</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">151,797</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_zY5o7ofxAGS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;&#160;&#160;Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">444,051</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,524</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_iI_zPOwsh21rPTg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">424,675</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17,927</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zbpierLcBkek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,588,615</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">320,248</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iNI_di_zYAiOFhAOQ5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,584,010</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(297,815</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_z9RCY5agWj6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation_iI_z6gxUl9dblYg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;&#160;&#160;&#160;Depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,605</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(22,433</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Summary of Operating Loss Carryforward</a></td>
<td class="text"><p id="xdx_892_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zPv7QMcA7cRk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zYENDrlL9PE9" style="display: none">Summary of Operating Loss Carryforward</span></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_134_zIUNOoP3rzEa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 3)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_497_20221231_zjBwkj1Wu1Yh" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_49F_20211231_zZONGVJtCiA9" style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iNI_di_zmJ0QSxopRXi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Income tax provision at federal statutory rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,584,531</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(746,778</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iNI_di_zyhZ985TWJH" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(399,174</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59,202</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_zVKR14O4RXk1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Stock-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0964">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">491,727</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsTaxCreditCarryforwardsOthers_iNI_di_zoHMOfr76WJa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,964</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,438</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsValuationAllowanceOne_iNI_di_zNsab0INGQ0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,992,669</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(297,815</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zDtRC7mosmRf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285022352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember', window );">Vehicles And Transportation Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember', window );">Vehicles And Transportation Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember', window );">Q A Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember', window );">Q A Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember', window );">Tooling And Molds [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember', window );">Tooling And Molds [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291809984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NetLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,536,540)<span></span>
</td>
<td class="num">$ (4,720,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_WeightedaverageNumberOfCommonSharesOutstanding', window );">Weighted average common shares outstanding &#8211; basic and diluted</a></td>
<td class="nump">6,910,717<span></span>
</td>
<td class="nump">6,802,464<span></span>
</td>
<td class="nump">6,878,737<span></span>
</td>
<td class="nump">5,913,763<span></span>
</td>
<td class="nump">6,135,938<span></span>
</td>
<td class="nump">2,888,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NetLossPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
<td class="num">$ (0.26)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.77)<span></span>
</td>
<td class="num">$ (1.03)<span></span>
</td>
<td class="num">$ (1.23)<span></span>
</td>
<td class="num">$ (1.63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NetLossOne', window );">Net loss</a></td>
<td class="num">$ (1,814,215)<span></span>
</td>
<td class="num">$ (1,279,304)<span></span>
</td>
<td class="num">$ (5,270,281)<span></span>
</td>
<td class="num">$ (6,067,193)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NetLossOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NetLossOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NetLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NetLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_WeightedaverageNumberOfCommonSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_WeightedaverageNumberOfCommonSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293345280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details 2) - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">1,926,610<span></span>
</td>
<td class="nump">1,717,936<span></span>
</td>
<td class="nump">740,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=XPON_StockOptionsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1', window );">[custom:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">829,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">802,830<span></span>
</td>
<td class="nump">888,436<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">1,075,000<span></span>
</td>
<td class="nump">829,500<span></span>
</td>
<td class="nump">710,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne', window );">[custom:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">888,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=XPON_RSUMember', window );">R S U [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">48,780<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=XPON_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=XPON_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=XPON_RSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=XPON_RSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285064576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ProccedsFromIpoNetsCost', window );">Procceds from IPO nets cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,772,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash balances exceeded FDIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositContractsAssets', window );">Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CustomerDepositsCurrent', window );">Customer deposits</a></td>
<td class="nump">$ 46,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">$ 436,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventory, Finished Goods</a></td>
<td class="nump">3,306,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,306,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,722,765<span></span>
</td>
<td class="nump">985,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">851,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">851,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,807,371<span></span>
</td>
<td class="nump">1,066,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryNetOfReserves', window );">inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,611<span></span>
</td>
<td class="nump">1,081,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing expense</a></td>
<td class="nump">238,163<span></span>
</td>
<td class="nump">$ 215,994<span></span>
</td>
<td class="nump">690,995<span></span>
</td>
<td class="nump">$ 527,732<span></span>
</td>
<td class="nump">239,814<span></span>
</td>
<td class="nump">67,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="nump">145,111<span></span>
</td>
<td class="nump">41,355<span></span>
</td>
<td class="nump">316,369<span></span>
</td>
<td class="nump">153,730<span></span>
</td>
<td class="nump">270,054<span></span>
</td>
<td class="nump">58,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Net proceeds from Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease', window );">FDIC Limits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">547,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_TreasuryRelatedPaper', window );">Treasury related paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AdjustmentsToBadDebtExpense', window );">Adjustments to BadDebt Expense</a></td>
<td class="nump">388<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="nump">19,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Inventory</a></td>
<td class="nump">3,306,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,306,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,722,765<span></span>
</td>
<td class="nump">$ 985,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Supplies', window );">Inventory purchases from foreign suppliers</a></td>
<td class="nump">102,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Shipping and handling fee</a></td>
<td class="nump">27,398<span></span>
</td>
<td class="nump">6,133<span></span>
</td>
<td class="nump">52,296<span></span>
</td>
<td class="nump">17,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ShippingAndHandlingCostsForShippingProduct', window );">Shipping and Handling Costs for Shipping Product</a></td>
<td class="nump">$ 58,141<span></span>
</td>
<td class="nump">$ 54,840<span></span>
</td>
<td class="nump">$ 149,898<span></span>
</td>
<td class="nump">$ 137,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventory, Finished Goods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,243,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,286,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,243,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AdjustmentsToBadDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AdjustmentsToBadDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ProccedsFromIpoNetsCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ProccedsFromIpoNetsCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ShippingAndHandlingCostsForShippingProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ShippingAndHandlingCostsForShippingProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_TreasuryRelatedPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_TreasuryRelatedPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerDepositsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current portion of money or property received from customers which is either to be returned upon satisfactory contract completion or applied to customer receivables in accordance with the terms of the contract or the understandings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerDepositsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositContractsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of assets as of the balance sheet date pertaining to amounts paid by the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483081/340-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483054/340-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositContractsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in carrying amount of the indemnification asset relating to loss sharing agreements with the Federal Deposit Insurance Corporation (FDIC). The change includes for example, but is not limited to, acquisitions, additional estimated losses, disposals, cash payments, accretion of discount and write-offs, net of recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after of valuation reserves and allowances, of inventory, classified as other, expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Supplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Supplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292917744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment Net (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 1,348,326<span></span>
</td>
<td class="nump">$ 1,394,619<span></span>
</td>
<td class="nump">$ 523,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(378,286)<span></span>
</td>
<td class="num">(250,861)<span></span>
</td>
<td class="num">(96,190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">970,040<span></span>
</td>
<td class="nump">1,143,758<span></span>
</td>
<td class="nump">427,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember', window );">Vehicles And Transportation Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">551,906<span></span>
</td>
<td class="nump">593,097<span></span>
</td>
<td class="nump">298,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">314,819<span></span>
</td>
<td class="nump">314,819<span></span>
</td>
<td class="nump">59,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureEquipmentMember', window );">Office Furniture Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">188,131<span></span>
</td>
<td class="nump">188,131<span></span>
</td>
<td class="nump">105,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">179,274<span></span>
</td>
<td class="nump">179,274<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEquipmentMember', window );">Warehouse Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">81,164<span></span>
</td>
<td class="nump">81,164<span></span>
</td>
<td class="nump">44,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember', window );">Q A Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">33,032<span></span>
</td>
<td class="nump">22,142<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember', window );">Tooling And Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 15,992<span></span>
</td>
<td class="nump">$ 15,992<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285148320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation expense</a></td>
<td class="nump">$ 50,507<span></span>
</td>
<td class="nump">$ 48,364<span></span>
</td>
<td class="nump">$ 153,714<span></span>
</td>
<td class="nump">$ 115,670<span></span>
</td>
<td class="nump">$ 164,767<span></span>
</td>
<td class="nump">$ 61,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DisposalsAndSalesOfFixedAssets', window );">Disposals and sales of fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,748<span></span>
</td>
<td class="nump">$ 51,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DisposalsAndSalesOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DisposalsAndSalesOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285100144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salaries and payroll liabilities</a></td>
<td class="nump">$ 222,411<span></span>
</td>
<td class="nump">$ 169,337<span></span>
</td>
<td class="nump">$ 12,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_RebateLiability', window );">Rebate liability</a></td>
<td class="nump">30,255<span></span>
</td>
<td class="nump">26,015<span></span>
</td>
<td class="nump">23,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DeferredIncomeAndDepositSublease', window );">Deferred income and deposit (sublease)</a></td>
<td class="nump">4,445<span></span>
</td>
<td class="nump">14,168<span></span>
</td>
<td class="nump">13,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions</a></td>
<td class="nump">22,534<span></span>
</td>
<td class="nump">9,720<span></span>
</td>
<td class="nump">29,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_FranchiseTax', window );">Franchise tax</a></td>
<td class="nump">4,999<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">26,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Other</a></td>
<td class="nump">14,996<span></span>
</td>
<td class="nump">86,302<span></span>
</td>
<td class="nump">26,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 299,793<span></span>
</td>
<td class="nump">$ 306,164<span></span>
</td>
<td class="nump">$ 140,618<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DeferredIncomeAndDepositSublease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DeferredIncomeAndDepositSublease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_FranchiseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_FranchiseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_RebateLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_RebateLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292644896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of long-term debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,196,843<span></span>
</td>
<td class="nump">$ 1,196,843<span></span>
</td>
<td class="nump">$ 117,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">361,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,475<span></span>
</td>
<td class="nump">2,127,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt Instrument, Unamortized Discount, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,196,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt Instrument, Unamortized Discount, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,196,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="num">(50,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,426)<span></span>
</td>
<td class="num">(51,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_LessNotePayableInDefaultPaid', window );">Less note payable in default (paid April 2022)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt, Excluding Current Maturities</a></td>
<td class="nump">311,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 439,049<span></span>
</td>
<td class="nump">779,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_SeniorSecuredPromissoryNotesMember', window );">Senior Secured Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_WarrantsToPurchase', window );">[custom:WarrantsToPurchase]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,196,843<span></span>
</td>
<td class="nump">117,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes Payable to Banks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">7,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,825<span></span>
</td>
<td class="nump">13,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableCreditUnionMember', window );">Note Payable Credit Union [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">15,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,364<span></span>
</td>
<td class="nump">24,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableSBAMember', window );">Note Payable S B A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">147,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,114<span></span>
</td>
<td class="nump">153,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableIndividualMember', window );">Note Payable Individual [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompanyMember', window );">Note Payable Finance Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">45,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompany1Member', window );">Note Payable Finance Company 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,963<span></span>
</td>
<td class="nump">96,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_GMFinancialMember', window );">G M Financial [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">729.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">$ 191,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251,209<span></span>
</td>
<td class="nump">$ 94,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_LessNotePayableInDefaultPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_LessNotePayableInDefaultPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_WarrantsToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_WarrantsToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_SeniorSecuredPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_SeniorSecuredPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableCreditUnionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableCreditUnionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableSBAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableSBAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableIndividualMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableIndividualMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompany1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompany1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_GMFinancialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_GMFinancialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293094160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 50,058<span></span>
</td>
<td class="nump">$ 71,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">52,934<span></span>
</td>
<td class="nump">77,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">50,982<span></span>
</td>
<td class="nump">82,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturingInYearsTwoAndThree', window );">2027</a></td>
<td class="nump">49,561<span></span>
</td>
<td class="nump">73,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2028</a></td>
<td class="nump">27,963<span></span>
</td>
<td class="nump">55,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Thereafter</a></td>
<td class="nump">129,991<span></span>
</td>
<td class="nump">150,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 361,489<span></span>
</td>
<td class="nump">$ 510,475<span></span>
</td>
<td class="nump">$ 2,127,464<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturingInYearsTwoAndThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second and third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturingInYearsTwoAndThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962297569824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholder Promissory Notes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DisclosureShareholderPromissoryNotesAbstract', window );"><strong>Shareholder Promissory Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherMinorityInterests', window );">Interest paid to the shareholders</a></td>
<td class="nump">$ 82,508<span></span>
</td>
<td class="nump">$ 92,007<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DisclosureShareholderPromissoryNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DisclosureShareholderPromissoryNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherMinorityInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of equity interests owned by noncontrolling shareholders, partners, or other equity holders in one or more of the entities consolidated into the reporting entity's financial statements other than joint ventures, limited partnerships, operating partnerships or interests held by preferred unit holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherMinorityInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292927248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 187,315<span></span>
</td>
<td class="nump">$ 198,795<span></span>
</td>
<td class="nump">$ 562,660<span></span>
</td>
<td class="nump">$ 561,949<span></span>
</td>
<td class="nump">$ 760,743<span></span>
</td>
<td class="nump">$ 304,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">3,527<span></span>
</td>
<td class="nump">4,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(10,440)<span></span>
</td>
<td class="num">(25,022)<span></span>
</td>
<td class="num">(39,476)<span></span>
</td>
<td class="num">(98,364)<span></span>
</td>
<td class="num">(123,386)<span></span>
</td>
<td class="num">(75,061)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">&#160;</a></td>
<td class="nump">$ 176,875<span></span>
</td>
<td class="nump">$ 174,223<span></span>
</td>
<td class="nump">$ 523,334<span></span>
</td>
<td class="nump">$ 466,662<span></span>
</td>
<td class="nump">$ 640,884<span></span>
</td>
<td class="nump">$ 233,867<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291948336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear', window );">2024</a></td>
<td class="nump">$ 731,243<span></span>
</td>
<td class="nump">$ 719,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">725,589<span></span>
</td>
<td class="nump">727,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">727,150<span></span>
</td>
<td class="nump">718,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">703,541<span></span>
</td>
<td class="nump">732,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">532,833<span></span>
</td>
<td class="nump">694,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Thereafter</a></td>
<td class="nump">112,569<span></span>
</td>
<td class="nump">471,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Total future minimum lease payments</a></td>
<td class="nump">3,532,925<span></span>
</td>
<td class="nump">4,062,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(649,708)<span></span>
</td>
<td class="num">(842,904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">2,883,217<span></span>
</td>
<td class="nump">3,220,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liability</a></td>
<td class="nump">506,743<span></span>
</td>
<td class="nump">465,055<span></span>
</td>
<td class="nump">$ 218,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent lease liability</a></td>
<td class="nump">2,376,474<span></span>
</td>
<td class="nump">2,754,964<span></span>
</td>
<td class="nump">$ 1,092,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 2,883,217<span></span>
</td>
<td class="nump">$ 3,220,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in remainder of current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292708208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details 2) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear', window );">2024</a></td>
<td class="nump">$ 42,491<span></span>
</td>
<td class="nump">$ 46,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears', window );">2025</a></td>
<td class="nump">17,922<span></span>
</td>
<td class="nump">36,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions', window );">Total future minimum lease payments&#160;</a></td>
<td class="nump">$ 60,413<span></span>
</td>
<td class="nump">$ 88,459<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481295/840-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481295/840-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481295/840-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481295/840-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296015632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Sub Rental Income</a></td>
<td class="nump">$ 123,386<span></span>
</td>
<td class="nump">$ 75,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DeferredIncomeAndSubleaseDeposit', window );">Deferred income and sublease deposit</a></td>
<td class="nump">$ 14,168<span></span>
</td>
<td class="nump">$ 13,690<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DeferredIncomeAndSubleaseDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DeferredIncomeAndSubleaseDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962288912048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">888,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice1Member', window );">Exercise Price 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 3.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">8 years 1 month 24 days<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice2Member', window );">Exercise Price 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 3.32<span></span>
</td>
<td class="nump">$ 2.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">1 year 1 month 9 days<span></span>
</td>
<td class="text">1 year 10 months 9 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice3Member', window );">Exercise Price 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="nump">$ 3.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">1 year 1 month 9 days<span></span>
</td>
<td class="text">1 year 10 months 9 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice4Member', window );">Exercise Price 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 3.32<span></span>
</td>
<td class="nump">$ 9.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">4 years 3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285012032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details1)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">4.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">105.00%<span></span>
</td>
<td class="nump">109.48%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.83%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113.32%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 3 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962399662816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details2)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1', window );">Weighted average Price exercisable</a></td>
<td class="nump">$ 3.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (in years) exercisable</a></td>
<td class="text">8 years 3 months 3 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=XPON_StockOptionsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstanding at beginning of period</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value Outstanding at beginning | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">829,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price granted</a></td>
<td class="nump">$ 3.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Aggregate intrinsic value granted</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price exercised</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value exercised | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price forfeited</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AggregateIntrinsicValueForfeited', window );">Aggregate intrinsic value forfeited | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period | shares</a></td>
<td class="nump">829,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstaning at end of period</a></td>
<td class="nump">$ 3.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term (in years)</a></td>
<td class="text">8 years 3 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value end of period | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period | shares</a></td>
<td class="nump">829,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value exercisable | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AggregateIntrinsicValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AggregateIntrinsicValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=XPON_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=XPON_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294687104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders Equity (Details 3) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">1,926,610<span></span>
</td>
<td class="nump">1,717,936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">772,830<span></span>
</td>
<td class="nump">858,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=XPON_UnrelatedToAnyPlanMember', window );">Unrelated To Any Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=XPON_StockOptionsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">1,075,000<span></span>
</td>
<td class="nump">829,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=XPON_UnrelatedToAnyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=XPON_UnrelatedToAnyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=XPON_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=XPON_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291813024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Options granted</a></td>
<td class="nump">$ 1,847,193<span></span>
</td>
<td class="nump">$ 267,336<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294820016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic', window );">Federal statutory tax rate</a></td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal', window );">State taxes, net of federal tax benefit</a></td>
<td class="num">(5.30%)<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">2640.00%<span></span>
</td>
<td class="nump">840.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent', window );">NQSO Comp &#8211; Other</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent', window );">EQ Comp &#8211; Other</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">13.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">True-up Adjustment</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to base erosion and anti-abuse tax (BEAT).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962296011984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">&#160;&#160;&#160;&#160;Federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">&#160;&#160;&#160;&#160;State Franchise Fees</a></td>
<td class="num">$ (8,850)<span></span>
</td>
<td class="nump">$ 9,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962297539856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details 2) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">&#160;&#160;&#160;&#160;Net Operating Losses</a></td>
<td class="nump">$ 1,719,889<span></span>
</td>
<td class="nump">$ 151,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">&#160;&#160;&#160;&#160;Stock-based compensation</a></td>
<td class="nump">444,051<span></span>
</td>
<td class="nump">150,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">&#160;&#160;&#160;&#160;Other</a></td>
<td class="nump">424,675<span></span>
</td>
<td class="nump">17,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</a></td>
<td class="nump">2,588,615<span></span>
</td>
<td class="nump">320,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(2,584,010)<span></span>
</td>
<td class="num">(297,815)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation', window );">&#160;&#160;&#160;&#160;Depreciation</a></td>
<td class="num">$ (4,605)<span></span>
</td>
<td class="num">$ (22,433)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294677152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details 3) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Income tax provision at federal statutory rate</a></td>
<td class="num">$ (1,584,531)<span></span>
</td>
<td class="num">$ (746,778)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State taxes</a></td>
<td class="num">(399,174)<span></span>
</td>
<td class="num">(59,202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">491,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers', window );">Other</a></td>
<td class="num">(8,964)<span></span>
</td>
<td class="nump">16,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_DeferredTaxAssetsValuationAllowanceOne', window );">Valuation allowance</a></td>
<td class="nump">1,992,669<span></span>
</td>
<td class="num">(297,815)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_DeferredTaxAssetsValuationAllowanceOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_DeferredTaxAssetsValuationAllowanceOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962294692752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_AccountsPayableRelatedPartiesCurrentOne', window );">Accounts Payables liability</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_AccountsPayableRelatedPartiesCurrentOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_AccountsPayableRelatedPartiesCurrentOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293322688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of estimated useful lives (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember', window );">Vehicles And Transportation Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember', window );">Vehicles And Transportation Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureAndEquipmentMember', window );">Office Furniture And Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureAndEquipmentMember', window );">Office Furniture And Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEequipmentMember', window );">Warehouse Eequipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEequipmentMember', window );">Warehouse Eequipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember', window );">Tooling And Molds [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember', window );">Tooling And Molds [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember', window );">Q A Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember', window );">Q A Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEequipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEequipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962292560256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 1,348,326<span></span>
</td>
<td class="nump">$ 1,394,619<span></span>
</td>
<td class="nump">$ 523,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(378,286)<span></span>
</td>
<td class="num">(250,861)<span></span>
</td>
<td class="num">(96,190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">970,040<span></span>
</td>
<td class="nump">1,143,758<span></span>
</td>
<td class="nump">427,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember', window );">Vehicles And Transportation Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">551,906<span></span>
</td>
<td class="nump">593,097<span></span>
</td>
<td class="nump">298,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">314,819<span></span>
</td>
<td class="nump">314,819<span></span>
</td>
<td class="nump">59,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureEquipmentMember', window );">Office Furniture Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">188,131<span></span>
</td>
<td class="nump">188,131<span></span>
</td>
<td class="nump">105,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember', window );">Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">179,274<span></span>
</td>
<td class="nump">179,274<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEquipmentMember', window );">Warehouse Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">81,164<span></span>
</td>
<td class="nump">81,164<span></span>
</td>
<td class="nump">44,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember', window );">Q A Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">33,032<span></span>
</td>
<td class="nump">22,142<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember', window );">Tooling And Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 15,992<span></span>
</td>
<td class="nump">$ 15,992<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_VehiclesAndTransportationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_OfficeFurnitureEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_WarehouseEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_QAEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=XPON_ToolingAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285081488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">$ 361,489<span></span>
</td>
<td class="nump">$ 510,475<span></span>
</td>
<td class="nump">$ 2,127,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="num">(50,058)<span></span>
</td>
<td class="num">(71,426)<span></span>
</td>
<td class="num">(51,135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt, Excluding Current Maturities</a></td>
<td class="nump">311,431<span></span>
</td>
<td class="nump">439,049<span></span>
</td>
<td class="nump">779,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_SeniorSecuredPromissoryNotesMember', window );">Senior Secured Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes Payable to Banks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">7,213<span></span>
</td>
<td class="nump">9,825<span></span>
</td>
<td class="nump">13,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableCreditUnionMember', window );">Note Payable Credit Union [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">15,514<span></span>
</td>
<td class="nump">19,364<span></span>
</td>
<td class="nump">24,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableSBAMember', window );">Note Payable S B A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">147,735<span></span>
</td>
<td class="nump">150,114<span></span>
</td>
<td class="nump">153,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableIndividualMember', window );">Note Payable Individual [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompanyMember', window );">Note Payable Finance Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">45,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompany1Member', window );">Note Payable Finance Company 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">79,963<span></span>
</td>
<td class="nump">96,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=XPON_GMFinancialMember', window );">G M Financial [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="nump">$ 191,027<span></span>
</td>
<td class="nump">$ 251,209<span></span>
</td>
<td class="nump">$ 94,890<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_SeniorSecuredPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_SeniorSecuredPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableCreditUnionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableCreditUnionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableSBAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableSBAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableIndividualMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableIndividualMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompany1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_NotePayableFinanceCompany1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=XPON_GMFinancialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=XPON_GMFinancialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285105696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice1Member', window );">Exercise Price 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NumberOfWarrantsnonplanOptionsOne', window );">[custom:NumberOfWarrantsnonplanOptionsOne-0]</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 3.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">8 years 1 month 24 days<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePricesMember', window );">Exercise Prices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">1 year 10 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice2Member', window );">Exercise Price 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 3.32<span></span>
</td>
<td class="nump">$ 2.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">1 year 1 month 9 days<span></span>
</td>
<td class="text">1 year 10 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NumberOfWarrantsnonplanOptionsTwo', window );">[custom:NumberOfWarrantsnonplanOptionsTwo-0]</a></td>
<td class="nump">521,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice3Member', window );">Exercise Price 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="nump">$ 3.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">1 year 1 month 9 days<span></span>
</td>
<td class="text">1 year 10 months 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NumberOfWarrantsnonplanOptionsThree', window );">[custom:NumberOfWarrantsnonplanOptionsThree-0]</a></td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice4Member', window );">Exercise Price 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 3.32<span></span>
</td>
<td class="nump">$ 9.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">4 years 3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NumberOfWarrantsnonplanOptionsFour', window );">[custom:NumberOfWarrantsnonplanOptionsFour-0]</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice5Member', window );">Exercise Price 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 9.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_NumberOfWarrantsnonplanOptionsFour', window );">[custom:NumberOfWarrantsnonplanOptionsFour-0]</a></td>
<td class="nump">148,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NumberOfWarrantsnonplanOptionsFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NumberOfWarrantsnonplanOptionsFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NumberOfWarrantsnonplanOptionsOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NumberOfWarrantsnonplanOptionsOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NumberOfWarrantsnonplanOptionsThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NumberOfWarrantsnonplanOptionsThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_NumberOfWarrantsnonplanOptionsTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_NumberOfWarrantsnonplanOptionsTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePricesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePricesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=XPON_ExercisePrice5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293218528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details 1)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
<td class="nump">4.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">105.00%<span></span>
</td>
<td class="nump">109.48%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.83%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113.32%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 3 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962285141568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details 2)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone', window );">Weighted average remaining contractual term (in years)</a></td>
<td class="text">8.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo]</a></td>
<td class="text">9.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree]</a></td>
<td class="text">7.51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_OptionMember', window );">Options Held [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Beginning balance | shares</a></td>
<td class="nump">829,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance</a></td>
<td class="nump">$ 3.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">$ 4.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance | shares</a></td>
<td class="nump">1,075,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 3.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at end of period | $</a></td>
<td class="nump">$ 567,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther', window );">Exercisable shares | shares</a></td>
<td class="nump">829,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance</a></td>
<td class="nump">$ 3.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at end of period | $</a></td>
<td class="nump">$ 567,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>XPON_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other increase (decrease) in number of shares reserved for issuance under non-option equity instrument agreements that is not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962293337056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details 3) - Restricted Stock Units (RSUs) [Member]<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Numbers of Shares beginning balance | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstanding at beginning of period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">48,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted avergare granted | $ / shares</a></td>
<td class="nump">$ 239,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Ending balance | shares</a></td>
<td class="nump">48,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price outstaning at end of period | $ / shares</a></td>
<td class="nump">$ 239,998<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139962291807936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders Equity (Details 4) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">1,926,610<span></span>
</td>
<td class="nump">1,717,936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">772,830<span></span>
</td>
<td class="nump">858,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=XPON_UnrelatedToAnyPlanMember', window );">Unrelated To Any Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=XPON_StockOptionsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">1,075,000<span></span>
</td>
<td class="nump">829,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved for future issuances</a></td>
<td class="nump">48,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=XPON_UnrelatedToAnyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=XPON_UnrelatedToAnyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=XPON_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=XPON_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>80
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MI)F XSLA]+EA%FAJU,E_4$L#!!0    ( &*+/UB],O\3/0<  &,D   8
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M0TX$-1^A[:$/EP\HE\*FU-<_Q920"Z0M^)^KU7E=R385>8/(G$9F)(@#/J0
MCR&!A,4B,M(=.M0A)V*=&[E1,%/Z.X=++2%+L#-VOV76U]3!#9F$;MKYHIT
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MIK<@3MI4U#N9,.NT$)2*@JKEH=3T(Z.HB'AOAC.OZW[\]$_GM5UBLQ&QTAD
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M<I6:1>&K'R*"\;N@,C+U5;F\VM9JMQ0!FPMSUV@BDMJSW7F]"A9C86.OL D
M2S&+&.\AQ+@3+? +J18SM2DUX8+[LDO?>>1*2>=7#4S-*-#8*V@"@(94HKX)
MKQ,JL!>E8K=NWU&I_E4[=GD[B5B$N),0KQ+%6-C8*VP"P%*B%^^\1Z7 G4R!
M!UGX=!?M@3@#O!N'$9)'W70?:*\2PVC<V"MN N&&H8PD[6O_G=2 (Q^+BIL]
M8\VS]"[+LR93<&)\,O4;K]YF7KW%7KTEOKR=-H).N\!>Q M02]^DWXV0#K8&
ME]OKA3"ASFCH5<48B1I[14T 5$(1.9*R3C=J.Q6#>%$Q3CNKV6C7,]5B8.E
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M*9@$\>[< Q@NGXSFQJNWF5=OL5=OB2]OIRGN.![SPO$^%8W27YL[HZ8M@ W
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MBG78B.-J5ZU@-DY(*\((F9SCKGUHDGE52WVIZ<XK=&)N=.I[X@5N -1G"L2
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M.GD,HBMS2PO$":U*6K_"GY-.0\L&=R!NF29UG!Q]'6 ^LMWI:(-?2"G[+UJ
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M+ %) '*(ILW-NQI.YRUJ!(2<#$4X*SAEY(6 @8"6NY*TBJ2RXCQY"X>;S.&
M88_(D6".2N^VR,36*3"9:@?_\9O'M2T$_39H#R$+E$$R V*Z"L08@T2]EZDT
M)>DZ<1A#]&&%E1PPR1%SS<Q_D0" 5F!W5IU(!">Z C(HRDKQ^0(1P," 17C
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M2JL+$X*%^@6H)+N-X%8#YTCC9"C)#TA1"ZN%RR)+4U/>!NN8(+C1^K2&N]5
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MQW"B"4!/-D%:RX:K K=Y:UVT!^)9SM]*CPMA%<)SV)<ILF&EXX%JN2ZM0S5
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M#4*TZ@;[\'P4G0\GQX#>C52E413RPML+7;!BFFH<S8%]#3X4FP:G8-,LGD3
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MRA=TG"7C4U"&>]->M0E7O0I7S87MSH*PM12 H"0B?^6'L^O0&::D%E[PB:M
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MU8\KX87:XAJO,+NV+5*K.%!C_6KMI1:90[DYN-*=NZ4GQ;E9R1%JE< Q4EL
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MFU<,QJY[8^(98QG<RL:L-;QO%K@XHK\YK>?BA &/(AO#$[OPKL5)BW>XN8#
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MU4Y:=DSA5E2_\4*7*W?A0H%[UE7Z7AQ_P$'/S/#EHE+V"<<^-IF[D'=*BWH
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MP#_JW_C11\ ?^:E$SDD-A""A']6>;N)G4D3;I+LY<CIRA*J@K2%'=U1FGEF
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M\*9'(ZQ1/6!O\<NSZ"*<=X7ZD\">!#YN A^?0__AP,^B=7.=#H)[(Y-O)[S
MK0[D&E;29$!=8;!8T:Y]:P 3*5"UZ]6ZXGTP&<)2%B43.\A82MN M% ;VL[%
M!DK%1<)+EI.6Y$PD".3B^32>],,PA+1",!+T@96&BAI;!970F%0*TPZ:&X5(
M.FDTO/SEV32.P[E[X*ZC^:L!_$&<_%Z%WRNN$ H[-/D.N#!(^3"OI:"[DNT\
M#C,0A2^@I,B8$%71@@A("8F'W?+ %)>5AI19Z#7Q@@],5*3M-A=C&TF3(+?
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MFPU_^5H8[TW%EVN\$"E+"_!\:1"'Y@<=T'T*O?XO4$L#!!0    ( &*+/U@
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M#2JHL89A,:7?;?>31KD9*1E*6E>\1,_0QY\#ARY/4P&/L<Y4]3'>AL)U+=M
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M;<'4]4="RQG+O^_ZOM 'P-_0$Q-$<%0P<$<>UTLEA^[R E#-VV>.C!;,:#N
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M"L*:##^ ]ZLT+<PON$'U]^=>_!]02P,$%     @ 8HL_6($[RU5("@  ,QT
M !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULO5E=;]LX%GW7KR \Z2 %
M%-N2O],D0)LFF ([3:=)9[!8[ ,MT;9:2?205!S/K]]S24F6$\7-#(I]:"I;
MY/WBN>?>2Y]MI/JF5T(8]I"EN3[OK(Q9G_9Z.EJ)C.NN7(L<;Q929=S@HUKV
M]%H)'MM-6=H+^_UQ+^-)WKDXL]]]4A=GLC!IDHM/BNDBR[C:OA.IW)QW@D[U
MQ>=DN3+T1>_B;,V7XE:8+^M/"I]ZM90XR42N$YDS)1;GG;?!Z>60UML%OR=B
MHQO/C#R92_F-/GR(SSM],DBD(C(D@>._>W$ITI0$P8P_2YF=6B5M;#Y7TJ^M
M[_!ESK6XE.D?26Q6YYUIA\5BP8O4?):;7T3ISXCD13+5]B_;N+6#08=%A38R
M*S?#@BS)W?_\H8Q#8\.T_\R&L-P0OG3#H-PPL(XZRZQ;[[GA%V=*;IBBU9!&
M#S8V=C>\27(ZQ5NC\#;!/G/Q(8]D)M@=?Q#ZK&<@D;[O1>7N=VYW^,SN&?M5
MYF:EV54>B[AE_^7A_4%X0$ /KM3^A)4_[\*#$F_%NLL&?9^%_7#09M#A[>]%
MA.V!W1X>,&=0AW=@Y0V^&U[V/M%1*G6A!/O/V[DV"@C^;UO(G<1ANT3*ZE.]
MYI$X[R!MM5#WHG/Q\T_!N/^FS=T?)&S/^6'M_/"0].]BZ^#N=MN"H.LUQ;*[
ME6"7,EOS?.NMN&9)'A5*B9@AU!KO>1ZS2.9:_%F(W*1;,$\D%;#&<LG62MXG
MEH_F8BNQTD :DBS)BHQ)QP_,X.P4-X*!,IDV](2'A8B%XBGI(V,,&>/1"A)A
M5DK853E\8IE#N""$,^#3B&PN5 W2;M,'1L1K\ ^6LT61INR>IP5WC)>"<GD>
M0;+]0&PEK*]D(H>[1OL>Q< P"@7<CM*"E)H5-_1MHF$,\)<FWP1"@:]SA,&X
M]S <WCHQ("'(IU=S@8CQ-/E+Q%WV5C.Y:''!1AFI8[_UJO3Q222T;>@/H@W.
M%2I!S(J<#F&9DU!K^USD8I$8>WK.XB2W@>11Y.*2Y$N<1FJ]MV2GG=$;6:2Q
MSY(%VXE$#!8+5 DK0=A'5(KZ'+OL>N^8OG,\UHOZ>&"0*K#N*/ 'T[Z%A V
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MB[4L R.TA/^Y.%'+E6A3>>+,0:!.]T!VN>=R(YVO7!URL'HN>=\_#<>I]Q$
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M[N?$7U'SZ?Q2L<#6?G<RZC#E?J)S'XQ<VU^YYM(8F=G'E>! #RW ^X64IOI
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M0>L#^/O$&-H8/L'V1Z?W U!+ P04    " !BBS]8ZB]7B0$#  "1"0  &0
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M3RB=PX#M537<I/V+Q#XA^%_P<+&U$_P-HA;/;0SU#GGWO'SL+<EC#KKO:HI
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M3M_].K0EJ@$L2-7=>ADO<<S4>&+]\<+2 3C</^Z?5X2,_EH/B&ZY#>B?3,;
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M5'8#/5]+HE_?6 ?-?P\6?P-02P,$%     @ 8HL_6*ZYR70V-   =_L  !D
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MGVNVC5-\$;:YB5(0C;BX@'8>+?\%')YQ[/$"SB8N#+X 4XX39,LBQ:D2  (
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MTDIPHZ)^89R>2"Q(2R:*[[FCMADJUVQCU+8L#&WT$!O0!Q:S7F^GVN(2LJJ
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M0 - "Q W!E_,,C"!EF:TT=$"Y12R052%^=2T\Y7BB3 AV(,@=)3/Z5P>4:/
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MSB<G5^;*!5 &4\KI6@!M5"4[[_CB#OVT8/<H8;#%U*V^F0NKG?@E&MC'"#Y
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MK0][L7E(GLMWKN)LQ_B=V%(JT=>RJ,3<W$I9G]JV2+:TC,6$U;2"DXSQ,I9
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MX4UA/LK]+Z*/)[)\J2QT^X5]9QOBBFFCC2Q[,([+O.I:_KW/PP$@]I\!L![
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MA>"@=K0 O\\D>J^^H0W:+\M7_P502P,$%     @ 8HL_6$.KDAFS!   ]PT
M !D   !X;"]W;W)K<VAE971S+W-H965T,S,N>&ULK5=M;]LV$/ZN7T&X0Y$
M7,TWD5*;&&B<#1NP=D63=1B&?9!M.A8JB2Y)Q^V_WY&2%7=5E"#KA\2DQ'MX
M]SQW1^IL;^Q'M]':H\]UU;CSR<;[[<OIU"TWNB[<"[/5#;Q9&UL7'J;V9NJV
M5A>K:%174T:(G-9%V4QF9_'9.SL[,SM?E8U^9Y';U75AOUSHRNS/)W1R>/"^
MO-GX\& Z.]L6-_I*^S^V[RS,ICW*JJQUXTK3(*O7YY/7].5<AO5QP8=2[]W1
M&(5(%L9\#)-?5^<3$AS2E5[Z@%# SZV>ZZH*0.#&IPYSTF\9#(_'!_2?8^P0
MRZ)P>FZJ/\N5WYQ/L@E:Z76QJ_Q[L_]%=_&D 6]I*A?_HWV[-F43M-PY;^K.
M&#RHRZ;]+3YW/!P99.0> ]89L,<:\,Z QT!;SV)8EX4O9F?6[)$-JP$M#"(W
MT1JB*9N@XI6W\+8$.S^;F[HN/<CB'2J:%9J;QI?-C6Z6I7;HY+I85-J=GDT]
M[!4LILL.]Z+%9??@YN@-(&T<^JE9Z=6 _7S<GK(1@"D$V4?*#I%>L%'$*[U]
M@3C!B!'&AQP:-[_42S"GT9R-N,-[XGG$XT\B_K)TR\JXG=7H[]<+YRVD^S]#
M*K2;B.%-0@MXZ;;%4I]/H,:=MK=Z,GO^C$KR:HB![P3V%1^BYT.,H<^NH#^M
M=I5&9HTJ#86)EL;YH9!'<8:]' 9/KC=6Z^0XSQ!DB=?U0MN8*F\!?.1]$E(I
M)@3J1\GO6VV+(&5RMQ/Z =%,84[3,,HSK/(P2B7#4I(XHC@7>7*U,=;_Z+6M
MCZP=>OXL8Y2]0B(EB,(?QT2IY$-ARU"?@TOO^4VN=HNX/"F;I:DU.J$$"T'0
M*3IA*0ZAP(CG6"@91N KEP*=)N"WDCA3,0(E,(-XP6_&,><"1D)*B(6AH;QZ
M@F+H'LG^TH4]: $EV4E!HQ11!7HG /I* "4)5B(XS8G )&-'9*-C!CE.F4("
M9T+V%*,1BGM*44]I8"6+_"G@5-+(GQ0$9UG@BG&.,ZG02-FD?=FDCRZ;]<Z'
MA@&G1%GO#C%MBR^AR0P5TBCR(V09VR^Y-KZH@BHA8 4*,<'#-$4*\BS-\C"1
M,%$8,CI,%%($N!<T3#*4<H8SSJ%(-5Q/UB 3HI3A5.8M]NCV+LB, T3.TN0W
M[1PJZ^W.0]:4#4!I2(D3*7*L2 ;BM( @# C$,:,JF>^L!9P.M8(D**O2?PDI
M3V3(H^2M:9;W+&*80ZT();X%'BJ/[Z/P'>,AQQ7-H41)*T @69&\HY]FP+CJ
MZ >&(#];^F4.=2'(,>-"4:RX?!3C8"P#W_P^OC,!KXDXXIL''S&A^0C?0D()
MI>DXWRH5.)?B6^"1$I-]B<FG"N .E7\@8:C,1M$?/*^2A[9,KO>ZNH4%[3&E
MFU5H??TYE73G5.S1#(N<MFE %4C%1H1-CDH)6J>@?+"W_[_H'B2T:_A=5/_M
M^#SF!Z9"M2%R"6V&M0%*."/)(UM%EF&1YH/]>'ITMZZUO8F?' Y.@EWCVVMV
M_[3_JGD=+_/3N^7M)]&;PMZ4C8/MUV!*7B@H?-M^9K03;[;QIKXP'N[]<;B!
M+S-MPP)XOS;&'R9A@_Y;;_8O4$L#!!0    ( &*+/UC1H8MM0 8  'L6   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;.U866_;.!!^UZ\8N&F1 *ZL
MP[+D' :2-+M;8-L-DAY8+/:!L<:V$$ET22K'O]\A==A.%*V3=M&7?;$E<F8X
MQ\>/(Q[><G$M%X@*[K(TET>]A5++_<% 3A>8,6GS)>8T,^,B8XI>Q7P@EP)9
M;)2R=. YSFB0L23O30[-V+F8'/)"I4F.YP)DD65,W)]@RF^/>FZO'KA(Y@NE
M!P:3PR6;XR6JS\MS06^#QDJ<9)C+A.<@<';4.W;W3R,M;P2^)'@KUYY!1W+%
M^;5^>1\?]1SM$*8X5=H"H[\;/,4TU8;(C6^5S5ZSI%9<?ZZM_V)BIUBNF,13
MGGY-8K4XZD4]B''&BE1=\-O?L(HGT/:F/)7F%VY+V5'0@VDA%<\J9?(@2_+R
MG]U5>5A3B)PG%+Q*P=M6P:\4?!-HZ9D)ZQU3;'(H^"T(+4W6](/)C=&F:))<
M5_%2"9I-2$]-+A6?7B]X&J.0;UY%GAL>P-FW(E'WL/N)7:4H]PX'BA;2XH-I
M9?2D-.H]870,'WBN%A+.\ACC%OW3;GW7ZS PH B;,+TZS!.OT^(E+FWPG3YX
MCN>W.=2M_@ZGI.X:=:_#';_)NF_L^4_8JS+\U_&55(*0_'=;CDL3PW83>G?O
MRR6;XE&/MJ]$<8.]R9M7[L@Y:(OO!QG;B';81#OLLCZY).J)BQ2!S^"&B807
M$FZ9$"Q7<L"7>CM+2*0L, :6QT!D(Q4])/F\+2__V6+6QR*[0F&19J.1\_SM
M,F4YU*IG=RBFB40X%\D4X:OA";)U?(.": \N4'.GMO9[,D/8_5/(/<L+^H[C
MP$Y@TZ]K1R,K\-Q^Y 6PX]N^!Y'M!E88E4*>/=9"KFL18,V(D3$C[E +D=K8
M=AW+MP.GK=B=&6HO-GQ_WDC3^O>\69MYLQ[E#=;R%@3C_M!WRPQ8$27&<@-W
ME2;+Y'(]3>7(9IJ&MA=84121J1%TX#EH\!QL#3%&&<FJ$ O92G8G+[=FG=TM
MZ;RCAQN>,I6DFC5<9VP/(W!=$V\C$2<W28QY+.$CSW$UKE!DL)OD<(^,<@J>
M'0#AT+4N$GD-,X%H"::0QB,??)J 3PNT3GFV9/D]+)B$*3T7&N-J@3!CB2"
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M,S?\:)G<J3K6:"=',M0,[/*W9D#DWL7N[F4'K,S<[*.K#_4"H#2&HMDJM?Y
MU+ED+X/: E :A=(8BF;+U-H"D?NF@C-[&=06V).J:V4&382=E(@M0+OAC]Q[
MX<]29M5>L[JIXU%FX_+HU1ETSP^E42B-H6BV4JTW$%U?LJ-!+0$HC4)I#$6S
M96HM@<A]4\&9'0UJ">Q)U;4Z<T<Z;E%#S< N?[O5C]S;5G<_.V2%!MWM0VD4
M2F,HFGV?;>L)Q,$%^UD,-06@- JE,13-EJDU!6+WO03G];,]<,>:ZL$=>K0F
M4 ?@I&FM!/ W'N.HGM)YY&J:%B7)Q,2P@JMKL_A3JP=?5@=:SNLG.YZEUC*O
MW\X$'PM5G6"^GTBIWPZJAT6:QX^&_P-02P,$%     @ 8HL_6'9O9W:L P
MS0X  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULK5==DYLV%/TK&I+)
M)#/-@L2G'9N9M;&W?4AG)YXT#YT^:$&V-0%$)=E._WTE8(G-RM1I>+&1..=<
MZ=P+Z,Y.C'\5>T(D^%;DI9A;>RFKJ6V+=$\*+.Y814IU9\MX@:4:\ITM*DYP
M5I.*W$:.$]@%IJ45S^JY1Q[/V$'FM"2/'(A#46#^SX+D[#2WH/4\\8GN]E)/
MV/&LPCNR(?)S]<C5R.Y4,EJ04E!6 DZV<^L>3A]"C:\!?U!R$F?70._DB;&O
M>O!;-K<<O2"2DU1J!:S^CF1)\EP+J67\W6I:74A-/+]^5E_7>U=[><*"+%G^
MA69R/[<B"V1DBP^Y_,1.OY)V/[[62UDNZE]P:K"!;X'T("0K6K):04'+YA]_
M:WTX(\!K!-024)_@72&X+<&]-8+7$KQ;(_@MP>\3@BN$H"4$MT8(6T*=?;MQ
MMTY-@B6.9YR= -=HI:8OZOS6;)416NI*W$BN[E+%D_&FJ4# MF!#=R7=TA27
M$MRG*3N4DI8[\,ARFE(BP-N$2$QS > [\!Y\WB3@[>MW,UNJ56@M.VTC+IJ(
MZ$I$%WQDI=P+L"HSDAGXR3!_\E_\]3 ?H@$!6]G7>8B>/5R@0<4-J>Z Z_P"
MD(-<PX*6M].1R8^?B[[ZN>CK87I"4D6'5^D/M]/A0"K<KIS=6L^]HF>JVS_O
MGX3DZIWWEZE8&SW/K*>_ U-1X93,+?6B%X0?B16_>04#YX,IT6.*)6.*K<84
M6X\I]C"2V$6Y>%VY>$/J\>_J4Y\S(4R%,<C\T<(84RP94VPUIMBZ$?-K,7T&
M.L;O0]\-?,^9V<?SI!N 7HB<R(\ZX$5"_2ZA_F!"O]1'#Y(!?"1<G:1 RHI"
MG7C$'JOE W44$Q*7F7X_O'D5(0@_Z(,,38&:!!G-#]+X25DT48.S]083Z(0P
MO-S7TH"+'.0%WB4N,>'"*'1[>JN7.'\"W3!P+W%K@QYT_8D;]7Q_B4-1% 43
MWVQ[T-D>#-J^Z'L(RO;) A7AC?LF6QO5Z+P,G#L4]$PUHN"D9ZD1%?8--:#@
MG=.WTXA"/=2#$766F@LKP\[*\'^_DL*73PV,H(>@WW/,!$3AQ'7Z=6@ ^BAT
M4 1[OAF @1.$<-*W;G!W/_IM&$FL281]=DHN"-_5#9  ]8&A^61TLUV/=5^W
M%KWY!9PNH6$^@=.5:7ZM>K6FM?H>MFGT/F*^HZ4 .=FJ):AR50;SIGEJ!I)5
M]=G]B4G5"=27>]5O$JX!ZOZ6,?D\T &Z#C;^%U!+ P04    " !BBS]8*P_L
MS?L#  "6%0  &0   'AL+W=O<FMS:&5E=',O<VAE970S."YX;6S-6-%NXC@4
M_14K*XUVI9DF3D(2NH#4DHYVI*V*BF;GH=H'-QBPFL19VY3NWZ_MA$ @6,/*
MFND+Q,X]Q]?GVC?V'6TI>^%KC 5X*_*2CYVU$-6UZ_)LC0O$KVB%2_EF25F!
MA&RRE<LKAM%"@XK<]3TO<@M$2F<RTGTS-AG1C<A)B6<,\$U1(/;O+<[I=NQ
M9]?Q2%9KH3K<R:A"*SS'XFLU8[+EMBP+4N"2$UH"AI=CYP9>IW"@ -KB+X*W
M_. 9J*D\4_JB&E\68\=3'N$<9T)1(/GWBJ<XSQ63]..?AM1IQU3 P^<=^V<]
M>3F99\3QE.;?R$*LQT[B@ 5>HDTN'NGV#]Q,2#N8T9SK7[!M;#T'9!LN:-&
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M:WIY&/; R'0L5!)=BH[;_?J1LJ*;%=;VZ!=;E+[OF-\1#W5(>;)A_$NYI%2
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M2M2$=Z9:&=W.?;+BRYQQD?Y;7QMP<M8G98R-;2^"3N]?N6&$HB$;(W'(=Z(
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M4T^P2H)U2'#>(-@EP3[5@E,2G%,MN"7!/21X;Q"\DN"=:L$O";Y*5A%=E9H
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MYV#7EU*:!\-UR/Y!+/\ 4$L#!!0    ( &*+/UB\DH#_C0(  '$&   9
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M)F$Z FO(U*]DZMO09_.$"H'8 MU2+8Y$C*/<;Y1 :RDDS<(X6YHDL.*VE:
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MA4*(<)&*.[KY I6AGN(+:,KU%6W*V*YCH:#@@F856"K($E+>\6.5B!V VS\
M\"J ]Q+0/0#H5(".-EHJT[;.L<#^F-$-8BI:LJF!SHU&2S<)49]Q(9A\FDB<
M\"])0#- ]_@1.&J=@\!)RC^.;2&Y580=5#RSDL<[P.-ZZ(H2$7/TF800[A/8
M4E2MS-LJFWE&QG,(VJCCGB#/\;P&0?/WPUV#G$Z=J([FZ[R9*'2>\""EO&"
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M=U^@UF,;3#B5]HEV56[8<U!22L7S&JP[R FKWGA?S^$(X/?/ ((:$#P&=,\
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M%A.,;BQ8=]/7!:@:_P%G"NTX^&5I+RS0+L&>;Y3"8^!F8K@"TU]02P,$%
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MB8 ]BH ]B]"&4Q!8IR"@]QJ<6,V@3L&>5(G9V=&1'-4#=_BM Q#0R^K=M>R
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M@HFJ0#W_P-6W8'.GNGZBO<!F\B]02P,$%     @ 8HL_6.$R'IT8!0  ^R
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M.D!]7S F#QT]05/C1W\!4$L#!!0    ( &*+/UAS1K4S#@0  -\.   9
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M(E=E\RHG1A:N8<REH?;CABGU>U1V [U?2&EV$TM0_X.(_@)02P,$%     @
M8HL_6'$^\1AX P  0!$  !D   !X;"]W;W)K<VAE971S+W-H965T-C<N>&UL
MQ5AM;]HP$/XK5B9-K;0V;Y"$#B*U=-,JK1J"LGZH]L$D!T1-XM0V4/[];"<-
MI$ VI*CP@<3)W7-^[AY;YW17A#ZS.0!'KTF<LIXVYSR[TG46S"'![))DD(HW
M4T(3S,60SG264<"A<DIBW3(,1T]PE&I^5ST;4+]+%CR.4AA0Q!9)@NGZ!F*R
MZFFF]O9@&,WF7#[0_6Z&9S "/LX&5(ST$B6,$DA91%)$8=K3KLVKOMF6#LKB
M=P0KMG6/))4)(<]R<!?V-$/."&((N(3 XK*$/L2Q1!+S>"E M3*F=-R^?T/_
MKL@+,A/,H$_BQRCD\Y[F:2B$*5[$?$A6/Z @I"88D)BI?[3*;=V.AH(%XR0I
MG,4,DBC-K_BU2,26@]DZX& 5#M;_.MB%@ZV(YC-3M&XQQWZ7DA6BTEJ@R1N5
M&^4MV$2I+..(4_$V$G[<'W$2/,])' )EZ-O+(N)K='8+'$<Q0ZUS=('8'%-@
M79V+:-)'#PKDFQS9.H0,V26RC2_(,BQ[CWN_WOT6 N%N*G>KZJX+CB51JR1J
M*3S[T'0DC8L;4?$0]4DBE@'#2DC7E.)T!D*:'$W6:-MN@-?J\?4*TQ ]_120
MZ(Y#PO[L2T<>O[4_OER.5RS# ?0TL=X8T"5H_N=/IF-\W9><AL JJ;++5-EU
MZ/X#X3@NZH[(% 4D242BF)0**L*%2&PA:+K@"PHH8FR!TV"_2O)8CHHE-Y6E
M;W8LQS&-KK[<9KS'SC7=CNV4=A4RK9),JY;,(Y;UY>CI'I()T+V5JT4XMG(-
M@57(MDNR[1.+O-UDJAH"JZ3**5/E?*#(G1WQNJ[EV>\UOFOFM;W6(8F[)16W
MELHXI1!C+J;[0-!UND:#&*>U@J_%.[:*#8%5J'LE=>_$@O>:3%5#8)54=<I4
M=3Y0\)T=)=N&^+W3^[^L*D1,8].S&+545-."?F6RTJQ6Z/5 QY:O*;0J[:U6
MS3RQV(L)-)6NAM"JZ=HT?&9MD]2PX(M@E?[$<-N[FM]CZ%F=]D'5;[HRL[XM
M&P+C- KD/I\O@'$:<8;.AJ,Q.Z]?!;7 1Y>U(;1J&C;]G-DZ]2IHM!]L"JV:
MKDU':-9V44VO@O:.N%N>Z^VL@48[.WWK>"N_+=QC.HO$QA_#5, ;EZZ(1O/C
M>C[@)%,GW@GAXORL;N> Q1%7&HCW4T+XVT >HLN/)OY?4$L#!!0    ( &*+
M/UBE>IS?*@,  $H2   -    >&PO<W1Y;&5S+GAM;-U874_;,!3]*Y$9$T@3
M:9L1FM%6VBHA3=HF)'C8&W(;I[7DV)GCLI9?CZ^=IA_X(L;#5I:JQ+['Y]QC
M^P9''=1F)=C-G#$3+4LAZR&9&U-]BN-Z.F<EK<]4Q:1%"J5+:FQ7S^*ZTHSF
M-9!*$?<ZG30N*9=D-)"+\JHT=315"VF&Y+P-1?[V-1^2;OJ11%YNK'(V)'<G
M[W\ME+E\%_G[T8>CH\[=Z>5^_,0!IR0.BIZ_0/2LT\&% <3$TY>)/Z>-25_L
M2KOAQU;($X\Q6C] LUDV3.@X<MQLRFA0*+G9FX3X@%6G)8ONJ1B2,15\HCFP
M"EIRL?+A'@2F2B@=&5L4-ET7(O6#A[N^!_72Z)1<*NUR^PS^[Z09O@>L>V"0
M"]$:[!$?& TJ:@S3\LIVW& 7? )%3?MV55F',TU7W=XYV1#<S2:9*)TSW:;I
MDG5H-!"L #N:S^9P-ZJ* 31&E;:1<SI3DCH/:T;3L+)3)L0-/$P_BQWM9;&U
M;QW8-=DVK:&FZ65\!_2WU;SVMNSK=*.*WROS96&G(UT?"I1=:U;PI>LOB]8
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MU+=P"PO[*]Y4]X;Y/\,7-WGAU\,AV34SV'>G;C2OMY_ ;C_?O?P'4$L#!!0
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M.'Y\EIUM^K=\-OXC;O$"4$L! A0#%     @ 8HL_6 =!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !B
MBS]84Q1B5N\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " !BBS]8F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &*+/UBQ]N8A
M90,  *\*   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " !BBS]8O3+_$ST'  !C)   &
M@(&I"P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 8HL_
M6+JLM5WF @  4@H  !@              ("!'!,  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( &*+/UCF%U75S 0  'L1   8
M      " @3@6  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" !BBS]8_7RWN/D+   .8P  &               @($Z&P  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 8HL_6"\OB*QW"@  S3,  !@
M             ("!:2<  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( &*+/UCT? G*J P  %Y5   8              " @18R  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !BBS]8O06*A?$"  !>
M"@  &               @('T/@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ 8HL_6(D:)RMN"@  EU,  !@              ("!&T(
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( &*+/UBZC&/V
MEP@  ),G   9              " @;],  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ 8HL_6-WB7;,R!@  '!4  !D
M ("!C54  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !B
MBS]8/_6)Q](Q  "YY   &0              @('V6P  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( &*+/UB#B++&_P,  ,<*   9
M          " @?^-  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#
M%     @ 8HL_6/N]:[.0 P  20H  !D              ("!-9(  'AL+W=O
M<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !BBS]8[Q9"J+($  !R
M#P  &0              @('\E0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM
M;%!+ 0(4 Q0    ( &*+/UB?::1Q< <  -08   9              " @>6:
M  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ 8HL_6&KI
M+=0T"@  >AX  !D              ("!C*(  'AL+W=O<FMS:&5E=',O<VAE
M970Q-RYX;6Q02P$"% ,4    " !BBS]8G_FWP- %  !)$   &0
M    @('WK   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M &*+/UBP:KE-I0@  !85   9              " @?ZR  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ 8HL_6 #Q6*])#0  >#(  !D
M             ("!VKL  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " !BBS]810\#&IX#  !A"   &0              @(%:R0  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( &*+/U@3HZ]?FA@
M (MN   9              " @2_-  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ 8HL_6($[RU5("@  ,QT  !D              ("!
M .8  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !BBS]8
M'WK'QOP"  #T"   &0              @(%_\   >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( &*+/UCJ+U>) 0,  )$)   9
M      " @;+S  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ 8HL_6!#L+$; *@  O(L  !D              ("!ZO8  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !BBS]8Z1%_9] %  !)$
M&0              @('A(0$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( &*+/UBNN<ET-C0  '?[   9              " @>@G 0!X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 8HL_6'S%4K5Y
M!   /PX  !D              ("!55P! 'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " !BBS]85MM(1,8#  #Y"0  &0
M@($%80$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( &*+
M/UB1O*]9? ,  &H)   9              " @0)E 0!X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ 8HL_6'C8TO$."@  91X  !D
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M=#,V+GAM;%!+ 0(4 Q0    ( &*+/UAV;V=VK ,  ,T.   9
M  " @6^( 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
M8HL_6"L/[,W[ P  EA4  !D              ("!4HP! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " !BBS]8<UZX.AX'  !,+@  &0
M            @(&$D $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( &*+/UAT;C,G\P0  .D@   9              " @=F7 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ 8HL_6,^E-A,@ P
MV L  !D              ("! YT! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " !BBS]8$1?&['D#  "+"P  &0              @(%:
MH $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( &*+/UA!
M/S:Q>P@  #E)   9              " @0JD 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ 8HL_6,.&E>[Q @  "PL  !D
M     ("!O*P! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &*+/UB\DH#_C0(  '$&   9              "
M@?:\ 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 8HL_
M6(2UB]N,!   1AL  !D              ("!NK\! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    " !BBS]8+37'AE\#   !#P  &0
M        @(%]Q $ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   ( &*+/UASSF@T- 0  *\3   9              " @1/( 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ 8HL_6.D8^XTM P  %@X
M !D              ("!?LP! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    " !BBS]8,L8"*5D"  "9!0  &0              @('BSP$
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( &*+/UA?/X%M
M' ,  -()   9              " @7+2 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ 8HL_6%1(X[UI @  QP8  !D
M ("!Q=4! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !B
MBS]8)5&70N8"  #P"0  &0              @(%EV $ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( &*+/UC_NC;8VP(  )@(   9
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M970V,BYX;6Q02P$"% ,4    " !BBS]8X3(>G1@%  #[(   &0
M    @(%=\0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (
M &*+/UA&EC%F$@,  .\+   9              " @:SV 0!X;"]W;W)K<VAE
M971S+W-H965T-C0N>&UL4$L! A0#%     @ 8HL_6'-&M3,.!   WPX  !D
M             ("!]?D! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"
M% ,4    " !BBS]8,F67D/H"  !-"   &0              @($Z_@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( &*+/UAQ/O$8> ,
M $ 1   9              " @6L! @!X;"]W;W)K<VAE971S+W-H965T-C<N
M>&UL4$L! A0#%     @ 8HL_6*5ZG-\J P  2A(   T              ( !
M&@4" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !BBS]8EXJ[',     3 @
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8;6Q02P4&     $L 2P"$%   &!,"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>190</ContextCount>
  <ElementCount>357</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/BalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StatementsOfOperations</Role>
      <ShortName>Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Stockholders Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StatementsOfStockholdersEquityDeficit</Role>
      <ShortName>Statements of Stockholders Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/BalanceSheetsStatement</Role>
      <ShortName>Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/BalanceSheetsParentheticalStatement</Role>
      <ShortName>Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Statement - Statements of Stockholders Equity (Deficit) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement</Role>
      <ShortName>Statements of Stockholders Equity (Deficit) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Statement - Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StatementsOfCashFlowsStatement</Role>
      <ShortName>Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Organization and Nature of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/OrganizationAndNatureOfOperations</Role>
      <ShortName>Organization and Nature of Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Liabilities for Sale of Future Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues</Role>
      <ShortName>Liabilities for Sale of Future Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Short-Term Revolving Loans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/Short-termRevolvingLoans</Role>
      <ShortName>Short-Term Revolving Loans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/Long-termDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Shareholder Promissory Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://expion360.com/role/ShareholderPromissoryNotes</Role>
      <ShortName>Shareholder Promissory Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://expion360.com/role/ConvertibleNotes</Role>
      <ShortName>Convertible Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Conversion to a C Corporation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/ConversionToCCorporation</Role>
      <ShortName>Conversion to a C Corporation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - 401(k) Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/KPlan</Role>
      <ShortName>401(k) Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Stockholder Promissory Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://expion360.com/role/StockholderPromissoryNotes</Role>
      <ShortName>Stockholder Promissory Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://expion360.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://expion360.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://expion360.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/Long-termDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://expion360.com/role/Long-termDebt</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://expion360.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Stockholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://expion360.com/role/StockholdersEquity</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://expion360.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Summary of Significant Accounting Policies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1</Role>
      <ShortName>Summary of Significant Accounting Policies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Summary of Significant Accounting Policies (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2</Role>
      <ShortName>Summary of Significant Accounting Policies (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Property and Equipment Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Property and Equipment, Net (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative</Role>
      <ShortName>Property and Equipment, Net (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Schedule of long-term debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/ScheduleOfLong-termDebtDetails</Role>
      <ShortName>Schedule of long-term debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Long-Term Debt (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/Long-termDebtDetails1</Role>
      <ShortName>Long-Term Debt (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/Long-termDebtTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Shareholder Promissory Notes (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative</Role>
      <ShortName>Shareholder Promissory Notes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/ShareholderPromissoryNotes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Commitments and Contingencies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/CommitmentsAndContingenciesDetails1</Role>
      <ShortName>Commitments and Contingencies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Commitments and Contingencies (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/CommitmentsAndContingenciesDetails2</Role>
      <ShortName>Commitments and Contingencies (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure -  Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure -  Stockholders Equity (Details1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails1</Role>
      <ShortName>Stockholders Equity (Details1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure -  Stockholders Equity (Details2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails2</Role>
      <ShortName>Stockholders Equity (Details2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure -  Stockholders Equity (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails3</Role>
      <ShortName>Stockholders Equity (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Stockholders??? Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>Stockholders??? Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/StockholdersEquityTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/IncomeTaxesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Income Taxes (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/IncomeTaxesDetails1</Role>
      <ShortName>Income Taxes (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/IncomeTaxesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Income Taxes (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/IncomeTaxesDetails2</Role>
      <ShortName>Income Taxes (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/IncomeTaxesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Income Taxes (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/IncomeTaxesDetails3</Role>
      <ShortName>Income Taxes (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/IncomeTaxesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/RelatedPartyTransactions</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Schedule of estimated useful lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails</Role>
      <ShortName>Schedule of estimated useful lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure</Role>
      <ShortName>Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/Long-termDebtDetails</Role>
      <ShortName>Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://expion360.com/role/Long-termDebtTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetailsDisclosure</Role>
      <ShortName>Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Stockholders Equity (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails1Disclosure</Role>
      <ShortName>Stockholders Equity (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Stockholders Equity (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails2Disclosure</Role>
      <ShortName>Stockholders Equity (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Stockholders Equity (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails3Disclosure</Role>
      <ShortName>Stockholders Equity (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="xpon_s-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Stockholders Equity (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://expion360.com/role/StockholdersEquityDetails4</Role>
      <ShortName>Stockholders Equity (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>xpon-20230930.xsd</File>
    <File>xpon-20230930_cal.xml</File>
    <File>xpon-20230930_def.xml</File>
    <File>xpon-20230930_lab.xml</File>
    <File>xpon-20230930_pre.xml</File>
    <File doctype="S-1/A" isDefinitelyFs="true" isUsgaap="true" original="xpon_s-1a.htm">xpon_s-1a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="956">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="11">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>86
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "xpon_s-1a.htm": {
   "nsprefix": "XPON",
   "nsuri": "http://expion360.com/20230930",
   "dts": {
    "schema": {
     "local": [
      "xpon-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "xpon-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "xpon-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "xpon-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xpon-20230930_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "xpon_s-1a.htm"
     ]
    }
   },
   "keyStandard": 259,
   "keyCustom": 98,
   "axisStandard": 8,
   "axisCustom": 0,
   "memberStandard": 12,
   "memberCustom": 24,
   "hidden": {
    "total": 148,
    "http://expion360.com/20230930": 49,
    "http://fasb.org/us-gaap/2023": 96,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 190,
   "entityCount": 1,
   "segmentCount": 38,
   "elementCount": 508,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 956,
    "http://xbrl.sec.gov/dei/2023": 11
   },
   "report": {
    "R1": {
     "role": "http://expion360.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://expion360.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Balance Sheets",
     "shortName": "Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://expion360.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Balance Sheets (Parenthetical)",
     "shortName": "Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://expion360.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Statements of Operations",
     "shortName": "Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-01-012021-12-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
     "longName": "00000005 - Statement - Statements of Stockholders Equity (Deficit)",
     "shortName": "Statements of Stockholders Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-01-012021-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://expion360.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Statements of Cash Flows",
     "shortName": "Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://expion360.com/role/BalanceSheetsStatement",
     "longName": "00000007 - Statement - Balance Sheets (Unaudited)",
     "shortName": "Balance Sheets (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:NotesPayableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://expion360.com/role/BalanceSheetsParentheticalStatement",
     "longName": "00000008 - Statement - Balance Sheets (Unaudited) (Parenthetical)",
     "shortName": "Balance Sheets (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement",
     "longName": "00000009 - Statement - Statements of Stockholders Equity (Deficit) (Unaudited)",
     "shortName": "Statements of Stockholders Equity (Deficit) (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember",
      "name": "us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://expion360.com/role/StatementsOfCashFlowsStatement",
     "longName": "00000010 - Statement - Statements of Cash Flows (Unaudited)",
     "shortName": "Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://expion360.com/role/OrganizationAndNatureOfOperations",
     "longName": "00000011 - Disclosure - Organization and Nature of Operations",
     "shortName": "Organization and Nature of Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://expion360.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000012 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://expion360.com/role/PropertyAndEquipmentNet",
     "longName": "00000013 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities",
     "longName": "00000014 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues",
     "longName": "00000015 - Disclosure - Liabilities for Sale of Future Revenues",
     "shortName": "Liabilities for Sale of Future Revenues",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://expion360.com/role/Short-termRevolvingLoans",
     "longName": "00000016 - Disclosure - Short-Term Revolving Loans",
     "shortName": "Short-Term Revolving Loans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://expion360.com/role/Long-termDebt",
     "longName": "00000017 - Disclosure - Long-Term Debt",
     "shortName": "Long-Term Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://expion360.com/role/ShareholderPromissoryNotes",
     "longName": "00000018 - Disclosure - Shareholder Promissory Notes",
     "shortName": "Shareholder Promissory Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:ShareholderPromissoryNotesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R19": {
     "role": "http://expion360.com/role/ConvertibleNotes",
     "longName": "00000019 - Disclosure - Convertible Notes",
     "shortName": "Convertible Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ConvertibleNotesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ConvertibleNotesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://expion360.com/role/CommitmentsAndContingencies",
     "longName": "00000020 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://expion360.com/role/ConversionToCCorporation",
     "longName": "00000021 - Disclosure - Conversion to a C Corporation",
     "shortName": "Conversion to a C Corporation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ConversionOfStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ConversionOfStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://expion360.com/role/StockholdersEquity",
     "longName": "00000022 - Disclosure - Stockholders\u2019 Equity",
     "shortName": "Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://expion360.com/role/IncomeTaxes",
     "longName": "00000023 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://expion360.com/role/KPlan",
     "longName": "00000024 - Disclosure - 401(k) Plan",
     "shortName": "401(k) Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:DefinedBenefitPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:DefinedBenefitPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://expion360.com/role/RelatedPartyTransactions",
     "longName": "00000025 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://expion360.com/role/SubsequentEvents",
     "longName": "00000026 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://expion360.com/role/StockholderPromissoryNotes",
     "longName": "00000027 - Disclosure - Stockholder Promissory Notes",
     "shortName": "Stockholder Promissory Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:ShareholderPromissoryNotesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R28": {
     "role": "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000028 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000029 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ScheduleOfEstimatedUsfulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ScheduleOfEstimatedUsfulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://expion360.com/role/PropertyAndEquipmentNetTables",
     "longName": "00000030 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables",
     "longName": "00000031 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://expion360.com/role/Long-termDebtTables",
     "longName": "00000032 - Disclosure - Long-Term Debt (Tables)",
     "shortName": "Long-Term Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://expion360.com/role/CommitmentsAndContingenciesTables",
     "longName": "00000033 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://expion360.com/role/StockholdersEquityTables",
     "longName": "00000034 - Disclosure - Stockholders\u2019 Equity (Tables)",
     "shortName": "Stockholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://expion360.com/role/IncomeTaxesTables",
     "longName": "00000035 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails",
     "longName": "00000036 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_OfficeEquipmentMember_srt_MinimumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfEstimatedUsfulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
     "longName": "00000037 - Disclosure - Summary of Significant Accounting Policies (Details 1)",
     "shortName": "Summary of Significant Accounting Policies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:NetLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:NetLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2",
     "longName": "00000038 - Disclosure - Summary of Significant Accounting Policies (Details 2)",
     "shortName": "Summary of Significant Accounting Policies (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ProccedsFromIpoNetsCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "XPON:LiquidityAndCapitalResourcesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "XPON:ProccedsFromIpoNetsCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "XPON:LiquidityAndCapitalResourcesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://expion360.com/role/PropertyAndEquipmentNetDetails",
     "longName": "00000040 - Disclosure - Property and Equipment Net (Details)",
     "shortName": "Property and Equipment Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R41": {
     "role": "http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative",
     "longName": "00000041 - Disclosure - Property and Equipment, Net (Details Narrative)",
     "shortName": "Property and Equipment, Net (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-07-012023-09-30",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "longName": "00000042 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://expion360.com/role/ScheduleOfLong-termDebtDetails",
     "longName": "00000043 - Disclosure - Schedule of long-term debt (Details)",
     "shortName": "Schedule of long-term debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-09-30",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31",
      "name": "XPON:LessNotePayableInDefaultPaid",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://expion360.com/role/Long-termDebtDetails1",
     "longName": "00000044 - Disclosure - Long-Term Debt (Details 1)",
     "shortName": "Long-Term Debt (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative",
     "longName": "00000045 - Disclosure - Shareholder Promissory Notes (Details Narrative)",
     "shortName": "Shareholder Promissory Notes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:OtherMinorityInterests",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "XPON:ShareholderPromissoryNotesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:OtherMinorityInterests",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "XPON:ShareholderPromissoryNotesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://expion360.com/role/CommitmentsAndContingenciesDetails",
     "longName": "00000046 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-07-012023-09-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://expion360.com/role/CommitmentsAndContingenciesDetails1",
     "longName": "00000047 - Disclosure - Commitments and Contingencies (Details 1)",
     "shortName": "Commitments and Contingencies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://expion360.com/role/CommitmentsAndContingenciesDetails2",
     "longName": "00000048 - Disclosure - Commitments and Contingencies (Details 2)",
     "shortName": "Commitments and Contingencies (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000049 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://expion360.com/role/StockholdersEquityDetails",
     "longName": "00000050 - Disclosure -  Stockholders Equity (Details)",
     "shortName": "Stockholders Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://expion360.com/role/StockholdersEquityDetails1",
     "longName": "00000051 - Disclosure -  Stockholders Equity (Details1)",
     "shortName": "Stockholders Equity (Details1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R52": {
     "role": "http://expion360.com/role/StockholdersEquityDetails2",
     "longName": "00000052 - Disclosure -  Stockholders Equity (Details2)",
     "shortName": "Stockholders Equity (Details2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "XPON:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "XPON:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://expion360.com/role/StockholdersEquityDetails3",
     "longName": "00000053 - Disclosure -  Stockholders Equity (Details 3)",
     "shortName": "Stockholders Equity (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R54": {
     "role": "http://expion360.com/role/StockholdersEquityDetailsNarrative",
     "longName": "00000054 - Disclosure - Stockholders\u2019 Equity (Details Narrative)",
     "shortName": "Stockholders\u2019 Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://expion360.com/role/IncomeTaxesDetails",
     "longName": "00000055 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://expion360.com/role/IncomeTaxesDetails1",
     "longName": "00000056 - Disclosure - Income Taxes (Details 1)",
     "shortName": "Income Taxes (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://expion360.com/role/IncomeTaxesDetails2",
     "longName": "00000057 - Disclosure - Income Taxes (Details 2)",
     "shortName": "Income Taxes (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://expion360.com/role/IncomeTaxesDetails3",
     "longName": "00000058 - Disclosure - Income Taxes (Details 3)",
     "shortName": "Income Taxes (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000059 - Disclosure - Related Party Transactions (Details Narrative)",
     "shortName": "Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "XPON:AccountsPayableRelatedPartiesCurrentOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "XPON:AccountsPayableRelatedPartiesCurrentOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
     "longName": "00000060 - Disclosure - Schedule of estimated useful lives (Details)",
     "shortName": "Schedule of estimated useful lives (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_custom_OfficeFurnitureAndEquipmentMember_srt_MinimumMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
     "longName": "00000061 - Disclosure - Property and Equipment, Net (Details)",
     "shortName": "Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R62": {
     "role": "http://expion360.com/role/Long-termDebtDetails",
     "longName": "00000062 - Disclosure - Long-Term Debt (Details)",
     "shortName": "Long-Term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R63": {
     "role": "http://expion360.com/role/StockholdersEquityDetailsDisclosure",
     "longName": "00000063 - Disclosure - Stockholders Equity (Details)",
     "shortName": "Stockholders Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30_custom_ExercisePrice1Member",
      "name": "XPON:NumberOfWarrantsnonplanOptionsOne",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_custom_ExercisePrice1Member",
      "name": "XPON:NumberOfWarrantsnonplanOptionsOne",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://expion360.com/role/StockholdersEquityDetails1Disclosure",
     "longName": "00000064 - Disclosure - Stockholders Equity (Details 1)",
     "shortName": "Stockholders Equity (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R65": {
     "role": "http://expion360.com/role/StockholdersEquityDetails2Disclosure",
     "longName": "00000065 - Disclosure - Stockholders Equity (Details 2)",
     "shortName": "Stockholders Equity (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-09-30",
      "name": "XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://expion360.com/role/StockholdersEquityDetails3Disclosure",
     "longName": "00000066 - Disclosure - Stockholders Equity (Details 3)",
     "shortName": "Stockholders Equity (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://expion360.com/role/StockholdersEquityDetails4",
     "longName": "00000067 - Disclosure - Stockholders Equity (Details 4)",
     "shortName": "Stockholders Equity (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2023-09-30",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xpon_s-1a.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "XPON_AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Guidance Issued but Not Yet Adopted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses and Other Current Liabilities",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r519"
     ]
    },
    "XPON_AccountsPayableRelatedPartiesCurrentOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AccountsPayableRelatedPartiesCurrentOne",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payables liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r218"
     ]
    },
    "XPON_AccruedInterestOnConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AccruedInterestOnConvertibleNote",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest on convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses and other current liabilities",
        "verboseLabel": "Accrued expenses and other current liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedSalesCommissionCurrent",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commissions",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r502"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated depreciation",
        "negatedTerseLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r142",
      "r400"
     ]
    },
    "XPON_AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition/modification of operating lease right-of-use asset and lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r519",
      "r617"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r426",
      "r571",
      "r572",
      "r573",
      "r600",
      "r619"
     ]
    },
    "XPON_AdjustmentsToBadDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AdjustmentsToBadDebtExpense",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to BadDebt Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising and Marketing Costs",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "XPON_AggregateIntrinsicValueForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AggregateIntrinsicValueForfeited",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value forfeited"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r322"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails",
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of debt discount - notes",
        "verboseLabel": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r60",
      "r85",
      "r266"
     ]
    },
    "XPON_AmortizationOfDebtDiscountSaleOfFutureRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AmortizationOfDebtDiscountSaleOfFutureRevenues",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of debt discount (sale of future revenues)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets [Default Label]",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r144",
      "r168",
      "r195",
      "r208",
      "r212",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r343",
      "r345",
      "r358",
      "r394",
      "r449",
      "r519",
      "r531",
      "r589",
      "r590",
      "r606"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r150",
      "r168",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r343",
      "r345",
      "r358",
      "r519",
      "r589",
      "r590",
      "r606"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://expion360.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r140",
      "r499"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning",
        "periodEndLabel": "Cash and cash equivalents, ending",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r87",
      "r164"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net change in cash and cash equivalents",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r87"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash balances exceeded FDIC",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_CashPaidRefundedForFranchiseTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "CashPaidRefundedForFranchiseTaxes",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid / (refunded) for franchise taxes"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_CashlessWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "CashlessWarrantExercises",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cashless warrant exercises"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r229",
      "r230",
      "r495",
      "r586"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total shares of common stock reserved for future issuances",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r571",
      "r572",
      "r600",
      "r616",
      "r619"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsParenthetical",
      "http://expion360.com/role/BalanceSheetsParentheticalStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsParenthetical",
      "http://expion360.com/role/BalanceSheetsParentheticalStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r437"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsParenthetical",
      "http://expion360.com/role/BalanceSheetsParentheticalStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsParenthetical",
      "http://expion360.com/role/BalanceSheetsParentheticalStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r72",
      "r437",
      "r455",
      "r619",
      "r620"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value $.001; 200,000,000 shares authorized; 6,802,464 and 4,300,000 issued and outstanding as of December 31, 2022 and 2021, respectively",
        "verboseLabel": "Common stock, par value $.001; 200,000,000 shares authorized; 6,910,717 and 6,802,464 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r396",
      "r519"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Major Customers",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r126"
     ]
    },
    "XPON_ConversionOfConvertibleNotesIntoCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ConversionOfConvertibleNotesIntoCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of 2021 convertible notes into common stock"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ConversionOfStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ConversionOfStockTextBlock",
     "presentation": [
      "http://expion360.com/role/ConversionToCCorporation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion to a C Corporation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-term debt, net of current portion and discount",
        "label": "Convertible Debt, Noncurrent",
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "XPON_ConvertibleNotesAndAccruedInterestConvertedToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ConvertibleNotesAndAccruedInterestConvertedToCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes and accrued interest converted to common stock"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ConvertibleNotesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ConvertibleNotesTextBlock",
     "presentation": [
      "http://expion360.com/role/ConvertibleNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible Notes",
        "label": "ConvertibleNotesTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r168",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r358",
      "r589"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r570",
      "r598"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State Franchise Fees",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r570",
      "r598"
     ]
    },
    "us-gaap_CustomerDepositsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerDepositsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits",
        "verboseLabel": "Customer deposits",
        "documentation": "The current portion of money or property received from customers which is either to be returned upon satisfactory contract completion or applied to customer receivables in accordance with the terms of the contract or the understandings."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "XPON_CustomerDepositsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "CustomerDepositsPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionOriginalDebtAmount1",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversion expense",
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34"
     ]
    },
    "us-gaap_DebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt, Current",
        "label": "Debt, Current",
        "documentation": "Amount of debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://expion360.com/role/Short-termRevolvingLoans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Revolving Loans",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r166",
      "r244",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r260",
      "r267",
      "r268",
      "r270"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r61",
      "r263"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r269",
      "r366",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r568"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r67"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r47",
      "r48",
      "r60",
      "r61",
      "r63",
      "r66",
      "r98",
      "r99",
      "r170",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r269",
      "r366",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r568"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Unamortized Discount, Current",
        "negatedLabel": "Debt Instrument, Unamortized Discount, Current",
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r63"
     ]
    },
    "XPON_DeferredIncomeAndDepositSublease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DeferredIncomeAndDepositSublease",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income and deposit (sublease)"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_DeferredIncomeAndSubleaseDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DeferredIncomeAndSubleaseDeposit",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income and sublease deposit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGrossAbstract",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net deferred tax asset",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subtotal",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r597"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax provision at federal statutory rate",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r597"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "State taxes",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r597"
     ]
    },
    "XPON_DeferredTaxAssetsTaxCreditCarryforwardsOthers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsOthers",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "DeferredTaxAssetsTaxCreditCarryforwardsOthers"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r597"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r597"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r597"
     ]
    },
    "XPON_DeferredTaxAssetsValuationAllowanceOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DeferredTaxAssetsValuationAllowanceOne",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "DeferredTaxAssetsValuationAllowanceOne"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanTextBlock",
     "presentation": [
      "http://expion360.com/role/KPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "401(k) Plan",
        "documentation": "The entire disclosure for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r389",
      "r516"
     ]
    },
    "us-gaap_DepositContractsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositContractsAssets",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposit",
        "documentation": "Carrying amount of assets as of the balance sheet date pertaining to amounts paid by the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228"
     ]
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r41"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r41"
     ]
    },
    "XPON_DisclosureConversionToCCorporationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DisclosureConversionToCCorporationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion To C Corporation"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_DisclosureConvertibleNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DisclosureConvertibleNotesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DisclosureLiabilitiesForSaleOfFutureRevenuesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities For Sale Of Future Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_DisclosureShareholderPromissoryNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DisclosureShareholderPromissoryNotesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Promissory Notes"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_DisclosureStockholderPromissoryNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DisclosureStockholderPromissoryNotesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder Promissory Notes"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_DisposalsAndSalesOfFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "DisposalsAndSalesOfFixedAssets",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposals and sales of fixed assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r545",
      "r546"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Net Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36"
     ]
    },
    "XPON_EffectOfInducedConversionOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "EffectOfInducedConversionOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of induced conversion of debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationBeatPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationBeatPercent",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NQSO Comp \u2013 Other",
        "documentation": "Percentage of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to base erosion and anti-abuse tax (BEAT)."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r599"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationFdiiPercent",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EQ Comp \u2013 Other",
        "documentation": "Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII)."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "True-up Adjustment",
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal statutory tax rate",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r599"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State taxes, net of federal tax benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax settlement."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r599"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued salaries and payroll liabilities",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r134",
      "r154",
      "r155",
      "r156",
      "r171",
      "r172",
      "r173",
      "r175",
      "r183",
      "r185",
      "r194",
      "r220",
      "r223",
      "r286",
      "r319",
      "r320",
      "r321",
      "r336",
      "r337",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r378",
      "r406",
      "r407",
      "r408",
      "r426",
      "r478"
     ]
    },
    "XPON_ExerciseOfWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ExerciseOfWarrantsShares",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise of warrants",
        "label": "ExerciseOfWarrantsShares"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ExercisePrice1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ExercisePrice1Member",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ExercisePrice2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ExercisePrice2Member",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ExercisePrice3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ExercisePrice3Member",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ExercisePrice4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ExercisePrice4Member",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ExercisePrice5Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ExercisePrice5Member",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 5 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ExercisePricesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ExercisePricesMember",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Prices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtendedProductWarrantyPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtendedProductWarrantyPolicy",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties",
        "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FDICIndemnificationAssetPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FDICIndemnificationAssetPeriodIncreaseDecrease",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FDIC Limits",
        "documentation": "Change in carrying amount of the indemnification asset relating to loss sharing agreements with the Federal Deposit Insurance Corporation (FDIC). The change includes for example, but is not limited to, acquisitions, additional estimated losses, disposals, cash payments, accretion of discount and write-offs, net of recoveries."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r15"
     ]
    },
    "XPON_FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of warrants issued in connection with long-term debt recorded as debt discount and additional paid-in capital"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_FranchiseTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "FranchiseTax",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Franchise tax"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_FranchiseTaxesRefund": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "FranchiseTaxesRefund",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Franchise taxes / (refund)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FutureMinimumSubleaseRentalsSaleLeasebackTransactions",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total future minimum lease payments",
        "documentation": "Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2024",
        "label": "Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next 12 Months",
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Three Years",
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Two Years",
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "XPON_GMFinancialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "GMFinancialMember",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "G M Financial [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on sale of property and equipment",
        "label": "(Gain) / Loss on sale of property and equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on sale of property and equipment",
        "verboseLabel": "(Gain) / Loss on sale of property &amp; equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossRelatedToLitigationSettlement",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Stock-based settlement",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguishment loss on debt settlement",
        "verboseLabel": "Extinguishment loss on debt settlement",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r45",
      "r46"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r168",
      "r195",
      "r207",
      "r211",
      "r213",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r358",
      "r506",
      "r589"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r94"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r78",
      "r111",
      "r195",
      "r207",
      "r211",
      "r213",
      "r391",
      "r402",
      "r506"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://expion360.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r325",
      "r330",
      "r331",
      "r334",
      "r338",
      "r340",
      "r341",
      "r342",
      "r422"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax (income) / expense",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r132",
      "r184",
      "r185",
      "r199",
      "r328",
      "r339",
      "r404"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r326",
      "r327",
      "r331",
      "r332",
      "r333",
      "r335",
      "r418"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for franchise taxes",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase / (Decrease) in accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Increase) / Decrease in accounts receivable",
        "label": "(Increase) / Decrease in accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase / (Decrease) in accrued expenses and other current liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "XPON_IncreaseDecreaseInAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IncreaseDecreaseInAllowanceForDoubtfulAccounts",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Increase / (Decrease) in allowance for doubtful accounts",
        "label": "IncreaseDecreaseInAllowanceForDoubtfulAccounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInCustomerDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInCustomerDeposits",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Decrease) in customer deposits",
        "documentation": "The increase (decrease) during the period in the amount of customer money held in customer accounts, including security deposits, collateral for a current or future transactions, initial payment of the cost of acquisition or for the right to enter into a contract or agreement."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeposits",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) in deposits",
        "verboseLabel": "(Increase) / Decrease in deposits",
        "documentation": "The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r65"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Increase) in inventory",
        "label": "(Increase) / Decrease in inventory",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "XPON_IncreaseDecreaseInLiabilityForRefunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IncreaseDecreaseInLiabilityForRefunds",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Decrease) in liability for refunds",
        "label": "IncreaseDecreaseInLiabilityForRefunds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in accrued expenses and other current liabilities",
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherDeposits",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase / (Decrease) in customer deposits",
        "documentation": "Amount of increase (decrease) in deposit liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in prepaid/in-transit inventory",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      },
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Increase) in prepaid expenses and other current assets",
        "negatedTerseLabel": "Increase in prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "XPON_IncreaseDecreaseInPrepaidintransitInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IncreaseDecreaseInPrepaidintransitInventory",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Increase) / Decrease in prepaid/in-transit inventory",
        "label": "IncreaseDecreaseInPrepaidintransitInventory"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IncreaseInAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IncreaseInAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in allowance for doubtful accounts"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IncreaseInRightofuseAssetsAndLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IncreaseInRightofuseAssetsAndLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      },
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in right-of-use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InducedConversionOfConvertibleDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InducedConversionOfConvertibleDebtExpense",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversion expense on induced conversion of convertible notes",
        "documentation": "Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_InterestAndOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestAndOtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest income",
        "label": "Interest and Other Income",
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r113",
      "r157",
      "r198",
      "r365",
      "r463",
      "r529",
      "r618"
     ]
    },
    "us-gaap_InterestPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaid",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash paid for interest",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r162",
      "r163"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Finished Goods",
        "verboseLabel": "Finished Inventory",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r500",
      "r519"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r139",
      "r148",
      "r224",
      "r225",
      "r226",
      "r388",
      "r503"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "XPON_IssuanceOfCommonStockInExchangeForPropertyAndequipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfCommonStockInExchangeForPropertyAndequipment",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock in exchange for property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfDetachableWarrantsToLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfDetachableWarrantsToLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of detachable warrants to long-term debt"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfOptionsInExchangeForServicesOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfOptionsInExchangeForServicesOne",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of options in exchange for services"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfRestrictedStockUnit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfRestrictedStockUnit",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of RSUs"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares, initial public offering, net of issuance costs"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of shares, initial public offering, net of issuance costs",
        "label": "Issuance of shares, initial public offering, net of issuance costs [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesInExchangeForBuildingSignage": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesInExchangeForBuildingSignage",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of shares in exchange for building signage",
        "label": "IssuanceOfSharesInExchangeForBuildingSignage"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesInExchangeForBuildingSignageValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesInExchangeForBuildingSignageValue",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares in exchange for building signage"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesInExchangeForIPOServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesInExchangeForIPOServices",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of shares in exchange for IPO services",
        "label": "Issuance of shares in exchange for IPO services [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesInExchangeForIPOServicesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesInExchangeForIPOServicesAmount",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares in exchange for IPO services"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesUponSettlementOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesUponSettlementOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares upon settlement of convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfSharesUponSettlementOfConvertibleNotesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfSharesUponSettlementOfConvertibleNotesShares",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of shares upon settlement of convertible notes",
        "label": "Issuance of shares upon settlement of convertible notes [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options granted",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "XPON_IssuanceOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfWarrantsInExchangeForServicesOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfWarrantsInExchangeForServicesOne",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of warrants in exchange for services"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_IssuanceOfWarrantsToUnderwriters": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "IssuanceOfWarrantsToUnderwriters",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of warrants to underwriters"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r518"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of lease cost",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "XPON_LessNotePayableInDefaultPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "LessNotePayableInDefaultPaid",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less note payable in default (paid April 2022)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total future minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r168",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r344",
      "r345",
      "r346",
      "r358",
      "r436",
      "r505",
      "r531",
      "r589",
      "r606",
      "r607"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Total liabilities and stockholders\u2019 equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r110",
      "r398",
      "r519",
      "r569",
      "r581",
      "r602"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r138",
      "r168",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r344",
      "r345",
      "r346",
      "r358",
      "r519",
      "r589",
      "r606",
      "r607"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_LiabilitiesForSaleOfFutureRevenuesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "LiabilitiesForSaleOfFutureRevenuesTextBlock",
     "presentation": [
      "http://expion360.com/role/LiabilitiesForSaleOfFutureRevenues"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities for Sale of Future Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_LiabilityForRefundsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "LiabilityForRefundsPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Refunds"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_LiabilityForSaleOfFutureRevenuesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "LiabilityForSaleOfFutureRevenuesNet",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for sale of future revenues, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit and short-term revolving loans",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r108"
     ]
    },
    "XPON_LiquidityAndCapitalResourcesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "LiquidityAndCapitalResourcesPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Going Concern, Liquidity and Capital Resources"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationSettlementExpense",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement expense",
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/Long-termDebtDetails1",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-Term Debt",
        "label": "Total",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r109",
      "r257",
      "r271",
      "r511",
      "r512",
      "r615"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current portion of long-term debt",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "XPON_LongTermDebtCurrent1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "LongTermDebtCurrent1",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of long-term debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturingInYearsTwoAndThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturingInYearsTwoAndThree",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second and third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r592"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r170",
      "r262"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r170",
      "r262"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r170",
      "r262"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r170",
      "r262"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r170",
      "r262"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term debt, net of current portion and discount",
        "verboseLabel": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://expion360.com/role/Long-termDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r43"
     ]
    },
    "XPON_ManufacturingEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ManufacturingEquipmentMember",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketingAndAdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising and marketing expense",
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r289",
      "r387",
      "r405",
      "r428",
      "r429",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r496",
      "r497",
      "r508",
      "r515",
      "r517",
      "r520",
      "r591",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ]
    },
    "XPON_MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Membership contributions reclassified to additional paid-in capital upon conversion to C corporation"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r289",
      "r387",
      "r405",
      "r428",
      "r429",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r496",
      "r497",
      "r508",
      "r515",
      "r517",
      "r520",
      "r591",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://expion360.com/role/OrganizationAndNatureOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Nature of Operations",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r133"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net cash provided by / (used in) financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net cash provided by / (used in) investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities",
        "verboseLabel": "Cash flows\u00a0from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "label": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r89",
      "r112",
      "r136",
      "r151",
      "r152",
      "r156",
      "r168",
      "r174",
      "r176",
      "r177",
      "r179",
      "r180",
      "r184",
      "r185",
      "r189",
      "r195",
      "r207",
      "r211",
      "r213",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r357",
      "r358",
      "r403",
      "r457",
      "r476",
      "r477",
      "r506",
      "r529",
      "r589"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r176",
      "r177",
      "r179",
      "r180",
      "r187",
      "r188",
      "r190",
      "r191",
      "r195",
      "r207",
      "r211",
      "r213",
      "r506"
     ]
    },
    "XPON_NetLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NetLoss",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss",
        "label": "NetLoss"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NetLossOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NetLossOne",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss",
        "label": "NetLossOne"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NetLossPerShareBasicAndDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NetLossPerShareBasicAndDiluted",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per share (basic and diluted)",
        "verboseLabel": "Basic and diluted net loss per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NonCashOperatingActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NonCashOperatingActivities",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total other (income) / expense",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other (Income) / Expense"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NotePayableCreditUnionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NotePayableCreditUnionMember",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable Credit Union [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NotePayableFinanceCompany1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NotePayableFinanceCompany1Member",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable Finance Company 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NotePayableFinanceCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NotePayableFinanceCompanyMember",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable Finance Company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NotePayableIndividualMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NotePayableIndividualMember",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable Individual [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NotePayableSBAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NotePayableSBAMember",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable S B A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder promissory notes, net of current portion",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r109",
      "r615"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of stockholder promissory notes",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "XPON_NotesPayableCurrent1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NotesPayableCurrent1",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note payable in default"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableToBanksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableToBanksMember",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable to Banks [Member]",
        "documentation": "A written promise to pay a note to a bank."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NumberOfWarrantsnonplanOptionsFour": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NumberOfWarrantsnonplanOptionsFour",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsnonplanOptionsFour-0]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NumberOfWarrantsnonplanOptionsOne": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NumberOfWarrantsnonplanOptionsOne",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsnonplanOptionsOne-0]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NumberOfWarrantsnonplanOptionsThree": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NumberOfWarrantsnonplanOptionsThree",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsnonplanOptionsThree-0]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_NumberOfWarrantsnonplanOptionsTwo": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "NumberOfWarrantsnonplanOptionsTwo",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsnonplanOptionsTwo-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_OfficeFurnitureAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "OfficeFurnitureAndEquipmentMember",
     "presentation": [
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Furniture And Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_OfficeFurnitureEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "OfficeFurnitureEquipmentMember",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Furniture Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r207",
      "r211",
      "r213",
      "r506"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r518"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of operating lease liability",
        "verboseLabel": "Current lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability, net of current portion",
        "verboseLabel": "Noncurrent lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases \u2013 right-of-use asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasesRentExpenseNet",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sub Rental Income",
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Operating Losses",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_OptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OptionMember",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Held [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received)."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r445",
      "r450",
      "r466",
      "r472",
      "r489",
      "r490",
      "r491",
      "r521",
      "r522"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of expenses incurred but not yet paid classified as other."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other assets",
        "label": "Other Assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r143",
      "r393",
      "r531"
     ]
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventoryInTransit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInventoryInTransit",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid/in-transit inventory",
        "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_OtherInventoryNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInventoryNetOfReserves",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "inventory",
        "documentation": "Amount, after of valuation reserves and allowances, of inventory, classified as other, expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r561"
     ]
    },
    "us-gaap_OtherMinorityInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherMinorityInterests",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/ShareholderPromissoryNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid to the shareholders",
        "documentation": "Carrying amount of equity interests owned by noncontrolling shareholders, partners, or other equity holders in one or more of the entities consolidated into the reporting entity's financial statements other than joint ventures, limited partnerships, operating partnerships or interests held by preferred unit holders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOperatingIncome",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other income",
        "label": "Other Operating Income",
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOperatingIncomeExpenseNet",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other (income) / expense",
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping and handling fee",
        "documentation": "Amount of selling, general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from sale of property and equipment",
        "verboseLabel": "Net proceeds from sale of property and equipment",
        "documentation": "The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_PaymentsOnLiabilityForSaleOfFutureRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "PaymentsOnLiabilityForSaleOfFutureRevenues",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments on liability for sale of future revenues"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_PaymentsOnLineofcreditAndShorttermRevolvingLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "PaymentsOnLineofcreditAndShorttermRevolvingLoans",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments on line-of-credit and short-term revolving loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsParenthetical",
      "http://expion360.com/role/BalanceSheetsParentheticalStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r273"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsParenthetical",
      "http://expion360.com/role/BalanceSheetsParentheticalStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r437"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value $.001; 20,000,000 shares authorized; zero shares issued and outstanding",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r395",
      "r519"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of Prior Year Presentation",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "XPON_ProccedsFromIpoNetsCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ProccedsFromIpoNetsCost",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Procceds from IPO nets cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of convertible notes, net of discount",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of long-term debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepurchaseOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from Warrants",
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ProceedsFromSaleOfFutureRevenuesNetOfDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ProceedsFromSaleOfFutureRevenuesNetOfDiscount",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of future revenues, net of discount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from exercise of warrants",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "XPON_ProceedsReceivedFromExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ProceedsReceivedFromExerciseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds received from exercise of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ProceedsReceivedFromExerciseOfWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ProceedsReceivedFromExerciseOfWarrantsShares",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds received from exercise of warrants",
        "label": "ProceedsReceivedFromExerciseOfWarrantsShares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment, Net",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r127",
      "r130",
      "r131"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment",
        "verboseLabel": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r141",
      "r401"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r392",
      "r401",
      "r519"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r127",
      "r130",
      "r399"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property and equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2024",
        "label": "Purchase Obligation, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of purchase arrangement to be paid in remainder of current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased of property and equipment in exchange for short-term payable"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of property and equipment in exchange for short-term payable",
        "verboseLabel": "Purchases of property and equipment in exchange for long-term debt"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of property and equipment in exchange for long-term debt"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_QAEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "QAEquipmentMember",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Q A Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_RSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "RSUMember",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R S U [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r288",
      "r289",
      "r314",
      "r315",
      "r316",
      "r386",
      "r387",
      "r405",
      "r428",
      "r429",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r496",
      "r497",
      "r508",
      "r515",
      "r517",
      "r520",
      "r523",
      "r585",
      "r591",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r234",
      "r288",
      "r289",
      "r314",
      "r315",
      "r316",
      "r386",
      "r387",
      "r405",
      "r428",
      "r429",
      "r485",
      "r486",
      "r487",
      "r488",
      "r492",
      "r496",
      "r497",
      "r508",
      "r515",
      "r517",
      "r520",
      "r523",
      "r585",
      "r591",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ]
    },
    "XPON_RebateLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "RebateLiability",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rebate liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r578",
      "r579",
      "r580"
     ]
    },
    "XPON_ReclassificationOfAccruedInterestToLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ReclassificationOfAccruedInterestToLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of accrued interest to long-term debt"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ReclassificationOfDepositToPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ReclassificationOfDepositToPropertyAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of deposit to property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ReclassificationOfModifiedConvertibleNoteToLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ReclassificationOfModifiedConvertibleNoteToLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of modified convertible note to long-term debt"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of modified member promissory note to convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://expion360.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r423",
      "r424",
      "r425",
      "r460",
      "r461",
      "r462",
      "r482",
      "r484"
     ]
    },
    "XPON_RelatedPartyTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "RelatedPartyTransactionsTextBlock",
     "presentation": [
      "http://expion360.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Related Party Transactions",
        "label": "RelatedPartyTransactionsTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on line of credit and short-term revolving loans",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r568"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      },
      "http://expion360.com/role/StatementsOfCashFlowsStatement": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows",
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments on long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r420"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r324",
      "r614"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": [
      "r135",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r193",
      "r221",
      "r222",
      "r337",
      "r354",
      "r355",
      "r356",
      "r357",
      "r367",
      "r377",
      "r378",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r135",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r193",
      "r221",
      "r222",
      "r337",
      "r354",
      "r355",
      "r356",
      "r357",
      "r367",
      "r377",
      "r378",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r100",
      "r397",
      "r410",
      "r415",
      "r421",
      "r438",
      "r519"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r171",
      "r172",
      "r173",
      "r175",
      "r183",
      "r185",
      "r220",
      "r223",
      "r319",
      "r320",
      "r321",
      "r336",
      "r337",
      "r347",
      "r349",
      "r350",
      "r352",
      "r355",
      "r406",
      "r408",
      "r426",
      "r619"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r498",
      "r504"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales, net",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r168",
      "r196",
      "r197",
      "r206",
      "r209",
      "r210",
      "r214",
      "r215",
      "r216",
      "r219",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r358",
      "r391",
      "r589"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]"
       }
      }
     },
     "auth_ref": [
      "r135",
      "r171",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r185",
      "r193",
      "r337",
      "r354",
      "r355",
      "r356",
      "r367",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r552",
      "r553",
      "r554",
      "r555",
      "r574",
      "r582",
      "r583",
      "r601",
      "r604",
      "r605"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://expion360.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accrued expenses and other current liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of anti-dilutive share",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "XPON_ScheduleOfCommonStockReservedForIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of common stock shares reserved for future issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://expion360.com/role/Long-termDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of long term debt payment",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net loss per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income before Income Tax, Domestic and Foreign",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "XPON_ScheduleOfEstimatedUsefulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of estimated useful lives",
        "label": "ScheduleOfEstimatedUsefulLivesTableTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ScheduleOfEstimatedUsfulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ScheduleOfEstimatedUsfulLivesTableTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful lives"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of future minimum sublease payments",
        "documentation": "Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of future minimum lease payment",
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Income before Income Tax, Domestic and Foreign",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://expion360.com/role/Long-termDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturities of Long-Term Debt",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r51"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of assumptions used",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "XPON_ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of various warrants/options issued and outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r215",
      "r507"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://expion360.com/role/BalanceSheetsStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "XPON_SeniorSecuredPromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "SeniorSecuredPromissoryNotesMember",
     "presentation": [
      "http://expion360.com/role/Long-termDebtDetails",
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Secured Promissory Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://expion360.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Expected dividends",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk free rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r316"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable shares",
        "documentation": "Other increase (decrease) in number of shares reserved for issuance under non-option equity instrument agreements that is not separately disclosed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable at end of period",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price forfeited",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value granted",
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Aggregate intrinsic value Outstanding at beginning",
        "periodEndLabel": "Aggregate intrinsic value end of period",
        "label": "Outstanding at end of period",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period",
        "periodEndLabel": "Outstanding at end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price outstanding at beginning of period",
        "periodEndLabel": "Weighted average exercise price outstaning at end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296"
     ]
    },
    "XPON_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average Price exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure",
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price granted",
        "verboseLabel": "Granted",
        "terseLabel": "Weighted avergare granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails",
      "http://expion360.com/role/StockholdersEquityDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails3Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Numbers of Shares beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r313"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value exercisable",
        "verboseLabel": "Exercisable at end of period",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual term (in years) exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance",
        "periodEndLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual term (in years)",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone": {
     "xbrltype": "stringItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining contractual term (in years)",
        "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2Disclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ShareholderPromissoryNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ShareholderPromissoryNotes",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder promissory notes"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ShareholderPromissoryNotesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ShareholderPromissoryNotesTextBlock",
     "presentation": [
      "http://expion360.com/role/ShareholderPromissoryNotes",
      "http://expion360.com/role/StockholderPromissoryNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shareholder Promissory Notes",
        "terseLabel": "Stockholder Promissory Notes",
        "label": "ShareholderPromissoryNotesTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Beginning balance",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShippingAndHandlingCostPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShippingAndHandlingCostPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping and Handling Costs",
        "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_ShippingAndHandlingCostsForShippingProduct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ShippingAndHandlingCostsForShippingProduct",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping and Handling Costs for Shipping Product"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term lease costs",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r518"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r165"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r26",
      "r134",
      "r154",
      "r155",
      "r156",
      "r171",
      "r172",
      "r173",
      "r175",
      "r183",
      "r185",
      "r194",
      "r220",
      "r223",
      "r286",
      "r319",
      "r320",
      "r321",
      "r336",
      "r337",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r378",
      "r406",
      "r407",
      "r408",
      "r426",
      "r478"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement",
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r194",
      "r390",
      "r417",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r458",
      "r459",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r478",
      "r524"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement",
      "http://expion360.com/role/StockholdersEquityDetails1",
      "http://expion360.com/role/StockholdersEquityDetails1Disclosure",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r194",
      "r390",
      "r417",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r458",
      "r459",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r478",
      "r524"
     ]
    },
    "XPON_StockIssuedAsResultOfLitigationSettlementShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "StockIssuedAsResultOfLitigationSettlementShares",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock issued as a result of litigation settlement",
        "label": "StockIssuedAsResultOfLitigationSettlementShares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of shares upon conversion of convertible notes",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r25",
      "r47",
      "r100",
      "r261"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares in exchange for service",
        "verboseLabel": "Issuance of shares in exchange for IPO services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for cash Share",
        "verboseLabel": "Issuance of shares, net of issuance costs",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r71",
      "r72",
      "r100",
      "r419",
      "r478",
      "r493"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r71",
      "r72",
      "r100",
      "r300"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares upon conversion of convertible notes",
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of stock options",
        "label": "Stock Issued During Period, Value, Employee Stock Ownership Plan",
        "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r55",
      "r71",
      "r72",
      "r100"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares in exchange for services",
        "verboseLabel": "Issuance of shares in exchange for IPO services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for cash",
        "verboseLabel": "Issuance of shares, net of issuance costs",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r71",
      "r72",
      "r100",
      "r426",
      "r478",
      "r493",
      "r530"
     ]
    },
    "XPON_StockIssuedDuringPeriodValueNewIssuesOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "StockIssuedDuringPeriodValueNewIssuesOne",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for cash class"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_StockIssuedDuringPeriodValueNewIssuesOneShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "StockIssuedDuringPeriodValueNewIssuesOneShares",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for cash Shares"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_StockIssuedDuringPeriodValueNewIssuesTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "StockIssuedDuringPeriodValueNewIssuesTwo",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for cash amount"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_StockIssuedDuringPeriodValueNewIssuesTwoShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "StockIssuedDuringPeriodValueNewIssuesTwoShares",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of new shares for cash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued as a result of litigation settlement",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r26",
      "r100"
     ]
    },
    "XPON_StockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "StockOptionsMember",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails2",
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails4",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://expion360.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficit",
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Total stockholders\u2019 equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r76",
      "r91",
      "r439",
      "r455",
      "r479",
      "r480",
      "r519",
      "r531",
      "r569",
      "r581",
      "r602",
      "r619"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://expion360.com/role/BalanceSheets",
      "http://expion360.com/role/BalanceSheetsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://expion360.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r167",
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r353",
      "r481",
      "r483",
      "r494"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r518"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://expion360.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r385"
     ]
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "presentation": [
      "http://expion360.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Operating Loss Carryforward",
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlowsStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://expion360.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Supplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Supplies",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory purchases from foreign suppliers",
        "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r509",
      "r584"
     ]
    },
    "XPON_ToolingAndMoldsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "ToolingAndMoldsMember",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tooling And Molds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_TreasuryRelatedPaper": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "TreasuryRelatedPaper",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury related paper"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UndistributedEarningsDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UndistributedEarningsDiluted",
     "crdr": "credit",
     "presentation": [
      "http://expion360.com/role/StatementsOfStockholdersEquityDeficitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants",
        "documentation": "The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed. Includes the adjustments resulting from the assumption that dilutive securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions."
       }
      }
     },
     "auth_ref": []
    },
    "XPON_UnrelatedToAnyPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "UnrelatedToAnyPlanMember",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrelated To Any Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r124",
      "r125",
      "r128",
      "r129"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://expion360.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable lease costs",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r518"
     ]
    },
    "XPON_VehiclesAndTransportationEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "VehiclesAndTransportationEquipmentMember",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure",
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vehicles And Transportation Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock",
     "presentation": [
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor and Foreign Concentrations of Inventory Suppliers"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_WarehouseEequipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "WarehouseEequipmentMember",
     "presentation": [
      "http://expion360.com/role/ScheduleOfEstimatedUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warehouse Eequipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_WarehouseEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "WarehouseEquipmentMember",
     "presentation": [
      "http://expion360.com/role/PropertyAndEquipmentNetDetails",
      "http://expion360.com/role/PropertyAndEquipmentNetDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warehouse Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://expion360.com/role/StockholdersEquityDetails3",
      "http://expion360.com/role/StockholdersEquityDetails4",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r522",
      "r525",
      "r526",
      "r527",
      "r528"
     ]
    },
    "XPON_WarrantsToPurchase": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "WarrantsToPurchase",
     "presentation": [
      "http://expion360.com/role/ScheduleOfLong-termDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WarrantsToPurchase]"
       }
      }
     },
     "auth_ref": []
    },
    "XPON_WeightedaverageNumberOfCommonSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://expion360.com/20230930",
     "localname": "WeightedaverageNumberOfCommonSharesOutstanding",
     "presentation": [
      "http://expion360.com/role/BalanceSheetsStatement",
      "http://expion360.com/role/StatementsOfOperations",
      "http://expion360.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average number of common shares outstanding",
        "verboseLabel": "Weighted average common shares outstanding \u2013 basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://expion360.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-8"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "40",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481194/470-20-40-16"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480637/718-40-25-10"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "230",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "83",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481161/840-30-50-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481295/840-40-50-2"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483081/340-30-45-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483054/340-30-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715-20/tableOfContent"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "715",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482236/912-715-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r554": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r555": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r556": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r557": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r564": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r565": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r566": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r567": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>87
<FILENAME>0001903596-24-000045-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001903596-24-000045-xbrl.zip
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M8!*%TG/H]E9OC'V(#(\"T$0%B,%FUPS59V>C:^DY3&6QJT4\AH$)^Q&='R"
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M(A_+/^35_U'5;\\KG6N.*\\91_[%+IRRF/'4C*7%G&K&V:]02P,$%     @
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M&7LZ@ 2@[P\2PE#LSQ!:IL13)"9*:)R0(Q8\T GA8Y%H/U@ML2@EC9)R#%[
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MM*A&;52V0Z]]["_GO%2E&F&E146JXX =4"T"@EF$],]&T&CQD6QPL -C-].
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MLXUC"#J+T =O\AK:WTSENMZT4[G[PY#MM0UMPLUBC/2]"M6[&&QN3FMMH<9
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MKV+FUD 30KMMF7-LB$Q":K4]5RSD9N;$E*]LC1J()\T.PZ2UPW"'Y:7W*H1
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MYS@@T^_MO_VX_Y9._I?2H/AE3I0X\J@.OK%VVW[XL^U3+ET_(A1'/ 1J!ZM
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MW.BAF'4_#?&,R\J<;9A)09&W!)$W%@Z)-OWV9O1VA0NQ,I'[VYLX3&I([EA
MF9;3DD8<I"[E9T]$P^K!I(JOUE+DB:LL!4!4+)IK)*=+1FMH'N>F)R0;8+A4
MF50-89Y F+S&(@1 <ME[VV?!W(UJT)<EFX4]N.GFMZGP4B(A^>UKDQ^-H.$@
M/>R_YG<D2':5H7?2Q5:^K $B8:\-S,?9N-UM[+HIRVS_TO;<27!DS[W8]GD"
M88(I6%32I<,G !25-EE=4:]3@-P3.PR\X"'B":E^_%W=CFV8=!B8@^>0-K'
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M@!0RE)A<60"=K+J9%T4X?"EU BMC^J'*TN4$UFH&*Y]"&=Y0W[(RMA_7L2V
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M24@X1>X.8BN*#=2S/JX"Q$#"D-W)579#W7[U=^62 HE!=JO7W],'(9-(<#5
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MK^*0;3IK6"*5=TL6#>P^9R3"@*BC1BAA$%%"?2V?1+I(PRS?9)WC#B=913K
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M!-20"^PWE*W0T;MO'[Y#C9;CSW^5W>=!1(;$N]?U0Y9(LD\)I5R10 &QX8%
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M![V**P:9@F]XI),'P29#D*-W5JE:?W+-%!'5])G-J)O<7A[B]80<1\8"@(/
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MB[#P[BE+HO'FF/\[2]T!5<TRH:1+EBF@=EDF$'/*,M*A/&0%5EW[D$/<F6S
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M)?=#@?]9D?#R[-DH#;=,W&WJ;37H?KIML2R8CDH#<)QJHA%'7![2$#KT1;L
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MC2C*N2S:4.&ESC9$_UT5)4OC?)]]""+Z^H0XGM*+NSN!H >]/50@EX7!##W
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MI.-\%=%E[NY6H9%\-H] [E7OX-W]EXS=&9N_WK:6]Z1!#*MBIA;1F/V*FL3
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M):* /ID.H3P]Z?#+>/H:O06%9C'HEA M2(J[(,$,YD,0?N[NE_X6ET]Q2N:
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M@9G&\!]@MU&?=/+0V>1N&RST*#J%GH$P6Z_SU\R<H$3N,EQ&\2HG3YW\#=H
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M>C\@STN@?ENG4<Z>U[>4A#2? NB4&/U(LXB':$1!S--3NKB\TCTY7VOD 2:
MZMBO:0W@30L@=#K;V5-9Y&@6Q]V[GU(WI;6P7Z(:,N@ <*!SMDEUJ8@GJ);"
M?D-J "==XJ)SP+-:;7IV&=[G64C%= @K8#\H-8 9!0CH)-4S@-)).<]%QA=6
MY1P'JHS]IM0 \C3 02<22%D_<G9Q)-W/^!/3,+4;&L+\,Q_C*)$E9E'4PWX7
M:M#X@T""/_1<-UME ;NQ7'V^D?X<$"YEZ%4?+>N1C&F\+V _)C7,\!P5YJEG
MB.B63FKPRFMAOS!E8J;H-HBGMC94[ ZU?Z>S,/JS4D-M:$M]/=) "PE'\FKH
MST@-80N""#IO93;M7*VNH]!56<[B&NAO0PU@2X4#.E&5P0^:\BQXR6F<J6X/
MEBT5;;J,V>C@V1NR*HFLJ0'%(R&>HH "GS!C*GU5&Q[P%M"?7!I N"Y.Z#-H
MI<.%MT2+RE8=] >1QB%/@ 4Z78TW7, '3<WRZ$\6C7#&U(T!.D7-)UF4' DK
MH#]&-.045XX".DOM!U5*#S[H;1I@=?2GAX8-,SA"Z'S6-Y:;RPO*P:>JA_ZR
MT&B;;1$FZ-3Q,%OH@M99&/TEH0$D2:1'9Z8:TJIDIK,P^DL_0\Q!L?2]=W+/
M)'Z(Z%BT9"^G)K6CK$T/^@PW\?=@<][($0KQ5TJJV/0<C[;5J4)BT@-7L)Y#
M^ 94M>F=GI$L'0L]UM7E'F;EV/5HSA#SQAH20%N\7B\6VN@OD6_7IK;8]?$]
MC^!MWLGC-+K,3L"_?%.J%^^KXG)#9V&;'J#I$2,JDAZ=F<JE5M6=DU9)FYZ,
MT;<1N^6>M&DHN$,H<6"**MCTU(RVRU*. OJ0NR6IXX?$.W?BD!JK22UH<>F[
M\B>ZU'5M>DQ&ESLX-N@TMI=='=/#KI=DAIL<UM"B.GOO'YM@US,R8\<D6$.@
MY+&FS22A^QJ3C=X*ZYY=.HT2*D;1+9D=6"MFT[,N^D9@A\3H//";*S=QM)09
M K5"-KU@HLM!A[13]DN0@#;W^)&$)'8"GNIEY8<^0X"]$5U<$Y08"L#Z-CTY
MHFT\:&&$/APW7N4\)?N5]*9=9V&;7O/H[5-O2S_A87H=A5%=L/("K_KI:W55
MFU[FT/?4 Y%!'Y=EGO R'BGOK9@X47F;7NK03^H@PV#2MQ=+T91+9JN@3<]]
M]"74MD7PH^.';.Y?A/G+L;7+E(#;R=#Z-CT<HFW):F$T:4?S%<7CD9-R1](T
M?]%).5"EE6QZ?D3?M:)$ WT \^5AT;FR2Z^#J^K9].Y(KYMT2DS0J1.:9#V,
M5+N>&!G-.+6&J^TNJ7BVFW8UH[TMM"P*DQ.RC&)2>=[K_(6*3%&G6,2OEQ0:
M?L66)0J-^#ZY- ED%I#!C]KT9(F^-66<#;Q-L"AW=$PA>O*37)Q;LLQ"KT-U
M>%+CSJ(V/6<")EPLCB43 UU0(/ZC1C&;7AO1GJR[)+9NN-!>LO[=D/CNB0)R
MXB2^2W?39WZ0I40T<%25;'H\1&L(P= PE*#\5\(2@1#/H3L<YY%<9RQK]N:-
M(M:?9)&E2>J$[)5R 36ZC=CT)(@65?W0LBY5^ W'Z(FDONL$BKSA/X'SAL_^
M4&OWD$=\9,GJ$8T4ZT7,N^OQ6+IR^A#+!JT_W;SC>@BAFR?U[N;3QSQ+GZ+8
M_[US&>P4LUUOPAG(89"@,U<)9-4?AZ#*$TY$K@&.343"QY^TTH2SE0/ L(^P
M_$4@#;+*"A-.7JX P3Z2Y%L(D52]]@Q3H,O2/<)&Q&2Q;,>J%J'@BNW"SXWM
MPK;-6;2<55N=Y<W._E T_$>KWB#J=]<-5!TK<K[HW+W\_FNSG&K<M=37].@#
MW+QKQLW7):JFU$7F@@Y9POW= #XJ92WCI*91(O KW:\F[D$F(%<@.D&OHY!-
M4O,7'\)%=[4ITM(M266'B$-0HUMGT<KQNQX]+,H+BEM&B$S9&OP(!*K8I.B6
M7?[ (LB<*XM:XYC08$(H,;J5+;ARJ>)%4<T:QX,&1R DT/EJ7K-4$24J;XV'
M08,AN>SHU.SH6JGYB:UE4/:Y0ZIW2+PFL1]YM =QBGL+".YIZ.]>,#_M*1D$
M>!"F2:#1: WSLZ&*.%5H!N+,E[L/S[*8JM,-UP;NK;\F7_E?I#LB4'5K?*V@
M^1$*QZ2CR062YM-+?^9;]:WQV_:D7@#(/G+/M3S_]444WY'XV7?[#OZ.9H":
M8#X&>L@D((1G'Q6B>K@T1".$[0!5PGR8\Z#)X4WI!!\%_&^+-8_F/G\AL>LG
MLC/8'DT!-<-\//20R4(*$Z9R"()!;^+()<0KGI"G*DU1*?N]6/[JQ+$3=KX;
MQ6I#*P.9-1]=+6161YIQS/A!?.23T"!6RB; ?HPID%/'96_G8GZAKM_<6U2%
MLFZ)^PJ"@Z$!6?G^G&I?D@7I8MEU$U4Z)K5;@1*$Z)WJ)=<>C,S/H<>2Z/@/
M[*Y&Z=T67V0IJLEK0>G&]VE!I#<T%#77P>%K'J)S2BX _B@24,2F G971&DZ
M=A6$TH+H.!)UW:C>;S](9U@Z]-RT");_'':FKJMWLK,.%&I$SPQ "IL<ZKV/
M$G\[AM-AB5>DU?]1CJ/.0]Q,2$-.$W5(M,"!T=5]0QRBAC2?.LG311!]3>0A
MS$??24.862LSWHQ5\<H;X;3"E#MJH9W]LK[0C?VS3^D]>?V<$.\RW.2)F;NI
M_YSG458G"^S1ECUW'H5$MH^3>R(VZ?U6[11]_NSX 8MRO8\J87K%@L3OT0/#
M"" -8<?X#"!<$H@ AW#2B0WGWC^S).63^'UT2]PH=/V U)"@ (PU YGY&G:(
MTF@*:)(,=/O_C%!>7)^S(M:0>BGL&*;1F.T2WM ^>+Z*XM3_G7]JL61/3I[Y
M"7^=/D\$>9&E64PD[QJP5G0;P8YC&DY4'ZDM&5GB;M_$9.5G*\F$K*Z*':<T
MWNP*A0F=T&WN5MK#=7&7=K&<)PE)DR,QFZIZV(%&HU$) \B4HS%T8_:DZQG)
M_WL9S@.Z+V$>N(LH/HNRAW29!7.7JY;0LZO9"'9 T#@3;#_H)FU@EZIZ2_B[
M8?=1U[F?>D@KJF-'!8T^LD%P35HQF.:[K!=E<COBL1M#)$RXM,JLNM#ZV&%%
MXZW?6H!-VIG3GB<W<!57^-1[;9TVT,.;1E,2?>30K;V.1;%8 /,P+GE:"EAM
M]$@F@P2+T;*0VLN0;A[IAZ3/O"NJH4<]&22S Q\+6:0;QK7C>X#78%0UT4.:
M#'+9C9+U=":*P%%H??3XJ9U1FXA"3'M9Y?<DML[\.B/<RZ U9V_KH(=L&=2$
M)C)[9G>7QL6-\]K7#MM410\GVX$1UL#)PLF>SU5]QG.C(GHTFLD]4Q=&%G))
MM2[.Z/Q2>TV\_I!2Y6^:@U>K9?2P-K-CNP?*AKWOE^$M>W(@6F8)R?W^M%-7
M["]RQJMN:& ;4&XM=J'UD-J200^7?8S -XU@$GO)[B&UW60SIT R4K2CM"TH
M^;MX(6!@O", ,W2ZJ;%8!#O-W7]E?DQJCY3260GPEJM.&U!Z=_%X )1>?8PF
M?2I6BGL1Q>5E9G:)F?[L94R1BQ5+K0_*!J#*L(L'"725 8C.I/?B\'EMC#4
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M^PF7K3)M6- :<5VUIO2@"T1^BW:KG]@#V7Q<YT'4]]7AHT4<M"5LUT1/-O6
MLF$ZE*2-ETV.K32ZTH<3D.?*M_2" K_-PDX'H6-36 $_=>C@-Q$48%@TP^9/
M0G[R0W^5K6X9S $UK[CT%U&\H/LFA\F?WU72GW8'-8\]%X^A":,B;:O>\#Y7
MA"F2B8RB-%IM8_N)#6I,#XQM6.;;R?QEJWLK [CX;0GDI7VGCTPH??:_.+$?
M94EQ4RU9\-1*21X)P!Q(69JDU#BBRJCIR>_?L-4O38PEI'73<GDFR?+U\JEB
M_M6)/3Z*"K%83&Q. I5OE?].?XH>YSO8"SSL.1(CX%JI,]5XOZI8<S?UG\NI
MNZ>>Z+:-O93WUHU^(!H_UF6F2=$A=G,E?B8L,PB;Y%C0F.:RH-<8]E&OSEK0
M!R;KQS*5)(U]-R7Y9/4Y]*E]RN:NL0>V]H>P$[V-,LI[PFN#>5YYMDIFE[?>
M#:D^7H5LB>_+*U:5$)/EDC#-(9M>WCHIOTM/=Y*!SYGO$:/7H]7)O8(U!H@6
M3>=YWT_(,HJW<IS1_R0ICSHL<GOI*T//AK$-]B$*,0C+25\1K5DWU$YD'J02
M#XI!$1)2O'2EKTL]&L4V[H?H46\,\>>5\J+%UMD<)<FI$\>O=% P@P7VYHI.
M*]BV?P^F>Z!D@RD'NT9S1E+'#P1F7L?;1O![-$7+;_DBS8@SM3AFD<TMD&E9
MU8)J9+8TV\CX'!!9KQ*PFO?1LGA<.MC)94I6D@3VD+IV4*BKM-#HW(J@U?02
MEE%Y\GI//SM_\?MP6:V\WV16):WL$BPCD_61;@D<7_J("Z"R'61J*"TX9+XB
MY';W/VX&\"??S2.$^7.3+/,'QVW3AT]D]4#B#H;RO-?0ZMB;60TMK"?VUL,'
M?=NQ6%*SD:C9*\H+BF-O)'JP)1?(Z+G/)R?,EM2(RF)J6<$&CKP*]A,?/0<+
M! =#%/S7'(9[1SGLQR)Z@BV4V!#"]Q'=,O"\EY^BP$ND* O*8N?[[XFT5'(S
M$WX2IY7)GOYK.]'3?_QVZX2/(BN8_KWR9SM,H[YV;EV6BI]RQU +E;WL(%3#
M#<-=QZL;R[*K ^W)7F 6T94R.!M%T,S&)EPM,#ME09D-/CDO2E3K1=!.!-2H
M=LF";E0+9ZTR+<%2XB0$5<:^* KVG4&WKFUD)N>V/^KVV[<?6M?WV\^.WK+G
M7F!A7I.4'?X(;,K-7R>5NJHA$^;)M@#U7XG_^)02SZ&?<![)=<9FWDUH'@O!
M2BHQV0)R=!O!]@;ID=@/(@NY+K11D$Y+/O"$E;##"WH-2 4$]G*W"+M,C8ID
MO "V_ZX7)Q71II[-2<O...ZV,WX:P\XX?LMVAD69_*!Q!.-\QPZO#V(>/UMB
M$@;*T=I]=0R:T;Y@A]*8&7+-EX!& PT_5F*@+">OW0W(8RR,?O2@B./@B![Y
MT=VY:V>E#/M0U[1#278P^$ :4T7&3*!(]7*E].ROJR#Z=A^HB+5;BD*!T=W1
MQ=UY56Q'HQCZGE"3A&XIC)YQW]Y]ENIVY>_89]E]5+HEGJG'18;-BO,5VS8<
M"3@8JW%L-_+(.X/:,R6CXH\^W8TBCC%;MFS>SC5NN$*-BY+]\X[8P3I>\^@N
M<]LGGVY7\#3<N=?,8&'2=[MU!SV?5+IU-]\XN'>'N'>I>A#(-:]&.4OVGMKN
MU888^.[138\ CLZNLG80T:U&(O#-.P]5$8TD*?LB"2%M%IH"U%W]-N,$@T,L
M]'35.VN)6ZL+01G&(_F<>H%\YY*0Y1*\B<DSRR@8O.8/%Q-/%@FIK@4VY(U$
M1XHTIX(_5'!#5O9-'+DN\1)FREVNHVN2)BSYLL!H%I9&WG^+EYZJ,:N0%7UK
M?.HD3Q=GEZ>7(3,F/=565U <>^NJYD+>?TO(.*.C,/%3EHB866')/$FHOHC9
M$)7'WAV"Z9 +C,['/ BBKRR1X$44GT790[K,@LVK-C%9^=EJ\^#3+7&)_UQ+
MRM:Q@^G;(+;K'<SH0,C0*3_-DC1:D;C0S*1X;4LR(XHJ8.=*A,^)<I$GG4OK
M,GRFHD3QZX4?^LD3\3Y&D2<9H*+RV/=IP63*!48?7IONW3I?/U&18M\)('34
MBP/9^,$>-KK$12>#3\*;+E+3=+$LDNA**)%6PKX)#28&(#HZ/9^<^ M)\WO#
M<X_.IJF?L&OQ>>XZ,4.J>D"2?D(G"08 .D],<>CGG]@E /),@HA?7U/2I*B&
M'1X 9@DD/CI);!].BGWX+5EGM,-.PO+.\HS28I94]?!\/;H\P1! )RK?G7MD
ME9]C%:\SD/2&+IZ1=QFZ,7M"YXSD_Q43I]L.E$A\'T8_A$PE]6 ?R:B!0P+V
MROJ-LQ;G].@L"L4=T5DA[KQ1:.?>/^G.C#\@=1^=.!Y[(%*\JO"3<UD-*-"(
M/@2E#);,4>/L*G\[AI."[R40R[ ';H*[;+T.?-FV9UL"2AF^+Z I%?JXX;NN
M.Q+0-A\_DI#$3L!-^Q53J32/1U':S5J-0,G"=Q7TP,;0NG/WY*_7^:[K/YW0
M8QUB1U;L%</R3]26]++.4!T>^*[1 )0@1)>!KDA"<G8>=5;F5JFF5;DFJ2RI
M^(?OFM%E92/\N>9-,S/:#G82<6'J&'4H&: J]H7AMY)2',SB(;/X(;,X_FW9
M0V;Q0V9QA8B'S.*CV*&'S.)[EEF</W[.7@>_7*WCZ)E;W>*KP$4M:27LL)C^
M6<8!6!C:WN7YS2^R./39>_6PP:2JA!T?T7,(P;#8LZ3OMN4A1TSZ_BL5ZRG*
M$N H$!?'/JWM";U*_LGFVC=W3'=(MK^S Z/I9-L?8\OQ,>Y.7:L"HZBW=_F?
M:WA,^G1I[KK9*N/GQF>$=M_-GS.F/P>$TQ.RBPAQZO_.?R]$1*P<XWW!VKV0
M2H_&!EE?XW[.-2XDCZP3]R1&5CNAB->DCV><U\*^63+^-%,!P_XC&WEF@ ]'
ML+.;/]4.;]!3 >SC,4YU"FK,/&)II)5L7=\5IS0 ( Q9P'0@K*/$"9A_[,X)
M2+)87O@OQ!->JF.U5)6L71YEV;%A2-@P^]%%/,Z(5\0Y;"Z*%3>2KGSGP0]X
M-ACI$?9Q<QHLFIV5[?+ID+<\*YJ>5=I&/]9V7OF=.#9<6,<9<>J94%8)9PX\
M7ZV#Z)60(F2R@K#R4AV@*O9\J":I,1."X3"5FI \T.^6G^T*>><9_IJET&<\
M.-"=_3>[QA0;@\N03F&$WX#@=RCO,MKE[O!T/B$KJZ';V7JH0W% ][X4*P%?
M!=GK*WZ24$25\Y&B&OHQE/9D!,+!T*"YB)V0RI.0>^=%,$#J1;!O4FL.AB[Y
MT!7_,DP)A2TM9%%JO*@\^D&?MJK+)4<GAINAQ7!LVP14S.LH=%5L:36"?7M:
MG\(>&*'SVNYNN9NI_$JYXJBJHQ_Y]EUY8+B,[/;??=K/31#=510^OJ,3T8K=
M9Y+N7M^WTGL6C;#\GD'9S,RC[6#O5+DLFZZJ-ZFB\E@^NH?T,J1]R !1U9V%
M[0CND[/0\L=UR($?(%WOUI4Z*EI8P1Y.!+HE)>3*IE!G-F>54Y8ZMKF[]-3H
MZ)8"/5"YV2U5;+*HO!UTR!1+P8?A-VI(Z$<Q3SI.O!O:;;HO9OEAHI0HWJP!
M5,3VI,EUJ';;#0P#NIG-^U18H>R^>/A%&5$LJ8*]NX51I);#J/^&?;?<3%/]
M\-//5%M"Z?"05\%.2 0?&!#1S:-^=S*'HETIBAXYV0OFEJSFX;T,/?_9]^A>
M%HIRNP9Z7H=>8(LD-X_YA1^RI*'L80\G?(7BWET+_4IY+^QE".P:_Z-^!!QI
M,G!L+"G6" P<[82"CY_RK_J*R::C'!1D8Z=.<)"%4J*;C_6-87E4<.NDY(Q?
M1\ES:D'=$.+ZR-$*"O>*U"6A L7<U1SV:F-R']T4J>H$0Z.K(/96"XBWJ/N6
M#(YJL-YB6;H962KO(I.WY/A"714[Q$%O3("QF/1-!3:EWQ=3NMRYM"V%'?R@
MQV.7A).FK"Y^/C7[+C5IY#=&%-6P0RZ&+%@"#-"GTWHO/X=./J40KYQ)E$$9
M\!:P'5E#^%,C\X:HU$@2:2Q@PPR90U)'UJ]:H<^_(+9UQZ8Q]X0^G8-?!!F/
M+\%NX8HD2<V1=4:63A:D-X[?M7MC=>15L'W2&CL(B.SH,V;5[H)$M(G*8R=:
MZ&]M2F/4)AG=U!73M'WTO1;4]*$9U,3K,FAF9]5 IMG1(91IX.CZY*3%D]FW
M9)V;P E+XN:'KK]V@LOPFO)\_Y4$S^13%*9/BI". <U:X/0"QT6-@J!5LZQ2
MBO\A3GS_-1J)_DUK-OC>S-#> &R";-,/2V(<^[9G@R?/(.-5T"SD/'S,^YE0
MU62I '4Y[JYO@U=O *<R4"SD4*&"%U$FRY#8KSD;7'SF1FT5L@D27DGQ,0;A
MO#D;?((&":]F1;&)\)'/48QZ^7K1(T%]]Q=NGGA&PX!"U8A;A670^;YU^6;;
MX&S;XHPW.5H*'7$&DZ(C8K$D.]4B]8=&$X@W(#_Y843'^&L9;:!Z@;2C/-9V
M4Q_GSB$EA\&&P<4OBN=/<U&;BCW:3NTL0B=A13Z6'YJ#JM(03\52:PK[4IM,
M2@T'D68S2$-O3=B\%3[R=-3L11O)L.LHB^SAZ455<]@)(4"W(NZ>HCAEJRR
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MK<9BWTU;TQV?@FKN!(^+3/%B:+N](]NHZT8SC\C>V>>A*C>A4Z'= FC3(C[
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M3 *'Y36/YN$KZY[T%7%Q<>N=UR/P(T? *$\5#THB9:BKH/5>UY&X$8.$'H*
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M], ,061G>UZH4!P7X^7-+2H$=^=YRIW7H/GX@;M7)]?7/SWISQ8Z>PO*#D8
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MEE<+6$C@[FG@'I1:P )I 7M/0):#5T*64@M84"U@F9"HU (61@M8/+1I:%]
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M:-((VB]R'ADPN.A6#&(MU5&7=B)L\(Y6)B@E-$=6/319%%<L[NQ.$O,&E9\
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M?W%)MC+P&#++9-G)C#P9L+S:[$Q6' .041;Y>]@-[#_#OYQ>'RX)G:DNM4;
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M98#;\>(X987 Y*V:!]Y@S6M"IG?0]OJH8?2P2Q\JLW^K5_9VJI5JM5I1G:4
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MUG, HU/=T'?51+46QI;]-.&4)7ZS961@Z9+0DE!+0ETW0N5$":H9)F)1Q25
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M!>LUKM3PF-V:CAQ3E@^/]Z]=V4I6CO!V[!9$_]JZU83J0RA">(L!( U/=L%
MN?6.$X[A3,8\6&I>+:Z?-@RN#AE$#ID4":3#P[.+,"-!Z:-AH\P3A-DQOZ<)
M/?+[P\)/+C*PW@9EQ@.SHI,0IWX"6U= O@$,WY2?$Z8#D/0E_A,1:IPG<7R
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MD^6Y[<(UWH6[C7>1YAE7,;.LBUI7\W6*N8_Q#>),F_9U&+\E@5%A TN2S(4
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M#P1E;WR[!".X:)L"46+!H@C+ \CA(:/Z93B5)1^^;5GPHT#+SMX/'%3\?-S
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M98$VLIK!?"B3 BXA^";<;@"J2T(,#,^DG-"@8;;VE'X=#SZ;&&[H"M:H7)'
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MOP"R2]<U=AZ+8]=0QU,X/<QY+W!S0=L"S54779RPY9NK@H-2W?WI1C930YF
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M/709A]WH.$*G)J ,.S_HO<6]UJ4$ZZHNI#DQ)M.]Y!J:77_MRXM+"C@6/L1
M9=\IO9L.X5-^QKA 4T)6W.8\LILBY@*"1:'>A5$O-X^3;958[*@+ ON[1V-%
M"//HYVL@YZ)_/]%M&PF>PL= <[=>:AE[C 0;SQ&UJP_?/GTT?"R7-.W:US[8
M42I/IC7I/5E*X:>]"_;M)KY*G'<ZWQ8>#;F)D8D0HH9H#FL(F$+/@;OZFF-<
M_ 86>%8ES!_4FN"+2* 7KWWO/,!7W-(&>5:$E@&X6@L,TD.&#M;K$):M?%'Y
MUG0K3M!;(7JMX)Q$6=N!I_-=?\+<#O6&P0X>=2QS;B9VM&,)C\JT#T].3W-N
MXL3?F*^91 T$[6S9CQDH3)X8"C3P2/^U:QCR:RX2/M-L,.L:_TQ)A4Z+#BL:
M.R:,,R2CS.UH:RDCQW$P>)3<,U09700N<LHU&MF6'^7$T>G!G(W">&SM-=M0
M=.AH$(_:;^RD4_3)<AK84G83$S1IP^@P0GQ-8=>'<';H+W@M2KVJ2-=AGE'4
M#&F].&[DZMF+@$<:">H) 2R]/8WTS>;4XUT!!@GIY>DXQ>70EMUKB^ 6&F<A
M9<;S-TPA)EWM_([;BMWAM\-5PV_$OC(S7]_T=MDMWFXP=HY<'ZPGT;-#1CW,
M>Q\B0/$!BLB?,S"A,-GA>V'#HHMIN,ZE@B>$:RT7:) B_>OLL_+S],_BR#BY
M>;%\73?7E8_!%N4,PP6V!  8S8?F#+\)UP\W*/1-BHO6:X%SL+FD7=8:*.I!
M"1?!J\!1ZQE]BYM^V6SW] AR QH".GCU,:1SS3QBDJH&UT795L2M6!.4@8,?
M)TX#]\7N):3M0)YD!2"Y 8C!LK:I-]+2<AH1KN'=]:@;:3S(87>'W8*788UT
MV4O6[ BS#V'J,_:(?NY;D,=H_?L]73]<*@R*C ]@TR+ 4?1!%GW2;$+^XV3G
M\\AWG.#U SST#ODZDX9HEA%)+X*I5LB_1^X@N_L^@!_U :#I0 \Z "><*],3
M(5&ET%$2U=.G#_/3)V?YDZ^^RB/-ZJ=?Y.?GI_GIV9/LNF!R4UJRL6649M5<
M#8?^TX=GI_F7CQX.OS><^3N\D\F3X?(Q\PB ;\]!5@\5X\ML7377G .*//!0
M'//M%;HKR'1Q:&-HBJGV-'YKJC^'(:5T %T OI:C]$]#J3T &/14=T..6W9@
M8>(6Y')Z("X(MMIA!@S[0-@I@S-.26*%Q\1D;%:-Q/L$>S:U2VK:!ZM?,R,8
M-&9U)!Z$M]\1#YY-T!G:&G>3B8BD%BU\!1NNN99A.^OFWH49)WR_<,*#0XQW
M<3P*'>T7)=?B9"&4_P%)T+2O40:<SLNH<X)L*N$:@.W*!4%,ABE-"UH2:'+A
M.#HVO#%*\!4\Z"WFJ#F[Q^VMLV#J.S!+?]PW3=_Q6'W]\?VKKW_Q4=77_[B+
M<#Y4YT/UUG<W=6U*&JK'S@0%)IX4+W@%)  2S2A] ".KCKBO0W1N1#FOE7A?
MSDWCR3H#QIH\M8FJAUI,M">AV<*+[6K25YZ/W=D.S';@R-TC?O-J5X%72XEC
MH!=LKFM E !X11S>"1%F KB:_==. ):+%MJ':]W%B*VAS":UW<:PEL%-A,*?
M]^^\?^?]>^SNT[JCU,U$@7%4-T4@/#929+]=C/0MQ$>=4=2*;D,;H1YA-4&6
M%"S,9Z9X#/6K&K-G7&5!4" 469;(TP*NB]B=SV=3\<<Q%;-%F+(([R\E5D(?
M!<(E@?>(H).TQ>#GWB\OZ[  +[#<@>S:55/V!USFV,XA>_8;V,X?<'<--M*\
M7^;]\NZ\W&U5 /$?%&&@:!2[=K'?$\!)U-H-U'H]T QR=RX67\+.XJ@YG%;5
MGH UAP/?#\DQ\8$WS;OBB-ZVP:,HM]AAIF"(B;X1J^]@F[_=NQ5P^E %ZK$2
MT5^;RSK[W^;?Q69+,-3O&NH.!E4$0"Z%?SZ[+/TZ^XN8[6_]E:^:+>)H7D#E
ME;!7@.)=$OHV1' =\3F^*3>T9,^_/#G[D^1\K"),JK<:?@G0JPNNA,*6N"P[
MMVC1/0N/6\ HR//^M3W)LT<G3_[$'8NF-)EG/[0G_$'<)% WC<1*UJ.$O^@-
ML!N>PT<S^8"M%>EKMX%V\U:@6@.M*R7 3,5C/5'9<N)K)3JB@,2"!G"/XF,U
MIMT+:?L0U21L_V@'CQ/^1\2SJ/),)2(L$^/@65?;H"T(52=:9"2DF8S4?X1;
MI8.E/01%A=TDN+94O=29:[5,\6TNCO--#Y0H2'Z'\3N\T!+969!Y'@6 6,P(
MOJO::0<P4BM?%7MBVG-;I/:B>$)TY*GAE':M@N+6Q5731G'7\<,9U+>5]C(D
M,'<80A%MX&'5WH1Y$ZA2P^VNBE61/0?=HLOLKV%58ZCV;4G.6MC%NQ9GY%E5
MM*_AQSJXB/RM[K*(/?W^3=@4'82-P;KL-M11SZ @ +-<&)BABLY#%T]/FO-#
M2+_=9LNJ*#>'!<)2IN>(5+JA0T *O[1P4&7JGS( \1T ";+K!:8<U>S-5F_(
M6.*?/$M2A9UP]]%/;[&:5$@. #E1A$#H2HBW\YVLMERP_NM=54&;&(O5;@',
MVK.(2U5<YXY7)JHV$V?R:(D25!6,:U@DY55!W+]+L=3<>09K<(%Z72K46Q?4
M1=:2S"3!5Y^9T2'D3MF'0\Z')U_G#%H-M^+K@WEOQ:[!"L?U!H7,L)81?KHN
M 2H*!_MJ!UWTU_1R#!DZL KSN 81'G1!_-N-BVLWW6>,@SWV8$5;=D.^%/@"
M+H&.K3K/TTOFR 6<+&Z<9Y?%%L_51X_!GC\Y?TH>B5U99;*R^#'_LB>-F\_*
MJ^3Y*$+U;3#A8=UA%V)X:<!C+W%.M+E)^F&HN8N'3&[K1@NZB;<$JLBK&P:%
MM'TB1#^*NJS711G>=]4LP[JN[_*I\K3J+T6GKO/,R 8C23M(YU\$J+4ME/PL
M:/^2C8-X49HCW&^XHMLLDD2 ?HC18+(4-KC3)I6<$/V,!P/Y2<D]G;GG^-BX
MS46I>044&A$77DN[QS_#=;I5J6#]M5]ANI$EF)!C9 <46;)C4/H$4.I;-#'R
M>;!3-X\MG)?1SZ$#KK"[6/L$;0-<:Q<K'G1RO#FZ Q5+>J3GZ^(I^+;'WJ3!
M4<I4S.-V,!H0%5,C8-AB,$VNN"C 583+"R/?#=='5_B">$-^MJ[=]26B*4<O
M?8MCQQT]=LBI6!?+!"UM/!IE)<&IEF8.?%%\BCP5RJ,&FWULV^E*I MSF%TK
MV+_!):0VE7S[WW1Z:F\U'2_0%.!Y)5,+1D?\YLA<XC!=3CN:W&A:S8E/1NO[
M&FD%BF&X#2]%4U&+ 14 6T,E?X32Z0UP84?R=)Q&=%#IR[*WPY-//:]<&UO[
MXCI&C"RE_KD*F(8JP;B!P:9F=>1K*NBULFM/G(FP,_ Q#FY.:0XBXH/AL9:>
M+T2[5=:&D J9Q-E$::FTUK<65BRP.\Z"]5D LVN6Z$!KAQDWNU@Z&W@LG$-K
ML[K49SZJDS;2#?PHB&N>W#]@W9<?%;#N#]24] JR("^8I.(NAX3'BI#4HXWH
M"R3<:+H.N)39\4&Y%S;H0-M8[["A!OC;J)];NB.PB&N(# F#_3?PYE7?^:GT
M^^62FN*K$A>\\H70\8#([;;9.&JS+:J!^"0Q *#ZI TM6<K>H,MN^U1DC5_M
M-N7FO;= W3@C'Z;'_,ACO*AC_]3Y(R)WA9/-H;W#<Y-'_=:CFB>!*!UD^ =L
MCZ0D $H-\C5(YN/3\].34QH.H=MOUJ/>Y=Q2"L0$5KBJ01\:N%)'S9G]I7B;
MQ]_BO1V:OQOA]Y$;@]<JR>[A.$/.CP23:>9NO;G*[C8SA"$3*++D8Q9,J-:A
M-]@$\Q3II'+B92RR\R\?A,?L+VG<B-\]QZ7EJ0]$R:*>T>_HP;X-YAX-2R0[
MT-0VI8E8UA?2UL@8$IZ9=:K9UC#Q.=JH:5F)MQVN$":]Q<7<C5LPV$7BRJ1!
MX.YDLQ\BFS2UJG7L]FI2!@/\733!8*&YF+3R2PB&^L;A*:#/QX62!&.,81(=
M'3:G'*VU-1&W/$GT_IETQGMWBQ4)KPP'R>"APT0>?4 F/\8&1OO%F'WXJ(S%
M7UC5S?(&4%7&;3UWJ_-:VA8EKB(:+^$BL(/-@9/*3*8C_!8'>?C:NH(N<E@+
MBZ(CMI$A-=#T_C*J$2;D^\<O3W^*]_I'4>TH.OR)1,#@;3!$EX\@@\W0J8IK
MAWVKW$C'K#AY@,6WR,!'.?B1XR7C%;VOMQZGW(TG+3.3!G>@*^)- -L'+\ /
M(-]CON)=]RO<OXL+T%@,4S3P ).78WH*N@TZ@W+K+JZF6QO6CVEO4G_V]&YR
MAL609Y0]H9?(T,/)CY^%-B.VQ _69\;D\)@ORX^X]2IX:0KIY-S_'+D/%WY0
M6(^L-?#55]BX_PS=17JJ<$0#927D0"QK_ELM1WPO)XJSREHVF5Y1UKF/;24!
M5!"IN+K8.@]S[\B@49>]4K>]O=&.,C_PX;/\T>.S_,FCQ[(X1!!6V:/6E$@L
M),)SOW7M8LJMQ:=MU.BHB1JN9N DK\1)&2Y+]Q9KCXD.U\CU+P3V0/O5U)AH
MQ'$Q2<36OF(DY*:'IM$QGN&@=D)L/3AH:CK%>\7D8[P/$[9-G9!HF;M+M2EC
M5WWX_N[XWM-WQJ$(_EQ5M(;*'IU.:AUC$@@& 4P!?>)BG'H#QW18),K1Z>&K
M9:MGQ?8M@IHQ;SY6+@;TDD3RM*O9EH$WZ:&N8CRDX2D\<I7 7!^9DA 4K6[_
MW+AX"?B BG:=^_3AR9</\RBRMT07)EYP^I5&(Q?CN=CJIX5%F!48*%8,&@<X
M/#FW#Y(2 B_CJDSH?^@ XUH_/)#E.B:<N-3!\E9A;/ 66K6+(#L#C:(!A3%Z
M<O+DR9^49O+2UPG0[O C?%0'"[#XR[K090'B"&]Q@!/JPF)#8US.IP>=[12I
M6!MGOK,JJYW4>T9%)_=JR@<W,3!R&:>GDF[?LLNB4(4F(>+5CEM:<Q,PMN[M
M<PD?TWJZN43TQ>G]*Q$]G$M$?\3%^ *9? VX@\L5A3-L\K^]<)$KH_ZBPWEG
MCX[S><J#TP7S@BQ1D4C*W5HJA< ,#-K3]/VU)Q[^II;T&5)/XHVP[+ZCT\YF
M((F16JT?YQM="L\&^' 8!\/,?)C;5,F=QP^7X,?!%?9#)B!F)B/4,0T04K22
MATE5>>4SD]?![["_P9@#<#ZQV5FGCX"(E^6B9%Y].F&NB#4_<6?YT83NE9[#
MF?&SH0D1BA'T=O@R->D8/+\*W@8)6<GS:4 3;CM14H'N[C3 N6UV6>$.83?(
M*QTB*&0N<%:)2I5XTO[3E>EJ (6+,"D_7^*R[:.R$2PL'RE: ;K685QP<&BX
M(?WP'"&Q!()-K\%C,Y<O*;GA+.':KQ0=BJ_*2)A\2F$(QT'UB3ZN4YRJTJI$
M"S Q8(8G3\F!0H0BH7I\!MQ.5?D:YI":D.7OE.F=*[I__NEP9<4=V-91<,76
MVTP=CVWSRF^X52B[@K10+)/E//X$!2.KWQD7&N-6<6G1\")-#.^]53/(7DKR
M^ZU3W5FQAL0(?0L)U9<<&YH,),>0#JQ9^!%N.%7#LCG+@J0?,.D1/C?.A)2(
M)K?R-PB&[,<K-)5Y4QEF!XM?HU>^K3F ?L5FX-I+H]=CH%Y#U9<W4#M%1R)^
ML0)[C.!KC9.0=[PFT>@E9N,GPRFTYGJ=$ )3#I%<EM)*'8@UA+A>=O[@@0I,
M#L&*99='91.24I+?QQ&S0Y6*53-G$"4B4/YU4-PN=,"JYEKH"'KA62=U1Q?U
MLC%IPV6M4NHD'Z'=Y@JQ$L-'BL9X;@\.ZP%M,632PDI!$0B?DD9%\4OL#37?
MG$W\GW].936(@!: "I:H9WT[>]F9ZJ?X>+G%8"1G @' I11^"Q"/F_+D;YWQ
M@4U-E[/&EGYS! YB9*\I"^,FH""OCA5%WU_5VJ55Z^QWJ5JC&71OA\$8"+7%
MLC=W7< AQ 5P4_D^5M4FHCF7^ 9)9?%PS?H T" YY ^7*.GK2+*^2N531%L8
M67.*2HY,(8F&+H"F'\5U6I 9UU4F$H4?U5'QM.MVA*,:PD:0BOWDRX=F6C^C
M@+[%]E^J=L6:!#:<8.14-=CNAH-Z.%W 6PKA%K?9E@5HK80 O?>KS_,4YY+4
MT*K*6H9;F[)CA4VS$7][>7-8S#A8VJ3R.;Q2PAGPZ9.31XZMM]3MRN[MRO6_
MMD;_46V-(XDV]]L3;4,BA%^1:7/O+-.6O8M,FSN>:;/B 9.)MNR=)=K<Z/0?
MHVQ2)"%N\U\1SBKR:RKIYFZ9=,/,VDGV(1)K[L;$6J)DP,;J_236W,>=6(NA
MR;$JV=G]JY)]-5?);@QA?XA:P9K\<R,%YTFY[K'>KP#]?D/63OI'PWTZ)ZT_
MP9KA&0#WF$J<(_DL'F4B$?R'2 S\[NF!7[R)R8#WH%Z1'T9X^70"DXZ&MW5J
M)4P>GA73LAG"^GWB!G+5,?]\2Q%Q@@?S>UA/9\WRV+)619]CY<,5RT440.\X
MWNO+O@J_!;#/>9BT\L]_IY7^$U\<IC''OYY]0Z&@YVH0*8:/!]1"7]]R/'-7
M8DF7 %I ^C1$J$12*/@.LT&IFG:B'1X[K4DK'.'8R/LSFI#8 F&VG3NR[9!(
MCR69(K$D)J7"T=\!L=4NYO.TSR923^XQ\X3QRE@+%SL].E)K;!Q0>W2=AN#)
MU*,[2I'5CF-Y51C'$1)7-=S!/-2"O.R8'SJB*T_\6&W-+>\=VD)*7^[?V4MF
M@Y=,5M7@'3%:"[X[1FN$6 *):O!WQP\/ER9<WE$1^!@M[NKANJ%WW=7<RQ56
M;[& I&V#A'[L7>5.>'%LX[II&3D8:Z!4&N;Z/SH/K?PSG9.P\91=@9NK3""A
M^<"%!XDU]*&9Z,1&<K_G\?>^V[858,>D',(O'1T4'B)(*R+*OR1[1J33K:&Q
M,-IQ9I"!3+L5=ILDN:(M>L)91Q=(L^P*7I<) ASH YXEEV9U#W Z#-._'Q0R
M^J$(\'[T9<]B>W63E&FC[K-"FAQ8SKVD J#UCPPN-O-&^>9HGYD(I[?]_/=
MY1*.K>Z2#6KK*=+W5YCD]S;S8$:%ZJ:#A:P%.X((;?RJ+&CE0R@"2<)6TT7/
M@""7/)'(*<.?%!D'V(Q4$()EW(=-N=CUFAS2E@4G-5>L "IM$%T%*%CX"JV'
M@Q/)YTV_P]27$RJ_7!V@\$B;LJL\B_:F5> &.L_A$+=KQ^IXHV#CH9N<9&^U
M=+-;+5UW?.GFHMI<;DL<"EX$9 ,)C8=?L&+7=W>9DX6 Q3X  W#]/B(-XL1"
M$4%AY8DMSN5K+!/8\*!V7/R/C="Q76&RBJ!4I=IA,R$H/OT,5K%H]!B_X0&(
M+FJB:\TEW_PP7L$'./SC@&*I4*LQXLNO@Z-?H4+["JT/PPI4B(*#EJ@H:ZHK
MAUA+!S"=M._@5IA^:7,,CRPHENUN$:)8.>;7317<!3*X]L2"9'E/Q%UMHMT1
MWA&[Q([<U/8G4,X9:C2+W3ZL%0>7@S%C8(:4MW+J6KF- T*$<>2N8VR1?D.\
M+[YA=N"&F(60)QT5'L!E(Y[G#:2BS?=5023QB8A9>7H#<C8@00 -NTC<K69S
M:@:UP3F8*J92I8,H4ME8I@MV_(#F;<K[<X?=/CBY67[9EM4ICB-J-#BJ.8K'
M"=%WY5JVOMG0N%"?&N;S$;_NAM_1I12S-!-HA7OFKB86/FD8/:#,GCME@V.H
M?T\1^7H2%G!;2Q\\!!2((/(Y:%G"7C[LQ(N:>D/REA@R)HD=8=P%<MRB,W%Y
MK,!#OJ(MF\&A-%J,YHJQ&#CL7'0WOAW2Z8G+)$<CJ35,LA24IA^W =4PH"0=
MXO7,EZ#F63:[KMH[P8HHC"]G8*.B^L@XV9Z]Z2<VLVM@X4@A U5R1"#A4O%O
MN(MRW&(V&O8^5E@)CWK;%7-LK0P-&#^UH:6G7'N8Q<OP^(1OF89 3HTIXF],
M5@UY$*.;AAUP_DTPC647>U5L:R2] U-0N^NB;0MFCM3N.6O7#]@P.L$C57R)
M=/8E"7A<M,5FPF$[=%X@V<]-!\;MCO_??F"X(YF"]W-6T&,,AMD=/"J&7_DH
M3XI;U%C/[U^-]=%<8_W=D\??62.%AYF<V;\-=&O3I50T&EC#X:F89QLD4(M5
M!!.TN*1#X%?6!?X0==W?\3%>B>,IWB8#GMQD2)0GKH#Q$-2CX6Q$ZMA8(A+K
M(V1&I)$B T#E0VJ,">%OP<*6FS(&-Y1HH>[:T,^-.VO4WQP[F$-GR+T+!S-%
M-HX\2@LY)A>2D:%M]"7=A_(ELV.^I'LK7S(_XDP.8PX*1$87^"T>YJ$A/LF>
M6GS"^%4(" DFQH_I'.Y=)>Q83\@Q7]6]O:]ZR%6E0C+[JB2O M[J0+GI@-/G
M1MD>^EJY";/>#E5F$Y,7+MF*UD6D%HOK8632T'# @HK*U.P0N^@0L_NMGK=U
M6M\",3L18<@CCOE*IN/CH;,/0[+LL:GP_8I?_1$7\RV<ZB_NGU/]>':J?^5B
M7$!=X#?<G>969#3+U7]^4OS_IZ>/8"&B#N:SIW]_]?V+'Y^^_-_LQQ>OGF<O
MG__7TY???O_C?V7?O7CY2_CG@[^]>/$_\///KYZ^>O[#\Q]?_?Q^G_3]%UV&
M[*2)/"1)+RVI2(S:4_I1%_P61J'GG!&%"K(7C%U8J-=%NWI0-<UK\FBDUBLP
M.[@#'TD;7U ;WQKJ,W@*G3]ZJEF;E/4.SA/^E#L_>S[B?*.R#J+IM;P\KI._
MQ:MF]E6-EVQJW^$9PN6#5P@:O]B;06J7MQX,2*HH3H_>"%NH1'[(5.AS;:B-
M_&S@H^Y=^/@_/7OS:9V?3C91BKF61EN?$S T#I0@*H&D@XJ7"O>;P)VM8]@8
M.W=S-[BFJ7^CV"[ VX::UIUOKX19(/ER? ^H%2,<2%P%;$((A_&N/?8])Z79
M\!C-)C@^MGNV!<<'R^JHE"DBG^F %-#<1OE+"J\)4V@ J&"5+QJLZL'".SS=
M6)Q#K,.0*;C6IB^_I^88^A@\46OZ1RVN8=A_5<3T'ER4?2-X>D S&!5CZ&S9
M;?'&F <]]+SH\$1*@/S(FT$V$I5U@!>M7)=10TQ Y1CZ@62YL%-VCK<']"++
M1N!?@<,__!TM@&[X:URKPU\2B&+X6W#00)D81&H'?R( M?Y:'JWS_O7HLPM?
ME?YJ?(T0%V)[W?@1&^BP"K[A\ ^P<,+0CE]*.N+U>32TI"Y -1'7P16B'12,
M056T\1=AN,!))^O!;GX-+8(E05A;#QNZ57$ID,JFQ11G"O692'SN&N"I^-Y.
M(@3>DH58G'5%&U1"WB.+106;X#D@?F\!FE1T34T=ZE09YS55(W)VUV(J7S/I
M+KE[B@@_<FMBO\:. VH09F@2-#YC%['H65G>#:*\R*UX+?XFBP3#N6-<>$.&
M^Y\T%DW+._ 6PW(">'0\=&"*8M&JP*' ])HG8!#LWWJU0S@5082$]-4=N?S=
M3;]_=W@^87!J1FW%,]C!&=PAADN73F=H0HS9!R/7];Y8Y61\K;FEL8533["X
MN ?6H(=G5A^?'.:<B,=/4B8>=+C)P^AIBX 5?X'95G.:P_7%<JTRE&*FS_<M
M&BW:C'C [7.K_B!))SGQ3IPP_!_9(2V*)D49'KB&&1M#&%36ET0$$W'C^.@M
MB"_Q;D&G##VP9=DN=QM2I>[(B!0MT=* ,E]O^01(/H0V-!V,\%&H*P+,C@>2
M=3Q.,F@T*=+=F^BEF;:&C3+HF+UKMVX9/DGJ>+?8KZ_@_<&(YPC]FX#N1:-T
M=-##(MP +A)2Z:K9 2-D4^G-[5\3\NK#M\Q^W5LREQ^X1YL&G'186KSF%-ST
M]7LLO6&T9B[[8%V$HV[_]4T7QL]VY;\]/4>T4ACL\0,3DG7IJVH+F9WZXC\_
M.?T$?PZ?6LK/;_U2U^6JOX2/GOYID$L89Q*.1,/A^5JY.29J@VF3 0J7PP^L
MY -\S].3\X=E_1['K5]]J-L^^>K1DX/W?<^+Y1<-DE@/,MRN#3LB6 OPE7Q?
M\BF]"O=N]^JI&_,(&3V*>CR<04@?%=\E_$\;7N@_< 6&I?C;-@_]WTF8@@,9
M%_QEB;3%7V</:+:.Y>;F73?ONM]EUS%- /ER>'A6#?3-.9$G+G8K5+:/YUZ2
MZ:$T5!%_J14-H"?H!I635;-;]*;7S10FE)4,H>@8WTLNX\0][=@%(>%AT,WN
M#$-%BIJC)MG>6TZ,%MRX'>%KEY<05W%_-'$S!.]O7?;\-+/=F.W&;#>.W?W%
M2"N90I\P3]?]I2,.G4YJ?D1RPG0$(AQ"45XP.ALON-%KMD;68,A'R!34W&$P
M[]!YA\X[](:3?0I/3OL/NQT=519P(]*^G7?5O*OF776+7;6(J7T%E?@5R/LR
MVN?2%U5_F?EMN?*;<DE0M5V/L((1B=RS%__X_ML'9T^RBZI9 $%G. OA6TAT
M<8U@LRZAB@"] ?KH1)5MWL3S)IXW\2TV,?"[$ IT*Z$N0M8<D:YWU'F/9 B7
M@*FMN$*?1JU4%2?T)A0UV[I@[)R  $JS>>?-.6_.>7,>N_N/OFBA*XL(.&"S
MM<6U5E4ZAT@M/#;_7F-:"IE\.P6R%@33\2O34(8,&!IB&I:'=H6<$@!U0G(-
M5 N%,!7$"!&(P<\ Q>$:\F/?9%6Q -W6&OK@,X7N,LF&E/<9:Y.M?!5\A'8?
MJVZEDM6@M5@C0 @)Q[#-SUB=6*9L?;@8.>J<QIKMR&Q'9CMR[.[_!;PZ-2NC
M7)7^&MUN(,V%DCD+CS ^2P %C.63II%V,Z#B@^VWW?5S!LKNP#_4F]Z,</_R
M_B'<GWQ4"/>[M3OF\VD^GPX%H8C&4FUC\4@?(,L9)&=W@$S:M<CY@[43H.OU
MJ0B!_C*K&@(8"6AKY"+G&KZ.F-[YR(-$\8 7@;):!E6&1)E-1Y"Q(6]!XJK;
M[)54; F8!D5<4#WJVMTVD@\#HRHU3%X",NLBTEM08]>BZ'MPI0$.TM10?<X%
MV4SR06U3ETN"LGEX8FP.@-$D0&[Z<,)L2SUIZ*TG-,CPM?F,GZW8;,5NL&(:
M3E\WV74P:9<-XEW#LJBPB0C3::7=R>:/P>2(HB$:)2%?@@\3/AU[P.EKF*CK
M8F@,";Q\F(^CO>R%2)DZ7M"\N>FL_;S)YTT^;_)C=_\;= [N-@]@Y^DA#,N"
M!2Z\#[MT 2UEI!,4_)!P@JY!G@9#Y@I._JS;-*\IN[:N0@0C(EC:'U[$;AGN
MTN96@!ASX[=54WW>M_.^G??M\<.9_/IPWD*&FIOBY%AT52GGYK(JR@UWHC M
MJ#T_9:\.90T,(1$C,V&#RF6Q-84)^/B+]F2>X9;S3IYW\NWAED;E.3C"#4JF
M@+(%[#1*8^=97[S),U]?E2$4AM0W<%K%]K0JG*\5AL]ABT*&$/O&YMTW[[YY
M]]VT^T0,B% >'&/6_MIIC,FZB%CV]?5EP;K8] =2X&+"HV()W$]"E K4#+U?
M7F('.#&8\?57HM @#5#0I3A-7^ILH6K>T?..GG?TVX.CBQ7P8(, &.SJGN4?
M,A(&\WW1DNY?!;GF'?G1X4SNJ1=1M_!><"96.G?EUYZ2[V'3 KE+<5&4==<?
MN&!9KX%3D32TR3F?-_6\J>=-?>SN_S=L(0AFPRX**V3315B5G-%N@.P89)9\
M^)A/#ESD.V=9LGD#SAMPWH W^<F'B$9=RLO+310"U53\]5"4=<$*5>0+"V6V
MX5X6Y:=Y=\Z[<]Z=-_B\!#:1NDKGZ[*Q_(*N]\7&Y(M>^[T5!$0,BLGXHC8A
M'IY,+3E4R86K@>Q(';L.I0%1BK@U-?DG(:V+TFMS2#MO[WE[OPV>+%Q-V!$W
M'N;M0GKRF6O5JJXC:HJH-S8@9XT.,W<J<;5FQ0*B!!8#^+1DM4@[GD/GP<V(
MWK V%2#:XYOB-2F@FR,<I0' EA3$PX<9-J;BF[?]^V;Z.\Z?.M*?W76.2%P[
MJ$/ C)':.]IJ?UE4:UR%S(49EA0(BQ$]*3F 99M!%;+UP4=<B( ZDRU"@L52
MM$W0S!F22&=)(B=IYG)B8+-<?GR=D^P[);-1%M$AG13S&PO1%"2+B+644CHD
M=Q_>S*&N%FJ\(9F>2%BG3+T1;*F-2%-4L5FDBFVP'VA90:D'6AB06I1H N%7
M^MPH;7GMW<I^DUDV$_F1P_.<6_9+.?\3:5Q@WT"B'R3WN68U*MC/5BZ [H]K
MA!^ .Y+O*A'F+1H*'MZ[AH(O3C^JAH)?L;3>#S/^8V7&__O/S[,7WV4_O7SQ
M[/GS;^\\Z7U4CF5Y6K3\"3\\T<!Z,I.@) R? W)=TL=;+D'C ZPJ"0.Q!44C
M1/2?I+X.N-%PT242#C'_)EA/T0TQJH0JAG-WK=- >GZWA=/AT_/3D]-L P*_
MR%^>%1<70(_;>Q<<EZX;C$_4'QMIA;&E1^%P\131XH?_TC1L=RV(H_5"7GN#
M!AK<T(532V6H,HX:@U'T>-@%OP"!#'QPAY-W+>V^\&R>BZK9M^%U5,,JRI[=
M\L4:1X\/R^NZ:?$P%)9[N"GQQP%4H@V^+YRHHA5P$J9&90;^3_GG'S3<A=^=
M/?JFR[X-K[&C"!>N]32<B_NNQ"=1I\,]4^98^,Q+]F["1UY$E <HH^%5S[_)
MPJW^5H;!795<;GK&CQN^&MXOA-3R:?'M?VS"8S_,LZ_R[%&>/<ZS)^1WG#WD
MR7)AWU#?,W/[XLE4W,3T!U%#YTG88$KF0>[=95_FR?WQYE_P0I%[8S"PJX5B
M$%A,?-W1O][%\Q"8/#HHELX_<D9C3XS14 6O?Q%N3*S1*5D+=FU#ZW=+/B,Z
MGST$,WM2 = 6$GL5$17C!<H?<?8CI$* ;2F_8EV^1Q<H5>I[7[=Y00!_8G%G
M#8,;-[1[7Y;J,VI8^!RBWS#;)$V!/  (HH3MJ1(1T)O$'S(]^]HU')EYTEA8
MP@NZ\-$O9OZJJ:X\+2*1N\*B<[EA'9?(5>VL3@<KN6G>KPX!1XA>NXQ)K^WJ
M7A;=9;:NFFL>;R,QPNH#\.Y,2* &B^IHG2]:Z,0"YA1_Y:MFBPE%OUX3]0(>
MXB8.XS3!B*'=<*DS*_?*AU.A7,"B0*G-:'M?EMWK[#OZV(DU?\+O4D+C29_5
M'C*.(;AT: M"(!6C6<_=7KK0(H,#[RQ\)J"?!\P.S%;G48@%-&P6S15QD$9I
M7@+ZQ*-,6LPX78)J(-ICQG?]G3R0]^/$/E$G]MOGKYZ__.'['Y^"R!.XLR^^
M^^[Y2Y!S^NGE]\^>WVVG-NI!LU(!J%:HWJ8186U9H-.I&KGQ0;G$U<%+BS^J
MDK+)07:?ULC9J:Z1'YZ^_)_GK[+O?_SNQ<L?:*$\_?';[-OO__']M\_#/WYZ
M\;?OG_WO75XJQV5P?R!$X/?1+?F=M'!_MT%X,?3.%\$MJT'LE%RS.ONQZ%;%
MO^#T>AJV4I6=Y=GYZ?FYD5[N]INP&.1H^/]^>O'CB9P%3_&0^FM1[R"[>':.
MW_U2!&_0Y0JFN6W>8"XM;.*S,Q. 9ER+GI)^_KBD(Q=__K:\ K&I5?93\,N7
M^]]/.EH&X?W=/_*BU\&9:5$RNVA)70B%=-%56O& =.($IMJE4&]M,#D1'1^^
M$OIL<"D5-IN\X*2<+*37.D^2P91A'L:DWZ+'M!570R)%6;2)GQ0/+TIM(V[#
M8_T'&+BBXMEZ5S.%,RJ8L<9;@3)S1)ZUVT*=R/(+-+453/$HS<..W\!1'#J"
M)%#,=Y%C5:(V$LCFN%7&+-OBJB1/;"%J;B2;9;RQ9HW!WE^:$/E1$LGXQY#'
M3U17HI?,7JXZO<8UGI"#R35JLR6SG 1TV$N'&+(M16](G7XY\2=]X?CH6.\(
ML0IV5UX5(!W'"^"[70O?(9?[BY+R (-Y@Z#3=FA+Z(34:LAD"#^R:%AFGU16
MIFVXQM*+KMR6 B_+9-9%I3\ NR^A3&+O+[+K!^XO2FOV.>YPTNX6)86O[E])
MX6PN*?P>GO99C,:^_QNJ[=YE7YIJ"9++G\CKCI,][A;)GAB]%X0V'/>@6V#B
MA"QYU5S[-GZ08S\0/Z$3"'+=8&7]&]\N2Y86:U'G'8Y.(,GAB%#>@:Z+9=LC
M$O-)Z@& $UVWNS'IY0Z,0T["*]S>JT)PQ+P1S#F5C U D[IZ(=W4EKB;PY6@
M^,Z#B)#INVJE7Z%L11BYHKXHP0%:-,WK[*JH=M-KK\ 8X6>_[3VRCGYQBI'&
M%]EUT0TBC$^_.GDL]1DD)AK\^?3DR1. 6-#$P]U2Q_+' X^E7YF*5F Q:GX"
MDPUX9DM6&UX5RF,-."UZ\:+K@, 8$3KTIZ2WFP5GM;YD&%=IS;K!LR=)=E+/
M'8_8'5XTW_*Z-[-G\L?DBF(%%#;+PO?7WM=HH$2R5.#,;$"213!><N"N4U4!
M56J+@POV^'6DD.*D?/)"GH**;Q=AH8 >-*$RT928#Y&K?M FCZ\9XJ'1ZXGA
M )UOUQ_9>O$K:/<B%<%G!YY54#)F;#$_#E1DP7/%V&8!)<3/ 3HG-&7A'XX;
M1]YF:%/;#&"Z\(!;?I+#=I2<XW#BA"508I0HZR@\QMO?V +HD*5!SX^C,W.'
M]]W3R;F?-3)GC._]POC:HT(L[EG^Z/%9_N318Y=ZD/7;ECS!,-?IY;F$L<X^
M?7CRY4,T.7B3[#-R#4LZU"1!BUI[1>4 LA@/,4;=I'X Y;((K+B^Q=-]CJ"&
MCQX-/!N(V4 <NSLY02N/;*9A!W[Z^#0_/3T%/^+6CE ^[[+WYC?<SJ<<1$8N
MQI+<O@PX R#=&P2.9U^=/#P66)Z=/#X:6+X"=] $+(E/*JXQ1 E' F.(7D_-
M36YT?">\7KC,V<GIX_0RD#I6OW84J]QA[_65%7;/R+:'2029:U8V@=A=!R=,
MNXL#LRBZ,J++>&%9E%OXKEX,\EI-7>UCY:-8P6-$+!.!;;'E(@;S[%A@<FDU
MBAM<K%- >J&C ]V&?";O8/)A<MD"98+QTJG'DN(?WO<L)-=_3P<L9_"#$:N*
M;1>,C_PK.7L_@;STD3.4SN!/.'L]?;8,\[%@RN,GT?Q=>\@_4NKWFXS?4P_X
M,VL5X1"3FX5'!B/YGY]\H0,P69@XBX6)B=M-/>M3!+:98^<6HS!U.+07B\_.
M3[_,S[]XG)\_?/CY>*1XL!^!GY,>.6=8]9#!J/RZEQ/BW9TU3V](]OR?;K?]
M\V=GGX?3:+?]<W(:CU[A#);+U#0-/O:G=,CAQ3[Y\Z>'+OIX\'',5'_R9P@"
M#GUE\@9V]?V6&?V%'<NI!7]TZL[-X?[?*'".G/ WYU2"G1IG)N7=CPWX+49Y
M8F0AY7OL8^]V.&_>(,-[WV:;T%A_'S-HMQKFM+TP.3?>WW"#(_3AAOO8ZGW+
M,28#\M-;9"5_IQ$&+_"N+V@:[(F<_M 9';E$[W/EGC[^=>,:0[C?YCY]!+F-
MCSR%0:['[Y&^>'6P%&8BGNFD8_8>DHY_-/:!.YCP>*=KPPWKRT?:%AD&F'1U
M2:8!65-[P=AKF%J:GIZO\B>/O\J_/'VB=XH7<L4!3#%2:KS!8FK'6$V.ZK^^
M0P/]!S7*<\+YCYAP?O08\\O3)68':1U<.<B003UD H!:@UA06R PHH',#QG?
M&^ B$YL.RU9ZW5BR.N=$I,.'^^8/9LOO9%;[C_NFZ3L>P]8^NG_8VO./"EO[
MQUV$\\DYGYRWOOO#\[/\\?G#++GBP8EB/"4_ZPC*]<'/61?/V2].OCB/R9'Y
MG)TW_KSQC]W][,O'^>TV_>GI0]GQAS"<'V3CNVD'^\G)V>F\\>>-/V_\V]W]
M_.$?-E9^>'(ZQ\KS5IZW\BWO_@7!*M^_[]YLN>WZ%KN;I3:]<-42IHI8,HH,
M<%1(Q.N :FK>XO,6G[?X43<]/SL[RQ\^_G_LO>ERVUB6+OH?3X%;;7?($1"3
M,ZG*ZHRKE.4L5=N6C^3,C+I_;H#DIH@R"+  4++JZ<^:]@ .$F6+DDCCG.CN
MM A@3VNO>7VKLR2PO4TNKN+(8I2@^X^021%ZN7R1^6IB  LN<,,_,\\>X[/^
MIYCJ,59=]NKZ5M>WNKYWNM=ZG0VM['Z[=8^5[:#@I)G&4*'KCV[VZA97M[BZ
MQ5NJ9\+2\M7V\G=?2J,P8ZH(8@U%R5RZC]@45OGNK0JS?*F@$A5I#?OL(5 8
M)@XE6+3 S1JJ^UW=[^I^W^D2"SKU^DJOF/<-HO=4>I6)V#8)?94(KJYH=46_
M600[ #]P@[C)1*]W%'2[1]YJX6R!SI,\RADRL=?L!:U^3U_TLO4,#V+S/RG^
M7$0NY"$[S:#9;X(H%_Q]*1\D'D"8,?3\<A9OA1Q07?/JFF^B:3M],M:(XQN!
MQ17?,H%]W@KJ''?;B9SF+IQDO2AR7UI6_4YF8JXK)4_=3@V4">\Z'$TT(3,!
M18_;];'C<D2H 1IG%5%@6 ECUR6UQU-%$>-SM^F<,6,M^M^8D6<M^E\9)U%
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M[*#.%L-]-AL<$&8!"#?@EJ+9#-1M*NJ#;(.;UXSQ+@&28M$J'I;R/I!?DB2
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M.B53QX[?! X&!GN'W>P6Z_RVM:M\1JY)9U/1K/L]M#!+]#K[1P1*:AQ]%1L
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M@R_!5^C<O6/30Y<; JN%1_63MH\'FLT\)^FG0$1CQY8&1MA-.,UN?=/O3?_
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M'F%R+G(6E\N7,4UG!KP]Y^[>>F'PULD$.]Q(/"=""XDX\Q+WH% 7JJ_X$D:
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M9)[Y8^#?,<W.8YM\G(5YD<V'U'Z8ZE<ZW0?EA$IKYALJKA@#<Z#8J5L13MM
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MO&.P:D7UM_\><UIACH(D1JV'^#;:,DF$ZFI L15G7%^*(65HTHL*6BEHR(@
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M:VW)^W<JEWJUSE+:[9JBDA.R1P5 Y#?4NH*%Z%:KUO2G\C&N[5Z)UT!1,D>
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M\2E0WJ1*VH(8D=3-2<95LBPGSMJ6UW(F_WG>;(%DD\08!#BX2&8^_7-NW6B
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MC7,T.HU1PE@++L9!K#5J?XA"I?X "5H9@W/>VMQ< L2K,!WLVHHH)%B#A8-
MYCI1/QQGY';W]XO0'KB*29Q22-TI1P/!XDX#;M0+I#50?DC!J^MQ'*I4_@&4
M=P4/[X'N4:$]*#I]23"B$E$T4YEERK8FAC0I7IDJ"6Z85%UD2Y+149IS !(=
M&6Y47@H1N@M#A-R/&_4IOH#Q)KR^'@;)Q+,"EPE:[SD-"-XCT[ST&4P=:C<[
MT@9VU3LA>4-3-YZHB3!0>THS]^(V"N-FO(J:H")%(2?^O[FQ.O:N#FB7';YM
MQ(,X Q<4__PK3D*,/9@6N9'/+K7]9JD'^P<U@YUY$V#1.SB2=.'Q+NJW:@?A
MFS*)% [T.S$I;.R2/(G)C:!^E/]T4W!+0(.#9"G:C%>R/CK22#M!ITYBGS[?
MXZAOL+C4]K<M258.,'!V0N2@9@VY]S0M%+<;S!MJGBFMX3&J@::&C^D]'$),
M.3Z8BQ2\4F :A:7H?-)RW_ -J(221M2/F\;+^R*V)?JKOC%O.$*4]D91M@28
M U= +*H2D<0SQL[=D:+&Z,,0+#!@)*9^=17$>4K7FU&<@\T^<*_\,%=[W" <
ME5X8DAG$J71(3F3K#-10 ;<// =-1%*9)LJ"-!ZH:_(02>O85[W#&)C6E1#J
M@J7(=,D(809#OY:UA-D'P_QERB93<Y2 M6)?*""'\A4L,9%NTDI]IDW4E=+N
MZ 8."0.;<5>O)5SV5MB6&F;*"!!>R0;KHY+XAATG;G/QICT \\4'48H;8D4Y
M18ZECD0X=##,NHHM+G/><'@)B9SZ:K-162VH )YE@I!M1T;B2]CB +(X\]'B
M_:'CO=P_]+J=(X]D,UC\R!OE"^>#]H]ZNO0>#^^YA7@KOA<57]%.C/E6V^L>
M','_#E!25^ZT7]9]8H,) <R%=U&&7(^W(B$FMX*_D\VVPDA!/T<+5NWT@BJ(
MM-"E8RR2;U%-<>:O$Z1:*"C=2-[E4!KH/C#]M>]<O%UDK P#I*)VV\7$/. D
M'[5.WS<)??/WHI8/ 7]FDI&'MZ7E&99(&1E2LF-JOX0+Q'0+HY!J'IHW.A*D
M\GQ*5@\P6B]@G8V*&90A7L\E7UU1C0.*H((UX(;^=?W22B8"?%9%Y3M<.@7R
M?'1P%XFPV(24\AK >\;0:3KV'"NZB7G<L$?@F23H/Z3ZLM,^)[-W@4H+?9 J
M]54V/=..1F!SP52X0(\,8BG.07=$<;2'EYYAG((Z=SA;&Z.II)%3/ NR0^MN
MJ158E/%,*=T6/,+P@Z\WH?X+<P,9\M5IZOBRPSM(05>^1MEHD02G!)L?Q /4
MS12&1O."]M!VC\'1)GLKBQW,1TBUM0?F D4C.3<!2=Z*6V%<I_:DB3C S$]S
M\975"$T4W]:!@QBI#ZS8B3:Z-$?P,6#$(.AS'M@"3F>*H=QBFGZ5"LG$)*99
MW,/\.G+;AQ8WVE.E[>C3C1P.!RY)NFP^EHD$HT88NEHT+EM=J-7CNJ'/_,@?
M^!M,=:"2?BMR #ZK4<Y6YL-JJ$?@)?1.K3A-$*$[Q6<*BFVH,+4B]#"<*DE_
M#L; T*JG+< T2XHT*LIO4]$57H?A)L$S8W#:*0\='!A_J+*9MJ7X9DA"K!AY
MC$$X4@%'D!7Z"6](ARC/6CJ7U$YT=8J*.G+)87XC\/G_9M=.4M0'Z$"#Z$SY
MMEFGF9/%7EYXDJ/MQWD>8IT&4B.$>IYF52CQ /U__+@:.-,XQ) ><R_%UP:8
MU^J1>T@A/%N\>UJ^HZ- 05^Z%P,-"(H[XRQ3/#R^G@T#'X45"?<;]M9)#%%N
MLGB_^<KL:'_[KLP.FRNS1PGSG^:CG*^XV,-$UER6!X[W,U.T'P;NG^_!O3ON
M4D(R><$L$6#0MZJ7Y&A.LA*^(9-[V6@;S+:]5^=:Q&V%<[@<Y6'@=KHEF1Z&
MSC /0TH0;[D?,8 @9J%EV%/D&*0[.XW]F,Q,C*WT8#*^W#65O1^=9QHI--HP
M!0-HDB)S>,4';T6D\3!7%.N@IB@%/ >C9U]!76.6B@^"$0-JTSPKE1WH_%+2
M14'A%%))0)2R:2O9NT746U=Y<=K]&/-4*7RFEU34J*"I0#'\@5B;)C!7Y_1P
M"!65]"8P =.[K8\]]W=2R*S>+TDCKXA '_/2QH0]EB84FY0JS+C3!@U:=)R"
MY-EVE8\UM'BY"(88)[-*'A#&AKTY Y,"'1'&\WE<-C:+]-O"\B1*XAL/+./,
M*'Z-OC854KH3H-,1NR05P\G'*Q@K[B#Q=JDB](K2!P^>C08AW56,L-90DH61
MF>)4TC+IZDDNJ;+X6]!W,.>1/.ZQ_[>?#-#XA/W M$VZ73\-\2H(?'ETUO),
M\KQPTR=V=8(G-4-VP8)(%'/?(Y&GA8?EE Y+)VS1P#DQKC7%(M&,[ES38!)P
MKJ4Y2\K*+$41*D5 I0@:16:H^*RT_0[%@C@#O#!7Z7IMZ <A)5=R7J3YY[#N
MTWS%-<'+7Q%%^ @-3I?5!8GT05 6GH9Q6V:>TP^N@I"$9#\)&$X6)!]P,2V-
M/ \A0C7"0IR (P7TVS1/44J*^U\D8'B<Z&8" ^4#-$D<5JC.H219ZU@Q<12$
MM;X,&_@3(DM.0AAQ!AWX'Y@S(!<G5@Z*OCR<HQ4B!8Y 4%Q/IS@47H;#";A+
MB8H6H6-+F-9#-DVQO8$U;IJ9V+TF"DD(+059B[FCCL'Q'$M\S+DY;AT!N?X@
MGDHLUDK5AWV+R#/319 7E[^?ECG0*$/VA#$%1QC!J?I?$AE%-Q7F@&JS+[[B
MA R\<A!D+.I .[["*38W,(LG0?J5KQQU(,H>ANC:T1_HX\4<9GJZ*B2*S?0)
M*KQ_:+E?8J"73!7U*?@X' I>Y@Q*%SAH2J#>IQ),^XME:6EM0A0G#HUYK2J&
MR*Q(HPK2-*\.*$I^_BSGR\S+!>:_!J\^X^Z\Y7I.JU#<*1>*NU:A^";8#TMN
M6R96C!ZHXK7B!"3W?**XE!$\E&O8Q3/*'YLYG,AU.?'I9O8SI7#353W_?BML
M<3!,I.2(4A8C31]*[\F(]X1SZF::1GS,61Q2"$:BFW_DDRDE!I(<>JWET"7^
M*)^F[FE??,-VQ]-ZZ(^+UY?X"\X+C-P%'RU83B<8(/?Z7Y7C#ZZ X7PV?RA9
M81C0;3H!4+AV.-]<=]BYU:R043K1[ZX#O",I9!%;)B%G?4SS'OR\2"ZD!*U4
ML5F54BV U(XW\',-TLMV(;WPO8SA&U.&('>G3APACUS'DBE)N40#NNT &>%'
MC+B$7@AS75!."D4M9\J]\DB_2NY,,*D?@LR&?@RZ%QP&RHNA(CWF>Y%A'_S(
MYQPOPDHY_B7%+*E^GI)M214JH.!FF%$&,WYK/G.FO79.@R(+C!ZY, :5CG87
M$J;I_M8(D4:(+/MZG58FX"&LH%#?5#\G_ZL4)+/S-!L.:SBLX;!E7R?@-/ )
M.8E)UQE8BMO1BGN,2;0^Y;ST IU6"F8LUB9>Q1F6T[@+6!)L]Q&\K0BPT>^/
M<ZQ M-D4M6;#J@VK-JQZ9U8ETS=.'(Q)I1RF+-G=XFMSUI64*ID<.DIU*$$2
M%)9SHH,7#7[?@\92,&Z+D0FW%)G@"+HY;ZYVR*>8,39$^2I>4R)!?3^A6@F\
M[S2>%L8HHIC*6ZAX8U&LA&L!Z,:H3V S?/NW^ 6I.'4PMLE?"R2?CZ;!-_H[
MP2[]+,2*N(%OX!R&8,H!=5&J.="F .!IK'Y*T_:C"+/]1E2*I'/9\?T?VJU.
M]]#M!6$H:@7KF'YQ=H*:CR&-VQ\K>@#P-(84_(P0[X;*\V5^M"CYN\1RK:Q"
MC1\ND1VZ;(4A?X'EPAR<8H#JRB@2.[#JKF M^V8EF*@81\"()%)1_@]4+]/(
M#UQ_PN4@DG1/Q_\+[L!.<+7KSGW7D?,?X.WU0)\H[ ]AB/5!FRB&)!M2R0QP
MDL"1<.*5K/_R_&R3X[<WYRZUMR]WZ:C)77JT3$TN,G93"?<;C6D$91'S=D0/
MGW_# BI8.\6P1?S;-5C$IXM'I$("+F^ZJXB'+SGSBD8C.@K+H[PL.=RIAA-@
M)+A%,RL ( E&V=7/+]!L3LUW4,.EO!C*J09Q"WZ%J?@&OT/^>19/)B#H+K,8
M^'*LN+8/?^\/09P%E+N-E=><9HZRMG.X#])V(M)V EJ.H&3BR#%:PUR#6NI#
MX)A%BP@J,UU%$!X4JRE=-%K^(MC9UA<M04Y%J(BW1M5<!;J=K:ITWL>JEG^\
MOV#Y[MSRG9N6OPD*P: 9(\>\*RXC-RT%J"@5QN)<@@D6 P1A)$RZ&0&'2(V?
M4UQ<:Y%1*'<LAG#_%?_M3Z9%8X0S?6/V_OV9]A:HX(#"UXD:H?43N7_DD7+;
M1QZ!3)BT:<)DYX)66.:5/\!") -9[/"G,9%:"AAY"E2Z@=?>^![ZD&)S\( 4
M:A_X4A4,/_X(G@FE_?'G.^U-H,$EB'?7JI<B"&V ,B^/"!=6Z:-N];%D,S+<
M^8[P2,#!^VP2]O3UO+"I#$=7GE."C$E8#.,_&)+.W$]ZE798*#"B$8(Q@NBE
MLB@7,T9B1+_""FXL7.:+3=8Y\/:,@-T* #,B1BZCXTQ",+7S) K2L=RZLB'Y
M,_WEE&4F7XQS<BX0XK<94]Q$X&PN^_ N&*)N^^"4'_I?%C[P)7X5JY2=MX@N
MW=[?^U]^YDQ(K'C"I2=.]OY'>@2 0H9/#.0>-Y:,R42>YS64IF\3ZJ7L>KN[
MX^_B8^W#G<&N!OZX1'0RKO"V53R>4?ME]X"/84*UM1M,O:=AJ T%NQF )#YI
M4G4+4@7:=-"<)$@6VXY  *) 7:,'@OZ,1H=6+5M>DV$D51N13>L:]@Z3GWA"
M#*9"U3)YJC4TW]X+C3LZ,XW<&JJE0HQE,J!B\.9&OKY<S*?L2U$A-=WO ^7
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MVO101P[.#_*<Q=SG!M-+(V^;61+"XC6Y%00Q3\F?5H/ CCO@N)?/6.PZX;V
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MVFGO[G1V=[J[L*)\NOY4<MA=>PK9< -$Q<E(.>_54%TE:C-IY*BAD0>=_9<
MI,C'43Y3T482R-%^0R"/K"37D@XVW>0P]='?F;RPPB2+!5<Q3P8R .=P#RB!
M%S^]JJOTIT)_$'9\!C>4Y']0N@T6E21@ 3T55059IE2K.,85G>*=B]QI,<_@
MN#KW.:XS&UBD.;7'/[7N?4[M8TSXJ+J:\<PD:W,;%T(T7>_#?*0$ALW*6-#[
M>EBU"!9O[*&^Q [H]L:EVQN'T/;:O[C6%81[\Q6$5PDK!W3-W7(_)"T>EUNL
M8F_H@2XIKOT"$R7%(^?O.=( J5-GPW>X!K'+U<Y^:C?JI/$7W);P*!_\I#^F
MYMTM]S7#=/\[#G2+&U.+Z10KP&Q73L']@@C7E+K[SD9M-\S$>->ZV854[7$>
M+I:E%<BHU".;8'[UQO@%^NJ;(H_6831$VJB8$A/E![3V#Z4\>/T;RGLL\GO;
M!YBN:*_Z4Q+$U#/4?LBSC@R1O#,&HVD?,]"%(]UA)_@1_)I.7:%,7ZOT0QJU
M<65C,K$IH9=0%B.-V]TO4">M>@\I:M6#30P6I 6PW'+FA@0*QY.Y$ASF+.!"
MA:GL63&,9^I!K&1EKS2#HJNA9R=X%N4GYY\__73V^8.3SM),34J#2_4#?8 3
MF1&\I]@"@V@YI2.(8M%/82!5;(1$"P2<S%)J&/PZ5O3-C\%7Y;[[_8-'A">M
M -[XP02><KXD>?\KR K*13J=P#+Z?JFQ1;%?02K P0%GL1+]Z?S/U[&?4,L"
M7X/A!W-;2R> >ULJTI$U.W8&>.U>T$]QV"0.:9A>'H2#"N^M(I_TOF)Q90J'
M_K_=:M]++-.MJ&MN10O93)+MIJN]D@S68]3)X06C+9:VSD)I.W>'!'0$&Q%)
M@8[=$:A=G9GTF(2II2P)0=8-@>M8N+RVP?%/#1]B@XN__##TY;]_,HQ00-#R
M6'?-6+!C10LGC 995Q[.JH(0$ZN]LCS^)U8SP0,1E@R$!=2LH@*+#S$5ILR<
MU_X,)H4M &<L>+6@;;^D BXLV<>/,<?>-"@LS3T/PR MCRE3QBZ&TO;2VL_V
MB0C$FOVDE;RQ)=UGU4_R@ 79AQ)7GH;Y) JLPN$WEH1?.#6SW!/$Q;*G];)Z
MS%3%E5*=!$RLR(@<^U=4S<L3)NU <$M8M,502P.%GV0$8O?*QV:EA)#1]]&(
MIXIOJR7[^87GG+V] )/EW86GH=5"X9)_?C);'F#Q2@04L!<&5UQ8F*;8#7,@
M/W#3KT$84M/F)"6%9FI./&GJCA5NB>"NI/UQ'(>5'K$.R5 0@MI4"*(T2[@U
M!A;&V#*5A'^JX?_C:( [B2/GAK:Y&[<!4H9YE=9NJRDJ%K)^X)2T( Q'$^"<
M?T(N(#GL47F..U%80!_T>65P0.SL,>*;K+1ZOJ/$'^2^*:FSF?,,#V#$;2,<
ML'3\/C D4]9EWZ@4P^FG W!5BG:B9<;')]LO7W:8HPP(7\'_..JG<0Q'^TWZ
M5 "5IE+LJ+_A5+[!@Q[/JTV;?&M4)\FKB7&TEJA13>Z%?6&=OK3&S:@0S/T:
MQ== =P:L9^6*\>YZZ<GUXLV%&MWM*]0X>5:%&IM*FF2R86Z2JW.3*@;;G''4
M<K65AC)&O[701)LWKF[M$#O%*)8(K7K$,]@HKCJWC*(QEZ>";YRQ09\N'J@L
MI]B7-,OB)3G&^S<*F81W83-TI/ =QPXKLUKBJ9<_5CCKESZ<;)"!(<V=Z/"\
MJ=L3 L&!QW[EHSFC\0BTI<7V6KOD,W=J/?9+K-PW)\--";+6XL^R 81=HDGS
MCN-T&F #,/$CJ8*>EH8F#^^P6!9(%U'L:G Q*LC7"!A:-51W:,DTHF*9Y<TC
M\]XV^XQ&OK ::H$U&' SADLRG]SW;"U15VLT*]PSLL(%C&IH@1L0<I5M%Z,O
M4#<8E_PC@AZ;AO0K!" (+" ^,8(FDSS21B#BE6"PU30/O\W6;8%671QLM).>
MK*JLU>55R:6V?;6]<?'3^PI]SAER=<X0R'0C^>&W[^ E+.9%X:EWOBSY\2WM
M^=I!&!TR@M\*KB]X-6R*EP)O[S[^\\)]'<0I&]$>@]3M?/33@?^?GQW\]2ZZ
MP]QHK$^%\EH,:"X:QGT"/$ 1B*$S"F]F8$-DXBJ(*YW6^-(Z@,AR&EQ>G*+Y
M(8&6M(\]!]N]<&-7;,GVR2@GKU@F2IYWTCIF45QB1SS.F7&O]:>.^?.[11!Y
M7F<ZL%\(!X+A9NPHDR$6(T@3O5ON^>GEEUWYB!49/<0/29MD^HBE(K6PU>-:
M"[(BNY$=IW%L^?K__K_SS^>7%#ZFJ 5!&H>S/?!*$(ME%,8]@K>,U#4%"K&S
MU6A6Q)$K<]T_$=UY.DW@OS1YD(GH,2-NL90>4NPM]1S+95X0,*?A+]4T8_^&
M8LG5#WB+]MNS ATU%@-UA55]=*.3F4-?,H/NRU<JG]YA+$.LM80_$,80/NZG
M&!MP_PKD3LNF@?I 67'E,+=]3NFH]RTVK,2H2J'PJ1W0.4,E_#;GZ+SQM]]_
M,OT.K=\EI1?PJ19H:^0%<)*'?$6"CWQ&P!P@6C_S"2)R!_Q#@Z*"O0 1A>BS
M2A49+)=D3Z0L#'9-GTLF1@2"++9%XE%F/Q!Y#X40A>8]0A5"98R@YP2 /1<Z
M1P0!0NX3,$I!#.(^AP5"@!5)+\7=N?-AB+ )L&Z^=DC!;>>K >:=@"#MZ#(D
MT4OTV=CB&#-\?PB^7"R1>-JQ-ZV/K=<MH XRL4I'02+R]Z PDG4_QJ0(P']6
M1$)3W/D 5 A^Y[V?C\8@,1SNB$XG9YK*_4[(ZQ'A)[UN7;8HYBEQ)A;;^J>_
M<7<Z:TI,AI]@&2$Q!0%_6N$,B7=40Q..5@^K".AKXQ.^9<4G2%"@*<T(.W.]
M]+; </H^GX_205U)!S6JOT[OFZC\0UI>1!8RF\5FA7Z 3&S#EW)OYY,8,!9!
M'=LRUU(0,T=*'N7!P,2P"^)P"-4,I.I+$[7F0+@]AVN1I9:P^_WTTZEF7$+$
M;?&/KBG45KE>Y/:1<&9_"_7V@CA3_7$4A_&(@J>H6M"30H0?_7-!7..[43,W
MU&5U<T/3BRXY4^Z*:2PG@3\4^&B<'(..4L_<XN*2,%:P<I:='L;O/6#A!RSH
M(R"I2P!78Y!$+$G]*/)[P2"(0W='^N*=O7XC_>MV$?$%Z#.9,<P4#9(R3%O*
MIX>[(>BU)8&K):@G4&8:P2CXV]=XMJ9!,IP'H461>*I.+67PJU2V$@04N<SP
MYTEY%]E<#6<BQQE[!P?B+4)H+RW?"U&>MN9.@A0PKJ=05S#9W]X+Y"F]3Y+9
MLYUL:_">'WW%;U_&.4HS=%9!;,9)%/CLW3MC_I*9,7<I3*D9!-(VX]H)H:EO
MV+B:P-D.]PMD;W1!<\;O03"Q*C6"!!Z-]_!G=DM2>ZTFBLXVD37)JF( YD"<
M]M<$)"B![KM%UCTXA'_'&D1/]-6<GK'DQ9.I&N+D8CCK6*V\@.>NCC#SW/W?
MELO)Y[=31T1[_$*]QOA=%$6:]Y'@AWF(H'R)FJ)7DB<BQ;1!261HYV XI3R!
M@AD\>#11A*Z;:GN5AF(/!Z_5?(0BMJ:'OF=/J<@RO/4M%MT$D1JU2"-ER851
M)K3KIRC[HJPT).L4Z=^.%/D^1_YP/\E/T-A&2F>P2%%\^6"F.S?I6SR>M$CE
M@%&[,/,D=5D43X)^$H^28"#!OM2"F,S%Y=:'U)_I>;./RU?5E4E7=.;;(/N"
M,N4R'F8(U8D3]P@O$<X!<?%(%&8*9-2(KIM2_:#698(99G4D'P89B0RM:[R*
M)T&J<>R#$O8C,^,C\=SX_E=KV0ZO ['CR^MP>)!Z7PW6];^(_ U6[CEO\"53
M127=*JH03=%QPXXT?)S?0/[P)0I#-9HYUG<OH@0!^O_2)$H^@U[COJRF8URZ
M)2LXG8)U\ 4CNN?6)3#2E0RW?RS#\2$[-F5JE6>=-&9HGEZ^.Z,IH:H+V4>S
MV$D!M<41ZG#0 [TD]@<]4?8Z^8RZ(N$'^@)HW9O!62E%'4% )ED#8*P<)GG(
M#IJ5K6:'H1:\:Y9X:*AB_]B*GM"R FFG82VJ*I+PBS=1ROL@2K_.L)5"81^*
M87)<?+U=8J2>&@'QH*+"R!A&!S+CGKV912!/Y/X;R#!$6XGFYYBK &-ML:U,
M*[#$7>E;E<OQ2_CPFT"-XGEW3VORR_-S=OU.NG.WTB+AO_=*NCZSB]J(E3G*
MV)O/6,7>? %]L'T7T"^;"^C')\VYXJZ%WS\6X^\MVSXF=PLLZE4![]U[3NMP
M2_.%1+6TZ&(#T4GL37+]"?6ZBDS'I1JD/M!6!JAO&R3@XILU<S=1^ Q]]2SN
M\T[%%<XT(3CFR%VL=$J',P9\AT<00Y<" A*9"2P'R[SE2;#&ZOW$%TW<WY$C
M-[>HR7%,30[Z878+$FY^1G$*"E)3'$!_WV2:!]9)FAX\!@BXS S4R-08=NAO
MZ;MRQZ09O#4PF/0T?]L#^R><23.?8N.NQVR_LOF!=_"$DHG7@.#N($XV1B48
MG3B*ZV>ED?9-789I'H(M6DIG4UJJU8#7--.T#\ S??(PI!@,$&9^Z8&VY$"W
M0 #<\_M_UE(RG$B)=[ /&L7YQ.$PE-@C*IC@Y5J/G;0D(--YZ-9O>"F1=NZ[
M^H0E>5N N]'3IY@PV<08I)O*#12Q1V$6+YPF=7/VRMW3N?T?\RK>A/<U3V)$
MHC1[C2#OT##%@_)E<>HTU98HUH@6O,W3P++N9VK"M7^ZU[4D2:F_E0&M+TW9
M?-G17[[[1\_VVLL^JM'02W*M88]Y]C BE40.B4KVVV9RQ[E$[F@U$@P][9S%
MTR"28#VW4%C,;AY3!@?*G$&LN&F7X,&7Y2R!RU,/:HIN#=%T,KE28!8E_8"=
M1WN:_\X'(]WD'+SH9$8W#WDFC6HD@"Y9\\1W1K&""HPK\M<>F2+N.2C$E%^\
MD1&\DMN+P:\*"]9PO8,- V!'/(D[$VQ_P$$!5('P(RDRF%7]:M/YO?@""RG9
M^#AALY+&9=EG/8@-H*?P67W9X!!NO_Z71Z\6=UT>(O8':8Q1.-VAK&!W^#'V
M"BERX<MK-#,9TNT_"$K8[@"K*,KMSN L'-PUW<)T(&133V=+1GW&,@ U5K\/
M'C]=B%*YP^UDZ;QY$D0++":=_UJ2XT3Q,TO2@.E%TD;?TCC^G(2HUQ>>Z;N^
M0'EK?@55%F))#-O(K'/[8I"&ZDIZ-MJSEI9\MD0<2WN^LL%'IJ5)\Z1X)3"D
ML0^E8FO>V-5]5[F/3TF:(&]8M[)!A$TN(FDH:<3<(#=R:L'VB 3PK*H;*M@!
MEX&/H?0:_+ML5.]8Q3IE%G<TBR_A\*D?4+"VM#]B(.M/['*@7K<_M']%-SD%
M>YM5EUG:62 HBM[&SYC!+TPTE2C79E#'N#1BCY730V *I6Q1.B6ZLI,0,??)
MJS&$16X4+62UI, 12I*$33"G9#>_\:^ :'Z'09.@_S7%'Y%PJ%%GO#".EE.1
MKDIA3WS=8%0RXS!/@IO17>L,K?E)\YR=6\_Y^5+4:=&?E"P8<:4<B4<55%"A
M#X\[!4L\8!&)2+#A]+:/<H,BTRF+6WSB/.HIDU0,==L*J/5%'OK8(3B5[L'V
MU3"8<2DY3VAFDD@G0[A^7%RKOK#= M)8'/MBEGMO$B$VI OH/3>T@!O1C:<E
ME\<IDG;K($;*R;?FUMD66RW=?!JMYT*855T>W.G:C C@D3 ;8RJ84[R-W@'B
M=Z1\84S-^J8)ZD [=T7GPJGYEF.4Y8)P:.PW4=) *#D3\H^B\;"5J<4)+\@
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M7#AI=4K,'@#A^HD[S*.^=#/@:K*;%X]6[I4/;Z-*B2.YKL.FG=0935?Q8::
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M;V.J,/#<3]B\?6"@VID5+Z@, 0TA8<7F=K#ANH;K;OKZ'_$X<O\5_^U/II[
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MO9PC^KV99:# -%-EW1" 7,2K!^'S^!J$0CH.IFX\Q<'RB$PAG-%/& BBI_9
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M"/P6-W>.!MR[>U9IE>59;;GQH2B.BA\439\<:AG!O;]A#.[]XKGPG/*PK5*
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MLY+^) D*OY@2,J.^3-4".)7+>H>'P@X,7 N"J-4>8[5A3;$9GO0T<H/IQ&"
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M&SC%MVE(K#FD(04E6->%5PH0!T':QS8F6$F(%>-6+6&-_\*H/]Q8S:JYU7!
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ML1SBFMG764S?*1*1[I51)XA"&/V1T(GE/3CE'@[X $CVKA\DNG_4]G%))X)
MDNB*"JU;A!@5E4!3E,#(*JFGR)FE0U/U^LC61\JA]'8GND9+3/C37=/(3@Z
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MSGPC8:_.5JE06X*V!VG,!9P4>31\+T5@+0(,Q[@%AB5'I>Q3'Y=S'&=)VT?
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M@]O;GGXL"SM3XL'>A!C]):DW$C"2VA=#.!]\,8\RU4KZO>/-_1RSIOH[Z&;
MCC!\HV *":=73MHWW"S'2R.5R=JG\\U718Q$Q^:\.,[PBNZ0<*46K(\O)$(?
MKA 8LV0SU_H4:IU&:H^<0NV1K>4*<0SVT>=<D606[$PI3OJ&<J0H>ST52;E@
M"A$13S84N:)E##L6G8YC,8!K&. 59(E'D 3QFED$==!4(-#O IH@">=1-$$U
MP7IY#V.&E'G]]:7,]U8I\^= #JQJY,"K7X[<H_]]/+[ZTSTY/CURKRX.3B\/
M#I<?0/ L=M^%X"MA*VUMEX!%ZQ0VI/>3KS5:4.F4!&:4#Y1+KUTPC+;YE.GI
M]7*V"9N)4DF$"5L5\M0C/P8]_.=_:I6M"I\)&!X=FH0PZ@,1"!]-P,+9R!PC
M,#K63B_2'-&'1C@L'U%9%50DZCGV3"4X#]L8%3M@2GAK'3\C MO^Z)4)9(@(
M7V9?XZ,V-+FXEAQ:<ZCLQ.N3Y%MQIMV*"G63#85TY[G@[_/(.0QT@ZU^X[,Y
MJ-K)E>_) 71=N2$?+2- 9Y0 RYSP7'DQ_#U/G*H"NB3F8%)-FG(\70"=M$#M
M$Q$[.2+.$WO62D,9!:2(N[:]":_OW_*Z.:"BPB0476#:/+0#)^_@ ):6Q";T
MQ)A89YS(>'/*17(U.;M^C#40#ZVY2Z.EZHD;"8F5$PY%0*R@32:"B ,G6 -0
M('E,<6=M9G*'BB4U"^0*46<0(T 1N<L4X0P& 0TN4@7?3$54OJTG[>K,NEJZ
M,^$0C,<XK=S^ !L!.H8C)I^L%9,+PAX&)7!*E7OGIU'((2D\IR15CKH>>RYG
M.RKI<Q47/KSLAMU9N 8)7)KC9N<0<?=HD%(JDYW-0AU>*.6H0^66J)##().I
M%>+VI0D\@5Q4>$"+]]P>\,0&B3;P((?437HR>VEQP>H)G/$$$2:9.TJ5B?<J
M7Z8E+)^T N3/';5IB@A,'A%KCL5#5W+3G+R!!Q''$$B\2^Q.TS,,E<U*PXX9
M^C4J*-T#NM=?_7B A=S5&EE2VQXO%MX-_[?C[>_M>-N5_4G$;\WS\$Q-4L.K
M;S>\_?J>FD] #U3#O>(DWC3)$XSQ8FQ+T""F2 J9;9)I,8"*AN2?97"Y$U2=
M8Y0H17>JWNY>U=O?W5/G;L"GK5B)/G0FNGR\B7^'=" !&ATE+._> PL6902&
M;D63Y4&>R\[91GN^#\W ;B8.,DBH^9#W\&!B\1PYRE@7N_#>76M;,QR""F'Y
MG4E$$UE-@*J"7D]Z=&X(3Q3."QMSLOR$MBO*51^2Q<V:P@[,#[+9)?S_[Q[+
M$,DQ-;[.A"MD!ADSF-W721<*^/ (0W==1W!E6BN!X[6HMI,^7-W?VM__SB1J
M#OV>959M> ZE;95P(.1LG90LI.9KC2T<I=FVTOL6^M!,S,Q59[FGUNM;]>^<
M,4\='<6IV)T)(\_S'O\2&TM0KU/[1^FQ;>$ME=*[0_3>Y8&)/K/1""^77YZ1
M "RM'F:)!PG9[EU0$VX[2K.^\UA>4:6 (TRC%L;XZ"T?RX7L#PV:>-9]',89
M1)V!3#]T1F8H4WA[1+$,.GUUI8K:RV07U0:@G*+<0$\D5:F: KFA+PBOQ7FP
M_%$--($[26LMJWD_+B..Q\A14*KLP,:'.^[!'*(\9EHG6"3+^9O]3"=+8-/2
ME<L/@]CQ)'=@I<CN0T=F8N6F-<K(3TFC*>XT[WW(.W.)(K)%[[@-4QNT&#6W
M$REC4\H//RI2,HS#^(75SG\:6]L-D-K$B%P-IB+65,<&S.=@47/.Y%9D:R1J
M?DKF])5LN+T.6=AH_W/>! OTJ<C/D\H=*H?+,!8E;;_./(_B7@]EH%R/2?2,
MT4PC&2Y'CHE(G!-;.-R,.R]F(5NK6K+<WJ.FQ!QSC'-^G8?Y?:;Z4HY786JJ
M4TE)7U$3H"'$W'Z75T9=S>"G8WTR7,EMU,0!R,IQE8BE+H&PPU!3PA(TR1=;
M XSF"ZU!X3)?F.PTRN9.N.0^?M/,J4;U=B\>MJF<IIHN8X=H0RK#.8)1//:3
M:GAZ<0YV=AOU*'R+97DH#+#Z)HEB+E@E1Q[6FC=3?C+/.%//@"-7#+7D)!23
M(R/&^\S.*EOO^0@*5_VDG#T:\D0Z@3KH&]/-]GLF2< MWOPU]QBH\F[IY>+5
MJC8PQPK*F"ZR0J '^[8RL9WNDY2,^I;?BTA>PU)OX):QN4K-?Z3 00](?9EE
MQ SIS.W7E\[<7Z4SGS$"_F/SK188QN_X:.I&)TJ614YEG+QH=6"+G KYL5>2
M"YF46W**'NUHCK$\/3,E.U/PWT9\-^D#-"%[)V<D2!/+M\3L/6TBL@%) #SZ
M8[!UTAPZ>\!EF8_P5!.V9U6X/?"'[&=W_2]1=] =C;3H-J)F:/4#YP#;3((Z
ML@)>?FG4)G<XN>!8)[G'L?88;++2LK]?'YR;?7R051[0B:O<[&J>6O[=+P#9
M<&'G]E10B>O^QC/!).*U*6];!1$"/^IHIG6D'#>*2SUV\>?6J1TO/PJ]\.%(
M@+9,41MLX0@V%B%9?N"H_GJ^$\"(&&=<#,!SIV[!-5L8#>,*V$%A(1NZ<:'-
MN$PQ%J'2E'IYZ"8(,^E?<#E!@<]:9Z >R49NY)*-^(4(1'T0<4"QAR:T[K^V
M?.2\%#KZ$J8M[*E$U<"UI[!@+0578,4K\?;BQ5OSN<0;Y:#3)!B *;5.]X()
M2L3&<@@72R640[08T%%&0XXMB0V7H[@<%<'&J*C7&0(=4:A70I6S2QDC*&VY
MY["XH0XH(P$VE$/_0*%@_@XKQ@ QW.5VA1!I5E)B)25>NI1H/:>4^&< 7@^5
M:7Z+F BBNRC0,N(_-:N^0K$D/HB8>:Q0<,N%@BJ 6(@]8?Z^GLLT<PV65>K4
M&3I^@'<@X3ST[](P26_\./HJ?C(LA(-[^C>8TH;GW?(!,<@.2<8,5MG';P"Y
M8V3;_-(:+RZ-2#;*(3<P.X6=LCVVL40PWD\&69:K7_1;!(-)UUQP^QT@HYZO
ML'DQR &D)1& 4$>:)Y$4!X3'#$CCHN"D75877"R2+-0*%T"7I@4?WJA\&(-B
MJ&;@[-87--MF.*8:V*1AG&(,H8 :>@?''11/<#1Y.RFL0&VU&/$PS:_%YU%]
MY(03]_([S:6B=0Y0/=ZD5Q+[V.15.L0CD1O)TBA?$$2.9V6>2QX_NOKB(VWQ
M9<$0C*U<+M^X\R[7A.I+!W#QY5@+C,C.$7>T4^^8(6:FU(<7@!'QYJO2+"$T
M3CZWDTXGN5?[[?B@2.R/CLX+U&_^W>\,.']\SJ>T;C"=,5WN 7U(!$M_Y]*,
MAWHGB.@8O7*5O$=4ZS2_@#C7JL&,0J%1#?EGU8!)D,UB87)+RZ\!.0*+7M(D
MCEJ,: P7(TM^=WUP*)%J!64X-@PPMA2 R-)JG75&UX>++UU>CD3&4@>=!"P&
M!93J#S5(B)(+S5QK-P8(A<!]^,%##2\TB5'H Q-9'DEP/;IC>^)0BBLN,?U^
M3A46HT<XI<MBH[S,;?I:4+N@"#" S%1]> LG@+4OH^MQ9KO2)4[]78V6/N?9
MIJA74&ZKLM)QQ?KY,+@YL=FK5205JP/A,7RP/]RD$-?Z?N,[) $VJ5+0U]T0
MR%)'U%0MXRV.;T1JR&SIG2>/$7E5Q-N>H>9TR2_?'RK( 4^#:]GP*K8X\)2P
MRF.0Y:VS!]\RSP<,2D()XW2$,UY;C?4F1JYZQ*'P_DVW/SG+>6B,6> ^.^_G
MH#A_9VD(?2:GK*)>=VH6V^ 5)HV% S.:D<R9:C-DM%$W3? R/+>98,F4U3 @
MDCG77E7XNV9=LA <P4P=I\X]:S9/KA%)C"DQ8%-JRP71C[58@WX&YCS^E1ZA
MQMDH',!Q#4\. D#?2(^39N %)BQ?0 E-X]65T.Q55B4T9=&])0_MPNE-"^[2
M$3\@TCHE:/MMCQL=WE=XWB.NC4P)['3V6U1RXA.:&+ 3UG>*Z:,K6VP80=5U
M?T]##@AZ#E?#8G#FB-!H6! V]$(#@ROZ?X7T/]"UT;TPY>D#GA@DD41<-<C3
M./:@9>A*;P2VBGW&/E=TGBG,8&5L:H M'JPPM7)]%K@/6H;@)Y?MA<9267A5
M;"RM6'#%@L^O@C3:86P%Z<?,CA! ;=(S&;5'TB),B^2*I%<D_?PDC>#N)K7%
ML6K5<CW$M&I/VLBS028-]>X(*WB*M*EG249A%KXPR,('<\R*6U;<\I*X)0V+
MO$+P2ZEP"Q>P:C@2Z[,T:XW:UW =VL(B-NE+WRJ&EC(#^/R9VDZ'_'<%6^T;
MLX[2232=5GR8QW 5+6<0]U-N\^1WB]67"6K&9\&:IH;,P(I#HJ5&S:H:7T6O
MU4ZZTUG0/"(#2,&;-KNA==".BB9G<5P(&8[T=?-D6$@<8MX<85;LUQ#<4F%A
M5$M,YZ:^CA?4C;).2"G-E:!9"9KG%C2C0V3;$8)2H+?DV0EV2B?C.+0@-P]-
MV'K<M# *37?0,^PE*<J<K'4;!@.:Q&TC#?, X"Y^0/./EYO&0[ L5&L5)*T!
M,YCB8.7H%1<JC'T(3A[-R;/GN!4'=O,*&2=(8QR7XNV/.1;C],HK5NR]8N]G
M9F\IG2FK]RY8%PQ9S7:TI1*%P4'M*6"3^Q'#Q)3> (^Q]$!F)8B@7B_T&<])
MI9P4[%I'1L(2Q'@BV!-C,#?XW;02?G<S-'#<W*?#F!PJA[7.B"?69 Y3B%3:
M]J,Z?G@Q_,PK Q'R<R=IPK:DZ)46HLYC]%.7#)ZC*F0):02H_<\D_2POU-)$
M&GA._[P\<@^ZP  XQGI=2E89U(^0#^"(DYL8;A8+$EMH?R2I$GIEDV<VN/S*
MLZ; %BIW5;'5AC=B13;QLH06,KX5@G-10U'H5\"W7*&)!6:X$@O0* AI^$]6
M=IV>766EZ!,>WDR2SYL@JU*$?TOO*)4*1/CNZG!D@%#QD2LYNY*SSRMGM4PD
M>9B/*>.OK=*4=A@@C(2G_!*$:4Y:XI;<8%-V+"!!.$?"8Q0:+S?+ARRA%"B!
M 8-*1T$2W$]KP 4$NAB (#<X$LYH.",01K2,Q\;;5XRX8L3G]F> I9I9*,2M
M@AH#5/N&A3QVVY$Q6D"Z'DW_)%93RHR&N_T]B)FGFD.9!#Q(J>4CQZ;^H'^;
MI#*IBH8%]Y%A_@8W* M$6W*P0P,MJ:Z!;-#M:KN'3 %?\+IH$2IB ?J_FP2(
M@$ S:3K^T-;Y]HPY"H6$('W\_LR9-#%!2AB;%K%B[A5SOUSF5B5RV2"2&6L$
M_<3(7H313)]*@>N M,5F%O-Z&CMG8?A9YIB3Y0M^A4=5^,(U8L(_F@?S[#6!
M#^VN#@+(XW7I\&S@=_V;<D.  0:MU:VX>,7%S\O%HQC--J".) 2+P;D9^*<8
MDV,P4^D +0\VY)I;HY+0@W2-%#!!E.?/S6*TC"(TQXK-7DV'^AR[SJ<QU[<Q
M5IR8;)^GLH6@*Y6KJ?)^A(I+2@Q-T'X$UC$!A /MBD(Y"+C3^8A'/CZ\T\UF
M1BMM23"TJ!ZC>%">_K)89,4C*QZ9.X^HV:U@ZJ4RPMO\L^?C.40]7^7+L9$,
M> +I/O\W2C%G2>>.@$PQ>NG'G]-!K]\:6B8H!3#1V)3>JD$V'>9DV:E^>5:?
M7_>D]HV=U]>^4?U7M6\\/UNLE,$+5 :<]6^%$1RTF5K/;D#2BV(N2VBFA*2'
M$#OJEYS>1$!SFG0#+DO*H7A"356=<3@*)@L[,LA&#"<J<G"[ YQ&UAER/3PA
M>\CD+CT',#<M?O9Y Y-A99:=C9ZXK12$Y>5MDO8W+X%1Q7W\)0QN,$JL".9U
M-[V::86JB2,,V"5.9(X-.A/Q#<KIB-UA>$L<IC1>+4L0,LFC:)L@!I#))3]G
M>+:$]RYG>\MG6SK1<ED;1*< 8:LZ9@Y'_.Z#_X60>Q?(\-;0U5?>6WUI(;3P
MM! @,\0GZJGAM64]=./P5JE&!9N5::@)?RO)=V^3@<4SN\P+I5""1S!)<3K)
M=07Y,@H%A#(9=NHTP_X]!IUT"[:!I)X$-S0S8()*OW)US5APA")LB\R!S86G
MY2RY+L7,12D.B:5 LZ[E Z>=# .T8NC4:+(. :QP5CLI3$!V<!:#P(I@=(U3
MX?*<3/RK4$&TT.<VI'XX*Z"T]-28D")<B<8-TX6\B$3B#S4NK@!D\6"(-"P"
M ;FJ9Z!P/TLK:];>OA\=NS7-=G ,E8$?''4T!)H,%9UU*K7"J*>9,F+7B*:P
MN U5@?!9R _LX .3MM.""XQ469(%K&>&HW6&&F9/@D@(4D(SSZ3(30\1H7'%
M^ >O,%@H7UF6CJ"O1W=^!^L^G76=)>HVK9,8Q)*_Q6EV&S0HQFV#-9?FAL 2
M?1IP-\^]3>Y9%1(M,O%9HM\4U EWVN?D]S?A?9M=NVS+T;L6"Q&(02%:%^8M
MFH(IJH$58'\95:<?$R1A)NT#^#6L&]-#>]S_5*TAG$O+'9/5W-4XBA^G95ZW
M1OY(]9-NZ*>=" 6)*;8DM#J!\IM1'<^*"*3?@EG8!$LC>&B8P /Q8C(2*3R+
M/&FO)ATL041@R4!^YQ-I^!:@7YI#:B,NME K!7[JT*26"9"-:I@+"/ 8K4_J
M4U+R3/51DK&X N5?<>**$Z=Q8I"#<+501QTR=LW\GS&@B;,/S&5\;6-TB1F7
M=WDT+"):H30\V[&&9\_ZLA7KKUA_Q?H/8WU3&^38_5,D!=H^=1MRPW!9)Y$:
M-,PN)3NVA9*AU02,%5^N^/+A?'D?*CSVT/&MV@ZK(H.&1 CO]6^CE*LYAOI[
MF>N7%W!8E1L>!B]A/PF8W3'&'/T>C066^D(9)F ]QK$>0[H=RQZ+X2RIA41E
MCL,K@):&%'FE"-9G1"U04V?]+(,SU98"G@./+NZK!W#\+$FS)9HLL5@I\J)C
M M>ADQ_I28$Z'0"9)2? TXXIW6#"O263.GV<% K4GG&)?!C[':2S <T:#6/'
M MC/!,95TL_8%P.?*.8M:!Z$255CL)6BOH]>?G/H<$I<OY&FV=GI[)=_HTM'
M@CRWE6X.,[R/IT1%2>Y#* EE*@ZQ3>+.T!FHN;>F;-6&)*9RU<R"%/YAB8YY
M9>"L#)P'&3AY'C!UV4Z^+GOEQ:^8:<5,#V6F]W!#/O?Z.5:!S6.:'*AVG)!R
M2S$#_YW,^*)V.KVV>_?UU7;75K7=+Y4[7MI>5_ISI3\GO!V+)C&VC=5-X+$A
MRIW&EW$00^^Q6* J&F=A1ME@@*X!(KT/\Z\M0O<Y,_3,XW<CJS:3:S=+!CY-
M?([$Y;".D +X]UBX"%]$R=FZ=0B:H^T/.GTIA!Y!Q9?TG 7=P8D JJ;)J#:S
M#+1X=#\^CJ:-I-13[L<K6T?FMOP>,3<\N!FBI0+&$&'@EWS5S7\5B\'HT_K\
M"@Z^!)W4 -#">IS2AYK)A10!6%E-*Q&\$L'37)BIHP"<)Q>[8R&#C+CL^+T,
M6Z+T_&T_0S=+A_!&ZL]]UX* -_B3&QZWXH[LA&K#S6^L'@%GL9NT=8+6!,VP
ME>#5#F+_#D0@=7'H.G^5L@%-X+,TME PQE2.Z/T(=K0GXZAI+FZ/,UKZ9=S8
M(%71ZM1%T6%70*W"$?46=S;DQ#A\%#]NAB[GRE#@RSN5_!=$O]5W&IM8HL9O
M\42;T1."0<@CO!D#D@YA)>M7LGXEZR?*>H/66T2B<6;"JBG@U,"R"D4FGCOA
M'7J.<A',AK)#B*GC&'Q@6\"P(,.9N^-D#/9SK-A_Q?XK]I_P=G$NH]AXCMJ'
M<I0/-6,S5LY%+/7$)GJ&XQQ"YQ$.X2Q^X*ID9>&=/'@K;>!FLF.E?RW7.QEV
MLO >?^_,E/[03;:YYLLTZ?;ZG:&[CIE]FG<B4%.(ABC&86W;O4W RM[@-2G@
MA75%LWJH@\1+#'9RQ[_/C15&.DS@1=3GZS/NU85&>77?OZ,%#3HW-A0C&/D>
MV\ZJ6-IZ Z$MDZ%M 2X[PG170NM*E_8&3?A>!WO;LU8GR4(F>'MH!9K*K1:X
M-.3DD*.17Z!J[)VV!C7U/K^&#2Z](-^#ZM7N*3S5MH-,7#MA!;O\9@+J^2:B
MS%6*O@N:ZKF63RX#41 '2]OQMX8(#@]N9748BB-)#2B(S*M'#\]XXWF(#F[9
ML<3AA":=&>;<P]T3@*@C/;,CK<KDZ*-AAG$Z'D(RH Y9>DY01GFJL7=D]N9L
M2H7FO]-)X"M]QH830N-9N.2*X\FD["<34#GPR(W0\,S-$$7$?^L$'/5Q]H=I
M-OJ]78W&3<@:5X7 V$-T9/-+M-=5]KKR!G&] V<*#(O[?I"BE$6OVD,Q^& R
MY*.68YX:;E'#O.A+V2"](V0:K*][Z'N7EMLG-\T*EB$<P;D!P'=FNXF$\2/(
M2[I-.D "KQR/XP"(:#PX*Y8QPRD(9)$*<CDS<[?&8V##DZ-S9 R.FR-%[J8$
MS[10)C,%+)@SU<..CPR_(!.SW(05M^&=(!11+*.XW:)I+;*SD;=;+QEY=OX$
M*!(W>@3<7$\Y)M0*\%^$P4#200LA#9D)&1/$N,Z#'GY:-6YFJBR=@'",EYZK
MZ>5]% ^$8ZAPDV3H88EM%T@(:=Z1+<^X62G-O<&0,VW#T_'6,!50%E<-\D&S
MQT>+A3 7L-K&0^@K.!P&".K39#^T5ASN82M!]\$#",(604&01427=PLRKD-X
MC2"^\/(NZ3TEWR>[$9;LS0JMXA3$;!"BJ&=KBA=KZT<S>@P!5),TDP5:B ]$
M"%07C<< 7D[49<T/VT(P,(0<0?P)O3Z_T_&<# T*'"F8Q!JCHX3O=$19]1J,
M/&T6O.17(.+7WIX7-LKVS$SP)@:B1%<Z<P6R0#Q;)@'1D:!4\0&C<Z.- &+8
M_]0J6Q7>KB!CE%.F@,Z@0%+ES,9?R9B3XT&W&2*<@;I]BX (HB//L(JV\RD1
M<JLI/*=+LDL>[2 RT=B=S2C"EYB 9J@)VWM]-6'U?U5-V#.1UA7A.VI'CP0V
MN&.9^-WD^2F-S.W=CD;I :ZDP2]JF!Z;$I95@8)%)0^5BG@XC%C?O?/3(2XO
MWUB>+1!')7?L"XI^"W."L4RY46 I^2D7&)\<WF82E@@W?!_C<O]=J^=6LWD?
MHM[ #W>"_'Z9B><9(#P 8[,;!C\VT^_?.@>P7. ._H>Z6C[:<[Q!^@/Z-OP[
M(I%Q@>R1G3Q![/XE'"A">I(ZY#6"77RA#6+KV)"S^)]-.>%C-ONC-O_S_:#3
MD:.7B_@Q&_3>KE<W8-L#%&_-MQ//GG[^P04CH!.UGO'P<^M8^.E'>GD185^B
M+Q'W@:CU=9P-^M@=BW(A=Q\'F%C@W_Q,<4O^67QZ,06/52V)DHM\*;59+^5?
MR! _DQ(Z5TJ(W5?T04#1J$NQ+X)_UGKG(^H=^=UM.4;:2%IGFOPM"WZD-\WU
M6F7;J]7WO%JCL5&:A:Q^ES^M3MCNS_.L_C,E'5FK%!9 'L8\5]#8VFZ,6T1)
MKM:HOD4OC!FMKAEMXCDUOGOR3/&B26.V1>PO^AJJWNY>U=O?W5N&XUB1P:+(
MH%;9>FX*^.[?=_G3U,/B[WW?VZVB"*B\.#;X!M5_K<N22LMPGNP6%ZS8=\9>
MVM,+K"?CS.>3Q<^KAE=7NFQ7.DFE/JD>?147^3Q"=A]8<M^K[.Z^#-I=F#O\
M^FZNL;4[UN]=R=)EDZ4K]?CJKG2E'I=?R%8K7FU[QZOO;K\,XEWYC-.4XO[*
M9WPU$G2E%%_=E:Z4XO(+65"*C6K=V]E](:)VY33._-:=K<K*:7PUPG2E'U_=
ME:[TX_(+6="/NWL5;W_G9055Y]0Z_B] @G@DX(/9SU-!,W!MY5026P LPT$'
MF\QO;F>IKY;!F-*](W-HJ5/'ZAE1@U3'-4)1;9UNKT=X?-VWA87;6A7J7I&R
M;A#5#TI-62G]AP#]N/NLT[%;C>!-5K])OK%HUM)R3WI/K*ZUPN@R/<9YRSW
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MYLU+#,<:^T#ESC:;ZFD#6CA-\ K5S':$]$\Z=V)JA'KBD-/"KAQ0J"1!9/I
M=!>:@1#A%SCQX$8XB<Y<;\IBO/*+T!"6?H>G>9 _=H_#(0UCN4D\-AX%7JW_
M.8S9H[R_33K2D2'*&1Y-'136DD0.E:^':$&-2Z6F)('/4FO)'%&VY=]'B1#;
M<F[T=A)QG6EV6(?FQBPOB_T8O96,\A48A9G,'/GQ^VB)Q49I:*5:GQA;<1C^
M4MFHV0 #>#T31KGW4S@?Q2 X$0B(1;26-'66?%I)BRRG%HT2),;3V)E!R.UU
M2@T"/\/3R5/%AW;![$@DH(.Q&+_3&K H(9CEOO*=Y.6T.D.;DQ*6.V_<,U[]
M#WCJTC'XQOT=GP!W\A3YS(=>OY7EG) *S64^WV\^)O=975#J\_G3G),;4Y:0
M\9=WY5>)LH%#%4Y1LR9M7[";!&&'F%R;UHZ2&MQ691O8Y/'Y_"?ZCKPA,,\R
M&1=XG!ZT0'8\-:;#$EK*NL]+*/J2%H J9E$J!$F<!DNL)+_/OB^9&+&\^U%I
MUBQ,[QATN2S00'81 F-&.*45\W-+?(6_)/ 3)CNO_EC>3>1!%)9W'S.8)+O_
M:INC]F^W.6;J;)P'.LN/3=.P[G M4//MF';&IUQ4OJ2KIDNZI)K<X6KR61;[
M,O"-<"=?@B^?ZI7M3]5J]=/7F]\OJG]>[/[Z^\[VFIL-NK#>(7WD!VNDPZ:;
MKYY_1$?GV";.7+-GL:.SB)'$/&T*=',]!J9@-M<BBWVOY6T;L 0\P?^NU<W!
M;._O?<)"E&JM#J?SQ^[^]>[OE]%U]O?:V(=/;I.=X\IJN+(JKVS_QO??Q=F7
MR]//W[*RT?KH>1VY*5!6@K@ZKGW&WNTD#5,U&F;&K1Z45SHM\^)'.T4U@50.
M/H6#;!,HH[>Y>9!EP*D'S8PF?7R*?OKTM5O;W_YE[^_X[+?:VN3K+D-I&U\F
M_Y;?I4YU4HN4O4\L7!_')_;GJ.Q]E@^6/? %+:;TRG9&KDRP!',W]]<?Q[\F
MM^>_= >?'W%S8WH^QJW6_G\%;+BZX4??L,V4V!QS$ ?X'PSW@M^.4<^#_B'X
MZ%CR1I&^3]'QIZY_</AU&%Q_^EH_N/[\^6#GLG=8GRO3JF>)]FT@ ,(L%%%"
M(UC5INMM0[.OXN$IK(7O)G91*G.@=#W_&?/,:JWP<;G%'Z,O/\1)_#[EB+H;
M@X7_WS6YCQ]FNHXU'B_UI7^!;3T'V5D;5<AFM;99KZZY#$?VW[7H2_^'>- -
MDGX0MB+$Y'#EAXP,KT$<\0,^7KYCG1Y]N=NL@43>7GN[Z]4J5:^VO?WC]_GU
MOAVWW0F7]8I/O3J_4V_ J>_6D2_F=^:E[+]K"WC)95V 3H=]@\%^&O9%Q.:Y
M_D.R>W$=5A,_:C^MP!_]?[5H-]6K]MPX["]8_DZFH4DGN6B&W5E[6]O?\RKU
MQE32>2;=->>SFR/;[2+;-3S8QS>>72FO'5F\=AS?P7Z2= B;R_-6UOCCE^OK
M#XUHKSE?,W@6;M++>E82L ]GT>RRM_9VVVO4*UX56U.7D6&FGM8<&60?A(M7
M:52]O;V%L$C58I$SK)_3FSN.J?0@*G#+V;NO.\V+OVI__['SW)KH'!L^HN![
MC*3R4K':Y@6PTYB#7#!G-2IK;ZO;56^G6EU.OGK(L<V/Q1I5.#:OL@<&=^U;
M-7@IB^U9+"8D>_2E%\99"%8O[3GGZ.?9[:_;P]Y/_[S?_GQRNQ!WK[B?B9&N
MF=@1RYEQ<S8NMJKS\W-A [6&F6-K,\;39B70ASQG)@*>X787+0-J0,R[56]W
M?[H,*#GVV<_N7W]G<Q1 =3""X<HJ]45<V53#N"!\KD#Z]$7Z@!CZ^K7:_O3U
MI]]/P_/W9^]K3^Q]7B5]["0IE1[/XRL])2]O R_7O/IVS=NK[BZG2G]2/FJ@
M9[';J'NURK=Z%K/FP1[E$;[ 2/6+6DRIR*KDK"BL\^T/SSM^W >1C6'#'F:F
M?TZ3+&,#ZOS\X.CTZV W^/0UN+[=O:S=]'Z[>F*71:V3R_S4(I^5(2<?W:(E
MV@Z:VO7];?!1]I=3H#WB_.8HX7;7WC9J=6_[FT^OE,7>Y4/3@R[5L0?OPEZ*
M72OX&OBY$^(/L/6#+C8T?J7?CSV63]'I\:<@^M3-+(8\NCN.?O[E%__O:_]E
M.376KN%*S+:7V/I=GQK\G<L]+UIR[*V]K34JWM[.W/R:C=6E/NI2YRC.]M?>
M[N]XU?WID<V'W>E4Z39VQY0<(!?(B"OM!75/?XF"B_?_Q!=[+\&.>/ZLVZ1C
M7+! V,%@IU?=KH/!/SUENURFQ.+3"CM5<)5JNQ[\N'*47@:MS,U1>E?,Z)14
M_OU:_S/H_?YGY_/Y$TLR6M"J>FP^*6W![XYO3D(_"R_P36?MCUE(Q_LIJE31
M#SX[^'I_W?STM>?O^E?7=\V[8+Y9[F]+X>DMP'=\S!E0FU/U#9_;9M+>'&0A
M!_Z>-S4UZ:@7K>IJ:V_KH.KVO.W&DI:8//SXYJCKZF@IU/:J7GWW6Q.CI2Q9
MMU@23&P$V<Q8PITF<4O%U?/<^/<@C(;-G;1U\)BTWA30]@=G[M2JE]@CFDQ_
MXZYET9R[O?9VI^[M5U;)N 7<TQQ%1&.1]S2U"MRRTE!.D/LI@D+[GIW?@W3G
MJ/=SM]5X62$S3M%QFO^5I_>M>UJTX-A!E5_#[%]C>BIK)3MFN9TYBHM=2F-L
M-[S:;NW))$9C)&<OD:K#K\/++B;M65+<-G9N?H^2:/N?.9H6T\5##=&B$3$#
MQ<%L@D"^\E!BHZ\1''(GG*D[X8%/>4!B>]%B8 \(;<?;V=_S]NL/UTVTQ<=+
M@E=Z/7.4 _M@-GB-6L/;K4ROSWC4[:S":R\M &-7<YY$#,(>A=E!'-C33!B\
M+1=S^\/_D-WM7'8&[Z)%QMRL-1G H-+Q&"_PQ%_48J;6RUM'7=:D>_;/'\V;
MQH<_H]\><^'SB;BI?MV.6>H+/.D7M9CI;=G2+W7N#[%9*E>V?7+X];K=^_2U
M>?;UZNOQ]<[90>?YNB1TIUZ/5_JXPQ[1UP]7QJ4'MF#;:;>R]K96KP#O?&O?
MS(L^L/E9,[M5"H)4%]-G9&>E#A'SJQNF*MI3RD'MQO%)XVO6:#3F"T[Q6&92
MB\:ZH%RP]%D"ZF..<-$\55M[NZS9]H><V!R9JK[V=KL.+MSVMQ[;U-0#"(UT
M$ 9YFY2"(M:O\CS6^WVW\;4=[PR:C\D)SD]+X;HGM0T]G?4R52Y//^)%\^#V
MVMMZ9<>K[DQ'AWB1C/CX0YPC6S:P5;+B[507PI8_Y9R$.(3E'Z9A$/5+-=T?
M!WO[67@2W!YNOPA-ARM&I*D6+9F=R-LD[6\BR*R;AHAG3QG[Q(\7SH\V1MYF
M%K8VHR^;MU$0A/ 9..Q:]*69=BJ5O3H^%+S;VAN!P;-WM!1\448HBV:#'=#G
MC8I7J2S$YJN/K551G#XL98CJ7S]W3F^;'XXO%QHIF6;OR6@*K)-54/*Y8A6M
MEIZYV7SBR2Y:&^V"?;/3\"JOHS)EIM.;(_]A57MUS]O=6X@:JGT*6V3UFE#5
M\'V27OJ=\*S]?M ?I.%%>!?&@S#3H"B*!^^#+Q<[5[_^\[7Y-"T:TY62FG>)
MTX$RV )R9)LV@3J)=O$D%=&S:J3]I=5(?YR?G?XP \4LFCO@!*M5KU&9GF-]
M7 &&8@X<1%*(M53SW'!TL?U'T'W?_Q(_IOIB3AJ)YJ5(*(]1_]O^H/-2Z'V_
MMMST7D8$"R;P/>QAJ"S,_'IOB?\DOKD"Z_U=V.R74_C=/S<W^R<GZ?#VA;7D
M3;').K S=DP"V-NK*VYA45QR>PNVZ_:JX!GL5KWMVJK\:)XW-$?A@;'8JE>=
M 75P$:@AH[E/J482@0*2Y>N?];\^?3WN_7U>_S,87N.)/*7JS&.'O)00XNBY
M+9J3J?R]L5OS]AO3 69>E%Y^X)G-D;>V^<RJWMX\6P96%3PO(I=OEU[;@MON
MUC@V BS\W_6?X K7JMGNTPJPDYQI0[XMA64+1I":)HP9X^=ET]*S7+1X0]"?
M^KY7V5Y20)$'G-H<!=P.XN[N>]M[<P1**J^1&Q-@&\-L\>WV2:41]WZM/%^7
MXMFX,.\X%GR) <RG8\!=1*C=;6Q[^\N:D7S<$<Z1&_<(@72_-A.\R;<%@B]O
M_33D<M#S-.E&688XQAC[R/'A]F_QAS_O?XJ.%UFL.G,,P%HTSOB55>,0ZO#U
M=1N10SG^FA;-SOMK;^NUQDPQJ97C_]![FI_,V*^LO=U;W#U-'5V1JRF2-J3[
MRB%(D,.O\>$?& @@20(2Y>#RZ.O]]=^?OOYQ,V@/PJ^5_J]/T\.HNI&^V??_
M]HK.IZL/VL?('2B3*NCCI\;77_PYS9&!:H@66MO9]VKS+ +Z5EWY<GWI%[68
M4OFT;\FG*<TXOW]N7?ZV&^S^%3^;FW&Y:LQ9U.6?IV$[!,N=6[*L(6J@B8(/
MQY^^?ODG^O"_:O-HO[/0H+1>ATM=6![8NRD-9P_=_YA)LKC^_>*4 &O]YWYZ
MEM+PU8"V<AZF9';@EEIF-NG[WR[^2"[NT\/SW;6WQ:>_>_339;[H19A]S>[?
MWYU4JC,@JL_P_,EJT,CPX]/W>2E^3E_/\L*\OL!%51^[J.VUMUN54DR)D5_(
MY%[ZSQMW=MK@UQX,^K=)&GT-@P)-[*=1W/OKM^['KXU1FAC/,>.>*K3PX?Y@
M)_MEY_S/B[\?=NS%Y\[!%,K?1-DM-!:PQH>9(=/7B"/$J Y@C#T_D5[<C)[H
M^GK-;]RO89JHWX-3@O7U5%8_Z&=]^ &\@9=1-E*M[BQ#V<BLF]F=WV:F=U$E
MW6X2%S7<X==__KRU--UN\'/]L-ZM[@9/U83*ZYI!XQV6;V9&=9<<G=3>Q\W]
MW?.;4=&V][A'BWRKGMU7+G_]Z_BF.56MS/#P^2JZW46MZ-%:;F]>6JY1?FE3
M5%PKZMP>_?5E+_B[Q.S9?=@CU?WO__);9W>[UVE.M74F//1)E-O^O!<X5\U6
M!VV&FFVNJNU!9'-,NJ\H.DY.=L/X.KC^NS6SZ.#'G1G]623#7_N]WI^_1W_\
M^> ;X34NGES@-AY.S]:.GV2%-814V:O4O.W2;-)D:D$3IWB?1[.3A[!_LSF\
M;O]S_D?OHH0\*@\D#WEFX_#][<G>Z8W_,9HG?<R;6Q^B[V:CCWFO<!NC=O5'
M2I-R2]CU,TSJO@M;8;<9IFZ]ZKE(V?0YW(+GPC)Z(3SR+NP\;[-/T>A;:# 9
MCKDA[+B<B=V93FM>(64XK1TASD775!P$083/]3OG?A0<QX=^+^K[G7R,Z_HB
M^*-RG?X9MY\1@H3_WZS7Q5E[FU'LMGC)STH>8XYQT3R%!1,-<*GVO9W&DE9,
M/.3DYLA?X&KL>?5&PZMN+YS'+L*^'\5A<.2G,2B)+#=3I1VUU%QDQ6[O?HN'
MOQ]??J[]=O-R&RB$'7-3CF@O2YR=GS(+9_H]SH??,UC3?]<V)Y$O]K/5O1U@
M_.WYC6=]Q6.,'GEU#Q8XTZ^N6D$[J%K!(OIYW]S44HO15*947(CHL4LL]OI7
MK<N#O3\^G'U^ 75;7'XQ'8%P"4EW,N6.7MF"C8IJE7IE=RH[WO[.0CJ"_KVW
M-#\#IEK#6ME:8\?;WIM>KCZOLJV=!R"6JB8N+5!^.CJ*]W9[E>2?QXQ^GH=9
MDP.6[CP8W73<:2XSNO&T6URTL*FO8*F?\.+F*'^VGPRP^OL^-M*_=9P?>^IY
M73^]B>!+E4)"M0U;WFS[W:@S_,&]BKK VJ?AO7N1=/W8XU]X[F681NTW+GTV
MB[Z&( XK-AE(G*^W^#=>W8:.WVHE77C@$,.'5(;N^FGH8J08KN\FI4!'2KTB
M_=LP"]UV%/MQ*R)K".Q7G/*7Y1;M_/C_;6ZZ[Z.P$_S@GOLW0%V7(,C"N 4O
MWM]S-S>%S(/H;C*%&H7(V]_L)[T?W!V\.OF%^L(.;L><%NZ4-SGM3.P'5XHT
MT8*]A>G(R^CLWF_:VU0;?.->#7NPS8,4N*/UQCT%GN%#.$UPXW7[2]^K;^%?
M\.Q^_!Z.I.1PTM#_O-D,@6G@83TZT<*!V)O7I&(35?[A]B)P<70G+X.^RVY@
MGJOXL?GVZ$L/A$1]I^(<QZVM'[]OOGT!BS+9F>8GSE[PFBXUDSG @M+?DR!:
MW?,ON^Q&25C"NSH=$;HDQ_'?\*F6^K<RZ>K@'E:K]4]?/_8^7/UT?7-R<P&V
MV: +6QC2)X"UU &XF^9G2G.8PUA[...+Q 'KKN/W,MB2^NF->Q\%_5M\2N6[
MM9F*H<?6/.=.^3Y$O8K?Z003E?[(I\OOL>P)VE3>/_J$AA*X^]5/GTQN]^3^
M^JZS&[_[YV9G;0ZO>QU/@)M'"O[O6FW-.L *'EM5'Z!D/W^*.M7?/O[:;1\T
MO^$ 9RZS?SAE38QHC-FWZ0:?YIC.N-7W28K6@OMGZ*>9>Q0'89!+2K[$0ZC/
M^Q"0ZY9FI=4)7G<CETM@S#2JSTNB"OSWY_.O1W^V/WT]_.OW#ZW_G?W2SG86
MXE^+6&[L?%=FN2.P6QXUK_"]O>\FR@\E]$L?/N)1J4_7OGN$ZZ3.,.\BO4^3
M+OFVE2K\;[Y>;F/M[:Y7W:EY>_7ISM+$DRAGP.4ZXJH^XCGZHY0P;U1WO>W]
MZ?&PF8^XE!_SU:99_ZPMV_W4S80I,\64M^]^[PRRK[5L9XZXZ*4B"U>"5AD"
M6KZ^5F93AV&=]],Q,&+3>GN[VUY]?R%C^OZ5-[40.8 XN(BUY.WN/ET[LXW2
M_G.:9-EYFK0QK7]%W<RLIP^_WOP1P;^5:#B^Z7<[M?[>WQ_K3U1/3TM#V(-V
M]+SX/M89/1T/[U/&9&_/V]Y>4H3I:<>V"(:J(;*HM[/=\'9KWXJ+-#T_'78Z
MP(\_AW&8^IV#.#@(NE$<8;<M5DP>\5P/4K/(2U\/C]/!??7^ET&VP,*T,2Z"
MK-5S;WBUE$3R<^M]M;)]MGMZ,M:N5;&:Z_^Q]Z7-:2O;HM_Y%7JNLZN2*MD;
M,;/WOJ["V$Z<>(K')%\H@1J0#1*1A&WX]6^MU=T:0(Q&@!/?4^=<!U"K>_6:
MQTQ.4TOY1(*A[U>8.)NA>'8Y75;3I?6U(<W'=1<[L1IVEYT"JY7RF^0VR.^7
M4@;$=L[X46KEK]VE\F*6$=NX%:4)L)=C(^S$AZ7,2*>*@=6JB7UV)E4FB^U)
MROFLFM.627[]^#9@^ IJFP.&.93NF4)VKNGP\R2>O58*;V^OB*W:3#*]8">_
MFZ9J*1\XKGY4_E:$@-A"T&S59F:VC3U!%S!S/3FYC$.X9I[7#%!PKQ^M'\67
M@G$U+*^W\D)N2S%I/YMEE?$P6I]ZF<?YK\L8/QL6,0O +1&=KH#)7:^ V\RQ
MV=0DW[: (EQ8^ *@8EIZ!S^M=+&),?8M.70&WW/&^>'+,OUY5M.?"3>$0!?[
ME/,ID_8ES-EJHI!["WTSIB+Z3#Q8'\X7,7LZHVK9UW;(GRDY/NFFY:+:R-P+
MZ^@%5<F^Z;8Q/>.BB6>O#9]O*O7+IVMVJ9?6*SZBVU$Z:,'8%G4?5USF>1W*
M(MD6 EAAKY5->09GX<+Z"( <\,6R!H;\[%CG*W/0I8"3CL%AN6*:]][G[,7/
M=1GG4U2G-;'YN52 M;ODRN0V3H.!KJV[=^@:09<$!673.$HUIZ9SKRWIG4N$
M(->XL/A<ODL'/4S>X+*C6Q[FD?>0@]2&3\?7ET_/G4'O>V9=<@2WAB)#SF?L
MB:V1FYW)K6U6OYX/?.OWC&4U*@_-:LLT6]BPS?(*F";J*<MF,,:0SRS357_>
M\DPRTD;\@M(3</MR].W'Z9>?=W?+J'()%H5SSU#43? &HR6SO+4Q5[,V89K-
M[NQG5U?F]QO7><]]38D(;C"DL\65Y0=-XQKAP-6Y;=G1$_MQ<J\Z/+V\"6)7
M=^7O=X>W/Y\_?<FM/5[.JRYM[D<V?3_RB)+\!E%R.D9.O)WU<8\\C:##-O[%
M]Q&<2=Q:(LRD ,Q$S>5 7L_1,VM5 ?%TQ+B6<4D\9A6.;5I]>$E0]G- )7'\
M=S?Z"W./7CQ'A[LP+=T9G'BLZ^+D(WC2L2G;0)I4,K".3 F9T]TWO3;4]-/!
MZ?#GA:TMPYR6#JSSNC[%P_UOVEV?&, W8(,4,><]G\NKV?(R'98V'CI9[UTD
M:[N4,'VYJ($4R"\SH.0]RK]-T>/\&(\&]!/BZ8!9#!./A\?6]6G_U]>O3]5E
M/#8K,Q=A9[^7LC<7VQB[CPVPWS*Z*TKYE>7 OV6C<75WEH2FETOO[)?GZO69
MQ/2U<^:-)SR2/O;M^<S\U+L^NOC$UFDLBJ8LL"\*&\Z"P7;W<)G!+B+ 7S^3
MR&FDHV4+H*<MCGT3F[C,9!6_^9TEJLOE:-A<,9,&YCY;EUOTSMY'S&^;MI<-
M!NX"YB'.R=D;![IK-BJ6<6AV^AXS@&%??7.,8<=YTC?)L!6PD/BP!>5#';<H
MQLK3)G]/UD#S6Z??SDJ9._6VCV45XV-5@&-@C[6]S.Q\I#^<P2][B\NR^P5O
M$3/U]PJKO\5)?D#)=>ZI?04S=& EV$>KCTU$+IJB(?[8L(JA_5.K5 WOVX]/
MRU2\+^/&DSO<%5M4+-HC9@TTQ 0I/OMEC3/+)F/88O!</=^8-A,C1T,:M&Q>
M+6=?.\GVC<+V5=0\%;8%JDPOE=1"^;7UQ^^M$9-HC5C^HULCYMY;(VZ^"^$;
M:(V8F] :,6X(-6]%JWP0/?8_(BM5;IY9YXDI9_"FMJNPL>9DT8E)VP"#./18
MIL]B#IUJ]]WKKSI[^)F?O]%B&+1C,-V:WHMQHDNR*:F4HBC[1\GOY7H3)?Y*
M>S5.4RV6[%B8X/^];^ZWW9QO6AU4:J%Q'(+*.4V#FMJS+23ZRHOI!C\+S1X[
M(RY9&S:R%_K5@6X\51Y>TP9S<7T\>>H,()59&%(3ADE)J)U^*^?MYM<C^UMQ
M7JA-=>>MDODD"$=M83B.CLN1 ,Q]ZY_I=S=E\U'_DP!8K@UO+[4OF1^]']]>
MLILY^>+-6N>1QY%(XFN$] )]5.>,XRYS97Z+UORJ6[2N5*$6<\V)HT?TVQ6F
M8F[I#:UFZ;@"S]=>2FBRY*68+%F5DR47NZ+5ZJ3OMS;UUD(#" _E ,+WZ]K6
MZ^)% /.X"A*_Q15F,T[=V-N7JMN+3MS-_D[PVWM#O/_&&F_H#:4ESGV ]]._
MGWZ1I*%LIM:(&9XR?0[L=6UX^/!4+GRMIK^;R4QH%,[E;/ZO6!*/E90'>D?'
M.)3NC04)TJ/@$^MG7C$&88(/H%P*MQT9SWH Z,5!?%['RU1?7_WLI/%\9]\?
M8L3:,ST\PP%KF1:Z9A0!GYV1TY67F=HP(T(NA@BF>5Q<[KDVMN651<QQO+V:
MRZ;5_!P-/I<?F_$:?)DT-F,Y^,\WQ7%5%S U*;W$83^[W<';@/N<K:#*I45:
M0;V)H\](9UX2Y^(]Q"M-=*8.0ME21DV79V>]38786+[B&[^%58(Y3_W]L\6R
M6BC,KC.>!\RQ"86'H]K'B>OVF7'8=P![+L%^L(T[O=-GH2Y^3?ZW9]8[[)HU
MX)<X[/:<>1?-BO'0=SV*C]>&]]?];.'1^CH\2[#)W03M!$]!Z@D.WN%)AGT0
M[.%FCY2%Z!^$YS&M)$,NT$TJLX'+Q>M,Z":GQ9R4/$^O][Y72J:OQ2P)O9TX
M$,TO8)<&SGSY@LGK17EM9S]?!J7HC8XQ62G]K^E2INE*^0S>Q_M=+'H74Z/U
MJ[@7+'PH9D%_V-Y<YOGTTDRZ\.9;E&X TU:!0SF.0UH^D6:FH3J+HV:3->"4
M)Y;1;S C#!+>S/?3T\_2P5.[_NMJ/?/")J@\?)\HF$V^TQ%QC3U^$T8T00G;
M2 )STK.FO5EZID*+&<BZ;8(@OZJFW)M'G.P[XJR$KQ<2[=-^%/!U:>1<-+DJ
M?V(=O33:NM5BQ[9ST#<[R&*O87&]Q4@8UH8_==?]4C]/MSX;VV#1FCBQ@&^9
M$OCK8M/D78!=K]B:71)VR9FN>>=@\/-"O[ER"M-,UUE@6MQL)8I9! 9;8Z$6
ML8ZP4'BMSK0)#K4PO6Z#!5K:V7^']084"_11E]7R' [J;=<K%@I\_#&8M (<
M*:1W]C-I-3U'?Z?E#,BY_.KG[)F^<6O#4K_TZ>PT<UA.)]-)?%ZU F5D0W?;
M*U8?YH@T<!0)0)*8YE X\V[,<SN;/YFJ.4A(*+2QA-S;_G&W14DHX-1>3=72
M;W0^R%SDM@7*00$G%RPSMN WA7'22D$!3/1, ;0";7MC G-J!3CY\(UJ!0E@
MT"IP(P>X44Q,&P@U"YOKW!<6JPV]K\-O9\YUY<#65^=M6%0)4!H=W5UU7/QP
M<7!P.96<1O"@_SPY^'G]Q3Y:0"-8(N)-2O%BA]X:O0"83C$_5SK*5G&<A4"^
M#7I! >#\QG2O)&&<N%Z Z:QY32UG7CO7;>-Z 0[#>J-Z00(8M K<P'3;?"8I
MO: ZV:5^"Z+KVI_(&@F_GV.R56UXW3X<5G_TKD_:G4W&G2<EBP7C9->1:G>\
M/"235BVN'GZ\]-FA.3R;G6$W V@K"E7,!Y&MT3LHX3B?*:J%W._@3)\%_2U0
M08II ?)W<*];&REB$JF:SV754G9[%>UY]9'RV]9'DL&E56!)AF-)7LV^.L-U
MDL=BKO@%__C8=JZ9\V0V4"_)''PNI =?NT_MQC9F2;ABHZO/CI@OO#$.L<0T
MC\-C,W/VJZK7[\N+)$@(""44[Q@[_[;H&46<YKH*%^ 6>E0W!?2I/"R'\'Z'
M]=HU#,RZ3)?44G%[@3^G?I'[O=/OE\2D5>!(@>-(>3OB(3?/=FTX'#R>G#T=
M/+E'R^@5J\^/4'310R4I1\:\H$G:@?'M<> YUEG]UP.+52,L]BQAXP,GR<B(
M?^2MT1R*._LE8*ASC(+?*AZT$,BW06,H 9S?8;P^30',]ZQ64+/:]J:IS*DI
MY-]X?<9J,6@%N%%*<]S()98_.>[//V2>#G9JO</N=<?107C=V*>VU;IA3I?7
MXA7J]2]IV\CKS_F-^AX,?Z?*L]BJXME*!S:[Z\%NWZOQYB+:WR;Y>1;F;AGC
M+V$*:+JLEK8X!W1.',(T[W<<6BWKSZP*.V)9?RF.]0='OK4,YCP[P*D=MS;L
M52IZ\^;G^0^]M2U!\###[X<V^\[N9Y'J&]?19F'KMC%YRH?.J-G\F\][*KS=
M?.@58LXJ<"*W*IR(9>V5::P]4AHF/9Z4"=W.?+TXNBI^[UHKS(1^#6=/-*;X
M6[/XWT:CGX6UV\;L@4/FTD6UN,71S3EQJ/C;:/2KP:%58$=A5=@1R_8S<6S_
MHH?+3^'Z+/WKV_>'[K=N.;,MJKW-]_S._Y>FW=]&Q9^!OMO&_HL[^\6RFOD-
MN/]OH^JO!(-6@1NE%>%&+.\_".7%G3/OQ&K8779JNVYM>)!./S;.2L?57_5U
MJ/6SI__ _I2.'90[CF8&O(GY%3-%Q)\RRF-NCK*03?(.O1'H+93B_:= ;T9;
M^0@C7%!52+[#?PFN-*<6,VFUE)_=H7?.*QWK]?]'W^8JKZN<3NZZ8J<8%2G5
M+..GFF7FFV+$?E:_,/>R92XU#V"V/3?'#+C,7GZB\)\RT$B;!41:=W'LI<<4
MP^[7.VRAH4?'\PP]&KV@U8P+N+OI5GKY*]TNQPP]JH\,/5KPU"L<AK2VW+^R
MAM273<]7.# !(9>5@ GAW=@,E43N<;[1*NO(*RQGQ!V^WU_B]Y>TIZ.<W=DO
MJ=E\7M5R[_>YB!JSY(4FKX^6<]BU5DMGU')^=B+JW%<Z4R/=[MM<Y66N@N[R
M.)@NDR^HN3E2M)>BNUC_4G%*5VH3-FOJESV H=FX:#89)L[2R KYTZKMXJBJ
M['/U*SN^R5\]+--*8]4EJZK"-]Y1^,[A&[YU5;$8G_ @GVG@_E?BS R42^WU
M$ U5I"2BA=:_MC\-"C]+E8(^I;!U43BNJA'X0D"*M1<SOKV869L>6Z#!DH6"
M6LQO;Y!@];>P)OA/99U% ?IWL$\">^):8VEG7\NI16P!F7GSQ2[E-]X&+%FD
M6@6ZE 6Z -F6$AE -:6?521@>')Y(6.&%2I'K0VK!P>-@^%SOI]9)JR69%^P
MT;0)V'Q2[3@.%X=?<NI*YR"K.=W"KXJ56:0/1Q@\20PI"9U]2[00+8U597FU
M.,=<\3? MJ82ZN85#\!T@/;6:AT3W!7)@WI%RL9,QX:6SBP)_X_;HFB\B?Y>
M\QTFFUYA7FFL3,_%RB2D:)$*!(;M;>?2<5Z^N]8RY4PK=$3@KF2ZXWM6XRS,
MR;T%,IB+FX:P<;M,-"V-Y4JJ!FIW/K.]/2#FQ9BWV[CHU1BS"ES(K0X77C6^
MZ:C;Z]@#QC@4GBWFN&VS=]G1K=JP=54M:<WKF^/<UN2OO[/UA8CT=])NM#=1
M-3/O8=[$F.9Y#[-";]TDO7-2"O9]M^?V3KXV!N9["O9["O:FDHBSVD(*]#OT
M1J"W4$G,GP*]5R?M3C9U$D]YT=(X:TG-9PMJ?HDLIO<4[)6:(7-<5R&YZXI-
MP3Y<(@7[J#;,9[W^\UW5*U:2"0TEEX*=V5"RUK(IV$?)19.^?SYVRZY^\_@I
MM]4IV.L+&M%4^U(:<RAFQXW^J)3/E20)KB4451)W^'Y_B=]?XI[:,@Y- S%1
M5@MS]!'ZHRYT-3G8ZU=(T7VD9=4"W&FN_)Z$G01]KH#RT"^F:6HA75#+A7RR
M6=A_>]B*<C^5^J\GU^OJ#J@A_RCI$=N5U,*FWC4[@W^4&[/+7.6</2M7=E>W
M5/Z!JEPSQVS^J]!O77/(0"].AV^>#-O__NXE_\:;-DOI#; F8,$!ZE0T>T\!
MO4.!-YAP?RT'DXIUAY*(O39SF=(T+="[,-G8E:J=&]ETZK__M[NK')NL8_RC
M7.HM0*AK]JO/0%G#%Z>5W5V!VH;Y-!TK TN)GW_7LWO_* 6\._&!?*" YPG
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M9_$+9MS8X=3/8:;ZQ?C:Z9^GL_KF,J.KH_G/Y">7W?NERBG3I.$CSXY-_4R
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MO=-G%\U[W7%TRW/1+85!10"'Q>B=]Z;7#FL$P$XP*]FHN/@OV943 _> TOB
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MX/+E@2C SU[02:@T^8L[Z$5W:4=423P"'?0MX8T'?C@CA9^+^!6<E^+AOI[
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M ( _TD<TR1[=9RJT3WZ0CFVU=KF"-^5(H@)E%(('O&^H<MUF;'0Z@6$S/D:
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M5I9?X])!)]BNCO9TWV![$;B-R76,II#A9.(-S>O3EX(^0]//1E1][$?DSM(
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M" 0A-)\V)PIY3*R:,: Y5GIE;#$?D@ID 0.DA_IB-&5RP!ZG&O!*=CL(:2Z
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M ILN,6RP(>O\:;%2_U@MHTPKK[1E$Z@K9'6[E[Y[9K6%D=6$I1JZ[:GST\]
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M)XIK4EVLH[N8+8JW>5%,1W+C%%Y\Z[AKN@]N,(@=T&5Q-W4BWY#,;B>R#CE
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M!\Y'.+CI2&+L;<.[!A"6!B7D=)'F BO5MZGW2X-LU*[$VH6;>L1<TNA[S A
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MA*2=--]^JXU@K"" .>!%.^&+=N!%._ B (T\.N%'@Y:'_!;<LA"N#'\)OF]
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MOBKP)4@-7N)NZ39E2NNSX5ENUR=\ \?OX\/F51 [M_O8"D_>0VTLVX##=$(
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MY%FP]:B[AF<.PFML*TODI>&OD_C1@3<]J"?\-2KX>A(D%[\U>FE"ZUG(C^[
M(Q"7DUHCT8?7/_S*6S_ZVB'6=X$5 $VGK'\JB&/.%>0,$N-AS#G'L5SJ%7N$
M"\D!C]%27IJ6\94L/T]_VW\</>B+N=$I.[0$SY<K$RG$)K(]=F]>Q;)*';+
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MB"*9%\/#L3XDL%^1U[#\,,H/I5@5PX^ 86P8?LL..< 'Z!X^>,QCV/SSG,
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MK##5QD\Q1ZOT-L5R1=!X5M&*.C^2LN(*M9+,%5DKI;IX>\D)-P"FN$QMU[E
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MZ^'E7N%'N^8/P^XB_%[R%[_6/[F_/I?^_#KH_%:+!B_++>T(>R=Y1[<97=W
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MWF7CF(,.OY, M4>SG/[%L:4\<-53<YFI@>MH]G"=G3"%F=+O_#:-205@JP2
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M"OKEP5:3-TTEFYH*]300\:R9#.]/P5['9XY  JQ,+[FQ:7+?^^D-$W)O;)C
M<8:\G8^T3-"P#MBC%V\:V).#M6@(/&F\-01#$B\QV*GQM'XJNH(7(BZ;A=P8
MV(I^6?4[6PM,T'7+ZRRP!&4[1_YNX>_.WZVN<_YN"D"X?F_<,0V^C%[F##W]
MPD#\IQ"$^C1+K1RWU K1=E8SC=@8&>7>_9>V[#QFQ2*K-D9/>^?YBX-[1R^
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M8R;2B-7T:5]_-R_+]7/7>'@/:?SGV@N41ZF9-J]0\6>!:P[_3D]*U:5*/+0
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MKULJG3A[E1?AI]7;6LOJF,!VL"<NS%G0VFW6DP;^ 9,T M(B(L8V _V^;;V
M >9JL$<5Z=^=W$TR#;#U."!E;7; SJ#IN'#"NF+ H_ _WLGP/D_\7_RP=X2Z
MDURN39L;+A_.L29384KI*BINI:WU%-W$#E!^T1+\C2$*,%).FOG.._OP3!"&
M"VW#,[T1T.)%<5+?D_1;\QQH33?H(9&LV;%4*:+92Y&&;HD#-$:5\XL?MY>J
MI+XT5]XLISRNT \;HY>+UJ_+SLWYZ1?L]-&U;'?[!L0N:F_+>$*:/K$4<U8E
MGI$>.#-VK'KSU(Y-% ;YJ##PN[VU0;4X7#NWK8$-OWKRZ=ZR'W%/]Y6^CGH1
M]S9),=_OLVWWM+$GIL;:&8C4L,[ [Y(T:FJ:"3,A%88"3 $%8R@FU[1YDL?6
MP$4)B>IO1[AE1@0,PM\9G@Z. )H!U9.MTBBHH>C;/4O5VSH*.%32;!K>3N!+
M0 P_@)!'^4?J!&0Q' GKI@=B?6"CD/3E/DS.,C5/@</O] Z-YAB>KS^6MZKG
MKM[J8H*AC;E#:BX\"JHC#50O>PBV9FB9*AMX;"8J"&O2D-XV<,7"MQ(V@8P!
M^/\Z&"X&4W.9I,W9V.;-B@.WR+?+:'<]NE%0#U-?'E+U3<VPGF.=GV9K_</G
M%&JA$_/!DT(-4QKLP$-;N[GQ N[\CHQ[_U]";3?_Z*V;]'__OUJY4ILE\V)R
MJZ?9WO2/G"?CF5SV%?\8>H]G]J[XAUP2Z7,6IH)R1<W"1$X5,$"S,!'46:N>
M _R@_LX$A7"-EH6I>.IXVS*S,2'/1\W"7)1,B#:I]&\6IL'\]BS,Q*/93/ R
MF(9F2^]G8V?4@9:%:4AR%F;!0EI9F$G;MGI9F =:)EF8A]7.PBQTQQEH.UF8
MR4U7SP2=FE8VZ.-9R<1V>/&.+,S%CY]G83+\GB$+4Y&RXEE(69B':V5A%BS4
MEH69X(W>JN< /U[(,0MSR8H-D U2]8+K69A+(3NR+"-6428(E=]P9&$J>"^1
MA7G\4\I, -JUGA5;S82YF!%EDZF !+^SR\)4=#,+LSBSGC*C<#:2/OJ3(6+-
M1H3D'RD[@CXC,8&LJ.!L2#-,D,C"/+*Q&Y0FDH6)8*9*%N;QP=$R(4TI+^7C
MSE@U3*@49I.FLO TE>(F367L9Y.F,OY3'W2 U+(PD^Q$8#9Y*K&?39[*E)^,
MY*GD-WDJD9]LY:GP0JLLS"4;L?^,Q.ON][,P"TSGSH3RR\BI9.G*+B.ACVQP
M;3,3Y*%J6!"AF]FPH)N9(-/>P,V(XE6\<J9,3"8;J1 ;(1+ZR880R8;9CAVX
M,S&10B9"1:HRS 2C4&5_)B:2A4EDR1S+2@95-G*&2==F0L,-^I:YN<X.?C;9
MW)&?33;WA)]--G?L9Y/-'?[1'+P;U9U,5!)OC)'83U:,D6PD+&W2N<=^J)%<
M%B:RB8.$?S9Y9.&?31Y9^&>31Q;[6:,\LK^V/UH=.+BMP2,Z [6@!EHMRS0U
MULB;NHA939=W3<0V8^21#?%?;E=SM"!L[W@=*WNZB9U$3544.N ML19A#G6L
MP_N7H)<7;R8VU!1;S-'#'!Y!%91@2GX_3/B;:7DM.'$">J^OM+PFI$(;7FNV
M='@UV+XNGU*LNR-S)UL*+LY9X[9@4SL+LV=F;>)=S/_=3;Q+Z]/$._T&FR>6
MV<&NDM@G,[&]9CE?C;77K(;::R8^WAA=2_?:05D]_G507E&/[,IX2\U"8W1N
M7>V=/=]\^[W?VMK%N;..FCC[K+?1?$W\S);M2VLFF:S"FI&"'-U!<<EZ[^;:
ME@&ZDR2_.TOG7;(]8JT$%T^DUZVNI@ZP*SO1&2KQ9%J5RE%:K15#M#IME,;H
MNW54K)<?[C1[O*W[8L\@1I=[U<;HR_Y16QK5SDYZP<M5W>D;"I 5;"8V@.6S
MQY,R+%3&_BGR'$=^"BN@JC>UDJ1^E$/:A$]"T*)7V!:BC"E\.-# '#&<CUO^
MIA7R]894*#9&P^K%WDNEJO=E?6M^S<-57@N(7ND[P)?>;Y^%4.T I?Y/K U@
M&BE:'C"NP-+'7D#LFM 4YGY#M-=QRDAVTY< IX!_^7];A:VIQDD(/^Z=RTW]
MP'Q1FO-$Z>;PUN;P_'"EI_#B"V>8/:\*B1GA7-](",E%04D6S+5FZI;M=^;O
M@U;6'<>RAW07Z7C5+\*38NO6 /VR)\UQ+=O9";>"/^7]GGVT E!,0==H$SO\
MNSDI_Z_0-V ,E6/+1QI+E_Y%YXY@QKWNT0P3@C7)=GW',?+BN@#^IMX;],+N
M9 @#P\'^>I&G<Z?X&ZR,.DPKMJ&#]0(/?U ^"J?*T$-M*(C"A^9'^A(J(VIP
MW184X?< MI4Z:B." ?D+KN=\XG=LX4,KX;%65S$[J*]S: /9EL&Z6+,]II;,
M[!Q@R82%0-B I-"I/?AKV D30!."5X [C7Z$FE-!?\)D4"L_*[:MX&'!2WV\
MCV)5%N5R%3QV!3<)1FQ9/3@0(!TPC3QDB!?-;ND1=)#"3D'&EM[L00K_"&?P
M:N <GX:N<8@N\*EF.QR/)'?X>\!:C O'(!0%R?_RD>_07P<./;SI0K%=X3CA
M:\<FPPD#Y_[C#K,6L%T<]1]O60[ODPZ6% /Q(,03.!^$[Y"K%1&H"5>G<F@+
M_U&*3#0U,H-[%K R 63 2&&\#!@;Q"R^.@R3P>,9@O7$>[>3F<8/B9W+ $F$
MNK([KJV@)-N&26E"3W.[%G;G;BD#&$%W>0#$C1V^JK>!EX@&@7,93?NP'5&\
M#C;DCG"OA5)AR=#'>;;0\ ?*UJ+S8RQ(Y(QTJ[0P7Y36$4(/\=89#;<X,=IS
MO/VC(\+7J.$SRB6<$8<["2&ZY!F8BB1*M;)8+0*7P@SZ;+W&4*1F\G&$%'K$
MI%UE_V9-Y<<\&EG,A0<+LP\1P=06\PP[[>W*^QW5H6.PA0M0&A.P[68L(QV;
MC6>KUZKY"0$#Q'QMH=S-UPKY1B/R'=<+*@S[6OU%=QH-#ZR+::]K)AHO?-V%
M@L<YI<-MC ;RH;17?_S5?"IOO7=;)F$GSN/L\<>V0:!OZR_;75T%M^N3 -LC
MZR]-VY#*E3(>*\@W^7,\$I&%XUT4Q:U\ DLB^<HK) _G7) 62O+7/[N]CO.K
M)(]*ZT+RE34C^7>8^1XV]7BC@%+YW_D\H$46_Y.U!@8\V8:>>86X9SM@<[&_
M@M+S;'/=!"O$,'RS[)]"01:YJJ?;&<\X )NJM%/]EVQ#K//LB622LPIRU)Y@
M;X=L6["H]3XAM:'6AH<<M*G@A9V!@M:JQKX&%K6UW;8(O6=G$JGP7:W.M:DI
M224OAO2. TY#: =22EJ(8O8_)GG$Z>;&V@,R\J73_>C*^J;??M^#><6W1W['
M_KQ34DU%,0[OR#2L;F\#&A/7OP@XX^+6;D64I>E8WFM ?1L^G9]/%V--S,*G
MUFWQK'3V4GI^;OXY?,I!Q9?#IZ6MW9I8E4MKS*<9#F<NT,QI@?6ANWB2ECF;
MN5/*5R>;.\72F+WS;0"C /V5(]:.(CQI7;UE: NP=E8N.C-"L3%Y65AHP &I
MAY/'/M',+9*,)S'+OZI._ZM[</+PL&J_:S'6#%MV8]JJ%R$GRUN[4DDL2<69
M!666:&W#?]/X[VBAT8_I_-?N.C>=H:O4>H_KS7^>E;(D_JL _]7$0GGM^&^Q
M49A,F237>_4=X1!HP^KI+>'8?!C80TR-41R$CR<HU_X,=DH%[ZF3[93"3F7<
M3L$K4#E?RHL;BR0MB;B?ED4").-)PD+O1_>'TKJZ^*6LMR2<;(GXJUV$!*R"
M!"Q6Q$IA=E\M2\2U8;AI#%=*RP0),5SOX<HH/7R_EOMKSG"338^%,EP-3?Z\
M**V?S?]W1$1T4]6?='6@&#O"+-E= F5W!;8$Y5MIXPGB$B9L# Q6P</2.V!(
MW=8"$!0/U($R;&R5ER5A-9#I"GU,(6'I(T8T?]WBR2*M%DM_PC?L\9&NNQKF
M1WG9(90DIIED$8U-\+/?=].K&\(<$)%^ZX/U16:2-T7=P82<!XT5(DG_AO.
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M5BDLU$/V<=^VGG3P;IFU!H,:N0!8EIFS:+P"_[Z@S]3SFWH$0WCN;9BA@$B
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MX A9?VG:AE21R[@>2JM+[H^PB-5E\@ VE)M1RIVJ+<=%]]*\.RF_M5LLI6"
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M,S5&U?+9=?[LL/_U+)V2OID\;'DG752019WC$N8YDYB2(Q!GV9!4D]*W4UO
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M0^3R2*?];DJ7A'6POEZZ?$V"/[AS<6-T3NH+!*7>T_.R$OE8J;=&_?H/ ,]
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MZCUD*^R!A0T7,[*5%Z"<8#^<CZ@-L(<NV"ZF+29E422R*5PBM_B(L27.99=
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M,GNP_'OMM%_J-_S?@%G0O,'_OE-*7+S:J)SL%^?_3;[9=UF2R%;9C/:.9>_
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MZ7R7;O331.\U 8*.ZTSGPX:UKZ8S :_O!&[O5(0>9N1*L._/+UT[^M;857Q
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M=@N+'7&@OPGG!N^X#SMMMPDV]"\F7(7M/M1#SZJ5*L/EIRL;IWS-RV>'0=_
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MX"_IW?=NKPW\O<DQT?#<#KX%>)'XQ*P/Z.%3[.;G@[RX9'?,!P8$V[ES&\#
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M!K6&6UL.@ZJ)9G"K<)6+59[FQH2^N1%:WH[/@OX0ZTE!IQRLUERS;)=.H2O
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M@R9IB@;-I,+9>4D%1SKVY27GI']8UT]"IEQ<&(A'-X>4&C%V)%PKL?\D;L6
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MQ20Z+4DJW1J#NH6+$?!\@GK?9Z@)-!@R QHR0*&#.^58=,R&Y[@=\@6D89&
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M_ZF''_>,LSZVZN%W@;U"4JM.^%9Y?AEOF!9N_N (T(\H>X!::ZP!R%E82MO
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M;O<ZWM[_#U!+ 0(4 Q0    ( &.+/UC6>RJ(>08  '!'   *
M  "  0    !E>%\Q,#<N:'1M4$L! A0#%     @ 8XL_6"&P=Y"J @  U0H
M  L              ( !H08  &5X7S(S+3$N:'1M4$L! A0#%     @ 8XL_
M6( AB(DN"0  %B@   H              ( != D  &5X7S4M,2YH=&U02P$"
M% ,4    " !CBS]8*2$IEV$)   ?"@  #0              @ '*$@  :6UA
M9V5?,# Q+FIP9U!+ 0(4 Q0    ( &.+/UCNSYYPIQ,  !_S   1
M      "  58<  !X<&]N+3(P,C,P.3,P+GAS9%!+ 0(4 Q0    ( &.+/U@?
M%DA5D1,  #4R 0 5              "  2PP  !X<&]N+3(P,C,P.3,P7V-A
M;"YX;6Q02P$"% ,4    " !CBS]8F>46E-$E  #SG ( %0
M@ 'P0P  >'!O;BTR,#(S,#DS,%]D968N>&UL4$L! A0#%     @ 8XL_6(Y9
MCLH&:   6_T% !4              ( !]&D  'AP;VXM,C R,S Y,S!?;&%B
M+GAM;%!+ 0(4 Q0    ( &.+/U@<=Z_T[%(  +.V!0 5              "
M 2W2  !X<&]N+3(P,C,P.3,P7W!R92YX;6Q02P$"% ,4    " !CBS]8Z)DG
MQSHZ! #:1B4 #0              @ %,)0$ >'!O;E]S+3%A+FAT;5!+!08
1    "@ * &H"  "Q7P4    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>xpon_s-1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:XPON="http://expion360.com/20230930"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="xpon-20230930.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_OfficeEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_OfficeEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ManufacturingEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ManufacturingEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_QAEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MaximumMember_custom_QAEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ToolingAndMoldsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_RSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:RSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">XPON:RSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OfficeFurnitureEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OfficeFurnitureEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ManufacturingEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ManufacturingEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarehouseEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_WarehouseEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_QAEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_QAEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ToolingAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ToolingAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SeniorSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeniorSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SeniorSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_NotesPayableToBanksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_NotesPayableToBanksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_NotesPayableToBanksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NotePayableCreditUnionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NotePayableCreditUnionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NotePayableCreditUnionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NotePayableSBAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NotePayableSBAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NotePayableSBAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NotePayableIndividualMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NotePayableIndividualMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NotePayableIndividualMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NotePayableFinanceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NotePayableFinanceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NotePayableFinanceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NotePayableFinanceCompany1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NotePayableFinanceCompany1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NotePayableFinanceCompany1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_GMFinancialMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_GMFinancialMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_GMFinancialMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePrice1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ExercisePrice1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePrice2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ExercisePrice2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePrice3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ExercisePrice3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ExercisePrice4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ExercisePrice4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_StockOptionsMember1100779328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_UnrelatedToAnyPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:UnrelatedToAnyPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_OfficeFurnitureAndEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_srt_MaximumMember_custom_OfficeFurnitureAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_WarehouseEequipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEequipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_srt_MaximumMember_custom_WarehouseEequipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEequipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ToolingAndMoldsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_QAEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_srt_MaximumMember_custom_QAEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:VehiclesAndTransportationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_OfficeFurnitureEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:OfficeFurnitureEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ManufacturingEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_WarehouseEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:WarehouseEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_QAEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:QAEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ToolingAndMoldsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">XPON:ToolingAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_SeniorSecuredPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:SeniorSecuredPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_NotesPayableToBanksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_NotePayableCreditUnionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableCreditUnionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_NotePayableSBAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableSBAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_NotePayableIndividualMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableIndividualMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_NotePayableFinanceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_NotePayableFinanceCompany1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:NotePayableFinanceCompany1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_GMFinancialMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">XPON:GMFinancialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ExercisePrice1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ExercisePricesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePricesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ExercisePrice2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ExercisePrice1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ExercisePrice3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ExercisePrice2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ExercisePrice4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ExercisePrice3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_ExercisePrice5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ExercisePrice4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">XPON:ExercisePrice4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_OptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_OptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_OptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_UnrelatedToAnyPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:UnrelatedToAnyPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894954</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">XPON:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-09-30" id="ixv-21393">true</dei:AmendmentFlag>
    <dei:AmendmentDescription contextRef="From2023-01-01to2023-09-30" id="ixv-21394">This amendment is being filed to comply with regulations.</dei:AmendmentDescription>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-09-30" id="ixv-21395">0001894954</dei:EntityCentralIndexKey>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0083"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:LiabilityForSaleOfFutureRevenuesNet
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0089"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:NotesPayableCurrent1
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0117"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0164"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0167"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0198"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:EffectOfInducedConversionOfDebt
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0211"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:EffectOfInducedConversionOfDebt
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0213"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfSharesInExchangeForBuildingSignageValue
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0218"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0225"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:StockIssuedDuringPeriodValueNewIssuesOne
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0232"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0239"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:StockIssuedDuringPeriodValueNewIssuesTwo
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfDetachableWarrantsToLongTermDebt
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfDetachableWarrantsToLongTermDebt
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0260"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfWarrantsToUnderwriters
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0263"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfWarrantsToUnderwriters
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfWarrantsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfWarrantsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfOptionsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfOptionsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0292"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfSharesInExchangeForIPOServicesAmount
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfSharesInExchangeForIPOServicesAmount
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0300"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfStockOptions
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0304"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfStockOptions
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0310"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:AccruedInterestOnConvertibleNote
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0347"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IncreaseInAllowanceForDoubtfulAccounts
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInCustomerDeposits
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IncreaseDecreaseInLiabilityForRefunds
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ProceedsFromSaleOfFutureRevenuesNetOfDiscount
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ConvertibleNotesAndAccruedInterestConvertedToCommonStock
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ReclassificationOfAccruedInterestToLongTermDebt
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ReclassificationOfModifiedConvertibleNoteToLongTermDebt
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfCommonStockInExchangeForPropertyAndequipment
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ReclassificationOfDepositToPropertyAndEquipment
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ConversionOfConvertibleNotesIntoCommonStock
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0485"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_ManufacturingEquipmentMember"
      id="xdx2ixbrl0629"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_QAEquipmentMember"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_SeniorSecuredPromissoryNotesMember"
      id="xdx2ixbrl0686"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableIndividualMember"
      id="xdx2ixbrl0700"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompanyMember"
      id="xdx2ixbrl0704"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0716"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:LessNotePayableInDefaultPaid
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0720"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:VariableLeaseCost
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0760"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:VariableLeaseCost
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0761"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_custom_StockOptionsMember"
      id="xdx2ixbrl0844"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_custom_StockOptionsMember"
      id="xdx2ixbrl0846"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31_custom_StockOptionsMember"
      id="xdx2ixbrl0848"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="xdx2ixbrl0854"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="xdx2ixbrl0855"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="xdx2ixbrl0857"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="xdx2ixbrl0859"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="xdx2ixbrl0861"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="xdx2ixbrl0863"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <XPON:AggregateIntrinsicValueForfeited
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="xdx2ixbrl0865"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-12-31_custom_StockOptionsMember"
      id="xdx2ixbrl0873"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2022-12-31_custom_StockOptionsMember"
      id="xdx2ixbrl0881"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0923"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0924"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0964"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0973"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0974"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-09-30"
      id="xdx2ixbrl1072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1073"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl1142"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl1147"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2022-07-012022-09-30"
      id="xdx2ixbrl1148"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl1150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl1152"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:FranchiseTaxesRefund
      contextRef="From2022-07-012022-09-30"
      id="xdx2ixbrl1168"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1195"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1208"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-04-012022-06-30"
      id="xdx2ixbrl1216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1222"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1225"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1226"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1238"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:ProceedsReceivedFromExerciseOfWarrants
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1271"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UndistributedEarningsDiluted
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1284"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1290"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfWarrants
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1301"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfWarrants
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1306"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1308"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfRestrictedStockUnit
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1311"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:IssuanceOfRestrictedStockUnit
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1317"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1340"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl1353"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:PaymentsOnLineofcreditAndShorttermRevolvingLoans
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1406"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:PaymentsOnLiabilityForSaleOfFutureRevenues
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl1416"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1418"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:CashlessWarrantExercises
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl1449"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1451"
      unitRef="USD"
      xsi:nil="true"/>
    <XPON:PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_RSUMember"
      id="xdx2ixbrl1596"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30_custom_ToolingAndMoldsMember"
      id="xdx2ixbrl1621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_custom_SeniorSecuredPromissoryNotesMember"
      id="xdx2ixbrl1676"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_SeniorSecuredPromissoryNotesMember"
      id="xdx2ixbrl1677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_custom_NotePayableIndividualMember"
      id="xdx2ixbrl1684"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableIndividualMember"
      id="xdx2ixbrl1685"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_custom_NotePayableFinanceCompanyMember"
      id="xdx2ixbrl1686"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompanyMember"
      id="xdx2ixbrl1687"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_custom_NotePayableFinanceCompany1Member"
      id="xdx2ixbrl1688"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl1726"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:VariableLeaseCost
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl1731"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:VariableLeaseCost
      contextRef="From2022-07-012022-09-30"
      id="xdx2ixbrl1732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:VariableLeaseCost
      contextRef="From2023-01-01to2023-09-30"
      id="xdx2ixbrl1733"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:VariableLeaseCost
      contextRef="From2022-01-012022-09-30"
      id="xdx2ixbrl1734"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl1846"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl1848"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-01-01to2023-09-30" id="ixv-22936">S-1/A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-09-30" id="ixv-22937">EXPION360 INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-09-30" id="ixv-22938">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-01to2023-09-30" id="ixv-22939">81-2701049</dei:EntityTaxIdentificationNumber>
    <dei:EntityFilerCategory contextRef="From2023-01-01to2023-09-30" id="ixv-22940">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-01-01to2023-09-30" id="ixv-22941">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-09-30" id="ixv-22942">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-01-01to2023-09-30" id="ixv-22943">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22944"
      unitRef="USD">7201244</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22945"
      unitRef="USD">773238</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22946"
      unitRef="USD">298035</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22947"
      unitRef="USD">775160</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22948"
      unitRef="USD">4530136</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22949"
      unitRef="USD">2051880</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryInTransit
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22950"
      unitRef="USD">141611</us-gaap:OtherInventoryInTransit>
    <us-gaap:OtherInventoryInTransit
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22951"
      unitRef="USD">1081225</us-gaap:OtherInventoryInTransit>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22952"
      unitRef="USD">171791</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22953"
      unitRef="USD">71703</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22954"
      unitRef="USD">12342817</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22955"
      unitRef="USD">4753206</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22956"
      unitRef="USD">1394619</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22957"
      unitRef="USD">523419</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22958"
      unitRef="USD">250861</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22959"
      unitRef="USD">96190</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22960"
      unitRef="USD">1143758</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22961"
      unitRef="USD">427229</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22962"
      unitRef="USD">3148455</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22963"
      unitRef="USD">1281371</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22964"
      unitRef="USD">63901</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22965"
      unitRef="USD">63901</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OtherAssets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22966"
      unitRef="USD">3212356</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22967"
      unitRef="USD">1345272</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22968"
      unitRef="USD">16698931</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22969"
      unitRef="USD">6525707</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22970"
      unitRef="USD">230250</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22971"
      unitRef="USD">63180</us-gaap:AccountsPayableCurrent>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22972"
      unitRef="USD">58</us-gaap:CustomerDepositsCurrent>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22973"
      unitRef="USD">436648</us-gaap:CustomerDepositsCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22974"
      unitRef="USD">306164</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22975"
      unitRef="USD">140618</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22976"
      unitRef="USD">550000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22977"
      unitRef="USD">465055</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22978"
      unitRef="USD">218788</us-gaap:OperatingLeaseLiabilityCurrent>
    <XPON:LiabilityForSaleOfFutureRevenuesNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22979"
      unitRef="USD">11502</XPON:LiabilityForSaleOfFutureRevenuesNet>
    <XPON:NotesPayableCurrent1
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22980"
      unitRef="USD">100000</XPON:NotesPayableCurrent1>
    <XPON:LongTermDebtCurrent1
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22981"
      unitRef="USD">571426</XPON:LongTermDebtCurrent1>
    <XPON:LongTermDebtCurrent1
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22982"
      unitRef="USD">51135</XPON:LongTermDebtCurrent1>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22983"
      unitRef="USD">1572953</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22984"
      unitRef="USD">1571871</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22985"
      unitRef="USD">439049</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22986"
      unitRef="USD">779486</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22987"
      unitRef="USD">2754964</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22988"
      unitRef="USD">1092861</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <XPON:ShareholderPromissoryNotes
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22989"
      unitRef="USD">325000</XPON:ShareholderPromissoryNotes>
    <XPON:ShareholderPromissoryNotes
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22990"
      unitRef="USD">825000</XPON:ShareholderPromissoryNotes>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-22991"
      unitRef="USD">5091966</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-22992"
      unitRef="USD">4269218</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-22993"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="ixv-22994"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-22995"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="ixv-22996"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-22997"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="ixv-22998"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-22999"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="ixv-23000"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23001"
      unitRef="Shares">6802464</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23002"
      unitRef="Shares">6802464</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="ixv-23003"
      unitRef="Shares">4300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="ixv-23004"
      unitRef="Shares">4300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23005"
      unitRef="USD">6802</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23006"
      unitRef="USD">4300</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23007"
      unitRef="USD">25239654</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23008"
      unitRef="USD">8355140</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23009"
      unitRef="USD">-13639491</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23010"
      unitRef="USD">-6102951</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23011"
      unitRef="USD">11606965</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23012"
      unitRef="USD">2256489</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23013"
      unitRef="USD">16698931</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23014"
      unitRef="USD">6525707</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23015"
      unitRef="USD">7162837</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23016"
      unitRef="USD">4517499</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23017"
      unitRef="USD">4874392</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23018"
      unitRef="USD">2871770</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23019"
      unitRef="USD">2288445</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23020"
      unitRef="USD">1645729</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23021"
      unitRef="USD">8241859</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23022"
      unitRef="USD">2909085</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23023"
      unitRef="USD">-5953414</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23024"
      unitRef="USD">-1263356</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23025"
      unitRef="USD">239</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23026"
      unitRef="USD">169</us-gaap:InterestAndOtherIncome>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23027"
      unitRef="USD">112133</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23028"
      unitRef="USD">2791087</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23029"
      unitRef="USD">1605916</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23030"
      unitRef="USD">554044</us-gaap:InterestExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23031"
      unitRef="USD">-13312</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23032"
      unitRef="USD">-8521</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherOperatingIncome
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23033"
      unitRef="USD">389</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23034"
      unitRef="USD">372</us-gaap:OtherOperatingIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23035"
      unitRef="USD">1591976</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23036"
      unitRef="USD">3448202</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23037"
      unitRef="USD">-7545390</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23038"
      unitRef="USD">-4711558</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23039"
      unitRef="USD">-8850</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23040"
      unitRef="USD">9300</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23041"
      unitRef="USD">-7536540</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23042"
      unitRef="USD">-4720858</us-gaap:NetIncomeLoss>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23043"
      unitRef="USDPShares">-1.23</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23044"
      unitRef="USDPShares">-1.63</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23045"
      unitRef="Shares">6135938</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23046"
      unitRef="Shares">2888695</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23047"
      unitRef="Shares">2430514</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23048"
      unitRef="USD">2431</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23049"
      unitRef="USD">-1382093</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="ixv-23050"
      unitRef="USD">-1379662</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23051"
      unitRef="Shares">59515</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23052"
      unitRef="USD">59</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23053"
      unitRef="USD">173098</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23054"
      unitRef="USD">173157</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <XPON:EffectOfInducedConversionOfDebt
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23055"
      unitRef="USD">112133</XPON:EffectOfInducedConversionOfDebt>
    <XPON:EffectOfInducedConversionOfDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23056"
      unitRef="USD">112133</XPON:EffectOfInducedConversionOfDebt>
    <XPON:IssuanceOfSharesInExchangeForBuildingSignage
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23057"
      unitRef="Shares">6667</XPON:IssuanceOfSharesInExchangeForBuildingSignage>
    <XPON:IssuanceOfSharesInExchangeForBuildingSignageValue
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23058"
      unitRef="USD">7</XPON:IssuanceOfSharesInExchangeForBuildingSignageValue>
    <XPON:IssuanceOfSharesInExchangeForBuildingSignageValue
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23059"
      unitRef="USD">19993</XPON:IssuanceOfSharesInExchangeForBuildingSignageValue>
    <XPON:IssuanceOfSharesInExchangeForBuildingSignageValue
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23060"
      unitRef="USD">20000</XPON:IssuanceOfSharesInExchangeForBuildingSignageValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23061"
      unitRef="Shares">81106</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23062"
      unitRef="USD">81</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23063"
      unitRef="USD">269919</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23064"
      unitRef="USD">270000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <XPON:StockIssuedDuringPeriodValueNewIssuesOneShares
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23065"
      unitRef="Shares">75662</XPON:StockIssuedDuringPeriodValueNewIssuesOneShares>
    <XPON:StockIssuedDuringPeriodValueNewIssuesOne
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23066"
      unitRef="USD">76</XPON:StockIssuedDuringPeriodValueNewIssuesOne>
    <XPON:StockIssuedDuringPeriodValueNewIssuesOne
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23067"
      unitRef="USD">251924</XPON:StockIssuedDuringPeriodValueNewIssuesOne>
    <XPON:StockIssuedDuringPeriodValueNewIssuesOne
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23068"
      unitRef="USD">252000</XPON:StockIssuedDuringPeriodValueNewIssuesOne>
    <XPON:IssuanceOfSharesUponSettlementOfConvertibleNotesShares
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23069"
      unitRef="Shares">1527647</XPON:IssuanceOfSharesUponSettlementOfConvertibleNotesShares>
    <XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23070"
      unitRef="USD">1527</XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes>
    <XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23071"
      unitRef="USD">5543832</XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes>
    <XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23072"
      unitRef="USD">5545359</XPON:IssuanceOfSharesUponSettlementOfConvertibleNotes>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23073"
      unitRef="Shares">30000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23074"
      unitRef="USD">30</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23075"
      unitRef="USD">108870</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23076"
      unitRef="USD">108900</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <XPON:StockIssuedDuringPeriodValueNewIssuesTwoShares
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23077"
      unitRef="Shares">88889</XPON:StockIssuedDuringPeriodValueNewIssuesTwoShares>
    <XPON:StockIssuedDuringPeriodValueNewIssuesTwo
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23078"
      unitRef="USD">89</XPON:StockIssuedDuringPeriodValueNewIssuesTwo>
    <XPON:StockIssuedDuringPeriodValueNewIssuesTwo
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23079"
      unitRef="USD">316311</XPON:StockIssuedDuringPeriodValueNewIssuesTwo>
    <XPON:StockIssuedDuringPeriodValueNewIssuesTwo
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23080"
      unitRef="USD">316400</XPON:StockIssuedDuringPeriodValueNewIssuesTwo>
    <XPON:IssuanceOfDetachableWarrantsToLongTermDebt
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23081"
      unitRef="USD">809806</XPON:IssuanceOfDetachableWarrantsToLongTermDebt>
    <XPON:IssuanceOfDetachableWarrantsToLongTermDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23082"
      unitRef="USD">809806</XPON:IssuanceOfDetachableWarrantsToLongTermDebt>
    <XPON:IssuanceOfWarrantsToUnderwriters
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23083"
      unitRef="USD">262354</XPON:IssuanceOfWarrantsToUnderwriters>
    <XPON:IssuanceOfWarrantsToUnderwriters
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23084"
      unitRef="USD">262354</XPON:IssuanceOfWarrantsToUnderwriters>
    <XPON:IssuanceOfWarrantsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23085"
      unitRef="USD">407700</XPON:IssuanceOfWarrantsInExchangeForServicesOne>
    <XPON:IssuanceOfWarrantsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23086"
      unitRef="USD">407700</XPON:IssuanceOfWarrantsInExchangeForServicesOne>
    <XPON:IssuanceOfOptionsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23087"
      unitRef="USD">79200</XPON:IssuanceOfOptionsInExchangeForServicesOne>
    <XPON:IssuanceOfOptionsInExchangeForServicesOne
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23088"
      unitRef="USD">79200</XPON:IssuanceOfOptionsInExchangeForServicesOne>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23089"
      unitRef="USD">-4720858</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23090"
      unitRef="USD">-4720858</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23091"
      unitRef="Shares">4300000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23092"
      unitRef="USD">4300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23093"
      unitRef="USD">8355140</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23094"
      unitRef="USD">-6102951</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23095"
      unitRef="USD">2256489</us-gaap:StockholdersEquity>
    <XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23096"
      unitRef="Shares">2466750</XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCostsShares>
    <XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23097"
      unitRef="USD">2466</XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts>
    <XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23098"
      unitRef="USD">14770021</XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts>
    <XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23099"
      unitRef="USD">14772487</XPON:IssuanceOfSharesIinitiaPpublicOfferingNetOfIssuanceCosts>
    <XPON:IssuanceOfSharesInExchangeForIPOServices
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23100"
      unitRef="Shares">35714</XPON:IssuanceOfSharesInExchangeForIPOServices>
    <XPON:IssuanceOfSharesInExchangeForIPOServicesAmount
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23101"
      unitRef="USD">36</XPON:IssuanceOfSharesInExchangeForIPOServicesAmount>
    <XPON:IssuanceOfSharesInExchangeForIPOServicesAmount
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23102"
      unitRef="USD">-36</XPON:IssuanceOfSharesInExchangeForIPOServicesAmount>
    <XPON:IssuanceOfStockOptions
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23103"
      unitRef="USD">2114529</XPON:IssuanceOfStockOptions>
    <XPON:IssuanceOfStockOptions
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23104"
      unitRef="USD">2114529</XPON:IssuanceOfStockOptions>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23105"
      unitRef="USD">-7536540</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23106"
      unitRef="USD">-7536540</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23107"
      unitRef="Shares">6802464</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23108"
      unitRef="USD">6802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23109"
      unitRef="USD">25239654</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23110"
      unitRef="USD">-13639491</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23111"
      unitRef="USD">11606965</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23112"
      unitRef="USD">7536540</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23113"
      unitRef="USD">4720858</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23114"
      unitRef="USD">164767</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23115"
      unitRef="USD">61084</us-gaap:Depreciation>
    <XPON:AccruedInterestOnConvertibleNote
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23116"
      unitRef="USD">103701</XPON:AccruedInterestOnConvertibleNote>
    <XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23117"
      unitRef="USD">295</XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues>
    <XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23118"
      unitRef="USD">95284</XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23119"
      unitRef="USD">1196843</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23120"
      unitRef="USD">117588</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23121"
      unitRef="USD">112133</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23122"
      unitRef="USD">2791087</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23123"
      unitRef="USD">13312</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23124"
      unitRef="USD">8521</us-gaap:GainLossOnDispositionOfAssets1>
    <XPON:IncreaseInAllowanceForDoubtfulAccounts
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23125"
      unitRef="USD">18804</XPON:IncreaseInAllowanceForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23126"
      unitRef="USD">2114529</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23127"
      unitRef="USD">188100</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23128"
      unitRef="USD">-458322</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23129"
      unitRef="USD">566435</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23130"
      unitRef="USD">2478256</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23131"
      unitRef="USD">1683602</us-gaap:IncreaseDecreaseInInventories>
    <XPON:IncreaseDecreaseInPrepaidintransitInventory
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23132"
      unitRef="USD">-939614</XPON:IncreaseDecreaseInPrepaidintransitInventory>
    <XPON:IncreaseDecreaseInPrepaidintransitInventory
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23133"
      unitRef="USD">728033</XPON:IncreaseDecreaseInPrepaidintransitInventory>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23134"
      unitRef="USD">100088</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23135"
      unitRef="USD">69552</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23136"
      unitRef="USD">-55784</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23137"
      unitRef="USD">-3792</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23138"
      unitRef="USD">11177</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInCustomerDeposits
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23139"
      unitRef="USD">-436590</us-gaap:IncreaseDecreaseInCustomerDeposits>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23140"
      unitRef="USD">165546</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23141"
      unitRef="USD">494553</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <XPON:IncreaseDecreaseInLiabilityForRefunds
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23142"
      unitRef="USD">58000</XPON:IncreaseDecreaseInLiabilityForRefunds>
    <XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23143"
      unitRef="USD">41286</XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities>
    <XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23144"
      unitRef="USD">19248</XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23145"
      unitRef="USD">-5468572</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23146"
      unitRef="USD">-3896830</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23147"
      unitRef="USD">567370</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23148"
      unitRef="USD">113694</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23149"
      unitRef="USD">51678</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23150"
      unitRef="USD">-515692</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23151"
      unitRef="USD">-113694</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23152"
      unitRef="USD">550000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23153"
      unitRef="USD">280000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23154"
      unitRef="USD">1385000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23155"
      unitRef="USD">1798420</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23156"
      unitRef="USD">26687</us-gaap:RepaymentsOfLongTermDebt>
    <XPON:ProceedsFromSaleOfFutureRevenuesNetOfDiscount
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23157"
      unitRef="USD">125000</XPON:ProceedsFromSaleOfFutureRevenuesNetOfDiscount>
    <XPON:PaymentsOnLiabilityForSaleOfFutureRevenues
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23158"
      unitRef="USD">-11797</XPON:PaymentsOnLiabilityForSaleOfFutureRevenues>
    <XPON:PaymentsOnLiabilityForSaleOfFutureRevenues
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23159"
      unitRef="USD">-329626</XPON:PaymentsOnLiabilityForSaleOfFutureRevenues>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23160"
      unitRef="USD">2781000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23161"
      unitRef="USD">14772487</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23162"
      unitRef="USD">838400</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23163"
      unitRef="USD">12412270</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23164"
      unitRef="USD">4493087</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23165"
      unitRef="USD">6428006</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23166"
      unitRef="USD">482563</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23167"
      unitRef="USD">773238</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="ixv-23168"
      unitRef="USD">290675</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23169"
      unitRef="USD">7201244</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23170"
      unitRef="USD">773238</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23171"
      unitRef="USD">435152</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23172"
      unitRef="USD">341257</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23173"
      unitRef="USD">300</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23174"
      unitRef="USD">1829</us-gaap:IncomeTaxesPaidNet>
    <XPON:ConvertibleNotesAndAccruedInterestConvertedToCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23175"
      unitRef="USD">173157</XPON:ConvertibleNotesAndAccruedInterestConvertedToCommonStock>
    <XPON:ReclassificationOfAccruedInterestToLongTermDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23176"
      unitRef="USD">5183</XPON:ReclassificationOfAccruedInterestToLongTermDebt>
    <XPON:ReclassificationOfModifiedConvertibleNoteToLongTermDebt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23177"
      unitRef="USD">100000</XPON:ReclassificationOfModifiedConvertibleNoteToLongTermDebt>
    <XPON:ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23178"
      unitRef="USD">250000</XPON:ReclassificationOfModifiedMemberPromissoryNoteToConvertibleNotes>
    <XPON:IssuanceOfCommonStockInExchangeForPropertyAndequipment
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23179"
      unitRef="USD">20000</XPON:IssuanceOfCommonStockInExchangeForPropertyAndequipment>
    <XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23180"
      unitRef="USD">2348509</XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability>
    <XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23181"
      unitRef="USD">1268089</XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability>
    <XPON:PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23182"
      unitRef="USD">181430</XPON:PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable>
    <XPON:PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23183"
      unitRef="USD">183058</XPON:PurchasesOfPropertyAndEquipmentInExchangeForShortTermPayable>
    <XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23184"
      unitRef="USD">170863</XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt>
    <XPON:ReclassificationOfDepositToPropertyAndEquipment
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23185"
      unitRef="USD">2000</XPON:ReclassificationOfDepositToPropertyAndEquipment>
    <XPON:ConversionOfConvertibleNotesIntoCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23186"
      unitRef="USD">3282701</XPON:ConversionOfConvertibleNotesIntoCommonStock>
    <XPON:FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23187"
      unitRef="USD">1072160</XPON:FairValueOfWarrantsIssuedInConnectionWithLongTermDebtRecordedAsDebtDiscountAndAdditionalPaidInCapita>
    <XPON:MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23188"
      unitRef="USD">827290</XPON:MembershipContributionsReclassifiedToAdditionalPaidInCapitalUponCconversionToCorporation>
    <us-gaap:NatureOfOperations contextRef="From2022-01-012022-12-31" id="ixv-10497">&lt;p id="xdx_809_eus-gaap--NatureOfOperations_zDLg00LvNmfh" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;1.&#160;&#160;&#160;
&lt;span id="xdx_827_zZvWsHtu3cjk"&gt;Organization and Nature of Operations&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expion360
Inc. (formerly Yozamp Products Company, LLC dba Expion360) (&#x201c;the Company&#x201d;) was incorporated in the state of Nevada in November
2021. Effective November 1, 2021, the Company converted to a C corporation. Prior to conversion, the Company was a limited liability
company (LLC) with an indefinite life organized in the State of Oregon in June 2016. The LLC elected to be treated as a Subchapter S
corporation effective January 1, 2017. Net profits and losses of the LLC and all distributions were allocated among the members in proportion
to the ownership units held. The Original LLC Agreement was amended and restated on January 1, 2021 to add additional members and a non-voting
class of member units. Upon conversion to a C corporation, all existing LLC members at the time of conversion were issued shares of common
stock and became shareholders of the Company. (See Note 11 &#x2013; Conversion to a C Corporation).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company designs, assembles, and distributes premium lithium batteries for RV, Marine, Golf, Industrial, Residential, and Off-The-Grid
needs. The Company uses lithium iron phosphate (LiFePO4) batteries. LiFePO4 batteries are considered a top choice for high energy density,
dependability, longevity, and safety, providing the ability to power anything, anywhere.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
in March 2020, the COVID-19 pandemic and the measures imposed to contain this pandemic have disrupted and may continue to impact the
Company&#x2019;s business. The magnitude of the impact of the COVID-19 pandemic on the Company&#x2019;s productivity, results of operations,
and financial position, and its disruption to the Company&#x2019;s business and battery development and timeline, will depend in part
on the length and severity of these restrictions and on the Company&#x2019;s ability to conduct business in the ordinary course.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10517">&lt;p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zZCSyj0UPyae" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&#160;&#160;&#160;
&lt;span id="xdx_82F_z1u578H1k60g"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zosCWUTDZP34" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_867_zcKmcVMiCX0f"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying audited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise noted, all references to shares and shareholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziidprNltiq8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zSrNnjseglo9"&gt;Reclassification
of Prior Year Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zAezeEXDtu25" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_z4jgPTONCSic"&gt;&lt;span id="xdx_860_z6aTGYt6Y5M5"&gt;Going
Concern, Liquidity and Capital Resources&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.&lt;/span&gt;&lt;/p&gt;






&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
presented in the accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations.
These factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within twelve months after the
date that the financial statements for the year ended December 31, 2022 are issued. However, management is working to address its cash
flow challenges, including raising additional capital, alternative supply chain resources, and in-house assembly lines.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Historically,
the Company&#x2019;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#x2019;s sales for 2022 increased 59% over sales for 2021, as product demand continued to rise. On April 1, 2022, the
Company completed an initial public offering and listing of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of
costs, totaled $&lt;span id="xdx_903_ecustom--ProccedsFromIpoNetsCost_c20220101__20221231_z7Q2DZxWDT4c" title="Procceds from IPO nets cost"&gt;14,772,487&lt;/span&gt;, of which approximately $2,464,000 was used to pay down principal and accrued interest on high interest-bearing
debt. The remaining proceeds will be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in China.
In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S. and an assembly
facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management has secured a secondary
source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption issues with China arise.
Management believes that these factors will contribute to achieving operating efficiency and profitability. However, there can be no
assurance that the Company will be successful in achieving its objectives, including achieving operating efficiency and profitability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#x2019;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--UseOfEstimates_z0ocRgWNWQZf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_z3EVxd0y6wca"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#x2019;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#x2019;s accounting estimates require the exercise of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbaeIGyik0Mb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zNC12ITNVsB"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Accounts are secured by the Federal Deposit Insurance Corporation
(&#x201c;FDIC&#x201d;) up to $250,000 per institution. At times, balances may exceed federally insured limits. The Company has not experienced
any losses in such accounts and management believes that the Company is not exposed to any significant credit risk with respect to its
cash and cash equivalents. As of December 31, 2022, cash balances exceeded FDIC limits by $&lt;span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zcGyEsa7W9l2" title="Cash balances exceeded FDIC"&gt;222,162&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt; text-indent: 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Company had two accounts totaling $&lt;span id="xdx_900_eus-gaap--DepositContractsAssets_iI_c20221231_zr5rvg17WSx8" title="Deposit"&gt;11,204&lt;/span&gt; with SVB. As of March 13, 2023 all funds were transferred to another
banking institution and no exposure currently exists.&lt;/span&gt;&lt;/p&gt;






&lt;p id="xdx_842_eus-gaap--ReceivablesPolicyTextBlock_zccEBi4gxRMb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zOIVAMD7VBVi"&gt;Accounts
Receivable&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any interest. The Company performs
ongoing credit evaluations of its customers and generally requires no collateral. An allowance for uncollectible accounts is recorded
to reduce accounts receivable to the estimated amount that will be collected. The allowance is based upon management&#x2019;s review of
the accounts receivable aging and specific identification of potentially uncollectible balances. Recoveries of accounts previously written
off and adjustments to the allowance for uncollectible accounts are recorded as adjustments to bad debt expense. The allowance for doubtful
accounts totaled $&lt;span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20221231_znRkir5rWLte" title="Allowance for doubtful accounts"&gt;18,804&lt;/span&gt; as of December 31, 2022. There was no allowance for doubtful accounts as of December 31, 2021, as management
believed all outstanding amounts to be fully collectible.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--CustomerDepositsPolicyTextBlock_zyS8bauBrXf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zEW3Jl2pLZOk"&gt;Customer
Deposits&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt; text-indent: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 and December 31, 2021, the Company had customer deposits totaling $&lt;span id="xdx_907_eus-gaap--CustomerDepositsCurrent_iI_c20221231_z8KvAEyLc4Wi" title="customer deposits"&gt;58&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--CustomerDepositsCurrent_iI_c20211231_zu7rv75fbhI1"&gt;436,648&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--InventoryPolicyTextBlock_zf1aQfkRjwJc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zdHpw0ZUqF8d"&gt;Inventory&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and accessories, resale items,
components, and related landing costs. As of December 31, 2022 and December 31, 2021, the Company had inventory that consisted of finished
assemblies totaling $&lt;span id="xdx_90F_eus-gaap--InventoryFinishedGoods_iBI_c20221231_z7JFutRuUqjk" title="Inventory, Finished Goods"&gt;2,722,765&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--InventoryFinishedGoods_iBI_c20211231_zzMpfUhaDOr"&gt;985,537&lt;/span&gt;, respectively, and raw materials (inventory components, parts, and packaging) totaling $&lt;span id="xdx_90A_eus-gaap--InventoryRawMaterials_iI_c20221231_zDQEPRX2l6Ac" title="Raw materials"&gt;1,807,371&lt;/span&gt;
and $&lt;span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20211231_z8ivsKbdTiph"&gt;1,066,343&lt;/span&gt;, respectively. The valuation of inventory includes fixed production overhead costs based on normal capacity of the assembly
warehouse. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of December 31, 2022 or December 31, 2021. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $&lt;span id="xdx_90C_eus-gaap--OtherInventoryNetOfReserves_iI_c20221231_zmmUIXDfpCmi" title=" inventory"&gt;141,611&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--OtherInventoryNetOfReserves_iI_c20211231_zfgxFRsSTnof"&gt;1,081,225&lt;/span&gt; at December 31, 2022 and December 31,
2021, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zBxViAQdVsP8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_ztqVhnYxB5Je"&gt;Vendor
and Foreign Concentrations of Inventory Suppliers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended December 31, 2022 and 2021, approximately 85% and 90%, respectively, of inventory purchases were made from foreign suppliers
in China and Hong Kong. Any adverse change in either the economic or political conditions abroad could negatively impact the Company&#x2019;s
supply chain. The inability to obtain product to meet sales demand could adversely affect results of operations. However, the Company
has secured a secondary source for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company
to source materials outside of China in the event it becomes necessary to do so.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zaxsA97CojTi" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zV00YnVTG9lb"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfEstimatedUsfulLivesTableTextBlock_zgjoYcW0kHt8" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zWohKwqbpHad" style="display: none"&gt;Schedule
of estimated useful lives&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zeyesCta2Ejd" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: black 1pt solid; width: 73%; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles
    and transportation equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z8JL4yFreas7"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zEDbhRClpoEb" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zxdcGLihMHHg"&gt;3&lt;/span&gt; - &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zHpM0h6TVSE6" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4gROOUSc534"&gt;3&lt;/span&gt; - &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zhWz2PaOHzpg" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zAiAlB8I49Hg"&gt;3&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTHLP9GmS5gf" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHNVfYLdWUv9"&gt;3&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_znEhEelnV84k" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and molds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zf1pseSy9Frd"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zidybgPumZf5"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zcUsV5UGCyba" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable
to assets retired are removed from the accounts, and the gain or loss on disposition is recognized in the Statements of Operations.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_zpvUbeR694Od" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zk0QKaOFMT74"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#x201c;ROU&#x201d;) assets represent the
Company&#x2019;s right to use an underlying asset during the lease term, and operating lease liabilities representthe Company&#x2019;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease
liabilities, and long-term operating lease liabilities on the Company&#x2019;s Balance Sheets. The Company does not have any finance
leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments over the lease
term at commencement date calculated using the Company&#x2019;s incremental borrowing rate applicable to the lease asset, unless the implicit
rate is readily determinable. ROU assets also include any lease payments made at or before lease commencement and exclude any lease incentives
received. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the
Company will exercise that option. Leases with a term of 12 months or less are not recognized on the Company&#x2019;s Balance Sheet. The
Company&#x2019;s leases do not contain any residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line
basis over the lease term.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for lease and non-lease components as a single lease component for all its leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zQLhdMjGG0e2" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zfIapyfWjTE2"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the asset
to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted cash flows,
the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value. Fair value is determined
primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No long-lived asset impairment was
recognized during the years ended December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ExtendedProductWarrantyPolicy_zduEi09mXQ5c" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zWZXkTaEJTF9"&gt;Product
Warranties&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company sells the majority of its products to customers along with conditional repair or replacement warranties. The Company&#x2019;s
branded DC mobile chargers are warrantied for two years from the date of sale. The company&#x2019;s branded VPR 4EVER Classic and Platinum
batteries and re-branded e360 and e360 Extreme Density batteries are warrantied at gradually lesser levels over a twelve-year period
from date of sale. The Company determines its estimated liability for warranty claims based on the Company&#x2019;s experience of the
amount of claims actually made. Management estimates no liability as of December 31, 2022 and December 31, 2021 because, historically,
there have been very few claims and costs for repairs or replacement parts have been nominal. It is possible that the Company&#x2019;s
estimate of a liability for product liability claims will change in the near term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--LiabilityForRefundsPolicyTextBlock_zrQ1zFEu2z69" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zwiLOZBMPZV8"&gt;Liability
for Refunds&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.
However, during 2020 the Company sold discontinued products and recorded a liability for refunds. As of December 31, 2020, the liability
totaled $58,000. During the year ended December 31, 2021, the Company issued credits totaling $58,000, respectively. As of December 31,
2021, all allowable discontinued products had been returned and the Company had no further refund liability. No refund liability was
recognized in the year ended December 31, 2022. Revenue is recorded net of this amount. Any returns of discontinued product are not added
back to inventory and therefore related costs are nominal and not recorded as an asset.&lt;/span&gt;&lt;/p&gt;






&lt;p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zW7E6Z2Oepa6" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zMrPJgFfm5Xc"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#x2019;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#x2019;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zdcgPMDe3Chk" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zbdgwFebNPs3"&gt;Concentration
of Major Customers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2022, sales to three customers totaled $2.9 million, comprising approximately 41% of total sales. These customers
represented 43% of total accounts receivable as of December 31, 2022. During the year ended December 31, 2021, sales to one customer
totaled $486,000, comprising 11% of total sales. This customer did not have an accounts receivable balance as of December 31, 2021, but
three other customers had accounts receivable balances totaling $658,000 and representing a total of 85% of total accounts receivable
as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_z1IF9QSTe9Ja" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_zgncV9FjaA1f"&gt;Shipping
and Handling Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling fees billed to customers are classified on the Statement of Operations as &#x201c;Sales, net&#x201d; and totaled $23,188 and
$25,688 during the years ended December 31, 2022 and 2021, respectively. Shipping and handling costs for shipping product to customers
totaled $169,335 and $102,653 during the years ended December 31, 2022 and 2021, respectively, and are classified in selling, general
and administrative expense in the accompanying Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zl60rvUr3Xt7" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zwb1FyLiAXC"&gt;Advertising
and Marketing Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $&lt;span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20221231_zSuwZEm8gAgf" title="Advertising and marketing expense"&gt;239,814&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--MarketingAndAdvertisingExpense_c20210101__20211231_zmuk9fe4SgDg"&gt;67,394&lt;/span&gt; for the
years ended December 31, 2022 and 2021, respectively, and is included in selling, general and administrative expense in the accompanying
Statements of Operations. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_z1UAWRgo5n11" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86B_zz0IHaYK31Jj"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $&lt;span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_z1puF02fZCJb" title="Research and development costs"&gt;270,054&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_zfoG7iw5qB"&gt;58,044&lt;/span&gt; for
the years ended December 31, 2022 and 2021, respectively, and are included in selling, general and administrative expenses in the accompanying
Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTaIjtjdXNag" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_zcuS6ynhcTGh"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
January 1, 2017 to October 31, 2021, the Company was not subject to federal or state income taxes since it was a limited liability company
taxed as an S corporation. The Company&#x2019;s taxable income or losses were allocated to its members in accordance with their respective
ownership percentages. Therefore, no provision or liability for federal income taxes was included in the accompanying financial statements
for the relevant periods in 2021. Certain states impose minimum franchise taxes on entities taxed as an S corporation. Accordingly, the
accompanying financial statements include provisions for state franchise tax fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-size: 10pt"&gt;Effective November 1, 2021, the Company converted
from an LLC to a C corporation and, as a result, became subject to corporate federal and state income taxes. Deferred tax assets and
liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts
of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including tax loss and credit carryforwards, and
liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences
are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that included the enactment date. Deferred income tax expense represents the change during the period in the deferred
tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;/p&gt;






&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of December 31, 2022 and 2021, the Company has not recorded any income tax provision/(benefit)
resulting from the CARES Act, mainly due to the Company&#x2019;s history of net operating losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#x201c;CAA&#x201d;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2022 and beyond.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zoC7OCnSrRU" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
1: &lt;/i&gt;Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
2: &lt;/i&gt;Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
3: &lt;/i&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, shareholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the shareholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--SegmentReportingPolicyPolicyTextBlock_znUfrRrVLwhl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zTgQ346zzUFi"&gt;Segment
Reporting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zS1YFMYdVbj9" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zB8JNZo8YXY4"&gt;Basic
and Diluted Net Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following shows the amounts used in computing net loss per share:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z50CTcwuN1m1" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_z44xU4SMZuO" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zrWQ6gqJKxi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20220101__20221231_z1r7BosSa6j9" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210101__20211231_zxvvFMeavWJj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NetLoss_zGDahUfcOWR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(7,536,540&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(4,720,858&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zzxXXZJfHJ82" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Weighted average common shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,135,938&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,888,695&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NetLossPerShareBasicAndDiluted_z46cR1iXMXG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1.63&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z6t2bLfiorm5" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the years ended December 31, 2022 and 2021, the Company has outstanding warrants and options convertible into 1,717,936 shares of
common stock, respectively. The following table sets forth the number of shares excluded from the computation of diluted loss per share,
as their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zdDUbMmPGSle" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zA4OfQuOT4Y2" style="display: none"&gt;Schedule of anti-dilutive share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_zNr6DvcK9ZY4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; padding-left: 5.4pt"&gt;Stock options&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zToARjhdbPki" style="width: 12%; text-align: right"&gt;829,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPDZLIp16ry7" style="width: 12%; text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPoKd9ZSYdH6" style="border-bottom: Black 1pt solid; text-align: right"&gt;888,436&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zOZV8xjYB656" style="border-bottom: Black 1pt solid; text-align: right"&gt;710,431&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zK3yOGTFlWT4" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,717,936&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zvdzQQEGM7hh" style="border-bottom: Black 2.5pt double; text-align: right"&gt;740,431&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_z9HzVV4rdFJl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zVBPAuuC3y8j" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zo0xyQIDHiJk"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation&#x2014;Stock Compensation&#x201d;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zXhYdKndQhDc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zen3BobqEmog"&gt;New
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt"&gt;In May 2021, the FASB issued ASU 2021-04,
&#x201c;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation
(Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for
Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the Emerging Issues Task Force).&#x201d;
ASU 2021-04 requires issuers to account for modifications or exchanges of freestanding equity-classified written call options that remain
equity classified after the modification or exchange based on the economic substance of the modification or exchange. Under the guidance,
an issuer determines the accounting for the modification or exchange based on whether the transaction was done to issue equity, to issue
or modify debt, or for other reasons. ASU 2021-04 is applied prospectively and is effective for fiscal years beginning after December
15, 2021, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of fiscal 2022, which
did not have a material impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;/p&gt;






&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU 2020-06, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts
in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity.
Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion
features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in
substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single
liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Similarly,
equity-classified convertible preferred stock instruments will be accounted for as single units of account in equity unless the conversion
feature needs to be bifurcated under Topic 815. The new guidance also made amendments to the earnings per share guidance in Topic 260,
Earnings Per Share, for convertible instruments, the most significant impact of which is requiring the use of the if-converted method
for diluted earnings per share calculation. Further, ASU 2020-06 made revisions to Subtopic 815-40, which provides guidance on how an
entity must determine whether a contract qualifies for a scope exception from derivative accounting. ASU 2020-06 is effective for fiscal
years beginning after December 15, 2021, with early adoption permitted. Adoption of the standard requires using either a modified retrospective
or a full retrospective approach. Effective January 1, 2021, the Company early adopted ASU 2020-06 using the modified retrospective approach.
Adoption of the new standard did not have a material impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2020, the FASB issued ASU 2020-01, Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint
Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.
The new guidance clarifies the interaction of accounting for the transition into and out of the equity method and the accounting for
measuring certain purchased options and forward contracts to acquire investments. ASU 2020-01 is effective for fiscal years beginning
after December 15, 2020, including interim periods within those fiscal years. Effective January 1, 2021, the Company adopted ASU 2020-01.
The adoption of this guidance did not have an impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zn9Wxsicv9kd" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zH4wjNyLkeD6"&gt;Accounting
Guidance Issued but Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2022, the FASB issued ASU 2022-04, &#x201c;Liabilities&#x2014;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#x201d; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#x2019;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company is currently evaluating the impact of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, &#x201c;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#x201d; which amends the guidance in Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the FASB issued ASU 2022-02, &#x201c;Financial Instruments&#x2014;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#x201d; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#x201c;CECL&#x201d;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have &lt;i&gt;not&lt;/i&gt; yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company is currently evaluating the impact of this standard on our financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#x201d; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company is currently evaluating the impact of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company is currently evaluating the impact of adopting this guidance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10523">&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zosCWUTDZP34" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_867_zcKmcVMiCX0f"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying audited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise noted, all references to shares and shareholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2022-01-012022-12-31" id="ixv-10538">&lt;p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziidprNltiq8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zSrNnjseglo9"&gt;Reclassification
of Prior Year Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <XPON:LiquidityAndCapitalResourcesPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10549">&lt;p id="xdx_840_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zAezeEXDtu25" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_z4jgPTONCSic"&gt;&lt;span id="xdx_860_z6aTGYt6Y5M5"&gt;Going
Concern, Liquidity and Capital Resources&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.&lt;/span&gt;&lt;/p&gt;






&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
presented in the accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations.
These factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within twelve months after the
date that the financial statements for the year ended December 31, 2022 are issued. However, management is working to address its cash
flow challenges, including raising additional capital, alternative supply chain resources, and in-house assembly lines.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Historically,
the Company&#x2019;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#x2019;s sales for 2022 increased 59% over sales for 2021, as product demand continued to rise. On April 1, 2022, the
Company completed an initial public offering and listing of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of
costs, totaled $&lt;span id="xdx_903_ecustom--ProccedsFromIpoNetsCost_c20220101__20221231_z7Q2DZxWDT4c" title="Procceds from IPO nets cost"&gt;14,772,487&lt;/span&gt;, of which approximately $2,464,000 was used to pay down principal and accrued interest on high interest-bearing
debt. The remaining proceeds will be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in China.
In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S. and an assembly
facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management has secured a secondary
source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption issues with China arise.
Management believes that these factors will contribute to achieving operating efficiency and profitability. However, there can be no
assurance that the Company will be successful in achieving its objectives, including achieving operating efficiency and profitability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#x2019;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</XPON:LiquidityAndCapitalResourcesPolicyTextBlock>
    <XPON:ProccedsFromIpoNetsCost
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23189"
      unitRef="USD">14772487</XPON:ProccedsFromIpoNetsCost>
    <us-gaap:UseOfEstimates contextRef="From2022-01-012022-12-31" id="ixv-10583">&lt;p id="xdx_843_eus-gaap--UseOfEstimates_z0ocRgWNWQZf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_z3EVxd0y6wca"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#x2019;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#x2019;s accounting estimates require the exercise of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10598">&lt;p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbaeIGyik0Mb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zNC12ITNVsB"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Accounts are secured by the Federal Deposit Insurance Corporation
(&#x201c;FDIC&#x201d;) up to $250,000 per institution. At times, balances may exceed federally insured limits. The Company has not experienced
any losses in such accounts and management believes that the Company is not exposed to any significant credit risk with respect to its
cash and cash equivalents. As of December 31, 2022, cash balances exceeded FDIC limits by $&lt;span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zcGyEsa7W9l2" title="Cash balances exceeded FDIC"&gt;222,162&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt; text-indent: 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Company had two accounts totaling $&lt;span id="xdx_900_eus-gaap--DepositContractsAssets_iI_c20221231_zr5rvg17WSx8" title="Deposit"&gt;11,204&lt;/span&gt; with SVB. As of March 13, 2023 all funds were transferred to another
banking institution and no exposure currently exists.&lt;/span&gt;&lt;/p&gt;






</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23190"
      unitRef="USD">222162</us-gaap:CashFDICInsuredAmount>
    <us-gaap:DepositContractsAssets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23191"
      unitRef="USD">11204</us-gaap:DepositContractsAssets>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10621">&lt;p id="xdx_842_eus-gaap--ReceivablesPolicyTextBlock_zccEBi4gxRMb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zOIVAMD7VBVi"&gt;Accounts
Receivable&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any interest. The Company performs
ongoing credit evaluations of its customers and generally requires no collateral. An allowance for uncollectible accounts is recorded
to reduce accounts receivable to the estimated amount that will be collected. The allowance is based upon management&#x2019;s review of
the accounts receivable aging and specific identification of potentially uncollectible balances. Recoveries of accounts previously written
off and adjustments to the allowance for uncollectible accounts are recorded as adjustments to bad debt expense. The allowance for doubtful
accounts totaled $&lt;span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20221231_znRkir5rWLte" title="Allowance for doubtful accounts"&gt;18,804&lt;/span&gt; as of December 31, 2022. There was no allowance for doubtful accounts as of December 31, 2021, as management
believed all outstanding amounts to be fully collectible.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23192"
      unitRef="USD">18804</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <XPON:CustomerDepositsPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10633">&lt;p id="xdx_84B_ecustom--CustomerDepositsPolicyTextBlock_zyS8bauBrXf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zEW3Jl2pLZOk"&gt;Customer
Deposits&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt; text-indent: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 and December 31, 2021, the Company had customer deposits totaling $&lt;span id="xdx_907_eus-gaap--CustomerDepositsCurrent_iI_c20221231_z8KvAEyLc4Wi" title="customer deposits"&gt;58&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--CustomerDepositsCurrent_iI_c20211231_zu7rv75fbhI1"&gt;436,648&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</XPON:CustomerDepositsPolicyTextBlock>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23193"
      unitRef="USD">58</us-gaap:CustomerDepositsCurrent>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23194"
      unitRef="USD">436648</us-gaap:CustomerDepositsCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10647">&lt;p id="xdx_84E_eus-gaap--InventoryPolicyTextBlock_zf1aQfkRjwJc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zdHpw0ZUqF8d"&gt;Inventory&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and accessories, resale items,
components, and related landing costs. As of December 31, 2022 and December 31, 2021, the Company had inventory that consisted of finished
assemblies totaling $&lt;span id="xdx_90F_eus-gaap--InventoryFinishedGoods_iBI_c20221231_z7JFutRuUqjk" title="Inventory, Finished Goods"&gt;2,722,765&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--InventoryFinishedGoods_iBI_c20211231_zzMpfUhaDOr"&gt;985,537&lt;/span&gt;, respectively, and raw materials (inventory components, parts, and packaging) totaling $&lt;span id="xdx_90A_eus-gaap--InventoryRawMaterials_iI_c20221231_zDQEPRX2l6Ac" title="Raw materials"&gt;1,807,371&lt;/span&gt;
and $&lt;span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20211231_z8ivsKbdTiph"&gt;1,066,343&lt;/span&gt;, respectively. The valuation of inventory includes fixed production overhead costs based on normal capacity of the assembly
warehouse. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of December 31, 2022 or December 31, 2021. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $&lt;span id="xdx_90C_eus-gaap--OtherInventoryNetOfReserves_iI_c20221231_zmmUIXDfpCmi" title=" inventory"&gt;141,611&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--OtherInventoryNetOfReserves_iI_c20211231_zfgxFRsSTnof"&gt;1,081,225&lt;/span&gt; at December 31, 2022 and December 31,
2021, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23195"
      unitRef="USD">2722765</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23196"
      unitRef="USD">985537</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23197"
      unitRef="USD">1807371</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23198"
      unitRef="USD">1066343</us-gaap:InventoryRawMaterials>
    <us-gaap:OtherInventoryNetOfReserves
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23199"
      unitRef="USD">141611</us-gaap:OtherInventoryNetOfReserves>
    <us-gaap:OtherInventoryNetOfReserves
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23200"
      unitRef="USD">1081225</us-gaap:OtherInventoryNetOfReserves>
    <XPON:VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10668">&lt;p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zBxViAQdVsP8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_ztqVhnYxB5Je"&gt;Vendor
and Foreign Concentrations of Inventory Suppliers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended December 31, 2022 and 2021, approximately 85% and 90%, respectively, of inventory purchases were made from foreign suppliers
in China and Hong Kong. Any adverse change in either the economic or political conditions abroad could negatively impact the Company&#x2019;s
supply chain. The inability to obtain product to meet sales demand could adversely affect results of operations. However, the Company
has secured a secondary source for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company
to source materials outside of China in the event it becomes necessary to do so.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10679">&lt;p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zaxsA97CojTi" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zV00YnVTG9lb"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfEstimatedUsfulLivesTableTextBlock_zgjoYcW0kHt8" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zWohKwqbpHad" style="display: none"&gt;Schedule
of estimated useful lives&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zeyesCta2Ejd" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: black 1pt solid; width: 73%; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles
    and transportation equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z8JL4yFreas7"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zEDbhRClpoEb" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zxdcGLihMHHg"&gt;3&lt;/span&gt; - &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zHpM0h6TVSE6" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4gROOUSc534"&gt;3&lt;/span&gt; - &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zhWz2PaOHzpg" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zAiAlB8I49Hg"&gt;3&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTHLP9GmS5gf" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHNVfYLdWUv9"&gt;3&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_znEhEelnV84k" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and molds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zf1pseSy9Frd"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zidybgPumZf5"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zcUsV5UGCyba" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable
to assets retired are removed from the accounts, and the gain or loss on disposition is recognized in the Statements of Operations.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <XPON:ScheduleOfEstimatedUsfulLivesTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10688">&lt;p id="xdx_89D_ecustom--ScheduleOfEstimatedUsfulLivesTableTextBlock_zgjoYcW0kHt8" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zWohKwqbpHad" style="display: none"&gt;Schedule
of estimated useful lives&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zeyesCta2Ejd" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: black 1pt solid; width: 73%; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles
    and transportation equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_z8JL4yFreas7"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zEDbhRClpoEb" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zxdcGLihMHHg"&gt;3&lt;/span&gt; - &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zHpM0h6TVSE6" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4gROOUSc534"&gt;3&lt;/span&gt; - &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zhWz2PaOHzpg" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zAiAlB8I49Hg"&gt;3&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTHLP9GmS5gf" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHNVfYLdWUv9"&gt;3&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_znEhEelnV84k" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and molds&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zf1pseSy9Frd"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zidybgPumZf5"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</XPON:ScheduleOfEstimatedUsfulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember"
      id="ixv-23201">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember"
      id="ixv-23202">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-12-31_us-gaap_OfficeEquipmentMember_srt_MinimumMember"
      id="ixv-23203">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2021-12-31_us-gaap_OfficeEquipmentMember_srt_MaximumMember"
      id="ixv-23204">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember_srt_MinimumMember"
      id="ixv-23205">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2021-12-31_custom_ManufacturingEquipmentMember_srt_MaximumMember"
      id="ixv-23206">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember_srt_MinimumMember"
      id="ixv-23207">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2021-12-31_custom_ManufacturingEquipmentMember_srt_MaximumMember"
      id="ixv-23208">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-12-31_custom_QAEquipmentMember_srt_MinimumMember"
      id="ixv-23209">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2021-12-31_srt_MaximumMember_custom_QAEquipmentMember"
      id="ixv-23210">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-12-31_custom_ToolingAndMoldsMember_srt_MinimumMember"
      id="ixv-23211">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2021-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember"
      id="ixv-23212">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10776">&lt;p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_zpvUbeR694Od" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zk0QKaOFMT74"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#x201c;ROU&#x201d;) assets represent the
Company&#x2019;s right to use an underlying asset during the lease term, and operating lease liabilities representthe Company&#x2019;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease
liabilities, and long-term operating lease liabilities on the Company&#x2019;s Balance Sheets. The Company does not have any finance
leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments over the lease
term at commencement date calculated using the Company&#x2019;s incremental borrowing rate applicable to the lease asset, unless the implicit
rate is readily determinable. ROU assets also include any lease payments made at or before lease commencement and exclude any lease incentives
received. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the
Company will exercise that option. Leases with a term of 12 months or less are not recognized on the Company&#x2019;s Balance Sheet. The
Company&#x2019;s leases do not contain any residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line
basis over the lease term.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for lease and non-lease components as a single lease component for all its leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10795">&lt;p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zQLhdMjGG0e2" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zfIapyfWjTE2"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the asset
to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted cash flows,
the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value. Fair value is determined
primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No long-lived asset impairment was
recognized during the years ended December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ExtendedProductWarrantyPolicy contextRef="From2022-01-012022-12-31" id="ixv-10806">&lt;p id="xdx_846_eus-gaap--ExtendedProductWarrantyPolicy_zduEi09mXQ5c" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zWZXkTaEJTF9"&gt;Product
Warranties&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company sells the majority of its products to customers along with conditional repair or replacement warranties. The Company&#x2019;s
branded DC mobile chargers are warrantied for two years from the date of sale. The company&#x2019;s branded VPR 4EVER Classic and Platinum
batteries and re-branded e360 and e360 Extreme Density batteries are warrantied at gradually lesser levels over a twelve-year period
from date of sale. The Company determines its estimated liability for warranty claims based on the Company&#x2019;s experience of the
amount of claims actually made. Management estimates no liability as of December 31, 2022 and December 31, 2021 because, historically,
there have been very few claims and costs for repairs or replacement parts have been nominal. It is possible that the Company&#x2019;s
estimate of a liability for product liability claims will change in the near term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ExtendedProductWarrantyPolicy>
    <XPON:LiabilityForRefundsPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10817">&lt;p id="xdx_845_ecustom--LiabilityForRefundsPolicyTextBlock_zrQ1zFEu2z69" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zwiLOZBMPZV8"&gt;Liability
for Refunds&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.
However, during 2020 the Company sold discontinued products and recorded a liability for refunds. As of December 31, 2020, the liability
totaled $58,000. During the year ended December 31, 2021, the Company issued credits totaling $58,000, respectively. As of December 31,
2021, all allowable discontinued products had been returned and the Company had no further refund liability. No refund liability was
recognized in the year ended December 31, 2022. Revenue is recorded net of this amount. Any returns of discontinued product are not added
back to inventory and therefore related costs are nominal and not recorded as an asset.&lt;/span&gt;&lt;/p&gt;






</XPON:LiabilityForRefundsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10834">&lt;p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zW7E6Z2Oepa6" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zMrPJgFfm5Xc"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#x2019;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#x2019;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-01-012022-12-31" id="ixv-10846">&lt;p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zdcgPMDe3Chk" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zbdgwFebNPs3"&gt;Concentration
of Major Customers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2022, sales to three customers totaled $2.9 million, comprising approximately 41% of total sales. These customers
represented 43% of total accounts receivable as of December 31, 2022. During the year ended December 31, 2021, sales to one customer
totaled $486,000, comprising 11% of total sales. This customer did not have an accounts receivable balance as of December 31, 2021, but
three other customers had accounts receivable balances totaling $658,000 and representing a total of 85% of total accounts receivable
as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ShippingAndHandlingCostPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10861">&lt;p id="xdx_84F_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_z1IF9QSTe9Ja" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_zgncV9FjaA1f"&gt;Shipping
and Handling Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling fees billed to customers are classified on the Statement of Operations as &#x201c;Sales, net&#x201d; and totaled $23,188 and
$25,688 during the years ended December 31, 2022 and 2021, respectively. Shipping and handling costs for shipping product to customers
totaled $169,335 and $102,653 during the years ended December 31, 2022 and 2021, respectively, and are classified in selling, general
and administrative expense in the accompanying Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShippingAndHandlingCostPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10872">&lt;p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zl60rvUr3Xt7" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zwb1FyLiAXC"&gt;Advertising
and Marketing Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $&lt;span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20221231_zSuwZEm8gAgf" title="Advertising and marketing expense"&gt;239,814&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--MarketingAndAdvertisingExpense_c20210101__20211231_zmuk9fe4SgDg"&gt;67,394&lt;/span&gt; for the
years ended December 31, 2022 and 2021, respectively, and is included in selling, general and administrative expense in the accompanying
Statements of Operations. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23213"
      unitRef="USD">239814</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23214"
      unitRef="USD">67394</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2022-01-012022-12-31" id="ixv-10886">&lt;p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_z1UAWRgo5n11" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86B_zz0IHaYK31Jj"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $&lt;span id="xdx_90A_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_z1puF02fZCJb" title="Research and development costs"&gt;270,054&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_zfoG7iw5qB"&gt;58,044&lt;/span&gt; for
the years ended December 31, 2022 and 2021, respectively, and are included in selling, general and administrative expenses in the accompanying
Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23215"
      unitRef="USD">270054</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23216"
      unitRef="USD">58044</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10899">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zTaIjtjdXNag" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_861_zcuS6ynhcTGh"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
January 1, 2017 to October 31, 2021, the Company was not subject to federal or state income taxes since it was a limited liability company
taxed as an S corporation. The Company&#x2019;s taxable income or losses were allocated to its members in accordance with their respective
ownership percentages. Therefore, no provision or liability for federal income taxes was included in the accompanying financial statements
for the relevant periods in 2021. Certain states impose minimum franchise taxes on entities taxed as an S corporation. Accordingly, the
accompanying financial statements include provisions for state franchise tax fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-size: 10pt"&gt;Effective November 1, 2021, the Company converted
from an LLC to a C corporation and, as a result, became subject to corporate federal and state income taxes. Deferred tax assets and
liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts
of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including tax loss and credit carryforwards, and
liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences
are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that included the enactment date. Deferred income tax expense represents the change during the period in the deferred
tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;/p&gt;






&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of December 31, 2022 and 2021, the Company has not recorded any income tax provision/(benefit)
resulting from the CARES Act, mainly due to the Company&#x2019;s history of net operating losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#x201c;CAA&#x201d;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2022 and beyond.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-01-012022-12-31" id="ixv-10933">&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zoC7OCnSrRU" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fair
Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
1: &lt;/i&gt;Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
2: &lt;/i&gt;Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
3: &lt;/i&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, shareholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the shareholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10963">&lt;p id="xdx_848_eus-gaap--SegmentReportingPolicyPolicyTextBlock_znUfrRrVLwhl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zTgQ346zzUFi"&gt;Segment
Reporting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10979">&lt;p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zS1YFMYdVbj9" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zB8JNZo8YXY4"&gt;Basic
and Diluted Net Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following shows the amounts used in computing net loss per share:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z50CTcwuN1m1" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_z44xU4SMZuO" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zrWQ6gqJKxi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20220101__20221231_z1r7BosSa6j9" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210101__20211231_zxvvFMeavWJj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NetLoss_zGDahUfcOWR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(7,536,540&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(4,720,858&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zzxXXZJfHJ82" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Weighted average common shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,135,938&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,888,695&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NetLossPerShareBasicAndDiluted_z46cR1iXMXG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1.63&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z6t2bLfiorm5" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the years ended December 31, 2022 and 2021, the Company has outstanding warrants and options convertible into 1,717,936 shares of
common stock, respectively. The following table sets forth the number of shares excluded from the computation of diluted loss per share,
as their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zdDUbMmPGSle" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zA4OfQuOT4Y2" style="display: none"&gt;Schedule of anti-dilutive share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_zNr6DvcK9ZY4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; padding-left: 5.4pt"&gt;Stock options&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zToARjhdbPki" style="width: 12%; text-align: right"&gt;829,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPDZLIp16ry7" style="width: 12%; text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPoKd9ZSYdH6" style="border-bottom: Black 1pt solid; text-align: right"&gt;888,436&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zOZV8xjYB656" style="border-bottom: Black 1pt solid; text-align: right"&gt;710,431&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zK3yOGTFlWT4" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,717,936&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zvdzQQEGM7hh" style="border-bottom: Black 2.5pt double; text-align: right"&gt;740,431&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_z9HzVV4rdFJl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-10996">&lt;p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z50CTcwuN1m1" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_z44xU4SMZuO" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zrWQ6gqJKxi1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20220101__20221231_z1r7BosSa6j9" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210101__20211231_zxvvFMeavWJj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NetLoss_zGDahUfcOWR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(7,536,540&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(4,720,858&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zzxXXZJfHJ82" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Weighted average common shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,135,938&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,888,695&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NetLossPerShareBasicAndDiluted_z46cR1iXMXG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1.63&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <XPON:NetLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23217"
      unitRef="USD">-7536540</XPON:NetLoss>
    <XPON:NetLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23218"
      unitRef="USD">-4720858</XPON:NetLoss>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23219"
      unitRef="Shares">6135938</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23220"
      unitRef="Shares">2888695</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23221"
      unitRef="USDPShares">-1.23</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23222"
      unitRef="USDPShares">-1.63</XPON:NetLossPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11054">&lt;p id="xdx_89C_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zdDUbMmPGSle" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zA4OfQuOT4Y2" style="display: none"&gt;Schedule of anti-dilutive share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_zNr6DvcK9ZY4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; padding-left: 5.4pt"&gt;Stock options&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zToARjhdbPki" style="width: 12%; text-align: right"&gt;829,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPDZLIp16ry7" style="width: 12%; text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPoKd9ZSYdH6" style="border-bottom: Black 1pt solid; text-align: right"&gt;888,436&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zOZV8xjYB656" style="border-bottom: Black 1pt solid; text-align: right"&gt;710,431&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zK3yOGTFlWT4" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,717,936&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zvdzQQEGM7hh" style="border-bottom: Black 2.5pt double; text-align: right"&gt;740,431&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <XPON:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23223"
      unitRef="Shares">829500</XPON:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23224"
      unitRef="Shares">30000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <XPON:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne
      contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="ixv-23225"
      unitRef="Shares">888436</XPON:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountOne>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="ixv-23226"
      unitRef="Shares">710431</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23227"
      unitRef="Shares">1717936</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23228"
      unitRef="Shares">740431</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11102">&lt;p id="xdx_842_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zVBPAuuC3y8j" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86F_zo0xyQIDHiJk"&gt;Stock-Based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation&#x2014;Stock Compensation&#x201d;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11120">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zXhYdKndQhDc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zen3BobqEmog"&gt;New
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt"&gt;In May 2021, the FASB issued ASU 2021-04,
&#x201c;Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation
(Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for
Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the Emerging Issues Task Force).&#x201d;
ASU 2021-04 requires issuers to account for modifications or exchanges of freestanding equity-classified written call options that remain
equity classified after the modification or exchange based on the economic substance of the modification or exchange. Under the guidance,
an issuer determines the accounting for the modification or exchange based on whether the transaction was done to issue equity, to issue
or modify debt, or for other reasons. ASU 2021-04 is applied prospectively and is effective for fiscal years beginning after December
15, 2021, and interim periods within those fiscal years. The Company adopted this standard in the first quarter of fiscal 2022, which
did not have a material impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;/p&gt;






&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU 2020-06, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts
in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity.
Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion
features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in
substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single
liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Similarly,
equity-classified convertible preferred stock instruments will be accounted for as single units of account in equity unless the conversion
feature needs to be bifurcated under Topic 815. The new guidance also made amendments to the earnings per share guidance in Topic 260,
Earnings Per Share, for convertible instruments, the most significant impact of which is requiring the use of the if-converted method
for diluted earnings per share calculation. Further, ASU 2020-06 made revisions to Subtopic 815-40, which provides guidance on how an
entity must determine whether a contract qualifies for a scope exception from derivative accounting. ASU 2020-06 is effective for fiscal
years beginning after December 15, 2021, with early adoption permitted. Adoption of the standard requires using either a modified retrospective
or a full retrospective approach. Effective January 1, 2021, the Company early adopted ASU 2020-06 using the modified retrospective approach.
Adoption of the new standard did not have a material impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2020, the FASB issued ASU 2020-01, Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint
Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.
The new guidance clarifies the interaction of accounting for the transition into and out of the equity method and the accounting for
measuring certain purchased options and forward contracts to acquire investments. ASU 2020-01 is effective for fiscal years beginning
after December 15, 2020, including interim periods within those fiscal years. Effective January 1, 2021, the Company adopted ASU 2020-01.
The adoption of this guidance did not have an impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <XPON:AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11149">&lt;p id="xdx_84E_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zn9Wxsicv9kd" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zH4wjNyLkeD6"&gt;Accounting
Guidance Issued but Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2022, the FASB issued ASU 2022-04, &#x201c;Liabilities&#x2014;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#x201d; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#x2019;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company is currently evaluating the impact of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, &#x201c;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#x201d; which amends the guidance in Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the FASB issued ASU 2022-02, &#x201c;Financial Instruments&#x2014;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#x201d; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#x201c;CECL&#x201d;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have &lt;i&gt;not&lt;/i&gt; yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company is currently evaluating the impact of this standard on our financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#x201d; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company is currently evaluating the impact of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company is currently evaluating the impact of adopting this guidance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11183">&lt;p id="xdx_800_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zohKyAPvYpPj" style="margin: 0 0 12pt; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&#160;&#160;&#160;
&lt;span&gt;&lt;span id="xdx_820_z71Nkdd2P4Va"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zheh2nDuemJ8" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zZSk3QJapL84" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment consist of the following:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zyl9ODh44zjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment Net (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: justify"&gt;Vehicles and transportation equipment&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zclfbL84mvbe" style="width: 12%; text-align: right"&gt;593,097&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_pp0p0_zG3wpTA6rw54" style="width: 12%; text-align: right"&gt;298,752&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zdpddnciDVFg" style="text-align: right"&gt;314,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z65RUMXXIru8" style="text-align: right"&gt;59,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zjrmdOX5amL4" style="text-align: right"&gt;188,131&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_z0TZg163v1Ak" style="text-align: right"&gt;105,003&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Manufacturing equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zJ3b1EQ3sDfa" style="text-align: right"&gt;179,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_pp0p0_zZSd6s2xG7Df" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0629"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Warehouse equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zWYP5jd0nDpe" style="text-align: right"&gt;81,164&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_pp0p0_zLQ3c69Ut6Y8" style="text-align: right"&gt;44,356&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;QA equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zdM4YNqCyVgj" style="text-align: right"&gt;22,142&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_z8ksLfKvcLB4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0633"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Tooling and Molds&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zVNzT45cvEV8" style="border-bottom: Black 1pt solid; text-align: right"&gt;15,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zkNU2KiDiQEf" style="border-bottom: Black 1pt solid; text-align: right"&gt;15,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zPsiNPMhdYJg" style="text-align: right"&gt;1,394,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zjGZJaS13Vzg" style="text-align: right"&gt;523,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSjZhBR4xesb" style="border-bottom: Black 1pt solid; text-align: right"&gt;(250,861&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20211231_zJKe8IIqHOge" style="border-bottom: Black 1pt solid; text-align: right"&gt;(96,190&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zLxkDFZBppW4" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,143,758&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_z3ZdTatSVR7l" style="border-bottom: Black 2.5pt double; text-align: right"&gt;427,229&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zDy05SZOBbbc" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense was $&lt;span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20220101__20221231_zBVtXSq4Iu8i" title="Depreciation expense"&gt;164,767&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20210101__20211231_zGYWn0tYEFTi"&gt;61,084&lt;/span&gt; for the years ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;






&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11188">&lt;p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zheh2nDuemJ8" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zZSk3QJapL84" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment consist of the following:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zyl9ODh44zjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment Net (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: justify"&gt;Vehicles and transportation equipment&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zclfbL84mvbe" style="width: 12%; text-align: right"&gt;593,097&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_pp0p0_zG3wpTA6rw54" style="width: 12%; text-align: right"&gt;298,752&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zdpddnciDVFg" style="text-align: right"&gt;314,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z65RUMXXIru8" style="text-align: right"&gt;59,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zjrmdOX5amL4" style="text-align: right"&gt;188,131&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_z0TZg163v1Ak" style="text-align: right"&gt;105,003&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Manufacturing equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zJ3b1EQ3sDfa" style="text-align: right"&gt;179,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_pp0p0_zZSd6s2xG7Df" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0629"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Warehouse equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zWYP5jd0nDpe" style="text-align: right"&gt;81,164&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_pp0p0_zLQ3c69Ut6Y8" style="text-align: right"&gt;44,356&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;QA equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zdM4YNqCyVgj" style="text-align: right"&gt;22,142&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_z8ksLfKvcLB4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0633"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Tooling and Molds&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zVNzT45cvEV8" style="border-bottom: Black 1pt solid; text-align: right"&gt;15,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zkNU2KiDiQEf" style="border-bottom: Black 1pt solid; text-align: right"&gt;15,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zPsiNPMhdYJg" style="text-align: right"&gt;1,394,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zjGZJaS13Vzg" style="text-align: right"&gt;523,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSjZhBR4xesb" style="border-bottom: Black 1pt solid; text-align: right"&gt;(250,861&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20211231_zJKe8IIqHOge" style="border-bottom: Black 1pt solid; text-align: right"&gt;(96,190&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zLxkDFZBppW4" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,143,758&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_z3ZdTatSVR7l" style="border-bottom: Black 2.5pt double; text-align: right"&gt;427,229&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember"
      decimals="0"
      id="ixv-23229"
      unitRef="USD">593097</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_VehiclesAndTransportationEquipmentMember"
      decimals="0"
      id="ixv-23230"
      unitRef="USD">298752</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="ixv-23231"
      unitRef="USD">314819</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="ixv-23232"
      unitRef="USD">59316</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_OfficeFurnitureEquipmentMember"
      decimals="0"
      id="ixv-23233"
      unitRef="USD">188131</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_OfficeFurnitureEquipmentMember"
      decimals="0"
      id="ixv-23234"
      unitRef="USD">105003</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember"
      decimals="0"
      id="ixv-23235"
      unitRef="USD">179274</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_WarehouseEquipmentMember"
      decimals="0"
      id="ixv-23236"
      unitRef="USD">81164</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_WarehouseEquipmentMember"
      decimals="0"
      id="ixv-23237"
      unitRef="USD">44356</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_QAEquipmentMember"
      decimals="0"
      id="ixv-23238"
      unitRef="USD">22142</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_ToolingAndMoldsMember"
      decimals="0"
      id="ixv-23239"
      unitRef="USD">15992</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_ToolingAndMoldsMember"
      decimals="0"
      id="ixv-23240"
      unitRef="USD">15992</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23241"
      unitRef="USD">1394619</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23242"
      unitRef="USD">523419</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23243"
      unitRef="USD">250861</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23244"
      unitRef="USD">96190</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23245"
      unitRef="USD">1143758</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23246"
      unitRef="USD">427229</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23247"
      unitRef="USD">164767</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23248"
      unitRef="USD">61084</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11344">&lt;p id="xdx_80F_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zUIwo8FtjeRk" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&#160;&#160;&#160;
&lt;span id="xdx_825_zl0NjqQc1UAl"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
expenses and other current liabilities consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zNqtcJxoSRDh" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zk7zzpCVD1D9" style="display: none"&gt;Schedule of accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_300_134_z9hlwjoLZxjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20221231_zmbIREaO27xe" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20211231_z8ny76WBoMjj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zhpqX93h8Hh1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Accrued salaries and payroll liabilities&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;169,337&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;12,449&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--RebateLiability_iI_zhjWjvLj3lhc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Rebate liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredIncomeAndDepositSublease_iI_zXQGniVBXt" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred income and deposit (sublease)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_zmtbonEZ5Olj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Commissions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FranchiseTax_iI_zemYreCq8QXg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Franchise tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InterestPayableCurrent_iI_zJTY80T7h5y" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,301&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zu62oANbk07c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;86,302&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,748&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_zAaV9OLnW0Lb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;306,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;140,618&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zhTvst50hEai" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11352">&lt;p id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zNqtcJxoSRDh" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zk7zzpCVD1D9" style="display: none"&gt;Schedule of accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_300_134_z9hlwjoLZxjj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20221231_zmbIREaO27xe" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20211231_z8ny76WBoMjj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zhpqX93h8Hh1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Accrued salaries and payroll liabilities&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;169,337&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;12,449&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--RebateLiability_iI_zhjWjvLj3lhc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Rebate liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredIncomeAndDepositSublease_iI_zXQGniVBXt" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred income and deposit (sublease)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,690&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_zmtbonEZ5Olj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Commissions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FranchiseTax_iI_zemYreCq8QXg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Franchise tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InterestPayableCurrent_iI_zJTY80T7h5y" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,301&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zu62oANbk07c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;86,302&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,748&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_zAaV9OLnW0Lb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;306,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;140,618&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23249"
      unitRef="USD">169337</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23250"
      unitRef="USD">12449</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <XPON:RebateLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23251"
      unitRef="USD">26015</XPON:RebateLiability>
    <XPON:RebateLiability
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23252"
      unitRef="USD">23010</XPON:RebateLiability>
    <XPON:DeferredIncomeAndDepositSublease
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23253"
      unitRef="USD">14168</XPON:DeferredIncomeAndDepositSublease>
    <XPON:DeferredIncomeAndDepositSublease
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23254"
      unitRef="USD">13690</XPON:DeferredIncomeAndDepositSublease>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23255"
      unitRef="USD">9720</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23256"
      unitRef="USD">29120</us-gaap:AccruedSalesCommissionCurrent>
    <XPON:FranchiseTax
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23257"
      unitRef="USD">400</XPON:FranchiseTax>
    <XPON:FranchiseTax
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23258"
      unitRef="USD">9300</XPON:FranchiseTax>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23259"
      unitRef="USD">222</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23260"
      unitRef="USD">26301</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23261"
      unitRef="USD">86302</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23262"
      unitRef="USD">26748</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23263"
      unitRef="USD">306164</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23264"
      unitRef="USD">140618</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11464">&lt;p id="xdx_808_ecustom--LiabilitiesForSaleOfFutureRevenuesTextBlock_z4CSxbB7gMzk" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&#160;&#160;&#160;
&lt;span id="xdx_826_z8D6PMigDQwb"&gt;Liabilities for Sale of Future Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 10, 2020 and January 26, 2021, Reliant Funding, under two separate ACH Total Receipts Purchase Agreements (&#x201c;Purchase Agreements&#x201d;),
purchased a 50% interest in the Company&#x2019;s future revenues for a total aggregate purchase price of $250,000. Pursuant to the terms
of the Purchase Agreements, the purchased percentage continued to be owned by Reliant Funding, until the Company paid the full purchased
amount of $349,750. Repayment of the purchased amount was achieved through 252 daily bank account withdrawals of $1,388 through December
15, 2021 and $694 thereafter through January 26, 2022. During the year ended December 31, 2022, the company repaid a total of $11,797,
including $295 of interest. During the year ended December 31, 2021, the company repaid a total of $329,626, including $95,284 of interest.
Interest was recognized at an effective annual interest rate of approximately 71%. As of December 31, 2021, the Company had a total remaining
liability related to the Purchase Agreements of $11,502 and total remaining payments of $11,797 (including interest). The Purchase Agreements
were secured by substantially all of the assets of the Company. As of December 31, 2022, the Company had no remaining liability related
to the Purchase Agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11474">&lt;p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zjeaCm706mAi" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&#160;&#160;&#160;
&lt;span id="xdx_822_zDX4zbSYyd6b"&gt;Short-Term Revolving Loans&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
January 2020 to October 2020, the Company received funds totaling $900,000 under four unsecured Working Capital Loan Agreements (&#x201c;WC
Loans&#x201d;) from two different third-party lenders. As of December 31, 2021, a balance of $550,000 remained outstanding under the WC
Loan Agreements and in accordance with the modified terms, the Company was subject to monthly extended maturity interest of one percent
on the ending outstanding monthly balance which increased one percent for each month beyond the extended maturity date. The WC Loans
were repaid in full in April 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms of each WC Loan are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$150,000 limit - dated
    January 25, 2020; monthly interest-only payments at 10% annual interest, principal payment of $70,000 paid during the year ended
    December 31, 2020, balance of $80,000 due 12 months from date of issue and paid in full at maturity in 2021. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$150,000 limit - dated
    January 28, 2020; monthly interest-only payments at 12% annual interest; principal due 12 months from date of issue. This note was
    modified effective January 1, 2021 to extend the maturity date to December 31, 2021 (see below) and was paid in full with a payment
    of $50,000 in July 2021 and $100,000 in September 2021.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$200,000 limit &#x2013;
    dated March 22, 2020; monthly interest-only payments at 15% annual interest; principal due 12 months from date of issue. This note
    was modified effective January 1, 2021 to extend the maturity date to December 31, 2021. The Company paid $50,000 towards the principal
    balance in November 2021.&#160;&#160;The balance of $150,000 was paid in full in April 2022 (see below).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$400,000 limit &#x2013;
    dated August 31, 2020; monthly interest-only payments at 10% annual interest; pursuant to the WC Loan, the maturity was to be determined
    by mutual agreement and was to be at least 30 days after a maturity date is agreed upon. The note was modified effective January
    1, 2021 to establish a maturity date of December 31, 2021, and was paid in full in April 2022 (see below).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
January 1, 2021, as noted above, three of the working capital loan agreements, all from the same investor, were modified. The modification
was to extend the maturity date on two of the notes from January 28, 2021 and March 22, 2021 to December 31, 2021, and to establish a
maturity date of December 31, 2021 for the WC Loan that left the maturity date open to negotiations in the original agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2021, a balance of $550,000 remained outstanding under the WC Loan Agreements and in accordance with the modified terms,
the Company was subject to monthly extended maturity interest of one percent on the ending outstanding monthly balance which increased
one percent for each month beyond the extended maturity date. The Company remained in compliance with all interest payments and paid
the WC Loans in full in April 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
fees incurred in connection with obtaining and modifying these agreements were nominal and, given the short-term maturity of one year,
were expensed as incurred. There was no accounting impact to the financial statements related to the modifications.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermDebtTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11546">&lt;p id="xdx_806_eus-gaap--LongTermDebtTextBlock_z0EFiONoxBPf" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.
&#160;&#160;&#160;&#160;&lt;span id="xdx_82A_zIzAhgzAfnyg"&gt;Long-Term Debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
debt consisted of the following at December 31, 2022 and 2021:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfDebtTableTextBlock_zWvGQ8QSbaRd" style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zRmASvuTs60l" style="display: none"&gt;Schedule of long-term debt&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Senior
    secured promissory notes &#x2013; various investors.&#160;&#160;Monthly payments of interest only at &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_uPure_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zZKyK8XpZqp1"&gt;10&lt;/span&gt;% plus deferred interest of
    5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity. Matures the earlier of (a)
    May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of control. The notes are senior
    to all other debt and are secured by substantially all assets of the Company. The notes included detachable warrants to purchase
    &lt;span id="xdx_90C_ecustom--WarrantsToPurchase_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zfMO8hsIn3fh"&gt;482,268&lt;/span&gt; shares of common stock at an exercise price of $3.32 per share (see Note 12 &#x2013; Stockholders&#x2019; Equity). Debt issuance
    costs and discount totaling $1,287,160 at date of issuance were being amortized and recognized as additional interest expense over
    the term of the notes using the straight-line method because it was not substantially different from the effective interest rate
    method. We determined the expected life of the notes to be the contractual term. Interest expense related to these notes includes
    amortization of debt issuance costs and discount in the amount of $&lt;span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zIQvOmcuQFHj"&gt;1,196,843&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zcEjj6PtTOS1"&gt;117,587&lt;/span&gt;, respectively, for the years ended December
    31, 2022 and 2021, respectively. The notes were paid in full in April 2022 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zYx3xMOCYyb6" style="width: 13%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0686"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zGD2ZUqapJPb" style="width: 11%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,600,000&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; bank. Payable in monthly installments of $332, including interest at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_ztDESItfaA9d"&gt;5.8&lt;/span&gt;% per annum, due August 2025, secured by
    equipment and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zvU6a1BVSu95" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,825&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zz2Qg31uUbaa" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; credit union. Payable in monthly installments of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zLhsfu3eCvTa"&gt;508&lt;/span&gt;, including interest at &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zTjJzB5BxKq9"&gt;5.45&lt;/span&gt;% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_znmtb46bodLd" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,364&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zjbcIG5QZno3" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,259&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; SBA. Economic Injury Disaster Loan payable in monthly installments of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z7S9irBvtpG3"&gt;731&lt;/span&gt;, including interest at &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zNsTbK2pbb4e"&gt;3.75&lt;/span&gt;% per annum,
    due May 2050, and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zd8BoxCpitk2" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,114&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zj40g99Pl7C1" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;153,193&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; individual. Monthly payments of interest only at &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3u5SAnmxLC7"&gt;10&lt;/span&gt;% per annum, matured December 31, 2021 resulting in the entire
    principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31,
    2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each
    month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the
    note in full in April 2022 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zGyosTYw3wae" style="width: 13%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0700"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3G2orNS6tW8" style="width: 11%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; finance company. Payable in monthly installments of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zPgQIe5dOFDi"&gt;994&lt;/span&gt;, including interest at &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zd3GuXrmp6zj"&gt;8.5&lt;/span&gt;% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a shareholder.&#160;&#160;The Note was paid in full September 2022.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_z1YywxSKXYOj" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0704"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zSpnkxWf2fOk" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,832&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; finance company.&#160;&#160;Payable in monthly installments of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_z59bSVoCe7Wb"&gt;2,204&lt;/span&gt;, including interest at &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zLySIJ8C9Dah"&gt;11.21&lt;/span&gt;% per annum, due
    August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;&#160;The note was paid in full January 2023.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zbRfObC7xhgi" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;79,963&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zjFe69Eaiate" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;96,155&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notes
    payable &#x2013; The Company has six and two notes payable to GM Financial for vehicles at September 30, 2022 and December 31, 2021.&#160;&#160;In
    April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;&#160;The agreement
    expires in April 2023 but prevailing GM Financial existing term notes will remain. The notes are payable in aggregate monthly installments
    of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zulP2wGynlJf"&gt;4,676&lt;/span&gt;, including interest at rates ranging from 5.89% to &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zH91DES1X3Xf"&gt;7.29&lt;/span&gt;% per annum, mature at various dates from October 2027 to May of
    2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zTgrFrT3rKEg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;251,209&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_z34paL0EJGEi" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20221231_zZ3tuazFx3xg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;510,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20211231_zF6oJOJqka66" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,127,464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    unamortized debt issuance costs and discount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20221231_z3dO63NDU293" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0716"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iNI_di_c20211231_zNEffcgIez0d" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,196,843&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    current portion&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zWSemRgK6Lb5" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(71,426&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;p style="margin: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtCurrent_iNI_di_c20211231_zuWkMCLA18o5" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(51,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    note payable in default (paid April 2022)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LessNotePayableInDefaultPaid_iI_c20221231_zZTzkQCrpdYc" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0720"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LessNotePayableInDefaultPaid_iI_c20211231_zUSCMNE3I5j3" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    debt, net of unamortized debt discount and current portion&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_ztvWlEmU7OD7" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;439,049&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zQsCDtF94WS2" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;779,486&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zUl6EhVWAMY2" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
maturities of long-term debt are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zWkH1ukykVXe" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zwZaZ5Ww3ut6" style="display: none"&gt;Schedule of long term debt payment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30C_134_zS5zgPNCBeJ7" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20221231_zVHKztI62H27"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="4"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years ending December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zuUkStE0Btw" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 52%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 4%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,426&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 27%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_zreanSVKUTGa" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,226&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zELk68BZ2CVb" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,237&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zAqdCSwZ0Jdf" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,963&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_z3nvIsw8ZUHf" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,305&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbaAMSVQt1Rh" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,318&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebt_iI_zxCGzJGaKiH9" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;510,475&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zmysnXVJXQtl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11554">&lt;p id="xdx_893_eus-gaap--ScheduleOfDebtTableTextBlock_zWvGQ8QSbaRd" style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zRmASvuTs60l" style="display: none"&gt;Schedule of long-term debt&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; padding-top: 5.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Senior
    secured promissory notes &#x2013; various investors.&#160;&#160;Monthly payments of interest only at &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_uPure_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zZKyK8XpZqp1"&gt;10&lt;/span&gt;% plus deferred interest of
    5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity. Matures the earlier of (a)
    May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of control. The notes are senior
    to all other debt and are secured by substantially all assets of the Company. The notes included detachable warrants to purchase
    &lt;span id="xdx_90C_ecustom--WarrantsToPurchase_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zfMO8hsIn3fh"&gt;482,268&lt;/span&gt; shares of common stock at an exercise price of $3.32 per share (see Note 12 &#x2013; Stockholders&#x2019; Equity). Debt issuance
    costs and discount totaling $1,287,160 at date of issuance were being amortized and recognized as additional interest expense over
    the term of the notes using the straight-line method because it was not substantially different from the effective interest rate
    method. We determined the expected life of the notes to be the contractual term. Interest expense related to these notes includes
    amortization of debt issuance costs and discount in the amount of $&lt;span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zIQvOmcuQFHj"&gt;1,196,843&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zcEjj6PtTOS1"&gt;117,587&lt;/span&gt;, respectively, for the years ended December
    31, 2022 and 2021, respectively. The notes were paid in full in April 2022 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zYx3xMOCYyb6" style="width: 13%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0686"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zGD2ZUqapJPb" style="width: 11%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,600,000&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; bank. Payable in monthly installments of $332, including interest at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_ztDESItfaA9d"&gt;5.8&lt;/span&gt;% per annum, due August 2025, secured by
    equipment and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zvU6a1BVSu95" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,825&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zz2Qg31uUbaa" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; credit union. Payable in monthly installments of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zLhsfu3eCvTa"&gt;508&lt;/span&gt;, including interest at &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zTjJzB5BxKq9"&gt;5.45&lt;/span&gt;% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_znmtb46bodLd" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,364&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zjbcIG5QZno3" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;24,259&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; SBA. Economic Injury Disaster Loan payable in monthly installments of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z7S9irBvtpG3"&gt;731&lt;/span&gt;, including interest at &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zNsTbK2pbb4e"&gt;3.75&lt;/span&gt;% per annum,
    due May 2050, and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zd8BoxCpitk2" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,114&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zj40g99Pl7C1" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;153,193&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; individual. Monthly payments of interest only at &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3u5SAnmxLC7"&gt;10&lt;/span&gt;% per annum, matured December 31, 2021 resulting in the entire
    principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31,
    2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each
    month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the
    note in full in April 2022 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zGyosTYw3wae" style="width: 13%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0700"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_z3G2orNS6tW8" style="width: 11%; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100,000&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; finance company. Payable in monthly installments of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zPgQIe5dOFDi"&gt;994&lt;/span&gt;, including interest at &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zd3GuXrmp6zj"&gt;8.5&lt;/span&gt;% per annum, due July 2026, secured
    by a vehicle and personally guaranteed by a shareholder.&#160;&#160;The Note was paid in full September 2022.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_z1YywxSKXYOj" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0704"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zSpnkxWf2fOk" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,832&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note
    payable &#x2013; finance company.&#160;&#160;Payable in monthly installments of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_z59bSVoCe7Wb"&gt;2,204&lt;/span&gt;, including interest at &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zLySIJ8C9Dah"&gt;11.21&lt;/span&gt;% per annum, due
    August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;&#160;The note was paid in full January 2023.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zbRfObC7xhgi" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;79,963&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zjFe69Eaiate" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;96,155&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notes
    payable &#x2013; The Company has six and two notes payable to GM Financial for vehicles at September 30, 2022 and December 31, 2021.&#160;&#160;In
    April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;&#160;The agreement
    expires in April 2023 but prevailing GM Financial existing term notes will remain. The notes are payable in aggregate monthly installments
    of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zulP2wGynlJf"&gt;4,676&lt;/span&gt;, including interest at rates ranging from 5.89% to &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zH91DES1X3Xf"&gt;7.29&lt;/span&gt;% per annum, mature at various dates from October 2027 to May of
    2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zTgrFrT3rKEg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;251,209&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_z34paL0EJGEi" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20221231_zZ3tuazFx3xg" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;510,475&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20211231_zF6oJOJqka66" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,127,464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    unamortized debt issuance costs and discount&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_c20221231_z3dO63NDU293" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0716"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iNI_di_c20211231_zNEffcgIez0d" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,196,843&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    current portion&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zWSemRgK6Lb5" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(71,426&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;p style="margin: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DebtCurrent_iNI_di_c20211231_zuWkMCLA18o5" style="padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(51,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less
    note payable in default (paid April 2022)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LessNotePayableInDefaultPaid_iI_c20221231_zZTzkQCrpdYc" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0720"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LessNotePayableInDefaultPaid_iI_c20211231_zUSCMNE3I5j3" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 5.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    debt, net of unamortized debt discount and current portion&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_ztvWlEmU7OD7" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;439,049&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zQsCDtF94WS2" style="border-bottom: Black 1pt solid; padding-top: 5.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;779,486&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 5.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember"
      decimals="INF"
      id="ixv-23265"
      unitRef="Pure">10</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <XPON:WarrantsToPurchase
      contextRef="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember"
      decimals="INF"
      id="ixv-23266"
      unitRef="Shares">482268</XPON:WarrantsToPurchase>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_custom_SeniorSecuredPromissoryNotesMember"
      decimals="0"
      id="ixv-23267"
      unitRef="USD">1196843</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-01-012021-12-31_custom_SeniorSecuredPromissoryNotesMember"
      decimals="0"
      id="ixv-23268"
      unitRef="USD">117587</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_SeniorSecuredPromissoryNotesMember"
      decimals="0"
      id="ixv-23269"
      unitRef="USD">1600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_us-gaap_NotesPayableToBanksMember"
      decimals="INF"
      id="ixv-23270"
      unitRef="Pure">5.8</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_us-gaap_NotesPayableToBanksMember"
      decimals="0"
      id="ixv-23271"
      unitRef="USD">9825</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_us-gaap_NotesPayableToBanksMember"
      decimals="0"
      id="ixv-23272"
      unitRef="USD">13135</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_us-gaap_NotesPayableToBanksMember"
      decimals="0"
      id="ixv-23273"
      unitRef="USD">508</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_NotePayableCreditUnionMember"
      decimals="INF"
      id="ixv-23274"
      unitRef="Pure">5.45</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableCreditUnionMember"
      decimals="0"
      id="ixv-23275"
      unitRef="USD">19364</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_NotePayableCreditUnionMember"
      decimals="0"
      id="ixv-23276"
      unitRef="USD">24259</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_custom_NotePayableSBAMember"
      decimals="0"
      id="ixv-23277"
      unitRef="USD">731</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_NotePayableSBAMember"
      decimals="INF"
      id="ixv-23278"
      unitRef="Pure">3.75</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableSBAMember"
      decimals="0"
      id="ixv-23279"
      unitRef="USD">150114</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_NotePayableSBAMember"
      decimals="0"
      id="ixv-23280"
      unitRef="USD">153193</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_NotePayableIndividualMember"
      decimals="INF"
      id="ixv-23281"
      unitRef="Pure">10</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_NotePayableIndividualMember"
      decimals="0"
      id="ixv-23282"
      unitRef="USD">100000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompanyMember"
      decimals="0"
      id="ixv-23283"
      unitRef="USD">994</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompanyMember"
      decimals="INF"
      id="ixv-23284"
      unitRef="Pure">8.5</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_NotePayableFinanceCompanyMember"
      decimals="0"
      id="ixv-23285"
      unitRef="USD">45832</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompany1Member"
      decimals="0"
      id="ixv-23286"
      unitRef="USD">2204</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_NotePayableFinanceCompany1Member"
      decimals="INF"
      id="ixv-23287"
      unitRef="Pure">0.1121</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompany1Member"
      decimals="0"
      id="ixv-23288"
      unitRef="USD">79963</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_NotePayableFinanceCompany1Member"
      decimals="0"
      id="ixv-23289"
      unitRef="USD">96155</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-01-012022-12-31_custom_GMFinancialMember"
      decimals="0"
      id="ixv-23290"
      unitRef="USD">4676</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-01-012022-12-31_custom_GMFinancialMember"
      decimals="INF"
      id="ixv-23291"
      unitRef="Pure">7.29</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_GMFinancialMember"
      decimals="0"
      id="ixv-23292"
      unitRef="USD">251209</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_GMFinancialMember"
      decimals="0"
      id="ixv-23293"
      unitRef="USD">94890</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23294"
      unitRef="USD">510475</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23295"
      unitRef="USD">2127464</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23296"
      unitRef="USD">1196843</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DebtCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23297"
      unitRef="USD">71426</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23298"
      unitRef="USD">51135</us-gaap:DebtCurrent>
    <XPON:LessNotePayableInDefaultPaid
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23299"
      unitRef="USD">-100000</XPON:LessNotePayableInDefaultPaid>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23300"
      unitRef="USD">439049</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23301"
      unitRef="USD">779486</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11856">&lt;p id="xdx_89A_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zWkH1ukykVXe" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zwZaZ5Ww3ut6" style="display: none"&gt;Schedule of long term debt payment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30C_134_zS5zgPNCBeJ7" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20221231_zVHKztI62H27"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="4"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years ending December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zuUkStE0Btw" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 52%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 4%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;71,426&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 27%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_zreanSVKUTGa" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,226&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zELk68BZ2CVb" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,237&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zAqdCSwZ0Jdf" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;73,963&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_z3nvIsw8ZUHf" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,305&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbaAMSVQt1Rh" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,318&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebt_iI_zxCGzJGaKiH9" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;510,475&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23302"
      unitRef="USD">71426</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23303"
      unitRef="USD">77226</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23304"
      unitRef="USD">82237</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturingInYearsTwoAndThree
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23305"
      unitRef="USD">73963</us-gaap:LongTermDebtMaturingInYearsTwoAndThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23306"
      unitRef="USD">55305</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23307"
      unitRef="USD">150318</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23308"
      unitRef="USD">510475</us-gaap:LongTermDebt>
    <XPON:ShareholderPromissoryNotesTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11936">&lt;p id="xdx_80B_ecustom--ShareholderPromissoryNotesTextBlock_ztoxFcwbLfac" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_822_zcs50HozZky2"&gt;Shareholder
Promissory Notes&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 and December 31, 2021, the Company had an outstanding principal balance of $825,000 due to shareholders under unsecured
Promissory Notes Agreements (&#x201c;Notes&#x201d;). The Notes require monthly interest-only payments at 10% per annum. The Notes mature
at various dates from August 2023 to December 2024 as follows: August 2023 - $500,000; January 2024 - $125,000; and December 2024 - $200,000.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 15, 2021, the Company modified another shareholder Note in the amount of $250,000 to be a convertible note for the same amount. The
shareholder also invested additional proceeds of $24,000 for a total convertible note of $274,000. The convertible note included detachable
warrants to purchase 548,000 shares of the Company&#x2019;s common stock. The convertible note bore interest at a rate of 10% per annum,
had an initial maturity of two years from date of issue, and was convertible at $0.50 per share. The modification resulted in a new effective
annual interest rate of 9.15%. There was no accounting impact to the financial statements related to these modifications. On October
29, 2021, concurrent with the anticipated conversion from an LLC to a C corporation, the convertible note and warrants were modified
under a Convertible Debenture Exercise and Waiver and Release Agreement and the shareholder agreed to convert the note and accrued interest
into 236,498 shares of common stock resulting in a conversion price of $1.21 per share (see Note 9 &#x2013;Convertible Notes).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
paid to the shareholders under the Notes totaled $&lt;span id="xdx_90F_eus-gaap--OtherMinorityInterests_iI_c20221231_zA0Z3p50Hrk1" title="Interest paid to the shareholders"&gt;82,508&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--OtherMinorityInterests_iI_c20211231_z0QupwYfidia"&gt;92,007&lt;/span&gt; during the years ended December 31, 2022 and 2021, respectively.
There was no accrued interest as of December 31, 2022 or 2021 related to these Notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</XPON:ShareholderPromissoryNotesTextBlock>
    <us-gaap:OtherMinorityInterests
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23309"
      unitRef="USD">82508</us-gaap:OtherMinorityInterests>
    <us-gaap:OtherMinorityInterests
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23310"
      unitRef="USD">92007</us-gaap:OtherMinorityInterests>
    <XPON:ConvertibleNotesTextBlock contextRef="From2022-01-012022-12-31" id="ixv-11962">&lt;p id="xdx_803_ecustom--ConvertibleNotesTextBlock_zhNglAH9OaR" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&#160;&#160;&#160;
&lt;span id="xdx_82E_zajzCHSqgom6"&gt;Convertible Notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2020
Convertible Notes &#x2013; Converted January 1, 2021&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
January 1, 2021, convertible debt holders were offered the opportunity for early conversion of their convertible notes into Class B LLC
member units. Three of the four convertible note holders converted notes with a principal balance of $170,000 and accrued interest of
$3,157 into 2,338 Class B member units (the equivalent of 59,515 shares of common stock) at per unit conversion prices ranging from $67
- $76 (per share prices ranging from $2.66 - $3.00). In accordance with FASB ASC 470-20, &lt;i&gt;Debt with Conversion and Other Options&lt;/i&gt;,
the fair value of the additional units issued under the induced conversion over the value of the number of units issuable under the original
terms of the convertible note agreements is recognized as debt conversion expense. Accordingly, upon early conversion on January 1, 2021,
the Company recognized $112,133 of debt conversion expense with a corresponding entry to equity of $285,290 consisting of the $173,157
of principal and accrued interest converted and the excess fair value of $112,133.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fourth convertible note holder opted out of the early conversion and instead, the original note with a principal balance of $100,000
was modified into a term loan effective January 1, 2021 (see Note 7 &#x2013; Long Term Debt). The modification included the elimination
of the conversion feature, an increase in the interest rate from the original 6% per annum to 10% per annum, to be paid monthly instead
of accrued, and an earlier maturity date of December 31, 2021. The modification resulted in a new effective annual interest rate of 9.58%,
and a revised one-year maturity on December 31, 2021 (see Note 6 &#x2013;Short-Term Revolving Loans). There was no accounting impact to
the financial statements related to this modification. The note was paid in full in April 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2021
Convertible Notes/Extinguishment Loss on Debt Settlement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
May to September 2021, the Company received gross proceeds of $2,929,000 from the issuance of unsecured convertible notes (the &#x201c;Notes&#x201d;),
of which $44,000 was received from existing shareholders. Of the total proceeds, $1,820,000 was received during the three months ended
September 30, 2021. Additionally, in May 2021, a shareholder converted a promissory note to a convertible note identical in terms discussed
below (see Note 8 &#x2013; Shareholder Promissory Notes).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt"&gt;At the option of the Note holders and after
the completion of a merger with a Special Purpose Acquisition Company (&#x201c;SPAC&#x201d;) or an Initial Public Offering (&#x201c;IPO&#x201d;),
the holder could convert all or a part of the outstanding principal and accrued interest into shares of common stock of the merged or
public company. The Notes included detachable warrants (&#x201c;Warrants&#x201d;) to purchase 3,862,000 shares of the merged or public
company. The Notes bore interest at a rate of 10% per annum, had an initial maturity of two years from date of issue, and were convertible
at per-share prices ranging from $0.50 to $2.50. Effective January 1, 2021, the Company early adopted ASU 2020-06, and accordingly, no
beneficial conversion features were recognized. The Notes were accounted for in accordance with ASC 470-20, &lt;i&gt;Debt with Conversion and
Other Options&lt;/i&gt; (&#x201c;ASC 470-20&#x201d;) and ASC 815-40, &lt;i&gt;Contracts in Entity&#x2019;s Own Equity&lt;/i&gt; (&#x201c;ASC 815-40&#x201d;)&lt;i&gt;.
&lt;/i&gt;Under ASC 815-40, to qualify for equity classification (or nonbifurcation, if embedded) the instrument (or embedded feature) must
be both (1) indexed to the issuer&#x2019;s stock and (2) meet the requirements of the equity classification guidance. Based upon the Company&#x2019;s
analysis, it was determined the Notes do contain embedded features indexed to its own stock, but do not meet the requirements for bifurcation
and recognition as derivatives, and therefore do not need to be separately recognized. Accordingly, the proceeds received from the issuance
of the Notes were recorded as a single liability measured at amortized cost on the consolidated Balance Sheet. The Company incurred $148,000
of debt issuance costs relating to the issuance of the Notes, which were recorded as a reduction to the Notes on the Balance Sheet. The
debt issuance costs were being amortized and recognized as additional interest expense over the term of the Notes using the straight-line
method because it is not substantially different from the effective interest rate. Amortization of debt discount totaled $27,271 through
the effective date of the conversion from LLC to a C corporation. Since the Warrants were not exercisable until a merger with a SPAC
or an IPO, there was no impact on the financial statements at date of grant.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 29, 2021, in anticipation of conversion from LLC to a C corporation, the Notes and Warrants were modified under Convertible Debenture
Exercise and Waiver and Release Agreements with the individual creditors. The Note holders agreed to settle the debt for an aggregate
of 1,527,647 shares of common stock with a fair value of $5,545,359 ($3.63 per share). Since this transaction involved contemporaneous
issuance of shares of common stock by the Company to the Note holders, the Company evaluated the transaction for modification and extinguishment
accounting and determined that the debt was extinguished as a result of the issuance of shares that do not represent the exercise of
a conversion right contained in the original terms of the Notes at issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
settlement of the debt resulted in a recognized loss of $2,262,658 recorded as extinguishment loss on debt settlement in November 2021,
calculated as the excess of the fair value of shares issued over the carrying amount of the debt. In addition, the fair value of warrants
of $407,700 issued in exchange for services related to the extinguished debt (see Note 12 &#x2013; Stockholders&#x2019; Equity) and the
unamortized portion of debt discount remaining at date of settlement of $120,729 were also recorded as extinguishment loss on debt settlement
for an aggregate loss of $2,791,087.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:ConvertibleNotesTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12016">&lt;p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zOdGAmeDWc21" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&#160;&#160;&#160;
&lt;span id="xdx_826_zyFvc7kK10Kk"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Operating
Leases&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company leases its warehouses and office space under long-term lease arrangements. None of its leases include characteristics specified
in ASC 842, &lt;i&gt;Leases&lt;/i&gt;, that require classification as financing leases, and accordingly, these leases are accounted for as operating
leases. The Company does not recognize a right-of-use asset and lease liability for short term leases, which have terms of 12 months
or less. For longer-term lease arrangements that are recognized on the Company&#x2019;s Balance Sheet, the right-of-use asset and lease
liability are initially measured at the commencement date based upon the present values of the lease payments due under the leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
implicit interest rates of the Company&#x2019;s lease arrangements are generally not readily determinable and as such, the Company applies
an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine
the present value of lease payments due under the arrangement. Under ASC 842, the incremental borrowing rate (IBR) for leases must be
(1) a rate of interest over a similar term, and (2) for an amount that is equal to the lease payments. The Company uses both the Federal
Reserve Economic Data (FRED) U.S. corporate debt effective yield and the U.S. Treasury rates adjusted for credit spread as the primary
data points for purposes of determining the IBR.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the first quarter of 2022, the Company entered into two new long-term, non-cancelable operating lease agreements for office and warehouse
space resulting in the Company recognizing an additional lease liability totaling of $2,348,509, representing the present value of the
lease payments discounted using an effective interest rate of 8.07% and 8.86%, and corresponding right-of-use assets of $2,348,509. The
leases expire in December 2026 and December 2028. The second lease contains one three-year option to renew. The lease is guaranteed by
a co-founder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt"&gt;In the first quarter of 2021, the Company
entered into a long-term, non-cancelable operating lease agreement for office and warehouse space resulting in the Company recognizing
an additional lease liability totaling of $1,268,089, representing the present value of the lease payments discounted using an effective
interest rate of 7.47% and a corresponding right-of-use asset of $1,268,089. The lease expires in January 2028 and contains one three-year
option to renew. The lease is guaranteed by a co-founder.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;








&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has two other leases that expire in January 2023 and February 2025. The leases generally provide for annual increases based on
a fixed amount and generally require the Company to pay real estate taxes, insurance, and repairs. Both leases are guaranteed by a co-founder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of total lease costs for the years ending December 31, 2022 and 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zt70SzrJsHw1" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zA4p04jJhsYk" style="display: none"&gt;Schedule of lease cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_133_zX3fB250hzhj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20220101__20221231_zRDtWRW2QH0l" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210101__20211231_zl44k8wUpsEd" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseCost_zmQTo6RBzj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;760,743&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;304,082&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ShortTermLeaseCost_z2KXGOEMdG5d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term lease costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--VariableLeaseCost_zdD6N9GLYygj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Variable lease costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0761"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z92E8zIzoqw4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(123,386&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(75,061&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LeaseCost_zGEze4ciKth5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;640,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;233,867&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zK6c1kkwLKi2" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
weighted-average remaining lease term was 5.49 years and 5.64 years as of December 31, 2022 and 2021, respectively. The weighted average
discount rate was 8.48% and 8.02%, as of December 31, 2022 and 2021, respectively. Operating cash flows from the operating leases totaled
$440,139 and $177,688 for the years ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total lease liability as of December 31, 2022 and 2021 was $3,220,019 and $1,311,649, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of December 31, 2022, for
years ending December 31:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zjn8IGfiNrgd" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zSRXGfWYN6n6" style="display: none"&gt;Schedule of future minimum lease payment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_134_zGHc7CoNIRSk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_499_20221231_zKR809Gf9WHc" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_z1ctjPjZ7uo1" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 75%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;719,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zu24xqSWsK7i" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;727,709&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zn7WlNmhEmMh" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;718,157&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_ze7t6y0FIfsb" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;732,061&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_zcvwntGDFkX8" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;694,040&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeDlFAgqoT5b" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;471,736&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zw2OCi6FrEF3" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,062,923 &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcZaGW3sYpI2" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(842,904&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zoRRLCDMRbGh" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,220,019
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zjMnNoXpuL2k" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;465,055&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zVzbnmDfgRp3" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Noncurrent lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,754,964
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zKv4gfUZwLpk" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,220,019
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zzuPucRkZaeh" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subleases&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company subleases office and warehouse space under three of its existing operating leases with similar terms as the Company&#x2019;s lease
agreements. Because the Company is not relieved of its primary obligations under the original lease, the Company accounts for the subleases
as a lessor. Sublease rental income is recorded based on the contractual rental payments which are not substantially different from recognition
on a straight-line basis over the lease term and totaled $&lt;span id="xdx_906_eus-gaap--OperatingLeasesRentExpenseNet_c20220101__20221231_ziE8GQVnIJR7" title="Sublease rental income"&gt;123,386&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--OperatingLeasesRentExpenseNet_c20210101__20211231_zdYG3v1hnLpg" title="Sub Rental Income"&gt;75,061&lt;/span&gt; during the years ended December 31, 2022 and 2021, respectively.
As of December 31, 2022 and 2021, deferred income and a sublease deposit totaled $&lt;span id="xdx_903_ecustom--DeferredIncomeAndSubleaseDeposit_iI_c20221231_zrwtzhbpkyb4" title="Deferred income and sublease deposit"&gt;14,168&lt;/span&gt; and $&lt;span id="xdx_904_ecustom--DeferredIncomeAndSubleaseDeposit_iI_c20211231_zAb689SXF2Nj"&gt;13,690&lt;/span&gt;, respectively, and is included in
accrued expenses and other current liabilities on the accompanying Balance Sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0 0 8pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following are the total future minimum sublease payments as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zogI97WN0Tzk" style="margin: 0 0 8pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zqERv2OqsW1b" style="display: none"&gt;Schedule of future minimum sublease payments&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_305_134_zhF1WH9OjIuk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20221231_zDQyzMww9bPa" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 79%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years ending December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zf6T9vcYuKN4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;46,147&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_z1tyWIw2oB23" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,242&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_iI_zeyWDgF05una" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,070&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zPHSI71m273d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease payments&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;88,459&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zFVc6lYAtst2" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may be involved from time to time in litigation or claims arising in the ordinary course of its business. While the ultimate
liability, if any, arising from these claims cannot be determined with certainty, the Company believes that the resolution of any such
matters will not likely have a material adverse effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2022, Expion360 Inc. (the &#x201c;Company&#x201d;) &lt;span style="background-color: white"&gt;received notice of a complaint (the
&#x201c;Complaint&#x201d;) filed against it in Oregon state court by Ravi Sinha. The Complaint alleges,&#160;&lt;/span&gt;&lt;i&gt;inter alia&lt;/i&gt;&lt;span style="background-color: white"&gt;,
that Mr. Sinha is entitled to 282,284 shares of the Company&#x2019;s common stock, or in the alternative, $300,000 plus interest in connection
with services he previously rendered the Company as its chief executive officer. On March 21, 2023, the Company entered into a settlement
agreement with Mr. Sinha and the matter has been resolved.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12064">&lt;p id="xdx_89C_eus-gaap--LeaseCostTableTextBlock_zt70SzrJsHw1" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zA4p04jJhsYk" style="display: none"&gt;Schedule of lease cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_133_zX3fB250hzhj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20220101__20221231_zRDtWRW2QH0l" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210101__20211231_zl44k8wUpsEd" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseCost_zmQTo6RBzj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;760,743&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;304,082&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ShortTermLeaseCost_z2KXGOEMdG5d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term lease costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--VariableLeaseCost_zdD6N9GLYygj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Variable lease costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0760"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0761"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z92E8zIzoqw4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(123,386&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(75,061&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LeaseCost_zGEze4ciKth5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;640,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;233,867&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23311"
      unitRef="USD">760743</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23312"
      unitRef="USD">304082</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23313"
      unitRef="USD">3527</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23314"
      unitRef="USD">4846</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23315"
      unitRef="USD">123386</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23316"
      unitRef="USD">75061</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23317"
      unitRef="USD">640884</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23318"
      unitRef="USD">233867</us-gaap:LeaseCost>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12152">&lt;p id="xdx_89F_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zjn8IGfiNrgd" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zSRXGfWYN6n6" style="display: none"&gt;Schedule of future minimum lease payment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_134_zGHc7CoNIRSk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_499_20221231_zKR809Gf9WHc" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_z1ctjPjZ7uo1" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 75%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;719,220&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zu24xqSWsK7i" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;727,709&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zn7WlNmhEmMh" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;718,157&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_ze7t6y0FIfsb" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;732,061&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_zcvwntGDFkX8" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;694,040&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeDlFAgqoT5b" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;471,736&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zw2OCi6FrEF3" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,062,923 &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zcZaGW3sYpI2" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(842,904&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zoRRLCDMRbGh" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,220,019
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zjMnNoXpuL2k" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;465,055&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zVzbnmDfgRp3" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Noncurrent lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,754,964
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zKv4gfUZwLpk" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,220,019
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23319"
      unitRef="USD">719220</us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23320"
      unitRef="USD">727709</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23321"
      unitRef="USD">718157</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23322"
      unitRef="USD">732061</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23323"
      unitRef="USD">694040</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23324"
      unitRef="USD">471736</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23325"
      unitRef="USD">4062923</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23326"
      unitRef="USD">842904</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23327"
      unitRef="USD">3220019</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23328"
      unitRef="USD">465055</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23329"
      unitRef="USD">2754964</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23330"
      unitRef="USD">3220019</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23331"
      unitRef="USD">123386</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23332"
      unitRef="USD">75061</us-gaap:OperatingLeasesRentExpenseNet>
    <XPON:DeferredIncomeAndSubleaseDeposit
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23333"
      unitRef="USD">14168</XPON:DeferredIncomeAndSubleaseDeposit>
    <XPON:DeferredIncomeAndSubleaseDeposit
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23334"
      unitRef="USD">13690</XPON:DeferredIncomeAndSubleaseDeposit>
    <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12307">&lt;p id="xdx_894_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zogI97WN0Tzk" style="margin: 0 0 8pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zqERv2OqsW1b" style="display: none"&gt;Schedule of future minimum sublease payments&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_305_134_zhF1WH9OjIuk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20221231_zDQyzMww9bPa" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 79%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years ending December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zf6T9vcYuKN4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;46,147&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_z1tyWIw2oB23" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,242&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_iI_zeyWDgF05una" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,070&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zPHSI71m273d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease payments&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;88,459&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>
    <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23335"
      unitRef="USD">46147</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear>
    <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23336"
      unitRef="USD">36242</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears>
    <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23337"
      unitRef="USD">6070</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears>
    <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactions
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23338"
      unitRef="USD">88459</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactions>
    <XPON:ConversionOfStockTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12383">&lt;p id="xdx_80E_ecustom--ConversionOfStockTextBlock_zdRfPj90rela" style="margin: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;11.&#160;&#160;&#160;&lt;span id="xdx_825_zsnBXAk3PPHj"&gt;
Conversion to a C Corporation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
November 1, 2021, the Company converted from an LLC to a C corporation under the State of Nevada statutes in anticipation of an upcoming
initial public offering, and changed its name to Expion360 Inc. The membership units of the existing LLC members and all existing convertible
note holders (see Note 9 - Convertible Notes) converted into an aggregate of 4,181,111 shares of common stock. Additionally, investors
purchased 88,889 shares of common stock for total proceeds of $316,400, and 30,000 shares of common stock were issued in exchange for
legal services. The 30,000 shares issued in exchange for legal services were valued at $108,900 at date of grant based on the per share
price of $3.63 paid for shares issued at the time of the conversion to a C corporation. The Company&#x2019;s issued and outstanding shares
of common stock totaled 4,300,000 upon conversion to a C corporation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:ConversionOfStockTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12395">&lt;p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zNvn7GEnEaBa" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&#160;&#160;&#160;&lt;span id="xdx_822_z3ypndUkQ1F"&gt;
Stockholders&#x2019; Equity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue an aggregate of 220,000,000 shares of capital stock, par value $0.001 per share, consisting of 200,000,000
shares of common stock and 20,000,000 shares of preferred stock. As of December 31, 2022 and December 31, 2021, 6,802,464 and 4,300,000
shares, respectively, of common stock were issued and outstanding. No shares of preferred stock have been issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
holder of common stock is entitled to one vote for each share of common stock. The holders of common stock have no conversion, redemption
or preemptive rights and shall be entitled to receive dividends when, as, and if declared by the board of directors. Upon dissolution,
liquidation, or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, subject
to the rights, if any, of the holders of any class or series stock having a preference over the right to participate with common stock
with respect to the distribution of assets of the Company upon such dissolution, liquidation, or winding up of the Company, the holders
of common stock shall be entitled to receive the remaining assets of the Company available for distribution to its stockholders ratably
in proportion to the number of shares of common stock held.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
no shares of preferred stock have been issued, no rights and privileges of preferred stockholders have been defined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial
Public Offering&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2022, the Company completed an initial public offering (&#x201c;IPO&#x201d;). A total of 2,466,750 shares of common stock were
sold at $7.00 per share in the IPO, for total gross proceeds of $17,267,250. The Company incurred IPO costs of $2,494,763 resulting in
net proceeds of $14,772,487. Additionally, during the year ended December 31, 2022,
the Company issued 35,714 shares of common stock at $7.00 per share to an outside third party in exchange for IPO services. The fair
value of the shares of $249,998 were recorded as an increase to common stock of $36 (35,714 shares at $.001 par value) and additional
paid in capital of $249,962 and a corresponding reduction to additional paid in capital of $249,998, resulting in a net decrease in additional
paid in capital of $36.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Issuance
of Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to conversion from an LLC to a C corporation, the following membership units were issued and included in the membership units that were
converted into 4,181,111 shares of common stock upon the Company&#x2019;s conversion to a C corporation (see Note 11 &#x2013; Conversion
to a C corporation).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 1, 2021, 8,000 membership units (equivalent to 192,234 shares) that were held in
                                            Trust were granted to three individuals.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 1, 2021, the Company issued 2,338 Class B member units (equivalent to 59,515 shares
                                            of common stock) upon the conversion of convertible notes and accrued interest totaling $173,157
                                            (see Note 9 - Convertible Notes).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 1, 2021, the Company issued 262 Class B membership units (equivalent to 6,667 shares
                                            of common stock) in exchange for building signage valued at $20,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            March 2021, the Company sold 3,185 Class B membership units (equivalent to 81,106 shares
                                            of common stock) to two new members for gross proceeds of $270,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            April 2021, the company sold 2,972 Class B membership units (equivalent to 75,662 shares
                                            of common stock) to one new member for gross proceeds of $252,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrants/Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2022, the Company issued warrants to IPO underwriters to purchase 148,005 shares of common stock at an exercise price of $9.10
per share. The warrants are exercisable 180 days after grant (September 27, 2022) and expire 5 years from date of grant (March 31, 2027).
The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions:
per share price of common stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest
rate of 2.55% and expected life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in
capital and a reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero
impact to additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2021, the Company issued 482,268 detachable warrants with secured promissory notes (see Note 7 &#x2013; Long-Term Debt) for the
purchase of common stock. The relative fair value of the warrants of $809,806 at the time of issuance was recorded as additional paid-in
capital with a corresponding debt discount reducing the carrying value of the notes. Additionally, the Company issued 77,163 warrants
to purchase shares of common stock to underwriters in connection with obtaining the notes. The fair value of the warrants of $262,354
was recorded as additional paid-in capital and reduced the carrying value of the notes. The warrants are exercisable at $3.32 per share
for a period of 10 years from date of grant. The fair value of the warrants was determined at date of issuance using the Black-Scholes
option-pricing model and the following assumptions: per share price of common stock on date of grant of $3.63, expected dividend yield
of 0%, expected volatility of 110.8%, risk-free interest rate of 1.63% and expected life based on contractual life of 10 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Also
in November 2021, the Company issued warrants to purchase 151,000 shares of common stock in in exchange for prior services related
to extinguished 2021 convertible notes and 30,000 options for the purchase of common stock in exchange for legal services. The
warrants are exercisable at $2.90 per share for a period of three years from the date of grant. The options are exercisable at $3.32
per share for a period of three years from the date of grant. The options issued were not issued under the Company&#x2019;s stock
option plans. The fair value of the warrants of $407,700 was recorded as additional paid-in-capital and expensed to extinguishment
loss on debt settlement (see Note 9 &#x2013; Convertible Notes). The fair value of the options of $79,200 was recorded as additional
paid-in capital with a
corresponding charge to legal expense. The fair value of the warrants and options was determined at date of issuance using the Black-Scholes
option-pricing model and the following assumptions: per share price of common stock on date of grant of $3.63, expected dividend yield
of 0%, expected volatility of 122.7%, risk-free interest rate of 0.71% and expected life based on contractual life of three years.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 and December 31, 2021, a total of 858,436 and 710,431 warrants were issued and outstanding, respectively. As of
December 31, 2022 and December 31, 2021, a total of 30,000 options, which were not issued under a specified plan, were outstanding. As
of December 31, 2022, below is a summary of the various warrants/options issued and outstanding:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zPf8dkwekrsb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zEzVKEpPWtxc" style="display: none"&gt;Schedule of various warrants/options issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zpjXu2OSB0dj" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 47%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number of
    warrants/non-plan options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 23%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
    Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 30%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    Average Remaining Life (Yrs)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zfwpDoIHXtF9" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;559,431&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zyr2oR9dgU52" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$3.32
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zg9KyrjASIWe"&gt;8.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zExQ0hbqZOh5" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;151,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_z28elCJ7994l" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$2.90
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zadaY99B6WYg"&gt;1.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zbAYHtpkB53l" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zvIaZ1h8hcv7" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$3.32
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zAL5rhjBdOp3"&gt;1.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zGLs1JzSux5" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;148,005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zvBMWrSErvjj" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$9.10
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zZEHNbQA7Aki"&gt;4.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231_zY5DYu6afXz8" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;888,436&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_z4tAEbfvc9c5" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Option Plans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Company had adopted two stock-based compensation plans, the 2021 Incentive Award Plan and the 2021 Employee
Stock Purchase Plan, both of which are described below and became effective upon the initial public offering. On May 2, 2022, the Company
granted 829,500 options under the 2021 Incentive Award Plan. No shares have been issued to date under the 2021 Employee Stock Purchase
Plan. The compensation cost that has been charged against operations was $2,114,529 for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;2021
Incentive Award Plan&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the Company&#x2019;s 2021 Incentive Award Plan is to enhance the Company&#x2019;s ability to attract, retain and motivate persons
who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities.
Various stock-based awards may be granted under the plan to eligible employees, consultants, and non-employee directors. The number of
shares issued under the plan is subject to limits and is adjusted annually. No more than 1,000,000 shares may be issued pursuant to the
exercise of incentive stock options. The aggregate share limit will be subject to an annual increase on the first day of each calendar
year ending on and including January 1, 2031, by a number of shares equal to the lesser of (i) a number equal to 5% of the aggregate
number of shares of the Company's common stock outstanding on the final day of the immediately preceding calendar year and (ii) such
smaller number of shares as is determined by the Company's board or committee. As of December 31, 2022, the aggregate number of shares
that can be issued under the Plan is 859,500 of which 829,500 have been granted. The number of shares granted, the exercise price, and
the terms will be determined at date of grant, however, the exercise price shall not be less than 100% of the fair value on the grant
date (110% for options granted to greater than 10% shareholders) and the term shall not exceed ten years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;2021
Employee Stock Purchase Plan&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-size: 10pt"&gt;The purpose of the Company&#x2019;s 2021 Employee
Stock Purchase Plan is to assist eligible employees of the Company in acquiring a stock ownership in the Company and to help such employees
provide for their future security and to encourage them to remain in the employment of the Company. The plan consists of a Section 423
Component and Non-Section 423 Component. The Section 423 Component is intended to qualify as an employee stock purchase plan and also
authorizes the grant of options. Options granted under the Non-Section 423 Component shall be granted pursuant to separate offerings
containing sub-plans. The Company may make one or more offerings under the plan. The duration and timing of each offering period may
be established or changed by the board, but in no event may an offering period exceed 27 months and in no event may the purchase period
for the option exceed the duration of the offering period under which it is established. On each exercise date for an offering period,
each participant shall automatically be deemed to have exercised the option to purchase the largest number of whole shares which can
be purchased under the offering. Option awards are generally granted with an exercise price equal to 85% of the lesser of the fair market
value of a share on (a) the applicable grant date and (b) the applicable exercise date, or such other price as designated by the administrator,
provided that in no event shall the option price be less that the per share par value price. The maximum number of shares granted under
the plan shall not exceed 2,500,000 shares.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&#160;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;






&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected
volatility was calculated based upon similar traded companies&#x2019; historical share price movements as adequate historical experience
is not available to provide a reasonable estimate. Expected term is calculated based on the simplified method as adequate historical
experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience
is available to provide a reasonable estimate of the expected term. The risk-free interest rate is calculated based on the yield from
U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and have no foreseeable plans
to pay dividends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has computed the fair value of all options granted during the year ended December 31, 2022 using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcJ8dxxZkHx8" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zeGzw2Rp6LDe" style="display: none"&gt;Schedule
of assumptions used&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zk1RpYJzRAt9" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    volatility 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z24FkFYmlO1i"&gt;109.48&lt;/span&gt;% - &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zcF9lTf9RPy3"&gt;113.32&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    dividends&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_zrSe1p1d5Dr5"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    term (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zqaEN7sJ00h2"&gt;2.5&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zj8KGAYwQ0R9"&gt;5.01&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk
    free rate	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z54s1WVuj283"&gt;2.83&lt;/span&gt;% &#x2013; &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z3TKXdHHvoUj"&gt;3.01&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_z3yIi7NqvRla" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the Company&#x2019;s stock option activity under the 2021 Incentive Plan:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zpsFvxsyKuK2" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zFX4jIZq1BZ7" style="display: none"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_301_134_zzfp0ZPVzO6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 51%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(in thousands
    except number of options and per options data)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average exercise price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average remaining contractual term (in years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    intrinsic value (1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zJAYO72S2l31" style="text-align: right" title="Outstanding at beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0844"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zQTcUdOPhvG3" style="text-align: right" title="Weighted average exercise price outstanding at beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0846"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zxMld6jCZh9c" style="text-align: right" title="Aggregate intrinsic value Outstanding at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0848"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zTrNZy6McZMb" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zHQto8BXgup6" style="text-align: right" title="Weighted average exercise price granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zAlcAOVbD7eg" style="text-align: right" title="Aggregate intrinsic value granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_ztSN20Ia76i" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0855"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zBwJkFHMJ5sb" style="text-align: right" title="Weighted average exercise price exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0857"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zr8qW9ktYPhj" style="text-align: right" title="Aggregate intrinsic value exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0859"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zoh55x7y0jse" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0861"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zRqC5AExY4T" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AggregateIntrinsicValueForfeited_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zFhE6mlaRA7g" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zju6BqTzL85b" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_z4Cl21GR35Za" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstaning at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zX3UKdaPNM48" title="Weighted average remaining contractual term (in years)"&gt;8.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zt1lLxMYkyLa" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0873"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zZg3Cuz3ukza" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_iI_c20221231_z3lKBCxLGzgl" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average Price exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zi952FVivqDj" title="Weighted average remaining contractual term (in years) exercisable"&gt;8.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zsWZalj4hiS8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0881"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AE_zzi8QPDGEpA7" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;(1)&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The
                                            aggregate intrinsic value of options outstanding and options exercisable as of December 31,
                                            2022 is $0, as all options are out of the money.&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
weighted-average grant-date fair value of the options granted during the nine months ended December 31, 2022 to employees and non-employees
was $&lt;span id="xdx_90E_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20220101__20221231_zuIYfec0Wn6c" title="Options granted"&gt;1,847,193&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20210101__20211231_zvI3H0h5dnH9"&gt;267,336&lt;/span&gt;, respectively. All options were immediately vested and there was no unrecognized compensation expense as
of December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common
Stock Reserved for Future Issuance &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of common stock shares reserved for future issuance as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_z90f1irLpWN6" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zgICDwR4qoh" style="display: none"&gt;Schedule
of common stock shares reserved for future issuance&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30D_133_z4kENF1cfmba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  Stockholders Equity (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 6pt; padding-left: 12pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20221231_znWZEU5eey41" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zly4ssWCud3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-indent: 6pt; padding-left: 12pt"&gt;Exercise of warrants 	&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;858,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zmxFQkzQUqvd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;Exercise of options unrelated to any Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zyYgm42BRNQb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 6pt; padding-left: 12pt"&gt;Exercise of stock options &#x2013; 2021 Incentive Award Plan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;829,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCBQtFy6EhV" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: 6pt; padding-left: 12pt"&gt;Total shares of common stock reserved for future issuances	&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,717,936&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12512">&lt;p id="xdx_895_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zPf8dkwekrsb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zEzVKEpPWtxc" style="display: none"&gt;Schedule of various warrants/options issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zpjXu2OSB0dj" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 47%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number of
    warrants/non-plan options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 23%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
    Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 30%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    Average Remaining Life (Yrs)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zfwpDoIHXtF9" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;559,431&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zyr2oR9dgU52" style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$3.32
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zg9KyrjASIWe"&gt;8.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zExQ0hbqZOh5" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;151,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_z28elCJ7994l" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$2.90
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zadaY99B6WYg"&gt;1.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zbAYHtpkB53l" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zvIaZ1h8hcv7" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$3.32
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zAL5rhjBdOp3"&gt;1.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zGLs1JzSux5" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;148,005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zvBMWrSErvjj" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$9.10
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zZEHNbQA7Aki"&gt;4.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231_zY5DYu6afXz8" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;888,436&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_ExercisePrice1Member"
      decimals="INF"
      id="ixv-23339"
      unitRef="Shares">559431</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31_custom_ExercisePrice1Member"
      decimals="INF"
      id="ixv-23340"
      unitRef="USDPShares">3.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2022-01-012022-12-31_custom_ExercisePrice1Member"
      id="ixv-23341">P8Y10M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_ExercisePrice2Member"
      decimals="INF"
      id="ixv-23342"
      unitRef="Shares">151000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31_custom_ExercisePrice2Member"
      decimals="INF"
      id="ixv-23343"
      unitRef="USDPShares">2.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2022-01-012022-12-31_custom_ExercisePrice2Member"
      id="ixv-23344">P1Y10M9D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_ExercisePrice3Member"
      decimals="INF"
      id="ixv-23345"
      unitRef="Shares">30000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31_custom_ExercisePrice3Member"
      decimals="INF"
      id="ixv-23346"
      unitRef="USDPShares">3.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2022-01-012022-12-31_custom_ExercisePrice3Member"
      id="ixv-23347">P1Y10M9D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_ExercisePrice4Member"
      decimals="INF"
      id="ixv-23348"
      unitRef="Shares">148005</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31_custom_ExercisePrice4Member"
      decimals="INF"
      id="ixv-23349"
      unitRef="USDPShares">9.10</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2022-01-012022-12-31_custom_ExercisePrice4Member"
      id="ixv-23350">P4Y3M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23351"
      unitRef="Shares">888436</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12622">&lt;p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcJ8dxxZkHx8" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zeGzw2Rp6LDe" style="display: none"&gt;Schedule
of assumptions used&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zk1RpYJzRAt9" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 61%; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    volatility 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z24FkFYmlO1i"&gt;109.48&lt;/span&gt;% - &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zcF9lTf9RPy3"&gt;113.32&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    dividends&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_zrSe1p1d5Dr5"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    term (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zqaEN7sJ00h2"&gt;2.5&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zj8KGAYwQ0R9"&gt;5.01&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk
    free rate	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z54s1WVuj283"&gt;2.83&lt;/span&gt;% &#x2013; &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z3TKXdHHvoUj"&gt;3.01&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      decimals="INF"
      id="ixv-23352"
      unitRef="Pure">1.0948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      decimals="INF"
      id="ixv-23353"
      unitRef="Pure">1.1332</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23354"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      id="ixv-23355">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      id="ixv-23356">P5Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      decimals="INF"
      id="ixv-23357"
      unitRef="Pure">0.0283</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      decimals="INF"
      id="ixv-23358"
      unitRef="Pure">0.0301</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12679">&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zpsFvxsyKuK2" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zFX4jIZq1BZ7" style="display: none"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_301_134_zzfp0ZPVzO6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure -  Stockholders Equity (Details2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 51%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(in thousands
    except number of options and per options data)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average exercise price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average remaining contractual term (in years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    intrinsic value (1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zJAYO72S2l31" style="text-align: right" title="Outstanding at beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0844"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zQTcUdOPhvG3" style="text-align: right" title="Weighted average exercise price outstanding at beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0846"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zxMld6jCZh9c" style="text-align: right" title="Aggregate intrinsic value Outstanding at beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0848"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zTrNZy6McZMb" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zHQto8BXgup6" style="text-align: right" title="Weighted average exercise price granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zAlcAOVbD7eg" style="text-align: right" title="Aggregate intrinsic value granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_ztSN20Ia76i" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0855"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zBwJkFHMJ5sb" style="text-align: right" title="Weighted average exercise price exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0857"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zr8qW9ktYPhj" style="text-align: right" title="Aggregate intrinsic value exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0859"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zoh55x7y0jse" style="border-bottom: Black 1pt solid; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0861"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zRqC5AExY4T" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AggregateIntrinsicValueForfeited_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zFhE6mlaRA7g" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zju6BqTzL85b" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_z4Cl21GR35Za" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price outstaning at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zX3UKdaPNM48" title="Weighted average remaining contractual term (in years)"&gt;8.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_fKDEp_zt1lLxMYkyLa" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0873"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zZg3Cuz3ukza" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_iI_c20221231_z3lKBCxLGzgl" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average Price exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zi952FVivqDj" title="Weighted average remaining contractual term (in years) exercisable"&gt;8.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20221231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zsWZalj4hiS8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate intrinsic value exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0881"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      decimals="INF"
      id="ixv-23359"
      unitRef="Shares">829500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      decimals="INF"
      id="ixv-23360"
      unitRef="USDPShares">3.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23361"
      unitRef="Shares">829500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23362"
      unitRef="USDPShares">3.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember1100779328"
      id="ixv-23363">P8Y3M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2022-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23364"
      unitRef="Shares">829500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <XPON:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23365"
      unitRef="USDPShares">3.43</XPON:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2022-01-012022-12-31" id="ixv-23366">P8Y3M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23367"
      unitRef="USD">1847193</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23368"
      unitRef="USD">267336</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-12964">&lt;p id="xdx_89D_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_z90f1irLpWN6" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zgICDwR4qoh" style="display: none"&gt;Schedule
of common stock shares reserved for future issuance&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30D_133_z4kENF1cfmba" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  Stockholders Equity (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 6pt; padding-left: 12pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20221231_znWZEU5eey41" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zly4ssWCud3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-indent: 6pt; padding-left: 12pt"&gt;Exercise of warrants 	&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;858,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zmxFQkzQUqvd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;Exercise of options unrelated to any Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zyYgm42BRNQb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 6pt; padding-left: 12pt"&gt;Exercise of stock options &#x2013; 2021 Incentive Award Plan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;829,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCBQtFy6EhV" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: 6pt; padding-left: 12pt"&gt;Total shares of common stock reserved for future issuances	&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,717,936&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


</XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2022-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="ixv-23369"
      unitRef="Shares">858436</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2022-12-31_custom_UnrelatedToAnyPlanMember"
      decimals="INF"
      id="ixv-23370"
      unitRef="Shares">30000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2022-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23371"
      unitRef="Shares">829500</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23372"
      unitRef="Shares">1717936</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13006">&lt;p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zZKsCIc5Jol9" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&#160;&#160;&#160;
&lt;span id="xdx_827_z9BdVN7137T7"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
losses before income taxes for the year ended December 31, 2022 and for the two months ending December 31, 2021 were generated primarily
from U.S. operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have no current or deferred provision for income taxes from continuing operations for the years ended December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
significant differences between the U.S. Federal statutory rate and our effective rate for financial reporting purposes are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEtVZfzLHWcj" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"&gt;&lt;span id="xdx_8B3_zjcQ6x77CPU2" style="display: none"&gt;Schedule
of Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zwbP73deKSi9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20220101__20221231_ztVgFHcgYj7h" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20210101__20211231_zoKi8J2nW6gc" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_dp_uPure_zGJmKRRETVVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Federal statutory tax rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_dp_uPure_zSsouv1ej8Pk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dt_uPure_zSDcgF6oc0bf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationBeatPercent_dp_uPure_z8hQMHG06fq6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;NQSO Comp &#x2013; Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationFdiiPercent_dp_uPure_z6JxTFJotrz" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;EQ Comp &#x2013; Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_uPure_zFBT1vmZ4Ww3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;True-up Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zKiFl8AjglZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zC4OARNncDdj" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_ziXukLYUoNWd" style="display: none"&gt;Schedule of Income
before Income Tax, Domestic and Foreign&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zb1NHB8OwHti" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20220101__20221231_zjevSpBUivch" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zHdMUqaY85k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of
    December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Current:&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_zo8Lkbra0hU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;Federal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0923"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0924"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zt5wGkkScfPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"&gt;&#160;&#160;&#160;&#160;State Franchise Fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(8,850&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;9,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8A0_zMccOFf4myda" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred tax assets and
liabilities are as follows for the year ended December 31, 2022 and two months ended December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income tax assets and liabilities consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zrqqWNaZpNL8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zCkmsuoyAI94" style="display: none"&gt;Schedule of Components of Income Tax Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_z4PMuvPF2Mrl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20221231_z89QQUgKEAVi" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20211231_zNPhNqwwS8d1" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_zPDkTJWsp4Y8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLossCarryforwards_iI_z1KojXuaItub" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&#160;&#160;&#160;&#160;Net Operating Losses&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,719,889&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;151,797&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_zY5o7ofxAGS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;444,051&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_iI_zPOwsh21rPTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;424,675&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17,927&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zbpierLcBkek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,588,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;320,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iNI_di_zYAiOFhAOQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,584,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(297,815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_z9RCY5agWj6f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation_iI_z6gxUl9dblYg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,605&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(22,433&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zTwZORa2tz13" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
financial reporting purposes, the Company incurred losses for the year ended December 31, 2022 and December 31, 2021 and for each period
since inception. Accordingly, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets.
At December 31, 2022, the Company had approximately $6.56 million of federal and state net operating losses.&lt;/span&gt;&lt;/p&gt;






&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation between the amount of income tax benefit determined by applying the U.S statutory income tax rate to pre-tax loss is as
follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zPv7QMcA7cRk" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zYENDrlL9PE9" style="display: none"&gt;Summary of Operating Loss Carryforward&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_309_134_zIUNOoP3rzEa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20221231_zjBwkj1Wu1Yh" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231_zZONGVJtCiA9" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iNI_di_zmJ0QSxopRXi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Income tax provision at federal statutory rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,584,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(746,778&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iNI_di_zyhZ985TWJH" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(399,174&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(59,202&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_zVKR14O4RXk1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Stock-based compensation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0964"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;491,727&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsTaxCreditCarryforwardsOthers_iNI_di_zoHMOfr76WJa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,964&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,438&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxAssetsValuationAllowanceOne_iNI_di_zNsab0INGQ0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,992,669&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(297,815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zDtRC7mosmRf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0973"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zzsIHje3BTw9" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
positions are evaluated in a two-step process. The Company first determines whether it is more likely than not that a tax position will
be sustained upon examination. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine
the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is
greater than 50% likely of being realized upon ultimate settlement. The aggregate changes in the balance of gross unrecognized tax benefits,
which excludes penalties and interest, for the year ended December 31, 2022 is zero.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to taxation in the United States and Oregon. There are no ongoing examinations by taxing authorities at this time.
The Company&#x2019;s various tax years 2017 through 2022 remain open for examination by various taxing jurisdictions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2022, the Company
has not accrued any penalties or interest related to uncertain tax positions&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 8pt 0 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
anticipation of an initial public offering, the Company converted from a limited liability company to a C corporation, a taxable entity,
effective November 1, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Through
October 31, 2021, the Company was treated as an S corporation for federal and state income tax purposes, such that the Company&#x2019;s
taxable income is reported by members in their respective tax returns and the Company was only subject to state franchise taxes and fees.
For the year ended December 31, 2022 the Company reversed the 2021 accrual of $9,300 and accrued only $450 for state income taxes, as
we do not anticipate owing more than the minimum state income taxes for 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
converting to a C corporation, the Company has incurred losses and consequently recorded no provision for state or federal income taxes
for the year ended December 31, 2022. The Company maintains a full valuation allowance on all deferred tax assets, as it has concluded
that it is more likely than not that these assets will not be realized. As of December 31, 2022 and December 31, 2021, there were no
material unrecognized tax benefits included in the accompanying balance sheets that would, if recognized, affect the effective tax rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13022">&lt;p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEtVZfzLHWcj" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"&gt;&lt;span id="xdx_8B3_zjcQ6x77CPU2" style="display: none"&gt;Schedule
of Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_308_134_zwbP73deKSi9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20220101__20221231_ztVgFHcgYj7h" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20210101__20211231_zoKi8J2nW6gc" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ended December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_dp_uPure_zGJmKRRETVVl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Federal statutory tax rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_dp_uPure_zSsouv1ej8Pk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dt_uPure_zSDcgF6oc0bf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationBeatPercent_dp_uPure_z8hQMHG06fq6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;NQSO Comp &#x2013; Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationFdiiPercent_dp_uPure_z6JxTFJotrz" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;EQ Comp &#x2013; Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13.4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_uPure_zFBT1vmZ4Ww3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;True-up Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0.4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zKiFl8AjglZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zC4OARNncDdj" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_ziXukLYUoNWd" style="display: none"&gt;Schedule of Income
before Income Tax, Domestic and Foreign&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zb1NHB8OwHti" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20220101__20221231_zjevSpBUivch" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zHdMUqaY85k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of
    December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Current:&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_zo8Lkbra0hU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;Federal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0923"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0924"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zt5wGkkScfPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"&gt;&#160;&#160;&#160;&#160;State Franchise Fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(8,850&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;9,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23373"
      unitRef="Pure">-0.210</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23374"
      unitRef="Pure">-0.210</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23375"
      unitRef="Pure">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23376"
      unitRef="Pure">-0.017</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23377"
      unitRef="Pure">26.4</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23378"
      unitRef="Pure">8.4</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23379"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23380"
      unitRef="Pure">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23381"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23382"
      unitRef="Pure">0.134</us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23383"
      unitRef="Pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23384"
      unitRef="Pure">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23385"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="ixv-23386"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13115">&lt;p id="xdx_890_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zC4OARNncDdj" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_ziXukLYUoNWd" style="display: none"&gt;Schedule of Income
before Income Tax, Domestic and Foreign&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zb1NHB8OwHti" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20220101__20221231_zjevSpBUivch" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zHdMUqaY85k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of
    December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Current:&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_zo8Lkbra0hU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;Federal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0923"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0924"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zt5wGkkScfPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"&gt;&#160;&#160;&#160;&#160;State Franchise Fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(8,850&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;9,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="ixv-23387"
      unitRef="USD">-8850</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="ixv-23388"
      unitRef="USD">9300</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13183">&lt;p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zrqqWNaZpNL8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zCkmsuoyAI94" style="display: none"&gt;Schedule of Components of Income Tax Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_z4PMuvPF2Mrl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20221231_z89QQUgKEAVi" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20211231_zNPhNqwwS8d1" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_zPDkTJWsp4Y8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLossCarryforwards_iI_z1KojXuaItub" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&#160;&#160;&#160;&#160;Net Operating Losses&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,719,889&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;151,797&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_zY5o7ofxAGS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&#160;&#160;&#160;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;444,051&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_iI_zPOwsh21rPTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;424,675&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17,927&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zbpierLcBkek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,588,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;320,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iNI_di_zYAiOFhAOQ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,584,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(297,815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_z9RCY5agWj6f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation_iI_z6gxUl9dblYg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&#160;&#160;&#160;Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,605&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(22,433&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23389"
      unitRef="USD">1719889</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23390"
      unitRef="USD">151797</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23391"
      unitRef="USD">444051</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23392"
      unitRef="USD">150524</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23393"
      unitRef="USD">424675</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23394"
      unitRef="USD">17927</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23395"
      unitRef="USD">2588615</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23396"
      unitRef="USD">320248</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23397"
      unitRef="USD">2584010</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23398"
      unitRef="USD">297815</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <XPON:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23399"
      unitRef="USD">-4605</XPON:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation>
    <XPON:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23400"
      unitRef="USD">-22433</XPON:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDepreciation>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13313">&lt;p id="xdx_892_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zPv7QMcA7cRk" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zYENDrlL9PE9" style="display: none"&gt;Summary of Operating Loss Carryforward&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_309_134_zIUNOoP3rzEa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20221231_zjBwkj1Wu1Yh" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20211231_zZONGVJtCiA9" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iNI_di_zmJ0QSxopRXi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Income tax provision at federal statutory rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,584,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(746,778&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iNI_di_zyhZ985TWJH" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(399,174&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(59,202&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_zVKR14O4RXk1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Stock-based compensation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0964"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;491,727&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsTaxCreditCarryforwardsOthers_iNI_di_zoHMOfr76WJa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,964&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,438&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxAssetsValuationAllowanceOne_iNI_di_zNsab0INGQ0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,992,669&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(297,815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zDtRC7mosmRf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0973"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23401"
      unitRef="USD">1584531</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23402"
      unitRef="USD">746778</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23403"
      unitRef="USD">399174</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23404"
      unitRef="USD">59202</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23405"
      unitRef="USD">491727</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <XPON:DeferredTaxAssetsTaxCreditCarryforwardsOthers
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23406"
      unitRef="USD">8964</XPON:DeferredTaxAssetsTaxCreditCarryforwardsOthers>
    <XPON:DeferredTaxAssetsTaxCreditCarryforwardsOthers
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23407"
      unitRef="USD">-16438</XPON:DeferredTaxAssetsTaxCreditCarryforwardsOthers>
    <XPON:DeferredTaxAssetsValuationAllowanceOne
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23408"
      unitRef="USD">-1992669</XPON:DeferredTaxAssetsValuationAllowanceOne>
    <XPON:DeferredTaxAssetsValuationAllowanceOne
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23409"
      unitRef="USD">297815</XPON:DeferredTaxAssetsValuationAllowanceOne>
    <us-gaap:DefinedBenefitPlanTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13427">&lt;p id="xdx_804_eus-gaap--DefinedBenefitPlanTextBlock_zXvR4SR9bad7" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.&#160;&#160;&#160;
&lt;span id="xdx_821_zh0Q5EmUpQTi"&gt;401(k) Plan&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted a 401(k) Plan (&#x201c;Plan&#x201d;) for the benefit of its employees. Employees may contribute to the Plan within defined
limits as defined by the Internal Revenue Service. Substantially all employees are eligible to participate. The Company has the option
to make profit sharing contributions at its discretion. No profit-sharing contributions have been made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DefinedBenefitPlanTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13437">&lt;p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zNgtp9RUrU2h" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.&#160;&#160;&#160;
&lt;span id="xdx_828_zdFv0LBS2WZi"&gt;Related Party Transactions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 and December 31, 2021, related party transactions consisted of Shareholder Promissory Notes (see Note 8 &#x2013;
Shareholder Promissory Notes).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 and December 31, 2021, related party transactions consisted of Accounts Payables liability to board members for
2022 board compensation in the amount of $&lt;span id="xdx_90A_ecustom--AccountsPayableRelatedPartiesCurrentOne_iI_c20221231_zjzEH1iVz8Eh" title="Accounts Payables liability"&gt;100,000&lt;/span&gt; and $&lt;span id="xdx_905_ecustom--AccountsPayableRelatedPartiesCurrentOne_iI_c20211231_zNYKjlqn9tz3"&gt;0&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <XPON:AccountsPayableRelatedPartiesCurrentOne
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23410"
      unitRef="USD">100000</XPON:AccountsPayableRelatedPartiesCurrentOne>
    <XPON:AccountsPayableRelatedPartiesCurrentOne
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23411"
      unitRef="USD">0</XPON:AccountsPayableRelatedPartiesCurrentOne>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-012022-12-31" id="ixv-13458">&lt;p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zx1L9HYbKae6" style="margin: 0; font-style: italic; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.&#160;&#160;&#160;
&lt;span id="xdx_82C_ze2sfdm73dri"&gt;Subsequent Events&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
date to which events occurring after December 31, 2022, the date of the most recent Balance Sheets, have been evaluated for possible
adjustment to the financial statements or disclosures is March 27, 2023, which is the date the financial statements were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 11, 2023, the Company filed an 8-K related to a published press release announcing a new product, the AURA POWERCAP&#x2122;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 20, 2023 the company paid off a note payable in the amount of $89,360.11 which included principal, interest and fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2023, the Company made certain leadership changes. On January 30, 2023, the Company filed an 8-K related to a press release
announcing these changes. On February 1, 2023, the Company filed an 8-K with the details of the leadership changes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2023, the Company had 88,000 warrants exercised of which 73,000 were cashless resulting in 31,102 additional shares of common stock
issued. The remaining 15,000 exercised shares were exercised for a total of $49,975 which included $175.00 in fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 21, 2023, the Company entered into a settlement agreement with Ravi Sinha related to a complaint filed against the Company by Mr.
Sinha in Oregon state court and the matter has been resolved.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23412"
      unitRef="USD">2910896</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23413"
      unitRef="USD">7201244</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23414"
      unitRef="USD">473284</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23415"
      unitRef="USD">298035</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23416"
      unitRef="USD">4158483</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23417"
      unitRef="USD">4530136</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryInTransit
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23418"
      unitRef="USD">102646</us-gaap:OtherInventoryInTransit>
    <us-gaap:OtherInventoryInTransit
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23419"
      unitRef="USD">141611</us-gaap:OtherInventoryInTransit>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23420"
      unitRef="USD">217550</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23421"
      unitRef="USD">171791</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23422"
      unitRef="USD">7862859</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23423"
      unitRef="USD">12342817</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23424"
      unitRef="USD">1348326</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23425"
      unitRef="USD">1394619</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23426"
      unitRef="USD">378286</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23427"
      unitRef="USD">250861</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23428"
      unitRef="USD">970040</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23429"
      unitRef="USD">1143758</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23430"
      unitRef="USD">2789160</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23431"
      unitRef="USD">3148455</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23432"
      unitRef="USD">58896</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23433"
      unitRef="USD">63901</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OtherAssets
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23434"
      unitRef="USD">2848056</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23435"
      unitRef="USD">3212356</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23436"
      unitRef="USD">11680955</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23437"
      unitRef="USD">16698931</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23438"
      unitRef="USD">437236</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23439"
      unitRef="USD">230250</us-gaap:AccountsPayableCurrent>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23440"
      unitRef="USD">46248</us-gaap:CustomerDepositsCurrent>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23441"
      unitRef="USD">58</us-gaap:CustomerDepositsCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23442"
      unitRef="USD">299793</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23443"
      unitRef="USD">306164</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23444"
      unitRef="USD">506743</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23445"
      unitRef="USD">465055</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23446"
      unitRef="USD">625000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23447"
      unitRef="USD">500000</us-gaap:NotesPayableCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23448"
      unitRef="USD">50058</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23449"
      unitRef="USD">71426</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23450"
      unitRef="USD">1965078</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23451"
      unitRef="USD">1572953</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23452"
      unitRef="USD">311431</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23453"
      unitRef="USD">439049</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23454"
      unitRef="USD">2376474</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23455"
      unitRef="USD">2754964</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23456"
      unitRef="USD">200000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23457"
      unitRef="USD">325000</us-gaap:NotesPayable>
    <us-gaap:Liabilities
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23458"
      unitRef="USD">4852983</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23459"
      unitRef="USD">5091966</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="ixv-23460"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23461"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="ixv-23462"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23463"
      unitRef="Shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="ixv-23464"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23465"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="ixv-23466"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23467"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="ixv-23468"
      unitRef="Shares">6910717</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="ixv-23469"
      unitRef="Shares">6910717</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23470"
      unitRef="Shares">6802464</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="ixv-23471"
      unitRef="Shares">6802464</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23472"
      unitRef="USD">6911</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23473"
      unitRef="USD">6802</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23474"
      unitRef="USD">25730833</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23475"
      unitRef="USD">25239654</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23476"
      unitRef="USD">-18909772</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23477"
      unitRef="USD">-13639491</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23478"
      unitRef="USD">6827972</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23479"
      unitRef="USD">11606965</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23480"
      unitRef="USD">11680955</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23481"
      unitRef="USD">16698931</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23482"
      unitRef="USD">1890115</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23483"
      unitRef="USD">1383011</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23484"
      unitRef="USD">5122415</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23485"
      unitRef="USD">5741075</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23486"
      unitRef="USD">1417552</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23487"
      unitRef="USD">980141</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23488"
      unitRef="USD">3752006</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23489"
      unitRef="USD">3770025</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23490"
      unitRef="USD">472563</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23491"
      unitRef="USD">402870</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23492"
      unitRef="USD">1370409</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23493"
      unitRef="USD">1971050</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23494"
      unitRef="USD">2290955</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23495"
      unitRef="USD">1662005</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23496"
      unitRef="USD">6363514</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23497"
      unitRef="USD">6479954</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23498"
      unitRef="USD">-1818392</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23499"
      unitRef="USD">-1259135</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23500"
      unitRef="USD">-4993105</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23501"
      unitRef="USD">-4508904</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23502"
      unitRef="USD">33048</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23503"
      unitRef="USD">64</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23504"
      unitRef="USD">100945</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23505"
      unitRef="USD">158</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23506"
      unitRef="USD">27491</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23507"
      unitRef="USD">34016</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23508"
      unitRef="USD">92067</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23509"
      unitRef="USD">1571848</us-gaap:InterestExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23510"
      unitRef="USD">-13312</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23511"
      unitRef="USD">3426</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23512"
      unitRef="USD">-13312</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23513"
      unitRef="USD">281680</us-gaap:LitigationSettlementExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23514"
      unitRef="USD">-471</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23515"
      unitRef="USD">-394</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23516"
      unitRef="USD">-389</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23517"
      unitRef="USD">-5557</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23518"
      unitRef="USD">20169</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23519"
      unitRef="USD">275834</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23520"
      unitRef="USD">1557989</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23521"
      unitRef="USD">-1812835</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23522"
      unitRef="USD">-1279304</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23523"
      unitRef="USD">-5268939</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23524"
      unitRef="USD">-6066893</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <XPON:FranchiseTaxesRefund
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23525"
      unitRef="USD">1380</XPON:FranchiseTaxesRefund>
    <XPON:FranchiseTaxesRefund
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23526"
      unitRef="USD">1342</XPON:FranchiseTaxesRefund>
    <XPON:FranchiseTaxesRefund
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23527"
      unitRef="USD">300</XPON:FranchiseTaxesRefund>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23528"
      unitRef="USD">-1814215</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23529"
      unitRef="USD">-1279304</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23530"
      unitRef="USD">-5270281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23531"
      unitRef="USD">-6067193</us-gaap:NetIncomeLoss>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="ixv-23532"
      unitRef="USDPShares">-0.26</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      id="ixv-23533"
      unitRef="USDPShares">-0.19</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2023-01-01to2023-09-30"
      decimals="INF"
      id="ixv-23534"
      unitRef="USDPShares">-0.77</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2022-01-012022-09-30"
      decimals="INF"
      id="ixv-23535"
      unitRef="USDPShares">-1.03</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="ixv-23536"
      unitRef="Shares">6910717</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      id="ixv-23537"
      unitRef="Shares">6802464</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2023-01-01to2023-09-30"
      decimals="INF"
      id="ixv-23538"
      unitRef="Shares">6878737</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2022-01-012022-09-30"
      decimals="INF"
      id="ixv-23539"
      unitRef="Shares">5913763</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23540"
      unitRef="Shares">4300000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23541"
      unitRef="USD">4300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23542"
      unitRef="USD">8355140</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23543"
      unitRef="USD">-6102951</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23544"
      unitRef="USD">2256489</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23545"
      unitRef="USD">-696853</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      id="ixv-23546"
      unitRef="USD">-696853</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23547"
      unitRef="Shares">4300000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23548"
      unitRef="USD">4300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23549"
      unitRef="USD">8355140</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23550"
      unitRef="USD">-6799804</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="ixv-23551"
      unitRef="USD">1559636</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23552"
      unitRef="Shares">2466750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23553"
      unitRef="USD">2466</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23554"
      unitRef="USD">14770021</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      id="ixv-23555"
      unitRef="USD">14772487</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23556"
      unitRef="Shares">35714</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23557"
      unitRef="USD">36</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23558"
      unitRef="USD">-36</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23559"
      unitRef="USD">2114529</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      id="ixv-23560"
      unitRef="USD">2114529</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23561"
      unitRef="USD">-4091036</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      id="ixv-23562"
      unitRef="USD">-4091036</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23563"
      unitRef="Shares">6802464</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23564"
      unitRef="USD">6802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23565"
      unitRef="USD">25239654</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23566"
      unitRef="USD">-10890840</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="ixv-23567"
      unitRef="USD">14355616</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23568"
      unitRef="USD">-1279304</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23569"
      unitRef="USD">-1279304</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23570"
      unitRef="Shares">6802464</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23571"
      unitRef="USD">6802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23572"
      unitRef="USD">25239654</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23573"
      unitRef="USD">-12170144</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-09-30"
      decimals="0"
      id="ixv-23574"
      unitRef="USD">13076312</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23575"
      unitRef="Shares">6802464</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23576"
      unitRef="USD">6802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23577"
      unitRef="USD">25239654</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23578"
      unitRef="USD">-13639491</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23579"
      unitRef="USD">11606965</us-gaap:StockholdersEquity>
    <XPON:ProceedsReceivedFromExerciseOfWarrantsShares
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23580"
      unitRef="Shares">46102</XPON:ProceedsReceivedFromExerciseOfWarrantsShares>
    <XPON:ProceedsReceivedFromExerciseOfWarrants
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23581"
      unitRef="USD">47</XPON:ProceedsReceivedFromExerciseOfWarrants>
    <XPON:ProceedsReceivedFromExerciseOfWarrants
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23582"
      unitRef="USD">49740</XPON:ProceedsReceivedFromExerciseOfWarrants>
    <XPON:ProceedsReceivedFromExerciseOfWarrants
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="ixv-23583"
      unitRef="USD">49787</XPON:ProceedsReceivedFromExerciseOfWarrants>
    <XPON:StockIssuedAsResultOfLitigationSettlementShares
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23584"
      unitRef="Shares">52000</XPON:StockIssuedAsResultOfLitigationSettlementShares>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23585"
      unitRef="USD">52</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23586"
      unitRef="USD">251628</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="ixv-23587"
      unitRef="USD">251680</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23588"
      unitRef="USD">-1977278</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="ixv-23589"
      unitRef="USD">-1977278</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23590"
      unitRef="Shares">6900566</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23591"
      unitRef="USD">6901</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23592"
      unitRef="USD">25541022</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23593"
      unitRef="USD">-15616769</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="ixv-23594"
      unitRef="USD">9931154</us-gaap:StockholdersEquity>
    <XPON:ExerciseOfWarrantsShares
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23595"
      unitRef="Shares">10151</XPON:ExerciseOfWarrantsShares>
    <us-gaap:UndistributedEarningsDiluted
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23596"
      unitRef="USD">10</us-gaap:UndistributedEarningsDiluted>
    <us-gaap:UndistributedEarningsDiluted
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23597"
      unitRef="USD">-20</us-gaap:UndistributedEarningsDiluted>
    <us-gaap:UndistributedEarningsDiluted
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="ixv-23598"
      unitRef="USD">-10</us-gaap:UndistributedEarningsDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23599"
      unitRef="USD">-1478788</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="ixv-23600"
      unitRef="USD">-1478788</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23601"
      unitRef="Shares">6910717</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23602"
      unitRef="USD">6911</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23603"
      unitRef="USD">25541002</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23604"
      unitRef="USD">-17095557</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="ixv-23605"
      unitRef="USD">8452356</us-gaap:StockholdersEquity>
    <XPON:IssuanceOfWarrants
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23606"
      unitRef="USD">65046</XPON:IssuanceOfWarrants>
    <XPON:IssuanceOfWarrants
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23607"
      unitRef="USD">65046</XPON:IssuanceOfWarrants>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23608"
      unitRef="USD">119525</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23609"
      unitRef="USD">119525</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <XPON:IssuanceOfRestrictedStockUnit
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23610"
      unitRef="USD">5260</XPON:IssuanceOfRestrictedStockUnit>
    <XPON:IssuanceOfRestrictedStockUnit
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23611"
      unitRef="USD">5260</XPON:IssuanceOfRestrictedStockUnit>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23612"
      unitRef="USD">-1814215</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23613"
      unitRef="USD">-1814215</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-23614"
      unitRef="Shares">6910717</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-23615"
      unitRef="USD">6911</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-23616"
      unitRef="USD">25730833</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-23617"
      unitRef="USD">-18909772</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23618"
      unitRef="USD">6827972</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23619"
      unitRef="USD">5270281</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23620"
      unitRef="USD">6067193</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:Depreciation
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23621"
      unitRef="USD">153714</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23622"
      unitRef="USD">115670</us-gaap:Depreciation>
    <XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23623"
      unitRef="USD">295</XPON:AmortizationOfDebtDiscountSaleOfFutureRevenues>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23624"
      unitRef="USD">1196843</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23625"
      unitRef="USD">3426</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23626"
      unitRef="USD">-13312</us-gaap:GainLossOnDispositionOfAssets1>
    <XPON:IncreaseDecreaseInAllowanceForDoubtfulAccounts
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23627"
      unitRef="USD">18804</XPON:IncreaseDecreaseInAllowanceForDoubtfulAccounts>
    <XPON:IncreaseDecreaseInAllowanceForDoubtfulAccounts
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23628"
      unitRef="USD">-19604</XPON:IncreaseDecreaseInAllowanceForDoubtfulAccounts>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23629"
      unitRef="USD">-251680</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23630"
      unitRef="USD">189831</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23631"
      unitRef="USD">2114529</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23632"
      unitRef="USD">-156445</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23633"
      unitRef="USD">475091</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23634"
      unitRef="USD">371653</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23635"
      unitRef="USD">-2984177</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23636"
      unitRef="USD">38964</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23637"
      unitRef="USD">812562</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23638"
      unitRef="USD">45759</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23639"
      unitRef="USD">134191</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23640"
      unitRef="USD">5005</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23641"
      unitRef="USD">-10976</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23642"
      unitRef="USD">206986</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23643"
      unitRef="USD">-87369</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherDeposits
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23644"
      unitRef="USD">46190</us-gaap:IncreaseDecreaseInOtherDeposits>
    <us-gaap:IncreaseDecreaseInOtherDeposits
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23645"
      unitRef="USD">-274857</us-gaap:IncreaseDecreaseInOtherDeposits>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23646"
      unitRef="USD">-6371</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23647"
      unitRef="USD">107407</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23648"
      unitRef="USD">22494</XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities>
    <XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23649"
      unitRef="USD">30454</XPON:IncreaseInRightofuseAssetsAndLeaseLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23650"
      unitRef="USD">-4207717</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23651"
      unitRef="USD">-4699620</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23652"
      unitRef="USD">20170</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23653"
      unitRef="USD">434458</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23654"
      unitRef="USD">36748</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23655"
      unitRef="USD">51679</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23656"
      unitRef="USD">16578</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23657"
      unitRef="USD">-382779</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <XPON:PaymentsOnLineofcreditAndShorttermRevolvingLoans
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23658"
      unitRef="USD">-550000</XPON:PaymentsOnLineofcreditAndShorttermRevolvingLoans>
    <XPON:PaymentsOnLiabilityForSaleOfFutureRevenues
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23659"
      unitRef="USD">-11797</XPON:PaymentsOnLiabilityForSaleOfFutureRevenues>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23660"
      unitRef="USD">148986</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23661"
      unitRef="USD">1784500</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23662"
      unitRef="USD">49777</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23663"
      unitRef="USD">14772487</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23664"
      unitRef="USD">-99209</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23665"
      unitRef="USD">12426190</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23666"
      unitRef="USD">-4290348</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23667"
      unitRef="USD">7343791</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23668"
      unitRef="USD">7201244</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="ixv-23669"
      unitRef="USD">773238</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23670"
      unitRef="USD">2910896</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-09-30"
      decimals="0"
      id="ixv-23671"
      unitRef="USD">8117029</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaid
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23672"
      unitRef="USD">92136</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23673"
      unitRef="USD">401037</us-gaap:InterestPaid>
    <XPON:CashPaidRefundedForFranchiseTaxes
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23674"
      unitRef="USD">1341</XPON:CashPaidRefundedForFranchiseTaxes>
    <XPON:CashPaidRefundedForFranchiseTaxes
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23675"
      unitRef="USD">300</XPON:CashPaidRefundedForFranchiseTaxes>
    <XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23676"
      unitRef="USD">-13993</XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability>
    <XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23677"
      unitRef="USD">2348509</XPON:AcquisitionModificationOfOperatingLeaseRightOfUseAssetAndLeaseLiability>
    <XPON:CashlessWarrantExercises
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23678"
      unitRef="USD">41</XPON:CashlessWarrantExercises>
    <XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23679"
      unitRef="USD">181430</XPON:PurchasesOfPropertyAndEquipmentInExchangeForLongTermDebt>
    <XPON:PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23680"
      unitRef="USD">170863</XPON:PurchasedOfPropertyAndEquipmentInExchangeForShorttermPayable>
    <us-gaap:NatureOfOperations contextRef="From2023-01-01to2023-09-30" id="ixv-17269">&lt;p id="xdx_80F_eus-gaap--NatureOfOperations_znCNF2sT6TAa" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1. &lt;span id="xdx_82E_zqxf4vA7YzK7"&gt;Organization
and Nature of Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expion360
Inc. (formerly Yozamp Products Company, LLC dba Expion360) (&#x201c;the Company&#x201d;) was incorporated in the state of Nevada in November
2021. Effective November 1, 2021, the Company converted to a C corporation. Prior to conversion, the Company was a limited liability
company (LLC) with an indefinite life organized in the State of Oregon in June 2016. The LLC elected to be treated as a Subchapter S
corporation effective January 1, 2017. Net profits and losses of the LLC and all distributions were allocated among the members in proportion
to the ownership units held. The Original LLC Agreement was amended and restated on January 1, 2021 to add additional members and a non-voting
class of member units. Upon conversion to a C corporation, all existing LLC members at the time of conversion were issued shares of common
stock and became stockholders of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company designs, assembles, and distributes premium lithium batteries for RV, Marine, Golf, Industrial, Residential, and Off-The-Grid
needs. The Company uses lithium iron phosphate (LiFePO4) batteries. LiFePO4 batteries are considered a top choice for high energy density,
dependability, longevity, and safety, providing the ability to power anything, anywhere.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Beginning
in March 2020, the COVID-19 pandemic and the measures imposed to contain this pandemic disrupted and may continue to impact the Company&#x2019;s
business. While certain restrictions have eased recently, the magnitude of the impact of any new measures from a resurgence in the COVID-19
pandemic on the Company&#x2019;s productivity, results of operations, and financial position, and its disruption to the Company&#x2019;s
business and battery development and timeline will depend in part on the length and severity of these restrictions and on the Company&#x2019;s
ability to conduct business in the ordinary course.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17287">&lt;p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zHPJaxbFW8ob" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2. &lt;span id="xdx_82F_zy6UdrppacW6"&gt;Summary
of Significant Accounting Policies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgJ63UfhQ0tb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zznQ4gIlN0Nb"&gt;Basis of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
results for the three- and nine-month periods ended September 30, 2023 and 2022 are not necessarily indicative of the results that may
be expected for the year ending December 31, 2023. The unaudited interim financial statements should be read in conjunction with our
Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise noted, all references to shares and stockholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziT5dCht3uFk" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zOHKhw3PteE6"&gt;Reclassification
of Prior Year Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zpNgy4pYKooc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;span id="xdx_863_z8gMJVTa1XI3"&gt;Going Concern,
Liquidity and Capital Resources&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;As presented in the
accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations. These factors
raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within twelve months after the date that
the financial statements for the three and nine month periods ended September 30, 2023 are issued. However, management is working
to address its cash flow challenges, including raising additional capital, managing inventory levels, identifying alternative supply
chain resources, and managing operational expenses.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;Historically, the
Company&#x2019;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#x2019;s sales for the three months ended September 30, 2023 increased 36.7% and sales for the nine months ended
September 30, 2023 decreased 10.8% compared to the same periods in 2022. For the nine months ended September 30, 2023, we received
net proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930_zTQpfpO0wX0e" title="Net proceeds from Warrants"&gt;49,777&lt;/span&gt; from warrant exercises. On April 1, 2022, the Company completed an initial public offering and listing
of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of costs, totaled $14,772,487, of which approximately
$2,464,000 was used to pay down principal and accrued interest on high interest-bearing debt. The remaining proceeds have thus
far and will continue to be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines&#160;to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in
China. In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S.
and an assembly facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management
has secured a secondary source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption
issues with China arise. Management believes that these factors will contribute to achieving operating efficiency and profitability.
However, there can be no assurance that the Company will be successful in achieving its objectives, including achieving operating
efficiency and profitability.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#x2019;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zANTPXXkTLag" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_z1k09Z9f0CFj"&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#x2019;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#x2019;s accounting estimates require the exercise of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zM1t2IcH1W45" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zHFji1q7K1Hc"&gt;Cash and Cash
Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Cash accounts are secured by the Federal Deposit Insurance Corporation
(&#x201c;FDIC&#x201d;) up to $250,000 per institution. At times, balances may exceed federally insured limits. Investment accounts are
placed in funds consisting of US Treasury-related ultra-short paper. The Company has not experienced any losses in such accounts and
management believes that the Company is not exposed to any significant credit risk with respect to its cash and cash equivalents. As
of September 30, 2023, cash balances exceeded FDIC limits by $&lt;span id="xdx_900_eus-gaap--FDICIndemnificationAssetPeriodIncreaseDecrease_c20230101__20230930_zDrWcHx38j4c" title="FDIC Limits"&gt;547,054&lt;/span&gt; and investment accounts totaling $&lt;span id="xdx_902_ecustom--TreasuryRelatedPaper_c20230101__20230930_zdNTbYrQulzj" title="Treasury related paper"&gt;2,100,847&lt;/span&gt; are invested in US
Treasury-related ultra-short paper.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&#160;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zg3CV4xsKrFl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zQx8Pw8Ksx8a"&gt;Accounts Receivable&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any
interest. The Company performs ongoing credit evaluations of its customers and generally requires no collateral. An allowance for
uncollectible accounts is recorded to reduce accounts receivable to the estimated amount that will be collected. The allowance
is based upon management&#x2019;s review of the accounts receivable aging and specific identification of potentially uncollectible
balances. Recoveries of accounts previously written off and adjustments to the allowance for uncollectible accounts are recorded
as adjustments to bad debt expense. For the three months ended September 30, 2023 and 2022, the Company wrote off $&lt;span id="xdx_902_ecustom--AdjustmentsToBadDebtExpense_c20230701__20230930_zhMWY4H08Hn1" title="Adjustments to bad debt expense"&gt;388&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--AdjustmentsToBadDebtExpense_c20220701__20220930_zDdBmfX45atg" title="Adjustments to BadDebt Expense"&gt;0&lt;/span&gt;,
respectively. For the nine months ended September 30, 2023 and 2022, the Company recovered a net of ($&lt;span id="xdx_907_ecustom--AdjustmentsToBadDebtExpense_c20230101__20230930_zPJnfsusliMk" title="Adjustments to BadDebt Expense"&gt;412&lt;/span&gt;) and wrote off $&lt;span id="xdx_90E_ecustom--AdjustmentsToBadDebtExpense_c20220101__20220930_zBP1XuFjh8ql" title="Adjustments to BadDebt Expense"&gt;19,604&lt;/span&gt;,
respectively. There was no allowance for doubtful accounts as of September 30, 2023 or December 31, 2022, as management believed
all outstanding amounts to be fully collectible.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--CustomerDepositsPolicyTextBlock_zNL2oEnKFQp7" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_z7xVitSlvKK5"&gt;Customer Deposits&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023 and December 31, 2022, the Company had customer deposits totaling $&lt;span id="xdx_90F_eus-gaap--CustomerDepositsCurrent_iI_c20230930_zcJaJUhl5srd" title="Customer deposits"&gt;46,248&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--CustomerDepositsCurrent_iI_c20221231_zXlNpb7xgH27"&gt;58&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_z1GJZfvW8of1" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zkDwjVdRHtk2"&gt;Inventory&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and
accessories, resale items, components, and related landing costs. As of September 30, 2023 and December 31, 2022, the Company had
inventory that consisted of finished assemblies&#160;totaling $&lt;span id="xdx_904_eus-gaap--InventoryFinishedGoods_iI_c20230930_zVVqLoTHmu1" title="Finished Inventory"&gt;3,306,972&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--InventoryFinishedGoods_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zd3owKutQuS6"&gt;3,243,485&lt;/span&gt;, respectively, and raw materials (inventory
components, parts, and packaging) totaling $&lt;span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20230930_zo57vJqNtxf4" title="Raw materials"&gt;851,511&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--InventoryRawMaterials_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zbJsGW95Todg"&gt;1,286,651&lt;/span&gt;, respectively. The valuation of inventory includes fixed production
overhead costs based on normal capacity of the assembly warehouse. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of September 30, 2023 or December 31, 2022. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $&lt;span id="xdx_90F_eus-gaap--Supplies_iI_c20230930_zwDUndQS8Tof" title="Inventory purchases from foreign suppliers"&gt;102,646&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--Supplies_iI_c20221231_zFz97mIRGusc"&gt;141,611&lt;/span&gt; at September 30, 2023 and December 31,
2022, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zSVrJSTrujuf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zuyyMUkC9sUk"&gt;Vendor and Foreign
Concentrations of Inventory Suppliers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;During the three
months ended September 30, 2023 and 2022, respectively, approximately 61% and 91%, respectively, of inventory purchases were made
from foreign suppliers in China and Hong Kong. During the nine months ended September 30, 2023 and 2022, respectively, approximately
71% and 92%, respectively, of inventory purchases were made from foreign suppliers in China and Hong Kong. Any adverse change in
either the economic or political conditions abroad could negatively impact the Company&#x2019;s supply chain. The inability to obtain
product to meet sales demand could adversely affect results of operations. However, the Company has secured a secondary source
for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company to source materials outside
of China in the event it becomes necessary to do so.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0 0 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zl6mWGf2skuf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_zvBO0PDWsi3f"&gt;Property and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zuXw7FtPdsIg" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zV5v1ps7r6D2" style="display: none"&gt;Schedule of estimated useful lives&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-top: black 1pt solid; padding: 0 0 0 10pt; width: 73%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles
    and transportation equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 25%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZV5XzKnP4tg"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zpOXQnsnhsSd"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zuIIeEWpXLRd"&gt;3&lt;/span&gt; - &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember_zp71G5Uph898"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zVhJtgsDPtx3"&gt;3&lt;/span&gt; - &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_z2aU44dnTkoh"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember__srt--RangeAxis__srt--MinimumMember_z7IJ1jOnBH4i"&gt;3&lt;/span&gt; - &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember_zGVSRvGMW8yb"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zcl7qmHKALgc"&gt;3&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zHwntN1vxfZ"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and molds&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4KW4plU2Hag"&gt;3&lt;/span&gt;
    - &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_ztN4onwQ4D17"&gt;10&lt;/span&gt; years&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_z62Oyv4K3jEj" style="margin: 0; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements
are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable to assets retired are removed from the accounts,
and the gain or loss on disposition is recognized in the Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zmsaz761uy13" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_867_z2uhXnc33Ek8"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#x201c;ROU&#x201d;) assets represent the Company&#x2019;s
right to use an underlying asset during the lease term, and operating lease liabilities represent&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Company&#x2019;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease liabilities,
and long-term operating lease liabilities on the Company&#x2019;s Balance Sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments
over the lease term at commencement date calculated using the Company&#x2019;s incremental borrowing rate applicable to the
lease asset, unless the implicit rate is readily determinable. ROU assets also include any lease payments made at or before
lease commencement and exclude any lease incentives received. The Company&#x2019;s lease terms may include options to extend
or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12
months or less are not recognized on the Company&#x2019;s Balance Sheet. The Company&#x2019;s leases do not contain any
residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease
term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for lease and non-lease components as a single lease component for all its leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHZVlaRWukAi" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_z3GfuMPhmwmd"&gt;Impairment of
Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;Long-lived assets
consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the
asset to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted
cash flows, the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value.
Fair value is determined primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No
long-lived asset impairment was recognized during the three or nine months ended September 30, 2023 or 2022.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ExtendedProductWarrantyPolicy_zyXGEm02mcJ7" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_z8MAFVzfacCg"&gt;Product Warranties&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;The Company sells
the majority of its products to customers along with conditional repair or replacement warranties. The Company&#x2019;s branded
DC mobile chargers are warrantied for two years from the date of sale and its branded VPR 4EVER Classic and Platinum batteries
are warrantied at gradually lesser levels over a twelve-year period from date of sale. The Company determines its estimated liability
for warranty claims based on the Company&#x2019;s experience of the amount of claims actually made. Management estimates no liability
as of September 30, 2023 and December 31, 2022 because, historically, there have been very few claims and costs for repairs&#160;or
replacement parts have been nominal. It is possible that the Company&#x2019;s estimate of liability for product liability claims
will change in the near term.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--LiabilityForRefundsPolicyTextBlock_zmaN7OQCgBK3" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zJX7B0uqI7R9"&gt;Liability for
Refunds&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;The Company does
not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zaieuIHfl2p" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zRUXrxLYomUc"&gt;Revenue Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#x2019;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#x2019;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zic28ONNMc66" style="margin: 0; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_867_zVF3VNW0l4w1"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three months ended September 30, 2023, sales to three customers totaled $700,071, comprising approximately 38% of total sales. These
customers represented 31% of total accounts receivable as of September 30, 2023. During the nine months ended September 30, 2023, sales
to two customers totaled $1,178,142, comprising approximately 23% of total sales. These customers represented 23% of total accounts receivable
as of September 30, 2023. Accounts receivable from three additional customers totaled $190,495, representing approximately 40% of accounts
receivable as of September 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During the
three months ended September 30, 2022, sales to two customers totaled $394,936, comprising approximately 28% of total sales. There
were no accounts receivable for these customers as of September 30, 2022. During the nine months ended September 30, 2022, sales
to two customers totaled $1,816,821, comprising approximately 32% of total sales. Accounts receivables for these customers totaled
$7,486, representing approximately 3% of total accounts receivable as of September 30, 2022. Accounts receivable from two additional
customers totaled $90,789, representing approximately 32% of total accounts receivables as of September 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zTFf5ClWxhW8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zrgvvuszgBz"&gt;Shipping and Handling
Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;Shipping and handling
fees billed to customers are classified in&#160;the Statement of Operations in &#x201c;Sales, net&#x201d; and totaled $&lt;span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230701__20230930_zYxhpTQflxFl" title="Shipping and handling fee"&gt;27,398&lt;/span&gt; and
$&lt;span id="xdx_90B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220701__20220930_zCjQcgfDGpHi" title="Shipping and handling fee"&gt;6,133&lt;/span&gt; during the three months ended September 30, 2023 and 2022, respectively, and $&lt;span id="xdx_903_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230101__20230930_z0NAnTn3OiP4" title="Shipping and handling fee"&gt;52,296&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220101__20220930_zae99EQTdkpj" title="Shipping and handling fee"&gt;17,514&lt;/span&gt; during the nine months
ended September 30, 2023 and 2022, respectively. Shipping and handling costs for shipping product to customers totaled $&lt;span id="xdx_906_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230701__20230930_zIZVrwz7Nox7" title="Shipping and handling costs for shipping product"&gt;58,141&lt;/span&gt;
and $&lt;span id="xdx_901_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220701__20220930_zzteob8JfWW5" title="Shipping and Handling Costs for Shipping Product"&gt;54,840&lt;/span&gt; during the three months ended September 30, 2023 and 2022, respectively, and $&lt;span id="xdx_903_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230101__20230930_zvZPFMRMfkvg" title="Shipping and Handling Costs for Shipping Product"&gt;149,898&lt;/span&gt; and $&lt;span id="xdx_902_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220101__20220930_z2w0cryYMxY2" title="Shipping and Handling Costs for Shipping Product"&gt;137,497&lt;/span&gt; during the nine
months ended September 30, 2023 and 2022, respectively, and are classified in selling, general, and administrative expense in the
accompanying Statements of Operations.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--AdvertisingCostsPolicyTextBlock_zOgCRPqN9Duh" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_z4X1Bsn8YSB6"&gt;Advertising and
Marketing Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $&lt;span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20230701__20230930_zzpF76DA7O77" title="Advertising and marketing expense"&gt;238,163&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--MarketingAndAdvertisingExpense_c20220701__20220930_zoBYJRoRQ5Lf"&gt;215,994&lt;/span&gt; for the
three months ended September 30, 2023 and 2022, respectively and $&lt;span id="xdx_90D_eus-gaap--MarketingAndAdvertisingExpense_c20230101__20230930_zfKEXxxy4Nce"&gt;690,995&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20220930_zbmh9L1WX0X1"&gt;527,732&lt;/span&gt; for the nine months ended September 30, 2023 and
2022, respectively, and is included in selling, general and administrative expense in the accompanying Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu2zb5uSlDg" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zIsTtfCV2Ls7"&gt;Research and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $&lt;span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20230701__20230930_z6QXmy9izALb" title="Research and development costs"&gt;145,111&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20220701__20220930_z8JZXu7QYOe9"&gt;41,355&lt;/span&gt; for
the three months ended September 30, 2023 and 2022, respectively, and $&lt;span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20230930_zLLzALUAO4wj"&gt;316,369&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20220930_zdrgDWnumJzi"&gt;153,730&lt;/span&gt; for the nine months ended September 30, 2023
and 2022, respectively, and are included in selling, general and administrative expenses in the accompanying Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z5amL6LL3PC4" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zfT5BlKB4KE4"&gt;Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
November 1, 2021, the Company converted from an LLC to a C corporation and, as a result, became subject to corporate federal and state
income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including
tax loss and credit carryforwards, and liabilities are measured using the enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that included the enactment date. Deferred income tax expense represents
the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation
allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not
be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of September 30, 2023 and December 31, 2022, the Company has not recorded any income tax
provision/(benefit) resulting from the CARES Act, mainly due to the Company&#x2019;s history of net operating losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#x201c;CAA&#x201d;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2023 and beyond.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zV7PliosUCK6" style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span id="xdx_86F_z0q4RC6OBOsi"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
1: &lt;/i&gt;Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
2: &lt;/i&gt;Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
3: &lt;/i&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, stockholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the stockholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z9J2A90KyAB1" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zXdAiAjaTVfh"&gt;Segment Reporting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zcjAReRD1ima" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_860_z1ojxA7cbqU7"&gt;Basic and Diluted
Net Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following shows the amounts used in computing net loss per share:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zePybWaSuLEg" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zQX2EFnNMBN3" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_134_zvweiPURMUYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20230701__20230930_zFiW3vb3LjVh" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220701__20220930_z75Hf7GwhZ0a" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230101__20230930_zwhv0JvhSnll" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20220930_zeHqbQ6AOtlj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Three
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nine
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NetLossOne_ziztUNeD3Qo6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,814,215&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,279,304&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,270,281&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6,067,193&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zwxiOedMoiLd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average common shares outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,910,717&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,802,464&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,878,737&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,913,763&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--NetLossPerShareBasicAndDiluted_z1yj24NP6Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.19&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.77&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1.03&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zhji71lzjJIj" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;As
of September 30, 2023 and December 31, 2022, the Company has outstanding warrants, options, and restricted stock units (&#x201c;RSUs&#x201d;)
convertible into 1,926,610&#160;and 1,717,936 shares of common stock, respectively. The following table sets forth the number of
shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive.&lt;/p&gt;



&lt;p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zyoB77o7qJjh" style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zZmAWA3vVak8" style="display: none"&gt;Schedule
of anti-dilutive share&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_z0ucSeAjt4h3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zUlM0wcirv51" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;802,830&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zT3f4cQ55Eul" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;888,436&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8RJRSgh28M1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,075,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQoUblAc9nu1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_z6xhWsB6cwAe" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_ziAg5Zah8Nad" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1596"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930_zJ2ZxiTDCpT3" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,926,610&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zOAG9Jemb06g" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,717,936&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zzG6p9PN8rl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zknouLL4YS84" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_zyjXuR8kfUwb"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation&#x2014;Stock Compensation&#x201d;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK2ONxRis2ni" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zjomQiUVvQp2"&gt;New Accounting
Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2022, the FASB issued ASU 2022-04, &#x201c;Liabilities&#x2014;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#x201d; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#x2019;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the
Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the FASB issued ASU 2022-02, &#x201c;Financial Instruments&#x2014;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#x201d; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#x201c;CECL&#x201d;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have &lt;i&gt;not&lt;/i&gt; yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company adopted this standard effective January 1, 2023, and the adoption of
this guidance did not have an impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#x201d; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the Company&#x2019;s
financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have
an impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zSnM0CB4zkV8" style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span id="xdx_860_zUd0W7Zv5zQf"&gt;Accounting Guidance Issued
but Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2023, the FASB issued ASU 2023-02, &#x201c;Investments&#x2014;Equity Method and Joint Ventures (Topic 323): Accounting for Investments
in Tax Credit Structures Using the Proportional Amortization Method.&#x201d; This ASU was issued to allow reporting entities to consistently
account for equity investments made primarily for the purpose of receiving income tax credits and other income tax benefits. ASU 2023-02
is effective for the Company for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.
The Company is currently evaluating the impact of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, &#x201c;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#x201d; which amends the guidance in Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17293">&lt;p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgJ63UfhQ0tb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86A_zznQ4gIlN0Nb"&gt;Basis of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited financial statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (U.S. GAAP) for interim financial information, and pursuant to the instructions to Form 10-Q and Article
10 of Regulation S-X promulgated by the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statement presentation. However, the Company believes that the disclosures
are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting primarily of
normal recurring accruals) considered necessary for a fair presentation have been included.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
results for the three- and nine-month periods ended September 30, 2023 and 2022 are not necessarily indicative of the results that may
be expected for the year ending December 31, 2023. The unaudited interim financial statements should be read in conjunction with our
Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise noted, all references to shares and stockholders in the accompanying financial statements have been restated retrospectively,
to reflect the equity structure of the C corporation as of the beginning of the first period presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2023-01-01to2023-09-30" id="ixv-17312">&lt;p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziT5dCht3uFk" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zOHKhw3PteE6"&gt;Reclassification
of Prior Year Presentation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified for consistency with current year presentation. These reclassifications had no effect on the
reported results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <XPON:LiquidityAndCapitalResourcesPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17323">&lt;p id="xdx_847_ecustom--LiquidityAndCapitalResourcesPolicyTextBlock_zpNgy4pYKooc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;span id="xdx_863_z8gMJVTa1XI3"&gt;Going Concern,
Liquidity and Capital Resources&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s activities are subject to significant risks and uncertainties, including failing to secure additional funding before
the Company achieves sustainable revenues and profit from operations. The Company expects to continue to incur additional losses for
the foreseeable future, and the Company may need to raise additional debt or equity financing to expand its presence in the marketplace,
develop new products, achieve operating efficiencies, and accomplish its long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and capital might be available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;As presented in the
accompanying financial statements, the Company has sustained recurring losses and negative cash flows from operations. These factors
raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within twelve months after the date that
the financial statements for the three and nine month periods ended September 30, 2023 are issued. However, management is working
to address its cash flow challenges, including raising additional capital, managing inventory levels, identifying alternative supply
chain resources, and managing operational expenses.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;Historically, the
Company&#x2019;s growth has been funded through a combination of sales of equity interests, third party debt, and working capital
loans. The Company&#x2019;s sales for the three months ended September 30, 2023 increased 36.7% and sales for the nine months ended
September 30, 2023 decreased 10.8% compared to the same periods in 2022. For the nine months ended September 30, 2023, we received
net proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromRepurchaseOfEquity_c20230101__20230930_zTQpfpO0wX0e" title="Net proceeds from Warrants"&gt;49,777&lt;/span&gt; from warrant exercises. On April 1, 2022, the Company completed an initial public offering and listing
of its shares on the Nasdaq Stock Market (IPO). Proceeds from the IPO, net of costs, totaled $14,772,487, of which approximately
$2,464,000 was used to pay down principal and accrued interest on high interest-bearing debt. The remaining proceeds have thus
far and will continue to be used, in part, to stock inventory to keep up with demand and to build in-house assembly lines&#160;to
improve the cash-flow cycle and help reduce the four-month turnaround that the Company currently experiences from suppliers in
China. In the first half of 2022, a distribution warehouse was set up in Indiana to better service customers throughout the U.S.
and an assembly facility was leased in Redmond, Oregon for future expansion of the in-house assembly lines. Additionally, management
has secured a secondary source for lithium iron phosphate cells used in its batteries that is based in Denmark, should supply disruption
issues with China arise. Management believes that these factors will contribute to achieving operating efficiency and profitability.
However, there can be no assurance that the Company will be successful in achieving its objectives, including achieving operating
efficiency and profitability.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the settlement of liabilities and commitments in the normal course of business; however, the above conditions
raise substantial doubt about the Company&#x2019;s ability to do so. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:LiquidityAndCapitalResourcesPolicyTextBlock>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23681"
      unitRef="USD">49777</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:UseOfEstimates contextRef="From2023-01-01to2023-09-30" id="ixv-17356">&lt;p id="xdx_840_eus-gaap--UseOfEstimates_zANTPXXkTLag" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_z1k09Z9f0CFj"&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could vary materially from the estimates
that were used. The Company&#x2019;s significant accounting estimates include the carrying value of accounts receivable and inventory,
the depreciable lives of fixed assets, and stock-based compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
events, including the extent and the duration of the COVID-19-related economic impacts and their effects, cannot be predicted with certainty
and, accordingly, the Company&#x2019;s accounting estimates require the exercise of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17371">&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zM1t2IcH1W45" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_862_zHFji1q7K1Hc"&gt;Cash and Cash
Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all cash amounts which are not subject to withdrawal restrictions or penalties and all highly liquid investments purchased
with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains its cash balances
with high-quality financial institutions located in the United States. Cash accounts are secured by the Federal Deposit Insurance Corporation
(&#x201c;FDIC&#x201d;) up to $250,000 per institution. At times, balances may exceed federally insured limits. Investment accounts are
placed in funds consisting of US Treasury-related ultra-short paper. The Company has not experienced any losses in such accounts and
management believes that the Company is not exposed to any significant credit risk with respect to its cash and cash equivalents. As
of September 30, 2023, cash balances exceeded FDIC limits by $&lt;span id="xdx_900_eus-gaap--FDICIndemnificationAssetPeriodIncreaseDecrease_c20230101__20230930_zDrWcHx38j4c" title="FDIC Limits"&gt;547,054&lt;/span&gt; and investment accounts totaling $&lt;span id="xdx_902_ecustom--TreasuryRelatedPaper_c20230101__20230930_zdNTbYrQulzj" title="Treasury related paper"&gt;2,100,847&lt;/span&gt; are invested in US
Treasury-related ultra-short paper.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&#160;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FDICIndemnificationAssetPeriodIncreaseDecrease
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23682"
      unitRef="USD">547054</us-gaap:FDICIndemnificationAssetPeriodIncreaseDecrease>
    <XPON:TreasuryRelatedPaper
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23683"
      unitRef="USD">2100847</XPON:TreasuryRelatedPaper>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17391">&lt;p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zg3CV4xsKrFl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zQx8Pw8Ksx8a"&gt;Accounts Receivable&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable are recorded at the invoiced amount, are due within a year or less, and generally do not bear any
interest. The Company performs ongoing credit evaluations of its customers and generally requires no collateral. An allowance for
uncollectible accounts is recorded to reduce accounts receivable to the estimated amount that will be collected. The allowance
is based upon management&#x2019;s review of the accounts receivable aging and specific identification of potentially uncollectible
balances. Recoveries of accounts previously written off and adjustments to the allowance for uncollectible accounts are recorded
as adjustments to bad debt expense. For the three months ended September 30, 2023 and 2022, the Company wrote off $&lt;span id="xdx_902_ecustom--AdjustmentsToBadDebtExpense_c20230701__20230930_zhMWY4H08Hn1" title="Adjustments to bad debt expense"&gt;388&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--AdjustmentsToBadDebtExpense_c20220701__20220930_zDdBmfX45atg" title="Adjustments to BadDebt Expense"&gt;0&lt;/span&gt;,
respectively. For the nine months ended September 30, 2023 and 2022, the Company recovered a net of ($&lt;span id="xdx_907_ecustom--AdjustmentsToBadDebtExpense_c20230101__20230930_zPJnfsusliMk" title="Adjustments to BadDebt Expense"&gt;412&lt;/span&gt;) and wrote off $&lt;span id="xdx_90E_ecustom--AdjustmentsToBadDebtExpense_c20220101__20220930_zBP1XuFjh8ql" title="Adjustments to BadDebt Expense"&gt;19,604&lt;/span&gt;,
respectively. There was no allowance for doubtful accounts as of September 30, 2023 or December 31, 2022, as management believed
all outstanding amounts to be fully collectible.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
    <XPON:AdjustmentsToBadDebtExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23684"
      unitRef="USD">388</XPON:AdjustmentsToBadDebtExpense>
    <XPON:AdjustmentsToBadDebtExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23685"
      unitRef="USD">0</XPON:AdjustmentsToBadDebtExpense>
    <XPON:AdjustmentsToBadDebtExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23686"
      unitRef="USD">412</XPON:AdjustmentsToBadDebtExpense>
    <XPON:AdjustmentsToBadDebtExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23687"
      unitRef="USD">19604</XPON:AdjustmentsToBadDebtExpense>
    <XPON:CustomerDepositsPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17406">&lt;p id="xdx_841_ecustom--CustomerDepositsPolicyTextBlock_zNL2oEnKFQp7" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_z7xVitSlvKK5"&gt;Customer Deposits&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023 and December 31, 2022, the Company had customer deposits totaling $&lt;span id="xdx_90F_eus-gaap--CustomerDepositsCurrent_iI_c20230930_zcJaJUhl5srd" title="Customer deposits"&gt;46,248&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--CustomerDepositsCurrent_iI_c20221231_zXlNpb7xgH27"&gt;58&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:CustomerDepositsPolicyTextBlock>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23688"
      unitRef="USD">46248</us-gaap:CustomerDepositsCurrent>
    <us-gaap:CustomerDepositsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23689"
      unitRef="USD">58</us-gaap:CustomerDepositsCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17419">&lt;p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_z1GJZfvW8of1" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86C_zkDwjVdRHtk2"&gt;Inventory&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is stated at the lower of cost (first in, first out) or net realizable value and consists of batteries and
accessories, resale items, components, and related landing costs. As of September 30, 2023 and December 31, 2022, the Company had
inventory that consisted of finished assemblies&#160;totaling $&lt;span id="xdx_904_eus-gaap--InventoryFinishedGoods_iI_c20230930_zVVqLoTHmu1" title="Finished Inventory"&gt;3,306,972&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--InventoryFinishedGoods_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zd3owKutQuS6"&gt;3,243,485&lt;/span&gt;, respectively, and raw materials (inventory
components, parts, and packaging) totaling $&lt;span id="xdx_908_eus-gaap--InventoryRawMaterials_iI_c20230930_zo57vJqNtxf4" title="Raw materials"&gt;851,511&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--InventoryRawMaterials_iI_c20221231__custom--RestatementAxis__custom--ScenarioPreviouslyReportedMember_zbJsGW95Todg"&gt;1,286,651&lt;/span&gt;, respectively. The valuation of inventory includes fixed production
overhead costs based on normal capacity of the assembly warehouse. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company periodically reviews its inventory for evidence of slow-moving or obsolete inventory and provides for an allowance when considered
necessary. The Company determined that no such reserve was necessary as of September 30, 2023 or December 31, 2022. The Company prepays
for inventory purchases from foreign suppliers. Prepaid inventory totaled $&lt;span id="xdx_90F_eus-gaap--Supplies_iI_c20230930_zwDUndQS8Tof" title="Inventory purchases from foreign suppliers"&gt;102,646&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--Supplies_iI_c20221231_zFz97mIRGusc"&gt;141,611&lt;/span&gt; at September 30, 2023 and December 31,
2022, respectively, and included inventory in transit where title had passed to the Company but had not yet been physically received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23690"
      unitRef="USD">3306972</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      id="ixv-23691"
      unitRef="USD">3243485</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23692"
      unitRef="USD">851511</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      id="ixv-23693"
      unitRef="USD">1286651</us-gaap:InventoryRawMaterials>
    <us-gaap:Supplies
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23694"
      unitRef="USD">102646</us-gaap:Supplies>
    <us-gaap:Supplies
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23695"
      unitRef="USD">141611</us-gaap:Supplies>
    <XPON:VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17440">&lt;p id="xdx_84D_ecustom--VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock_zSVrJSTrujuf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zuyyMUkC9sUk"&gt;Vendor and Foreign
Concentrations of Inventory Suppliers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;During the three
months ended September 30, 2023 and 2022, respectively, approximately 61% and 91%, respectively, of inventory purchases were made
from foreign suppliers in China and Hong Kong. During the nine months ended September 30, 2023 and 2022, respectively, approximately
71% and 92%, respectively, of inventory purchases were made from foreign suppliers in China and Hong Kong. Any adverse change in
either the economic or political conditions abroad could negatively impact the Company&#x2019;s supply chain. The inability to obtain
product to meet sales demand could adversely affect results of operations. However, the Company has secured a secondary source
for lithium iron phosphate cells used in its batteries from a supplier in Denmark, enabling the Company to source materials outside
of China in the event it becomes necessary to do so.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0 0 8pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</XPON:VendorAndForeignConcentrationsOfInventorySuppliersPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17460">&lt;p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zl6mWGf2skuf" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_zvBO0PDWsi3f"&gt;Property and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less depreciation calculated on the straight-line basis over the estimated useful lives of the related
assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zuXw7FtPdsIg" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zV5v1ps7r6D2" style="display: none"&gt;Schedule of estimated useful lives&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-top: black 1pt solid; padding: 0 0 0 10pt; width: 73%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles
    and transportation equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 25%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZV5XzKnP4tg"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zpOXQnsnhsSd"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zuIIeEWpXLRd"&gt;3&lt;/span&gt; - &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember_zp71G5Uph898"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zVhJtgsDPtx3"&gt;3&lt;/span&gt; - &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_z2aU44dnTkoh"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember__srt--RangeAxis__srt--MinimumMember_z7IJ1jOnBH4i"&gt;3&lt;/span&gt; - &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember_zGVSRvGMW8yb"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zcl7qmHKALgc"&gt;3&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zHwntN1vxfZ"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and molds&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4KW4plU2Hag"&gt;3&lt;/span&gt;
    - &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_ztN4onwQ4D17"&gt;10&lt;/span&gt; years&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_z62Oyv4K3jEj" style="margin: 0; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements
are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Betterments,
renewals, and extraordinary repairs that extend the lives of the assets are capitalized; other repairs and maintenance charges are expensed
as incurred. The cost and related accumulated depreciation and amortization applicable to assets retired are removed from the accounts,
and the gain or loss on disposition is recognized in the Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <XPON:ScheduleOfEstimatedUsefulLivesTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17469">&lt;p id="xdx_897_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zuXw7FtPdsIg" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zV5v1ps7r6D2" style="display: none"&gt;Schedule of estimated useful lives&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-top: black 1pt solid; padding: 0 0 0 10pt; width: 73%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles
    and transportation equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 25%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MinimumMember_zZV5XzKnP4tg"&gt;5&lt;/span&gt;
    - &lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember__srt--RangeAxis__srt--MaximumMember_zpOXQnsnhsSd"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; width: 1%; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zuIIeEWpXLRd"&gt;3&lt;/span&gt; - &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureAndEquipmentMember_zp71G5Uph898"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MinimumMember_zVhJtgsDPtx3"&gt;3&lt;/span&gt; - &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember__srt--RangeAxis__srt--MaximumMember_z2aU44dnTkoh"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember__srt--RangeAxis__srt--MinimumMember_z7IJ1jOnBH4i"&gt;3&lt;/span&gt; - &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEequipmentMember_zGVSRvGMW8yb"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember__srt--RangeAxis__srt--MinimumMember_zcl7qmHKALgc"&gt;3&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_zHwntN1vxfZ"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0 0 0 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and molds&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember__srt--RangeAxis__srt--MinimumMember_z4KW4plU2Hag"&gt;3&lt;/span&gt;
    - &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_ztN4onwQ4D17"&gt;10&lt;/span&gt; years&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-top: 0; padding-right: 0; padding-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</XPON:ScheduleOfEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MinimumMember"
      id="ixv-23696">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember_srt_MaximumMember"
      id="ixv-23697">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_OfficeFurnitureAndEquipmentMember_srt_MinimumMember"
      id="ixv-23698">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_srt_MaximumMember_custom_OfficeFurnitureAndEquipmentMember"
      id="ixv-23699">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MinimumMember"
      id="ixv-23700">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_ManufacturingEquipmentMember_srt_MaximumMember"
      id="ixv-23701">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_WarehouseEequipmentMember_srt_MinimumMember"
      id="ixv-23702">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_srt_MaximumMember_custom_WarehouseEequipmentMember"
      id="ixv-23703">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_ToolingAndMoldsMember_srt_MinimumMember"
      id="ixv-23704">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_srt_MaximumMember_custom_ToolingAndMoldsMember"
      id="ixv-23705">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_custom_QAEquipmentMember_srt_MinimumMember"
      id="ixv-23706">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-09-30_srt_MaximumMember_custom_QAEquipmentMember"
      id="ixv-23707">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17550">&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zmsaz761uy13" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_867_z2uhXnc33Ek8"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at inception. Operating lease right-of-use (&#x201c;ROU&#x201d;) assets represent the Company&#x2019;s
right to use an underlying asset during the lease term, and operating lease liabilities represent&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Company&#x2019;s
obligation to make lease payments arising from the lease. Operating leases are included in ROU assets, current operating lease liabilities,
and long-term operating lease liabilities on the Company&#x2019;s Balance Sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
ROU assets and lease liabilities are initially recognized based on the present value of the future minimum lease payments
over the lease term at commencement date calculated using the Company&#x2019;s incremental borrowing rate applicable to the
lease asset, unless the implicit rate is readily determinable. ROU assets also include any lease payments made at or before
lease commencement and exclude any lease incentives received. The Company&#x2019;s lease terms may include options to extend
or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12
months or less are not recognized on the Company&#x2019;s Balance Sheet. The Company&#x2019;s leases do not contain any
residual value guarantees. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease
term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for lease and non-lease components as a single lease component for all its leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17571">&lt;p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHZVlaRWukAi" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_868_z3GfuMPhmwmd"&gt;Impairment of
Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;Long-lived assets
consist primarily of property and equipment. When events or circumstances indicate the carrying value of a long-lived asset may
be impaired, the Company estimates the future undiscounted cash flows to be derived from the use and eventual disposition of the
asset to assess whether or not a potential impairment exists. If the carrying value exceeds the estimate of future undiscounted
cash flows, the impairment is calculated as the excess of the carrying value of the asset over the estimate of its fair value.
Fair value is determined primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No
long-lived asset impairment was recognized during the three or nine months ended September 30, 2023 or 2022.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ExtendedProductWarrantyPolicy contextRef="From2023-01-01to2023-09-30" id="ixv-17583">&lt;p id="xdx_847_eus-gaap--ExtendedProductWarrantyPolicy_zyXGEm02mcJ7" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_z8MAFVzfacCg"&gt;Product Warranties&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;The Company sells
the majority of its products to customers along with conditional repair or replacement warranties. The Company&#x2019;s branded
DC mobile chargers are warrantied for two years from the date of sale and its branded VPR 4EVER Classic and Platinum batteries
are warrantied at gradually lesser levels over a twelve-year period from date of sale. The Company determines its estimated liability
for warranty claims based on the Company&#x2019;s experience of the amount of claims actually made. Management estimates no liability
as of September 30, 2023 and December 31, 2022 because, historically, there have been very few claims and costs for repairs&#160;or
replacement parts have been nominal. It is possible that the Company&#x2019;s estimate of liability for product liability claims
will change in the near term.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ExtendedProductWarrantyPolicy>
    <XPON:LiabilityForRefundsPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17603">&lt;p id="xdx_846_ecustom--LiabilityForRefundsPolicyTextBlock_zmaN7OQCgBK3" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zJX7B0uqI7R9"&gt;Liability for
Refunds&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;The Company does
not have a formal return policy but does accept returns under its warranty policies. Returns have historically been minimal.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:LiabilityForRefundsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17615">&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zaieuIHfl2p" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_864_zRUXrxLYomUc"&gt;Revenue Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s revenue is generated from the sale of products consisting primarily of batteries and accessories. The Company recognizes
revenue when control of goods or services is transferred to its customers in an amount that reflects the consideration it is expected
to be entitled to in exchange for those goods or services. To determine revenue recognition, the Company performs the following five
steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligation(s) in the contract; (iii)&#160;determine
the transaction price; (iv)&#160;allocate the transaction price to the performance obligation(s) in the contract; and (v)&#160;recognize
revenue when (or as) the performance obligation(s) are satisfied. Revenue is recognized upon shipment or delivery to the customer, as
that is when the customer obtains control of the promised goods and the Company&#x2019;s performance obligation is considered satisfied.
As such, accounts receivable is recorded at the time of shipment or will call, when the Company&#x2019;s right to the consideration becomes
unconditional and the Company determines there are no uncertainties regarding payment terms or transfer of control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-01-01to2023-09-30" id="ixv-17626">&lt;p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zic28ONNMc66" style="margin: 0; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_867_zVF3VNW0l4w1"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
customer is considered a major customer when net revenue attributable to the customer exceeds 10% of total revenue for the period or
outstanding receivable balances exceed 10% of total receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three months ended September 30, 2023, sales to three customers totaled $700,071, comprising approximately 38% of total sales. These
customers represented 31% of total accounts receivable as of September 30, 2023. During the nine months ended September 30, 2023, sales
to two customers totaled $1,178,142, comprising approximately 23% of total sales. These customers represented 23% of total accounts receivable
as of September 30, 2023. Accounts receivable from three additional customers totaled $190,495, representing approximately 40% of accounts
receivable as of September 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During the
three months ended September 30, 2022, sales to two customers totaled $394,936, comprising approximately 28% of total sales. There
were no accounts receivable for these customers as of September 30, 2022. During the nine months ended September 30, 2022, sales
to two customers totaled $1,816,821, comprising approximately 32% of total sales. Accounts receivables for these customers totaled
$7,486, representing approximately 3% of total accounts receivable as of September 30, 2022. Accounts receivable from two additional
customers totaled $90,789, representing approximately 32% of total accounts receivables as of September 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ShippingAndHandlingCostPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17645">&lt;p id="xdx_848_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zTFf5ClWxhW8" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_zrgvvuszgBz"&gt;Shipping and Handling
Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;Shipping and handling
fees billed to customers are classified in&#160;the Statement of Operations in &#x201c;Sales, net&#x201d; and totaled $&lt;span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230701__20230930_zYxhpTQflxFl" title="Shipping and handling fee"&gt;27,398&lt;/span&gt; and
$&lt;span id="xdx_90B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220701__20220930_zCjQcgfDGpHi" title="Shipping and handling fee"&gt;6,133&lt;/span&gt; during the three months ended September 30, 2023 and 2022, respectively, and $&lt;span id="xdx_903_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20230101__20230930_z0NAnTn3OiP4" title="Shipping and handling fee"&gt;52,296&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20220101__20220930_zae99EQTdkpj" title="Shipping and handling fee"&gt;17,514&lt;/span&gt; during the nine months
ended September 30, 2023 and 2022, respectively. Shipping and handling costs for shipping product to customers totaled $&lt;span id="xdx_906_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230701__20230930_zIZVrwz7Nox7" title="Shipping and handling costs for shipping product"&gt;58,141&lt;/span&gt;
and $&lt;span id="xdx_901_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220701__20220930_zzteob8JfWW5" title="Shipping and Handling Costs for Shipping Product"&gt;54,840&lt;/span&gt; during the three months ended September 30, 2023 and 2022, respectively, and $&lt;span id="xdx_903_ecustom--ShippingAndHandlingCostsForShippingProduct_c20230101__20230930_zvZPFMRMfkvg" title="Shipping and Handling Costs for Shipping Product"&gt;149,898&lt;/span&gt; and $&lt;span id="xdx_902_ecustom--ShippingAndHandlingCostsForShippingProduct_c20220101__20220930_z2w0cryYMxY2" title="Shipping and Handling Costs for Shipping Product"&gt;137,497&lt;/span&gt; during the nine
months ended September 30, 2023 and 2022, respectively, and are classified in selling, general, and administrative expense in the
accompanying Statements of Operations.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShippingAndHandlingCostPolicyTextBlock>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23708"
      unitRef="USD">27398</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23709"
      unitRef="USD">6133</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23710"
      unitRef="USD">52296</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23711"
      unitRef="USD">17514</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <XPON:ShippingAndHandlingCostsForShippingProduct
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23712"
      unitRef="USD">58141</XPON:ShippingAndHandlingCostsForShippingProduct>
    <XPON:ShippingAndHandlingCostsForShippingProduct
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23713"
      unitRef="USD">54840</XPON:ShippingAndHandlingCostsForShippingProduct>
    <XPON:ShippingAndHandlingCostsForShippingProduct
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23714"
      unitRef="USD">149898</XPON:ShippingAndHandlingCostsForShippingProduct>
    <XPON:ShippingAndHandlingCostsForShippingProduct
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23715"
      unitRef="USD">137497</XPON:ShippingAndHandlingCostsForShippingProduct>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17665">&lt;p id="xdx_84C_eus-gaap--AdvertisingCostsPolicyTextBlock_zOgCRPqN9Duh" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_869_z4X1Bsn8YSB6"&gt;Advertising and
Marketing Costs&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company expenses advertising and marketing costs as incurred. Advertising and marketing expense totaled $&lt;span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20230701__20230930_zzpF76DA7O77" title="Advertising and marketing expense"&gt;238,163&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--MarketingAndAdvertisingExpense_c20220701__20220930_zoBYJRoRQ5Lf"&gt;215,994&lt;/span&gt; for the
three months ended September 30, 2023 and 2022, respectively and $&lt;span id="xdx_90D_eus-gaap--MarketingAndAdvertisingExpense_c20230101__20230930_zfKEXxxy4Nce"&gt;690,995&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20220930_zbmh9L1WX0X1"&gt;527,732&lt;/span&gt; for the nine months ended September 30, 2023 and
2022, respectively, and is included in selling, general and administrative expense in the accompanying Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23716"
      unitRef="USD">238163</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23717"
      unitRef="USD">215994</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23718"
      unitRef="USD">690995</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23719"
      unitRef="USD">527732</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2023-01-01to2023-09-30" id="ixv-17688">&lt;p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zu2zb5uSlDg" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_866_zIsTtfCV2Ls7"&gt;Research and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred. Research and development costs charged to expense amounted to $&lt;span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20230701__20230930_z6QXmy9izALb" title="Research and development costs"&gt;145,111&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20220701__20220930_z8JZXu7QYOe9"&gt;41,355&lt;/span&gt; for
the three months ended September 30, 2023 and 2022, respectively, and $&lt;span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_c20230101__20230930_zLLzALUAO4wj"&gt;316,369&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20220930_zdrgDWnumJzi"&gt;153,730&lt;/span&gt; for the nine months ended September 30, 2023
and 2022, respectively, and are included in selling, general and administrative expenses in the accompanying Statements of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23720"
      unitRef="USD">145111</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23721"
      unitRef="USD">41355</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23722"
      unitRef="USD">316369</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23723"
      unitRef="USD">153730</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17703">&lt;p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z5amL6LL3PC4" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_865_zfT5BlKB4KE4"&gt;Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
November 1, 2021, the Company converted from an LLC to a C corporation and, as a result, became subject to corporate federal and state
income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of exiting assets and liabilities and their respective tax basis. Deferred tax assets, including
tax loss and credit carryforwards, and liabilities are measured using the enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that included the enactment date. Deferred income tax expense represents
the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation
allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not
be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency
economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort
to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic. Some of the more
significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period
for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the
previously enacted Tax Cuts and Jobs Act. As of September 30, 2023 and December 31, 2022, the Company has not recorded any income tax
provision/(benefit) resulting from the CARES Act, mainly due to the Company&#x2019;s history of net operating losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#x201c;CAA&#x201d;). The CAA includes provisions
extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the
impact of the CAA and its impact on its financial statements in 2023 and beyond.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-01to2023-09-30" id="ixv-17722">&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zV7PliosUCK6" style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span id="xdx_86F_z0q4RC6OBOsi"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;. ASC Topic
820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
1: &lt;/i&gt;Quoted prices (unadjusted) in active markets for identical assets or liabilities that are accessible at the measurement date.
The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
2: &lt;/i&gt;Observable prices that are based on inputs not quoted on active markets but corroborated by market data. These inputs include
quoted prices for similar assets or liabilities; quoted market prices in markets that are not active; or other inputs that are observable
or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Level
3: &lt;/i&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to
Level 3 inputs. In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the
use of unobservable inputs to the extent possible, as well as consider counterparty credit risk in the assessment of fair value.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist principally of cash and cash equivalents, accounts receivable, accounts payable, short-term
revolving loans, stockholder promissory notes, and long-term debt. The fair value of cash and cash equivalents, accounts receivable,
accounts payable, and short-term revolving loans approximates their respective carrying values because of the short-term nature of those
instruments. The fair value of the stockholder promissory notes, convertible notes, and long-term debt approximates their respective
carrying values because the interest rate approximates market rates available to the Company for similar obligations with the same maturities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17759">&lt;p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z9J2A90KyAB1" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zXdAiAjaTVfh"&gt;Segment Reporting&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently operates in one reportable segment. An operating segment is defined as a component of an enterprise for which discrete
financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) to evaluate performance
and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17770">&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zcjAReRD1ima" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_860_z1ojxA7cbqU7"&gt;Basic and Diluted
Net Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
basic net loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the period.
Diluted earnings or loss per share adjusts the basic earnings or loss per share for the potentially dilutive impact of securities (e.g.,
options and warrants).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
calculate basic and diluted net loss per share using the weighted average number of common shares outstanding during the periods presented.
In periods of a net loss position, basic and diluted weighted average common shares are the same. For the diluted earnings per share
calculation, we adjust the weighted average number of common shares outstanding to include dilutive stock options, warrants, unvested
restricted stock units and shares associated with the conversion of any convertible notes or preferred stock, when applicable. We use
the if-converted method for calculating any potential dilutive effect of convertible notes and convertible preferred stock on diluted
net loss per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following shows the amounts used in computing net loss per share:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zePybWaSuLEg" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zQX2EFnNMBN3" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_134_zvweiPURMUYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20230701__20230930_zFiW3vb3LjVh" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220701__20220930_z75Hf7GwhZ0a" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230101__20230930_zwhv0JvhSnll" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20220930_zeHqbQ6AOtlj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Three
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nine
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NetLossOne_ziztUNeD3Qo6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,814,215&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,279,304&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,270,281&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6,067,193&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zwxiOedMoiLd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average common shares outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,910,717&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,802,464&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,878,737&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,913,763&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--NetLossPerShareBasicAndDiluted_z1yj24NP6Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.19&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.77&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1.03&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zhji71lzjJIj" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;As
of September 30, 2023 and December 31, 2022, the Company has outstanding warrants, options, and restricted stock units (&#x201c;RSUs&#x201d;)
convertible into 1,926,610&#160;and 1,717,936 shares of common stock, respectively. The following table sets forth the number of
shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive.&lt;/p&gt;



&lt;p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zyoB77o7qJjh" style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zZmAWA3vVak8" style="display: none"&gt;Schedule
of anti-dilutive share&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_z0ucSeAjt4h3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zUlM0wcirv51" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;802,830&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zT3f4cQ55Eul" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;888,436&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8RJRSgh28M1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,075,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQoUblAc9nu1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_z6xhWsB6cwAe" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_ziAg5Zah8Nad" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1596"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930_zJ2ZxiTDCpT3" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,926,610&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zOAG9Jemb06g" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,717,936&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zzG6p9PN8rl" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17787">&lt;p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zePybWaSuLEg" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zQX2EFnNMBN3" style="display: none"&gt;Schedule of net loss per share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_134_zvweiPURMUYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20230701__20230930_zFiW3vb3LjVh" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220701__20220930_z75Hf7GwhZ0a" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230101__20230930_zwhv0JvhSnll" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20220930_zeHqbQ6AOtlj" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Three
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nine
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NetLossOne_ziztUNeD3Qo6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,814,215&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,279,304&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,270,281&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6,067,193&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--WeightedaverageNumberOfCommonSharesOutstanding_zwxiOedMoiLd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average common shares outstanding &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,910,717&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,802,464&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,878,737&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,913,763&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--NetLossPerShareBasicAndDiluted_z1yj24NP6Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.26&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.19&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.77&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1.03&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <XPON:NetLossOne
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23724"
      unitRef="USD">-1814215</XPON:NetLossOne>
    <XPON:NetLossOne
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23725"
      unitRef="USD">-1279304</XPON:NetLossOne>
    <XPON:NetLossOne
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23726"
      unitRef="USD">-5270281</XPON:NetLossOne>
    <XPON:NetLossOne
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23727"
      unitRef="USD">-6067193</XPON:NetLossOne>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="ixv-23728"
      unitRef="Shares">6910717</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      id="ixv-23729"
      unitRef="Shares">6802464</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2023-01-01to2023-09-30"
      decimals="INF"
      id="ixv-23730"
      unitRef="Shares">6878737</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:WeightedaverageNumberOfCommonSharesOutstanding
      contextRef="From2022-01-012022-09-30"
      decimals="INF"
      id="ixv-23731"
      unitRef="Shares">5913763</XPON:WeightedaverageNumberOfCommonSharesOutstanding>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="ixv-23732"
      unitRef="USDPShares">-0.26</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      id="ixv-23733"
      unitRef="USDPShares">-0.19</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2023-01-01to2023-09-30"
      decimals="INF"
      id="ixv-23734"
      unitRef="USDPShares">-0.77</XPON:NetLossPerShareBasicAndDiluted>
    <XPON:NetLossPerShareBasicAndDiluted
      contextRef="From2022-01-012022-09-30"
      decimals="INF"
      id="ixv-23735"
      unitRef="USDPShares">-1.03</XPON:NetLossPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-17946">&lt;p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zyoB77o7qJjh" style="margin: 2.25pt 0 0 1.95pt; text-align: justify; text-indent: 34.05pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zZmAWA3vVak8" style="display: none"&gt;Schedule
of anti-dilutive share&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_z0ucSeAjt4h3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zUlM0wcirv51" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;802,830&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zT3f4cQ55Eul" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;888,436&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8RJRSgh28M1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,075,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQoUblAc9nu1" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_z6xhWsB6cwAe" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RSUMember_ziAg5Zah8Nad" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1596"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930_zJ2ZxiTDCpT3" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,926,610&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_zOAG9Jemb06g" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,717,936&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23736"
      unitRef="Shares">802830</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23737"
      unitRef="Shares">888436</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="ixv-23738"
      unitRef="Shares">1075000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="ixv-23739"
      unitRef="Shares">829500</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_custom_RSUMember"
      decimals="INF"
      id="ixv-23740"
      unitRef="Shares">48780</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-01to2023-09-30"
      decimals="INF"
      id="ixv-23741"
      unitRef="Shares">1926610</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23742"
      unitRef="Shares">1717936</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18050">&lt;p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zknouLL4YS84" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_86D_zyjXuR8kfUwb"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation&#x2014;Stock Compensation&#x201d;, which
requires compensation costs to be recognized at grant date fair value over the requisite service period of each of the awards. The Company
recognizes forfeitures of awards as they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock options is determined using the Black-Scholes-Merton option pricing model. In order to calculate the fair value of
the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected
dividend yield and expected life. Changes to assumptions could cause significant adjustments to the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18068">&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK2ONxRis2ni" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span id="xdx_863_zjomQiUVvQp2"&gt;New Accounting
Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2022, the FASB issued ASU 2022-04, &#x201c;Liabilities&#x2014;Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier
Finance Program Obligations,&#x201d; which is intended to enhance the transparency surrounding the use of supplier finance programs in
connection with the purchase of goods and services. Supplier finance programs may also be referred to as reverse factoring, payables
finance, or structured payables arrangements. The amendments in ASU 2022-04 require a buyer that uses supplier finance programs to disclose
sufficient qualitative and quantitative information about the program to allow a user of financial statements to understand the program&#x2019;s
nature, activity during the period, changes from period to period, and potential magnitude. ASU 2022-04 is effective for all entities
for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods with those fiscal years, except
for the requirement to disclose roll forward information, which is effective prospectively for fiscal years beginning after December
15, 2023. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the
Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the FASB issued ASU 2022-02, &#x201c;Financial Instruments&#x2014;Credit Losses (Topic 326): Troubled Debt Restructurings and
Vintage Disclosures,&#x201d; which addresses and amends areas identified by the FASB as part of its post-implementation review of the
accounting standard that introduced the current expected credit losses (&#x201c;CECL&#x201d;) model. The amendments eliminate the accounting
guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan
refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require disclosure
of current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures.
For entities, such as Expion360 Inc., that have &lt;i&gt;not&lt;/i&gt; yet adopted the CECL accounting model in ASU 2016-13, the effective date for
the amendments in ASU 2022-02 is the same as the effective date in ASU 2016-13 (i.e., fiscal years beginning after December 15, 2022,
including interim periods within those fiscal years). The Company adopted this standard effective January 1, 2023, and the adoption of
this guidance did not have an impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities
from Contracts with Customers.&#x201d; ASU 2021-08 requires contract assets and contract liabilities acquired in a business combination
to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, on the acquisition date as if the
acquirer had entered into the original contract at the same date and on the same terms as the acquiree. ASU 2021-08 is effective for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for public business entities. The
Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have an impact on the Company&#x2019;s
financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. This ASU replaces the incurred loss impairment
methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range
of reasonable and supportable information for credit loss estimates on certain types of financial instruments, including trade receivables.
In addition, new disclosures are required. The ASU, as subsequently amended, is effective for the Company for fiscal years beginning
after December 15, 2022. The Company adopted this standard effective January 1, 2023, and the adoption of this guidance did not have
an impact on the Company&#x2019;s financial statements or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <XPON:AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18099">&lt;p id="xdx_84A_ecustom--AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock_zSnM0CB4zkV8" style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span id="xdx_860_zUd0W7Zv5zQf"&gt;Accounting Guidance Issued
but Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2023, the FASB issued ASU 2023-02, &#x201c;Investments&#x2014;Equity Method and Joint Ventures (Topic 323): Accounting for Investments
in Tax Credit Structures Using the Proportional Amortization Method.&#x201d; This ASU was issued to allow reporting entities to consistently
account for equity investments made primarily for the purpose of receiving income tax credits and other income tax benefits. ASU 2023-02
is effective for the Company for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.
The Company is currently evaluating the impact of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU 2022-03, &#x201c;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject
to Contractual Sale Restrictions,&#x201d; which amends the guidance in Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;, to clarify that a contractual
restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is
not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and
measure a contractual sale restriction. In addition, the ASU introduces new disclosure requirements for equity securities subject to
contractual sale restrictions that are measured at fair value. ASU 2022-03 is effective for fiscal years beginning after December 15,
2023, including interim periods within those fiscal years for public business entities. The Company is currently evaluating the impact
of this standard on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:AccountingGuidanceIssuedButNotYetAdoptedPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18115">&lt;p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z4GFxnyrfzK7" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.
&lt;span id="xdx_825_zWG33FeT4426"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property and equipment
consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zdaIUz23Il85" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_z4Y1xZWpzqea" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_305_134_zOfQ6BgUoqf8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, Net (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles and transportation
    equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zmhsxJUgBDNb" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;551,906&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zyLFZEgqsNU9" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;593,097&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zXagIjEVvhof" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314,819&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zAFW8MlYhu6g" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314,819&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zUUYEEV7yPG" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;188,131&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zFnXkyfj7IGj" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;188,131&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zdnBMdaZ2bJ" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;179,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zBxYP1sx2i43" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;179,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSUenEwxox74" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;81,164&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSR022k9Qzwg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;81,164&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zaTF3uav4Tcf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,032&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zWwlDJtq3DMd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and Molds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z8fU3Q1peZRk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1621"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z9cWHbJvWOFd" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930_zp1L0wYDBBcb" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,348,326&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zsAJvBmZMx6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,394,619&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
    accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230930_zqrB59mhZ0C" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(378,286&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSlyRdJTtSlj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(250,861&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230930_z3Fu8HJbJTc4" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;970,040&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zfF1SGzFjrgd" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,143,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_za00vqdEvNXe" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;Depreciation expense
was $&lt;span id="xdx_906_eus-gaap--DepreciationAndAmortization_c20230701__20230930_zLomK7IhHLHh" title="Depreciation expense"&gt;50,507&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--DepreciationAndAmortization_c20220701__20220930_zLvA60oLnhs2" title="Depreciation expense"&gt;48,364&lt;/span&gt; for the three months ended September 30, 2023 and 2022, respectively. Depreciation expense was $&lt;span id="xdx_90F_eus-gaap--DepreciationAndAmortization_c20230101__20230930_zzppiBdgjAAh" title="Depreciation expense"&gt;153,714&lt;/span&gt;&#160;and
$&lt;span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20220101__20220930_zFPUOMgQcP6h" title="Depreciation expense"&gt;115,670&lt;/span&gt; for the nine months ended September 30, 2023 and 2022, respectively. There were disposals and sales of fixed assets during
the nine months ended September 30, 2023 and 2022 resulting in the net cash received of $&lt;span id="xdx_90E_ecustom--DisposalsAndSalesOfFixedAssets_c20230101__20230930_zrFkVZLDD3Tl" title="Disposals and sales of fixed assets"&gt;36,748&lt;/span&gt; and $&lt;span id="xdx_909_ecustom--DisposalsAndSalesOfFixedAssets_c20220101__20220930_z31xWulygkEj"&gt;51,679&lt;/span&gt;, respectively. &#160;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18123">&lt;p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zdaIUz23Il85" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_z4Y1xZWpzqea" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_305_134_zOfQ6BgUoqf8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, Net (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vehicles and transportation
    equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zmhsxJUgBDNb" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;551,906&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehiclesAndTransportationEquipmentMember_zyLFZEgqsNU9" style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;593,097&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zXagIjEVvhof" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314,819&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zAFW8MlYhu6g" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;314,819&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zUUYEEV7yPG" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;188,131&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeFurnitureEquipmentMember_zFnXkyfj7IGj" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;188,131&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zdnBMdaZ2bJ" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;179,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ManufacturingEquipmentMember_zBxYP1sx2i43" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;179,274&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warehouse equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSUenEwxox74" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;81,164&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseEquipmentMember_zSR022k9Qzwg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;81,164&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;QA equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zaTF3uav4Tcf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,032&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--QAEquipmentMember_zWwlDJtq3DMd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,142&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tooling
    and Molds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z8fU3Q1peZRk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1621"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ToolingAndMoldsMember_z9cWHbJvWOFd" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,992&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230930_zp1L0wYDBBcb" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,348,326&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zsAJvBmZMx6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,394,619&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
    accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230930_zqrB59mhZ0C" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(378,286&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zSlyRdJTtSlj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(250,861&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230930_z3Fu8HJbJTc4" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;970,040&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zfF1SGzFjrgd" style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,143,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30_custom_VehiclesAndTransportationEquipmentMember"
      decimals="0"
      id="ixv-23743"
      unitRef="USD">551906</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_VehiclesAndTransportationEquipmentMember"
      decimals="0"
      id="ixv-23744"
      unitRef="USD">593097</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="ixv-23745"
      unitRef="USD">314819</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="ixv-23746"
      unitRef="USD">314819</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30_custom_OfficeFurnitureEquipmentMember"
      decimals="0"
      id="ixv-23747"
      unitRef="USD">188131</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_OfficeFurnitureEquipmentMember"
      decimals="0"
      id="ixv-23748"
      unitRef="USD">188131</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30_custom_ManufacturingEquipmentMember"
      decimals="0"
      id="ixv-23749"
      unitRef="USD">179274</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_ManufacturingEquipmentMember"
      decimals="0"
      id="ixv-23750"
      unitRef="USD">179274</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30_custom_WarehouseEquipmentMember"
      decimals="0"
      id="ixv-23751"
      unitRef="USD">81164</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_WarehouseEquipmentMember"
      decimals="0"
      id="ixv-23752"
      unitRef="USD">81164</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30_custom_QAEquipmentMember"
      decimals="0"
      id="ixv-23753"
      unitRef="USD">33032</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_QAEquipmentMember"
      decimals="0"
      id="ixv-23754"
      unitRef="USD">22142</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_ToolingAndMoldsMember"
      decimals="0"
      id="ixv-23755"
      unitRef="USD">15992</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23756"
      unitRef="USD">1348326</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23757"
      unitRef="USD">1394619</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23758"
      unitRef="USD">378286</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23759"
      unitRef="USD">250861</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23760"
      unitRef="USD">970040</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23761"
      unitRef="USD">1143758</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23762"
      unitRef="USD">50507</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23763"
      unitRef="USD">48364</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23764"
      unitRef="USD">153714</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23765"
      unitRef="USD">115670</us-gaap:DepreciationAndAmortization>
    <XPON:DisposalsAndSalesOfFixedAssets
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23766"
      unitRef="USD">36748</XPON:DisposalsAndSalesOfFixedAssets>
    <XPON:DisposalsAndSalesOfFixedAssets
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23767"
      unitRef="USD">51679</XPON:DisposalsAndSalesOfFixedAssets>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18374">&lt;p id="xdx_80A_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zRHfi0uWeo6i" style="margin: 0; font-weight: bold; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.
&lt;span id="xdx_828_zgkKIx4BkOde"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued expenses
and other current liabilities consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zk6LTjun6jrc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zdOXwVRN5Wrb" style="display: none"&gt;Schedule of accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30C_134_zvzUAiCUBNYc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230930_zQR2rqhREBhf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20221231_zgsXy1V5Yusa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zq0jMIv8Urz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued salaries
    and payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;222,411&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;169,337&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--RebateLiability_iI_zUizvKchRVtd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rebate liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,255&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,015&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_z8sMPuBMufDe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commissions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,720&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--FranchiseTax_iI_zOfKItefXA8i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Franchise tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,999&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredIncomeAndDepositSublease_iI_ziHGz8pZebJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred income and deposit
    (sublease)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,445&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_zss7oswqOJGk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zkncTLZllNej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,996&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;86,302&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_z972uapb0iC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;299,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;306,164&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zZHfzGEsQUH5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18382">&lt;p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zk6LTjun6jrc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zdOXwVRN5Wrb" style="display: none"&gt;Schedule of accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30C_134_zvzUAiCUBNYc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses and Other Current Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230930_zQR2rqhREBhf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20221231_zgsXy1V5Yusa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zq0jMIv8Urz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued salaries
    and payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;222,411&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;169,337&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--RebateLiability_iI_zUizvKchRVtd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Rebate liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,255&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,015&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedSalesCommissionCurrent_iI_z8sMPuBMufDe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commissions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,720&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--FranchiseTax_iI_zOfKItefXA8i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Franchise tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,999&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredIncomeAndDepositSublease_iI_ziHGz8pZebJ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred income and deposit
    (sublease)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,445&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,168&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_zss7oswqOJGk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;153&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_zkncTLZllNej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,996&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;86,302&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_z972uapb0iC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;299,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;306,164&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23768"
      unitRef="USD">222411</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23769"
      unitRef="USD">169337</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <XPON:RebateLiability
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23770"
      unitRef="USD">30255</XPON:RebateLiability>
    <XPON:RebateLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23771"
      unitRef="USD">26015</XPON:RebateLiability>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23772"
      unitRef="USD">22534</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23773"
      unitRef="USD">9720</us-gaap:AccruedSalesCommissionCurrent>
    <XPON:FranchiseTax
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23774"
      unitRef="USD">4999</XPON:FranchiseTax>
    <XPON:FranchiseTax
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23775"
      unitRef="USD">400</XPON:FranchiseTax>
    <XPON:DeferredIncomeAndDepositSublease
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23776"
      unitRef="USD">4445</XPON:DeferredIncomeAndDepositSublease>
    <XPON:DeferredIncomeAndDepositSublease
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23777"
      unitRef="USD">14168</XPON:DeferredIncomeAndDepositSublease>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23778"
      unitRef="USD">153</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23779"
      unitRef="USD">222</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23780"
      unitRef="USD">14996</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23781"
      unitRef="USD">86302</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23782"
      unitRef="USD">299793</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23783"
      unitRef="USD">306164</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18559">&lt;p id="xdx_802_ecustom--LiabilitiesForSaleOfFutureRevenuesTextBlock_zSCqK8Q4K48j" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.
&lt;span id="xdx_829_zy5ZbsItla3"&gt;Liabilities for Sale of Future Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"&gt;On December 8, 2020
and January 26, 2021, Reliant Funding, under two separate ACH Total Receipts Purchase Agreements (&#x201c;Purchase Agreements&#x201d;),
purchased a 50% interest in the Company&#x2019;s future revenues for a total aggregate purchase price of $250,000. Pursuant to the
terms of the Purchase Agreements, the purchased percentage continued to be owned by Reliant Funding, until the Company paid the
full purchased amount of $349,750. Repayment of the purchased amount was achieved through 252 daily bank account withdrawals of
$1,388 through December 15, 2021 and $694 thereafter through January 26, 2022. There were no payments made in the three months&#160;ended
September 30, 2023 or the same period for 2022. Interest was recognized at an effective annual interest rate of approximately 71%.
The Purchase Agreements were secured by substantially all of the assets of the Company. As of September 30, 2023 and December 31,
2022, the Company had no remaining liability related to the Purchase Agreements.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:LiabilitiesForSaleOfFutureRevenuesTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18570">&lt;p id="xdx_805_eus-gaap--DebtDisclosureTextBlock_z7OPXUQd1dxb" style="margin: 0; font-weight: bold; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.
&lt;span id="xdx_82E_zxPcZQgTOMGe"&gt;Short-Term Revolving Loans&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2020, the Company received funds under four unsecured Working Capital Loan Agreements (&#x201c;WC Loans&#x201d;). As of December 31, 2022,
the loans had been repaid and a balance of $0 was outstanding. Under the WC Loan Agreements and in accordance with the modified terms,
the Company was subject to monthly extended maturity interest of one percent on the ending outstanding monthly balance which increased
one percent for each month beyond the extended maturity date. The WC Loans were repaid in full in April 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The terms of each WC Loan are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$200,000
                                                                                                                                   limit
                                                                                                                                   &#x2013;
                                                                                                                                   dated
                                                                                                                                   March
                                                                                                                                   22,
                                                                                                                                   2020;
                                                                                                                                   monthly
                                                                                                                                   interest-only
                                                                                                                                   payments
                                                                                                                                   at
                                                                                                                                   15%
                                                                                                                                   annual
                                                                                                                                   interest;
                                                                                                                                   principal
                                                                                                                                   due
                                                                                                                                   12
                                                                                                                                   months
                                                                                                                                   from
                                                                                                                                   date
                                                                                                                                   of
                                                                                                                                   issue.
                                                                                                                                   This
                                                                                                                                   note
                                                                                                                                   was
                                                                                                                                   modified
                                                                                                                                   effective
                                                                                                                                   January
                                                                                                                                   1,
                                                                                                                                   2021
                                                                                                                                   to
                                                                                                                                   extend
                                                                                                                                   the
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   to
                                                                                                                                   December
                                                                                                                                   31,
                                                                                                                                   2021.
                                                                                                                                   The
                                                                                                                                   Company
                                                                                                                                   paid
                                                                                                                                   $50,000
                                                                                                                                   towards
                                                                                                                                   the
                                                                                                                                   principal
                                                                                                                                   balance
                                                                                                                                   in
                                                                                                                                   November
                                                                                                                                   2021.
                                                                                                                                   The
                                                                                                                                   balance
                                                                                                                                   of
                                                                                                                                   $150,000
                                                                                                                                   was
                                                                                                                                   paid
                                                                                                                                   in
                                                                                                                                   full
                                                                                                                                   in
                                                                                                                                   April
                                                                                                                                   2022
                                                                                                                                   (see
                                                                                                                                   below).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$400,000
                                                                                                                                   limit
                                                                                                                                   &#x2013;
                                                                                                                                   dated
                                                                                                                                   August
                                                                                                                                   31,
                                                                                                                                   2020;
                                                                                                                                   monthly
                                                                                                                                   interest-only
                                                                                                                                   payments
                                                                                                                                   at
                                                                                                                                   10%
                                                                                                                                   annual
                                                                                                                                   interest;
                                                                                                                                   pursuant
                                                                                                                                   to
                                                                                                                                   the
                                                                                                                                   WC
                                                                                                                                   Loan,
                                                                                                                                   the
                                                                                                                                   maturity
                                                                                                                                   was
                                                                                                                                   to
                                                                                                                                   be
                                                                                                                                   determined
                                                                                                                                   by
                                                                                                                                   mutual
                                                                                                                                   agreement
                                                                                                                                   and
                                                                                                                                   was
                                                                                                                                   to
                                                                                                                                   be
                                                                                                                                   at
                                                                                                                                   least
                                                                                                                                   30
                                                                                                                                   days
                                                                                                                                   after
                                                                                                                                   a
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   is
                                                                                                                                   agreed
                                                                                                                                   upon.
                                                                                                                                   The
                                                                                                                                   note
                                                                                                                                   was
                                                                                                                                   modified
                                                                                                                                   effective
                                                                                                                                   January
                                                                                                                                   1,
                                                                                                                                   2021
                                                                                                                                   to
                                                                                                                                   establish
                                                                                                                                   a
                                                                                                                                   maturity
                                                                                                                                   date
                                                                                                                                   of
                                                                                                                                   December
                                                                                                                                   31,
                                                                                                                                   2021,
                                                                                                                                   and
                                                                                                                                   was
                                                                                                                                   paid
                                                                                                                                   in
                                                                                                                                   full
                                                                                                                                   in
                                                                                                                                   April
                                                                                                                                   2022
                                                                                                                                   (see
                                                                                                                                   below).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
fees incurred in connection with obtaining and modifying these agreements were nominal and, given the short-term maturity of one year,
were expensed as incurred. There was no accounting impact to the financial statements related to the modifications.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;/p&gt;



</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermDebtTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18608">&lt;p id="xdx_808_eus-gaap--LongTermDebtTextBlock_zS1WeD6dIZD6" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.
&lt;span id="xdx_823_zOoRBNwTJqCc"&gt;Long-Term Debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt consisted of the
following at September 30, 2023 and December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zKoF4A6jVerj" style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B8_zGCFf1z9NLmj" style="display: none"&gt;Schedule of long term debt payment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zy8PBx78ip2i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-Term Debt (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="margin: 0"&gt;Senior secured promissory notes &#x2013; various investors.&#160;&#160;Monthly payments of interest only at
10% plus deferred interest of 5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity.
Matures the earlier of (a) May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of
control. The notes are senior to all other debt and are secured by substantially all assets of the Company. The notes included
detachable warrants to purchase 482,268 shares of common stock at an exercise price of $3.32 per share (see Note 10 &#x2013; Stockholders&#x2019;
Equity in Item 1 &#x2013; Financial Statements of Part I &#x2013; Financial Information). Debt issuance costs and discount totaling
$1,287,160 at date of issuance were being amortized and recognized as additional interest expense over the term of the notes using
the straight-line method because it was not substantially different from the effective interest rate method. We determined the
expected life of the notes to be the contractual term. Interest expense related to these notes includes amortization of debt issuance
costs and discount in the amount of $0 and $1,196,843, respectively, for the three months and nine months ended September 30, 2022,
respectively. The notes were paid in full in April 2022.&lt;/p&gt;


&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zu2E1BAkZbv6" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1676"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zSYhmgsZ52z5" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="width: 56%; font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; bank. Payable in monthly installments of $332, including interest at 5.8% per annum, due August 2025, secured by equipment and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zWzRoJiUKBif" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;7,213&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zoU4N5Nx5wwb" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,825&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; credit union. Payable in monthly installments of $508, including interest at 5.45% per annum, due July 2026, secured by a vehicle and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_z6Z8spHtDLjj" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;15,514&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zfhsTgyta9mk" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,364&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; SBA. Economic Injury Disaster Loan payable in monthly installments of $731, including interest at 3.75% per annum, due May 2050, and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z3mXhXacRPZa" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;147,735&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zmjRl5jKS2pa" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;150,114&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; individual. Monthly payments of interest only at 10% per annum, matured December 31, 2021 resulting in the entire principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31, 2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the note in full in April 2022.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zgZhqMNgTbPj" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1684"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zbVAN2AVINy4" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1685"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; finance company. Payable in monthly installments of $994, including interest at 8.5% per annum, due July 2026, secured by a vehicle and personally guaranteed by a stockholder.&#160;The Note was paid in full September 2022.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zCd81AxtILH8" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1686"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zMkCo5LyeyF3" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1687"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; finance company.&#160;Payable in monthly installments of $2,204, including interest at 11.21% per annum, due August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;The note was paid in full January 2023.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zoQEMg6apxVk" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1688"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zhaiJhr26jC" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;79,963&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Notes payable &#x2013; The Company has acquired six notes payable to GM Financial for vehicles.&#160;In April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;The agreement expired in April 2023 but was renewed for a commercial line up to $350,000 and prevailing GM Financial existing term notes will remain. The new agreement expires in April 2024.&#160;One note was paid off when the corresponding vehicle was sold in May 2023, so there are five notes remaining at September 30, 2023.&#160;The notes are currently payable in aggregate monthly installments of $4,084, including interest at rates ranging from 5.89% to 7.29% per annum, mature at various dates from October 2027 to May of 2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zYWmn3bXZ9Ri" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;191,027&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zHD2sHkbLt8c" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;251,209&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930_zOorhTjIBqxh" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;361,489&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20221231_zrd187XCFUzi" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;510,475&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--DebtCurrent_iNI_di_c20230930_z9fb3gRYLdg9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(50,058&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zeSIpKKGmET6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(71,426&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt, net of unamortized debt discount and current portion&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebtNoncurrent_iI_c20230930_zPjwHvUcLtxi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;311,431&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zgdRYecSgZ67" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;439,049&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




&lt;p id="xdx_8A8_zQ01OvCLcxPj" style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0 0 8pt"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future maturities of long-term debt are
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zoBjrwmp3Mi4" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zmgYdrwEu1v2" style="display: none"&gt;Schedule of Maturities of Long-Term Debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zjGUubLmMe11" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230930_z88lrVy2dXJj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="4"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Twelve months ending September 30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zTotBDrcuNs" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 50%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 6%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 38%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_z6sqjfZ2mVbb" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,934&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zWG8oml8sPx1" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,982&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zm5GU6aGDNe5" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;49,561&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_zUsPYrM1L2Ae" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,963&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbXNV0Ba8wa3" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;129,991&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LongTermDebt_iI_zTfYwgAEQi2l" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;361,489&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AC_zcHIuxVQy0fb" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18616">&lt;p id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zKoF4A6jVerj" style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B8_zGCFf1z9NLmj" style="display: none"&gt;Schedule of long term debt payment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zy8PBx78ip2i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-Term Debt (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
30, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="margin: 0"&gt;Senior secured promissory notes &#x2013; various investors.&#160;&#160;Monthly payments of interest only at
10% plus deferred interest of 5% accrued monthly to be paid at maturity.&#160;&#160;A minimum of one year interest is due at maturity.
Matures the earlier of (a) May 15, 2023, (b) the closing of a qualified subsequent financing or (c) the closing of a change of
control. The notes are senior to all other debt and are secured by substantially all assets of the Company. The notes included
detachable warrants to purchase 482,268 shares of common stock at an exercise price of $3.32 per share (see Note 10 &#x2013; Stockholders&#x2019;
Equity in Item 1 &#x2013; Financial Statements of Part I &#x2013; Financial Information). Debt issuance costs and discount totaling
$1,287,160 at date of issuance were being amortized and recognized as additional interest expense over the term of the notes using
the straight-line method because it was not substantially different from the effective interest rate method. We determined the
expected life of the notes to be the contractual term. Interest expense related to these notes includes amortization of debt issuance
costs and discount in the amount of $0 and $1,196,843, respectively, for the three months and nine months ended September 30, 2022,
respectively. The notes were paid in full in April 2022.&lt;/p&gt;


&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zu2E1BAkZbv6" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1676"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredPromissoryNotesMember_zSYhmgsZ52z5" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="width: 56%; font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; bank. Payable in monthly installments of $332, including interest at 5.8% per annum, due August 2025, secured by equipment and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zWzRoJiUKBif" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;7,213&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--NotesPayableToBanksMember_zoU4N5Nx5wwb" style="width: 12%; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,825&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; credit union. Payable in monthly installments of $508, including interest at 5.45% per annum, due July 2026, secured by a vehicle and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_z6Z8spHtDLjj" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;15,514&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableCreditUnionMember_zfhsTgyta9mk" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,364&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; SBA. Economic Injury Disaster Loan payable in monthly installments of $731, including interest at 3.75% per annum, due May 2050, and personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_z3mXhXacRPZa" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;147,735&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableSBAMember_zmjRl5jKS2pa" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;150,114&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; individual. Monthly payments of interest only at 10% per annum, matured December 31, 2021 resulting in the entire principal balance recorded in current portion of long-term debt on the accompanying Balance Sheets for the year ending December 31, 2021; pursuant to the note, the past due balance is subject to 1% additional monthly interest which increases one percent for each month beyond maturity date, unsecured. The Company remained in compliance with the extended maturity interest payments and paid the note in full in April 2022.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zgZhqMNgTbPj" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1684"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableIndividualMember_zbVAN2AVINy4" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1685"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; finance company. Payable in monthly installments of $994, including interest at 8.5% per annum, due July 2026, secured by a vehicle and personally guaranteed by a stockholder.&#160;The Note was paid in full September 2022.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zCd81AxtILH8" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1686"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompanyMember_zMkCo5LyeyF3" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1687"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Note payable &#x2013; finance company.&#160;Payable in monthly installments of $2,204, including interest at 11.21% per annum, due August 2026, secured by a vehicle and personally guaranteed by a co-founder.&#160;The note was paid in full January 2023.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zoQEMg6apxVk" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1688"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--NotePayableFinanceCompany1Member_zhaiJhr26jC" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;79,963&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Notes payable &#x2013; The Company has acquired six notes payable to GM Financial for vehicles.&#160;In April 2022, the Company secured a commercial line up to $300,000 to be used to finance vehicle purchases.&#160;The agreement expired in April 2023 but was renewed for a commercial line up to $350,000 and prevailing GM Financial existing term notes will remain. The new agreement expires in April 2024.&#160;One note was paid off when the corresponding vehicle was sold in May 2023, so there are five notes remaining at September 30, 2023.&#160;The notes are currently payable in aggregate monthly installments of $4,084, including interest at rates ranging from 5.89% to 7.29% per annum, mature at various dates from October 2027 to May of 2028, and are secured by the related vehicles. Two of the notes are personally guaranteed by a co-founder.&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20230930__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zYWmn3bXZ9Ri" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;191,027&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--GMFinancialMember_zHD2sHkbLt8c" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;251,209&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230930_zOorhTjIBqxh" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;361,489&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20221231_zrd187XCFUzi" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;510,475&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--DebtCurrent_iNI_di_c20230930_z9fb3gRYLdg9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(50,058&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--DebtCurrent_iNI_di_c20221231_zeSIpKKGmET6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(71,426&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt, net of unamortized debt discount and current portion&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--LongTermDebtNoncurrent_iI_c20230930_zPjwHvUcLtxi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;311,431&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--LongTermDebtNoncurrent_iI_c20221231_zgdRYecSgZ67" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;439,049&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_us-gaap_NotesPayableToBanksMember"
      decimals="0"
      id="ixv-23784"
      unitRef="USD">7213</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_us-gaap_NotesPayableToBanksMember"
      decimals="0"
      id="ixv-23785"
      unitRef="USD">9825</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_custom_NotePayableCreditUnionMember"
      decimals="0"
      id="ixv-23786"
      unitRef="USD">15514</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableCreditUnionMember"
      decimals="0"
      id="ixv-23787"
      unitRef="USD">19364</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_custom_NotePayableSBAMember"
      decimals="0"
      id="ixv-23788"
      unitRef="USD">147735</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableSBAMember"
      decimals="0"
      id="ixv-23789"
      unitRef="USD">150114</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_NotePayableFinanceCompany1Member"
      decimals="0"
      id="ixv-23790"
      unitRef="USD">79963</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30_custom_GMFinancialMember"
      decimals="0"
      id="ixv-23791"
      unitRef="USD">191027</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31_custom_GMFinancialMember"
      decimals="0"
      id="ixv-23792"
      unitRef="USD">251209</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23793"
      unitRef="USD">361489</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23794"
      unitRef="USD">510475</us-gaap:LongTermDebt>
    <us-gaap:DebtCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23795"
      unitRef="USD">50058</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23796"
      unitRef="USD">71426</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23797"
      unitRef="USD">311431</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="ixv-23798"
      unitRef="USD">439049</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18865">&lt;p id="xdx_89F_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zoBjrwmp3Mi4" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zmgYdrwEu1v2" style="display: none"&gt;Schedule of Maturities of Long-Term Debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_306_134_zjGUubLmMe11" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Long-Term Debt (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230930_z88lrVy2dXJj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="4"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Twelve months ending September 30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_zTotBDrcuNs" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 50%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 6%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 38%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,058&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_z6sqjfZ2mVbb" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,934&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zWG8oml8sPx1" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,982&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermDebtMaturingInYearsTwoAndThree_iI_zm5GU6aGDNe5" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;49,561&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_zUsPYrM1L2Ae" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,963&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_zbXNV0Ba8wa3" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;129,991&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LongTermDebt_iI_zTfYwgAEQi2l" style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;361,489&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23799"
      unitRef="USD">50058</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23800"
      unitRef="USD">52934</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23801"
      unitRef="USD">50982</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturingInYearsTwoAndThree
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23802"
      unitRef="USD">49561</us-gaap:LongTermDebtMaturingInYearsTwoAndThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23803"
      unitRef="USD">27963</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23804"
      unitRef="USD">129991</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23805"
      unitRef="USD">361489</us-gaap:LongTermDebt>
    <XPON:ShareholderPromissoryNotesTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18943">&lt;p id="xdx_806_ecustom--ShareholderPromissoryNotesTextBlock_zbWD2LTaljQj" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.
&lt;span id="xdx_824_zXHvZpM5ggfj"&gt;Stockholder Promissory Notes&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of both September 30, 2023 and December 31, 2022, the Company had an outstanding principal balance of $825,000 due to stockholders under
unsecured Promissory Notes Agreements (&#x201c;Notes&#x201d;). The Notes require monthly interest-only payments at 10% per annum. The Notes
mature at various dates from January 2024 to December 2024 as follows: January 2024 - $125,000; August 2024 - $500,000 (this note would
have matured at August 2023, but in June 2023, an agreement was signed extending the maturity date to August 2024); and December 2024
- $200,000.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
paid to the stockholders under the Notes totaled $20,627 and $20,627 during the three months ended September 30, 2023 and September 30,
2022, respectively. Interest paid to the stockholders under the Notes totaled $61,881 and $61,881 during the nine months ended September
30, 2023 and September 30, 2022, respectively. There was no accrued interest as of September 30, 2023 or December 31, 2022 related to
these Notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</XPON:ShareholderPromissoryNotesTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18958">&lt;p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z2yRbwEpMP07" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.
&lt;span id="xdx_823_zLEra1kaGuNa"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Operating Leases&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company leases its warehouses and office space under long-term lease arrangements. None of its leases include characteristics specified
in ASC 842, &lt;i&gt;Leases&lt;/i&gt;, that require classification as financing leases, and accordingly, these leases are accounted for as operating
leases. The Company does not recognize a right-of-use asset and lease liability for short-term leases, which have terms of 12 months
or less. For longer-term lease arrangements that are recognized on the Company&#x2019;s Balance Sheet, the right-of-use asset and lease
liability are initially measured at the commencement date based upon the present values of the lease payments due under the leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
implicit interest rates of the Company&#x2019;s lease arrangements are generally not readily determinable and as such, the Company applies
an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine
the present value of lease payments due under the arrangement. Under ASC 842, the incremental borrowing rate (IBR) for leases must be
(1) a rate of interest over a similar term, and (2) for an amount that is equal to the lease payments. The Company uses both the Federal
Reserve Economic Data (FRED) U.S. corporate debt effective yield and the U.S. Treasury rates adjusted for credit spread as the primary
data points for purposes of determining the IBR.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;In the first quarter
of 2022, the Company entered into two new long-term, non-cancelable operating lease agreements for office and warehouse space resulting
in the Company recognizing an additional lease liability totaling of $2,348,509, representing the present value of the lease payments
discounted using an effective interest rate of 8.07% and 8.86%, and corresponding right-of-use assets of $2,348,509. The leases
expire in December 2026 &#160;and December 2028. The second lease contains one three-year option to renew. The lease is guaranteed
by a co-founder.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the first quarter of 2021, the Company entered into a long-term, non-cancelable operating lease agreement for office and warehouse space
resulting in the Company recognizing an additional lease liability totaling of $1,268,089, representing the present value of the lease
payments discounted using an effective interest rate of 7.47% and a corresponding right-of-use asset of $1,268,089. The lease expires
in January 2028&#160;and contains one three-year option to renew. The lease is guaranteed by a co-founder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;The Company has two
other leases&#x2014;one that expired in January 2023 and one that expires in February 2025. The leases generally provide for annual
increases based on a fixed amount and generally require the Company to pay real estate taxes, insurance, and repairs. Both leases
are guaranteed by a co-founder.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 8pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following
is a summary of total lease costs during the three months and nine months ended September 30, 2023 and 2022:&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zUAagphrgysl"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_z7C6NbVV0b2l" style="display: none"&gt;Schedule of lease cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_zOChwuWPpONg" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20230701__20230930_zpCtb6u0TWQd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220701__20220930_zjn2Ukg1guri" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20230101__20230930_zcjxah3v4pwb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20220930_z1mY7KClAx0i" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Three
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nine
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OperatingLeaseCost_zdHXFyt8Q7Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;187,315&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;198,795&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;562,660&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;561,949&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ShortTermLeaseCost_zgwvc8sv9ttj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1726"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;450&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,077&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--VariableLeaseCost_z768GSysIESf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Variable
    lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1733"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1734"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z0LQlFs692Q3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sublease
    income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,440&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(25,022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(39,476&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(98,364&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LeaseCost_z86NS0NEpHNk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;176,875&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;174,223&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;523,334&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;466,662&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AD_zW5wITcJk2x" style="margin: 0; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0 0 8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
weighted-average remaining lease term was 4.78 years and 5.49 years as of September 30, 2023 and December 31, 2022, respectively. The
weighted average discount rate was 8.48% and 8.48%, as of September 30, 2023 and December 31, 2022, respectively. Operating cash flows
from the operating leases totaled $116,591 and $115,442 for the three months ended September 30, 2023 and 2022, respectively, and $350,794
and $322,112 for the nine months ended September 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total lease liability as of September 30, 2023 and December 31, 2022 was $2,883,217 and $3,220,019, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 8pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of September 30, 2023, for
years ending September 30:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zcBi2eWnGRt2" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zwg0sSJc4HTj" style="display: none"&gt;Schedule of future minimum lease payment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_302_134_z0HXTQAeHOf3" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20230930_zqFoQwRjYQfd" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_znS99N1KgNG1" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 73%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;731,243&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_znalB1v5wi7f" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;725,589&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zJS3yuqzzhm9" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;727,150&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_zoHsE6MDZw31" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;703,541&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_z9jztcz5qWF" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;532,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeWcnKvm6tf2" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;112,569&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zeoRzoYcHEtc" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,532,925&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z6rqGlGgqvL5" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(649,708&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zSMg30yILxG4" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,883,217
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zAeEkhFBNy9h" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;506,743&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zgPRi5p0tFGl" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Noncurrent lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,376,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseLiability_iI_zZFLI6RvWVh4" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,883,217
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zHLyThV1AnC6" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subleases&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;The Company subleases
office and warehouse space under one of its existing operating leases with similar terms as the Company&#x2019;s lease agreements.
Because the Company is not relieved of its primary obligations under the original lease, the Company accounts for the subleases
as a lessor. Sublease rental income is recorded based on the contractual rental payments which are not substantially different
from recognition on a straight-line basis over the lease term and totaled $10,440 and $25,022 &#160;during the three months ended
September 30, 2023 and 2022, respectively, and $39,476 and $98,364 &#160;during the nine months ended September 30, 2023 and 2022,
respectively. As of September 30, 2023 and December 31, 2022, deferred income and a sublease deposit totaled $4,445 and $14,168,
respectively, and is included in accrued expenses and other current liabilities on the accompanying Balance Sheets.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 8pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following
are the total future minimum sublease payments as of September 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zqFyPOJdbvG9" style="margin: 0 0 8pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zJZs93bZvkCe" style="display: none"&gt;Schedule of
future minimum sublease payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_ziZ4s47ADuQ2" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 77%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Twelve months ending September
    30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20230930_zU4ARZkGlgTi" style="width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zViBC96lzPGb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42,491&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_zUwuxibF07l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,922&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zcBEZH0QOODb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease
    payments&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;60,413&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_zK0DL6lKgUn1" style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Litigation&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may be involved from time to time in litigation or claims arising in the ordinary course of its business. While the ultimate
liability, if any, arising from these claims cannot be determined with certainty, the Company believes that the resolution of any such
matters will not likely have a material adverse effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&#160;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 22, 2022, Expion360 Inc. (the &#x201c;Company&#x201d;) &lt;span style="background-color: white"&gt;received notice of a complaint (the
&#x201c;Complaint&#x201d;) filed against it in Oregon state court by Ravi Sinha. The Complaint alleges,&#160;&lt;/span&gt;&lt;i&gt;inter alia&lt;/i&gt;&lt;span style="background-color: white"&gt;,
that Mr. Sinha is entitled to 282,284 shares of the Company&#x2019;s common stock, or in the alternative, $300,000 plus interest in connection
with services he previously rendered the Company as its chief executive officer. On March 21, 2023, the Company entered into a settlement
agreement with Mr. Sinha and the matter has been resolved with cash and the issuance of common stock (see Note 10 &#x2013; Stockholders&#x2019;
Equity&lt;/span&gt; in Item 1 &#x2013; Financial Statements of Part I &#x2013; Financial Information&lt;span style="background-color: white"&gt;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-18995">&lt;p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zUAagphrgysl"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_z7C6NbVV0b2l" style="display: none"&gt;Schedule of lease cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30B_134_zOChwuWPpONg" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20230701__20230930_zpCtb6u0TWQd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220701__20220930_zjn2Ukg1guri" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20230101__20230930_zcjxah3v4pwb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20220930_z1mY7KClAx0i" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Three
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nine
    Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OperatingLeaseCost_zdHXFyt8Q7Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;187,315&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;198,795&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;562,660&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;561,949&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ShortTermLeaseCost_zgwvc8sv9ttj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1726"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;450&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,077&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--VariableLeaseCost_z768GSysIESf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Variable
    lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1733"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1734"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SubleaseIncome_iN_di_z0LQlFs692Q3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sublease
    income&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,440&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(25,022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(39,476&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(98,364&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LeaseCost_z86NS0NEpHNk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;176,875&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;174,223&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;523,334&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;466,662&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23806"
      unitRef="USD">187315</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23807"
      unitRef="USD">198795</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23808"
      unitRef="USD">562660</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23809"
      unitRef="USD">561949</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23810"
      unitRef="USD">450</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23811"
      unitRef="USD">150</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23812"
      unitRef="USD">3077</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23813"
      unitRef="USD">10440</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23814"
      unitRef="USD">25022</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23815"
      unitRef="USD">39476</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23816"
      unitRef="USD">98364</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="ixv-23817"
      unitRef="USD">176875</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2022-07-012022-09-30"
      decimals="0"
      id="ixv-23818"
      unitRef="USD">174223</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2023-01-01to2023-09-30"
      decimals="0"
      id="ixv-23819"
      unitRef="USD">523334</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      id="ixv-23820"
      unitRef="USD">466662</us-gaap:LeaseCost>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-19245">&lt;p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zcBi2eWnGRt2" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zwg0sSJc4HTj" style="display: none"&gt;Schedule of future minimum lease payment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_302_134_z0HXTQAeHOf3" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20230930_zqFoQwRjYQfd" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_iI_znS99N1KgNG1" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 73%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;731,243&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_znalB1v5wi7f" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;725,589&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_zJS3yuqzzhm9" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;727,150&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_zoHsE6MDZw31" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;703,541&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_z9jztcz5qWF" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;532,833&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_zeWcnKvm6tf2" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;112,569&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_zeoRzoYcHEtc" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,532,925&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z6rqGlGgqvL5" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(649,708&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zSMg30yILxG4" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,883,217
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zAeEkhFBNy9h" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;506,743&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zgPRi5p0tFGl" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Noncurrent lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,376,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseLiability_iI_zZFLI6RvWVh4" style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,883,217
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23821"
      unitRef="USD">731243</us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23822"
      unitRef="USD">725589</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23823"
      unitRef="USD">727150</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23824"
      unitRef="USD">703541</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23825"
      unitRef="USD">532833</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23826"
      unitRef="USD">112569</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23827"
      unitRef="USD">3532925</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23828"
      unitRef="USD">649708</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23829"
      unitRef="USD">2883217</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23830"
      unitRef="USD">506743</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23831"
      unitRef="USD">2376474</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23832"
      unitRef="USD">2883217</us-gaap:OperatingLeaseLiability>
    <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-19389">&lt;p id="xdx_899_eus-gaap--ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_zqFyPOJdbvG9" style="margin: 0 0 8pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zJZs93bZvkCe" style="display: none"&gt;Schedule of
future minimum sublease payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_ziZ4s47ADuQ2" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 77%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Twelve months ending September
    30,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20230930_zU4ARZkGlgTi" style="width: 17%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_iI_zViBC96lzPGb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42,491&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_iI_zUwuxibF07l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,922&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FutureMinimumSubleaseRentalsSaleLeasebackTransactions_iI_zcBEZH0QOODb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total future minimum lease
    payments&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;60,413&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>
    <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23833"
      unitRef="USD">42491</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear>
    <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23834"
      unitRef="USD">17922</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears>
    <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactions
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="ixv-23835"
      unitRef="USD">60413</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactions>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-19458">&lt;p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8mEXorYBGFe" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.
&lt;span id="xdx_822_zV5OosiIvbO8"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="font-weight: normal; color: windowtext"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue an aggregate of 220,000,000 &#160;&#160;shares of capital stock, par value $0.001 per share, consisting
of 200,000,000 shares of common stock and 20,000,000 shares of preferred stock. On March 31, 2023, at the closing price of $4.84 per
share, the Company issued 52,000 shares of common stock as part of the settlement agreement with Mr. Sinha dated March 21, 2023. As of
September 30, 2023 and December 31, 2022, 6,910,717 and 6,802,464 shares, respectively, of common stock were issued and outstanding.
No shares of preferred stock have been issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
holder of common stock is entitled to one vote for each share of common stock. The holders of common stock have no conversion, redemption
or preemptive rights and shall be entitled to receive dividends when, as, and if declared by the board of directors. Upon dissolution,
liquidation, or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, subject
to the rights, if any, of the holders of any class or series stock having a preference over the right to participate with common stock
with respect to the distribution of assets of the Company upon such dissolution, liquidation, or winding up of the Company, the holders
of common stock shall be entitled to receive the remaining assets of the Company available for distribution to its stockholders ratably
in proportion to the number of shares of common stock held.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
no shares of preferred stock have been issued, no rights and privileges of preferred stockholders have been defined.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Initial Public
Offering&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2022, the Company completed an initial public offering (&#x201c;IPO&#x201d;). A total of 2,466,750 shares of common stock were
sold at $7.00 per share in the IPO, for total gross proceeds of $17,267,250. The Company incurred IPO costs of $2,494,763 resulting in
net proceeds of $14,772,487. Additionally, during the year ended December 31, 2022, the Company issued 35,714 shares of common stock
at $7.00 per share to an outside third party in exchange for IPO services. The fair value of the shares of $249,998 were recorded as
an increase to common stock of $36 (35,714 shares at $.001 par value) and additional paid in capital of $249,962 and a corresponding
reduction to additional paid in capital of $249,998, resulting in a net decrease in additional paid in capital of $36.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrants/Options&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;On August 10, 2023,
the Company issued 25,000 warrants to their investor relations firm in accordance with a letter of engagement signed July 22, 2022,
to purchase 25,000 shares of common stock at an exercise price of $5.00 per share. The warrants expire 2 years from date of grant
(August 9, 2025). The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model
and following assumptions: per share price of common stock on date of grant $5.20, expected dividend yield of 0%, expected volatility
of 88%, risk-free interest rate of 4.82% and expected life based on contractual life of 2 years. The fair value of $65,046&#160;
was recorded as an increase in additional paid-in capital and expensed to Legal and Professional Services.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2022, the Company issued warrants to IPO underwriters to purchase 148,005 shares of common stock at an exercise price of $9.10
per share. The warrants are exercisable 180 days after grant (September 27, 2022) and expire 5 years from date of grant (March 31, 2027).
The fair value of the warrants was determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions:
per share price of common stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest
rate of 2.55% and expected life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in
capital and a reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero
impact to additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2023, 15,000 warrants exercisable at $3.32 per share were exercised on a cash basis which resulted
in the issuance of 15,000 shares of common stock. In addition, 22,606 warrants exercisable at $3.32 per share were exercised using the
cashless conversion option, which resulted in the issuance of 10,151 shares of common stock. This leaves 521,825 warrants remaining with
an exercise price of $3.32.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2023, 73,000 warrants exercisable at $2.90 per share were exercised using the cashless conversion
option which resulted in the issuance of 31,102 shares of common stock. This leaves 78,000 warrants remaining with an exercise price
of $2.90.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.35pt"&gt;As of September
30, 2023 and December 31, 2022, a total of 772,830 and 858,436 warrants were issued and outstanding, respectively. As of September
30, 2023 and December 31, 2022, a total of 30,000 options, which were not issued under a specified plan, were outstanding. As of
September 30, 2023, below is a summary of the various warrants/options issued and outstanding:&lt;/p&gt;

&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_89D_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zdD8GKq3aiYa" style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B7_zm75MT70gd62" style="display: none"&gt;Schedule of various warrants/options issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_301_134_zABaZfFVn2lh" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 47%; text-align: center"&gt;&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number
                                               of warrants/non-plan options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;/td&gt;
    &lt;td style="width: 23%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 30%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average Remaining
    Life (Yrs)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfWarrantsnonplanOptionsOne_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zKbapBLbOX7e" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zZsB6XKMCa3b" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePricesMember_zKne3ypdaBk9"&gt;1.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_984_ecustom--NumberOfWarrantsnonplanOptionsTwo_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zo9CS0bUS2lb" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;521,825&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zCTh5SGjeYje" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$3.32 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zBp8z7jLCqMi"&gt;8.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98C_ecustom--NumberOfWarrantsnonplanOptionsThree_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zTzqyoS76RNe" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;78,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zt1ripov30J3" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$2.90 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zclT3p4JMwBe"&gt;1.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_985_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_z7B1Ksldnlf" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zah7kwM60dXh" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$3.32 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zW8SCQXV7SH7"&gt;1.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_981_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_zcMZ6goDaZC6" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;148,005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_z6UiFSsNAFFe" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$9.10
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zgg7PK4bJNLd"&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zLl2b9MbIvle" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock Option Plans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;As of September 30,
2023, the Company had adopted two stock-based compensation plans, the 2021 Incentive Award Plan and the 2021 Employee Stock Purchase
Plan, both of which are described below and became effective upon the initial public offering. On May 2, 2022, the Company granted
829,500 options and on August&#160; 23, 2023, the Company granted 245,500 options and 48,780 restricted stock units (&#x201c;RSUs&#x201d;)
under the 2021 Incentive Award Plan. No shares have been issued to date under the 2021 Employee Stock Purchase Plan. The compensation
cost that has been charged against operations was $2,114,529 for the year ended December 31, 2022 and $124,785 for the three months
ended September 30, 2023.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;2021 Incentive Award Plan&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"&gt;The purpose of the
Company&#x2019;s 2021 Incentive Award Plan is to enhance the Company&#x2019;s ability to attract, retain and motivate persons who
make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities.
Various stock-based awards may be granted under the plan to eligible employees, consultants, and non-employee directors. The number
of shares issued under the plan is subject to limits and is adjusted annually. No more than 1,000,000 shares may be issued pursuant
to the exercise of incentive stock options. The aggregate share limit will be subject to an annual increase on the first day of
each calendar year ending on and including January 1, 2031, by a number of shares equal to the lesser of (i) a number equal to
5% of the aggregate number of shares of the Company's common stock outstanding on the final day of the immediately preceding calendar
year and (ii) such smaller number of shares as is determined by the Company's board or committee. As of September 30, 2023, the
aggregate number of shares that can be issued under the Plan is 1,199,623, of which 1,075,000 options and 48,780 RSUs have been
granted. The number of shares granted, the exercise price, and the terms will be determined at date of grant; however, the exercise
price shall not be less than 100% of the fair value on the grant date (110% for options granted to greater than 10% stockholders)
and the term shall not exceed ten years.&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the Company&#x2019;s 2021 Employee Stock Purchase Plan is to assist eligible employees of the Company in acquiring a stock
ownership in the Company and to help such employees provide for their future security and to encourage them to remain in the employment
of the Company. The plan consists of a Section 423 Component and Non-Section 423 Component. The Section 423 Component is intended to
qualify as an employee stock purchase plan and also authorizes the grant of options. Options granted under the Non-Section 423 Component
shall be granted pursuant to separate offerings containing sub-plans. The Company may make one or more offerings under the plan. The
duration and timing of each offering period may be established or changed by the board, but in no event may an offering period exceed
27 months and in no event may the purchase period for the option exceed the duration of the offering period under which it is established.
On each exercise date for an offering period, each participant shall automatically be deemed to have exercised the option to purchase
the largest number of whole shares which can be purchased under the offering. Option awards are generally granted with an exercise price
equal to 85% of the lesser of the fair market value of a share on (a) the applicable grant date and (b) the applicable exercise date,
or such other price as designated by the administrator, provided that in no event shall the option price be less that the per share par
value price. The maximum number of shares granted under the plan shall not exceed 2,500,000 shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected
volatility was calculated based upon similar traded companies&#x2019; historical share price movements as adequate historical experience
is not available to provide a reasonable estimate. Expected term is calculated based on the simplified method as adequate historical
experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience
is available to provide a reasonable estimate of the expected term. The risk-free interest rate is calculated based on the yield from
U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and have no foreseeable plans
to pay dividends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has computed the fair value of all options granted during the year ended December 31, 2022 using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ztNSL32BluSd" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zaGwniah05M8" style="display: none"&gt;Schedule of assumptions used&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_301_134_zP37qo3NCmWb" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    volatility 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z5Q8Iu4ucnH8" title="Expected Volatility"&gt;109.48&lt;/span&gt;% - &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zdJpsBdwwVzl" title="Expected Volatility"&gt;113.32&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    dividends&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_z56B65SB3sea" title="Expected dividends"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    term (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zdbmgFKkfCJ6" title="Expected term (in years)"&gt;2.5&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zBce8gkxjiif" title="Expected term (in years)"&gt;5.01&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk free
    rate	&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2wORi2sMc9" title="Risk free rate"&gt;2.83&lt;/span&gt;% &#x2013; &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z9fLngVTHOxa" title="Risk free rate"&gt;3.01&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has computed the fair value of the 245,500 options granted during the nine months ended September 30, 2023 using the following
assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expected
    volatility 	&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zcwAmmtAG005" title="Expected volatility"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expected
    dividends&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20230101__20230930_zwaiTZw8rcu8" title="Expected dividends"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expected
    term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_znnUS4AW0cO3" title="Term"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Risk
    free rate	&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230101__20230930_zje8AmlukpNa" title="Risk free rate"&gt;4.33&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A4_zGDKPfmcidVc" style="margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following table
summarizes the Company&#x2019;s stock option activity under the 2021 Incentive Plan:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z34PqlRSQKW3" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zPfQrUvEmeP2" style="display: none"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zZo1xjomvR11" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 53%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(in thousands
    except number of options and per options data)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average exercise price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average remaining contractual term (in years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    intrinsic value (1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zV1RbkHg5RKc" style="text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zqQTWpASTkz3" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_c20230101__20230930_zoIxiPNl1wAa" style="text-align: right" title="Weighted average remaining contractual term (in years)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.76&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_hus-gaap--AwardTypeAxis__us-gaap--OptionMember_zf1LTcykw98i" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;245,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zc7l5pLlrkOi" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.92&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zmtib1YqEBZ6" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,075,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zEJqQXdp4z4j" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.77&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_c20230101__20230930_zyNJ9fklntAh" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zZSCUdyZAHgd" style="border-bottom: black 1pt solid; text-align: right" title="Outstanding at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;567,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zL0TfMxpgLk7" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zuYL48xG3eph" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_c20230101__20230930_zDxeoYCBytaf" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.51&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_z0zO4r5djEx3" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;567,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;(1)&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The aggregate intrinsic
    value of options outstanding and options exercisable at beginning of period is $0, as all options are out of the money.&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zm0IKKHLQUz9" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;



&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the three months ended
September 30, 2023 and 2022, the weighted-average grant-date fair value of the options granted to employees and non-employees was $998,924
and $1,847,193, respectively. Unrecognized compensation expense related to employees was $234,737 as of September 30, 2023. The options
granted in May 2022 were vested 100% at time of grant. The options granted in August 2023 began to vest in equal quarterly installments
beginning September 30, 2023 and ending June 30, 2026.&lt;/p&gt;
&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following table
summarizes the Company&#x2019;s restricted stock unit (&#x201c;RSU&#x201d;) activity under the 2021 Incentive Plan:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zSsS8b617s7b" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"&gt;&lt;span id="xdx_8B2_zy8whRJJDSZe" style="display: none"&gt;Share-Based
Payment Arrangement, Restricted Stock Unit, Activity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_134_zUJ6sN1EO8pe" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 68%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(in thousands
    except number of options and per options data)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of restricted stock awards&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average grant-date fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nonvested at beginning of year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZ2PPCLrj7d" style="text-align: right" title="Numbers of Shares beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1846"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6YprpuKHP6k" style="text-align: right" title="Begining balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1848"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKzVANoGVwK9" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSyN7aXs5ARe" style="text-align: right" title="Weighted avergare granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;239,998&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nonvested at end of year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6xOLtHw31rg" style="border-bottom: black 1pt solid; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUhwOgnif0R5" style="border-bottom: black 1pt solid; text-align: right" title="Weigthed Average Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;239,998&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zZrbcU0QBAv3" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
was $0.2 million of total unrecognized compensation cost related to non-vested RSUs that are expected to be recognized over a period
of up to 0.70 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Common Stock Reserved
for Future Issuance &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of common stock shares reserved for future issuance as of September 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_zXiJted72Hya" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_z2xjurY2BhMc" style="display: none"&gt;Schedule of common stock shares reserved for future issuance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_305_134_zvYcYYRcQA6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20230930_z1XzTdBLhml2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zD7IQnOKj873" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 71%; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of warrants 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;772,830&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zO8rm0iRvH5d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of options unrelated to any Plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zI24wLcLgZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of stock options &#x2013; 2021 Incentive Award Plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,075,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzFie7Js2KOa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of restricted stock units &#x2013; 2021 Incentive Award Plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCiODbzqpC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    shares of common stock reserved for future issuances	&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,926,610&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_z1gwMGplld3k" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-19518">&lt;p id="xdx_89D_ecustom--ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock_zdD8GKq3aiYa" style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_8B7_zm75MT70gd62" style="display: none"&gt;Schedule of various warrants/options issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_301_134_zABaZfFVn2lh" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 47%; text-align: center"&gt;&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number
                                               of warrants/non-plan options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;/td&gt;
    &lt;td style="width: 23%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 30%; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average Remaining
    Life (Yrs)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfWarrantsnonplanOptionsOne_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zKbapBLbOX7e" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zZsB6XKMCa3b" style="border-top: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$5.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePricesMember_zKne3ypdaBk9"&gt;1.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_984_ecustom--NumberOfWarrantsnonplanOptionsTwo_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zo9CS0bUS2lb" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;521,825&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zCTh5SGjeYje" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$3.32 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1Member_zBp8z7jLCqMi"&gt;8.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98C_ecustom--NumberOfWarrantsnonplanOptionsThree_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zTzqyoS76RNe" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;78,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zt1ripov30J3" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$2.90 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2Member_zclT3p4JMwBe"&gt;1.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_985_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_z7B1Ksldnlf" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zah7kwM60dXh" style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$3.32 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3Member_zW8SCQXV7SH7"&gt;1.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_981_ecustom--NumberOfWarrantsnonplanOptionsFour_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_zcMZ6goDaZC6" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;148,005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice5Member_z6UiFSsNAFFe" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;$9.10
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4Member_zgg7PK4bJNLd"&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</XPON:ScheduleOfVariousWarrantsOptionsIssuedAndOutstandingTableTextBlock>
    <XPON:NumberOfWarrantsnonplanOptionsOne
      contextRef="AsOf2023-09-30_custom_ExercisePrice1Member"
      decimals="INF"
      id="ixv-23836"
      unitRef="Shares">25000</XPON:NumberOfWarrantsnonplanOptionsOne>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_ExercisePrice1Member"
      decimals="INF"
      id="ixv-23837"
      unitRef="USDPShares">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2023-01-012023-09-30_custom_ExercisePricesMember"
      id="ixv-23838">P1Y10M9D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <XPON:NumberOfWarrantsnonplanOptionsTwo
      contextRef="AsOf2023-09-30_custom_ExercisePrice2Member"
      decimals="INF"
      id="ixv-23839"
      unitRef="Shares">521825</XPON:NumberOfWarrantsnonplanOptionsTwo>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_ExercisePrice2Member"
      decimals="INF"
      id="ixv-23840"
      unitRef="USDPShares">3.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2023-01-012023-09-30_custom_ExercisePrice1Member"
      id="ixv-23841">P8Y1M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <XPON:NumberOfWarrantsnonplanOptionsThree
      contextRef="AsOf2023-09-30_custom_ExercisePrice3Member"
      decimals="INF"
      id="ixv-23842"
      unitRef="Shares">78000</XPON:NumberOfWarrantsnonplanOptionsThree>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_ExercisePrice3Member"
      decimals="INF"
      id="ixv-23843"
      unitRef="USDPShares">2.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2023-01-012023-09-30_custom_ExercisePrice2Member"
      id="ixv-23844">P1Y1M9D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <XPON:NumberOfWarrantsnonplanOptionsFour
      contextRef="AsOf2023-09-30_custom_ExercisePrice4Member"
      decimals="INF"
      id="ixv-23845"
      unitRef="Shares">30000</XPON:NumberOfWarrantsnonplanOptionsFour>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_ExercisePrice4Member"
      decimals="INF"
      id="ixv-23846"
      unitRef="USDPShares">3.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2023-01-012023-09-30_custom_ExercisePrice3Member"
      id="ixv-23847">P1Y1M9D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <XPON:NumberOfWarrantsnonplanOptionsFour
      contextRef="AsOf2023-09-30_custom_ExercisePrice5Member"
      decimals="INF"
      id="ixv-23848"
      unitRef="Shares">148005</XPON:NumberOfWarrantsnonplanOptionsFour>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_ExercisePrice5Member"
      decimals="INF"
      id="ixv-23849"
      unitRef="USDPShares">9.10</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="From2023-01-012023-09-30_custom_ExercisePrice4Member"
      id="ixv-23850">P3Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-19630">&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ztNSL32BluSd" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zaGwniah05M8" style="display: none"&gt;Schedule of assumptions used&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_301_134_zP37qo3NCmWb" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    volatility 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z5Q8Iu4ucnH8" title="Expected Volatility"&gt;109.48&lt;/span&gt;% - &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zdJpsBdwwVzl" title="Expected Volatility"&gt;113.32&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    dividends&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20220101__20221231_z56B65SB3sea" title="Expected dividends"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    term (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zdbmgFKkfCJ6" title="Expected term (in years)"&gt;2.5&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zBce8gkxjiif" title="Expected term (in years)"&gt;5.01&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk free
    rate	&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2wORi2sMc9" title="Risk free rate"&gt;2.83&lt;/span&gt;% &#x2013; &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z9fLngVTHOxa" title="Risk free rate"&gt;3.01&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-indent: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has computed the fair value of the 245,500 options granted during the nine months ended September 30, 2023 using the following
assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expected
    volatility 	&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zcwAmmtAG005" title="Expected volatility"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expected
    dividends&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_uPure_c20230101__20230930_zwaiTZw8rcu8" title="Expected dividends"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Expected
    term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_znnUS4AW0cO3" title="Term"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 6pt; padding-left: 12pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Risk
    free rate	&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230101__20230930_zje8AmlukpNa" title="Risk free rate"&gt;4.33&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      decimals="INF"
      id="ixv-23851"
      unitRef="Pure">1.0948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      decimals="INF"
      id="ixv-23852"
      unitRef="Pure">1.1332</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="ixv-23853"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      id="ixv-23854">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      id="ixv-23855">P5Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      decimals="INF"
      id="ixv-23856"
      unitRef="Pure">0.0283</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      decimals="INF"
      id="ixv-23857"
      unitRef="Pure">0.0301</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-01-012023-09-30_srt_MinimumMember"
      decimals="INF"
      id="ixv-23858"
      unitRef="Pure">1.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-01to2023-09-30"
      decimals="INF"
      id="ixv-23859"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-09-30_srt_MinimumMember"
      id="ixv-23860">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-01to2023-09-30"
      decimals="INF"
      id="ixv-23861"
      unitRef="Pure">0.0433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-19736">&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z34PqlRSQKW3" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zPfQrUvEmeP2" style="display: none"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30A_134_zZo1xjomvR11" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 53%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(in thousands
    except number of options and per options data)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average exercise price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average remaining contractual term (in years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    intrinsic value (1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zV1RbkHg5RKc" style="text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zqQTWpASTkz3" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone_c20230101__20230930_zoIxiPNl1wAa" style="text-align: right" title="Weighted average remaining contractual term (in years)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.76&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_hus-gaap--AwardTypeAxis__us-gaap--OptionMember_zf1LTcykw98i" style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;245,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zc7l5pLlrkOi" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.92&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zmtib1YqEBZ6" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,075,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zEJqQXdp4z4j" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.77&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo_c20230101__20230930_zyNJ9fklntAh" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zZSCUdyZAHgd" style="border-bottom: black 1pt solid; text-align: right" title="Outstanding at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;567,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zL0TfMxpgLk7" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;829,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zuYL48xG3eph" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_c20230101__20230930_zDxeoYCBytaf" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.51&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--OptionMember_z0zO4r5djEx3" style="border-bottom: black 1pt solid; text-align: right" title="Exercisable at end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;567,595&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;(1)&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The aggregate intrinsic
    value of options outstanding and options exercisable at beginning of period is $0, as all options are out of the money.&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2022-12-31_us-gaap_OptionMember"
      decimals="INF"
      id="ixv-23862"
      unitRef="Shares">829500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-12-31_us-gaap_OptionMember"
      decimals="INF"
      id="ixv-23863"
      unitRef="USDPShares">3.43</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone contextRef="From2023-01-01to2023-09-30" id="ixv-23864">8.76</XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermone>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-09-30_us-gaap_OptionMember"
      decimals="INF"
      id="ixv-23865"
      unitRef="USDPShares">4.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-09-30_us-gaap_OptionMember"
      decimals="INF"
      id="ixv-23866"
      unitRef="Shares">1075000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-09-30_us-gaap_OptionMember"
      decimals="INF"
      id="ixv-23867"
      unitRef="USDPShares">3.77</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo contextRef="From2023-01-01to2023-09-30" id="ixv-23868">9.02</XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-09-30_us-gaap_OptionMember"
      decimals="0"
      id="ixv-23869"
      unitRef="USD">567595</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther
      contextRef="From2023-01-012023-09-30_us-gaap_OptionMember"
      decimals="INF"
      id="ixv-23870"
      unitRef="Shares">829500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2023-09-30_us-gaap_OptionMember"
      decimals="INF"
      id="ixv-23871"
      unitRef="USDPShares">3.43</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree contextRef="From2023-01-01to2023-09-30" id="ixv-23872">7.51</XPON:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-09-30_us-gaap_OptionMember"
      decimals="0"
      id="ixv-23873"
      unitRef="USD">567595</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-20010">&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zSsS8b617s7b" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"&gt;&lt;span id="xdx_8B2_zy8whRJJDSZe" style="display: none"&gt;Share-Based
Payment Arrangement, Restricted Stock Unit, Activity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_307_134_zUJ6sN1EO8pe" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 68%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(in thousands
    except number of options and per options data)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of restricted stock awards&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    average grant-date fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nonvested at beginning of year&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZ2PPCLrj7d" style="text-align: right" title="Numbers of Shares beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1846"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6YprpuKHP6k" style="text-align: right" title="Begining balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1848"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKzVANoGVwK9" style="text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSyN7aXs5ARe" style="text-align: right" title="Weighted avergare granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;239,998&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nonvested at end of year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6xOLtHw31rg" style="border-bottom: black 1pt solid; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUhwOgnif0R5" style="border-bottom: black 1pt solid; text-align: right" title="Weigthed Average Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;239,998&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="ixv-23874"
      unitRef="Shares">48780</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="ixv-23875"
      unitRef="USDPShares">239998</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="ixv-23876"
      unitRef="Shares">48780</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="ixv-23877"
      unitRef="USDPShares">239998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-20162">&lt;p id="xdx_895_ecustom--ScheduleOfCommonStockReservedForIssuanceTableTextBlock_zXiJted72Hya" style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_z2xjurY2BhMc" style="display: none"&gt;Schedule of common stock shares reserved for future issuance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_305_134_zvYcYYRcQA6j" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders Equity (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20230930_z1XzTdBLhml2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zD7IQnOKj873" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 71%; padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of warrants 	&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 17%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;772,830&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--UnrelatedToAnyPlanMember_zO8rm0iRvH5d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of options unrelated to any Plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__custom--StockOptionsMember_zI24wLcLgZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of stock options &#x2013; 2021 Incentive Award Plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,075,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzFie7Js2KOa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    of restricted stock units &#x2013; 2021 Incentive Award Plan&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;48,780&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_zCiODbzqpC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 12pt; text-indent: 6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    shares of common stock reserved for future issuances	&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,926,610&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</XPON:ScheduleOfCommonStockReservedForIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="ixv-23878"
      unitRef="Shares">772830</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2023-09-30_custom_UnrelatedToAnyPlanMember"
      decimals="INF"
      id="ixv-23879"
      unitRef="Shares">30000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2023-09-30_custom_StockOptionsMember"
      decimals="INF"
      id="ixv-23880"
      unitRef="Shares">1075000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2023-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="ixv-23881"
      unitRef="Shares">48780</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="ixv-23882"
      unitRef="Shares">1926610</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-20230">&lt;p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zvouYfSEF9I8" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.
&lt;span id="xdx_82B_zqfAlZ9QMkz1"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The Company
has incurred losses and consequently recorded no provision beyond the minimum or base tax rate for state or federal income taxes
for the three or nine months ended September 30, 2023. The Company maintains a full valuation allowance on all deferred tax assets,
as it has concluded that it is more likely than not that these assets will not be realized. As of September 30, 2023 and December
31, 2022, there were no material unrecognized tax benefits included in the accompanying balance sheets that would, if recognized,
affect the effective tax rate. For the three months ended September 30, 2023, the Company accrued $1,380 for 2023 state income
taxes, and for the three months ended September 30, 2022, the Company accrued and incurred state taxes of $0. For the nine months
ended September 30, 2023, the Company has net state tax expenses totaling $1,341 due to a small refund, and for the nine months
ended September 30, 2022, the Company incurred state taxes of $300.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-20241">&lt;p id="xdx_807_eus-gaap--DefinedBenefitPlanTextBlock_zlmh7pA5Dh5a" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.
&lt;span id="xdx_824_zpMSTJRrlFgf"&gt;401(k) Plan&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted a 401(k) Plan (&#x201c;Plan&#x201d;) for the benefit of its employees. Employees may contribute to the Plan within defined
limits as defined by the Internal Revenue Service. Substantially all employees are eligible to participate. The Company has the option
to make profit sharing contributions at its discretion. No profit-sharing contributions have been made.&lt;/span&gt;&lt;/p&gt;




&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DefinedBenefitPlanTextBlock>
    <XPON:RelatedPartyTransactionsTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-20256">&lt;p id="xdx_80E_ecustom--RelatedPartyTransactionsTextBlock_zzeHvqrLrxA1" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.
&lt;span id="xdx_826_zJqmuZUbBwFh"&gt;Related Party Transactions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2023 and December 31, 2022, related party transactions consisted of Stockholder Promissory Notes (see Note 8 &#x2013;
Stockholder Promissory Notes in Item 1 &#x2013; Financial Statements of Part I &#x2013; Financial Information).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</XPON:RelatedPartyTransactionsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-01-01to2023-09-30" id="ixv-20266">&lt;p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_z23DddUT4Y6i" style="margin: 2pt 0 0; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.
&lt;span id="xdx_827_zcz1LV9zih3i"&gt;Subsequent Events&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
date to which events occurring after September 30, 2023, the date of the most recent Balance Sheets, have been evaluated for possible
adjustment to the financial statements or disclosures is November 7, 2023, which is the date the financial statements were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 27.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 13, 2023, the Company held its Annual Meeting of Stockholders (the &#x201c;Annual Meeting&#x201d;) during which the Company&#x2019;s
stockholders approved an amendment to the Company&#x2019;s 2021 Incentive Award Plan to increase by 250,000 the number of shares of Common
Stock authorized for issuance under the plan. The Company filed an 8-K related to the results of the Annual Meeting on October 16, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 12, 2023, the Company filed an 8-K related to a published press release introducing a pilot program to offer transformative solar
and energy storage solutions in partnership with REPM Corp.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;img alt="Icon

Description automatically generated" src="image_001.jpg" style="height: 84px; width: 80px"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Expion360 Inc.&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Up to 1,781,978 Shares of Common Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;PROSPECTUS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;The date of this prospectus is January 31,
2024&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;PART&#160;II&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;INFORMATION NOT REQUIRED IN PROSPECTUS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table sets forth the various expenses
to be incurred in connection with the sale and distribution of the Shares being registered hereby, all of which will be borne by us (except
any underwriting discounts and commissions and expenses incurred for brokerage, accounting, tax or legal services or any other expenses
incurred in disposing of the shares). All amounts shown are estimates except the SEC registration fee.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SEC
Filing Fee&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,146.77&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounting
Fees and Expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Legal
Fees and Expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;80,000&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Miscellaneous&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;94,646.77&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Nevada Revised Statutes (&#x201c;NRS&#x201d;) 78.138(7)
provides that, subject to limited statutory exceptions and unless the articles of incorporation or an amendment thereto (in each case
filed on or after October 1, 2003) provide for greater individual liability, a director or officer is not individually liable to a corporation
or its stockholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director or officer
unless it is proven that: (i) the act or failure to act constituted a breach of his or her fiduciary duties as a director or officer and
(ii) the breach of those duties involved intentional misconduct, fraud or a knowing violation of law.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;NRS 78.7502(1) provides that a corporation may indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of the
fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses,
including attorneys&#x2019; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection
with the action, suit or proceeding if the person (i) is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner
which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe the conduct was unlawful. NRS 78.7502(2) provides that a corporation may indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the
right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee
or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys&#x2019;
fees actually and reasonably incurred by the person in connection with the defense or settlement of the action or suit if the person (a)
is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed
to the best interests of the corporation. To the extent that a director, officer, employee or agent of a corporation has been successful
on the merits or otherwise in defense of any such action, suit or proceeding, or in defense of any claim, issue or matter therein, the
corporation shall indemnify him or her against expenses, including attorneys&#x2019; fees, actually and reasonably incurred by him or her
in connection with the defense. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a
plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to NRS 78.138
or did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the
corporation, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was
unlawful. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent
jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation,
unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines
upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such
expenses as the court deems proper.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;NRS 78.751(1) provides that any discretionary indemnification
pursuant to NRS 78.7502 (unless ordered by a court or advanced pursuant to NRS 78.751(2)), may be made by the corporation only as authorized
in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances.
The determination must be made (i) by the stockholders; (ii) by the board of directors by majority vote of a quorum consisting of directors
who were not parties to the action, suit or proceeding; (iii) if a majority vote of a quorum consisting of directors who were not parties
to the action, suit or proceeding so orders, by independent legal counsel in a written opinion; or (iv) if a quorum consisting of directors
who were not parties to the action, suit or proceeding cannot be obtained, by independent legal counsel in a written opinion. NRS 78.751(2)
provides that the corporation&#x2019;s articles of incorporation or bylaws, or an agreement made by the corporation, may provide that the
expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding must be paid by the corporation
as they are incurred and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on
behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that the director
or officer is not entitled to be indemnified by the corporation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the NRS, the indemnification pursuant to NRS
78.7502 and advancement of expenses authorized in or ordered by a court pursuant to NRS 78.751:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Does not exclude any other
rights to which a person seeking indemnification or advancement of expenses may be entitled under the articles of incorporation or any
bylaw, agreement, vote of stockholders or disinterested directors or otherwise, for either an action in the person&#x2019;s official capacity
or an action in another capacity while holding office, except that indemnification, unless ordered by a court pursuant to NRS 78.7502
or for the advancement of expenses made pursuant to NRS 78.751(2), may not be made to or on behalf of any director or officer if a final
adjudication establishes that the director&#x2019;s or officer&#x2019;s acts or omissions involved intentional misconduct, fraud or a knowing
violation of the law and was material to the cause of action; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 27pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Continues for a person who
has ceased to be a director, officer, employee or agent and inures to the benefit of the heirs, executors and administrators of such
a person.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A right to indemnification or to advancement of expenses
arising under a provision of the articles of incorporation or any bylaw is not eliminated or impaired by an amendment to such provision
after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or
proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission
explicitly authorizes such elimination or impairment after such action or omission has occurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Articles of Incorporation of the Company provide
that to the fullest extent permitted under the NRS (including, without limitation, to the fullest extent permitted under NRS 78.7502 and
78.751(3)) and other applicable law, we shall indemnify our directors and officers in their respective capacities as such and in any and
all other capacities in which any of them serves at our request. The Articles of Incorporation further provide that the liability of its
directors and officers shall be eliminated or limited to the fullest extent permitted by the NRS, and that if the NRS are amended to further
eliminate or limit or authorize corporate action to further eliminate or limit the liability of directors or officers, the liability of
our directors and officers shall be eliminated or limited to the fullest extent permitted by the NRS, as so amended from time to time;
and in addition to any other rights of indemnification permitted by the laws of the State of Nevada or as may be provided for by in our
Bylaws or by agreement, the expenses of directors and officers incurred in defending a civil or criminal action, suit or proceeding, involving
alleged acts or omissions of such director or officer in his or her capacity as a director or officer of the Company, must be paid, by
us or through insurance purchased and maintained by the Company or through other financial arrangements made by us, as they are incurred
and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director
or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that he or she is not entitled to be
indemnified by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further, we have entered into indemnification arrangements
with each of its directors and executive officers that may be broader than the specific indemnification provisions contained in the NRS.
Such arrangements may require us, among other things, to advance expenses and otherwise indemnify its executive officers and directors
against certain liabilities that may arise by reason of their status or service as executive officers or directors, to the fullest extent
permitted by law. We intend to enter into indemnification arrangements with any new directors and executive officers in the future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We also have director and officer insurance&#160;providing
for indemnification for our directors and officers for certain liabilities, and such insurance provides for indemnification of our directors
and officers for liabilities under the&#160;Securities Act.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES
&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following sets forth information regarding
all unregistered securities sold by the Registrant since January 1, 2019. Each of the issuances was exclusively to &#x201c;accredited
investors&#x201d; as defined in&#160;Regulation D&#160;under the&#160;Securities Act&#160;and in reliance on the exemptions available
pursuant to&#160;Regulation D&#160;under, and Section 4(a)(2) of, the&#160;Securities Act). &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In August and October 2020,
we received proceeds totaling $270,000 from the issuance of four Convertible Notes (&#x201c;2020 Notes&#x201d;). The 2020 Notes accrue
monthly interest at 6% per annum and include two options for conversion: (1) automatic conversion of the principal balance and accrued
interest into new financing securities issued in a new financing round of at least $1.0 million, not including the 2020 Notes &#x2014;
the conversion price will be equal to 85% of the price per unit at which the investor in the new financing purchased their equity securities;
(2) optional conversion in founder securities if (a) the Company gives the investor notice of its intent to prepay its 2020 Note, or
(b) the Company has not consummated a new financing prior to maturity. The conversion price is equal to $17.0 million divided by the
number of founder securities outstanding at the date of the 2020 Notes (100,000 units), or $170.00 per unit. The 2020 Notes mature three
years from date of issue. The outstanding balance at December 31, 2020, was $273,157, including accrued interest of $3,157, which was
recognized as interest expense during 2020.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In late 2020, all convertible
debt holders were offered the opportunity for early conversion of their convertible notes into Class B member units effective January
1, 2021. Three of the four convertible note holders converted notes with a principal balance of $170,000 and accrued interest of $3,157
into 2,338 Class B member units at per unit conversion prices ranging from $67.00 - $76.00. In accordance with FASB&#160;ASC 470-20,&#160;&lt;i&gt;Debt
with Conversion and Other Options&lt;/i&gt;, the fair value of the additional units issued under the induced conversion over the value of the
number of units issuable under the original terms of the convertible note agreements is recognized as debt conversion expense. Accordingly,
upon early conversion on January 1, 2021, the Company recognized $112,133 of debt conversion expense with a corresponding entry to members&#x2019;
deficit of $285,290 consisting of the $173,157 of principal and interest converted and the excess fair value of $112,133. The fourth
convertible note holder opted out of the early conversion and instead, the original note was modified into a term loan effective January
1, 2021. The modification included the elimination of the conversion feature, an increase in the interest rate from the original 6% per
annum to 10% per annum, to be paid monthly instead of accrued, and an earlier maturity date of December 31, 2021. The modification resulted
in a new effective annual interest rate of 9.58%, and a revised one-year maturity on December 31, 2021. The modification resulted in
less than a 10% difference in the present values of cash flows of the original note compared to the modified note. Accordingly, there
was no accounting changes related to these modifications.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On January 1, 2021, we issued
2,338 Class B member units upon the conversion of convertible notes and accrued interest totaling $173,157.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On January 1, 2021, we issued
262 Class B membership units in exchange for building signage valued at $20,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In March and April 2021, we
sold 6,157 of Class B membership units to three new members for gross proceeds of $522,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May 15, 2021, we modified
a Promissory Note Agreement in the amount of $250,000 to be a convertible note for the same amount with detachable warrants to purchase
548,000 shares of Common Stock. The modification resulted in a new effective annual interest rate of 9.15%. The modification resulted
in less than a 10% difference in the present values of cash flows of the original note compared to the modified note. Accordingly, there
was no accounting changes related to these modifications. The convertible note was issued under the same terms and conditions as the
convertible notes issued to third-party investors and therefore, in substance, was not a capital transaction. Effective November 1, 2021,
all terms under the convertible note, including the warrants, were rescinded and the member agreed to convert the note at a conversion
price of $1.21 per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            October 29, 2021, in anticipation of conversion from LLC to a C corporation, the Notes and
                                            Warrants were modified under Convertible Debenture Exercise and Waiver and Release Agreements
                                            with the individual creditors. The Note holders agreed to settle the debt for an aggregate
                                            1,527,647 shares of common stock with a fair value of $5,545,359 ($3.63 per share). Since
                                            this transaction involved contemporaneous issuance of shares of common stock by the Company
                                            to the Note holders, we evaluated the transaction for modification and extinguishment accounting
                                            and determined that the debt was extinguished as a result of the issuance of shares that
                                            do not represent the exercise of a conversion right contained in the original terms of the
                                            Notes at issuance.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In November 2021, we issued
30,000 shares of Common Stock in exchange for legal services.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In November 2021, we issued
482,268 detachable warrants with secured promissory notes for the purchase of Common Stock. The relative fair value of the warrants of
$809,806 at the time of issuance was recorded as additional paid-in capital with a corresponding debt discount reducing the carrying
value of the notes. Additionally, we issued 77,163 warrants to purchase shares of Common Stock to underwriters in connection with obtaining
the notes. The fair value of the warrants of $262,354 was recorded as additional paid-in capital and reduced the carrying value of the
notes. The warrants are exercisable at $3.32 per share for a period of ten years from date of grant. The fair value of the warrants was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $3.63, expected dividend yield of 0%, expected volatility of 110.8%, risk-free interest rate of 1.63% and expected
life based on contractual life of 10 years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Also in November 2021, we issued
warrants to purchase 151,000 shares of Common Stock in exchange for prior services related to extinguished 2021 convertible notes and
30,000 options for the purchase of common stock in exchange for legal services. The warrants are exercisable at $2.90 per share for a
period of three years from the date of grant. The options are exercisable at $3.32 per share for a period of three years from the date
of grant. The options issued were not issued under the Company&#x2019;s stock option plans. The fair value of the warrants of $407,700
was recorded as additional paid-in-capital and expensed to extinguishment loss on debt settlement. The fair value of the options of $79,200
was recorded as additional paid-in capital with a corresponding charge to legal expense. The fair value of the warrants and options was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $3.63, expected dividend yield of 0%, expected volatility of 122.7%, risk-free interest rate of 0.71% and expected
life based on contractual life of three years.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On November 22, 2021, we completed
a private placement (the &#x201c;Secured Note Financing&#x201d;). In connection therewith, we issued an aggregate of $1,600,000 of 15%
senior secured notes (the &#x201c;Senior Secured Notes&#x201d;) and warrants to purchase an aggregate of 559,431 shares of common stock
at an exercise price of $3.32 per share (the &#x201c;Warrants Senior Secured Notes&#x201d;). After deducting offering related expenses,
including legal fees of $15,000 and certain diligence and advisory fees of $200,000 paid to an entity owned by the spouse of an employee
of the underwriter, the net proceeds to us were approximately $1,385,000. Out of the total warrants, warrants to purchase 28,935 shares
of our common stock were issued to the same entity owned by the spouse of an employee of the underwriter that received the advisory fee.
The maturity date of the Senior Secured Notes is the earlier of (i) May 15, 2023, (ii) the closing a Qualified Subsequent Equity Financing
and (iii) the closing of a Change of Control. The Senior Secured Notes bear interest at a rate of 15% per annum of which (i) 10% accrues
from the Closing Date and is paid to holder within 10 days after the first day of each month and (ii) 5% accrues and compound annually
and payable in arrears on the Maturity Date. The Senior Secured Notes are general secured obligations as set forth in a security agreement
between us and the noteholders. The Warrants are exercisable for a period of 10-years from the date of issuance and may be exercised
via cashless exercise/net exercise provisions contained in the Warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(12)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December
31, 2021, we received gross proceeds of $2,929,000 from the issuance of unsecured convertible notes, of which $44,000 was received from
existing members/shareholders. Additionally, a member/shareholder converted a promissory note to a convertible note identical in terms
discussed below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(13)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On April 1, 2022, we issued
warrants to IPO underwriters to purchase 148,005 shares of Common Stock at an exercise price of $9.10 per share. The warrants are exercisable
180 days after grant (September 27, 2022) and expire five years from date of grant (March 31, 2027). The fair value of the warrants was
determined at date of issuance using the Black-Scholes option-pricing model and the following assumptions: per share price of common
stock on date of grant of $7, expected dividend yield of 0%, expected volatility of 110.03%, risk-free interest rate of 2.55% and expected
life based on contractual life of 5 years. The fair value of $916,238 was recorded as an increase in additional-paid-in capital and a
reduction to additional paid-in capital since the warrants were issued as IPO fees to underwriters, resulting in a zero impact to additional
paid-in capital.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In March 2023, holders of 73,000
warrants we previously issued on November 9, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities
Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) with an exercise price of $2.90 exercised their warrants on a cashless basis,
which resulted in the issuance of an additional 31,102 shares of Common Stock. During the same period, holders of 15,000 warrants previously
issued by the Company on November 22, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities
Act with an exercise price of $3.32 exercised their warrants by paying the exercise price, which resulted in the issuance of an additional
15,000 shares of common stock and the receipt by the Company of $49,800.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(15)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 31, 2023, at the closing
price of $4.84 per share, the Company issued 52,000 shares of Common Stock in reliance on the exemption from registration pursuant to
Section 4(a)(2) of the Securities Act as part of the settlement agreement with Ravi Sinha dated March 21, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(16)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In April 2023, holders of 22,606
warrants previously issued by the Company on November 22, 2021 in reliance on the exemption from registration pursuant to Section 4(a)(2)
of the Securities Act with an exercise price of $3.32 exercised their warrants on a cashless basis, which resulted in the issuance of
an additional 10,151 shares of Common Stock.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(17)&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On August 10, 2023, we issued
25,000 warrants to our investor relations firm in accordance with a letter of engagement signed July 22, 2022, as partial compensation
for services provided by the investor relations firm. The warrants were issued in reliance on the exemption from registration pursuant
to Section 4(a)(2) of the Securities Act. The warrants are fully vested and exercisable with an expiration date two years from date of
issue (August 9, 2025) and are exercisable at a price of $5.00 per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;ITEM 16. EXHIBIT&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;See the Exhibit Index immediately
preceding the signature page hereto for a list of exhibits filed as part of this Registration Statement on Form&#160;S-1,&#160;which Exhibit
Index is incorporated herein by reference.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
Statement Schedules.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;All other schedules have
been omitted because the information required to be set forth therein is not applicable or is shown in the consolidated financial statements
or related notes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;ITEM 17. UNDERTAKINGS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The undersigned registrant
hereby undertakes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
include any prospectus required by Section&#160;10(a)(3)&#160;of the Securities Act;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration
Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b)&#160;if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#x201c;Calculation of Filing Fee&#x201d;
table in the effective Registration Statement; and&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any
material change to such information in the Registration Statement;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;provided, however, &lt;/i&gt;that paragraphs (a)(1)(i),
(a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act
that are incorporated by reference in the Registration Statement, or is contained in a form of prospectus filed pursuant to Rule 424(b)
that is part of the Registration Statement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining any liability under the Securities Act, each such post- effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of this Offering.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining liability under the Securities Act to any purchaser:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus filed pursuant to Rule&#160;424(b)(3)&#160;shall be deemed to be part of the Registration Statement as of the date the filed
prospectus was deemed part of and included in the Registration Statement; and&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5)&#160;or (b)(7)&#160;as part of a registration statement in reliance
on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing
the information required by Section&#160;10(a)&#160;of the Securities Act shall be deemed to be part of and included in the registration
statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of
sale of securities in this Offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and
any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the Registration Statement relating
to the securities in the Registration Statement to which that prospectus relates, and this Offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof. &lt;i&gt;Provided, however&lt;/i&gt;, that no statement made in a registration statement or
prospectus that is part of the Registration Statement or made in a document incorporated or deemed incorporated by reference into the
Registration Statement or prospectus that is part of the Registration Statement will, as to a purchaser with a time of contract of sale
prior to such effective date, supersede or modify any statement that was made in the Registration Statement or prospectus that was part
of the Registration Statement or made in any such document immediately prior to such effective date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;That,
for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the
securities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The undersigned registrant undertakes that in a primary
offering of securities of the undersigned registrant pursuant to this Registration Statement, regardless of the underwriting method used
to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications,
the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the
undersigned registrant;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant&#x2019;s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&#x2019;s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated by reference in
the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim
for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;b&gt;	EXHIBIT INDEX&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-top: 2pt"&gt;&lt;b&gt;Exhibit&lt;br/&gt;
Number&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-top: 2pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&lt;b&gt;Form&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&lt;b&gt;Exhibit&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt none; border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&lt;b&gt;Filing Date&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;3.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex3_1.htm"&gt;Articles of Incorporation of the Company, effective as of November 4, 2021&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;3.2&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex3_2.htm"&gt;Bylaws of the Company currently in effect&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3.2&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;4.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_1.htm"&gt;Form of the Company&#x2019;s common stock certificate&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;4.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;4.2&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_4.htm"&gt;Form of Representative&#x2019;s Warrant&lt;/a&gt; &lt;span style="color: blue"&gt;&lt;span style="text-decoration: underline"&gt;Agreement&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;4.4&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;4.3&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex4_5.htm"&gt;Form of Senior Secured Promissory Note issued to bridge loan investors&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;4.5&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;4.4&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/ex10_15.htm"&gt;Form of Warrant with an Exercise Price of $2.90&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.12&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/30/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;4.5&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/ex10_16.htm"&gt;Form of Warrant with an Exercise Price of $3.32&#160;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.13&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/30/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;5.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="ex_5-1.htm"&gt;&lt;span style="background-color: white"&gt;Opinion of Stradling Yocca Carlson &amp;amp; Rauth LLP&lt;/span&gt;&#160;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_1.htm"&gt;Form of common stock warrant issued to Selling Stockholders&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.2&#x2020; &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_2.htm"&gt;Expion360 Inc. 2021 Incentive Award Plan&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.2&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.3&#x2020; &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_3.htm"&gt;Expion360 Inc. 2021 Employee Stock Purchase Plan&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.3&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.4&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_7.htm"&gt;Form of Security Agreement issued to bridge loan investors&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.7&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.5&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_8.htm"&gt;Commercial Lease of premises at 2045 SW Deerhound Avenue Redmond, OR&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.8&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.6&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex10_11.htm"&gt;Commercial Lease of premises at 1266 SW Lake Blvd., Redmond, OR&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.11&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.7&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000149/sfsxpon8k040522ex1_1.htm"&gt;Underwriting Agreement dated March 31, 2022, between the Company and Alexander Capital, LP as Representative of the Underwriters&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;8-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;1.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;4/05/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.8&#x2020;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_1.htm"&gt;Amended and Restated Employment Agreement, between John Yozamp and Expion360 Inc., dated January 26, 2023&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;8-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;2/01/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.9&#x2020;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_2.htm"&gt;&lt;span style="color: #0000EE"&gt;Amended and Restated Employment Agreement, between Brian Schaffner and Expion360 Inc., dated January 26, 2023&lt;/span&gt;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;8-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;2/01/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.10&#x2020;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_3.htm"&gt;&lt;span style="color: #0000EE"&gt;Amended and Restated Employment Agreement, between Paul Shoun and Expion360 Inc., dated January 26, 2023&lt;/span&gt;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;8-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;2/01/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.11&#x2020;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/ex10_4.htm"&gt;&lt;span style="color: #0000EE"&gt;Amended and Restated Employment Agreement, between Greg Aydelott and Expion360 Inc., dated January 26, 2023&lt;/span&gt;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;8-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;2/01/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.14*&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000983/ex10_2.htm"&gt;&lt;span style="background-color: white"&gt;Common Stock Purchase Agreement, dated December 27, 2023, between Expion360 Inc. and Tumim Stone Capital, LLC&lt;/span&gt;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;8-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.2&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;12/29/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;10.15*&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="http://www.sec.gov/Archives/edgar/data/1894954/000190359623000983/ex10_3.htm"&gt;Registration Rights Agreement, dated December 27, 2023, between Expion360 Inc. and Tumim Stone Capital, LLC&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;8-K&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;10.3&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;12/29/2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;21.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000125/f2sexpion121721s1ex21_1.htm"&gt;&lt;span style="color: #0000EE"&gt;Subsidiaries of the Company&lt;/span&gt;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;S-1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;21.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;3/31/2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;23.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="ex_23-1.htm"&gt;Consent of M&amp;amp;K CPAS PLLC&#160;&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;23.2&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="ex_5-1.htm"&gt;Consent of Stradling Yocca Carlson &amp;amp; Rauth LLP (included in Exhibit 5.1)&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;24.1&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="#p_001"&gt;Power of Attorney (reference is made to the signature page hereto)&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;101.INS&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;Inline XBRL Instance Document&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;101.SCH&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;Inline XBRL Taxonomy Extension Schema Document&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;101.CAL&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;Inline XBRL Taxonomy Extension Calculation Linkbase Document&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;101.DEF&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;Inline XBRL Taxonomy Extension Definition Linkbase Document&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;101.LAB&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;Inline XBRL Taxonomy Extension Label Linkbase Document&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;101.PRE&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;Inline XBRL Taxonomy Extension Presentation Linkbase Document&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;104&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;-&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;107&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt"&gt;&lt;a href="ex_107.htm"&gt;Filing Fee Table&lt;/a&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-top: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2020;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 90%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Indicates a management
contract or compensatory plan or arrangement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 90%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
schedules and exhibits to this agreement have been omitted pursuant to Item&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;601(a)(5)&lt;span style="background-color: white"&gt;&#160;of&#160;&lt;/span&gt;Regulation
S-K&lt;span style="background-color: white"&gt;. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;SIGNATURES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pursuant to the requirements of the Securities Act
of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the Redmond, Oregon, on this 31st day of January, 2024.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 48%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;EXPION360 INC.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;By: /s/ Brian Schaffner&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Brian Schaffner&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chief Executive Officer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Principal Executive Officer)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pursuant to the requirements of the Securities Act
of 1933, this Amendment No. 1 to Registration Statement on Form&#160;S-1 has been signed by the following persons in the
capacities and on the dates indicated.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 25%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Signature&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 55%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Title&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 18%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;/s/ Brian Schaffner&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chief Executive Officer and Director&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Brian Schaffner&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(&lt;i&gt;Principal Executive Officer&lt;/i&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;/s/ Greg Aydelott&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chief Financial Officer&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Greg Aydelott&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;(Principal Financial and Accounting Officer)&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;/s/
    *&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Director&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;George Lefevre&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;/s/
    *&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Director&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Steven M. Shum&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;/s/
    *&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Director&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Paul Shoun&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;/s/
    *&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Director&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tien Q. Nguyen&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;*By: /s/ Brian Schaffner, attorney-in-fact&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;II-11&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"&gt;&lt;div style="border-top: Black 2pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;



</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
